GLP-1 Market
LLY $1143.12 ▲ +0.0% NVO $37.54 ▲ +0.6% PFE $27.41 ▼ -1.4% VKTX $29.28 ▼ -2.2% KLRA $10.84 ▲ +4.3% GPCR $27.59 ▼ -0.3% RHHBY $52.51 ▲ +0.5%
Market data delayed up to 20 min · Source: Twelve Data
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

Estrone

Company
Khyber Medical University Peshawar
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
311 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

311 recruiting studies currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Oct 6, 2026

Find a Clinical Trial Near Me

See recruiting studies for Estrone and check eligibility with the study team.

Select conditions
Match
Treatment type

"Added to GLP-1" means the investigational treatment is being studied on top of an existing GLP-1-based therapy.

Your ZIP code is only used to calculate distance to trial sites — it isn't stored.

Trial details
  • Recruiting NCT NCT01072825

    A European Network for the Investigation of Gender Incongruence

    University Hospital, Ghent 125 participants Est. completion 2030-12-31 4 sites
    Other conditions: Physical and Psychological Evaluation of Hormonal Therapy in Transsexual Persons
    View official trial listing →
  • Recruiting NCT NCT02081924

    Reproductive Hormones During Sustained Administration of Kisspeptin

    Not yet reported Imperial College London 76 participants Est. completion 2027-11-30 1 site
    Other conditions: Fertility Disorders, Hypothalamic Dysfunction
    View official trial listing →
  • Recruiting NCT NCT02476786

    Endocrine Treatment Alone for Elderly Patients With Estrogen Receptor Positive Operable Breast Cancer and Low Recurrence Score

    Not yet reported Washington University School of Medicine 50 participants Est. completion 2032-07-31 1 site
    Other conditions: Breast Cancer, Cancer of Breast, Breast Neoplasms, Cancer of the Breast
    View official trial listing →
  • Recruiting NCT NCT02535221

    Neoadjuvant Endocrine Therapy Versus Chemotherapy in Premenopausal Patients With ER+ & HER2- Breast Cancer

    Not yet reported Peking University 234 participants Est. completion 2026-12-31 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT02819882

    A Prospective Registry Study in Patients With Unresectable Locally Advanced or Metastatic Breast Cancer (MBC)

    Spanish Breast Cancer Research Group 1867 participants Est. completion 2026-06 40 sites
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Recruiting NCT NCT03011684

    Fertility Preservation Using Tamoxifen and Letrozole in Estrogen Sensitive Tumors Trial

    Not yet reported University of California, San Francisco 309 participants Est. completion 2028-03-31 1 site
    Other conditions: Infertility
    View official trial listing →
  • Recruiting NCT NCT03299179

    The Effects of the Female Hormones on Cerebral Perfusion

    University Ghent 62 participants Est. completion 2027-12-31 1 site
    Other conditions: Cerebral Perfusion, Contraception, Menstrual Cycle
    View official trial listing →
  • Recruiting NCT NCT03401047

    Study to Assess Potential Impairments in Estradiol Augmentation of Gonadotropin Secretion in Polycystic Ovary Syndrome

    Not yet reported University of Virginia 37 participants Est. completion 2025-12-01 1 site
    Other conditions: Polycystic Ovary Syndrome
    View official trial listing →
  • Recruiting NCT NCT03424005

    A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer

    Not yet reported, Not yet reported Hoffmann-La Roche 1132 participants Est. completion 2030-09-30 53 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT03621904

    PROMOTE Study: Prediction of Response Of HorMOnal Treatment in Advanced and Recurrent Endometrial Cancer

    Radboud University Medical Center 150 participants Est. completion 2027-09-01 1 site
    Other conditions: Endometrial Cancer Stage III, Endometrial Cancer Stage IV, Endometrial Cancer Recurrent
    View official trial listing →
  • Recruiting NCT NCT03624244

    Evaluation of Clinical Impact of Interruption VS Maintenance of AI in Patients With Locally Advanced/ Metastatic Low Grade Endometrial Stromal Sarcoma (LGESS)

    Not yet reported Centre Leon Berard 40 participants Est. completion 2031-01 22 sites
    Other conditions: Low Grade Endometrial Stromal Sarcoma
    View official trial listing →
  • Recruiting NCT NCT03675893

    RESOLVE: Abemaciclib + Letrozole +/- Metformin or Gedatolisib in Endometrial Cancer

    Not yet reported Dana-Farber Cancer Institute 110 participants Est. completion 2031-08-01 3 sites Stand-alone
    Other conditions: Endometrial Cancer
    View official trial listing →
  • Recruiting NCT NCT03875378

    Transdermal Estrogen in Women With Anorexia Nervosa

    Not yet reported Pouneh K. Fazeli, MD 66 participants Est. completion 2028-12-31 1 site Stand-alone
    Obstructive sleep apnea
    View official trial listing →
  • Recruiting NCT NCT04043520

    Bioenergetic Effects of Aging and Menopause (BEAM)

    Not yet reported University of Colorado, Denver 57 participants Est. completion 2024-08-31 1 site Stand-alone
    Other conditions: Menopause, Obesity, Abdominal, Aging, Weight Gain
    View official trial listing →
  • Recruiting NCT NCT04074720

    Prospective Breast Cancer Biospecimen Collection

    Thomas Jefferson University 200 participants Est. completion 2028-07-01 1 site
    Other conditions: Breast Cancer, Invasive Breast Cancer, Carcinoma in Situ of the Breast
    View official trial listing →
  • Recruiting NCT NCT04111978

    MAintenance Therapy With Aromatase Inhibitor in Epithelial Ovarian Cancer (MATAO)

    Not yet reported Swiss GO Trial Group 540 participants Est. completion 2032-07-01 53 sites
    Other conditions: Ovarian Neoplasm Epithelial, Fallopian Tube Neoplasms, Peritoneal Neoplasms, High-grade Serous Ovarian Carcinoma (HGSOC), Low-grade Serous Ovarian Carcinoma (LGSOC), Ovarian Endometrioid Carcinoma
    View official trial listing →
  • Recruiting NCT NCT04113993

    Bazedoxifene -Treatment for Women With Schizophrenia

    Not yet reported The Alfred 160 participants Est. completion 2026-12-31 1 site
    Other conditions: Schizophrenia, Schizophreniform Disorders, Schizo Affective Disorder
    View official trial listing →
  • Recruiting NCT NCT04174352

    FES Imaging to Optimize Tamoxifen for Metastatic Breast Cancer

    Not yet reported University of Wisconsin, Madison 12 participants Est. completion 2027-12 2 sites Stand-alone
    Other conditions: ERα+ Breast Cancer, ESR1 Gene Mutation
    View official trial listing →
  • Recruiting NCT NCT04263298

    Fulvestrant Versus Capecitabine as Maintenance Therapy After First-line Chemotherapy in Patients With HR+/HER2- Metastatic Breast Cancer

    Not yet reported Herui Yao 210 participants Est. completion 2030-05-01 13 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT04288427

    5-Alpha Reductase 2 as a Marker of Resistance to 5ARI Therapy

    Not yet reported Beth Israel Deaconess Medical Center 120 participants Est. completion 2026-11-30 1 site Stand-alone
    Other conditions: Benign Prostatic Hyperplasia, Prostate Hyperplasia, Prostate Disease, Prostate Hypertrophy, Prostate Pain, Lower Urinary Tract Symptoms, Urinary Obstruction, Urinary Tract Disease
    View official trial listing →
  • Recruiting NCT NCT04312399

    Hormone Replacement Trial Against ALzheimers' Disease

    Not yet reported University Hospital, Ghent 600 participants Est. completion 2028-12-31 1 site
    Other conditions: Postmenopausal Symptoms, Alzheimer Disease
    View official trial listing →
  • Recruiting NCT NCT04356664

    Benefit of GnRH Agonist Before Frozen Embryo Transfer in Patients With Endometriosis and/or Adenomyosis

    Not yet reported, Not yet reported Hopital Foch 180 participants Est. completion 2026-06-18 1 site
    Other conditions: Endometriosis, Adenomyosis, Infertility, Female
    View official trial listing →
  • Recruiting NCT NCT04439370

    Autonomic Regulation of Blood Pressure in Premature and Early Menopausal Women

    University of Minnesota 160 participants Est. completion 2026-12-30 1 site
    Other conditions: Hypertension, Menopause, Premature, Menopause, Blood Pressure
    View official trial listing →
  • Recruiting NCT NCT04476485

    Sj-subway, a Predictor for the Recurrence of High-risk Hormone Receptor-positive Breast That is Sensitive to Extended Endocrine Therapy

    Shengjing Hospital 1000 participants Est. completion 2026-12-31 12 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT04478305

    Affect of Duavive on Mood & Anxiety Symptoms

    Not yet reported St. Joseph's Healthcare Hamilton 30 participants Est. completion 2025-12 1 site
    Other conditions: Menopause, Depression, Anxiety, Sleep, Menopause Related Conditions
    View official trial listing →
  • Recruiting NCT NCT04596592

    Pubertal Blockade and Estradiol Effects on Cardiometabolic Health for Transitioning Youth

    University of Colorado, Denver 90 participants Est. completion 2026-07-31 1 site
    Other conditions: Transgenderism, Gender Dysphoria, Insulin Sensitivity
    View official trial listing →
  • Recruiting NCT NCT04601116

    The MASTER Study (MAmmary Cancer STatin ER Positive Study)

    Not yet reported Aarhus University Hospital 3360 participants Est. completion 2035-01-01 1 site
    Other conditions: Breast Cancer Female, Estrogen Receptor Positive Tumor
    View official trial listing →
  • Recruiting NCT NCT04606446

    Study of PF-07248144 in Advanced or Metastatic Solid Tumors

    Not yet reported Pfizer 320 participants Est. completion 2029-08-10 44 sites
    Other conditions: Locally Advanced or Metastatic ER+ HER2- Breast Cancer, Locally Advanced or Metastatic Castration-resistant Prostate Cancer, Locally Advanced or Metastatic Non-small Cell Lung Cancer
    View official trial listing →
  • Recruiting NCT NCT04685148

    Maternal Mental Health Trial

    Not yet reported, Not yet reported Vibe G Frøkjær, MD, PhD 220 participants Est. completion 2030-12-31 1 site
    Other conditions: Major Depressive Disorder, Postpartum Depression
    View official trial listing →
  • Recruiting NCT NCT04783857

    Modifying Progesterone and Estradiol Levels to Prevent Postpartum Cigarette Smoking Relapse and Reduce Secondhand Smoke Exposure in Infants and Children

    Not yet reported University of Minnesota 171 participants Est. completion 2027-06-02 1 site
    Other conditions: Smoking, Smoking Cessation, Smoking Reduction
    View official trial listing →
  • Recruiting NCT NCT04802759

    A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast Cancer

    Not yet reported, Not yet reported Hoffmann-La Roche 316 participants Est. completion 2029-05-30 32 sites Stand-alone
    Other conditions: Inoperable, Locally Advanced or Metastatic, ER-positive Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT04812912

    Changes in Reproductive and Sexual Health in People With Early Onset Colorectal Cancer

    Memorial Sloan Kettering Cancer Center 120 participants Est. completion 2027-03-18 7 sites
    Other conditions: Colorectal Cancer, Colorectal Neoplasms, Colorectal Carcinoma
    View official trial listing →
  • Recruiting NCT NCT04824014

    4FMFES-PET Imaging of ER+ Advanced Breast Cancers

    Not yet reported Centre de recherche du Centre hospitalier universitaire de Sherbrooke 150 participants Est. completion 2026-12-31 1 site
    Other conditions: ER+ Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT04838249

    Effects of Cross-sex Hormone Therapy on Eating Behavior, Metabolism, Energy Balance and Cardiovascular System

    University of Leipzig 80 participants Est. completion 2026-05 1 site
    Other conditions: Transsexualism, Transgenderism, Adiposity, Eating Behavior, Arterial Stiffness, Microangiopathy
    View official trial listing →
  • Recruiting NCT NCT04872166

    A Study of BTX-A51 in People With Advanced Solid Tumor and Breast Cancer

    Not yet reported Edgewood Oncology Inc. 112 participants Est. completion 2027-05 6 sites
    Other conditions: Advanced Solid Tumor, Metastatic Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT04965766

    Patritumab Deruxtecan (U3-1402) in Unresectable Locally Advanced or Metastatic Breast Cancer

    Not yet reported Gustave Roussy, Cancer Campus, Grand Paris 139 participants Est. completion 2030-04-11 11 sites
    Other conditions: Metastatic Breast Cancer, Advanced Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT04985266

    A Trial of Early Detection of Molecular Relapse With Circulating Tumour DNA Tracking and Treatment With Palbociclib Plus Fulvestrant Versus Standard Endocrine Therapy in Patients With ER Positive HER2 Negative Breast Cancer

    Not yet reported Royal Marsden NHS Foundation Trust 1100 participants Est. completion 2030-09-01 49 sites
    Other conditions: ER+ Breast Cancer, HER2-negative Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT05044962

    Kuwa Free! - Live Free!

    Not yet reported University of Alabama at Birmingham 700 participants Est. completion 2027-03-31 1 site Stand-alone
    Other conditions: HIV Infections, Contraception, Drug-drug Interaction
    View official trial listing →
  • Recruiting NCT NCT05113368

    Regorafenib Combined With Fulvestrant in Recurrent Low-Grade Serous Ovarian Cancer

    Not yet reported Sarah K. Lynam MD 31 participants Est. completion 2027-02 1 site
    Other conditions: Ovarian Cancer, Serous Ovarian Cancer
    View official trial listing →
  • Recruiting NCT NCT05169762

    Feminizing Treatment in Transgender Women and Non-binary Persons

    Odense University Hospital 100 participants Est. completion 2035-09-01 1 site
    Other conditions: Transgenderism
    View official trial listing →
  • Recruiting NCT NCT05181033

    Lenvatinib+Letrozole Versus Fulvestrant in Metastatic ER+/HER2- Breast Cancer, Post Progression on Al + CDK4/6 Inhibitor

    Not yet reported National University Hospital, Singapore 120 participants Est. completion 2027-08 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT05187832

    A Study of AND019 in Women With ER Positive HER2 Negative Advanced or Metastatic Breast Cancer

    Not yet reported Kind Pharmaceuticals LLC 61 participants Est. completion 2026-11 1 site
    Other conditions: Advanced or Metastatic Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT05190094

    Prediction of Treatment Efficacy of the Combination of Palbociclib/(Letrozole or Anastrozole) in First Line Metastatic Women With Luminal, HER2 Negative Advanced Breast Cancer, Using Infrared Laser Spectroscopy Analysis on Liquid Biopsies.

    Not yet reported International Cancer Research Group, United Arab Emirates 80 participants Est. completion 2026-06 7 sites
    Other conditions: Hormonal Receptors Positive, HER2 Negative, Advanced Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT05221021

    Vaginal Estradiol vs Oral Beta-3 Agonist for Overactive Bladder Syndrome

    Not yet reported Walter Reed National Military Medical Center 152 participants Est. completion 2027-01-30 1 site
    Other conditions: Overactive Bladder Syndrome
    View official trial listing →
  • Recruiting NCT NCT05280028

    HRT on Overactive Bladder Symptoms, Sexual Function, Depressive Symptoms, Autonomic Function, and Arterial Stiffness

    Far Eastern Memorial Hospital 100 participants Est. completion 2026-12-31 1 site
    Other conditions: Menopausal Syndrome
    View official trial listing →
  • Recruiting NCT NCT05282277

    Examining the Effects of Estradiol on Neural and Molecular Response to Reward

    Not yet reported University of North Carolina, Chapel Hill 103 participants Est. completion 2026-12-31 1 site
    Other conditions: Depression, Psychosis, Anhedonia
    View official trial listing →
  • Recruiting NCT NCT05283421

    Improving Diagnostics in Cervical Dysplasia

    Not yet reported University of Aarhus 150 participants Est. completion 2026-08-16 1 site
    Other conditions: Cervical Cancer
    View official trial listing →
  • Recruiting NCT NCT05293366

    LOng COvid COmorbidities: Endocrine,Metabolic,Neuropsychiatric,Muscle,Cardiovascular,Pulmonary,Dermatologic Dysfunctions

    Federico II University 100 participants Est. completion 2027-01-27 1 site
    Other conditions: Long Covid-19
    View official trial listing →
  • Recruiting NCT NCT05304962

    FIH Study of RGT-419B Alone and With Endocrine Therapy in HR-Positive, HER2-Negative Advanced/Metastatic Breast Cancer

    Not yet reported Regor Pharmaceuticals Inc. 64 participants Est. completion 2027-03-31 8 sites Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT05305924

    Fulvestrant+Abemaciclib With Run-In of Fulvestrant in Er-Positive, Her2-Negative Metastatic Breast Cancer

    Not yet reported The Methodist Hospital Research Institute 28 participants Est. completion 2027-12-01 1 site
    Other conditions: ER-Positive Breast Cancer, HER2-negative Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT05307705

    A Study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors

    Not yet reported Eli Lilly and Company 260 participants Est. completion 2026-12 50 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT05316935

    GnRHa + Letrozole in Non-obese Progestin-insensitive Endometrial Cancer and Atypical Hyperplasia Patients

    Not yet reported, Not yet reported Xiaojun Chen 80 participants Est. completion 2028-03-30 2 sites
    Other conditions: Endometrial Neoplasms, Atypical Endometrial Hyperplasia, Progesterone Resistance
    View official trial listing →
  • Recruiting NCT NCT05318755

    China Gender-affirming Hormone Therapy Study

    Peking University Third Hospital 240 participants Est. completion 2028-12-31 1 site
    Other conditions: Transgender, Gender Incongruence
    View official trial listing →
  • Recruiting NCT NCT05325632

    Study of HER2 Directed Dendritic Cell (DC1) Vaccine + Weekly Paclitaxel, Trastuzumab & Pertuzumab

    Not yet reported H. Lee Moffitt Cancer Center and Research Institute 53 participants Est. completion 2027-09 1 site Stand-alone
    Other conditions: HER2-positive Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT05333328

    OFS in Premenopausal Node+ Breast Cancer With Low Genomic Risk

    Not yet reported Gangnam Severance Hospital 418 participants Est. completion 2033-01 2 sites
    Other conditions: Breast Cancer, Estrogen Receptor Positive Tumor, HER2-negative Breast Cancer, Premenopausal Breast Cancer, Node-positive Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT05343572

    Bone Marrow Derived Stem Cells Mobilization for Treatment of Abnormal Endometrium

    Not yet reported Hugh Taylor 90 participants Est. completion 2027-12 1 site
    Other conditions: Asherman Syndrome, Atrophic Endometrium, Recurrent Implantation Failure
    View official trial listing →
  • Recruiting NCT NCT05362760

    Combination of Abemaciclib and Endocrine Therapy in Hormone Receptor Positive HER2 Negative Locally Advanced or Metastatic Breast Cancer With Focus on Digital Side Effect Management

    Not yet reported Prof. Wolfgang Janni 300 participants Est. completion 2029-04 54 sites
    Other conditions: Hormone Receptor-positive Metastatic Breast Cancer, HER2-negative Metastatic Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT05379556

    LOng COvid COmorbidities: Andrological, Reproductive, Sexual Dysfunctions in Patients Recovered From COVID-19

    Federico II University 100 participants Est. completion 2027-01-27 1 site
    Other conditions: Long Covid-19
    View official trial listing →
  • Recruiting NCT NCT05386108

    Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer

    Not yet reported, Not yet reported Stemline Therapeutics, Inc. 73 participants Est. completion 2026-12 86 sites
    Other conditions: Breast Neoplasms, Brain Neoplasms, Neoplasms by Site, Neoplasms, Breast Diseases, Central Nervous System Neoplasms, Brain Diseases, Central Nervous System Diseases
    View official trial listing →
  • Recruiting NCT NCT05457972

    Postpartum Vaginal Estrogen for Breastfeeding Patients

    Not yet reported University Hospitals Cleveland Medical Center 100 participants Est. completion 2026-12-31 1 site Stand-alone
    Other conditions: Breastfeeding, Postpartum Sexual Dysfunction, Vaginal Atrophy
    View official trial listing →
  • Recruiting NCT NCT05467891

    Ribociclib And Endocrine Treatment of Physician's Choice for Locoregional Recurrent, Resected Hormone Receptor Positive HER2 Negative Breast Cancer

    Not yet reported Oana Danciu 200 participants Est. completion 2029-08-15 21 sites
    Other conditions: Locoregional Recurrence, Hormone Receptor-positive Breast Cancer, HER2-negative Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT05472792

    Compare Adjuvant Monotherapy With Endocrine or Accelerated Partial Breast Irradiation After Lumpectomy

    Not yet reported UNC Lineberger Comprehensive Cancer Center 90 participants Est. completion 2032-04-15 1 site
    Other conditions: Breast Cancer, Quality of Life
    View official trial listing →
  • Recruiting NCT NCT05473273

    Descriptive Analysis of Serum Immunological Markers During an Euploid Frozen Embryo Transfer in a Natural Cycle.

    ART Fertility Clinics LLC 40 participants Est. completion 2026-12-30 1 site
    Other conditions: Infertility, Female
    View official trial listing →
  • Recruiting NCT NCT05515354

    Smoking Cessation and Menstrual Cycle Phase

    Not yet reported Centre for Addiction and Mental Health 1200 participants Est. completion 2026-12-31 1 site
    Substance use disorder Other conditions: Nicotine Dependence, Tobacco Smoking, Smoking Cessation, Nicotine Use Disorder
    View official trial listing →
  • Recruiting NCT NCT05524584

    Anastrazole, Fulvestrant & Abemaciclib for HR+HER2- Metastatic Breast Cancer

    Not yet reported University of California, Irvine 20 participants Est. completion 2031-12-31 1 site
    Other conditions: Breast Cancer, Metastatic Breast Cancer, Hormone Receptor-positive Breast Cancer, HER2-negative Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT05536128

    Evaluating the Efficacy and Safety of Fulvestrant Plus DNA Damage Repair Inhibitors After a CDK4/6 Inhibitor

    Not yet reported Seoul National University Hospital 64 participants Est. completion 2025-12-31 1 site
    Other conditions: Advanced Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT05541367

    Estrogen Receptor (ER) PET/CT Imaging in Breast Cancer

    Tongji Hospital 80 participants Est. completion 2026-12-31 1 site
    Other conditions: Breast Cancer, TNBC - Triple-Negative Breast Cancer, Estrogen-receptor-negative Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT05564377

    Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

    Not yet reported National Cancer Institute (NCI) 2900 participants Est. completion 2030-07-01 483 sites
    Other conditions: Advanced Malignant Solid Neoplasm, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Locally Advanced Malignant Solid Neoplasm, Malignant Female Reproductive System Neoplasm, Metastatic HER2-Negative Breast Carcinoma, Metastatic Malignant Solid Neoplasm, Recurrent Endometrial Carcinoma, Recurrent Fallopian Tube Carcinoma, Recurrent Malignant Female Reproductive System Neoplasm, Recurrent Malignant Solid Neoplasm, Recurrent Ovarian Carcinoma, Recurrent Primary Peritoneal Carcinoma, Unresectable HER2-Negative Breast Carcinoma, Unresectable Malignant Solid Neoplasm
    View official trial listing →
  • Recruiting NCT NCT05573126

    Phase 1/2 Study to Evaluate EP0062 as Monotherapy and in Combination in Patients With Advanced or Metastatic AR+/HER-2-/ER+ Breast Cancer

    Not yet reported, Not yet reported Ellipses Pharma 95 participants Est. completion 2028-02 14 sites
    Other conditions: Hormone Receptor-positive Breast Cancer, Hormone Receptor Positive HER-2 Negative Breast Cancer, Metastatic Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT05586724

    Micronized Progesterone Versus Norethisterone Acetate in Combination With Estrogen as Menopausal Hormone Therapy

    Not yet reported Angelica Lindén Hirschberg 520 participants Est. completion 2027-12 1 site
    Other conditions: Menopausal Symptoms
    View official trial listing →
  • Recruiting NCT NCT05586802

    Sex Steroids Balance for Metabolic and Reproductive Health in Klinefelter Syndrome

    Not yet reported Georgios Papadakis 150 participants Est. completion 2027-04-30 1 site
    Other conditions: Klinefelter Syndrome
    View official trial listing →
  • Recruiting NCT NCT05594095

    SNF Platform Study of HR+/ HER2-advanced Breast Cancer

    Not yet reported Fudan University 620 participants Est. completion 2026-12-01 1 site
    Other conditions: Breast Neoplasm, Breast Cancer, Hormone Receptor Positive Tumor, HER2-negative Breast Cancer, Advanced Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT05601440

    Liquid-biopsy Informed Platform Trial to Evaluate CDK4/6-inhibitor Resistant ER+/HER2- Metastatic Breast Cancer

    Not yet reported Canadian Cancer Trials Group 484 participants Est. completion 2028-06-30 10 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT05601700

    Letrozole for Estrogen/Progesterone Receptor Positive Low-grade Serous Epithelial Ovarian Cancer (LEPRE Trial)

    Not yet reported Ente Ospedaliero Ospedali Galliera 132 participants Est. completion 2029-09-22 19 sites
    Other conditions: Carcinoma, Ovarian Epithelial, Low Grade Serous Adenocarcinoma of Ovary
    View official trial listing →
  • Recruiting NCT NCT05608252

    VS-6766+Abema+Fulv in Met HR+/HER- BC

    Not yet reported, Not yet reported Adrienne G. Waks 63 participants Est. completion 2028-12-31 3 sites
    Other conditions: Breast Cancer, Hormone Receptor-positive Breast Cancer, Hormone Receptor Positive HER-2 Negative Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT05646862

    A Study Evaluating the Efficacy and Safety of Inavolisib Plus Fulvestrant Compared With Alpelisib Plus Fulvestrant in Participants With HR-Positive, HER2-Negative, PIK3CA Mutated, Locally Advanced or Metastatic Breast Cancer Post CDK4/6i and Endocrine Combination Therapy

    Not yet reported Hoffmann-La Roche 420 participants Est. completion 2029-03-30 210 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT05672901

    Silicone Gel vs. Estrogen Vaginal Cream for the Management of Genitourinary Syndrome of Menopause

    Not yet reported Stratpharma AG 100 participants Est. completion 2026-09 3 sites
    Other conditions: Genitourinary Syndrome of Menopause
    View official trial listing →
  • Recruiting NCT NCT05683418

    A Study to Evaluate the Safety and Tolerability of TOS-358 in Women With HR+ HER2- Breast Cancer

    Not yet reported Totus Medicines 241 participants Est. completion 2027-12 18 sites
    Other conditions: HR+/HER2-negative Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT05696626

    Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation

    Not yet reported LeonaBio 600 participants Est. completion 2028-04 224 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT05704036

    Estrogen Supplementation and Bone Health in Women With CF

    Not yet reported Johns Hopkins University 75 participants Est. completion 2027-01 1 site Stand-alone
    Other conditions: Cystic Fibrosis, Hypoestrogenism
    View official trial listing →
  • Recruiting NCT NCT05716516

    STUDY02001740;22SCH740: Estradiol For ER+ Advanced Breast Cancer (ESTHER)

    Not yet reported Dartmouth-Hitchcock Medical Center 36 participants Est. completion 2027-05 1 site
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT05735080

    Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer

    Not yet reported, Not yet reported Incyclix Bio 150 participants Est. completion 2027-09 18 sites
    Other conditions: Breast Cancer, Breast Cancer Metastatic, Hormone Receptor Positive Tumor, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast, Ovarian Cancer, CCNE1 Amplification, Solid Tumor, Advanced Cancer, Metastatic Cancer
    View official trial listing →
  • Recruiting NCT NCT05746793

    At High-risk for Pre-eclampsia After Assisted Reproductive Technology

    CRG UZ Brussel 1050 participants Est. completion 2027-10-01 1 site
    Other conditions: Pre-Eclampsia
    View official trial listing →
  • Recruiting NCT NCT05768139

    First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

    Not yet reported, Not yet reported Eli Lilly and Company 880 participants Est. completion 2030-07 65 sites
    Other conditions: Breast Cancer, Solid Tumors, Adult
    View official trial listing →
  • Recruiting NCT NCT05774951

    A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy

    Not yet reported AstraZeneca 4300 participants Est. completion 2036-05-29 709 sites
    Other conditions: Breast Cancer, Early Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT05787470

    State of Hormones Impact Nociceptive Expression

    University of Alabama at Birmingham 120 participants Est. completion 2027-07-31 1 site
    Other conditions: Pain, Gender Identity
    View official trial listing →
  • Recruiting NCT NCT05816655

    Comparison of Clinical Efficacy Between Letrozole + Ribociclib and Fulvestrant + Letrozole + Ribociclib in Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer

    Not yet reported Korea University Guro Hospital 202 participants Est. completion 2029-06-30 2 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT05837325

    Is the AMH Intrafollicular Level a Predictor of the Ploidy Status of the Blastocyst?

    ART Fertility Clinics LLC 300 participants Est. completion 2026-12-31 1 site
    Other conditions: Infertility, Female, Infertility
    View official trial listing →
  • Recruiting NCT NCT05862272

    A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis

    Not yet reported Sumitomo Pharma Switzerland GmbH 1000 participants Est. completion 2030-09 120 sites
    Other conditions: Uterine Fibroids, Endometriosis
    View official trial listing →
  • Recruiting NCT NCT05867251

    Study of AVZO-021 in Patients With Advanced Solid Tumors

    Not yet reported, Not yet reported Avenzo Therapeutics, Inc. 430 participants Est. completion 2030-01-31 13 sites Stand-alone
    Other conditions: Advanced Solid Tumor, HR+/HER2- Breast Cancer, HR+, HER2-, Advanced Breast Cancer, CCNE1 Amplification, Epithelial Ovarian Cancer, Primary Peritoneal Cancer, Fallopian Tube Cancer, Endometrial Cancer, TNBC - Triple-Negative Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT05872204

    Abemaciclib and Letrozole in Patients With Estrogen Receptor-positive Rare Ovarian Cancer

    Not yet reported Universitaire Ziekenhuizen KU Leuven 100 participants Est. completion 2028-01 12 sites
    Obstructive sleep apnea Other conditions: Low Grade Serous Ovarian Carcinoma
    View official trial listing →
  • Recruiting NCT NCT05879926

    Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

    Not yet reported NRG Oncology 3960 participants Est. completion 2034-07 1261 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT05899010

    MIcronized PROgesterone in Frozen Embryo Transfer Cycles

    Not yet reported Fundación Santiago Dexeus Font 1020 participants Est. completion 2028-04 1 site
    Other conditions: Infertility
    View official trial listing →
  • Recruiting NCT NCT05901428

    TCb vs EC-T in High Risk ER+/HER2- Breast Cancer

    Not yet reported Fudan University 1736 participants Est. completion 2032-06 1 site
    Other conditions: Hormone Receptor Positive HER-2 Negative Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT05916196

    [18F]FES PET/.CT in Uterine Cancer

    Not yet reported Abramson Cancer Center at Penn Medicine 30 participants Est. completion 2028-08-01 1 site Stand-alone
    Other conditions: Uterine Cancer
    View official trial listing →
  • Recruiting NCT NCT05933395

    Genetically-informed Therapy for ER+ Breast Cancer Post-CDK4/6 Inhibitor

    Not yet reported Dartmouth-Hitchcock Medical Center 135 participants Est. completion 2031-10 1 site
    Other conditions: Advanced Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT05934708

    Examining the Role of Female Endogenous Sex Hormones in Eccentric Exercise

    Not yet reported University of Southern California 30 participants Est. completion 2026-08 1 site Stand-alone
    Other conditions: Inflammatory Response
    View official trial listing →
  • Recruiting NCT NCT05949541

    Efficacy of Everolimus Combined With First-line Endocrine Therapy for HR+/HER2- SNF1-subtype Advanced Breast Cancer

    Not yet reported Fudan University 265 participants Est. completion 2028-01 1 site
    Other conditions: Breast Cancer, Advanced Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT05953090

    VALOR: Vaginal Atrophy & Long-term Observation of Recovery

    Not yet reported Stratpharma AG 2000 participants Est. completion 2028-12 14 sites Stand-alone
    Other conditions: Atrophic Vaginitis, Vaginal Atrophy, Genitourinary Syndrome of Menopause, Lichen Sclerosus of Vulva, Lichen Planus of Vulva, Lichen Simplex of Vulva (Disorder)
    View official trial listing →
  • Recruiting NCT NCT05960370

    Impact of Endometrial Compaction on Reproductive Outcomes After Cryotransfer of Euploid Embryos in a Natural Cycle

    Instituto Bernabeu 206 participants Est. completion 2025-06-15 1 site
    Other conditions: Infertility Due to Nonimplantation
    View official trial listing →
  • Recruiting NCT NCT05969795

    Comparison of Live Birth Rate in Natural Cycle Single Euploid FET Versus Without Luteal Phase Support

    Not yet reported ART Fertility Clinics LLC 342 participants Est. completion 2026-09-30 3 sites
    Other conditions: Pregnancy Related, Infertility, Female
    View official trial listing →
  • Recruiting NCT NCT05982496

    18F FES-PET/MRI for Tailoring Treatment of Luminal A and Lobular Breast Cancer

    Not yet reported Università Vita-Salute San Raffaele 119 participants Est. completion 2029-12-01 1 site Stand-alone
    Other conditions: Breast Cancer Female, Lobular Breast Carcinoma, PET/MRI, Axillary Lymphadenopathy, Luminal A Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT05989347

    Study to Evaluate Biomarkers and Safety of Dapagliflozin Concomitant With Neoadjuvant Therapy

    Not yet reported Yale University 20 participants Est. completion 2027-12 1 site Stand-alone
    Other conditions: Breast Cancer, Hyperinsulinism, HER2-negative Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT06006091

    The Effectiveness of the Letrozole-induced Endometrial Preparation Protocol in Frozen-thawed Embryo Transfer (FET)

    Not yet reported International Peace Maternity and Child Health Hospital 858 participants Est. completion 2027-08-01 1 site
    Other conditions: Letrozole, Infertility, Female
    View official trial listing →
  • Recruiting NCT NCT06028555

    International Active Surveillance Study: Native Estrogen Estetrol (E4) Safety Study

    Center for Epidemiology and Health Research, Germany 101000 participants Est. completion 2028-10-31 1 site
    Other conditions: Contraception, Birth Control
    View official trial listing →
  • Recruiting NCT NCT06067503

    Biomarkers to Detect Endocrine Therapy Resistance

    Not yet reported University of Wisconsin, Madison 8 participants Est. completion 2026-12 1 site
    Other conditions: Metastatic Cancer, Breast Cancer, Lobular Breast Carcinoma
    View official trial listing →
  • Recruiting NCT NCT06072807

    Brain [18F]-FES PET/CT in Patients With Estrogen-Receptor Positive Breast Cancer

    Not yet reported Weill Medical College of Cornell University 20 participants Est. completion 2027-12 1 site
    Other conditions: Breast Cancer, Brain Metastases
    View official trial listing →
  • Recruiting NCT NCT06086704

    Study of 18F-FFNP Breast PET/MRI

    Not yet reported University of Wisconsin, Madison 53 participants Est. completion 2030-08-31 1 site Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT06101303

    Endometriosis Pain

    Washington University School of Medicine 120 participants Est. completion 2029-09-01 1 site
    Other conditions: Pelvic Pain, Endometriosis
    View official trial listing →
  • Recruiting NCT NCT06107673

    Dalpiciclib Plus AI (Neoadjuvant Endocrine Therapy) Compared With Neoadjuvant Chemotherapy in Early Breast Cancer (EBC)

    Not yet reported Hebei Medical University Fourth Hospital 144 participants Est. completion 2028-12-01 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT06120283

    BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors

    Not yet reported BeOne Medicines 433 participants Est. completion 2029-12 61 sites
    Other conditions: Advanced Solid Tumor, Advanced Breast Cancer, Metastatic Breast Cancer, Hormone-receptor-positive Breast Cancer, Hormone Receptor Positive Breast Carcinoma, Hormone Receptor Positive Malignant Neoplasm of Breast, HER2-negative Breast Cancer, Hormone Receptor Positive HER-2 Negative Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT06127979

    A Study of Changes in Ki67 Expression in People With Breast Cancer Receiving Endocrine Therapy Before Surgery

    Not yet reported Memorial Sloan Kettering Cancer Center 42 participants Est. completion 2028-11 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT06145308

    Precision Treatment of Recurrent/Metastatic Salivary Gland Carcinoma Guided by Molecular Typing

    Not yet reported Peking Union Medical College 39 participants Est. completion 2028-07-10 2 sites
    Other conditions: Salivary Gland Carcinoma, Precision Therapy
    View official trial listing →
  • Recruiting NCT NCT06159608

    Sex Differences in the Vascular Effects of E-cigarette Use

    Not yet reported Anna Stanhewicz, PhD 80 participants Est. completion 2026-12 1 site
    Other conditions: E-cigarette Use
    View official trial listing →
  • Recruiting NCT NCT06176261

    DATO-BASE: DATOpotamab-deruxtecan for Breast Cancer Brain metAstaSEs

    Not yet reported Nancy Lin, MD 58 participants Est. completion 2029-01-01 3 sites Stand-alone
    Other conditions: Breast Cancer, Breast Cancer Female, Metastatic Triple-Negative Breast Carcinoma, ER Positive Breast Cancer, HER2-negative Breast Cancer, HER2 Negative Breast Carcinoma, ER-negative Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT06179303

    Functional Imaging in Prediction of Response to Abemaciclib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer

    Not yet reported University of Washington 60 participants Est. completion 2028-06-01 3 sites
    Other conditions: Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Locally Advanced Unresectable HER2-Negative Breast Carcinoma, Locally Advanced Unresectable Hormone Receptor-Positive Breast Carcinoma, Metastatic HER2-Negative Breast Carcinoma, Metastatic Hormone Receptor-Positive Breast Carcinoma
    View official trial listing →
  • Recruiting NCT NCT06186271

    International Active Surveillance Study: Safety of Estrogen Estetrol (E4) Contraceptive Study (INAS-SEECS)

    Center for Epidemiology and Health Research, Germany 68100 participants Est. completion 2029-06 1 site
    Other conditions: Contraception
    View official trial listing →
  • Recruiting NCT NCT06197295

    Efficacy of Combined Pharmacotherapy Versus Solifenacin With Vaginal Estrogen Cream for Women With Detrusor Overactivity

    Not yet reported Mackay Memorial Hospital 200 participants Est. completion 2026-12-31 1 site Stand-alone
    Other conditions: Urinary Bladder, Overactive, Effect of Drug
    View official trial listing →
  • Recruiting NCT NCT06201234

    Evaluating the Addition of Elacestrant (Oral SERD) to Olaparib (PARP-inhibitor) in Patients With Advanced/Metastatic HR+/HER2- Breast Cancer

    Not yet reported GBG Forschungs GmbH 176 participants Est. completion 2028-12-31 36 sites
    Other conditions: Hormone Receptor Positive HER-2 Negative Breast Cancer, Advanced or Metastatic Breast Cancer, BRCA1 Mutation, BRCA2 Mutation
    View official trial listing →
  • Recruiting NCT NCT06202261

    A Study of TQB2930 for Injection Monotherapy or Combination Therapy in Patients With Recurrent/Metastatic Breast Cancer

    Not yet reported, Not yet reported Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 154 participants Est. completion 2027-10 2 sites Stand-alone
    Other conditions: Metastatic Breast Cancer, Recurrent Breast Cancer, Advanced Malignancies
    View official trial listing →
  • Recruiting NCT NCT06208410

    A Clinical Study of JS105 in Combination With Other Anti-tumor Therapies in Patients With Solid Tumors

    Not yet reported, Not yet reported Risen (Suzhou) Pharma Tech Co., Ltd. 306 participants Est. completion 2027-02-26 1 site
    Other conditions: Advanced Solid Tumors
    View official trial listing →
  • Recruiting NCT NCT06218303

    Prototype DAA/TAA Vaccine Targeting MUC1 for Immune Interception and Prevention in Ductal Carcinoma In Situ

    Not yet reported Finn, Olivera, PhD 50 participants Est. completion 2029-12-31 1 site Stand-alone
    Other conditions: Ductal Carcinoma in Situ
    View official trial listing →
  • Recruiting NCT NCT06222957

    The Effects of HER2 Receptor Signaling on Human Brown Fat Activity

    Copenhagen University Hospital, Rigshospitalet 30 participants Est. completion 2026-03-01 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT06239376

    Artificial Cycle With or Without GnRH Agonist Pre-treatment for Frozen Embryo Transfer in Adenomyosis Patients

    Not yet reported Mỹ Đức Hospital 222 participants Est. completion 2027-05-30 1 site
    Other conditions: Adenomyosis, IVF, Frozen Embryo Transfer
    View official trial listing →
  • Recruiting NCT NCT06245681

    Effects of Cross-sex Hormone Treatment on Cardiac Function, Myocardial and Hepatic Fat Content

    Medical University of Vienna 40 participants Est. completion 2028-10-20 1 site
    Other conditions: Gender Dysphoria
    View official trial listing →
  • Recruiting NCT NCT06247267

    The Effect of Sex Steroid Replacement Therapy in the Hypogonadism and Transgender Active-Duty Population

    Walter Reed National Military Medical Center 75 participants Est. completion 2025-08 1 site
    Other conditions: Hypogonadism, Gender Identity Dysphoria
    View official trial listing →
  • Recruiting NCT NCT06260033

    Stereotactic Body Radiation Therapy and FES PET/CT Imaging for the Treatment of Oligoprogressive Estrogen Receptor Positive Metastatic Breast Cancer

    Not yet reported City of Hope Medical Center 18 participants Est. completion 2026-10-29 2 sites
    Other conditions: Anatomic Stage IV Breast Cancer AJCC v8, Estrogen Receptor-Positive Breast Carcinoma, Metastatic Breast Carcinoma
    View official trial listing →
  • Recruiting NCT NCT06264882

    Cardiometabolic Consequences of the Loss of Ovarian Function

    Not yet reported University of Colorado, Denver 100 participants Est. completion 2028-08-31 1 site
    Other conditions: Menopause, Estrogen Deficiency, Aging, Adiposity
    View official trial listing →
  • Recruiting NCT NCT06280560

    Impact of IVF Hormonal Therapy on Endometrial Receptivity and Endometrial Senescent Cell Pathological Accumulation

    Fundación IVI 60 participants Est. completion 2026-12-30 1 site
    Other conditions: Endometrial Receptivity
    View official trial listing →
  • Recruiting NCT NCT06291675

    Gender-Affirming Hormone Therapy and Its Impact on Myocardial Mass and Cardiac Function, Heart, Liver and Pancreatic Fat Content

    Medical University of Vienna 50 participants Est. completion 2033-03-03 1 site
    Other conditions: Gender Dysphoria, Hormone Therapy Induced Morphologic Change
    View official trial listing →
  • Recruiting NCT NCT06307184

    Assessing the Convenience of Natural Proliferative Phase Frozen Embryo Transfer

    Instituto Valenciano de Infertilidade de Lisboa 530 participants Est. completion 2026-12 1 site
    Other conditions: Frozen Embryo Transfer
    View official trial listing →
  • Recruiting NCT NCT06334315

    Oral Contraceptive Pill (OCP) Pharmacogenomics

    Not yet reported Yale University 700 participants Est. completion 2028-05 2 sites
    Other conditions: Contraception, Pharmacogenomic Drug Interaction
    View official trial listing →
  • Recruiting NCT NCT06343870

    Estradiol and Testosterone Subdermal Implants for Menopause Treatment (ESTIME)

    Not yet reported University of Sao Paulo General Hospital 140 participants Est. completion 2027-04-30 1 site
    Other conditions: Menopause, Testosterone Deficiency, Estrogen Deficiency
    View official trial listing →
  • Recruiting NCT NCT06357442

    Assessment of Endometrial Thickness Among Adolescent and Young Adult Patients on Estrogen Replacement Therapy Using Daily Oral Micronized Progesterone Versus the Etonogestrel Implant.

    University of Colorado, Denver 34 participants Est. completion 2026-07-01 1 site
    Other conditions: Primary Ovarian Insufficiency, Hypogonadotropic Hypogonadism, Hormone Replacement Therapy
    View official trial listing →
  • Recruiting NCT NCT06361940

    Molecular Analyses to Predict Pathways of Endocrine Resistance Following Short Term Neoadjuvant Endocrine Treatment in Patients With Hormone Receptor-Positive HER2-negative Breast Cancer

    Not yet reported Medical College of Wisconsin 100 participants Est. completion 2029-12 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT06366347

    ALPINE: Maintenance Letrozole/Abemaciclib

    Not yet reported Dana-Farber Cancer Institute 32 participants Est. completion 2029-03-01 6 sites
    Other conditions: Endometrial Cancer, Recurrent Endometrial Cancer, TP53
    View official trial listing →
  • Recruiting NCT NCT06372119

    Letrozole-stimulated Cycle Strategy Versus Artificial Cycle Strategy (LETSACT)

    Not yet reported Mỹ Đức Hospital 790 participants Est. completion 2026-04 2 sites
    Other conditions: Embryo Transfer, Irregular Menstruation, Letrozole, Hormone Replacement Therapy
    View official trial listing →
  • Recruiting NCT NCT06380751

    Saruparib (AZD5305) Plus Camizestrant or Plus Endocrine Therapy, Compared With CDK4/6 Inhibitor Plus Endocrine Therapy or Plus Camizestrant in HR-Positive, HER2-Negative (IHC 0, 1+, 2+/ ISH Non-amplified), BRCA1, BRCA2, or PALB2m Advanced Breast Cancer

    Not yet reported AstraZeneca 788 participants Est. completion 2031-12-30 306 sites
    Other conditions: Advanced Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT06382948

    Elacestrant + Everolimus in Patients ER+/HER2-, ESR1mut, Advanced Breast Cancer Progressing to ET and CDK4/6i.

    Not yet reported MedSIR 300 participants Est. completion 2028-04 104 sites Stand-alone
    Other conditions: Advanced Breast Cancer, ER-positive Breast Cancer, HER2-negative Breast Cancer, ESR1 Gene Mutation
    View official trial listing →
  • Recruiting NCT NCT06409390

    Sequential Therapies Modeled on Evolutionary Dynamics for Breast Cancer

    Not yet reported H. Lee Moffitt Cancer Center and Research Institute 15 participants Est. completion 2027-04 1 site
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT06439524

    The Effect of Medical Management Following Excisional Surgery for Endometriosis: A Randomized Controlled Trial

    Not yet reported Main Line Health 110 participants Est. completion 2028-12-01 1 site
    Other conditions: Endometriosis
    View official trial listing →
  • Recruiting NCT NCT06439693

    The SAPPHO Study: Sequential Therapy With Curative Intent in de Novo HER2+ Metastatic Breast Cancer

    Not yet reported Dana-Farber Cancer Institute 72 participants Est. completion 2033-03-30 1 site
    Other conditions: Breast Cancer Female, Breast Cancer, Breast Cancer Metastatic, Estrogen Receptor-positive Breast Cancer, HER2-positive Breast Cancer, Stage IV Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT06450301

    Senescent Endometrial Cells in Patients with Thin Endometrial Lining

    Trio Fertility 100 participants Est. completion 2027-06 1 site
    Other conditions: Asherman's Syndrome, Thin Endometrial Lining, Cell Senescence
    View official trial listing →
  • Recruiting NCT NCT06452394

    NEODOXy: Targeting Breast Cancer Stem Cells With Doxycycline

    Not yet reported Swiss Cancer Institute 50 participants Est. completion 2028-12-31 8 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT06455969

    Adaptions and Resiliency to Multi-Stressor OpeRations

    Not yet reported Bradley Nindl 120 participants Est. completion 2027-08 1 site Stand-alone
    Other conditions: Musculoskeletal Injury, Hypogonadism, Hormonal Contraception
    View official trial listing →
  • Recruiting NCT NCT06479720

    Efficacy of Solifenacin or Mirabegron With Local Estrogen Versus Combination Pharmacotherapy for Overactive Bladder

    Not yet reported Mackay Memorial Hospital 300 participants Est. completion 2026-12-31 1 site Stand-alone
    Other conditions: Effect of Drug, Urinary Bladder, Overactive
    View official trial listing →
  • Recruiting NCT NCT06492616

    A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

    Not yet reported Stemline Therapeutics, Inc. 4220 participants Est. completion 2032-10 567 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT06497894

    No More Sleepless Nights in Perimenopause

    Not yet reported Insel Gruppe AG, University Hospital Bern 54 participants Est. completion 2027-01-30 1 site
    Other conditions: Insomnia, Menopause
    View official trial listing →
  • Recruiting NCT NCT06500208

    Neoadjuvant Adebrelimab and Chemotherapy in High-rish ER+/HER2- BC

    Not yet reported Shanghai Jiao Tong University School of Medicine 48 participants Est. completion 2026-12-31 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT06502548

    Endometriosis Transcriptomic Cell Atlas

    Not yet reported University Hospital, Toulouse 92 participants Est. completion 2027-09 1 site
    Other conditions: Endometriosis, Infertility
    View official trial listing →
  • Recruiting NCT NCT06515470

    Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of BTX-9341 in Advanced and/or Metastatic Breast Cancer

    Not yet reported Biotheryx, Inc. 82 participants Est. completion 2027-12-31 6 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT06520982

    Early Neurovascular Adaptations in Aging Women

    Not yet reported University of Missouri-Columbia 64 participants Est. completion 2028-06-30 1 site
    Other conditions: Women, Sympathetic Nervous System, Aging, Blood Flow
    View official trial listing →
  • Recruiting NCT NCT06525155

    Effect GnRH Agonist Administration in Endometriosis Cyst Patients

    Not yet reported Rumah Sakit Pusat Angkatan Darat Gatot Soebroto 32 participants Est. completion 2025-02 1 site
    Other conditions: Endometriosis
    View official trial listing →
  • Recruiting NCT NCT06530459

    The MUSE Study for Menopausal Arthralgia

    Not yet reported, Not yet reported National University Hospital, Singapore 100 participants Est. completion 2028-04 1 site
    Other conditions: Arthralgia, Menopause, Perimenopausal Disorder, Joint Pain, Postmenopausal Disorder
    View official trial listing →
  • Recruiting NCT NCT06533865

    Romosozumab as an Adjunct to Physiologic Estrogen Replacement in Functional Hypothalamic Amenorrhea

    Not yet reported Massachusetts General Hospital 114 participants Est. completion 2029-04 2 sites
    Other conditions: FHA (Functional Hypothalamic Amenorrhea)
    View official trial listing →
  • Recruiting NCT NCT06534125

    Acutherapy to Prevent Aromatase Inhibitor-Associated Arthralgias in Non-Hispanic Black Postmenopausal Women With Early-Stage Breast Cancer

    Not yet reported Emory University 150 participants Est. completion 2027-12-31 4 sites
    Other conditions: Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, HER2-Negative Breast Carcinoma, Hormone Receptor-Positive Breast Carcinoma
    View official trial listing →
  • Recruiting NCT NCT06544473

    Determining Dose Equivalence Between Oral and Transdermal Estrogen Treatment in Women With Turner Syndrome

    Not yet reported Aarhus University Hospital 50 participants Est. completion 2026-12-31 1 site
    Other conditions: Turner Syndrome, Hypogonadism; Ovarian, Hormone Replacement Therapy, Estrogen Replacement Therapy, Estrogen Deficiency
    View official trial listing →
  • Recruiting NCT NCT06555068

    A Trial of HRS-6209 in Combination With Fulvestrant, Letrozole, HRS-8080, or HRS-1358 in Breast Cancer Patients

    Not yet reported, Not yet reported Jiangsu HengRui Medicine Co., Ltd. 528 participants Est. completion 2028-08 1 site
    Other conditions: Advanced Unresectable or Metastatic Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT06570460

    Long Term Effects of Oral Versus Transdermal Estrogen Replacement Therapy in Turner Syndrome

    Not yet reported Aarhus University Hospital 50 participants Est. completion 2026-12-31 1 site
    Other conditions: Turner Syndrome, Hypogonadism; Ovarian, Hormone Replacement Therapy, Estrogen Replacement Therapy, Estrogen Deficiency
    View official trial listing →
  • Recruiting NCT NCT06572930

    Serum FSH Monitoring for Identification of an Optimal Range During Ovarian Stimulation

    ART Fertility Clinics LLC 150 participants Est. completion 2026-12-01 1 site
    Other conditions: Ovarian Stimulation
    View official trial listing →
  • Recruiting NCT NCT06583408

    The REgistry of Very Early Estrogen and AnovuLation

    Mayo Clinic 100000 participants Est. completion 2029-08-01 2 sites
    Other conditions: Hypothalamic Amenorrhea, Functional, Hypothalamic Amenorrhea, Functional Hypogonadotropic Hypogonadism
    View official trial listing →
  • Recruiting NCT NCT06607757

    Capivasertib Plus Fulvestrant vs. Fulvestrant in Primary High-risk Lobular Breast Cancer

    Not yet reported GBG Forschungs GmbH 120 participants Est. completion 2026-08-31 25 sites
    Other conditions: CCCA Assessed by Ki67 Drop Below <2.7% From Baseline
    View official trial listing →
  • Recruiting NCT NCT06618703

    Brain Irradiation for Childhood Cancer - Endocrine Monitoring During the First Years

    Not yet reported University Hospital, Angers 230 participants Est. completion 2030-10 3 sites
    Other conditions: Endocrine; Deficiency, Hypothalamo-Pituitary Disorder, Radiotherapy Side Effect
    View official trial listing →
  • Recruiting NCT NCT06624644

    A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma

    Not yet reported, Not yet reported Linnaeus Therapeutics, Inc. 135 participants Est. completion 2031-02 9 sites Stand-alone
    Other conditions: Melanoma (Skin Cancer), Melanoma Stage IIIB-IV, Cutaneous Melanoma, Unresectable Melanoma
    View official trial listing →
  • Recruiting NCT NCT06624839

    Evaluating Gardasil HPV Vaccine Humoral and Cellular Immune Responses in People With and Without HIV

    Not yet reported University of Maryland, Baltimore 120 participants Est. completion 2028-01 2 sites Stand-alone
    Other conditions: Human Papilloma Virus, Anal Dysplasia, HIV
    View official trial listing →
  • Recruiting NCT NCT06625775

    Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

    Not yet reported TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics) 392 participants Est. completion 2028-11 44 sites
    Other conditions: Solid Tumor, Adult, Metastatic Breast Cancer, Advanced Breast Cancer, HER2 Mutation-Related Tumors, HER2-positive Metastatic Breast Cancer, KRAS Mutant Metastatic Colorectal Cancer, Metastatic Lung Cancer, Metastatic Colorectal Cancer, Advanced Lung Cancer, HR-positive, HER2-negative Advanced Breast Cancer, HER2-positive Advanced Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT06644794

    Progesterone-modified Natural Cycle for FET

    Not yet reported Shandong University of Traditional Chinese Medicine 336 participants Est. completion 2028-12-01 1 site
    Other conditions: Infertility, Female
    View official trial listing →
  • Recruiting NCT NCT06656819

    The Modulatory Effect of Female Sex Hormones on Spinal Neuroplasticity

    University of Texas Southwestern Medical Center 50 participants Est. completion 2027-12-31 1 site
    Other conditions: Healthy
    View official trial listing →
  • Recruiting NCT NCT06663072

    Study to Test the Combination of Fulvestrant With Lu-DOTATATE for Advanced Pancreatic Neuroendocrine Tumors

    Not yet reported University of Chicago 25 participants Est. completion 2026-11 1 site
    Other conditions: Metastatic Pancreatic Neuroendocrine Tumor
    View official trial listing →
  • Recruiting NCT NCT06666439

    Longitudinal Tumor Burden Quantification Using Circulating Tumor DNA in Metastatic Lobular Breast Cancer

    Julia Foldi 20 participants Est. completion 2029-10-31 1 site
    Other conditions: Metastatic Invasive Lobular Carcinoma (mILC)
    View official trial listing →
  • Recruiting NCT NCT06679491

    Impact of Menstrual Cycle-Based Resistance Training on Neuromuscular Performance in Female Athletes

    Not yet reported Universite de La Reunion 60 participants Est. completion 2027-12-31 1 site Stand-alone
    Other conditions: Menstrual Cycle, Resistance Training, Neuromuscular Function, Female Athlete, Women Health, Oral Contraceptive Pill, Muscle Strenght, Hormones, Periodized Training
    View official trial listing →
  • Recruiting NCT NCT06683248

    The Effects of Night Shift Work on Health Across the Menstrual Cycle

    Not yet reported Uppsala University 60 participants Est. completion 2025-12-31 1 site
    Other conditions: Sleep Deprivation, Menstrual Cycle, Brain Health, Metabolism, Microbiota, Immune System
    View official trial listing →
  • Recruiting NCT NCT06686537

    Convergent Mechanisms Underlying Reprometabolic Syndrome in Women

    Not yet reported University of Colorado, Denver 20 participants Est. completion 2027-12 2 sites
    Other conditions: Infertility, Female, Obesity
    View official trial listing →
  • Recruiting NCT NCT06690866

    Negative Emotionality and Epigenetics During Puberty

    International Research Training Group 2804 100 participants Est. completion 2026-04 1 site
    Other conditions: Puberty, Healthy, Stress
    View official trial listing →
  • Recruiting NCT NCT06704516

    COmmencing Menopausal HOrmone Replacement Therapy and the Effect on Metabolic-dysfunction Associated Steatotic Liver Disease: a Pilot Mechanistic Study

    Not yet reported University of Oxford 10 participants Est. completion 2026-01-01 1 site
    MASLD Other conditions: Menopause
    View official trial listing →
  • Recruiting NCT NCT06726148

    Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and in Patients With Other Advanced Solid Tumors

    Not yet reported, Not yet reported Novartis Pharmaceuticals 280 participants Est. completion 2028-09-25 33 sites
    Other conditions: Advanced HR+/HER2- Breast Cancer, Advanced CCNE1-amplified Solid Tumors, Extensive-stage Small Cell Lung Cancer
    View official trial listing →
  • Recruiting NCT NCT06734533

    Anlotinib-based Combination Therapy in Patients with Hormone Receptor-positive(HR+) Metastatic Breast Cancer(MBC) .

    Hunan Cancer Hospital 80 participants Est. completion 2025-12-30 1 site
    Other conditions: HR+ Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT06736704

    SNV4818 in Participants With Advanced Solid Tumors

    Not yet reported, Not yet reported Pikavation Therapeutics, Inc. 320 participants Est. completion 2027-06 12 sites
    Other conditions: Advanced Solid Tumors
    View official trial listing →
  • Recruiting NCT NCT06737380

    UC-MSC Cell Therapy Study for Systemic Lupus Erythematosus (SLE) Patients

    Not yet reported LiveKidney.Bio 10 participants Est. completion 2026-07 1 site
    Other conditions: SLE, Lupus, Systemic Lupus Erthematosus, Systemic Lupus Erythematosus, Systemic Lupus Erythematosus (SLE)
    View official trial listing →
  • Recruiting NCT NCT06738966

    A Study of BL0175 Injection in Postmenopausal Female Adults With HR-positive, Locally Advanced or Metastatic Cancer

    Not yet reported Shanghai Best-Link Bioscience, LLC 9 participants Est. completion 2027-12-26 2 sites Stand-alone
    Other conditions: Breast Cancer, Ovarian Cancer, Endometrial Cancer
    View official trial listing →
  • Recruiting NCT NCT06745466

    Disentangling the Effects of Daily Stress, Sleep, and Sex Hormones on Accelerated Vascular Aging in Midlife Women

    Not yet reported University of Delaware 30 participants Est. completion 2027-10 1 site Stand-alone
    Other conditions: Estrogen, Premenopause
    View official trial listing →
  • Recruiting NCT NCT06756932

    BGB-21447 (Bcl-2 Inhibitor) Combinations for Adults With Hormone-Receptor Positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Metastatic Breast Cancer

    Not yet reported BeOne Medicines 120 participants Est. completion 2027-07-30 14 sites
    Other conditions: Hormone-receptor-positive Breast Cancer, HER2-negative Breast Cancer, Metastatic Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT06757634

    Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)

    Not yet reported Celcuity Inc 1180 participants Est. completion 2033-07-30 203 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT06758128

    Genetic and Immunity in Heart Failure

    Fondazione Policlinico Universitario Agostino Gemelli IRCCS 215 participants Est. completion 2026-09-30 2 sites
    Heart failure
    View official trial listing →
  • Recruiting NCT NCT06784193

    Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors

    Not yet reported Olema Pharmaceuticals, Inc. 180 participants Est. completion 2027-08-30 25 sites Stand-alone
    Other conditions: Advanced or Metastatic ER+ HER2- Breast Cancer (mBC), Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC), Advanced or Metastatic Castration-Resistant Prostate Cancer (mCRPC), Metastatic Breast Cancer, Fulvestrant, Palazestrant
    View official trial listing →
  • Recruiting NCT NCT06785129

    Endometriosis and Migraine

    Washington University School of Medicine 120 participants Est. completion 2030-01-01 1 site
    Other conditions: Migraine, Endometriosis
    View official trial listing →
  • Recruiting NCT NCT06798571

    Role of Menopause in Thermoregulation

    Not yet reported Penn State University 24 participants Est. completion 2026-12-01 1 site Stand-alone
    Other conditions: Menopause, Aging
    View official trial listing →
  • Recruiting NCT NCT06807580

    Progesterone in Gender Affirming Hormone Therapy Study

    Not yet reported Emory University 40 participants Est. completion 2027-02 1 site
    Other conditions: Transgender Women
    View official trial listing →
  • Recruiting NCT NCT06840093

    Outcomes of Limited Postoperative Restrictions Following Sling Placement: A Randomized Controlled Trial

    Not yet reported University of Iowa 84 participants Est. completion 2027-06-30 1 site Stand-alone
    Other conditions: Postoperative Restriction, Midurethral Sling, Mesh, Stress Urinary Incontinence
    View official trial listing →
  • Recruiting NCT NCT06851754

    Hormone Replacement Therapy in Adolescents With Premature Ovarian Insufficiency

    Not yet reported Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 185 participants Est. completion 2031-12-31 1 site Stand-alone
    Other conditions: Premature Ovarian Insufficiency
    View official trial listing →
  • Recruiting NCT NCT06852365

    Combined Oral Contraceptive Pill and Resistance Starch

    Not yet reported University of Pennsylvania 100 participants Est. completion 2028-04 1 site
    Metabolic syndrome Other conditions: Polycystic Ovary Syndrome
    View official trial listing →
  • Recruiting NCT NCT06856174

    Menopausal HT for Women Living With HIV (HoT)

    Not yet reported Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 105 participants Est. completion 2027-09-20 23 sites
    Other conditions: HIV Infection, Menopause
    View official trial listing →
  • Recruiting NCT NCT06856200

    A Study of Sirolimus (Albumin-Bound) in Combination With Palbociclib and Fulvestrant for the Treatment of Advanced Breast Cancer

    Not yet reported Fudan University 36 participants Est. completion 2026-06 1 site
    Other conditions: Advanced HR - Positive, HER2 - Negative Breast Cancer, Resistant to (Neo)Adjuvant Endocrine Therapy
    View official trial listing →
  • Recruiting NCT NCT06866119

    Effects of Estrogen on Heart Health in Women With Primary Ovarian Insufficiency

    Massachusetts General Hospital 45 participants Est. completion 2029-06-30 1 site
    Other conditions: Primary Ovarian Insufficiency, Premature Menopause, Metabolic Complications, Endothelial Function (FMD), Estrogen Replacement Therapy
    View official trial listing →
  • Recruiting NCT NCT06869486

    Insomnia´s Impact on DNA Stability, Cardio-metabolic Health and Lifestyle Behaviors

    Universidad Autonoma de Baja California 300 participants Est. completion 2026-12-31 1 site
    Other conditions: Insomnia, Cardiorespiratory Fitness, Metabolic Disease
    View official trial listing →
  • Recruiting NCT NCT06873971

    Er:YAG Laser Combined With Vaginal Estriol for Genitourinary Syndrome of Menopause

    Not yet reported University of Nove de Julho 60 participants Est. completion 2026-12-31 1 site
    Other conditions: Genitourinary Syndrome of Menopause
    View official trial listing →
  • Recruiting NCT NCT06896617

    Impact of the Presence of the Corpus Luteum on Pregnancies Obtained Through Frozen Embryo Transfer(FET)

    Not yet reported Fundacion Clinic per a la Recerca Biomédica 334 participants Est. completion 2026-12-20 1 site
    Other conditions: Infertilities, Embryo Transfer
    View official trial listing →
  • Recruiting NCT NCT06905210

    Study of New Antiandrogenic Progestogen + Low-dose Estrogen for Moderate Acne Vulgaris

    Not yet reported Eurofarma Laboratorios S.A. 531 participants Est. completion 2027-03 1 site
    Other conditions: Acne Vulgaris, Acne Vulgaris on the Face
    View official trial listing →
  • Recruiting NCT NCT06933407

    Elastographic Assessment of Suburethral Tissue in Continent and Incontinent Women

    Szeged University 80 participants Est. completion 2030-01-01 1 site
    Other conditions: Urinary Incontinence, Urinary Incontinence, Stress, Urinary Incontinence (UI), Urinary Bladder, Overactive, Incontinence, Overactive Bladder, Stress Urinary Incontinence, Stress Urinary Incontinence (SUI)
    View official trial listing →
  • Recruiting NCT NCT06936930

    Reproductive and Mental Health of Patients With Aplastic Anemia

    Institute of Hematology & Blood Diseases Hospital, China 600 participants Est. completion 2027-12-31 1 site
    Other conditions: Aplastic Anemia, Reproductive Health
    View official trial listing →
  • Recruiting NCT NCT06953076

    Ultrasound Transformation of Myomas During Relugolix-Estradiol-Norethisterone Treatment: The MySaturn Study

    Fondazione Policlinico Universitario Agostino Gemelli IRCCS 111 participants Est. completion 2027-05-02 1 site
    Other conditions: Uterine Bleeding, Uterine Leiomyomas, Uterine Hemorrhage, Uterine Neoplasms
    View official trial listing →
  • Recruiting NCT NCT06954961

    A Study to Evaluate D-0502 in Subjects With ER+ Her2- Locally Advanced or Metastatic Breast Cancer

    Not yet reported InventisBio Co., Ltd 640 participants Est. completion 2028-12-31 2 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT06964906

    Neoadjuvant High-Intensity Focused Ultrasound (HIFU) Combined With Toripalimab and Chemotherapy for ER-Positive /HER2-Negative Breast Cancer

    Not yet reported Second Affiliated Hospital, Zhejiang University, School of Medicine 30 participants Est. completion 2030-12-31 1 site
    Other conditions: ER+/HER2- Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT06969326

    Topical Estrogen: Brief Intervention to Improve Postoperative Experience for Transgender Men Undergoing Hysterectomy

    Not yet reported Women and Infants Hospital of Rhode Island 48 participants Est. completion 2026-12-01 1 site
    Other conditions: Postoperative Bleeding, Gender Dysphoria, Hysterectomy
    View official trial listing →
  • Recruiting NCT NCT06970912

    ctDNA-Guided De-Escalation of Adjuvant Chemotherapy With Dalpiciclib in HR-Positive/HER2-Negative Breast Cancer

    Not yet reported Peking University People's Hospital 393 participants Est. completion 2029-12-31 1 site
    Other conditions: Hormone Receptor-Positive Breast Cancer, High-risk Breast Cancer, Early-Stage Breast Cancer, HER2-negative Breast Cancer, ctDNA Monitoring, Breast Cancer Early Stage Breast Cancer (Stage 1-3)
    View official trial listing →
  • Recruiting NCT NCT06974604

    Preventing Dato-DXd Associated Stomatitis With Dexamethasone Mouthwash, TROPION-DM

    Not yet reported Brown University 60 participants Est. completion 2029-05-31 1 site
    Other conditions: Breast Neoplasms, Lung Neoplasms
    View official trial listing →
  • Recruiting NCT NCT06975111

    Focusing on the Menopausal Transition to Improve Mid-Life Women's Health

    Not yet reported, Not yet reported University of Colorado, Denver 200 participants Est. completion 2030-10-01 3 sites Stand-alone
    Other conditions: Menopause, Menopause Hot Flashes, Menopause Related Conditions, Cardiovascular
    View official trial listing →
  • Recruiting NCT NCT06979596

    A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015)

    Not yet reported Merck Sharp & Dohme LLC 250 participants Est. completion 2027-11-04 60 sites
    Other conditions: Malignant Neoplasm
    View official trial listing →
  • Recruiting NCT NCT06982521

    Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

    Not yet reported Relay Therapeutics, Inc. 540 participants Est. completion 2031-12-31 243 sites
    Other conditions: PIK3CA Mutation, HER2- Negative Breast Cancer, Hormone Receptor Positive Tumor, Breast Cancer, Metastatic Breast Cancer, Advanced Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT06993506

    Real-world Study of SKB264 Monotherapy or Combination Therapy in Recurrent or Metastatic HER2-negative Breast Cancer

    Cancer Institute and Hospital, Chinese Academy of Medical Sciences 500 participants Est. completion 2027-10-31 19 sites
    Other conditions: HER2-negative Breast Cancer, Recurrence, Metastasis
    View official trial listing →
  • Recruiting NCT NCT06995482

    Multiple Ascending Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of KSHN001034 in Healthy Postmenopausal Female Volunteers

    Not yet reported Kashiv BioSciences, LLC 40 participants Est. completion 2026-06 2 sites
    Other conditions: Healthy Postmenopausal Women
    View official trial listing →
  • Recruiting NCT NCT06997029

    A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors

    Not yet reported Bristol-Myers Squibb 234 participants Est. completion 2028-12-14 21 sites
    Other conditions: Advanced Solid Tumor, Advanced Breast Cancer, Advanced Ovarian Cancer
    View official trial listing →
  • Recruiting NCT NCT06998108

    Study of BEBT-209 in Combination With Fulvestrant Versus Placebo in Combination With Fulvestrant in Patients With HR+/HER2- Locally Advanced or Metastatic Breast Cancer Who Have Progressed After Prior Endocrine Therapy

    Not yet reported BeBetter Med Inc 330 participants Est. completion 2026-06-30 1 site
    Other conditions: HR+/HER2- Locally Advanced, Metastatic Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT06998407

    ORION-1: Study of AVZO-023 as a Single Agent and in Combination With AVZO-021, and/or Endocrine Therapy in Advanced Solid Tumors

    Not yet reported, Not yet reported Avenzo Therapeutics, Inc. 380 participants Est. completion 2030-08 16 sites Stand-alone
    Other conditions: HR+/HER2- Breast Cancer, HR+, HER2-, Advanced Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT07010146

    Role of Estrogen on Skeletal Outcomes in FHA

    Not yet reported University of Virginia 150 participants Est. completion 2030-05-31 2 sites
    Other conditions: Bone Strength, Bone Density, FHA (Functional Hypothalamic Amenorrhea)
    View official trial listing →
  • Recruiting NCT NCT07013643

    A Study to Investigate the Effect of AZD6234, AZD9550, and a Combination of AZD9550 and AZD6234 on Pharmacokinetics of Combined Oral Contraceptive Ethinyl Estradiol/Levonorgestrel in Healthy Female Participants Living With Overweight or Obesity

    Not yet reported AstraZeneca 50 participants Est. completion 2027-07-09 2 sites
    Other conditions: Healthy Participants
    View official trial listing →
  • Recruiting NCT NCT07015476

    Retrospective Observational Evaluation of the Bone Mineral Density Outcome in Young Women With Amenorrhea

    IRCCS Azienda Ospedaliero-Universitaria di Bologna 180 participants Est. completion 2026-11 1 site
    Other conditions: Amenorrhea
    View official trial listing →
  • Recruiting NCT NCT07022340

    Hemodynamics After Resistance Training

    Not yet reported University of Michigan 50 participants Est. completion 2026-12 1 site
    Other conditions: Perimenopause
    View official trial listing →
  • Recruiting NCT NCT07024173

    A Phase 3 Study of HRS-8080 Versus Treatment Chosen by Physicians in Locally Advanced and Metastatic Breast Cancer

    Not yet reported Shandong Suncadia Medicine Co., Ltd. 240 participants Est. completion 2027-12 2 sites
    Other conditions: Locally Advanced Breast Cancer, Metastatic Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT07029399

    A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors

    Not yet reported NiKang Therapeutics, Inc. 361 participants Est. completion 2027-12-31 18 sites
    Other conditions: HR+ Breast Cancer, Triple Negative Breast Cancer (TNBC), CCNE1 Amplified Advanced Solid Tumors, HR+ HER2- Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT07030426

    Vaginal Estrogen for Improvement of Outcomes Following Pelvic Organ Prolapse Surgery

    Not yet reported Sarah Wozney 180 participants Est. completion 2029-09-30 2 sites
    Other conditions: Pelvic Organ Prolapse (POP)
    View official trial listing →
  • Recruiting NCT NCT07032506

    Intrauterine Stent Placement Following Hysteroscopic Septum Resection

    Not yet reported Weill Medical College of Cornell University 320 participants Est. completion 2031-12-31 3 sites
    Other conditions: Intrauterine Adhesion
    View official trial listing →
  • Recruiting NCT NCT07037082

    Understanding Cycles to Improve Women's Health

    University Hospital, Montpellier 320 participants Est. completion 2029-07-01 1 site
    Other conditions: Woman of Reproductive Age, Socioeconomic Factors
    View official trial listing →
  • Recruiting NCT NCT07043322

    Clinical Study to Evaluate Efficacy of Cabergoline to Coasting in Reducing the Incidence of Ovarian Hyperstimulation Syndrome

    Not yet reported Tanta University 150 participants Est. completion 2026-11-20 1 site
    Other conditions: Gynecologic Disease
    View official trial listing →
  • Recruiting NCT NCT07053982

    Use of a New Diagnostic Tool in the Detection and Characterization of Endometriosis Lesions

    Not yet reported University Hospital, Toulouse 20 participants Est. completion 2028-03 1 site Stand-alone
    Other conditions: Endometriosis
    View official trial listing →
  • Recruiting NCT NCT07061093

    Prospective Evaluation on the Role Exerted by Hormonal Contraceptives on 24-h Blood Pressure. A Prospective Observational Study

    Ospedale Policlinico San Martino 96 participants Est. completion 2026-01-31 1 site
    Other conditions: Cardiovascular System Diseases (&Amp; [Cardiac])
    View official trial listing →
  • Recruiting NCT NCT07062965

    A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.

    Not yet reported Pfizer 400 participants Est. completion 2030-11-04 202 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT07065643

    Sex Hormones as Regulators of the Age- and Sex-dependent Benefits of Caloric Restriction

    Not yet reported University of Aberdeen 75 participants Est. completion 2027-12 1 site
    Other conditions: Overweight and Obese Adults, Healthy
    View official trial listing →
  • Recruiting NCT NCT07083635

    Transdermal Ethinyl Estradiol and Norelgestromin for Irregular Bleeding in Contraceptive Implant Users

    Not yet reported Chulalongkorn University 40 participants Est. completion 2026-12 1 site
    Other conditions: Menstruation Disturbances, Metrorrhagia, Uterine Hemorrhage, Contraception Behavior
    View official trial listing →
  • Recruiting NCT NCT07084714

    Moderate Aerobic Exercise for Managing Menstrual Cycle Symptoms

    Not yet reported University of Colorado, Colorado Springs 35 participants Est. completion 2026-08 1 site Stand-alone
    Other conditions: Premenstrual Syndrome, Menstrual Cycle, Menstrual Distress (Dysmenorrhea), Menstrual Bleeding, Heavy
    View official trial listing →
  • Recruiting NCT NCT07100106

    A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer

    Not yet reported, Not yet reported Genentech, Inc. 285 participants Est. completion 2028-08-31 64 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT07100782

    Estradiol-mediated Inflammation and Central Sensitization in the Pathophysiology of Endometriosis-associated Pelvic Pain

    Not yet reported University of Michigan 130 participants Est. completion 2028-09 1 site
    Other conditions: Endometriosis, Pelvic Pain
    View official trial listing →
  • Recruiting NCT NCT07109726

    A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

    Not yet reported, Not yet reported Terremoto Biosciences Inc. 205 participants Est. completion 2029-02-28 20 sites
    Other conditions: Breast Cancer, Endometrial Cancer, Ovarian Cancer, Lung Squamous Cell Carcinoma, Head and Neck Squamous Cell Carcinoma, Esophageal Squamous Cell Carcinoma, Solid Tumor, Cervical Cancer
    View official trial listing →
  • Recruiting NCT NCT07110883

    A Clinical Study of SYS6023 in Patients With Advanced Solid Tumors

    Not yet reported CSPC Megalith Biopharmaceutical Co.,Ltd. 400 participants Est. completion 2028-10-31 2 sites Stand-alone
    Other conditions: Advanced Solid Tumor
    View official trial listing →
  • Recruiting NCT NCT07115082

    Clinical Study on the Safety and Efficacy of Human Amniotic Mesenchymal Stem Cells in the Treatment of Premature Ovarian Insufficiency

    Not yet reported, Not yet reported Yan Hongli 50 participants Est. completion 2026-03-30 1 site
    Other conditions: Premature Ovarian Insufficiency
    View official trial listing →
  • Recruiting NCT NCT07117630

    An Open-Label, Bayesian Adaptive Phase II Clinical Study in HR+/HER2- Advanced Breast Cancer After Progression on Standard Therapy

    Not yet reported Fudan University 60 participants Est. completion 2027-12 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT07138222

    IMmune checkPoint Inhibitor Related gonAdal toxiCiTy in Premenopausal Women and Men With Melanoma

    Peter MacCallum Cancer Centre, Australia 80 participants Est. completion 2027-12 6 sites
    Other conditions: Melanoma (Skin Cancer)
    View official trial listing →
  • Recruiting NCT NCT07148921

    Perception of Pain During Gender Affirming Hormone Therapy

    Medical University of Vienna 40 participants Est. completion 2026-03 1 site
    Other conditions: Transgender Persons, Pain Threshold, Perception of Pain, Sex Hormones
    View official trial listing →
  • Recruiting NCT NCT07160504

    Vaginal Estrogen Treatment and Effect on Hemostatic Parameters in Postmenopausal Women

    Not yet reported University of Aarhus 90 participants Est. completion 2026-12-31 1 site
    Other conditions: Vagina Atrophy
    View official trial listing →
  • Recruiting NCT NCT07171970

    IVM - Fresh ET (THE SAIGON PROTOCOL) Versus IVF - FET in PCOS Women

    Not yet reported Mỹ Đức Hospital 600 participants Est. completion 2028-01-15 1 site Stand-alone
    Other conditions: Polycystic Ovary Syndrome (PCOS), In Vitro Maturation of Oocytes, Fresh Embryo Transfer
    View official trial listing →
  • Recruiting NCT NCT07174336

    A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

    Not yet reported Eli Lilly and Company 800 participants Est. completion 2033-05 361 sites
    Other conditions: Breast Neoplasms, Neoplasm Metastasis
    View official trial listing →
  • Recruiting NCT NCT07180160

    Iparomlimab and Tuvonralimab (QL1706) in Patients With HR-positive, HER2-negative Advanced Breast Cancer

    Not yet reported Wenjin Yin 123 participants Est. completion 2028-03 1 site
    Other conditions: Advanced Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT07187947

    Cardiovascular Health of Transgender Individuals During the Gender-affirming Pathway

    IRCCS Azienda Ospedaliero-Universitaria di Bologna 500 participants Est. completion 2035-12-31 1 site
    Cardiovascular disease Other conditions: Gender Incongruence, Cardiovascular (CV) Risk, Cardiovascular Health Status
    View official trial listing →
  • Recruiting NCT NCT07191717

    Imlunestrant and Abemaciclib for the Treatment of Estrogen Receptor Positive Breast Cancer in Patients With Minimal Residual Disease, MIRI Trial

    Not yet reported Jonsson Comprehensive Cancer Center 42 participants Est. completion 2031-04-30 1 site
    Other conditions: Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, Invasive Breast Carcinoma, Localized Estrogen Receptor-Positive Breast Carcinoma, Localized Human Epidermal Growth Factor Receptor (HER2)-Negative Breast Carcinoma
    View official trial listing →
  • Recruiting NCT NCT07198724

    ERADICATE: A Phase Ib/II Study of Elacestrant Plus Trastuzumab Deruxtecan in Patients With CDK4/6 Inhibitor and Endocrine-resistant HR+/HER2-low or HER2-ultralow Metastatic Breast Cancer

    Not yet reported, Not yet reported Kristina A. Fanucci 65 participants Est. completion 2038-06-01 1 site Stand-alone
    Other conditions: Metastatic Breast Cancer, HER2 Low Breast Carcinoma, HER2-negative Breast Cancer, Breast Cancer, Breast Cancer Female
    View official trial listing →
  • Recruiting NCT NCT07207070

    A Randomised, Open-label, Multicentre Phase III Clinical Study to Evaluate the Efficacy and Safety of JS105 Combined With Dalpiciclib and Fulvestrant Compared With Dalpiciclib and Fulvestrant in Patients With PIK3CA-mutated, HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer.

    Not yet reported Risen (Suzhou) Pharma Tech Co., Ltd. 312 participants Est. completion 2030-05-31 2 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT07209449

    A Study of Elacestrant Alone or in Combination With Abemaciclib in People With Endometrial Cancer

    Not yet reported Memorial Sloan Kettering Cancer Center 75 participants Est. completion 2028-10-01 7 sites
    Other conditions: Endometrial Cancer
    View official trial listing →
  • Recruiting NCT NCT07222215

    PhII Randomized CAPecitabine + ELAcestrant vs. Capecitabine Alone in ER+ Breast Cancer (CAPELA)

    Not yet reported Kristina A. Fanucci 297 participants Est. completion 2030-10-01 1 site Stand-alone
    Other conditions: Estrogen-receptor-positive Breast Cancer, Metastatic Breast Cancer, Breast Cancer, Hormone Receptor Positive Breast Cancer, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast, HER2- Breast Cancer, ESR1 Gene Mutation, ER Wildtype, Breast Neoplasms
    View official trial listing →
  • Recruiting NCT NCT07222267

    An Investigational Study of BG-75202 Alone and in Combination With Other Therapeutic Agents in Adults With Advanced Solid Tumors

    Not yet reported BeOne Medicines 86 participants Est. completion 2037-01-13 31 sites Stand-alone
    Other conditions: Breast Cancer, Advanced Solid Tumor
    View official trial listing →
  • Recruiting NCT NCT07226349

    A Study of BG-75098 Alone and in Combination With Other Agents in Adults With Advanced Solid Tumors

    Not yet reported BeOne Medicines 105 participants Est. completion 2028-11-01 23 sites
    Other conditions: Advanced Solid Tumor
    View official trial listing →
  • Recruiting NCT NCT07242131

    Efficacy of Oral Contraceptive, Progesterone, and Inositol on Menstrual Regulation in PCOS

    Not yet reported Ege University 150 participants Est. completion 2026-06-01 1 site
    Other conditions: Polycystic Ovary Syndrome (PCOS)
    View official trial listing →
  • Recruiting NCT NCT07242352

    Marker - Adjusted Therapy Comparing Adjuvant Elacestrant With Standard Endocrine Treatment in Genomically and/or Clinically High-risk ER+/HER2- eBC

    Not yet reported Women's Cancer Study Group GmbH 1520 participants Est. completion 2033-09-30 33 sites
    Other conditions: Breast Cancer, HR+/HER2- Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT07254429

    COMPASS - COpenhagen MenoPAuSe Study

    Not yet reported Martin Blomberg Jensen 192 participants Est. completion 2028-05 1 site
    Other conditions: Menopausal Osteoporosis, Bone Markers
    View official trial listing →
  • Recruiting NCT NCT07262138

    Active Surveillance in Older Women With ER+ Breast Cancer

    University of Pittsburgh 50 participants Est. completion 2030-12-31 1 site
    Other conditions: Early Stage Estrogen Receptor (ER) Positive Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT07268183

    How Estrogen Fluctuations Before Diagnosis Affect the Size Prolactin-secreting Tumors

    Hospices Civils de Lyon 180 participants Est. completion 2027-01-06 1 site
    Other conditions: Prolactinoma, Macroprolactinoma
    View official trial listing →
  • Recruiting NCT NCT07278323

    Frozen Shoulder and Hormone Replacement Therapy

    Not yet reported University of California, San Francisco 60 participants Est. completion 2026-12 1 site Stand-alone
    Other conditions: Adhesive Capsulitis of the Shoulder, Frozen Shoulder
    View official trial listing →
  • Recruiting NCT NCT07287098

    A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer

    Not yet reported Eli Lilly and Company 600 participants Est. completion 2029-12 88 sites
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Recruiting NCT NCT07287917

    Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors

    Not yet reported, Not yet reported Aminex Therapeutics, Inc. 92 participants Est. completion 2028-12-29 20 sites
    Other conditions: Melanoma (Skin Cancer), HER2-low Hormone Receptor Positive Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT07288359

    Study of GVV858 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors

    Not yet reported, Not yet reported Novartis Pharmaceuticals 205 participants Est. completion 2031-05-09 15 sites
    Other conditions: Advanced HR+/HER2- Breast Cancer, Advanced CCNE1-amplified Solid Tumors, Metastatic Castration-resistant Prostate Cancer
    View official trial listing →
  • Recruiting NCT NCT07314073

    [18F]FES PET/CT for the Detection of Distant Metastasis in Low-grade ER-positive Stage III Breast Cancer

    Not yet reported Asan Medical Center 85 participants Est. completion 2029-12-31 1 site
    Other conditions: Stage III Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT07318805

    A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors

    Not yet reported Pfizer 260 participants Est. completion 2030-04-14 13 sites Stand-alone
    Other conditions: Advanced Breast Cancer, Metastatic Breast Cancer (HR+/ HER2-), Colorectal Cancer, Metastatic Colorectal Adenocarcinoma, Triple Negative Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT07338955

    Validating and Assessing Reliability

    Bahria University 385 participants Est. completion 2026-01-20 1 site
    Other conditions: Upper Limb Disability
    View official trial listing →
  • Recruiting NCT NCT07340190

    A Drug-drug Interaction Study to Evaluate the Effects of Pelabresib on the Pharmacokinetics of Repaglinide, Midazolam, and Combined Oral Contraceptive in Patients With Advanced Malignancies

    Not yet reported Novartis Pharmaceuticals 24 participants Est. completion 2028-04-07 6 sites
    Other conditions: Advanced Malignancies
    View official trial listing →
  • Recruiting NCT NCT07340541

    Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies

    Not yet reported UNC Lineberger Comprehensive Cancer Center 700 participants Est. completion 2031-06-02 6 sites Stand-alone
    Other conditions: Breast Cancer, Metastatic Breast Cancer, Triple Negative Breast Cancer, Estrogen-receptor-positive Breast Cancer, Hormone Receptor Negative Breast Carcinoma
    View official trial listing →
  • Recruiting NCT NCT07347600

    A Study to Evaluate the Effectiveness and Safety of Inavolisib in Participants With Endocrine-resistant, PIK3CA-mutated, Hormone Receptor-positive, HER2-negative Locally Advanced or Metastatic Breast Cancer

    Hoffmann-La Roche 500 participants Est. completion 2029-12-31 30 sites
    Other conditions: Locally Advanced Breast Cancer, Metastatic Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT07358468

    Association Between Peri-Transfer Endometrial Peristalsis And Live Birth In Modified Natural Cycle Frozen Embryo Transfer: A Prospective Cohort Study

    Mỹ Đức Hospital 384 participants Est. completion 2027-12-01 2 sites
    Other conditions: Infertility, Endometrial Peristalsis, Uterine Contraction, Endometrial Waves, Frozen Embryo Transfer (FET), Uterine Peristalsis
    View official trial listing →
  • Recruiting NCT NCT07361263

    Plasma Oxytocin Response to Oral Estrogens in Healthy Controls and AVP-Deficiency

    Not yet reported University Hospital, Basel, Switzerland 28 participants Est. completion 2027-02 1 site Stand-alone
    Other conditions: AVP Deficiency, Diabetes Insipidus
    View official trial listing →
  • Recruiting NCT NCT07368998

    To Study the Effect of Inavolisib in Combination With Fulvestrant in Participants With Breast Cancer

    Not yet reported Hoffmann-La Roche 80 participants Est. completion 2031-10-31 34 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT07389733

    A Study of HRS-6208 in Combination With HRS-8080, or Fulvestrant, or Letrozole, With or Without HRS-6209 in Patients With Advanced Unresectable or Metastatic Breast Cancer

    Not yet reported, Not yet reported Shandong Suncadia Medicine Co., Ltd. 180 participants Est. completion 2028-12 2 sites
    Other conditions: Advanced Unresectable or Metastatic Breast Cancer of Adults
    View official trial listing →
  • Recruiting NCT NCT07400419

    Effects of Resistance Exercise Among TGD Individuals Initiating Estrogen-Based Gender-Affirming Hormone Therapy

    Not yet reported Massachusetts General Hospital 40 participants Est. completion 2028-04-01 1 site
    Other conditions: Muscle Mass and Strength
    View official trial listing →
  • Recruiting NCT NCT07400523

    Ribociclib in Hormone Receptor-positive, HER2-negative Early Breast Cancer With Residual Disease After Neoadjuvant Chemotherapy

    Not yet reported Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 446 participants Est. completion 2031-02-10 4 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT07405801

    A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus Ribociclib Plus Fulvestrant in Participants With Advanced Breast Cancer

    Not yet reported Hoffmann-La Roche 80 participants Est. completion 2030-02-26 58 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT07406412

    Hormonal Regulation of Cardiometabolic Health Study

    University of Jyvaskyla 120 participants Est. completion 2028-12-15 7 sites
    Other conditions: Menopause Surgical
    View official trial listing →
  • Recruiting NCT NCT07419594

    Estradiol and Intrusive Memories

    Not yet reported Charite University, Berlin, Germany 273 participants Est. completion 2028-02-29 1 site Stand-alone
    Other conditions: PTSD, Intrusive Memories, Intrusion Symptom, Trauma, Intrusion
    View official trial listing →
  • Recruiting NCT NCT07421895

    A Prospective Multicenter Observational Real-world Study of Retained Products of Conception

    The Third Xiangya Hospital of Central South University 600 participants Est. completion 2032-12-31 1 site
    Other conditions: Retained Products of Conception, RPOC
    View official trial listing →
  • Recruiting NCT NCT07421908

    Investigating the Association Between Diagnostic and Therapeutic Management Models and Prognosis of Intrauterine Adhesions Based on a Large-Scale Prospective Cohort Study

    Not yet reported The Third Xiangya Hospital of Central South University 5000 participants Est. completion 2035-03-01 1 site Stand-alone
    Other conditions: Intrauterine Adhesion
    View official trial listing →
  • Recruiting NCT NCT07422506

    A Real-World Study Comparing the Efficacy of Different Treatment Regimens for Early Missed Abortion

    Not yet reported The Third Xiangya Hospital of Central South University 580 participants Est. completion 2035-01-01 1 site Stand-alone
    Other conditions: Missed Abortion, Early Pregnancy Failure
    View official trial listing →
  • Recruiting NCT NCT07425990

    FET-LET-2x2: Clinical Pregnancy Rates After Frozen Embryo Transfer in Natural and Modified Natural Cycles

    Not yet reported University of Novi Sad 120 participants Est. completion 2027-03 1 site
    Other conditions: Infertility Female, Frozen Embryo Transfer (FET)
    View official trial listing →
  • Recruiting NCT NCT07426822

    Rash & Diarrhea Prophylaxis With Capivasertib

    Not yet reported Maryam Lustberg 108 participants Est. completion 2029-04 1 site
    Other conditions: Metastatic HR+/HER2- Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT07427394

    Study to Evaluate the Safety and Tolerability of Camizestrant in Combination With Atirmociclib in Women With Advanced Breast Cancer

    Not yet reported AstraZeneca 24 participants Est. completion 2027-12-28 6 sites
    Other conditions: Advanced Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT07446400

    A Trial to Examine the Interaction of Repinatrabit With Ethinyl Estradiol/Norethindrone, Metformin,Carbamazepine, Rosuvastatin, and Methotrexate When Administered Together

    Not yet reported Otsuka Pharmaceutical Development & Commercialization, Inc. 48 participants Est. completion 2026-11-07 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Recruiting NCT NCT07467772

    Ph 2 Elacestrant in ER Positive Uterine Sarcomas

    Not yet reported Dana-Farber Cancer Institute 30 participants Est. completion 2028-04 1 site Stand-alone
    Obstructive sleep apnea Other conditions: Uterine Sarcoma, Endometrial Stromal Sarcoma, ESS, Perivascular Epithelioid Cell Tumors, Uterine PEComa, Estrogen Receptor Positive Tumor, uLMS
    View official trial listing →
  • Recruiting NCT NCT07498478

    Efficacy and Safety of Tinengotinib Tablets Combined With Fulvestrant Injection in Patients With HR Positive and HER-2 Negative Recurrent or Metastatic Breast Cancer Who Have Failed Prior Treatment

    Not yet reported TransThera Sciences (Nanjing), Inc. 94 participants Est. completion 2027-12-31 13 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT07499804

    Effect of Tadalafil on Endometrial Thickness and Frozen Embryo Transfer Outcomes

    Not yet reported Beni-Suef University 100 participants Est. completion 2026-04-30 1 site
    Other conditions: IVF, Infertility, Female
    View official trial listing →
  • Recruiting NCT NCT07499817

    Effect of Pentoxyfilline on Endometrial Thickness and Frozen Embryo Transfer Outcomes

    Not yet reported Beni-Suef University 100 participants Est. completion 2026-04-30 1 site
    Other conditions: Embryo Transfer, IVF, Infertility
    View official trial listing →
  • Recruiting NCT NCT07539090

    Evaluate the Effect of Vimseltinib on Pharmacokinetics of Combined Oral Contraceptive (Ethinyl Estradiol/Levonorgestrel)

    Not yet reported Deciphera Pharmaceuticals, LLC 24 participants Est. completion 2026-10 1 site
    Other conditions: Healthy Participants
    View official trial listing →
  • Recruiting NCT NCT07540572

    A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors

    Not yet reported IDEAYA Biosciences 160 participants Est. completion 2030-06-30 11 sites
    Obstructive sleep apnea Other conditions: ER+, HER 2- Breast Cancer, Non-small Cell Lung Cancer (NSCLC), Castration-resistant Prostate Cancer (CRPC)
    View official trial listing →
  • Recruiting NCT NCT07541079

    A Study Evaluating Adherence, Tolerability, and Patient Reported Outcomes of Giredestrant in Participants With ER+/HER2- Early Breast Cancer Who Are Intolerant to Adjuvant Aromatase Inhibitor Therapy (novERA Breast Cancer)

    Not yet reported Genentech, Inc. 300 participants Est. completion 2034-06-30 2 sites
    Other conditions: Early Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT07568509

    Identifying Oxytocin Deficiency in Pediatric Patients With Pituitary Disease

    Not yet reported Massachusetts General Hospital 20 participants Est. completion 2027-04 1 site
    Other conditions: Arginine Vasopressin Deficiency, Oxytocin Deficiency, Pediatric Disease, Hypopituitarism
    View official trial listing →
  • Recruiting NCT NCT07580846

    ATENEA Study: Adherence to Creatine-Based Nutritional Supplementation in Estrogen-Depleted Women

    Margan Biotech 100 participants Est. completion 2026-10-01 4 sites
    Other conditions: Menopause, Estrogen Deficiency
    View official trial listing →
  • Recruiting NCT NCT07580950

    The Research of Integrated Traditional Chinese and Western Medicine on Hypothalamic Amenorrhea

    Not yet reported Peking Union Medical College Hospital 210 participants Est. completion 2028-06-30 1 site
    Other conditions: Functional Hypothalamic Amenorrhea
    View official trial listing →
  • Recruiting NCT NCT07604272

    Reversing InGuinal Hernia Trial: The Evaluation of Sex Hormones to Reverse Inguinal Hernias in Males

    Not yet reported Northwestern University 30 participants Est. completion 2028-07 1 site
    Other conditions: Inguinal Hernia Unilateral, Inguinal Hernia Bilateral, Inguinal Hernia Without Obstruction or Gangrene, Inguinal Hernia, Without Mention of Obstruction or Gangrene
    View official trial listing →
  • Recruiting NCT NCT07604571

    Study of IEV407 as Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer

    Not yet reported Novartis Pharmaceuticals 194 participants Est. completion 2032-06-08 7 sites
    Other conditions: Advanced HR+/HER2- Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT07612215

    Elacestrant in Advanced Triple Positive Breast Cancer

    Not yet reported, Not yet reported NYU Langone Health 50 participants Est. completion 2030-05 1 site Stand-alone
    Other conditions: ER Positive, HER2 Positive Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT07616427

    Fovinaciclib Plus Aromatase Inhibitors and Dual HER2 Blockade in a Response-Adapted Neoadjuvant Strategy for HR-Positive/HER2-Positive Early Breast Cancer

    Not yet reported Second Affiliated Hospital, Zhejiang University, School of Medicine 100 participants Est. completion 2033-05-20 3 sites
    Other conditions: HR+/HER2+ Early Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT07616453

    Efficacy and Safety of Culmerciclib Plus Aromatase Inhibitors in a Response-Adapted Neoadjuvant Strategy for Highly Proliferative ER-Positive/HER2-Negative Breast Cancer

    Not yet reported Second Affiliated Hospital, Zhejiang University, School of Medicine 45 participants Est. completion 2033-05-05 1 site
    Other conditions: HR+/HER2- Early Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT07617454

    Effects of Estrogen on Muscle Gain During 12-weeks of Exercise in Post-menopausal Women

    Not yet reported Mette Hansen 30 participants Est. completion 2027-08-01 1 site Stand-alone
    Other conditions: Menopause Related Conditions, Exercise Training
    View official trial listing →
  • Recruiting NCT NCT07620587

    The Role of Estradiol and Progesterone on Appetite Regulation and Energy Balance

    Not yet reported Wilfrid Laurier University 60 participants Est. completion 2028-08-31 1 site
    Other conditions: Energy Balance, Physiology - Regulation of Appetite and Food Intake
    View official trial listing →
  • Recruiting NCT NCT07647328

    A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer

    Not yet reported AstraZeneca 150 participants Est. completion 2029-02-28 89 sites
    Other conditions: ER-Positive HER2-Negative Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT07649356

    Significance of Estrogen Status for Muscle Function, Physical Fitness, and Physiological Health Parameters - a Comparison of Age-matched Groups of Women Before and After Menopause.

    Mette Hansen 30 participants Est. completion 2027-08-01 1 site
    Other conditions: Muscle Mass and Strength, Menopause
    View official trial listing →
  • Recruiting NCT NCT07666555

    A Phase II Clinical Study of the Efficacy and Safety of Culmerciclib Rechallenge in HR-positive, HER2-negative Breast Cancer Patients With Resistance to First-line Endocrine Therapy.

    Not yet reported Fudan University 98 participants Est. completion 2029-12-30 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT07675213

    Endometrial Peristalsis and Pregnancy Outcomes in Hormone Replacement Therapy (HRT) - Frozen Embryo Transfer (FET) Cycles

    Mỹ Đức Hospital 442 participants Est. completion 2027-12-01 1 site
    Other conditions: Infertility, Endometrial Peristalsis, Uterine Contraction, Endometrial Waves, Frozen Embryo Transfer (FET), Uterine Peristalsis, Hormone Replacement Therapy (HRT)
    View official trial listing →
  • Recruiting NCT NCT07686718

    To Establish Whether Individuals With Premenstrual Dysphoric Disorder (PMDD) Demonstrate a Different Luteal-phase Sex Hormone Profile and Ratio Compared With Asymptomatic Controls.

    Lancaster University 50 participants Est. completion 2027-08-01 1 site
    Other conditions: Premenstrual Dysphoric Disorder ( PMDD)
    View official trial listing →
  • Recruiting NCT NCT07697781

    Office Hysteroscopy in Postmenopausal Women: A Randomized Trial of Cervical Preparation Strategies

    Not yet reported Faculty of Medicine of Tunis 120 participants Est. completion 2026-09-30 1 site Stand-alone
    Other conditions: Postmenopausal Women, Intrauterine Diseases, Endometrial Pathology, Postmenopausal Bleeding, Abnormal Uterine Bleeding (AUB)
    View official trial listing →
  • Recruiting NCT NCT07697924

    CURENDO (Cord-blood Uterine Regeneration Endometrium): Platelet-rich Plasma Therapy Derived From Umbilical Cord Blood for the Treatment of Endometrial Pathologies (Asherman Syndrome / Endometrial Atrophy / Thin Endometrium)

    Not yet reported Fundación IVI 35 participants Est. completion 2029-12 1 site
    Other conditions: Asherman Syndrome
    View official trial listing →
  • Recruiting NCT NCT07704658

    Pralsetinib DDI Study in Patients With Advanced or Metastatic Solid Tumors

    Not yet reported Rigel Pharmaceuticals 12 participants Est. completion 2027-08-30 2 sites
    Other conditions: NSCLC (Non-small Cell Lung Cancer), Thyroid Cancer, Solid Tumor Malignancies, Advanced Malignancies
    View official trial listing →
  • Recruiting NCT NCT07792408

    Effects of VX-407 on the Pharmacokinetics of Combined Oral Contraceptives

    Not yet reported Vertex Pharmaceuticals Incorporated 148 participants Est. completion 2027-03-20 1 site
    Other conditions: Autosomal Dominant Polycystic Kidney Disease (ADPKD)
    View official trial listing →
  • Recruiting NCT NCT07794150

    A Study to Assess the Skin Irritation and Sensitization of Estradiol/Levonorgestrel TDS in Healthy Postmenopausal Subjects

    Not yet reported Corium Innovations, Inc. 250 participants Est. completion 2027-05-31 2 sites
    Other conditions: Menopause, Healthy Female Participants
    View official trial listing →
  • Recruiting NCT NCT07795736

    Charactertizing Growth Hormone Deficiency in Traumatic Brain Injury

    University of Calgary 200 participants Est. completion 2028-11-01 2 sites
    Other conditions: Growth Hormone Deficiency, Traumatic Brain Injury
    View official trial listing →
  • Recruiting NCT NCT07796880

    Neoadjuvant Culmerciclib Combined With Endocrine Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer

    Not yet reported Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 80 participants Est. completion 2033-03-15 1 site
    Other conditions: Hormone Receptor-Positive Breast Cancer, HER2 Low Breast Carcinoma, Early-Stage Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT07831499

    Cyclic vs. Constant Estradiol: Regimens' Effects on Brain Health

    Not yet reported University of Colorado, Denver 40 participants Est. completion 2028-07-15 1 site
    Other conditions: Menopause, Healthy Adult, Brain, Postmenopausal
    View official trial listing →
  • Terminated NCT NCT00000175

    The Effects of Sex Hormones on Cognition and Mood in Older Adults

    Not yet reported National Institute on Aging (NIA) Est. completion 2005-06 1 site
    Other conditions: Cognition Disorders, Mood Disorders
    View official trial listing →
  • Completed NCT NCT00000176

    Alzheimer's Disease Prevention Trial

    Not yet reported National Institute on Aging (NIA) Est. completion 2007-09 22 sites
    Other conditions: Alzheimer Disease, Memory Disorders
    View official trial listing →
  • Completed NCT NCT00000177

    Estrogen Hormone Protocol

    Not yet reported National Institute on Aging (NIA) 120 participants Est. completion 1999-01 25 sites
    Other conditions: Alzheimer Disease
    View official trial listing →
  • Completed NCT NCT00000380

    Growth Hormone Releasing Hormone (GHRH) Treatment for Age-Related Sleep Disturbances

    Not yet reported University of Washington Est. completion 2007-07
    Other conditions: Sleep Disorders
    View official trial listing →
  • Completed NCT NCT00000399

    Bone Estrogen Strength Training

    Not yet reported University of Arizona 300 participants Est. completion 2001-01 1 site
    Other conditions: Osteoporosis
    View official trial listing →
  • Terminated NCT NCT00000419

    Safety of Estrogens in Lupus: Hormone Replacement Therapy

    Not yet reported NYU Langone Health 350 participants Est. completion 2002-08 16 sites
    Other conditions: Systemic Lupus Erythematosus
    View official trial listing →
  • Completed NCT NCT00000420

    Safety of Estrogens in Lupus: Birth Control Pills

    Not yet reported NYU Langone Health 350 participants Est. completion 2003-08 15 sites
    Other conditions: Systemic Lupus Erythematosus
    View official trial listing →
  • Completed NCT NCT00000421

    Serologically Active, Clinically Stable Systemic Lupus Erythematosus

    Not yet reported NYU Langone Health 154 participants Est. completion 2003-08 3 sites
    Other conditions: Systemic Lupus Erythematosus
    View official trial listing →
  • Terminated NCT NCT00000430

    Low-Dose Hormone Replacement Therapy and Alendronate for Osteoporosis

    Not yet reported National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 240 participants Est. completion 2004-09 1 site
    Other conditions: Osteopenia, Osteoporosis
    View official trial listing →
  • Completed NCT NCT00000466

    Postmenopausal Estrogen/Progestin Interventions (PEPI)

    Not yet reported National Heart, Lung, and Blood Institute (NHLBI) Est. completion 2000-10
    Cardiovascular disease Other conditions: Bone Diseases, Coronary Disease, Diabetes Mellitus, Heart Diseases, Hypercholesterolemia, Hypertension, Myocardial Ischemia, Osteoporosis, Thrombosis, Postmenopause
    View official trial listing →
  • Completed NCT NCT00000482

    Coronary Drug Project

    Not yet reported National Heart, Lung, and Blood Institute (NHLBI) Est. completion 1985-03
    Cardiovascular disease Other conditions: Coronary Disease, Heart Diseases, Myocardial Ischemia
    View official trial listing →
  • Completed NCT NCT00000483

    Coronary Drug Project Mortality Surveillance

    Not yet reported National Heart, Lung, and Blood Institute (NHLBI) Est. completion 1985-03
    Cardiovascular disease Other conditions: Coronary Disease, Heart Diseases, Myocardial Ischemia
    View official trial listing →
  • Completed NCT NCT00000549

    Estrogen Replacement and Atherosclerosis (ERA) in Older Women

    Not yet reported National Heart, Lung, and Blood Institute (NHLBI) Est. completion 2000-07
    Cardiovascular disease Other conditions: Coronary Arteriosclerosis, Coronary Disease, Heart Diseases, Myocardial Ischemia, Postmenopause
    View official trial listing →
  • Completed NCT NCT00000555

    Women's Angiographic Vitamin and Estrogen Trial (WAVE)

    Not yet reported National Heart, Lung, and Blood Institute (NHLBI) Est. completion 2003-05
    Cardiovascular disease Other conditions: Coronary Arteriosclerosis, Coronary Disease, Heart Diseases, Myocardial Ischemia, Postmenopause
    View official trial listing →
  • Completed NCT NCT00000601

    Postmenopausal Hormone Therapy in Unstable Angina

    Not yet reported National Heart, Lung, and Blood Institute (NHLBI) Est. completion 2000-06
    Cardiovascular disease Other conditions: Angina, Unstable, Coronary Disease, Heart Diseases, Postmenopause
    View official trial listing →
  • Completed NCT NCT00000605

    Estrogen and Graft Atherosclerosis Research Trial (EAGER)

    Not yet reported National Heart, Lung, and Blood Institute (NHLBI) Est. completion 2002-07
    Cardiovascular disease Other conditions: Coronary Arteriosclerosis, Coronary Disease, Heart Diseases, Myocardial Ischemia, Postmenopause
    View official trial listing →
  • Completed NCT NCT00000611

    Women's Health Initiative (WHI)

    Not yet reported National Heart, Lung, and Blood Institute (NHLBI)
    Cardiovascular disease Other conditions: Bone Diseases, Breast Neoplasms, Colonic Neoplasms, Coronary Disease, Heart Diseases, Myocardial Ischemia, Osteoporosis, Postmenopause
    View official trial listing →
  • Completed NCT NCT00000612

    Soy Estrogen Alternative Study (SEA)

    Not yet reported National Heart, Lung, and Blood Institute (NHLBI) Est. completion 1998-12
    Cardiovascular disease Other conditions: Endometrial Hyperplasia, Heart Diseases, Menopausal Complaints, Uterine Diseases, Menopause
    View official trial listing →
  • Completed NCT NCT00000897

    A Study to Evaluate the Effects of Different Methods of Birth Control on the Drug Actions of Zidovudine (an Anti-HIV Drug) in HIV-Positive Women and to Compare Zidovudine Metabolism in Men and Women

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 42 participants 6 sites
    Other conditions: HIV Infections
    View official trial listing →
  • Completed NCT NCT00001221

    Effect of Biosynthetic Growth Hormone and/or Ethinyl Estradiol on Adult Height in Patients With Turner Syndrome

    Not yet reported Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 160 participants Est. completion 2003-09 1 site
    Other conditions: Gonadal Dysgenesis, Turner's Syndrome
    View official trial listing →
  • Completed NCT NCT00001253

    The Effects of Estrogen on Cognition in Girls With Turner Syndrome

    Not yet reported Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 950 participants Est. completion 2004-03 1 site
    Other conditions: Gonadal Dysgenesis, Turner's Syndrome
    View official trial listing →
  • Completed NCT NCT00001259

    A Treatment Study for Premenstrual Syndrome (PMS)

    Not yet reported National Institute of Mental Health (NIMH) 60 participants Est. completion 2020-02-06 1 site
    Other conditions: Premenstrual Syndrome, Menstruation Disturbances
    View official trial listing →
  • Completed NCT NCT00001275

    Ovarian Follicle Function in Patients With Primary Ovarian Failure

    Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 1134 participants Est. completion 2017-02-08 1 site
    Other conditions: Amenorrhea, Hypoaldosteronism, Hypogonadism, Infertility, Premature Ovarian Failure
    View official trial listing →
  • Completed NCT NCT00001285

    Effects of Sex Hormones on Circadian Rhythm in Men and Women

    National Institute of Mental Health (NIMH) 73 participants Est. completion 2000-06 1 site
    Other conditions: Bipolar Disorder, Circadian Rhythm, Depressive Disorder
    View official trial listing →
  • Completed NCT NCT00001322

    The Effects of Reproductive Hormones on Mood and Behavior

    Not yet reported, Not yet reported National Institute of Mental Health (NIMH) 100 participants Est. completion 2020-03-03 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT00001343

    The Effects of Hormones in Growth Hormone-Treated Girls With Turner Syndrome

    Not yet reported Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 80 participants Est. completion 2007-10-10 2 sites
    Other conditions: Dwarfism, Turner's Syndrome
    View official trial listing →
  • Completed NCT NCT00001454

    Hormonal Effects on the Uterus and Endometrium

    Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 129 participants Est. completion 2015-07-27 1 site
    Other conditions: Pregnancy
    View official trial listing →
  • Completed NCT NCT00001521

    Three Drug Combination Therapy Versus Conventional Treatment of Children With Congenital Adrenal Hyperplasia

    Not yet reported Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 66 participants Est. completion 2024-04-01 1 site
    Other conditions: Congenital Adrenal Hyperplasia (CAH)
    View official trial listing →
  • Completed NCT NCT00001770

    Progestin (Progesterone-Like Hormones) Induced Dysphoria (Depressed Mood, Irritability, Anxiety)

    National Institute of Mental Health (NIMH) 50 participants Est. completion 2003-03 1 site
    Other conditions: Depressive Disorder, Mood Disorder, Psychomotor Agitation
    View official trial listing →
  • Completed NCT NCT00001848

    The Safety and Effectiveness of Surgery With or Without Raloxifene for the Treatment of Pelvic Pain Caused by Endometriosis

    Not yet reported Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 612 participants Est. completion 2006-01 1 site
    Other conditions: Endometriosis, Pelvic Pain
    View official trial listing →
  • Completed NCT NCT00001890

    Effects of Hormone Therapy on the Immune Systems of Postmenopausal Women With Chronic Infections

    Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 80 participants Est. completion 2001-03 1 site
    Other conditions: Atherosclerosis, Chlamydia Infections, Cytomegalovirus Infections, Pneumonia, Bacterial, Postmenopause
    View official trial listing →
  • Completed NCT NCT00001951

    Hormone Replacement in Young Women With Premature Ovarian Failure

    Not yet reported Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 250 participants Est. completion 2006-10 1 site
    Other conditions: Healthy, Osteoporosis, Premature Ovarian Failure
    View official trial listing →
  • Completed NCT NCT00002721

    Doxorubicin Plus Estramustine in Treating Patients With Metastatic Prostate Cancer

    Not yet reported University of New Mexico 18 participants Est. completion 2013-06 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Status unknown NCT NCT00002775

    Docetaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer

    Not yet reported, Not yet reported Herbert Irving Comprehensive Cancer Center 37 participants 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00002855

    Chemotherapy Plus Hormone Therapy Versus Androgen Suppression in Treating Patients With Metastatic or Unresectable Prostate Cancer

    Not yet reported M.D. Anderson Cancer Center 306 participants Est. completion 2005-06 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00002967

    Octreotide, Tamoxifen, and Chemotherapy in Treating Women With Breast Cancer

    Not yet reported NSABP Foundation Inc Est. completion 2006-03 108 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT00003066

    Docetaxel Combined With Estramustine in Treating Women With Metastatic Breast Cancer

    Not yet reported Herbert Irving Comprehensive Cancer Center 40 participants 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00003084

    Combination Chemotherapy With Ketoconazole in Treating Patients With Prostate Cancer

    Not yet reported M.D. Anderson Cancer Center 75 participants Est. completion 2002-11 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00003098

    Diet and Estrogen Metabolism in Postmenopausal Women

    Not yet reported Jonsson Comprehensive Cancer Center 12 participants Est. completion 2004-06 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00003394

    Combination Chemotherapy in Treating Patients With Advanced Prostate Cancer

    Not yet reported, Not yet reported Memorial Sloan Kettering Cancer Center 18 participants Est. completion 2003-04 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00003584

    Combination Chemotherapy With or Without Prednisone in Treating Patients With Recurrent and/or Metastatic Kidney Cancer

    Not yet reported University of New Mexico 35 participants Est. completion 2000-12 1 site
    Other conditions: Kidney Cancer
    View official trial listing →
  • Status unknown NCT NCT00003633

    Combination Chemotherapy in Treating Patients With Advanced Prostate Cancer

    Not yet reported Herbert Irving Comprehensive Cancer Center 12 participants 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Status unknown NCT NCT00003717

    Paclitaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer

    Not yet reported St. Barnabas Medical Center 17 participants 2 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00003771

    Hormone Replacement Therapy and the Risk of Breast Cancer Recurrence in Women With Previous Early Stage Breast Cancer

    Not yet reported Regional Oncologic Center 1300 participants Est. completion 2004-02 6 sites
    Other conditions: Breast Cancer, Menopausal Symptoms
    View official trial listing →
  • Completed NCT NCT00003992

    Chemotherapy Plus Monoclonal Antibody Therapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Overexpresses HER2

    Not yet reported National Cancer Institute (NCI) 200 participants Est. completion 2009-03 45 sites Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00004001

    S9916, Combination Therapy in Treating Patients With Advanced Prostate Cancer That Has Not Responded to Hormone Therapy

    Not yet reported SWOG Cancer Research Network 770 participants Est. completion 2007-01 16 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00004054

    Hormone Therapy Plus Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Prostate Cancer

    Not yet reported Radiation Therapy Oncology Group 397 participants Est. completion 2013-11 54 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00004105

    Combination Chemotherapy in Treating Patients With Advanced Cancer

    Not yet reported, Not yet reported NYU Langone Health 1 site
    Other conditions: Leukemia, Lymphoma, Sarcoma, Unspecified Adult Solid Tumor, Protocol Specific
    View official trial listing →
  • Completed NCT NCT00004274

    Effect of Estrogen on Mental and Social Functioning in Girls With Turner's Syndrome

    Not yet reported National Institute of Neurological Disorders and Stroke (NINDS) 260 participants 1 site
    Other conditions: Turner's Syndrome
    View official trial listing →
  • Completed NCT NCT00004565

    Susceptibility to Breast Cancer

    National Cancer Institute (NCI) 737 participants Est. completion 2012-05-04 1 site
    Other conditions: Breast Cancer, Healthy
    View official trial listing →
  • Completed NCT NCT00004650

    Phase III Randomized Study of the Effect of Postmenopausal Estrogen Replacement Therapy on Alveolar Bone Loss

    Not yet reported National Institute of Dental and Craniofacial Research (NIDCR) 150 participants
    Other conditions: Osteoporosis
    View official trial listing →
  • Completed NCT NCT00004763

    Phase II Randomized Study of Leuprolide Vs Oral Contraceptive Therapy Vs Leuprolide and Oral Contraceptive Therapy for Ovarian Hyperandrogenism

    Not yet reported National Center for Research Resources (NCRR) 45 participants
    Other conditions: Hyperandrogenism
    View official trial listing →
  • Completed NCT NCT00005011

    Combined Hormone Replacement in Menstrually-Related Mood Disorders

    National Institute of Mental Health (NIMH) 22 participants Est. completion 2016-10-28 1 site
    Other conditions: Premenstrual Syndrome, Depression
    View official trial listing →
  • Completed NCT NCT00005048

    Estramustine and Paclitaxel in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy

    Not yet reported NYU Langone Health 2 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00005108

    Effects of Hormone Replacement Therapy on Inflammation and Stiffening of Artery Walls

    Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 25 participants Est. completion 2002-01 1 site
    Other conditions: Atherosclerosis, Healthy, Vascular Disease
    View official trial listing →
  • Completed NCT NCT00005185

    Myocardial Infarction and Non-contraceptive Estrogen Use

    National Heart, Lung, and Blood Institute (NHLBI) Est. completion 1990-03
    Cardiovascular disease Other conditions: Heart Diseases, Menopause, Postmenopause
    View official trial listing →
  • Completed NCT NCT00005446

    Endogenous Estrogen and Coronary Heart Disease in Women

    NYU Langone Health
    Cardiovascular disease Other conditions: Coronary Disease, Heart Diseases, Postmenopause
    View official trial listing →
  • Completed NCT NCT00005466

    Stroke and MI in Users of Estrogen/Progestogen

    National Heart, Lung, and Blood Institute (NHLBI) Est. completion 1995-07
    Cardiovascular disease Other conditions: Heart Diseases, Coronary Disease, Cerebrovascular Accident, Postmenopause
    View official trial listing →
  • Completed NCT NCT00005627

    Estramustine, Docetaxel, and Carboplatin in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy

    Not yet reported Dana-Farber Cancer Institute Est. completion 2003-04 2 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Status unknown NCT NCT00005768

    Estrogen Modulation of Mood and Cognition Following Monoaminergic Depletion in Post-Menopausal Women

    Not yet reported National Center for Research Resources (NCRR) 1 site
    Other conditions: Menopause
    View official trial listing →
  • Completed NCT NCT00005810

    Combination Chemotherapy Plus Filgrastim in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy

    Not yet reported Alliance for Clinical Trials in Oncology 40 participants Est. completion 2006-06 7 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00005822

    SU5416 and Doxorubicin in Treating Patients With Stage IIIB or Stage IV Inflammatory Breast Cancer

    Not yet reported Case Comprehensive Cancer Center 21 participants Est. completion 2003-10 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00005847

    Chemotherapy With or Without Biological Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy

    Not yet reported Eastern Cooperative Oncology Group 19 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00005879

    LY353381 in Preventing Breast Cancer in Women With Hyperplasia

    Not yet reported University of Kansas Medical Center 199 participants Est. completion 2008-07 2 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT00005923

    The Effect of Estrogen and Progesterone Levels on Knee and Ankle Joint Laxity

    National Center for Research Resources (NCRR) 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00005970

    Doxorubicin Hydrochloride, Cyclophosphamide, and Pacltaxel With or Without Trastuzumab in Treating Women With HER2-Positive Node-Positive or High-Risk Node-Negative Breast Cancer

    Not yet reported National Cancer Institute (NCI) 3436 participants Est. completion 2010-01-27 157 sites
    Other conditions: Breast Adenocarcinoma, HER2 Positive Breast Carcinoma, Stage IA Breast Cancer AJCC v7, Stage IB Breast Cancer AJCC v7, Stage IIA Breast Cancer AJCC v6 and v7, Stage IIB Breast Cancer AJCC v6 and v7, Stage IIIA Breast Cancer AJCC v7
    View official trial listing →
  • Completed NCT NCT00006133

    Randomized Study of Oral Contraceptives or Hormone Replacement Therapy in Women With Systemic Lupus Erythematosus

    Not yet reported National Center for Research Resources (NCRR) 970 participants 17 sites
    Other conditions: Systemic Lupus Erythematosus
    View official trial listing →
  • Completed NCT NCT00006324

    Hormonal Birth Control and the Risk of Acquiring HIV

    Not yet reported Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 6360 participants Est. completion 2002-12 1 site
    Other conditions: HIV Infections
    View official trial listing →
  • Completed NCT NCT00006399

    Effects of Estrogen on Memory in Post-Menopausal Women and Patients With Alzheimer's Disease

    Not yet reported National Center for Research Resources (NCRR) 45 participants Est. completion 2004-03 1 site
    Other conditions: Alzheimer Disease
    View official trial listing →
  • Status unknown NCT NCT00006903

    Fulvestrant in Treating Patients With Recurrent, Persistent, or Metastatic Endometrial Cancer

    Not yet reported Gynecologic Oncology Group 67 participants
    Other conditions: Recurrent Uterine Corpus Carcinoma, Stage III Uterine Corpus Cancer AJCC v7, Stage IV Uterine Corpus Cancer AJCC v7
    View official trial listing →
  • Completed NCT NCT00009659

    Use of the Synthetic Hormone CDB-2914 in Treating Symptoms of Menopause

    Not yet reported Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 58 participants Est. completion 2001-12 1 site
    Other conditions: Postmenopause
    View official trial listing →
  • Terminated NCT NCT00010153

    ICI 182780 in Treating Women With Stage I or Stage II Primary Breast Cancer

    Not yet reported European Organisation for Research and Treatment of Cancer - EORTC 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00010829

    Macrobiotic Diet and Flax Seed: Effects on Estrogens, Phytoestrogens, & Fibrinolytic Factors

    Not yet reported National Center for Complementary and Integrative Health (NCCIH) Est. completion 2005-12 1 site
    Cardiovascular disease Other conditions: Osteoporosis, Breast Cancer, Endometrial Cancer
    View official trial listing →
  • Completed NCT NCT00012025

    ICI 182780 in Treating Women With Metastatic Breast Cancer

    Not yet reported Alliance for Clinical Trials in Oncology 80 participants Est. completion 2008-08 25 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00013546

    Hormone Replacement Therapy to Treat Turner Syndrome

    Not yet reported Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 92 participants Est. completion 2002-12 1 site
    Other conditions: Osteoporosis, Turner's Syndrome
    View official trial listing →
  • Completed NCT NCT00014352

    Combination Chemotherapy Plus Warfarin in Treating Patients With Prostate Cancer

    Not yet reported Memorial Sloan Kettering Cancer Center 1 site
    Other conditions: Prostate Cancer, Thromboembolism
    View official trial listing →
  • Completed NCT NCT00016107

    Combination Chemotherapy Plus Bevacizumab in Treating Patients With Metastatic Prostate Cancer

    Not yet reported National Cancer Institute (NCI) 72 participants 1 site
    Other conditions: Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer, Stage IV Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00018343

    Alzheimer's Disease and Aging: Therapeutic Potential of Estrogen

    Not yet reported US Department of Veterans Affairs Est. completion 2001-03 1 site
    Other conditions: Alzheimer's Disease
    View official trial listing →
  • Completed NCT NCT00021372

    Paclitaxel and Estramustine in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

    Not yet reported Fox Chase Cancer Center 25 participants Est. completion 2006-09 17 sites
    Other conditions: Lymphoma
    View official trial listing →
  • Completed NCT NCT00022516

    Low-dose Oral Cyclophosphamide and Methotrexate Maintenance for Hormone Receptor-negative Early Breast Cancer

    Not yet reported ETOP IBCSG Partners Foundation 1086 participants Est. completion 2016-08 36 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT00024167

    Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer

    Not yet reported M.D. Anderson Cancer Center 265 participants 40 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00025194

    Ixabepilone With or Without Estramustine in Treating Patients With Progressive Prostate Cancer

    Not yet reported, Not yet reported Memorial Sloan Kettering Cancer Center Est. completion 2006-07 4 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00026039

    Women's Estrogen for Stroke Trial (WEST)

    Not yet reported National Institute of Neurological Disorders and Stroke (NINDS)
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT00026286

    Hormone Replacement Therapy for Hot Flashes and/or Vaginal Symptoms in Postmenopausal Women Receiving Tamoxifen for Breast Cancer

    Not yet reported Eastern Cooperative Oncology Group Est. completion 2007-06-15 24 sites
    Other conditions: Breast Cancer, Hot Flashes, Menopausal Symptoms
    View official trial listing →
  • Completed NCT NCT00027859

    Hormone Therapy Compared With Combination Chemotherapy in Treating Patients With Prostate Cancer

    Not yet reported Eastern Cooperative Oncology Group 98 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00028769

    S0032, Combination Chemotherapy Plus Hormone Therapy in Treating Patients With Metastatic Prostate Cancer

    Not yet reported SWOG Cancer Research Network 41 participants Est. completion 2011-07 91 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00029159

    The Effect of Androgen and Growth Hormone on Height and Learning in Girls With Turner Syndrome

    Not yet reported Thomas Jefferson University 200 participants Est. completion 2012-06 2 sites
    Other conditions: Turner Syndrome
    View official trial listing →
  • Completed NCT NCT00029757

    Buccal Estrogen in Toothpaste Study: Systemic Absorption of Estradiol When Administered Mixed With Toothpaste in Postmenopausal or Surgically Menopausal Women

    Not yet reported National Center for Research Resources (NCRR) 15 participants 1 site
    Other conditions: Menopause, Postmenopause
    View official trial listing →
  • Completed NCT NCT00030095

    2-Methoxyestradiol in Treating Patients With Advanced Solid Tumors

    Not yet reported National Cancer Institute (NCI) 2 sites
    Other conditions: Unspecified Adult Solid Tumor, Protocol Specific
    View official trial listing →
  • Completed NCT NCT00030654

    Hormone Therapy Plus Chemotherapy in Treating Patients With Prostate Cancer

    Not yet reported Radiation Therapy Oncology Group 21 participants Est. completion 2005-02-04 78 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00033358

    Hormone Therapy in Preventing Endometrial Cancer in Patients With a Genetic Risk For Hereditary Nonpolyposis Colon Cancer

    Not yet reported National Cancer Institute (NCI) 52 participants 1 site
    Other conditions: Endometrial Cancer
    View official trial listing →
  • Completed NCT NCT00038168

    Intravenous Estramustine With Taxol in Hormone Refractory Prostate Adenocarcinoma

    Not yet reported, Not yet reported M.D. Anderson Cancer Center 14 participants Est. completion 2003-01 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00038246

    Study of Paclitaxel, Estramustine Phosphate and Thalidomide for Patients With Metastatic Androgen-Independent Prostate Carcinoma

    Not yet reported, Not yet reported M.D. Anderson Cancer Center 40 participants Est. completion 2004-12 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00041431

    Estrogen, Cytokines and Heart Failure in Women

    Not yet reported National Heart, Lung, and Blood Institute (NHLBI) Est. completion 2003-12
    Cardiovascular diseaseHeart failure Other conditions: Heart Diseases, Menopause
    View official trial listing →
  • Completed NCT NCT00041899

    Comparison of Blood Levels of Two Formulations of the Selective Hormone Receptor Modulator CDB-2914

    Not yet reported Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 15 participants Est. completion 2005-03 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00042289

    Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy

    National Institute of Allergy and Infectious Diseases (NIAID) 1578 participants Est. completion 2020-09-30 62 sites
    Other conditions: HIV Infections
    View official trial listing →
  • Completed NCT NCT00043069

    Calcium With or Without Estrogen and/or Risedronate in Preventing Osteoporosis in Patients With Prostate Cancer

    Not yet reported Alliance for Clinical Trials in Oncology 71 participants Est. completion 2010-01 114 sites Stand-alone
    Other conditions: Osteoporosis, Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00044291

    Phase III Study of Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer

    Not yet reported Intarcia Therapeutics 865 participants Est. completion 2006-01 63 sites
    Other conditions: Breast Neoplasms, Neoplasms, Hormone-dependent
    View official trial listing →
  • Terminated NCT NCT00044837

    Hormone Replacement Therapy and Anti-HIV Drugs in HIV-Infected, Postmenopausal Women

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 120 participants 1 site
    Other conditions: HIV Infections
    View official trial listing →
  • Completed NCT NCT00044876

    Treatment of Uterine Fibroids With CDB-2914, an Experimental Selective Progesterone Receptor Antagonist

    Not yet reported Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 56 participants Est. completion 2015-10-01 1 site
    Other conditions: Leiomyoma
    View official trial listing →
  • Completed NCT NCT00046826

    Docetaxel, Estramustine, and Thalidomide in Treating Patients With Prostate Cancer Previously Treated With Hormone Therapy

    Not yet reported Nuvance Health Est. completion 2009-10 2 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00049062

    Anastrozole and ZD 1839 in Treating Postmenopausal Women With Metastatic Breast Cancer

    Not yet reported The University of Texas Health Science Center at San Antonio Est. completion 2007-10 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00050011

    Zoledronic Acid - Letrozole Adjuvant Synergy Trial (ZFAST) - Cancer Treatment Related Bone Loss in Postmenopausal Women With Estrogen Receptor Positive and/or Progesterone Receptor Positive Breast Cancer Receiving Adjuvant Hormonal Therapy

    Not yet reported Novartis Pharmaceuticals 602 participants Est. completion 2009-01 44 sites
    Other conditions: Breast Neoplasms, Osteoporosis
    View official trial listing →
  • Completed NCT NCT00050141

    Study of Letrozole Plus Tipifarnib or Placebo in the Treatment of Advanced Breast Cancer

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 121 participants Est. completion 2008-01 23 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00052845

    Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy

    Not yet reported Alliance for Clinical Trials in Oncology 80 participants Est. completion 2009-04 80 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00056082

    Celecoxib in Preventing Breast Cancer in At-Risk Premenopausal Women

    Not yet reported University of Kansas Medical Center 110 participants Est. completion 2013-07 3 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT00056901

    Screening Evaluation for Women With Postpartum Depression

    National Institute of Mental Health (NIMH) 68 participants Est. completion 2017-12-24 1 site
    Other conditions: Postpartum Depression, Depression
    View official trial listing →
  • Completed NCT NCT00057941

    Anastrozole and ZD1839 Compared With Fulvestrant and ZD1839 in Postmenopausal Women w/ Metastatic Breast Cancer

    Not yet reported National Cancer Institute (NCI) 148 participants Est. completion 2012-06 1 site
    Other conditions: Estrogen Receptor-positive Breast Cancer, Progesterone Receptor-positive Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer
    View official trial listing →
  • Terminated NCT NCT00059228

    Clinical Trial of Estrogen for Postpartum Depression

    Not yet reported National Institute of Mental Health (NIMH) 12 participants Est. completion 2016-11-15 1 site
    Other conditions: Postpartum Depression, Depression
    View official trial listing →
  • Completed NCT NCT00060736

    The Effects of Estrogen Withdrawal on Mood Symptoms in Women

    National Institute of Mental Health (NIMH) 60 participants Est. completion 2016-04-27 1 site
    Other conditions: Perimenopausal Depression, Post Menopausal, Healthy, Depression
    View official trial listing →
  • Completed NCT NCT00065325

    The Evaluation of the Efficacy and Tolerability of FASLODEX (Fulvestrant) and AROMASIN (Exemestane) in Hormone Receptor Positive Postmenopausal Women With Advanced Breast Cancer

    Not yet reported AstraZeneca 694 participants Est. completion 2014-09 117 sites
    Other conditions: Locally Advanced Breast Cancer, Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT00066157

    Alzheimer's Disease: Therapeutic Potential of Estrogen

    Not yet reported, Not yet reported University of Wisconsin, Madison 42 participants Est. completion 2007-12 1 site
    Other conditions: Alzheimer Disease
    View official trial listing →
  • Completed NCT NCT00066703

    Triptorelin With Either Exemestane or Tamoxifen in Treating Premenopausal Women With Hormone-Responsive Breast Cancer

    Not yet reported ETOP IBCSG Partners Foundation 2672 participants Est. completion 2024-10-23 228 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00067509

    Emergency Contraception (ECP): Reducing Unintended Pregnancies

    Not yet reported Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 1100 participants Est. completion 2004-05 2 sites
    Other conditions: Contraception, Pregnancy
    View official trial listing →
  • Completed NCT NCT00068328

    Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer

    Alliance for Clinical Trials in Oncology 1706 participants Est. completion 2016-12 85 sites
    Other conditions: Breast Cancer, Psychosocial Effects of Cancer and Its Treatment
    View official trial listing →
  • Completed NCT NCT00068419

    Sulindac and Tamoxifen in Treating Patients With Desmoid Tumor

    Not yet reported Children's Oncology Group 70 participants Est. completion 2010-04-26 1 site Stand-alone
    Other conditions: Desmoid Tumor
    View official trial listing →
  • Completed NCT NCT00068601

    S0230 Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer

    Not yet reported SWOG Cancer Research Network 257 participants Est. completion 2016-09 34 sites
    Other conditions: Breast Cancer, Infertility, Menopausal Symptoms
    View official trial listing →
  • Active, not recruiting NCT NCT00070564

    S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer

    Not yet reported SWOG Cancer Research Network 3294 participants Est. completion 2027-01 542 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00072293

    Surgical Resection With or Without Axillary Lymph Node Dissection in Treating Women With Node-Negative Breast Cancer and Sentinel Lymph Node Micrometastases

    Not yet reported ETOP IBCSG Partners Foundation 931 participants Est. completion 2017-03-31 31 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00075764

    S0226 Anastrozole With or Without Fulvestrant as First-Line Therapy in Postmenopausal Women With Metastatic Breast Cancer

    Not yet reported SWOG Cancer Research Network 695 participants Est. completion 2018-10-01 426 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00076050

    Using Soy Estrogens to Prevent Bone Loss and Other Menopausal Symptoms

    Not yet reported University of Miami 248 participants Est. completion 2009-06 1 site
    Other conditions: Menopause, Osteoporosis, Osteopenia
    View official trial listing →
  • Completed NCT NCT00077025

    Comparing Anastrozole-Placebo to the Combination Anastrozole-ZD1839 in Postmenopausal Patients With Estrogen Receptor and/or Progesterone Receptor Metastatic Breast Cancer

    Not yet reported AstraZeneca 174 participants Est. completion 2013-05 27 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT00077168

    Adjuvant Radiation Therapy Compared With Observation After Surgery in Treating Women With Estrogen Receptor Positive or Progesterone Receptor Positive Ductal Carcinoma In Situ of the Breast Who Are Receiving Tamoxifen or Anastrozole

    Not yet reported Institute of Cancer Research, United Kingdom 2000 participants 29 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT00079248

    Hormone Replacement Therapy in Relieving Menopausal Symptoms in Postmenopausal Women With Previous Stage I or Stage II Breast Cancer

    Not yet reported Institute of Cancer Research, United Kingdom 1 site
    Other conditions: Breast Cancer, Hot Flashes, Menopausal Symptoms, Osteoporosis
    View official trial listing →
  • Withdrawn NCT NCT00080613

    Neoadjuvant and Adjuvant Exemestane in Treating Postmenopausal Women With Locally Advanced Hormone Receptor-Positive Breast Cancer

    Not yet reported Robert H. Lurie Cancer Center 1 site
    Other conditions: Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT00080756

    Deslorelin Combined With Low-Dose Add-Back Estradiol and Testosterone in Preventing Breast Cancer in Premenopausal Women Who Are at High Risk for This Disease

    Not yet reported City of Hope Medical Center 11 participants Est. completion 2024-10-15 1 site
    Other conditions: brca1 Mutation Carrier, brca2 Mutation Carrier, Breast Cancer
    View official trial listing →
  • Completed NCT NCT00081705

    Estrogen Receptor Variants, HDL, and Atherosclerosis

    National Heart, Lung, and Blood Institute (NHLBI) Est. completion 2007-02
    Cardiovascular disease Other conditions: Atherosclerosis, Coronary Arteriosclerosis, Heart Diseases
    View official trial listing →
  • Completed NCT NCT00082810

    Tipifarnib and Fulvestrant in Hormone Receptor-Positive Metastatic Breast Cancer

    Not yet reported National Cancer Institute (NCI) 33 participants Est. completion 2008-09 1 site
    Other conditions: Estrogen Receptor-positive Breast Cancer, Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    View official trial listing →
  • Completed NCT NCT00083005

    Docetaxel, Estramustine, and Thalidomide in Treating Patients With Androgen-Independent Metastatic Adenocarcinoma of the Prostate

    Not yet reported National Institutes of Health Clinical Center (CC) 60 participants Est. completion 2007-12 2 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00083824

    Estrogen, HDL, and Coronary Heart Disease in Women

    Not yet reported, Not yet reported Tufts University 309 participants Est. completion 2007-02 1 site Stand-alone
    Cardiovascular disease Other conditions: Coronary Disease, Heart Diseases, Coronary Arteriosclerosis
    View official trial listing →
  • Completed NCT NCT00084396

    Neoadjuvant Letrozole in Treating Postmenopausal Women With Estrogen-Receptor Positive and/or Progesterone-Receptor Positive Stage II, Stage IIIA, or Stage IIIB Breast Cancer

    Not yet reported Washington University School of Medicine 115 participants Est. completion 2016-09 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Withdrawn NCT NCT00084565

    Paclitaxel, Topotecan, and Estramustine in Treating Patients With Metastatic Hormone-Refractory Prostate Cancer

    Not yet reported Fox Chase Cancer Center Est. completion 2004-11
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00088153

    Effects of Anorexia Nervosa on Bone Mass in Adolescents

    Not yet reported, Not yet reported Massachusetts General Hospital 110 participants Est. completion 2011-06 1 site Stand-alone
    Obstructive sleep apnea
    View official trial listing →
  • Terminated NCT NCT00089414

    Treatment of Menstrually Related Disorders With Continuous v. Interrupted Oral Contraceptives

    Not yet reported National Institute of Mental Health (NIMH) 5 participants Est. completion 2010-06 1 site
    Other conditions: Premenstrual Syndrome, PMS, Premenstrual Dysphoric Disorder, PMDD, Depression
    View official trial listing →
  • Completed NCT NCT00090857

    Letrozole in Preventing Breast Cancer in Postmenopausal Women

    Not yet reported Dana-Farber Cancer Institute 49 participants Est. completion 2013-03 5 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00093002

    Fulvestrant (FASLODEX™) as a Treatment in Postmenopausal Women With Estrogen Receptor Positive Breast Cancer

    Not yet reported AstraZeneca 179 participants Est. completion 2007-07 31 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00097058

    Estrogen Use in Protection From Cognitive Decline

    Stanford University 71 participants Est. completion 2014-11 1 site
    Other conditions: Aging, Menopause
    View official trial listing →
  • Terminated NCT NCT00097344

    The CAT Study: Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer

    Not yet reported Intarcia Therapeutics 842 participants Est. completion 2006-08 104 sites
    Other conditions: Breast Neoplasms, Neoplasms, Hormone-Dependent
    View official trial listing →
  • Active, not recruiting NCT NCT00099437

    Comparison of Fulvestrant (FASLODEX™) 250 mg and 500 mg in Postmenopausal Women With Oestrogen Receptor Positive Advanced Breast Cancer Progressing or Relapsing After Previous Endocrine Therapy.

    Not yet reported AstraZeneca 736 participants Est. completion 2026-12-31 106 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00100360

    Hormonal Causes of Menstrual-Related Mood Disorders

    National Institute of Mental Health (NIMH) 22 participants Est. completion 2016-12-15 1 site
    Other conditions: Mood Disorders, Depression
    View official trial listing →
  • Completed NCT NCT00100451

    Aging, Exercise, and Hormonal Influences of Fat Metabolism

    Not yet reported US Department of Veterans Affairs Est. completion 2001-06 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT00100854

    Erlotinib With or Without Fulvestrant in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

    Not yet reported Translational Oncology Research International 108 participants Est. completion 2018-09-05 1 site
    Other conditions: Lung Cancer
    View official trial listing →
  • Completed NCT NCT00102141

    Effect of Angeliq on Blood Pressure (BP) in Postmenopausal Hypertensive Women

    Not yet reported Bayer 750 participants Est. completion 2005-07
    Other conditions: Hypertension, Postmenopause
    View official trial listing →
  • Completed NCT NCT00104572

    Effects of Aromatase Inhibition Versus Testosterone in Older Men With Low Testosterone: Randomized-Controlled Trial.

    Not yet reported National Institute on Aging (NIA) 44 participants Est. completion 2015-01 1 site
    Other conditions: Hypogonadism, Diabetes, Sarcopenia, Osteoporosis, Depression
    View official trial listing →
  • Completed NCT NCT00108238

    Estrogen Alternatives Study

    Not yet reported US Department of Veterans Affairs Est. completion 2006-12 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00108849

    Vagifem Low Dose for Postmenopausal Atrophic Vaginitis Symptoms

    Not yet reported Novo Nordisk A/S 309 participants Est. completion 2007-05 57 sites
    Other conditions: Menopause, Postmenopausal Vaginal Atrophy
    View official trial listing →
  • Completed NCT NCT00111241

    Changes in Knee Articular Cartilage Volume in Women on Aromatase Inhibitors

    Monash University 115 participants Est. completion 2011-12 1 site
    Other conditions: Arthralgia
    View official trial listing →
  • Completed NCT NCT00113100

    Mechanisms of Skin Repair by Topical Estrogen

    Not yet reported University of Michigan 152 participants Est. completion 2007-06 1 site
    Other conditions: Skin Wrinkling
    View official trial listing →
  • Completed NCT NCT00114270

    Letrozole With or Without Zoledronate in Treating Healthy Postmenopausal Women With High Breast Density

    Not yet reported University of Virginia Est. completion 2007-06 1 site
    Other conditions: Breast Cancer, Osteoporosis
    View official trial listing →
  • Completed NCT NCT00115024

    EPAT: Estrogen in the Prevention of Atherosclerosis Trial

    Not yet reported, Not yet reported National Institute on Aging (NIA) 222 participants Est. completion 1998-11 1 site
    Other conditions: Atherosclerosis, Postmenopause
    View official trial listing →
  • Completed NCT NCT00115505

    Quality of Life, Employment, and Informal Care Costs in Women Who Are Receiving Chemotherapy for Breast Cancer

    Alliance for Clinical Trials in Oncology 307 participants Est. completion 2016-06 227 sites
    Other conditions: Breast Carcinoma
    View official trial listing →
  • Withdrawn NCT NCT00117260

    Study to Evaluate the Safety and Efficacy of Seasonale for Treatment of Low Bone Mineral Density

    Not yet reported Duramed Research Est. completion 2007-08
    Other conditions: Osteopenia
    View official trial listing →
  • Completed NCT NCT00117273

    A Study to Evaluate Suppression of the Pituitary-Ovarian Axis With Three Different Oral Contraceptive Regimens

    Not yet reported Duramed Research 36 participants Est. completion 2006-06 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00119262

    Bevacizumab and Combination Chemotherapy in Patients With Lymph Node Positive Breast Cancer

    Not yet reported National Cancer Institute (NCI) 226 participants Est. completion 2009-09 1 site
    Other conditions: Male Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer
    View official trial listing →
  • Terminated NCT NCT00123539

    Estrogen Replacement to Reduce Risk of Neurologic Injury After Coronary Artery Bypass Graft Surgery

    Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 334 participants Est. completion 2005-08 1 site
    Cardiovascular disease Other conditions: Coronary Disease, Heart Diseases, Neurologic Manifestations
    View official trial listing →
  • Status unknown NCT NCT00126464

    Fulvestrant or Tamoxifen in Treating Postmenopausal Women Who Are Undergoing Surgery for Ductal Carcinoma in Situ of the Breast

    Not yet reported Cedars-Sinai Medical Center 100 participants 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT00127075

    POPART'MUS: Prevention of Post Partum Relapses With Progestin and Estradiol in Multiple Sclerosis

    Not yet reported Hospices Civils de Lyon 300 participants Est. completion 2012-04 1 site
    Other conditions: Multiple Sclerosis
    View official trial listing →
  • Completed NCT NCT00128934

    Study Evaluating Combination of Levonorgestrel (LNG) and Ethinyl Estradiol (EE) in Premenstrual Dysphoric Disorder

    Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 744 participants Est. completion 2007-12 83 sites
    Other conditions: Menstruation Disturbances, Premenstrual Syndrome
    View official trial listing →
  • Completed NCT NCT00131495

    Study of Transdermal Testosterone Patches in Menopausal Women With Low Libido

    Not yet reported Warner Chilcott 814 participants Est. completion 2007-02 1 site
    Other conditions: Hypoactive Sexual Desire Disorder
    View official trial listing →
  • Terminated NCT NCT00131924

    High-Dose Esterified Estrogens in Treating Postmenopausal Women With Metastatic Breast Cancer That Has Failed Previous Hormone Therapy

    Not yet reported Northwestern University 1 participants Est. completion 2006-01 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT00132756

    Liposomal Doxorubicin and Estramustine Phosphate: Study in Taxane Resistant, Hormone Refractory Advanced Prostate Cancer

    Not yet reported, Not yet reported Morton Plant Mease Health Care 30 participants 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00133354

    Arimidex Multicenter Trial in Growth Hormone (GH) Deficient Boys

    Not yet reported, Not yet reported Nemours Children's Clinic 53 participants Est. completion 2010-08 1 site
    Other conditions: Hypopituitarism
    View official trial listing →
  • Completed NCT NCT00134654

    Two Doses of Conjugated Estrogen (Premarin) in Patients With Androgen-Independent Prostate Cancer

    Not yet reported Dana-Farber Cancer Institute 48 participants Est. completion 2011-06 3 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00134680

    Letrozole, Herceptin in Her2neu +, Estrogen Receptor [ER] and/or Progesterone Receptor [PR] Positive, MBC

    Not yet reported Duke University 33 participants Est. completion 2005-07 4 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT00134745

    Defining the Optimal Hormonal Replacement Therapy in Turner Syndrome

    Not yet reported Line Cleemann 43 participants Est. completion 2013-03 1 site
    Other conditions: Turner Syndrome
    View official trial listing →
  • Completed NCT NCT00136032

    Growth Hormone Administration and Its Effects on Cardiovascular Risk Factors in Growth Hormone Deficient Women

    Not yet reported Massachusetts General Hospital 63 participants Est. completion 2006-11 1 site
    Other conditions: Growth Hormone Deficiency
    View official trial listing →
  • Completed NCT NCT00137371

    Study Evaluating Conjugated Estrogen Cream for Atrophic Vaginitis

    Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 480 participants Est. completion 2007-09 49 sites
    Other conditions: Atrophic Vaginitis, Atrophy, Vaginitis
    View official trial listing →
  • Terminated NCT NCT00138125

    Fulvestrant and/or Trastuzumab as First-Line Therapy in Treating Postmenopausal Women With Stage IV Breast Cancer

    Not yet reported Translational Oncology Research International 2 participants Est. completion 2009-12 3 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00140998

    Estrogen Treatment (Oral vs. Patches) in Turner Syndrome

    Not yet reported Nemours Children's Clinic 16 participants Est. completion 2004-06 1 site
    Other conditions: Turner Syndrome, Hypogonadism, Premature Ovarian Failure
    View official trial listing →
  • Terminated NCT NCT00141544

    The Efficacy of ESTRATEST® Tablets in Relieving Menopausal Symptoms in Estrogenized, Non-Hysterectomized Postmenopausal Women

    Not yet reported Solvay Pharmaceuticals 28 participants Est. completion 2008-03 78 sites
    Other conditions: Menopause
    View official trial listing →
  • Terminated NCT NCT00141557

    The Efficacy of ESTRATEST® Tablets in Relieving Menopausal Symptoms in Estrogenized, Hysterectomized Postmenopausal Women

    Not yet reported Solvay Pharmaceuticals 133 participants Est. completion 2008-03 78 sites
    Other conditions: Menopause
    View official trial listing →
  • Completed NCT NCT00141570

    Study of the Efficacy of ESTRATEST® H.S. Tablets in Relieving Menopausal Symptoms in Estrogenized Postmenopausal Women

    Not yet reported Solvay Pharmaceuticals 350 participants Est. completion 2007-06 77 sites
    Other conditions: Menopause
    View official trial listing →
  • Completed NCT NCT00145522

    Study to Compare the Effect of Hormone Replacement Therapy (HRT) on Breast and Cardiovascular Metabolic Markers in Postmenopausal Women

    Not yet reported Solvay Pharmaceuticals 135 participants Est. completion 2009-03 11 sites
    Other conditions: Menopause
    View official trial listing →
  • Completed NCT NCT00146146

    Testosterone and Its Metabolites in GID

    Not yet reported Unita Complessa di Ostetricia e Ginecologia 15 participants Est. completion 2008-01 1 site
    Other conditions: Transsexualism
    View official trial listing →
  • Completed NCT NCT00146601

    Fulvestrant in Premenopausal Women With Hormone Receptor-Positive Breast Cancer

    Not yet reported Dana-Farber Cancer Institute 35 participants Est. completion 2007-07 4 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00149604

    AFTER: Altering Fat Through Estrogen and Raloxifene

    Not yet reported National Institute on Aging (NIA) 108 participants Est. completion 2006-02 1 site
    Other conditions: Postmenopause
    View official trial listing →
  • Status unknown NCT NCT00150163

    Odense Androgen Study: Study of Androgens, Body Composition, and Muscle Function in Danish Men

    Odense University Hospital 800 participants Est. completion 2008-12 1 site
    Other conditions: Bone Diseases
    View official trial listing →
  • Completed NCT NCT00151060

    Estramustine, Etoposide and Paclitaxel Treatment for Hormonally Responsive Adenocarcinoma of the Prostate

    Not yet reported University of Michigan Rogel Cancer Center 28 participants Est. completion 2006-06 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00151073

    Estramustine, Docetaxel and Zoledronate Treatment in Hormone-Refractory Adenocarcinoma of the Prostate

    Not yet reported University of Michigan Rogel Cancer Center 28 participants Est. completion 2007-09 1 site
    Other conditions: Hormone-Refractory Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00151086

    Oral Estramustine and Oral Vinorelbine in the Treatment of Hormone-Refractory Prostate Cancer

    Not yet reported, Not yet reported University of Michigan Rogel Cancer Center 33 participants Est. completion 2006-08 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00152282

    A Study to Evaluate the Safety and Effectiveness of Asoprisnil and Estrogen Administration to Postmenopausal Women

    Not yet reported Abbott 105 participants Est. completion 2001-08
    Other conditions: Amenorrhea, Postmenopause
    View official trial listing →
  • Completed NCT NCT00152295

    A Long-Term Study to Evaluate the Safety of Asoprisnil and Estrogen Administration to Postmenopausal Women

    Not yet reported Abbott 18 participants Est. completion 2001-12
    Other conditions: Postmenopause
    View official trial listing →
  • Status unknown NCT NCT00154180

    Kronos Early Estrogen Prevention Study (KEEPS)

    Not yet reported Kronos Longevity Research Institute 728 participants Est. completion 2012-07 9 sites
    Other conditions: Menopause, Arteriosclerosis
    View official trial listing →
  • Completed NCT NCT00160173

    Efficacy Study Comparing 0.9 g and 1.25 g Estrogel With Placebo for Vasomotor Symptoms and Vulvar and Vaginal Atrophy

    Not yet reported ASCEND Therapeutics 221 participants Est. completion 2005-09-06 109 sites
    Other conditions: Postmenopausal Symptoms
    View official trial listing →
  • Completed NCT NCT00160316

    Endometrial Safety Study of a 0.5 mg Estradiol and 2.5 mg Dydrogesterone Combination

    Not yet reported Solvay Pharmaceuticals 454 participants Est. completion 2007-12 22 sites
    Other conditions: Postmenopause
    View official trial listing →
  • Completed NCT NCT00160342

    Comparison of Estrogen and Methyltestosterone Combination Treatments for Postmenopausal Hot Flushes

    Not yet reported Solvay Pharmaceuticals 1251 participants Est. completion 2007-09 125 sites
    Other conditions: Hot Flushes, Menopause, Postmenopause
    View official trial listing →
  • Completed NCT NCT00161681

    Study Evaluating Levonorgestrel/Ethinyl Estradiol (LNG/EE) in PMS

    Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 200 participants Est. completion 2006-08 48 sites
    Other conditions: Premenstrual Syndrome
    View official trial listing →
  • Completed NCT NCT00163033

    Study to Evaluate 3 Dosages of Estetrol After 28 Days Administration in Healthy Postmenopausal Women

    Not yet reported Pantarhei Bioscience 49 participants Est. completion 2007-09 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00165399

    Docetaxel, Estramustine and Short Term Androgen Withdrawal for Patients With a Rising PSA After Local Treatment

    Not yet reported Dana-Farber Cancer Institute 62 participants Est. completion 2005-12-31 5 sites
    Other conditions: Adenocarcinoma of the Prostate, Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00167648

    Neoadjuvant Estradiol or Androgen Deprivation in Clinically Localized Prostate Cancer

    Not yet reported University of Washington 17 participants Est. completion 2006-12 2 sites
    Other conditions: Cancer, Prostate Neoplasms
    View official trial listing →
  • Completed NCT NCT00167921

    Study Comparing Premarin® Vaginal Cream Versus Premarin® Oral Tablets in Atrophic Vaginitis

    Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 24 participants 2 sites
    Other conditions: Atrophic Vaginitis
    View official trial listing →
  • Status unknown NCT NCT00169299

    Herbal Alternatives for Menopause Symptoms (HALT Study)

    Not yet reported Kaiser Permanente 351 participants Est. completion 2004-09 1 site
    Other conditions: Vasomotor Symptoms Associated With Menopause
    View official trial listing →
  • Completed NCT NCT00171340

    Zoledronic Acid in the Prevention of Cancer Treatment Related Bone Loss in Postmenopausal Women Receiving Letrozole for Breast Cancer.

    Not yet reported Novartis Pharmaceuticals 1065 participants Est. completion 2010-02 106 sites
    Other conditions: Bone Loss, Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT00173550

    Perception and Attitude Toward Estrogen Therapy Among Surgically Menopausal Women

    National Taiwan University Hospital 200 participants 1 site
    Other conditions: Menopause, Premature, Hysterectomy, Ovariectomy, Estrogen Replacement Therapy, Attitude, Perception
    View official trial listing →
  • Terminated NCT NCT00176644

    Phase II Trial of Transdermal Estradiol for Hormone Refractory Prostate Cancer

    Not yet reported University of Medicine and Dentistry of New Jersey 23 participants Est. completion 2008-12 6 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00179426

    Effect of Antiseizure Medication on Hormone Levels and Sexual Function in Men With Epilepsy

    Beth Israel Deaconess Medical Center 175 participants Est. completion 2006-06 1 site
    Other conditions: Seizure Disorder, Epilepsy
    View official trial listing →
  • Completed NCT NCT00182091

    Effects of Growth Hormone Administration on Cardiovascular Risk in Cured Acromegalics With Growth Hormone Deficiency

    Not yet reported Massachusetts General Hospital 75 participants Est. completion 2010-12 1 site
    Other conditions: Acromegaly, Growth Hormone Deficiency, Pituitary Disease
    View official trial listing →
  • Completed NCT NCT00183924

    Estramustine, Docetaxel, and Carboplatin for Patients With Hormone Refractory Prostate Cancer Progressing After Mitoxantrone-Based Chemotherapy.

    Not yet reported University of Southern California 20 participants Est. completion 2008-12 1 site
    Other conditions: Prostate Adenocarcinoma
    View official trial listing →
  • Completed NCT NCT00185224

    Metabolism Study to Investigate the Impact of a Sequential Oral Contraceptive

    Not yet reported Bayer 58 participants Est. completion 2006-03 1 site
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT00185237

    Treatment of Hot Flushes in Asian Women With Ultra-low Dose Estradiol Patch

    Not yet reported Bayer 165 participants Est. completion 2006-11
    Other conditions: Hot Flashes
    View official trial listing →
  • Completed NCT NCT00185328

    Efficacy and Tolerability of Angeliq in Thai Women

    Not yet reported Bayer 55 participants Est. completion 2006-12
    Other conditions: Postmenopause
    View official trial listing →
  • Completed NCT NCT00185419

    A Clinical Study on Yasmin® vs. Marvelon® in Chinese Women Requiring Contraception

    Not yet reported Bayer 842 participants Est. completion 2006-03 1 site
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT00185458

    Assessment of the Transfer of Using Levonorgestrel Intrauterine System (LNG IUS) as a Contraceptive to Using it as Part of Hormone Replacement Therapy (HRT).

    Not yet reported Bayer 394 participants Est. completion 2008-05 12 sites
    Other conditions: Menopause
    View official trial listing →
  • Completed NCT NCT00185484

    Efficacy and Safety Oral Contraceptive Study

    Not yet reported Bayer 1113 participants Est. completion 2006-01
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT00186121

    Estradiol Suppression for the Treatment of Metastatic Breast Cancer in Premenopausal Women

    Not yet reported Stanford University 35 participants Est. completion 2013-06 1 site Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00193050

    Weekly Gemcitabine, Epirubicin, and Docetaxel in Locally Advanced or Inflammatory Breast Cancer

    Not yet reported SCRI Development Innovations, LLC 110 participants Est. completion 2009-03 Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00193193

    Weekly Paclitaxel, Low-Dose Estramustine, and Carboplatin in the Treatment of Hormone Refractory Prostate Carcinoma

    Not yet reported SCRI Development Innovations, LLC 100 participants Est. completion 2007-02
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00193271

    Adjuvant Docetaxel and Estramustine Phosphate for High Risk Localized Prostate Cancer

    Not yet reported SCRI Development Innovations, LLC 30 participants Est. completion 2007-05 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Terminated NCT NCT00193726

    Estrogen Priming to Increase the Efficacy of Adjuvant Chemotherapy in Operable Breast Cancer

    Not yet reported Sudeep Gupta 273 participants Est. completion 2012-03-30 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00195455

    Study Evaluating Estradiol/Trimegestone in Vasomotor Symptoms (VMS) in Post-Menopausal Women.

    Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 133 participants Est. completion 2007-03 6 sites
    Other conditions: Postmenopause
    View official trial listing →
  • Completed NCT NCT00195559

    Study Evaluating Combination of Levonorgestrel and Ethinyl Estradiol in Pre-Menstrual Dysphoric Disorder

    Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 526 participants Est. completion 2007-12 51 sites
    Other conditions: Premenstrual Syndrome, Menstruation Disturbances
    View official trial listing →
  • Completed NCT NCT00196313

    A Study to Evaluate the Efficacy of Seasonique for the Treatment of Cyclic Pelvic Pain

    Not yet reported Duramed Research 95 participants Est. completion 2008-10 13 sites
    Other conditions: Dysmenorrhea
    View official trial listing →
  • Completed NCT NCT00196326

    Open-label Study to Evaluate the Efficacy and Safety of an Extended-cycle, Low Dose Combination Oral Contraceptive

    Not yet reported Duramed Research 2235 participants Est. completion 2007-06 55 sites
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT00196352

    A Multicenter Study to Evaluate the Safety of Seasonique, an Oral Contraceptive.

    Not yet reported Duramed Research 320 participants Est. completion 2006-11 11 sites
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT00196365

    A Study to Evaluate the Efficacy of Seasonique for the Treatment of Cyclic Pelvic Pain

    Not yet reported Duramed Research 97 participants Est. completion 2007-07 18 sites
    Other conditions: Dysmenorrhea
    View official trial listing →
  • Completed NCT NCT00196378

    A Clinical Trial to Evaluate the Safety and Efficacy of Enjuvia 0.3 mg for the Treatment of Vulvovaginal Atrophy

    Not yet reported Duramed Research 300 participants Est. completion 2006-02 38 sites
    Other conditions: Menopause
    View official trial listing →
  • Completed NCT NCT00201864

    Exemestane in Combination With Fulvestrant in Postmenopausal Women With Hormone Sensitive Advanced Breast Cancer

    Not yet reported Ohio State University Comprehensive Cancer Center 40 participants Est. completion 2014-02 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT00203996

    Polycystic Ovary Syndrome (PCOS) and Sleep Apnea

    Not yet reported University of Chicago 37 participants Est. completion 2008-06 1 site Stand-alone
    Obstructive sleep apnea Other conditions: Polycystic Ovary Syndrome
    View official trial listing →
  • Status unknown NCT NCT00204074

    Treatment of Menstrual Migraine With Sequential, Transdermal, 17-Beta-Estradiol. A Double-Blind, Randomised, Cross-Over Trial.

    Not yet reported, Not yet reported University Hospital, Linkoeping Est. completion 2005-07 1 site
    Other conditions: Migraine
    View official trial listing →
  • Completed NCT NCT00204438

    Administration of Oral Contraceptives at Different Times of the Follicular Phase of the Menstrual Cycle

    Not yet reported University of Saskatchewan 45 participants Est. completion 2002-12 1 site
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT00204451

    Human Ovarian Follicular Dynamics and Emergency Contraception

    Not yet reported University of Saskatchewan 40 participants Est. completion 2006-06 1 site
    Other conditions: Contraception
    View official trial listing →
  • Terminated NCT NCT00206414

    Arimidex/Faslodex/Iressa Study: A Trial Using Arimidex, Faslodex and Iressa in Women With Breast Cancer

    Not yet reported Baylor Breast Care Center 15 participants Est. completion 2006-09 1 site
    Other conditions: BREAST CANCER
    View official trial listing →
  • Completed NCT NCT00206544

    Anti-Estrogens - A Potential Treatment for Bipolar Affective Disorder in Women?

    Not yet reported The Alfred 51 participants Est. completion 2007-12 1 site
    Other conditions: Bipolar Disorder, Mania, Schizoaffective Disorder
    View official trial listing →
  • Completed NCT NCT00206570

    Clinical Estradiol Trial in Women With Schizophrenia

    Not yet reported Bayside Health 100 participants Est. completion 2004-12 1 site
    Other conditions: Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder
    View official trial listing →
  • Terminated NCT NCT00210028

    Study Assessing Efficacy of ZARNESTRA™ Combined With Tamoxifen in Patients With Advanced or Metastatic Breast Cancer

    Not yet reported Institut Claudius Regaud 40 participants Est. completion 2008-08 3 sites
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Completed NCT NCT00212277

    Efficacy and Safety,Long-term Study of Low-dose Oral Contraceptive Pill to Treat Dysmenorrhea.

    Not yet reported Nobelpharma Est. completion 2007-02
    Other conditions: Dysmenorrhea
    View official trial listing →
  • Completed NCT NCT00212342

    Efficacy and Safety Study of Low Dose Oral Contraceptive Pill to Treat Dysmenorrhea

    Not yet reported Nobelpharma 100 participants Est. completion 2006-03
    Other conditions: Dysmenorrhea
    View official trial listing →
  • Completed NCT NCT00213096

    Effects of Hormonal Contraceptives on Liver Proteins and Coagulation Factors: A Comparison of a Contraceptive Vaginal Ring and an Oral Contraceptive

    Not yet reported Population Council 50 participants Est. completion 2004-02 1 site
    Other conditions: Contraception
    View official trial listing →
  • Terminated NCT NCT00217464

    Fulvestrant in Treating Patients With Recurrent Prostate Cancer

    Not yet reported Roswell Park Cancer Institute 17 participants Est. completion 2010-03 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Status unknown NCT NCT00218205

    A Study of Epirubicin With Estramustine Phosphate and Celecoxib for the Treatment of Prostate Cancer

    Not yet reported Department of Veterans Affairs, New Jersey 28 participants Est. completion 2006-06 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00220324

    Pearl Index Study With Low Dose Combined Oral Contraceptive

    Not yet reported Bayer 840 participants Est. completion 2005-11 25 sites
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT00220454

    Effect of Estrogen & Stress for Postmenopausal Women

    Not yet reported Seattle Institute for Biomedical and Clinical Research 40 participants Est. completion 2005-03
    Other conditions: Aging
    View official trial listing →
  • Completed NCT NCT00224094

    A Comparison of Patch vs. Pill Estrogen Therapy on Testosterone Levels and Thyroid Tests in Menopausal Women

    Not yet reported Watson Pharmaceuticals 27 participants 1 site
    Other conditions: Menopause
    View official trial listing →
  • Completed NCT NCT00227942

    Estrogen for Treating Depression in Menopausal Women With Hot Flashes and Insomnia

    Not yet reported Hadine Joffe, MD 86 participants Est. completion 2007-11 1 site Stand-alone
    Other conditions: Sleep Initiation and Maintenance Disorders, Depression
    View official trial listing →
  • Completed NCT NCT00229450

    Estrogen and Perimenopausal Depression

    Not yet reported University of California, Los Angeles 17 participants Est. completion 2004-08 1 site Stand-alone
    Other conditions: Depressive Disorder, Major, Menopause
    View official trial listing →
  • Completed NCT NCT00229697

    Phase II Metastatic ER+/PgR+ Nolvadex +/- Iressa Study

    Not yet reported AstraZeneca 317 participants Est. completion 2015-06 55 sites
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Completed NCT NCT00230815

    A Phase 3b Study to Evaluate Subject Satisfaction With Follitropin Alfa Injection in Oligoanovulatory Infertile Women Undergoing Ovulation Induction

    Not yet reported EMD Serono 62 participants Est. completion 2005-11
    Other conditions: Infertility
    View official trial listing →
  • Completed NCT NCT00232505

    Cetuximab + / - Carboplatin for Estrogen Receptor-Negative, Progesterone Receptor-Negative Metastatic Breast Cancer

    Not yet reported UNC Lineberger Comprehensive Cancer Center 112 participants Est. completion 2012-08-12 14 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00234403

    A Trial to Evaluate the Combination of Iressa & Faslodex® in Patients With Advanced or Metastatic Breast Cancer

    Not yet reported AstraZeneca 60 participants Est. completion 2007-10 7 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00234676

    POETRY: Study of Estrogen Replacement Therapy in Postmenopausal Women With Parkinson's Disease

    Not yet reported The Parkinson Study Group 23 participants Est. completion 2006-03 6 sites
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT00234819

    Study Evaluating Bazedoxifene/Conjugated Estrogen Combinations in Symptoms Associated With Menopause

    Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 325 participants Est. completion 2007-02 7 sites
    Other conditions: Vasomotor Symptoms Associated With Menopause
    View official trial listing →
  • Terminated NCT NCT00236301

    Dose Effects of Hormone Therapy (Two Doses of Estradiol Associated to Progesterone) on Inflammatory Markers

    Not yet reported Assistance Publique - Hôpitaux de Paris 99 participants Est. completion 2007-01 1 site
    Other conditions: Healthy Symptomatic Menopausal Women
    View official trial listing →
  • Completed NCT NCT00236769

    A Study of Efficacy and Safety With the Transdermal Contraceptive System.

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 1751 participants Est. completion 1999-10
    Other conditions: Contraception, Female Contraception
    View official trial listing →
  • Completed NCT NCT00236782

    A Study of Efficacy and Safety With the Transdermal Contraceptive System Versus Mercilon.

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 1517 participants Est. completion 1999-03
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT00236795

    A Study of Efficacy and Safety With the Transdermal Contraceptive System Versus Triphasil.

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 1494 participants Est. completion 1999-03
    Other conditions: Contraception, Female Contraception
    View official trial listing →
  • Completed NCT NCT00237042

    Managing Temporomandibular Disorder (TMD) Symptoms

    Not yet reported University of Washington 252 participants Est. completion 2010-06 1 site
    Other conditions: Temporomandibular Joint Disorders
    View official trial listing →
  • Completed NCT NCT00237198

    Study of Safety and Efficacy of Letrozole Monotherapy as Second-line Endocrine Therapy in Postmenopausal Patients With Advanced Breast Cancer Who Received Previous Anti-estrogen Treatment

    Not yet reported Novartis Pharmaceuticals 47 participants 24 sites
    Other conditions: Postmenopausal Women With Advanced Breast Cancer
    View official trial listing →
  • Completed NCT NCT00238732

    Study Evaluating Bazedoxifene/Conjugated Estrogen Combinations in Vasomotor Symptoms Associated With Menopause

    Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 650 participants Est. completion 2007-03 63 sites
    Other conditions: Vaginal Atrophy
    View official trial listing →
  • Completed NCT NCT00239343

    Phase II Trial of Preoperative Therapy With Gefitinib and Chemotherapy in Patients With ERneg Breast Cancer

    Not yet reported AstraZeneca 160 participants Est. completion 2007-05 8 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00240071

    Study of Avastin (Bevacizumab) to Reverse Acquired Estrogen Independence in Previously Hormone Responsive Metastatic Breast Ca.

    Not yet reported University of Alabama at Birmingham 30 participants Est. completion 2011-04 1 site Stand-alone
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT00241449

    A Trial Comparing the Efficacy and Tolerability of Faslodex With Nolvadex in Postmenopausal Women With Advanced Breast Cancer

    Not yet reported AstraZeneca 51 participants Est. completion 2012-01 139 sites
    Other conditions: Breast Cancer, Metastasis
    View official trial listing →
  • Completed NCT NCT00242710

    Study Evaluating Bazedoxifene/Conjugated Estrogens Combinations In Postmenopausal Women

    Not yet reported Pfizer 1083 participants Est. completion 2008-09 9 sites Stand-alone
    Other conditions: Endometrial Hyperplasia, Osteoporosis
    View official trial listing →
  • Completed NCT NCT00244998

    Fulvestrant in Treating Patients With Advanced Prostate Cancer

    Not yet reported Roswell Park Cancer Institute 20 participants Est. completion 2012-06 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00245921

    Study Evaluating Levonorgestrel and Ethinyl Estradiol for Oral Contraception

    Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 2000 participants Est. completion 2005-10
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT00248963

    Study Evaluating Levonorgestrel and Ethinyl Estradiol in Oral Contraception

    Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 600 participants Est. completion 2004-10
    Other conditions: Oral Contraceptive
    View official trial listing →
  • Terminated NCT NCT00249847

    Study of PET Scans and Serotonin in Hot Flashes Treatment

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 5 participants Est. completion 2008-04 1 site Stand-alone
    Other conditions: Hot Flashes
    View official trial listing →
  • Completed NCT NCT00251082

    Vasomotoric Symptoms Study of a 0.5 mg Estradiol and 2.5 mg Dydrogesterone Combination

    Not yet reported Solvay Pharmaceuticals 391 participants Est. completion 2007-10 18 sites
    Other conditions: Postmenopause
    View official trial listing →
  • Completed NCT NCT00252408

    Danish Osteoporosis Prevention Study

    Not yet reported University of Aarhus 2000 participants Est. completion 2003-12 1 site
    Other conditions: Osteoporosis
    View official trial listing →
  • Withdrawn NCT NCT00252811

    A Study of ZD1839 Effects on Cell Proliferation in Breast Cancer

    Not yet reported AstraZeneca 60 participants 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00253422

    Study of Faslodex +/- Concomitant Arimidex v Exemestane Following Progression on Non-steroidal Aromatase Inhibitors

    Not yet reported Institute of Cancer Research, United Kingdom 698 participants Est. completion 2022-11-28 2 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00253539

    Arzoxifene or Tamoxifen in Preventing Breast Cancer in Premenopausal Women at High Risk for Breast Cancer

    Not yet reported The Cleveland Clinic 3 participants Est. completion 2005-04
    Other conditions: Breast Cancer, Hereditary Breast/Ovarian Cancer (brca1, brca2)
    View official trial listing →
  • Completed NCT NCT00254189

    Study Evaluating Effects of Levonorgestrel and Ethinyl Estradiol on Ovulation

    Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 60 participants Est. completion 2004-10
    Other conditions: Ovulation
    View official trial listing →
  • Completed NCT NCT00254865

    A Comparative Pharmacokinetic Study of ORTHO EVRA (a Transdermal Contraceptive Patch) and CILEST (an Oral Contraceptive) in Healthy Female Volunteers

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 34 participants Est. completion 2003-03
    Other conditions: Contraception, Female Contraception
    View official trial listing →
  • Completed NCT NCT00255125

    Role of Soy Supplementation in Prostate Cancer Development

    Not yet reported VA Office of Research and Development 86 participants Est. completion 2009-10 1 site
    Other conditions: Prostate Neoplasm
    View official trial listing →
  • Completed NCT NCT00255463

    Phase II Neoadjuvant ER+/PgR + Arimidex +/- Iressa Study

    Not yet reported AstraZeneca 185 participants Est. completion 2005-11 34 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00256698

    Anastrozole Monotherapy Versus Maximal Oestrogen Blockade With Anastrozole and Fulvestrant Combination Therapy

    Not yet reported AstraZeneca 514 participants Est. completion 2012-02 85 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00258063

    A Study to Evaluate the Exposure of Norelgestromin and Ethinyl Estradiol From Commercial Lots of EVRA (a Transdermal Contraceptive Patch Manufactured by LOHMANN Therapie-Systeme) and CILEST (an Oral Contraceptive)

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 60 participants Est. completion 2004-09
    Other conditions: Contraception, Female Contraception
    View official trial listing →
  • Completed NCT NCT00258076

    A Study to Evaluate the Hormone Exposure From Multiple Commercial Lots of ORTHO EVRA (a Transdermal Contraceptive Patch)

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 53 participants Est. completion 2004-09
    Other conditions: Contraception, Female Contraception
    View official trial listing →
  • Completed NCT NCT00261482

    Evaluation of Women's Experience With EVRA (Norelgestromin + Ethinyl Estradiol) Transdermal Contraceptive Patch Compared With Previous Methods of Contraception.

    Not yet reported Janssen Pharmaceutica N.V., Belgium 778 participants Est. completion 2004-12
    Other conditions: Contraception, Female Contraception
    View official trial listing →
  • Completed NCT NCT00263341

    Safety and Efficacy of a Contraceptive Vaginal Ring Delivering Nestorone® and Ethinyl Estradiol

    Not yet reported Population Council 1135 participants Est. completion 2014-08 12 sites
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT00264407

    Neural Changes in the Aging Auditory System

    University of Rochester 126 participants Est. completion 2005-02 2 sites
    Alcohol use disorder Other conditions: Progesterone, Estrogens, Hearing, Psychoacoustics
    View official trial listing →
  • Completed NCT NCT00265759

    Exemestane, Letrozole, or Anastrozole in Treating Postmenopausal Women Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer

    Not yet reported Alliance for Clinical Trials in Oncology 622 participants Est. completion 2019-11-27 3 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00266032

    Study on Safety and Efficacy of an Oral Contraceptive in Long Cycles

    Not yet reported Bayer 1166 participants Est. completion 2008-10 35 sites
    Other conditions: Contraception
    View official trial listing →
  • Terminated NCT NCT00267553

    Treatment and Survival Continuation Study of Atamestane Plus Toremifene vs Letrozole in Advanced Breast Cancer

    Not yet reported Intarcia Therapeutics 200 participants Est. completion 2006-06 35 sites
    Other conditions: Breast Neoplasms, Neoplasms, Hormone-Dependent
    View official trial listing →
  • Active, not recruiting NCT NCT00268476

    Systemic Therapy in Advancing or Metastatic Prostate Cancer: Evaluation of Drug Efficacy

    Not yet reported, Not yet reported Medical Research Council 11992 participants Est. completion 2030-12 120 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00269620

    PARIS or PAtch RIng Study: A Trial to Evaluate NuvaRing Versus OrthoEvra

    Not yet reported University of Pittsburgh 500 participants Est. completion 2006-12 10 sites
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT00272740

    SAKK - a Trial to Evaluate Antitumor Efficacy of Faslodex® After Aromatase Inhibitor Failure in Advanced Breast Cancer

    Not yet reported AstraZeneca 93 participants 8 sites
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Completed NCT NCT00272935

    A Clinical Trial to Demonstrate the Efficacy and Safety of Cenestin 0.3 mg for the Treatment of Hot Flashes

    Not yet reported Duramed Research 400 participants Est. completion 2007-05 49 sites
    Other conditions: Hot Flashes
    View official trial listing →
  • Completed NCT NCT00274469

    A Clinical Trial to Compare Efficacy and Tolerability of Faslodex With Arimidex in Patients With Advanced Breast Cancer

    Not yet reported AstraZeneca 205 participants Est. completion 2017-01-13 41 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT00276081

    Gabapentin Versus Estrogen for the Treatment of Hot Flashes

    Not yet reported University of Rochester 60 participants Est. completion 2004-09 1 site
    Other conditions: Hot Flashes
    View official trial listing →
  • Completed NCT NCT00278915

    Faslodex in McCune-Albright Syndrome

    Not yet reported AstraZeneca 30 participants Est. completion 2023-07-20 16 sites
    Other conditions: Puberty, Precocious, McCune-Albright Syndrome
    View official trial listing →
  • Completed NCT NCT00283608

    Pharmacogenetics of Anastrozole in Postmenopausal Women With Estrogen Receptor-Positive and/or Progesterone Receptor-Positive Stage I, Stage II, or Stage III Breast Cancer

    Mayo Clinic 1000 participants Est. completion 2010-03 4 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00283816

    Impact of Metformin in Teens With Polycystic Ovary Syndrome (PCOS) on Oral Contraceptive Therapy

    Not yet reported University of Rochester 36 participants Est. completion 2008-01 1 site
    Other conditions: Polycystic Ovary Syndrome
    View official trial listing →
  • Completed NCT NCT00286364

    Short-Term Androgen Priming Before COS Using Aromatase Inhibitor and hCG During Early-Follicular-Phase GnRH Antagonist Administration - a Randomized Controlled Trial

    Not yet reported Copenhagen University Hospital, Rigshospitalet 1 site
    Other conditions: Infertility
    View official trial listing →
  • Completed NCT NCT00288002

    Combination Chemotherapy With or Without Capecitabine and/or Trastuzumab Before Surgery in Treating Women With Stage I, Stage II, or Stage III Breast Cancer

    Not yet reported GBG Forschungs GmbH 1500 participants 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00290251

    Treatment of Uterine Fibroids With the Selective Progesterone Receptor Modulator CDB-2914

    Not yet reported National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 72 participants Est. completion 2010-08 2 sites
    Other conditions: Leiomyoma
    View official trial listing →
  • Completed NCT NCT00293059

    Efficacy and Safety Study for the Treatment of Dysfunctional Uterine Bleeding

    Not yet reported Bayer 190 participants Est. completion 2008-05 46 sites Stand-alone
    Other conditions: Metrorrhagia
    View official trial listing →
  • Completed NCT NCT00294463

    Effects of Tibolone Treatment on the Endometrium

    Not yet reported Erasmus Medical Center 35 participants Est. completion 2005-03 1 site
    Other conditions: Postmenopause, Osteoporosis
    View official trial listing →
  • Completed NCT NCT00298025

    A Study to Compare the Safety and Efficacy of Cetrotide® 3 Milligram (mg) Versus Antagon™ in Women Undergoing Ovarian Stimulation

    Not yet reported EMD Serono 185 participants Est. completion 2004-05
    Other conditions: Infertile Women Undergoing Assisted Reproductive Technology (ART)
    View official trial listing →
  • Completed NCT NCT00301353

    Effects of Phytoestrogen-rich Diets on Bone Turnover in Postmenopausal Women

    Not yet reported TNO 300 participants Est. completion 2004-07 3 sites
    Other conditions: Osteoporosis
    View official trial listing →
  • Withdrawn NCT NCT00301587

    A Study to Evaluate Folate Levels in Women Taking Oral Contraceptives

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Est. completion 2004-12
    Other conditions: Neural Tube Defects, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Nervous System Malformations
    View official trial listing →
  • Terminated NCT NCT00302731

    Bioidentical 'Natural' Hormone Evaluation in Early Menopause

    Not yet reported Jeanne Drisko, MD, CNS, FACN 21 participants Est. completion 2014-09 1 site
    Other conditions: Menopause
    View official trial listing →
  • Completed NCT NCT00303524

    Comparative Study of Oestradiol Suppression: Zoladex 10.8mg/3 Month vs. 3.6mg/Month in ER +ve EBC Pre-menopausal Patients

    Not yet reported AstraZeneca 170 participants Est. completion 2009-02 22 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT00303615

    Androgen Therapy for Management of Estrogen/Progesterone Receptor Negative ER(-)PR(-) Metastatic Breast Cancer

    Not yet reported Legacy Health System 5 participants Est. completion 2007-07 1 site
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT00303784

    Prostate Adenocarcinoma TransCutaneous Hormones

    Not yet reported University College, London 2200 participants Est. completion 2021-08 32 sites
    Other conditions: Anemia, Cardiovascular Complications, Hot Flashes, Osteoporosis, Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00305448

    A Clinical Trial to Compare Efficacy and Tolerability of Fulvestrant 250mg, 250mg (Plus 250mg Loading Regimen) and 500mg

    Not yet reported AstraZeneca 143 participants Est. completion 2012-02 35 sites
    Other conditions: Advanced Breast Cancer, Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT00305825

    Bevacizumab and Letrozole in Treating Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer That Cannot Be Removed By Surgery

    Not yet reported University of California, San Francisco 43 participants Est. completion 2016-05-24 2 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00306618

    Safety and Efficacy Study of Panzem NCD to Treat Glioblastoma

    Not yet reported CASI pharmaceuticals, Inc. 27 participants Est. completion 2008-12 1 site
    Other conditions: Recurrent Glioblastoma Multiforme
    View official trial listing →
  • Completed NCT NCT00307632

    An Open-label Study to Evaluate Contraceptive Efficacy and Safety of the Transdermal Contraceptive System of Norelgestromine and Ethinyl Estradiol

    Not yet reported Janssen-Cilag Farmaceutica Ltda. 580 participants Est. completion 2004-12 12 sites
    Other conditions: Contraception
    View official trial listing →
  • Terminated NCT NCT00307775

    Vaginal Estrogen for the Treatment of Faecal Incontinence in Women

    Not yet reported London North West Healthcare NHS Trust 43 participants Est. completion 2011-10 1 site
    Other conditions: Fecal Incontinence
    View official trial listing →
  • Completed NCT NCT00307801

    Efficacy and Safety Study for the Treatment of Dysfunctional Uterine Bleeding

    Not yet reported Bayer 231 participants Est. completion 2008-05 36 sites Stand-alone
    Other conditions: Metrorrhagia
    View official trial listing →
  • Completed NCT NCT00309855

    Testosterone-Driven Growth-Hormone (GH) Secretion in Aging Men

    Not yet reported Mayo Clinic 80 participants Est. completion 2008-08 1 site
    Other conditions: Aging
    View official trial listing →
  • Completed NCT NCT00310531

    3-year Study of Menostar Versus Evista to Prevent Osteoporosis in Post-menopausal Women

    Not yet reported Bayer 500 participants Est. completion 2007-06
    Other conditions: Osteopenia
    View official trial listing →
  • Completed NCT NCT00310791

    Adrenal and Gonadal Hormone Replacement in Anorexia Nervosa

    Not yet reported, Not yet reported Boston Children's Hospital 80 participants Est. completion 2010-12 1 site Stand-alone
    Obstructive sleep apnea
    View official trial listing →
  • Completed NCT NCT00313170

    A Clinical Trial to Compare Efficacy and Tolerability of Fulvestrant 250mg, 250mg Plus 250mg Loading Regimen and 500mg

    Not yet reported AstraZeneca 144 participants Est. completion 2019-03-13 34 sites
    Other conditions: Advanced Breast Cancer, Metastatic Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT00315107

    Estrogen Treatment in Acromegalic Women

    Not yet reported Université de Montréal 30 participants Est. completion 2007-08 1 site
    Other conditions: Acromegaly
    View official trial listing →
  • Completed NCT NCT00318318

    Beneficial Effects of Oral Premarin Estrogen Replacement Therapy Assessed by Human Genome Array

    Not yet reported London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 20 participants Est. completion 2007-02 1 site
    Other conditions: Healthy, Estrogen Replacement Therapy
    View official trial listing →
  • Completed NCT NCT00319163

    Study Comparing Two Manufacturing Processes for Levonorgestrel 90 mg/Ethinyl Estradiol 20 mg (LNG/EE) in Healthy, Cycling Women

    Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 26 participants Est. completion 2006-11 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00319566

    Heart and Estrogen-Progestin Replacement Study (HERS)

    Not yet reported University of California, San Francisco 2430 participants Est. completion 2001-07 1 site
    Other conditions: Coronary Heart Disease
    View official trial listing →
  • Completed NCT NCT00320580

    An Open-Label Study to Compare the Bleeding Profile of Norelgestromin/Ethinyl Estradiol in an Extended Regimen to Norelgestromin/Ethinyl Estradiol Given in a Traditional Regimen

    Not yet reported McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc. 239 participants Est. completion 2003-03
    Other conditions: Metrorrhagia
    View official trial listing →
  • Completed NCT NCT00322348

    Study of Zoladex Given Every 12 Weeks Versus Given Every Month in Advanced Breast Cancer (ABC) Pre-menopausal Women

    Not yet reported AstraZeneca 98 participants Est. completion 2009-11 14 sites
    Other conditions: Advanced Breast Cancer
    View official trial listing →
  • Completed NCT NCT00324259

    Study of Physiological and High Dose Estradiol in the Treatment of Hormone Receptor Positive Metastatic Breast Cancer

    Not yet reported Washington University School of Medicine 66 participants Est. completion 2014-08 7 sites
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Status unknown NCT NCT00326404

    Continuous Versus Cyclic Use of Oral Contraceptive Pills in Adolescents

    Not yet reported The Hospital for Sick Children 130 participants Est. completion 2009-05 1 site
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT00327769

    Faslodex Advanced Breast Cancer Local Chinese Study

    Not yet reported AstraZeneca 234 participants Est. completion 2007-09 12 sites
    Other conditions: Advanced Breast Cancer
    View official trial listing →
  • Completed NCT NCT00328120

    Faslodex 500mg Multiple Dose Tolerability Study in BC Patients

    Not yet reported AstraZeneca 20 participants Est. completion 2010-06 5 sites
    Other conditions: Advanced Breast Cancer
    View official trial listing →
  • Completed NCT NCT00328497

    A Combination Study to Determine the Safety and Efficacy of Panzem NCD With Avastin in Metastatic Carcinoid Tumors

    Not yet reported CASI pharmaceuticals, Inc. 31 participants Est. completion 2009-12 1 site
    Other conditions: Carcinoid Tumor
    View official trial listing →
  • Terminated NCT NCT00328926

    Luveris® (Lutropin Alfa for Injection) in Women With Hypogonadotropic Hypogonadism (Luteinizing Hormone [LH] Less Than [<] 1.2 International Unit Per Liter [IU/L])

    Not yet reported EMD Serono 11 participants Est. completion 2012-05 1 site
    Other conditions: Hypogonadotropic Hypogonadism
    View official trial listing →
  • Completed NCT NCT00331071

    Postmarketing Study of ORTHO EVRA (Norelgestromin and Ethinyl Estradiol Contraceptive Patch) in Relation to Venous Thromboembolism (Blood Clots), Stroke and Heart Attacks

    Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 334 participants Est. completion 2006-03
    Other conditions: Contraception, Female Contraception
    View official trial listing →
  • Completed NCT NCT00331123

    Study of Transdermal Testosterone Patches in Surgically Menopausal Women With Low Libido

    Not yet reported Warner Chilcott 562 participants Est. completion 2006-07 3 sites
    Other conditions: Hypoactive Sexual Desire Disorder
    View official trial listing →
  • Completed NCT NCT00331214

    Study of Transdermal Testosterone Patches in Surgically Menopausal Women With Low Libido

    Not yet reported Warner Chilcott 533 participants Est. completion 2006-07 3 sites
    Other conditions: Hypoactive Sexual Desire Disorder
    View official trial listing →
  • Completed NCT NCT00332553

    Study of Hot Flashes and Night Sweats in Postmenopausal Women Receiving Combination Raloxifene and Oral Estrogen

    Not yet reported Eli Lilly and Company 150 participants Est. completion 2004-05 1 site
    Other conditions: Vasomotor Symptoms, Endometrial Safety
    View official trial listing →
  • Completed NCT NCT00334295

    Fulvestrant for the Treatment of Recurrent or Metastatic Endometrial Carcinoma.

    Not yet reported AstraZeneca 35 participants Est. completion 2011-01 9 sites
    Other conditions: Endometrial Carcinoma
    View official trial listing →
  • Status unknown NCT NCT00334971

    Aromatase Activity and Ovarian Growth Factors in African-American Versus Caucasian Women

    Not yet reported Massachusetts General Hospital 116 participants Est. completion 2018-01 1 site
    Other conditions: Healthy, Fragile X Syndrome
    View official trial listing →
  • Completed NCT NCT00335218

    Fat Distribution in Healthy Early Postmenopausal Women

    Not yet reported Bayer 67 participants Est. completion 2004-08 3 sites
    Other conditions: Healthy, Postmenopause
    View official trial listing →
  • Completed NCT NCT00338052

    Study of Bleeding With Extended Administration of an Oral Contraceptive

    Not yet reported Warner Chilcott 207 participants Est. completion 2007-05 23 sites
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT00338728

    Letrozole and Imatinib Mesylate in Treating Postmenopausal Participants With Estrogen or Progesterone Positive Metastatic Breast Cancer

    Not yet reported M.D. Anderson Cancer Center 59 participants Est. completion 2018-11-27 1 site
    Other conditions: Anatomic Stage IV Breast Cancer AJCC v8, Estrogen Receptor Positive, KIT Positive, PDGFR Positive, Postmenopausal, Progesterone Receptor Positive, Prognostic Stage IV Breast Cancer AJCC v8
    View official trial listing →
  • Completed NCT NCT00340652

    Effects of Infant Diets on Estrogen Activity and Development

    National Institute of Environmental Health Sciences (NIEHS) 157 participants Est. completion 2012-08-22 2 sites
    Other conditions: Hormone
    View official trial listing →
  • Completed NCT NCT00340665

    Study of Infant Diets on Estrogen Activity and Development

    National Institute of Environmental Health Sciences (NIEHS) 239 participants Est. completion 2012-08-22 2 sites
    Other conditions: Infant Formula, Estrogen Activity
    View official trial listing →
  • Completed NCT NCT00342095

    Hormonal and Environmental Risk Factors for Developing Systemic Lupus Erythematosus: The Carolina Lupus (CLU) Study

    National Institute of Environmental Health Sciences (NIEHS) 640 participants Est. completion 2007-03-07 6 sites
    Other conditions: Systemic Lupus Erythematosus
    View official trial listing →
  • Completed NCT NCT00342498

    Estrogen Receptor Gene Mutations

    National Institute of Environmental Health Sciences (NIEHS) Est. completion 2008-06-17 2 sites
    Other conditions: Mutations, Hormones
    View official trial listing →
  • Completed NCT NCT00344383

    An Open-Label Study Evaluating Breakthrough Bleeding and Spotting With Norgestimate/Ethinyl Estradiol Tablets Administered as an Extended Regimen

    Not yet reported McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc. 61 participants Est. completion 2004-07
    Other conditions: Metrorrhagia
    View official trial listing →
  • Completed NCT NCT00350480

    Treatment of Non-Gestational Acute Uterine Bleeding: A Randomized Trial

    Not yet reported Kaiser Permanente 240 participants Est. completion 2005-06 1 site
    Other conditions: Uterine Hemorrhage, Menorrhagia
    View official trial listing →
  • Status unknown NCT NCT00351416

    Letrozole Treatment in Normal and GnRH Deficient Women

    Not yet reported, Not yet reported Massachusetts General Hospital 15 participants 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT00356447

    Safety/Efficacy Study of Drospirenone/Estradiol to Treat Postmenopausal Chinese Women With Vasomotor Symptoms.

    Not yet reported Bayer 249 participants Est. completion 2007-10 9 sites
    Other conditions: Vasomotor Symptoms
    View official trial listing →
  • Completed NCT NCT00357006

    A Definitive Estrogen Patch Study (ADEPT)

    Not yet reported The Alfred 180 participants Est. completion 2013-12 1 site
    Other conditions: Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder(Not in Manic Phase)
    View official trial listing →
  • Completed NCT NCT00357110

    Anastrozole and Fulvestrant Compared to Anastrozole as Adjuvant Treatment of Postmenopausal Patients With Breast Cancer

    Not yet reported AstraZeneca 13 participants Est. completion 2008-10 25 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00357604

    Atazanavir and Ritonavir (ATV/RTV) and an Oral Contraceptive in Healthy Females

    Not yet reported Bristol-Myers Squibb 22 participants Est. completion 2006-11 1 site
    Other conditions: HIV Infections
    View official trial listing →
  • Terminated NCT NCT00358098

    Study to Determine the Utility of FES-PET and FDG-PET in the Prediction of Response to Hormone Therapy in Women With Estrogen Positive Metastatic Breast Cancer

    AHS Cancer Control Alberta 51 participants Est. completion 2013-06 1 site
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT00361075

    Midlife Cholesterol Study

    Not yet reported Northwestern University 120 participants Est. completion 2005-05 2 sites
    Cardiovascular disease Other conditions: Menopause, Postmenopause, Premenopause
    View official trial listing →
  • Completed NCT NCT00361543

    Selective Estrogen Receptor Modulators - A Potential Treatment for Psychotic Symptoms of Schizophrenia

    Not yet reported The Alfred 54 participants Est. completion 2014-12 1 site
    Other conditions: Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder
    View official trial listing →
  • Completed NCT NCT00365599

    Phase II Trial of SAHA & Tamoxifen for Patients With Breast Cancer

    Not yet reported H. Lee Moffitt Cancer Center and Research Institute 43 participants Est. completion 2012-08 8 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00367276

    Study to Evaluate the Effect of Six Cycles of Treatment With a Combined Oral Contraceptive (EE 0.30 mg/DRSP 3 mg) on Quality of Life.

    Not yet reported Bayer 221 participants Est. completion 2004-05
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00367536

    Study Evaluating Three Bazedoxifene/Conjugated Estrogens Combination Tablet Formulations Versus BZA Oral Solution

    Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 24 participants Est. completion 2006-08
    Other conditions: Postmenopause
    View official trial listing →
  • Completed NCT NCT00368459

    Raloxifene for Women With Alzheimer's Disease

    Not yet reported Stanford University 42 participants Est. completion 2012-01 4 sites Stand-alone
    Other conditions: Alzheimer Disease
    View official trial listing →
  • Withdrawn NCT NCT00370019

    Effects of an Estrogen Replacement Therapy Skin Patch on Ovulation in Women With Premature Ovarian Failure

    Not yet reported Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Est. completion 2011-12-12 1 site
    Other conditions: Premature Ovarian Failure
    View official trial listing →
  • Completed NCT NCT00371345

    Study of Dasatinib (BMS-354825) in Patients With Advanced Estrogen/Progesterone Receptor-positive (ER+/PR+) or Her2/Neu-positive (Her2/Neu+)Breast Cancer

    Not yet reported Bristol-Myers Squibb 92 participants Est. completion 2009-05 23 sites
    Other conditions: Breast Cancer, Metastasis
    View official trial listing →
  • Completed NCT NCT00371956

    Raloxifene for Prevention of Bone Loss in Postmenopausal Patients Receiving Chronic Corticosteroid Therapy

    Not yet reported Tuen Mun Hospital 114 participants Est. completion 2010-02 1 site
    Other conditions: Osteoporosis
    View official trial listing →
  • Terminated NCT NCT00372996

    Study Of CP-751,871 In Combination With Exemestane In Postmenopausal Women With Hormone Receptor Positive Advanced Breast Cancer

    Not yet reported Pfizer 219 participants Est. completion 2014-06 62 sites
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Completed NCT NCT00375622

    Anti-Estrogen Therapy for Hereditary Hemorrhagic Telangiectasia A Double-Blind Placebo-Controlled Clinical Trial

    Not yet reported Rabin Medical Center 60 participants Est. completion 2006-06 1 site
    Other conditions: Hereditary Hemorrhagic Telangiectasia
    View official trial listing →
  • Completed NCT NCT00377988

    A Postmarketing Study of the Risk of Venous Thromboembolism (Blood Clots), Myocardial Infarction (Heart Attacks), and Stroke Among Women Using ORTHO EVRA (Norelgestromin and Ethinyl Estradiol Contraceptive Patch) Compared With Women Who Take Oral Contraceptives for Birth Control

    Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 423 participants Est. completion 2008-10
    Other conditions: Contraception, Female Contraception
    View official trial listing →
  • Terminated NCT NCT00379197

    Phase II of Naltrexone in Hormone-Refractory Metastatic Breast Cancer

    Not yet reported Masonic Cancer Center, University of Minnesota 13 participants Est. completion 2013-05 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00380887

    Study Comparing Four New Formulations for Premarin in Healthy Postmenopausal Women

    Wyeth is now a wholly owned subsidiary of Pfizer 54 participants
    Other conditions: Postmenopause
    View official trial listing →
  • Completed NCT NCT00384046

    Testosterone Therapy in Naturally Menopausal Women With Low Sexual Desire Receiving Transdermal Estrogen

    Not yet reported Warner Chilcott 272 participants Est. completion 2007-07 31 sites
    Other conditions: Hypoactive Sexual Desire Disorder
    View official trial listing →
  • Status unknown NCT NCT00386022

    The Effects of Aging and Estrogen on the Pituitary

    Not yet reported, Not yet reported Massachusetts General Hospital 19 participants Est. completion 2018-01 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Terminated NCT NCT00387829

    DuraGen Plus® Adhesion Barrier for Use in Spinal Surgery

    Not yet reported Integra LifeSciences Corporation 347 participants Est. completion 2011-12 36 sites
    Other conditions: Spinal Injuries, Adhesions
    View official trial listing →
  • Completed NCT NCT00390455

    Fulvestrant With or Without Lapatinib in Treating Postmenopausal Women With Stage III or Stage IV Breast Cancer That is Hormone Receptor-Positive

    Not yet reported National Cancer Institute (NCI) 295 participants Est. completion 2014-07-02 368 sites
    Other conditions: Estrogen Receptor Positive, HER2 Positive Breast Carcinoma, HER2/Neu Negative, Progesterone Receptor Positive, Recurrent Breast Carcinoma, Stage IIIB Breast Cancer AJCC v7, Stage IIIC Breast Cancer AJCC v7, Stage IV Breast Cancer AJCC v6 and v7
    View official trial listing →
  • Completed NCT NCT00391417

    Efficacy and Safety of a Topical Estradiol Gel for Treatment of Postmenopausal Symptoms

    Not yet reported BioSante Pharmaceuticals 431 participants Est. completion 2005-04
    Other conditions: Hot Flashes
    View official trial listing →
  • Completed NCT NCT00391807

    Study of Safety and Efficacy of an Oral Contraceptive

    Not yet reported Warner Chilcott 1683 participants Est. completion 2008-09 66 sites
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT00393172

    Women in Steady Exercise Research [Formerly Women, Oxidative Stress, Exercise and Estrogens (WOSEE)]

    Not yet reported, Not yet reported University of Minnesota 400 participants Est. completion 2010-03 1 site
    Other conditions: Breast Cancer, Obesity
    View official trial listing →
  • Completed NCT NCT00394771

    A Study to Evaluate Bleeding Patterns With Three Different Doses of DR-1031 Compared to Seasonale

    Not yet reported Duramed Research 567 participants Est. completion 2008-03 50 sites
    Other conditions: Breakthrough Bleeding
    View official trial listing →
  • Completed NCT NCT00396799

    Bioequivalence Study Of Bazedoxifene/Conjugated Estrogen Tablets In Postmenopausal Women

    Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer Est. completion 2006-11
    Other conditions: Menopause
    View official trial listing →
  • Completed NCT NCT00399685

    Drug Interaction - Oral Contraceptive

    Not yet reported Bristol-Myers Squibb 28 participants Est. completion 2007-08 2 sites
    Other conditions: HIV Infections
    View official trial listing →
  • Completed NCT NCT00401219

    Study Comparing Bioavailability of 3 New Formulations of Premarin/MPA With Premarin/MPA (PREMPRO) Reference Formulation

    Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer Est. completion 2007-02
    Other conditions: Estrogen Replacement Therapy
    View official trial listing →
  • Completed NCT NCT00402636

    Rapamycin+Estradiol- vs. Rapamycin-Eluting Stents to Reduce Restenosis (ISAR-PEACE)

    Not yet reported Deutsches Herzzentrum Muenchen 502 participants Est. completion 2006-10 2 sites
    Other conditions: Coronary Heart Disease
    View official trial listing →
  • Withdrawn NCT NCT00402935

    Ovarian Damage in Young Premenopausal Women Undergoing Chemotherapy for Cancer

    Case Comprehensive Cancer Center Est. completion 2007-05 1 site
    Other conditions: Leukemia, Long-term Effects Secondary to Cancer Therapy in Adults, Long-term Effects Secondary to Cancer Therapy in Children, Lymphoma, Sexual Dysfunction and Infertility, Sexuality and Reproductive Issues, Unspecified Adult Solid Tumor, Protocol Specific, Unspecified Childhood Solid Tumor, Protocol Specific
    View official trial listing →
  • Completed NCT NCT00405938

    Bevacizumab Given With Either Anastrozole or Fulvestrant With Trastuzumab for Postmenopausal Metastatic Breast Cancer

    Not yet reported SCRI Development Innovations, LLC 79 participants Est. completion 2011-06 11 sites
    Other conditions: Breast Cancer, Breast Neoplasms
    View official trial listing →
  • Completed NCT NCT00413062

    Efficacy and Safety Study of the Combined Oral Contraceptive NOMAC-E2 Compared to a COC Containing DRSP/EE (292002)(P05722)

    Not yet reported Organon and Co 2281 participants Est. completion 2008-08
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT00413764

    Efficacy of Tibolone Versus Transdermal E2/NETA on Sexual Function in Naturally Postmenopausal Women (P06089)

    Not yet reported Organon and Co 358 participants Est. completion 2005-11-15
    Other conditions: Sexual Dysfunction
    View official trial listing →
  • Completed NCT NCT00417430

    Efficacy of Faslodex in Treatment of SLE Clinical, Serologic, and Molecular Studies

    Not yet reported The Center for Rheumatic Disease, Allergy, & Immunology 20 participants Est. completion 2006-12 1 site
    Other conditions: Systemic Lupus Erythematosus
    View official trial listing →
  • Completed NCT NCT00423917

    Fulvestrant and Bevacizumab in Treating Patients With Metastatic Breast Cancer

    Not yet reported Alliance for Clinical Trials in Oncology 36 participants Est. completion 2017-01-15 205 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00424203

    Doxorubicin and Cyclophosphamide in Treating Older Women With Stage I, Stage II, or Stage III Breast Cancer That Has Been Removed By Surgery

    Not yet reported UNICANCER 40 participants Est. completion 2011-11 17 sites
    Other conditions: Breast Cancer, Cognitive/Functional Effects, Depression, Malnutrition, Psychosocial Effects of Cancer and Its Treatment
    View official trial listing →
  • Completed NCT NCT00425776

    Treatment of Hot Flushes in Breast Cancer Patients With Acupuncture

    Not yet reported Vejle Hospital 94 participants Est. completion 2010-01 1 site
    Other conditions: Breast Cancer, Postmenopause
    View official trial listing →
  • Completed NCT NCT00426972

    Trial of Zesteem (Estradiol) in Healing of Split Thickness Skin Graft Donor Sites

    Not yet reported Renovo 148 participants Est. completion 2008-10 30 sites
    Other conditions: Burn, Trauma, Varicose Ulcer
    View official trial listing →
  • Completed NCT NCT00427245

    Goserelin in Preventing Early Menopause in Premenopausal Women Undergoing Chemotherapy for Stage I, Stage II, or Stage III Breast Cancer

    Not yet reported Anglo Celtic Cooperative Oncology Group 400 participants 66 sites
    Other conditions: Breast Cancer, Infertility, Menopausal Symptoms
    View official trial listing →
  • Completed NCT NCT00428311

    Effects of Metformin vs Oral Contraceptives on CV Risk Markers in PCOS

    Not yet reported Hospital Universitario Ramon y Cajal 50 participants Est. completion 2006-10 1 site
    Other conditions: Polycystic Ovary Syndrome
    View official trial listing →
  • Completed NCT NCT00431093

    Trial to Compare the Effects of Tibolone (Livial®) and Continuous Combined Low-Dose Estradiol/Noresterone (Activelle®)

    Not yet reported Organon and Co 570 participants Est. completion 2005-03
    Other conditions: Menopause
    View official trial listing →
  • Completed NCT NCT00431132

    Endometrial Safety of a Low Dose of Vagifem® in Postmenopausal Women With Atrophic Vaginitis

    Not yet reported Novo Nordisk A/S 336 participants Est. completion 2008-11 42 sites
    Other conditions: Menopause, Postmenopausal Vaginal Atrophy
    View official trial listing →
  • Completed NCT NCT00433589

    Genetic Testing or Clinical Assessment in Determining the Need for Chemotherapy in Women With Breast Cancer That Involves No More Than 3 Lymph Nodes

    Not yet reported European Organisation for Research and Treatment of Cancer - EORTC 6600 participants Est. completion 2020-03 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00435175

    Acute Metabolic Effects of Estradiol

    Not yet reported University of Aarhus 8 participants Est. completion 2006-07 1 site
    Other conditions: Postmenopause
    View official trial listing →
  • Terminated NCT NCT00438321

    Effect of Increasing Testosterone on Insulin Sensitivity in Men With the Metabolic Syndrome

    Not yet reported Massachusetts General Hospital 66 participants Est. completion 2010-02-26 1 site
    Metabolic syndrome
    View official trial listing →
  • Status unknown NCT NCT00439972

    Oral Versus Patch Hormonal Contraceptive Effects on Metabolism, Clotting, Inflammatory Factors and Vascular Reactivity

    Not yet reported University of Washington 36 participants Est. completion 2011-12 1 site
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT00442689

    Metabolic Syndrome in PCOS: Precursors and Interventions

    Not yet reported Northwestern University 97 participants Est. completion 2012-11 1 site
    Metabolic syndrome Other conditions: Polycystic Ovary Syndrome
    View official trial listing →
  • Completed NCT NCT00443716

    Determination of Adipocyte Parameters in Iliac Crest Biopsies From Post Menopausal Women

    Not yet reported Mayo Clinic 60 participants Est. completion 1989-04 1 site
    Other conditions: Osteoporosis, Postmenopausal
    View official trial listing →
  • Completed NCT NCT00444535

    Lapatinib and Bevacizumab for Metastatic Breast Cancer

    Not yet reported Novartis Pharmaceuticals 52 participants Est. completion 2020-06-19 9 sites
    Other conditions: Neoplasms, Breast
    View official trial listing →
  • Completed NCT NCT00446030

    Pilot Study of the Safety & Efficacy of Two Docetaxel-Based Regimens Plus Bevacizumab for the Adjuvant Treatment of Subjects With Node Positive or High Risk Node Negative Breast Cancer

    Not yet reported Sanofi 127 participants Est. completion 2010-08 1 site Stand-alone
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Completed NCT NCT00446199

    Low-dose Hormone Therapy for Relief of Vasomotor Symptoms

    Not yet reported Bayer 735 participants Est. completion 2008-11 76 sites
    Other conditions: Vasomotor Symptoms, Hot Flashes
    View official trial listing →
  • Withdrawn NCT NCT00447863

    Study Evaluating the Bioequivalence of Levonorgestrel/Ethinyl Estradiol Combinations in Cycling Women

    Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer Est. completion 2007-08
    Other conditions: Contraception
    View official trial listing →
  • Status unknown NCT NCT00449254

    Phase 2a Randomized, Double-Blind Study of Oleoyl-Estrone in Male Morbidly Obese Adults

    Not yet reported Manhattan Pharmaceuticals 24 participants 3 sites
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT00451204

    A Combination Trial of Copaxone Plus Estriol in Relapsing Remitting Multiple Sclerosis (RRMS)

    Not yet reported University of California, Los Angeles 158 participants Est. completion 2014-07 16 sites
    Other conditions: Relapsing Remitting Multiple Sclerosis
    View official trial listing →
  • Completed NCT NCT00451555

    Enzastaurin Plus Fulvestrant vs. Placebo Plus Fulvestrant in Breast Cancer

    Not yet reported Eli Lilly and Company 156 participants Est. completion 2018-10-18 21 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00454805

    AZD2171 in Addition to Fulvestrant in Patients With Advanced Breast Cancer.

    Not yet reported AstraZeneca 75 participants Est. completion 2016-04 16 sites
    Other conditions: Advanced Breast Cancer
    View official trial listing →
  • Completed NCT NCT00455156

    Study of the Safety, Efficacy and Cycle Control of a Contraceptive Vaginal Ring

    Not yet reported Premier Research 1200 participants Est. completion 2011-09 15 sites
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT00455741

    Postmenopausal Women Estrogen and Progesterone Infusion

    Not yet reported, Not yet reported Massachusetts General Hospital 20 participants Est. completion 2015-08-22 1 site
    Other conditions: Postmenopause, Aging
    View official trial listing →
  • Completed NCT NCT00455962

    Effect of Race on Gonadotropin Responses

    Not yet reported, Not yet reported Massachusetts General Hospital 23 participants Est. completion 2011-12 1 site
    Other conditions: Premenopause, Healthy
    View official trial listing →
  • Terminated NCT NCT00459810

    Paclitaxel Poliglumex and Estradiol in Treating Patients With Stage IV Prostate Cancer

    Not yet reported OHSU Knight Cancer Institute 21 participants Est. completion 2009-07 2 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00463450

    Efficacy of Gynodian® Depot in Women With Impaired Well-being

    Not yet reported Bayer 140 participants Est. completion 2004-04
    Other conditions: Hormone Replacement Therapy
    View official trial listing →
  • Completed NCT NCT00463489

    Lifestyle Intervention Study in Adjuvant Treatment of Early Breast Cancer

    Not yet reported Ontario Clinical Oncology Group (OCOG) 338 participants Est. completion 2018-06 21 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00463788

    Cetuximab and Cisplatin in the Treatment of "Triple Negative" (Estrogen Receptor [ER] Negative, Progesterone Receptor [PgR] Negative, and Human Epidermal Growth Factor Receptor 2 [HER2] Negative) Metastatic Breast Cancer

    Not yet reported Merck KGaA, Darmstadt, Germany 181 participants Est. completion 2011-02 46 sites
    Other conditions: Breast Neoplasm
    View official trial listing →
  • Completed NCT NCT00464516

    Preoperative Estetrol in Breast Cancer

    Not yet reported Pantarhei Bioscience 30 participants Est. completion 2010-03 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00464789

    Study Evaluating Bazedoxifene/Conjugated Estrogens Combinations In Healthy Postmenopausal Women

    Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer Est. completion 2007-05
    Other conditions: Menopause
    View official trial listing →
  • Completed NCT NCT00465075

    Study Evaluating Bazedoxifene/Conjugated Estrogens Combinations in Fed and Fasting in Healthy, Postmenopausal Women

    Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 24 participants Est. completion 2007-04 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00465192

    Efficacy and Safety of 17-Beta Estradiol in Treatment of Atrophic Vaginitis

    Not yet reported Novo Nordisk A/S 230 participants Est. completion 1995-11-30
    Other conditions: Menopause, Postmenopausal Vaginal Atrophy
    View official trial listing →
  • Completed NCT NCT00465894

    Detrol Long Acting (LA) vs Estrace Vaginal Cream for the Treatment of Overactive Bladder Symptoms

    Not yet reported University of Alabama at Birmingham 58 participants Est. completion 2011-12
    Other conditions: Overactive Bladder
    View official trial listing →
  • Completed NCT NCT00468715

    Bicalutamide in Treating Patients With Metastatic Breast Cancer

    Not yet reported Memorial Sloan Kettering Cancer Center 28 participants Est. completion 2021-06-24 8 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00471991

    Valette (Combined Oral Contraceptive SH T04769G and SH D00659AF) Low Ovulation Inhibition

    Not yet reported Bayer 60 participants Est. completion 2007-12 1 site
    Other conditions: Oral Contraceptive
    View official trial listing →
  • Completed NCT NCT00472004

    Study Comparing 17B Estradiol/TMG CC 1mg Vs. Tibolone In Postmenopausal Women

    Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 204 participants Est. completion 2009-12 1 site
    Other conditions: Vasomotor Symptoms
    View official trial listing →
  • Completed NCT NCT00474851

    The Effect of Hormonal Add-Back Therapy in Adolescents Treated With a GnRH Agonist for Endometriosis: A Randomized Trial

    Not yet reported Boston Children's Hospital 53 participants Est. completion 2015-01 1 site
    Other conditions: Endometriosis
    View official trial listing →
  • Completed NCT NCT00475553

    Management of Breakthrough Bleeding During Extended Therapy Use With NuvaRing®

    Not yet reported Scott and White Hospital & Clinic 75 participants Est. completion 2008-05 1 site
    Other conditions: Breakthrough Bleeding, Breakthrough Spotting
    View official trial listing →
  • Completed NCT NCT00476645

    Fulvestrant in Hormone Refractory Prostate Cancer

    Not yet reported Stanford University 10 participants Est. completion 2009-12 1 site
    Other conditions: Prostatic Neoplasms, Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00477633

    Study of Safety and Efficacy of an Oral Contraceptive

    Not yet reported Warner Chilcott 1700 participants Est. completion 2009-02 63 sites
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT00479674

    Phase II Study With Abraxane, Bevacizumab and Carboplatin in Triple Negative Metastatic Breast Cancer

    Not yet reported Duke University 41 participants Est. completion 2014-03 4 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00479778

    Study Of Pharmacokinetic (PK) Profile of Bazedoxifene (BZA) in 2 BZA/Conjugated Estrogen Forms

    Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 72 participants Est. completion 2007-07 1 site
    Other conditions: Postmenopause
    View official trial listing →
  • Completed NCT NCT00480532

    A Study of Continuous Oral Contraceptives and Doxycycline

    Not yet reported Oregon Health and Science University 131 participants Est. completion 2011-05 2 sites
    Other conditions: Contraceptives, Oral
    View official trial listing →
  • Completed NCT NCT00481455

    Phase 2 Study of Panzem Nanocrystal Colloidal Dispersion (NCD) in Combination With Fixed-Dose Temozolomide to Patients With Recurrent Glioblastoma Multiforme (GBM)

    Not yet reported CASI pharmaceuticals, Inc. 15 participants Est. completion 2008-10 1 site
    Other conditions: Recurrent Glioblastoma Multiforme
    View official trial listing →
  • Completed NCT NCT00481650

    Observational Trial With Leios/Alesse

    Wyeth is now a wholly owned subsidiary of Pfizer Est. completion 2007-03
    Other conditions: Contraceptives, Oral, Combined
    View official trial listing →
  • Completed NCT NCT00484107

    Tolerability & Safety of Premarin Vaginal Cream in Indian Postmenopausal Women

    Wyeth is now a wholly owned subsidiary of Pfizer 200 participants Est. completion 2006-10
    Other conditions: Postmenopause
    View official trial listing →
  • Status unknown NCT NCT00490308

    The Influence of Estradiol Supplementation During the Luteal in Patients Undergoing IVF Treatment

    Not yet reported Assaf-Harofeh Medical Center 120 participants Est. completion 2008-08 1 site
    Other conditions: Infertility
    View official trial listing →
  • Completed NCT NCT00491595

    Phase I Clinical Study of Soy Isoflavones in Healthy, Post-Menopausal Women

    Not yet reported University of North Carolina 36 participants Est. completion 2005-07
    Other conditions: Drug Toxicity
    View official trial listing →
  • Terminated NCT NCT00498901

    Letrozole and Goserelin or Leuprolide in Treating Premenopausal Estrogen Receptor-Positive Patients With Stage IV Breast Cancer

    Not yet reported University of Washington 1 participants Est. completion 2008-11 2 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00499083

    Paclitaxel, Cyclophosphamide & Doxorubicin, Autologous Dendritic Cells & Surgery in Stage II/III Breast Cancer (Women)

    Not yet reported University of Nebraska 17 participants Est. completion 2010-01-28 2 sites Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT00503841

    Erlotinib in Treating Women Undergoing Surgery For Stage I, Stage II, or Stage III Breast Cancer

    Not yet reported Barbara Ann Karmanos Cancer Institute 44 participants Est. completion 2010-05 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00504816

    A Study of the Effects of GSK189075 on PK Profiles of an Oral Contraceptive Pill When Given to Healthy Female Volunteers

    Not yet reported GlaxoSmithKline 22 participants Est. completion 2008-04 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00505752

    Investigation of a Long-Acting Follicle Stimulating Hormone in Infertile Women Undergoing Assisted Reproductive Technology (ART)

    Not yet reported Merck KGaA, Darmstadt, Germany 520 participants Est. completion 2008-09 1 site
    Other conditions: Infertility
    View official trial listing →
  • Status unknown NCT NCT00506480

    Assessment of Endometrial Receptivity in Recipients of Donated Oocytes

    Not yet reported Hadassah Medical Organization 100 participants Stand-alone
    Other conditions: Embryo Implantation
    View official trial listing →
  • Completed NCT NCT00511342

    Effects on Bone Mineral Density (BMD) of the Combined Oral Contraceptive NOMAC-E2 Compared to a COC Containing LNG/EE (292005)(P05765)(COMPLETED)

    Not yet reported Organon and Co 110 participants Est. completion 2009-06
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT00511355

    Effects on Hemostasis, Lipids, Carbohydrate Metabolism, Adrenal & Thyroid Function of the Combined Oral Contraceptive NOMAC-E2 Compared to a COC Containing LNG-EE (292004)(COMPLETED)(P05764)

    Not yet reported Organon and Co 121 participants Est. completion 2008-01
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT00511433

    Effects on Ovarian Function of the Combined Oral Contraceptive NOMAC-E2 Compared to a COC Containing DRSP/EE (292003)(COMPLETED)(P05723)

    Not yet reported Organon and Co 48 participants Est. completion 2008-01
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT00511784

    Relative Risks for Non-fatal Venous Thromboembolism, Ischemic Stroke and Myocardial Infarction in Users of ORTHO EVRA(Norelgestromin and Ethinyl Estradiol Contraceptive Patch) Compared to Levonorgestrel-containing Oral Contraceptives.

    Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 440 participants Est. completion 2007-06
    Other conditions: Contraception, Female Contraception, Fertility Control
    View official trial listing →
  • Completed NCT NCT00513916

    Effect of Dietary Soy on Estrogens in Breast Fluid, Blood, and Urine Samples From Healthy Women

    Not yet reported University of Hawaii Cancer Research Center 100 participants Est. completion 2012-02 1 site
    Other conditions: Breast Cancer, Healthy, no Evidence of Disease
    View official trial listing →
  • Completed NCT NCT00516698

    Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer

    Alliance for Clinical Trials in Oncology 140 participants Est. completion 2009-12 180 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00517556

    Continuous Administration of Oral Contraceptive, Primary Dysmenorrhea

    Not yet reported, Not yet reported Milton S. Hershey Medical Center 38 participants Est. completion 2011-04 1 site
    Other conditions: Dysmenorrhea
    View official trial listing →
  • Status unknown NCT NCT00519454

    Estrogen and Gender Biased Autoimmunity

    The Center for Rheumatic Disease, Allergy, & Immunology 75 participants Est. completion 2013-12 1 site
    Other conditions: Systemic Lupus Erythematosus
    View official trial listing →
  • Completed NCT NCT00522262

    Alberta Physical Activity and Breast Cancer Prevention (ALPHA) Trial

    Not yet reported AHS Cancer Control Alberta 320 participants Est. completion 2007-07 2 sites
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Completed NCT NCT00522873

    Endometrial Safety Study

    Not yet reported Bayer 662 participants Est. completion 2009-08 59 sites
    Other conditions: Postmenopause
    View official trial listing →
  • Completed NCT NCT00534417

    Phase II Trial of Capecitabine With Fulvestrant for Postmenopausal Women With Hormone Receptor Positive Metastatic Breast Cancer

    Not yet reported Accelerated Community Oncology Research Network 41 participants Est. completion 2011-09 10 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT00534846

    The Effect of Toremifene Treatment to the Magnetic Resonance Imaging (MRI) Findings in Premenstrual Mastalgia

    Not yet reported Satakunta Central Hospital 10 participants Est. completion 2009-02 1 site
    Other conditions: Breast Pain
    View official trial listing →
  • Completed NCT NCT00537836

    ZK283197 for Treatment of Vasomotor Symptoms

    Not yet reported Bayer 116 participants Est. completion 2008-12 4 sites
    Other conditions: Vasomotor System
    View official trial listing →
  • Status unknown NCT NCT00541086

    Study of Anastrozole, Letrozole, or Exemestane With or Without Tamoxifen in Treating Postmenopausal Women With Hormone-Responsive Breast Cancer That Has Been Completely Removed By Surgery

    Not yet reported Gruppo Italiano Mammella (GIM) 3697 participants Est. completion 2020-07 5 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00541281

    Safety and Efficacy Study of of Docetaxel vs Docetaxel Estramustine in Hormone Refractory Prostatic Cancer

    Not yet reported Cliniques universitaires Saint-Luc- Université Catholique de Louvain 150 participants Est. completion 2006-02 19 sites
    Other conditions: Hormone Resistant Prostate Cancer, Metastatic Prostate Cancer
    View official trial listing →
  • Terminated NCT NCT00543127

    Fulvestrant (Faslodex) + Anastrozole (Arimidex) vs Anastrozole

    Not yet reported Spanish Breast Cancer Research Group 870 participants Est. completion 2016-07 53 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00544882

    A Study to Evaluate Hormone Patterns and Ovarian Follicular Activity With DR-1021

    Not yet reported Teva Branded Pharmaceutical Products R&D, Inc. 61 participants Est. completion 2008-03-31 4 sites
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00545077

    Bevacizumab + Endocrine Treatment vs Endocrine Treatment as First Line in Postmenopausal Women

    Not yet reported Spanish Breast Cancer Research Group 380 participants Est. completion 2014-07-24 70 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT00547001

    Comparison of Hormonal Therapy: Mediating Hot Flashes Tapering Regimens for Mediating Hot Flashes

    Not yet reported Hartford Hospital 235 participants Est. completion 2009-11 1 site
    Other conditions: Hot Flashes, Night Sweats
    View official trial listing →
  • Completed NCT NCT00548977

    Genetic Studies Spermatogenic Failure

    National Cheng-Kung University Hospital 283 participants Est. completion 2005-02 1 site
    Other conditions: Oligospermia, Azoospermia, Male Infertility
    View official trial listing →
  • Completed NCT NCT00549666

    A Randomized, Placebo-Controlled, Two-Period, Crossover Study to Evaluate the Effect of Lurasidone HCl on Oral Contraceptive Pharmacokinetics in Healthy Female Subjects

    Not yet reported Sumitomo Pharma America, Inc. 23 participants Est. completion 2007-12 1 site
    Other conditions: Pharmacokinetics
    View official trial listing →
  • Completed NCT NCT00550303

    Study Comparing Formulations of Bazedoxifene/Conjugated Estrogens

    Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 28 participants Est. completion 2007-11
    Other conditions: Healthy
    View official trial listing →
  • Terminated NCT NCT00551733

    Carboplatin With Either Paclitaxel Poliglumex or Paclitaxel in Treating Women With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer

    Not yet reported CTI BioPharma 450 participants Est. completion 2007-12-25 41 sites
    Other conditions: Lung Cancer
    View official trial listing →
  • Terminated NCT NCT00551785

    Surveillance Study of Women Taking Intrinsa®

    Center for Epidemiology and Health Research, Germany 328 participants Est. completion 2012-06 1 site
    Other conditions: Ovariectomy, Hysterectomy, Hypoactive Sexual Desire Disorder
    View official trial listing →
  • Completed NCT NCT00554632

    Birth Control Pill vs Birth Control Patch Study

    Not yet reported University of Vermont 24 participants Est. completion 2005-08
    Other conditions: Venous Thrombosis
    View official trial listing →
  • Terminated NCT NCT00560924

    Preventive Effect of Treatment With Estradiol Vaginal Tablets on Recurrent Urinary Tract Infections in Post-menopausal Women

    Not yet reported Novo Nordisk A/S 6 participants Est. completion 2004-03-17 1 site
    Other conditions: Menopause, Urinary Infections
    View official trial listing →
  • Withdrawn NCT NCT00562341

    Effect of Lap-Band Induced Weight Loss on Serum PSA Levels

    Maimonides Medical Center Est. completion 2009-12-31 1 site
    Other conditions: Obesity, Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00563472

    Feasibility Study Into the Contraceptive Effect of Estetrol

    Not yet reported Pantarhei Bioscience 52 participants Est. completion 2008-08 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00563576

    Pilot Study of Femring Estrogen Supplementation During Depo-Provera Initiation

    Not yet reported Columbia University 71 participants Est. completion 2009-02 1 site Stand-alone
    Other conditions: Metrorrhagia
    View official trial listing →
  • Terminated NCT NCT00565916

    Evaluating the Roles of Estrogen and Progesterone in Heart Metabolism

    Not yet reported Washington University School of Medicine 22 participants Est. completion 2008-01 1 site Stand-alone
    Other conditions: Postmenopausal Syndrome
    View official trial listing →
  • Completed NCT NCT00566553

    The Effect of Grape Seed Extract on Estrogen Levels of Postmenopausal Women

    Not yet reported Mayo Clinic 39 participants Est. completion 2011-09 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00567164

    Efficacy and Safety of Two Flexible Extended Regimens of BAY86-5300 (SH T00186D) in Comparison With the Conventional Regimen of YAZ

    Not yet reported Bayer 1887 participants Est. completion 2009-11 85 sites
    Other conditions: Contraception, Ovulation Inhibition, Contraceptives, Oral
    View official trial listing →
  • Completed NCT NCT00569244

    SH T00186 in the Treatment of Primary Dysmenorrhea

    Not yet reported Bayer 223 participants Est. completion 2009-12 27 sites
    Other conditions: Primary Dysmenorrhea
    View official trial listing →
  • Completed NCT NCT00569543

    Effect of Tamoxifen or an Aromatase Inhibitor on Estrogen Metabolism in Women Treated for Newly Diagnosed Breast Cancer

    University of Nebraska 27 participants Est. completion 2012-08-02 2 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT00570258

    Randomized, Double Blind Multicenter Phase II Study of Time to Progression on Fulvestrant in Combination With Erlotinib or Placebo in Hormone Receptor-Positive Metastatic Breast Cancer (MBC) Subjects Who Progressed on First Line Hormonal Therapy

    Not yet reported University of Arkansas 27 participants Est. completion 2017-12 6 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT00570323

    Arimidex With or Without Faslodex In Postmenopausal Women With HR Positive Breast Cancer

    Not yet reported Mothaffar Rimawi 72 participants Est. completion 2018-12-05 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00570440

    Continuous Use of COCs

    Not yet reported FHI 360 362 participants Est. completion 2010-10 2 sites
    Other conditions: Pregnancy Prevention
    View official trial listing →
  • Completed NCT NCT00570921

    Study of Combined Fulvestrant and Everolimus in Advanced/Metastatic Breast Cancer After Aromatase Inhibitor Failure

    Not yet reported Mara Chambers 33 participants Est. completion 2015-01 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00572351

    The Effects of Red Wine and White Wine on Blood Estrogen and Progesterone Levels

    Not yet reported Cedars-Sinai Medical Center 44 participants Est. completion 2007-03 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00572390

    Oestrogen Withdrawal in Hypopituitary Women

    Not yet reported University of Aarhus 38 participants Est. completion 2002-02 1 site
    Other conditions: Hypopituitarism
    View official trial listing →
  • Completed NCT NCT00572819

    Hysteroscopy After Pretreatment With Misoprostol and Estradiol Trial

    Not yet reported Ullevaal University Hospital 100 participants Est. completion 2009-05 1 site
    Other conditions: Cervical Ripening
    View official trial listing →
  • Completed NCT NCT00572858

    Estrogen Deficiency and Cardiovascular Disease in Premenopausal Women

    Cedars-Sinai Medical Center 75 participants Est. completion 2020-10 1 site
    Other conditions: Estrogen Deficiency
    View official trial listing →
  • Terminated NCT NCT00573755

    Sorafenib and Letrozole, Anastrozole, or Exemestane in Treating Postmenopausal Women With Estrogen Receptor-Positive and/or Progesterone Receptor-Positive Metastatic Breast Cancer

    Not yet reported Mayo Clinic 4 participants Est. completion 2013-04 3 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Withdrawn NCT NCT00576225

    CT-2103/Carboplatin vs Paclitaxel/Carboplatin for NSCLC in Women With Estradiol > 25 pg/mL

    Not yet reported CTI BioPharma Est. completion 2010-04-05 44 sites
    Other conditions: NSCLC
    View official trial listing →
  • Completed NCT NCT00580112

    An Efficacy Study of Trabectedin in the Treatment of Participants With Specific Subtypes of Metastatic Breast Cancer

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 127 participants Est. completion 2011-08 33 sites Stand-alone
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Completed NCT NCT00580333

    Preoperative Cisplatin and Bevacizumab in ER-, PR-, HER2 Negative Breast Cancer

    Not yet reported Massachusetts General Hospital 51 participants Est. completion 2020-06 3 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00580775

    Study of Early Hormone Replacement Therapy on Risk Factors for Sudden Cardiac Death

    Yale University 25 participants Est. completion 2010-12 1 site
    Other conditions: Menopausal Women
    View official trial listing →
  • Active, not recruiting NCT NCT00585507

    Efficacy and Safety of 500mg of Fulvestrant

    Not yet reported Beth Israel Deaconess Medical Center 40 participants Est. completion 2027-03-15 5 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00586898

    Rapid Hormonal Cycling as Treatment for Patients With Prostate Cancer: The Men's Cycle

    Not yet reported Memorial Sloan Kettering Cancer Center 36 participants Est. completion 2009-03 1 site Stand-alone
    Other conditions: Prostate, Cancer, Hormonal Cycling
    View official trial listing →
  • Active, not recruiting NCT NCT00587886

    Estrogen, Diet, Genetics and Endometrial Cancer

    Memorial Sloan Kettering Cancer Center 1315 participants Est. completion 2026-12-31 1 site
    Other conditions: Cancer, Endometrial Cancer, Ovarian Cancer, Corpus Uteri, Endometrium
    View official trial listing →
  • Completed NCT NCT00589134

    The Effects of Estradiol and Progesterone on Arginine Vasopressin Regulation and Serum Sodium Concentration

    Not yet reported Yale University 26 participants Est. completion 2009-12 1 site
    Other conditions: Exercise Induced Hyponatremia
    View official trial listing →
  • Terminated NCT NCT00592007

    Study Evaluating the Addition of Fulvestrant to Erlotinib in Stage IIIB/IV Non-Small Cell Lung Cancer

    Not yet reported Lyudmila Bazhenova, M.D. 7 participants Est. completion 2012-04 1 site
    Other conditions: Non Small Cell Lung Carcinoma
    View official trial listing →
  • Completed NCT NCT00592579

    A Phase 2 Study With Panzem in Patients With Relapsed or Plateau Phase Multiple Myeloma

    Not yet reported CASI pharmaceuticals, Inc. 60 participants Est. completion 2008-09 2 sites
    Other conditions: Relapsed Multiple Myeloma, Plateau Phase Multiple Myeloma
    View official trial listing →
  • Completed NCT NCT00592839

    Study to Evaluate the Effects of Synthetic Conjugated Estrogens, B (SCE-B) on Nocturnal Vasomotor Symptoms in Postmenopausal Women

    Not yet reported Duramed Research 157 participants Est. completion 2009-02 17 sites
    Other conditions: Nocturnal Vasomotor Symptoms
    View official trial listing →
  • Completed NCT NCT00593294

    Oral Contraceptive and Cardiovascular Risk in PCOS

    Not yet reported Federico II University 150 participants Est. completion 2007-12 1 site
    Other conditions: Polycystic Ovary Syndrome
    View official trial listing →
  • Completed NCT NCT00600106

    Data Analyses for Ancillary WISE Femhrt Hormone Replacement Study

    Not yet reported Cedars-Sinai Medical Center 37 participants Est. completion 2010-03 1 site
    Other conditions: Myocardial Ischemia
    View official trial listing →
  • Completed NCT NCT00604825

    Treatment Of Hot Flashes/Flushes In Postmenopausal Women (WARM Study)

    Not yet reported GlaxoSmithKline 356 participants Est. completion 2008-07-23 87 sites
    Other conditions: Menopausal and Female Climacteric States
    View official trial listing →
  • Completed NCT NCT00608062

    Sex Hormones and Atherosclerosis Prevention in Perimenopausal Women

    Not yet reported University of Colorado, Denver 155 participants Est. completion 2012-10-25 1 site
    Other conditions: Arterial Stiffening, Aging, Menopause
    View official trial listing →
  • Completed NCT NCT00608972

    Phase II Trial of Doxil, Carboplatin, Bevacizumab in Triple Negative Untreated Metastatic Breast Cancer

    Not yet reported Rutgers, The State University of New Jersey 31 participants Est. completion 2015-09-25 7 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT00611104

    Studying the Effect of Freeze-Dried Table Grape Powder on Blood Estrogen Levels in Postmenopausal Women

    Mayo Clinic 20 participants Est. completion 2014-08-22 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00611975

    Effect of Antidepressants on Sex Hormone Levels and Sexual Functioning

    Not yet reported Weill Medical College of Cornell University 83 participants Est. completion 2008-09
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00612508

    Hormonal Contraception and Vaginal Health

    Not yet reported Oregon Health and Science University 14 participants Est. completion 2008-05 1 site
    Other conditions: Contraceptive Usage, Vaginal Epithelial Disruption
    View official trial listing →
  • Completed NCT NCT00612560

    Flaxseed, Aromatase Inhibitors and Breast Tumor Characteristics

    Not yet reported Roswell Park Cancer Institute 28 participants Est. completion 2014-04 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00617188

    Fulvestrant in Treating Patients With Recurrent Ovarian Epithelial Cancer

    Not yet reported Masonic Cancer Center, University of Minnesota 26 participants Est. completion 2008-07 1 site
    Other conditions: Ovarian Cancer
    View official trial listing →
  • Status unknown NCT NCT00617500

    Climacteric Clinical Trial : the Use of Complementary Therapy and Hormonal Replacement

    Not yet reported Sociedade Hospital Samaritano 278 participants Est. completion 2009-11 2 sites
    Other conditions: Climacteric
    View official trial listing →
  • Completed NCT NCT00619866

    An Efficacy and Safety Study of Elagolix (NBI-56418) in Women With Endometriosis

    Not yet reported AbbVie 155 participants Est. completion 2009-08-28
    Other conditions: Endometriosis, Pain
    View official trial listing →
  • Status unknown NCT NCT00623116

    A Study to Characterize Epidemiology, Clinical and Genetic Features of Kallmann Syndrome in Finland

    Not yet reported Hospital for Children and Adolescents, Finland 50 participants Est. completion 2025-12 1 site
    Other conditions: Kallmann Syndrome
    View official trial listing →
  • Completed NCT NCT00624130

    Yasmin 20 Cycle Control - Yasmin 20 Versus Mercilon in Healthy Female Volunteers

    Not yet reported Bayer 453 participants Est. completion 2005-06 17 sites
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT00626340

    Brain Imaging Study in Menopausal Women With and Without Major Depressive Disorder

    Not yet reported University of Pennsylvania 18 participants Est. completion 2008-07 1 site
    Other conditions: Menopause, Depression
    View official trial listing →
  • Status unknown NCT NCT00629278

    Combination Chemotherapy and Trastuzumab in Treating Women With Stage I, Stage II, or Stage III HER2-Positive Breast Cancer

    Not yet reported Azienda Ospedaliero-Universitaria di Modena 2500 participants 6 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00629616

    Efficacy of Anastrozole and Fulvestrant in Patients With ER Positive, HER2 Negative, Operable Breast Cancer

    Not yet reported UNICANCER 116 participants Est. completion 2018-04 6 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00631124

    A Study to Evaluate Inhibition of Ovulation of Two Oral Estrogen/Progestogen Regimens in Healthy, Young Females Over a Period of 3 Treatment Cycles

    Not yet reported Bayer 103 participants Est. completion 2008-12 2 sites Stand-alone
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT00632723

    IRESSA™ (Gefitinib) in Breast Cancer Patients

    Not yet reported AstraZeneca 54 participants Est. completion 2005-10
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00633360

    The Oral Contraceptive Pill for Premenstrual Worsening of Depression

    Not yet reported Massachusetts General Hospital 32 participants Est. completion 2011-05 1 site
    Other conditions: Premenstrual Syndrome, Depression
    View official trial listing →
  • Completed NCT NCT00635713

    Second Line Breast Cancer Trial

    Not yet reported AstraZeneca 588 participants Est. completion 2004-09
    Other conditions: Advanced Breast Cancer
    View official trial listing →
  • Completed NCT NCT00640224

    Insulin Resistance, Polycystic Ovary Syndrome, and Bone Research Study

    Not yet reported Silva Arslanian 65 participants Est. completion 2015-07 1 site
    Other conditions: Polycystic Ovary Syndrome
    View official trial listing →
  • Completed NCT NCT00647933

    An Open-label, Single Center Trial to Assess the Pharmacokinetics, Pharmacodynamics and Safety of Org 36286 (P07004)

    Not yet reported Organon and Co 24 participants Est. completion 2000-12
    Other conditions: Infertility
    View official trial listing →
  • Completed NCT NCT00649090

    A Study to Evaluate the Safety of Adjuvant Treatment With Exemestane Following Previous Treatment With Tamoxifen in Postmenopausal Women With Estrogen Sensitive Primary Breast Cancer

    Not yet reported Pfizer 1549 participants Est. completion 2007-04 61 sites
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Completed NCT NCT00649896

    Evaluation of Adhesion Quality of a New Formulation of the Mylan Estradiol Transdermal System 0.025 mg/Day and Climara® Transdermal System 0.025 mg/Day

    Not yet reported Mylan Pharmaceuticals Inc 76 participants Est. completion 2003-09 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00650442

    Evaluation of Adhesion Quality and Irritation of an Alternate Second Generation Estradiol Transdermal System

    Not yet reported Mylan Pharmaceuticals Inc 39 participants Est. completion 2003-02 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00651469

    Evaluate Safety and Efficacy of an OC Preparation vs Placebo for 6 Treatment Cycles in Women With Moderate Acne.

    Not yet reported Bayer 534 participants Est. completion 2004-07 27 sites
    Other conditions: Acne Vulgaris
    View official trial listing →
  • Completed NCT NCT00651599

    Treatment of Vasomotor Symptoms in Korean Post Menopausal Women

    Not yet reported Bayer 90 participants Est. completion 2005-05 4 sites
    Other conditions: Vasomotor Symptoms
    View official trial listing →
  • Completed NCT NCT00651846

    Investigate Impact of Yasmin vs Microgynon on Hemostasis Parameters in Healthy Women

    Not yet reported Bayer 43 participants Est. completion 2005-02 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00653016

    An Open-label, Multicentre Study on Preference and Satisfaction of Canadian Women for the Transdermal Contraceptive Patch vs. Previous Primary Contraceptive Method

    Not yet reported Janssen-Ortho Inc., Canada 405 participants Est. completion 2003-08
    Other conditions: Female Contraception
    View official trial listing →
  • Completed NCT NCT00653614

    Cycle Control and Safety of E2-DRSP

    Not yet reported Bayer 635 participants Est. completion 2009-06 25 sites
    Other conditions: Contraceptive, Oral, Hormonal
    View official trial listing →
  • Completed NCT NCT00656981

    Evaluate Safety and Efficacy of an Oral Contraceptive (OC) Preparation Versus Placebo for 6 Treatment Cycles in Women With Moderate Acne

    Not yet reported Bayer 541 participants Est. completion 2004-06 22 sites
    Other conditions: Acne Vulgaris
    View official trial listing →
  • Completed NCT NCT00660803

    Retrospective Brazilian Study of Fulvestrant in Advanced Breast Cancer

    AstraZeneca 200 participants Est. completion 2009-04 4 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT00661531

    Estrogen in Postmenopausal Women With ER Positive Metastatic Breast Cancer After Failure of Sequential Endocrine Therapy

    Not yet reported Georgetown University 11 participants Est. completion 2015-06 3 sites
    Other conditions: Breast Cancer, Cancer of the Breast, Neoplasms, Breast
    View official trial listing →
  • Completed NCT NCT00662454

    Oral Contraceptive Efficacy and Body Weight

    Not yet reported Oregon Health and Science University 120 participants Est. completion 2006-05 1 site
    Other conditions: Contraception, Body Weight
    View official trial listing →
  • Completed NCT NCT00666822

    Compliance to a Hormone Therapy Regimen in Breast Cancer

    Case Comprehensive Cancer Center 178 participants Est. completion 2015-12 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00668252

    Circulating Endothelium Progenitor Cells and Endogenous Oestrogen in Healthy Subjects

    Assistance Publique - Hôpitaux de Paris 48 participants Est. completion 2007-04 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00668538

    Uptake of the Antifungal Miconazole and Effect on Estrogen Metabolizing Enzymes in Humans

    Not yet reported University of Southern Denmark 20 participants Est. completion 2008-08 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00673686

    Study to Investigate the Effect of Missed Pills on Follicular Development in Two Application Regimens of SH T 00186 D

    Not yet reported Bayer 105 participants Est. completion 2005-02 1 site
    Other conditions: Contraceptives, Oral
    View official trial listing →
  • Terminated NCT NCT00674557

    Exemestane With or Without ATN-224 in Treating Postmenopausal Women With Recurrent or Advanced Breast Cancer

    Not yet reported Cancer Research UK 111 participants Est. completion 2009-03 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00675688

    Study Evaluating Safety and Efficacy of Bazedoxifene/Conjugated Estrogens Combinations in Postmenopausal Women

    Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 3544 participants Est. completion 2006-01
    Other conditions: Endometrial Hyperplasia, Osteoporosis
    View official trial listing →
  • Status unknown NCT NCT00675779

    Efficacy Study of Atorvastatin in Pelvic Pain Relief in Women With Endometriosis

    Not yet reported Poznan University of Medical Sciences 44 participants Est. completion 2011-03 1 site
    Other conditions: Endometriosis, Pain
    View official trial listing →
  • Completed NCT NCT00676663

    Study to Evaluate Exemestane With and Without Entinostat (SNDX-275) in Treatment of Postmenopausal Women With Advanced Breast Cancer

    Not yet reported Syndax Pharmaceuticals 130 participants Est. completion 2012-11-26 38 sites
    Other conditions: Breast Cancer, Estrogen Receptor-Positive Breast Cancer, Breast Cancer, Estrogen Receptor-Positive, ER+ Breast Cancer
    View official trial listing →
  • Completed NCT NCT00680667

    Clinical Trial of Trametes Versicolor in Women With Breast Cancer

    Not yet reported Masonic Cancer Center, University of Minnesota 11 participants Est. completion 2011-04 2 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00680797

    Metabolic Effects of Androgenicity in Aging Men and Women

    Not yet reported VA Office of Research and Development 33 participants Est. completion 2016-12-31 1 site Stand-alone
    Other conditions: Aging, Insulin Resistance
    View official trial listing →
  • Terminated NCT NCT00684216

    Second-line Endocrine Treatment Followed by Capecitabine Versus Capecitabine Followed by Endocrine Treatment in Patients With Metastatic ER Positive Breast Cancer

    Not yet reported, Not yet reported The Netherlands Cancer Institute 10 participants Est. completion 2013-05 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00685009

    The Women's Health Initiative Memory Study (The WHIMS Study)

    National Heart, Lung, and Blood Institute (NHLBI) 7525 participants Est. completion 2008-03 1 site
    Other conditions: Dementia Syndromes
    View official trial listing →
  • Status unknown NCT NCT00687648

    Cyclophosphamide, Methotrexate, and Prednisolone With or Without Aromatase Inhibitor Therapy in Treating Postmenopausal Women With Metastatic Breast Cancer

    Not yet reported National Cancer Centre, Singapore 70 participants 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00687739

    Prevention of Obesity in Women Via Estradiol Regulation

    Not yet reported University of Colorado, Denver 79 participants Est. completion 2014-06 1 site
    Other conditions: Obesity
    View official trial listing →
  • Status unknown NCT NCT00688194

    Fulvestrant With or Without Lapatinib and/or Aromatase Inhibitor Therapy in Treating Postmenopausal Women With Metastatic Breast Cancer That Progressed After Previous Aromatase Inhibitor Therapy

    Not yet reported Gruppo Italiano Mammella (GIM) 396 participants 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT00694733

    Regulation of Cortisol Metabolism and Fat Patterning

    Not yet reported Oregon Health and Science University 140 participants Est. completion 2024-09 1 site
    Other conditions: Obesity, Menopausal Syndrome
    View official trial listing →
  • Completed NCT NCT00696111

    Metabolic Study of Women With Polycystic Ovary Syndrome and Sleep Apnea

    Not yet reported University of Chicago 18 participants Est. completion 2022-06-30 1 site Stand-alone
    Obstructive sleep apnea Other conditions: Polycystic Ovary Syndrome
    View official trial listing →
  • Completed NCT NCT00697307

    Bioequivalence Study of Patches With Different Release Profiles

    Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 43 participants Est. completion 2003-07
    Other conditions: Female Contraception
    View official trial listing →
  • Completed NCT NCT00698035

    Vaginal Testosterone Cream vs ESTRING for Vaginal Dryness or Decreased Libido in Early Stage Breast Cancer Patients

    Not yet reported University of California, San Francisco 76 participants Est. completion 2012-12 1 site
    Other conditions: Sexual Dysfunction, Physiological
    View official trial listing →
  • Completed NCT NCT00699751

    A Phase III Study of Radium-223 Dichloride in Patients With Symptomatic Hormone Refractory Prostate Cancer With Skeletal Metastases

    Not yet reported Bayer 921 participants Est. completion 2014-02-13 134 sites
    Other conditions: Hormone Refractory Prostate Cancer, Bone Metastases
    View official trial listing →
  • Completed NCT NCT00700232

    ABCB4 Gene Mutations in Intrahepatic Cholestasis of Pregnancy and Controls

    University Hospital, Tours 120 participants Est. completion 2009-07 1 site
    Other conditions: Intrahepatic Cholestasis of Pregnancy
    View official trial listing →
  • Completed NCT NCT00701337

    Effect of 17ß-estradiol on Inflammatory-immune Responses in Post-menopausal Women According to Administration Route

    Not yet reported University Hospital, Toulouse 40 participants Est. completion 2010-01 1 site
    Other conditions: Postmenopausal
    View official trial listing →
  • Completed NCT NCT00702520

    Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established in Clinical Trial 38833 (P05783)

    Organon and Co 15 participants Est. completion 2008-01-15
    Other conditions: Pregnancy, Neonates
    View official trial listing →
  • Completed NCT NCT00702858

    Trial of Blue Citrus Compared to Placebo in Patients Receiving Aromatase Inhibitor Therapy for Estrogen Receptor Positive Post-Menopausal Breast Cancer

    Not yet reported Legacy Health System 30 participants Est. completion 2011-06
    Other conditions: Breast Cancer, Joint Pain
    View official trial listing →
  • Terminated NCT NCT00705822

    Combination of Docetaxel + Estramustine + Hydrocortisone Versus Docetaxel + Prednisone in Patients With Advanced Prostate Cancer

    Not yet reported Sanofi 54 participants Est. completion 2009-07 1 site
    Other conditions: Prostatic Neoplasms
    View official trial listing →
  • Completed NCT NCT00706225

    Study Evaluating Potential Drug Interaction Of Bazedoxifene & Premarin In Healthy Postmenopausal Women

    Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 30 participants Est. completion 2008-07 1 site
    Other conditions: Postmenopause
    View official trial listing →
  • Completed NCT NCT00707525

    Embryo Aneuploidies and Ovarian Stimulation

    Not yet reported Instituto Valenciano de Infertilidad, IVI VALENCIA Est. completion 2010-02 1 site
    Other conditions: Embryo Aneuploidies
    View official trial listing →
  • Completed NCT NCT00709189

    Bioequivalence Study of the Oral Contraceptive Tablet Containing Norgestimate (NGM)/Ethinyl Estradiol (EE) With or Without Folic Acid in Healthy Women.

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 53 participants Est. completion 2005-08
    Other conditions: Female Contraception, Contraception, Therapeutic Equivalency, Pharmacokinetics
    View official trial listing →
  • Completed NCT NCT00709332

    A Drug Interaction Study of Folic Acid and Oral Contraceptive Tablets Containing Norgestimate (NGM)/Ethinyl Estradiol (EE) in Healthy Women.

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 47 participants Est. completion 2005-02
    Other conditions: Drug Interactions, Contraception, Pharmacokinetics
    View official trial listing →
  • Completed NCT NCT00709644

    Bioequivalence Study of the Oral Contraceptive (OC) Tablet Containing Norgestimate (NGM)/Ethinyl Estradiol (EE) With or Without Folic Acid in Healthy Women.

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 54 participants Est. completion 2005-08
    Other conditions: Pharmacokinetics, Therapeutic Equivalency, Contraceptives, Oral
    View official trial listing →
  • Completed NCT NCT00714233

    Treatment of Adolescent Polycystic Ovary Syndrome (PCOS)

    Not yet reported University of Rochester 43 participants Est. completion 2007-12
    Other conditions: Polycystic Ovary Syndrome
    View official trial listing →
  • Terminated NCT NCT00722072

    Sorafenib and Fulvestrant in Treating Patients With Locally Advanced or Metastatic Breast Cancer That Did Not Respond to Aromatase Inhibitor Therapy

    Not yet reported OHSU Knight Cancer Institute 12 participants Est. completion 2012-07 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00722761

    Safety and Efficacy Of Drospirenone and Ethinyl Estradiol vs Placebo in the Treatment of Truncal Acne

    Not yet reported Massachusetts General Hospital 30 participants Est. completion 2012-04 1 site
    Other conditions: Acne Vulgaris
    View official trial listing →
  • Terminated NCT NCT00722800

    A Study to Examine the Safety and Efficacy of Drospirenone and Ethinyl Estradiol (YAZ) Versus Placebo In HS

    Not yet reported Massachusetts General Hospital 4 participants Est. completion 2011-12 1 site
    Other conditions: Hidradenitis Suppurativa
    View official trial listing →
  • Completed NCT NCT00725374

    A Study to Investigate the Effects of Tibolone (Livial®) on Breast Tissue in Postmenopausal Women With Breast Cancer (Study 32971)(P06469)

    Not yet reported Organon and Co 102 participants Est. completion 2005-04-15
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00727129

    Study to Evaluate Divigel for the Treatment of Postmenoupausal Symptoms

    Not yet reported Upsher-Smith Laboratories 495 participants Est. completion 2005-08
    Other conditions: Postmenopausal Symptoms
    View official trial listing →
  • Completed NCT NCT00728949

    A Study for Safety and Effectiveness of IMC-A12 by Itself or Combined With Antiestrogens to Treat Breast Cancer

    Not yet reported Eli Lilly and Company 93 participants Est. completion 2015-02 9 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Terminated NCT NCT00729404

    Inhibition of Ovulation, Patch, Ethinylestradiol and Gestodene

    Not yet reported Bayer 17 participants Est. completion 2009-02 3 sites
    Other conditions: Contraception, Ovulation Inhibition
    View official trial listing →
  • Completed NCT NCT00729859

    CEP-1 Hormonal Regulation of Circulating Endothelial Progenitor Cells and HDL-C in Men

    Not yet reported University of Washington 31 participants Est. completion 2010-05
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00732693

    Evaluation of Physiologic and Standard Sex Steroid Replacement Regimens in Women With Premature Ovarian Failure

    Not yet reported University of Edinburgh 42 participants Est. completion 2006-11 2 sites
    Other conditions: Premature Ovarian Failure
    View official trial listing →
  • Completed NCT NCT00740025

    Once Daily vs Twice Daily Administration of Gonadotropins in Assisted Reproductive Technologies (ART)

    Virginia Center for Reproductive Medicine 200 participants Est. completion 2010-01 1 site
    Other conditions: Pregnancy
    View official trial listing →
  • Completed NCT NCT00740194

    Reciprocal Influence of Sex Steroid Environment and Adipocyte Function in Men

    Not yet reported, Not yet reported University Hospital, Ghent 20 participants Est. completion 2010-08 1 site
    Other conditions: Healthy
    View official trial listing →
  • Terminated NCT NCT00744328

    Postpartum Depression: Transdermal Estradiol Versus Sertraline

    Not yet reported Northwestern University 85 participants Est. completion 2013-09 1 site
    Other conditions: Postpartum Depression
    View official trial listing →
  • Completed NCT NCT00745108

    Tibolone Endometrium Study (Study 32972)(P06470)

    Not yet reported Organon and Co 32 participants Est. completion 2005-07-21
    Other conditions: Postmenopausal Women
    View official trial listing →
  • Completed NCT NCT00745173

    Study Evaluating Premarin and Bazedoxifene Potential Interaction

    Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 30 participants Est. completion 2008-10 1 site
    Other conditions: Postmenopause
    View official trial listing →
  • Completed NCT NCT00745901

    Study to Evaluate Cycle Control With Norgestimate/Ethinyl Estradiol and Drospirenone/Ethinyl Estradiol in Healthy Sexually Active Females

    Not yet reported Ortho-McNeil Janssen Scientific Affairs, LLC 355 participants Est. completion 2008-10
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT00746096

    Efficacy and Safety Study of Low Dose Oral Contraceptive Pill to Treat Primary Dysmenorrhea

    Not yet reported Nobelpharma 115 participants Est. completion 2009-09
    Other conditions: Dysmenorrhea
    View official trial listing →
  • Completed NCT NCT00750100

    Low Dose hCG in the Late Follicular Phase

    Not yet reported Universitair Ziekenhuis Brussel 70 participants Est. completion 2008-11 1 site
    Other conditions: Infertility
    View official trial listing →
  • Completed NCT NCT00752635

    Comparison of Efficacy and Safety of Norgestimate-ethinyl Estradiol and Cyproterone Acetate-ethinyl Estradiol in the Treatment of Acne Vulgaris

    Not yet reported Johnson & Johnson Taiwan Ltd 48 participants Est. completion 2005-09
    Other conditions: Acne Vulgaris
    View official trial listing →
  • Terminated NCT NCT00752986

    ZACtima FASlodex Trial in Postmenopausal Advance Breast Cancer Patients Instead of ZACtima FASlodex Trial

    Not yet reported Genzyme, a Sanofi Company 39 participants Est. completion 2013-09 11 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00754065

    To Compare SH T00658ID Over Ortho Tri-Cyclen Lo (US/Canada)

    Not yet reported Bayer 409 participants Est. completion 2011-05-10 59 sites Stand-alone
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT00754325

    Randomized Trial of Fulvestrant With or Without Dasatinib in Men and Postmenopausal Women Who Have Hormone Receptor-positive Advanced Breast Cancer Previously Treated With an Aromatase Inhibitor

    Not yet reported Bristol-Myers Squibb 100 participants Est. completion 2014-01 28 sites
    Other conditions: Advanced Breast Cancer
    View official trial listing →
  • Completed NCT NCT00755313

    Effects of Chemotherapy on the Brain in Women With Newly Diagnosed Early-Stage Breast Cancer

    University of California, San Francisco 81 participants Est. completion 2014-06-06 1 site
    Other conditions: Breast Cancer, Chemotherapeutic Agent Toxicity, Cognitive/Functional Effects, Fatigue, Long-term Effects Secondary to Cancer Therapy in Adults, Neurotoxicity, Psychosocial Effects of Cancer and Its Treatment
    View official trial listing →
  • Completed NCT NCT00755885

    Abiraterone Acetate in Treating Postmenopausal Women With Advanced or Metastatic Breast Cancer

    Not yet reported, Not yet reported Cancer Research UK 77 participants Est. completion 2016-06-04 6 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT00759642

    Lapatinib in Women With Metastatic Breast Cancer Who Have Failed Prior Antihormone Therapy

    Not yet reported University of Kansas Medical Center 33 participants Est. completion 2018-08-20 3 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT00764881

    Effects of SH T00658ID on Libido

    Not yet reported Bayer 217 participants Est. completion 2010-07 32 sites Stand-alone
    Other conditions: Contraception, Libido
    View official trial listing →
  • Completed NCT NCT00766038

    Recombinant Human Growth Hormone During Rehabilitation From Traumatic Brain Injury.

    Not yet reported University of Pennsylvania 63 participants Est. completion 2013-12 3 sites
    Other conditions: Traumatic Brain Injury
    View official trial listing →
  • Completed NCT NCT00767520

    Safety and Efficacy of Exemestane Plus Dasatinib Versus Placebo for Advanced ER+ Breast Cancer

    Not yet reported Bristol-Myers Squibb 155 participants Est. completion 2012-12 21 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00773695

    A Study of Bevacizumab (Avastin) in Combination With Neoadjuvant Treatment Regimens in Participants With Primary Human Epidermal Growth Factor Receptor 2 (HER2) Negative Breast Cancer

    Not yet reported Hoffmann-La Roche 150 participants Est. completion 2022-11-09 3 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00774267

    Study Evaluating Changes In Mammographic Breast Density

    Pfizer 507 participants Est. completion 2010-04 26 sites
    Other conditions: Osteoporosis
    View official trial listing →
  • Terminated NCT NCT00774878

    Study of AVE1642 (IGF-1R/CD221) in Combination With Fulvestrant (Faslodex®) in Postmenopausal Patients With Advanced Hormono-dependent Breast Cancer

    Not yet reported Sanofi 18 participants Est. completion 2010-11 3 sites
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Completed NCT NCT00775086

    Bioequivalence Study of Patches With Different Equilibration Profiles

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 42 participants Est. completion 2004-08
    Other conditions: Female Contraception
    View official trial listing →
  • Completed NCT NCT00775242

    Efficacy and Safety of Estradiol and Progesterone Microspheres for the Treatment of Climacteric Symptoms.

    Not yet reported, Not yet reported Centro A.F. de Estudios Tecnologicos, S.A. 103 participants Est. completion 2008-11 1 site
    Other conditions: Menopause
    View official trial listing →
  • Completed NCT NCT00778609

    Effect of a New Oral Contraceptive Pill on Hormone Related Symptoms Such as Pelvic Pain and Headache

    Not yet reported Bayer 449 participants Est. completion 2010-12 63 sites Stand-alone
    Other conditions: Oral Contraceptive, Headache, Pelvic Pain
    View official trial listing →
  • Completed NCT NCT00781456

    A Multicenter Study to Evaluate the Efficacy of a 91-Day Extended Cycle Oral Contraceptive for Menstrually-Related Migraine Headaches

    Not yet reported Duramed Research 109 participants Est. completion 2011-08 22 sites
    Other conditions: Migraine
    View official trial listing →
  • Completed NCT NCT00784888

    Research Of Quality Of Life And Safety Outcomes Of Postmenopausal Breast Cancer Patients Switching From Tamoxifen Therapy To Aromatase Inhibitor Therapy

    Pfizer 344 participants Est. completion 2011-12 16 sites
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Status unknown NCT NCT00789022

    Glutamatergic Amino Acids and Oxytocin Levels in the Plasma of Patients in First Psychotic Episode (FPE)- Before and After Neuroleptic Treatment

    Shalvata Mental Health Center 80 participants 1 site
    Other conditions: Schizophrenia, Schizophreniform, Schizoaffective Disorder, Brief Psychotic Episode
    View official trial listing →
  • Completed NCT NCT00789802

    A Randomized Controlled Trial of Oral Naproxen and Transdermal Estradiol for Bleeding in LNG-IUC

    Not yet reported Washington University School of Medicine 129 participants Est. completion 2011-01 1 site
    Other conditions: Contraception, Bleeding
    View official trial listing →
  • Completed NCT NCT00799708

    A Study of the Effect of Estrogen on Estrogen Receptor Biomarkers in Healthy Postmenopausal Women (0000-094)(COMPLETED)

    Not yet reported Merck Sharp & Dohme LLC 27 participants Est. completion 2008-10
    Other conditions: Postmenopause
    View official trial listing →
  • Completed NCT NCT00799929

    IVF Clinical Trial of Two Different Treatment Protocols.

    Not yet reported New Hope Fertility Center 564 participants Est. completion 2014-10 1 site
    Other conditions: Infertility
    View official trial listing →
  • Completed NCT NCT00803335

    The Effects of Local Vaginal Estrogen in Postmenopausal Women With Pelvic Organ Prolapse

    Not yet reported TriHealth Inc. 54 participants Est. completion 2011-05 1 site
    Other conditions: Pelvic Organ Prolapse, Vaginal Atrophy
    View official trial listing →
  • Withdrawn NCT NCT00804960

    Does Letrozole Improve the Outcomes and/or Reduce the Cost of IVF-ET Cycles?

    Not yet reported Center for Human Reproduction Est. completion 2010-04 1 site
    Other conditions: Infertility
    View official trial listing →
  • Completed NCT NCT00805207

    Sex Steroids, Sleep, and Metabolic Dysfunction in Women

    Not yet reported Washington University School of Medicine 61 participants Est. completion 2013-03 1 site Stand-alone
    Obstructive sleep apnea Other conditions: Polycystic Ovary Syndrome (PCOS), Obesity
    View official trial listing →
  • Completed NCT NCT00805415

    Ovulation Inhibition of Two 4-phasic Oral Contraceptive Regimens

    Not yet reported Bayer 209 participants Est. completion 2004-02 2 sites Stand-alone
    Other conditions: Ovulation Inhibition
    View official trial listing →
  • Completed NCT NCT00808132

    Study Evaluating The Effects Of Bazedoxifene/Conjugated Estrogens On Endometrial Safety And Postmenopausal Osteoporosis

    Not yet reported Pfizer 1886 participants Est. completion 2011-02 178 sites
    Other conditions: Menopause, Osteoporosis
    View official trial listing →
  • Completed NCT NCT00811369

    Trial to Evaluate the Therapeutic Benefit of Fulvestrant in Combination With ZACTIMA in Postmenopausal Women With Bone Predominant, Hormone Receptor Positive Metastatic Breast Cancer

    Not yet reported Ontario Clinical Oncology Group (OCOG) 126 participants Est. completion 2013-08 13 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Terminated NCT NCT00816556

    A Trial to Evaluate the Efficacy of Low Dose Vaginal Estrogens in the Treatment of Atrophic Vaginitis

    Not yet reported Maire Mac Bride 63 participants Est. completion 2011-12 1 site
    Other conditions: Atrophic Vaginitis
    View official trial listing →
  • Terminated NCT NCT00816582

    PET/CT Guided Fulvestrant Therapy for Patients With Recurrent or Metastatic Breast Cancer

    Not yet reported British Columbia Cancer Agency 17 participants Est. completion 2018-07 4 sites Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00818519

    GA YAZ ACNE in China Phase III

    Not yet reported Bayer 179 participants Est. completion 2010-05 7 sites
    Other conditions: Acne Vulgaris
    View official trial listing →
  • Completed NCT NCT00820664

    A Clinical Study to Evaluate the Effects of Estrogen in Healthy Postmenopausal Women

    Not yet reported Merck Sharp & Dohme LLC 29 participants Est. completion 2009-05
    Other conditions: Postmenopausal Symptoms
    View official trial listing →
  • Completed NCT NCT00821496

    Evaluate the Effect of VI-0521 on the Pharmacokinetics of Oral Contraceptive in Healthy Female Subjects

    Not yet reported VIVUS LLC 20 participants Est. completion 2009-04 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00825617

    Quantitative Liver Functions in Turner Syndrome With and Without Hormone Replacement Therapy

    Not yet reported University of Aarhus 16 participants Est. completion 2000-06 1 site
    Other conditions: Turner Syndrome
    View official trial listing →
  • Withdrawn NCT NCT00826839

    Oral Microdose Lupron Versus Luteal Estradiol Trial in Poor Responder In Vitro Fertilization (IVF) Patients

    Not yet reported Weill Medical College of Cornell University Est. completion 2012-01 1 site
    Other conditions: Infertility
    View official trial listing →
  • Withdrawn NCT NCT00827151

    Bone Mass Accrual in Adolescent Athletes

    Not yet reported Massachusetts General Hospital Est. completion 2015-01 1 site
    Other conditions: Amenorrhea, Bone Loss
    View official trial listing →
  • Completed NCT NCT00827632

    Obesity, Oral Contraception, and Ovarian Suppression

    Not yet reported Columbia University 226 participants Est. completion 2008-12 1 site
    Other conditions: Ovarian Suppression
    View official trial listing →
  • Completed NCT NCT00828854

    Study of the Effect of the Addition of SNDX-275 (Entinostat) to Continued Aromatase Inhibitor (AI) Therapy in Postmenopausal Women With ER+ Breast Cancer Whose Disease is Progressing

    Not yet reported Syndax Pharmaceuticals 27 participants Est. completion 2009-11-24 6 sites
    Other conditions: ER+ Breast Cancer
    View official trial listing →
  • Completed NCT NCT00830492

    Clomiphene Citrate (CC)/Gonadotropin/Gonadotropin Releasing Hormone (GnRH) Antagonist Versus Gonadotropin/GnRH Agonist

    Not yet reported Yazd Research & Clinical Center for Infertility 200 participants Est. completion 2008-12 1 site
    Other conditions: Ovarian Stimulation
    View official trial listing →
  • Completed NCT NCT00830973

    The Clinical and Economic Impact of Pharmacogenomic Testing for Tamoxifen Metabolism in Postmenopausal Women Receiving Tamoxifen for Prevention of Recurrent Breast Cancer

    Medco Health Solutions, Inc. 184 participants Est. completion 2009-01 1 site
    Other conditions: Breast Neoplasms, Tamoxifen
    View official trial listing →
  • Completed NCT NCT00834678

    Bendamustine and Erlotinib in Treating Patients With Stage IIIB, Stage IIIC, or Stage IV Breast Cancer

    Not yet reported, Not yet reported Ohio State University Comprehensive Cancer Center 11 participants Est. completion 2014-09 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00837616

    Estrogen Dosing in Turner Syndrome: Pharmacology and Metabolism

    Not yet reported Nemours Children's Clinic 41 participants Est. completion 2012-12 3 sites
    Other conditions: Turner Syndrome, Hypogonadism, Premature Ovarian Failure
    View official trial listing →
  • Completed NCT NCT00839696

    Total Xenoestrogen Body Burden in Relation to Mammographic Density, a Marker of Breast Cancer Rlisk

    University of Wisconsin, Madison 270 participants Est. completion 2010-04 1 site
    Other conditions: Breast Cancer Risk
    View official trial listing →
  • Completed NCT NCT00842751

    Oral T7 Oral Testosterone in Man

    Not yet reported University of Washington 11 participants Est. completion 2009-12 1 site
    Other conditions: Healthy Males, Male Contraceptive
    View official trial listing →
  • Completed NCT NCT00843336

    Comparison of Two Internet Supported Natural Family Planning Methods

    Not yet reported Marquette University 358 participants Est. completion 2013-12 2 sites Stand-alone
    Other conditions: Pregnancy
    View official trial listing →
  • Completed NCT NCT00843570

    Natural Versus HRT Cycles in Frozen Embryo Replacement Treatment

    Not yet reported University of Oxford 159 participants Est. completion 2013-05 2 sites
    Other conditions: Infertility
    View official trial listing →
  • Status unknown NCT NCT00844012

    Continuous Postoperative Use of Low-Dose Combined Oral Contraceptivesfor for Endometriosis-Related Chronic Pelvic Pain

    Not yet reported University Magna Graecia 60 participants Est. completion 2010-07 1 site
    Other conditions: Endometriosis, Chronic Pelvic Pain
    View official trial listing →
  • Completed NCT NCT00847366

    Open Label Trial of Perifosine in Patients Currently Being Treated on Perifosine Trials in Solid Tumors or Multiple Myeloma

    Not yet reported AEterna Zentaris 10 participants Est. completion 2012-12 Stand-alone
    Other conditions: Non Small Cell Lung Cancer, Solid Tumors, Metastatic Breast Cancer, Sarcomas
    View official trial listing →
  • Terminated NCT NCT00847821

    Observational Study Analyzing RNA Expression Of Endometrial Biopsy Samples From Placebo, Bazedoxifene/Conjugated Estrogens And Raloxifene

    Wyeth is now a wholly owned subsidiary of Pfizer 185 participants Est. completion 2010-08 22 sites
    Other conditions: Postmenopause
    View official trial listing →
  • Completed NCT NCT00856050

    Letrozole in Women With Advanced Estrogen/Progesterone Receptor Positive Uterine Leiomyosarcoma

    Not yet reported Dana-Farber Cancer Institute 27 participants Est. completion 2014-03 1 site
    Obstructive sleep apnea
    View official trial listing →
  • Completed NCT NCT00856492

    S0800, Nab-Paclitaxel, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer

    Not yet reported SWOG Cancer Research Network 215 participants Est. completion 2015-12 366 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00859508

    Study of SyntheCelTM Dura Replacement to Other Dura Replacements

    Not yet reported Synthes USA HQ, Inc. 99 participants Est. completion 2009-01 8 sites
    Other conditions: Cranial Dura Repair
    View official trial listing →
  • Completed NCT NCT00860964

    A Study of Prevention and Treatment of Postmenopausal Osteoporosis in Chinese Women

    Not yet reported Peking Union Medical College 221 participants Est. completion 2006-12 Stand-alone
    Other conditions: Osteoporosis
    View official trial listing →
  • Completed NCT NCT00863655

    Everolimus in Combination With Exemestane in the Treatment of Postmenopausal Women With Estrogen Receptor Positive Locally Advanced or Metastatic Breast Cancer Who Are Refractory to Letrozole or Anastrozole

    Not yet reported Novartis Pharmaceuticals 724 participants Est. completion 2014-12-04 200 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00864214

    A Pharmacokinetic Evaluation of Bioidentical Compounded Estrogen Cream and Natural Progesterone

    Not yet reported Mayo Clinic 40 participants Est. completion 2010-04 1 site Stand-alone
    Other conditions: Menopause
    View official trial listing →
  • Status unknown NCT NCT00866437

    Evaluation of Efficacy/Safety of EVE-PMS Skin Test Panel

    Not yet reported EVE Medical Systems Ltd. 40 participants Est. completion 2010-11 1 site Stand-alone
    Other conditions: Premenstrual Syndrome
    View official trial listing →
  • Completed NCT NCT00870168

    Studying Biopsy Samples in Women Undergoing First-Line Chemotherapy for Metastatic Breast Cancer

    Not yet reported Centre Jean Perrin 60 participants 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT00870220

    Initiating Transdermal Estradiol Therapy in Turner's Syndrome

    Not yet reported University of Chicago 1 participants Est. completion 2011-03 3 sites
    Other conditions: Turner's Syndrome
    View official trial listing →
  • Completed NCT NCT00871858

    Anastrozole or Fulvestrant in Treating Postmenopausal Patients With Breast Cancer

    Not yet reported Institut Bergonié 120 participants Est. completion 2018-07-02 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT00873262

    Evaluation of Safety/Efficacy of Diagnostic Skin Test Panel and Desensitization Hormone Kit for Treatment of Premenstrual Syndrome (PMS)

    Not yet reported EVE Medical Systems Ltd. 20 participants Est. completion 2010-11 1 site
    Other conditions: Premenstrual Syndrome
    View official trial listing →
  • Completed NCT NCT00873483

    US Ovulation Inhibition Study in Obese Women

    Not yet reported Bayer 173 participants Est. completion 2010-03-03 6 sites
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT00877097

    Effects of Continuous Combined Hormone Replacement Therapy and Clodronate on Bone Mineral Density (BMD) in Osteoporotic Women

    Not yet reported Kuopio University Hospital 167 participants Est. completion 2009-02
    Other conditions: Osteoporosis
    View official trial listing →
  • Completed NCT NCT00883272

    Effect of DT56a (Femarelle) on the Coagulation System in the Treatment of Postmenopausal Women

    NYU Langone Health 32 participants Est. completion 2009-06 1 site
    Other conditions: Menopause, Thrombophilia
    View official trial listing →
  • Status unknown NCT NCT00887380

    STARS Breast Trial (Study of Anastrozole and Radiotherapy Sequencing)

    Not yet reported Trans Tasman Radiation Oncology Group 2023 participants Est. completion 2024-12 34 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT00889512

    The Luveris In Vitro Fertilization Trial

    Not yet reported University Reproductive Associates 14 participants Est. completion 2013-11 1 site
    Other conditions: Infertility, Hypothalamic Amenorrhea, Hyperprolactinemia
    View official trial listing →
  • Terminated NCT NCT00892268

    Acupuncture or Medication in Reducing Pain in Postmenopausal Women With Breast Cancer and Joint Pain

    Not yet reported University of Arizona 68 participants Est. completion 2009-10
    Other conditions: Breast Cancer, Menopausal Symptoms, Pain
    View official trial listing →
  • Completed NCT NCT00893061

    Letrozole, Anastrozole, Exemestane, or Tamoxifen Citrate in Treating Postmenopausal Women With Breast Cancer

    Not yet reported Centre Oscar Lambret 44 participants Est. completion 2014-11-26 3 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00896571

    Transdermal Contraceptive Patch - Endometrial Effects Study

    Not yet reported Bayer 92 participants Est. completion 2011-08 1 site
    Other conditions: Contraception
    View official trial listing →
  • Status unknown NCT NCT00896636

    Study of Breast Tissue in Women Not Previously Diagnosed With Breast Cancer Who Are Undergoing Fine Needle Aspiration

    Northwestern University 385 participants Est. completion 2022-01 1 site
    Other conditions: Breast Cancer, Healthy, no Evidence of Disease
    View official trial listing →
  • Status unknown NCT NCT00897065

    Biomarkers in Predicting Response to Tamoxifen and Letrozole in Postmenopausal Women With Primary Breast Cancer Treated on Clinical Trial CAN-NCIC-MA17

    Massachusetts General Hospital 957 participants 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00897208

    Studying Biomarkers in Nipple Fluid, Urine, and Blood Samples From Women With Newly Diagnosed Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer and in Women at Risk of Developing Breast Cancer

    Mayo Clinic 316 participants Est. completion 2015-06-30 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00897299

    Identifying Genes That Predict Recurrence in Women With Breast Cancer Treated With Chemotherapy

    Eastern Cooperative Oncology Group 900 participants Est. completion 2005-10-08
    Other conditions: Breast Cancer, Estrogen Receptor, Her-2, Pgr
    View official trial listing →
  • Status unknown NCT NCT00897728

    Study of Tumor and Blood Samples From Women With Breast Cancer

    Institut Curie 180 participants 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00898976

    Biomarkers in Native American Women With Breast Cancer

    Alliance for Clinical Trials in Oncology 120 participants Est. completion 2007-05
    Other conditions: Breast Cancer
    View official trial listing →
  • Withdrawn NCT NCT00899639

    Studying Tumor Tissue Samples From Patients With Early-Stage Breast Cancer

    Rutgers, The State University of New Jersey Est. completion 2008-05
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00900133

    Study of Calgranulin A/B Levels in Patients With Newly Diagnosed Stage I,II,III Breast Cancer

    Case Comprehensive Cancer Center 60 participants Est. completion 2006-12 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT00900653

    Low Dose Estriol With Lactobacilli Treatment for Preventing Recurrent Urinary Tract Infection in Postmenopausal Women

    Not yet reported Yonsei University 142 participants Est. completion 2010-07 1 site
    Other conditions: Urinary Tract Infections
    View official trial listing →
  • Suspended NCT NCT00901290

    Determine the Effects of C-administration of AZD7325 and an Oral Contraceptive in Healthy Female Subjects

    Not yet reported AstraZeneca 56 participants Est. completion 2009-09 1 site
    Other conditions: Pharmacokinetics
    View official trial listing →
  • Completed NCT NCT00901589

    Marine n-3 Polyunsaturated Fatty Acids in Pre- and Postmenopausal Women

    Not yet reported Aalborg University Hospital 92 participants Est. completion 2009-05 1 site
    Other conditions: Postmenopause, Premenopause
    View official trial listing →
  • Completed NCT NCT00902746

    Efficacy and Safety, Long-Term Study of NPC-01 to Treat Dysmenorrhea Associated With Endometriosis

    Not yet reported Nobelpharma 149 participants Est. completion 2012-02
    Other conditions: Dysmenorrhea
    View official trial listing →
  • Terminated NCT NCT00903006

    Trial of Fulvestrant, MK-0646, and Dasatinib for Metastatic Hormone Receptor-Positive HER2-Negative Breast Cancer

    Not yet reported, Not yet reported M.D. Anderson Cancer Center 11 participants Est. completion 2013-05 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00905684

    Effects of Counseling on the Continuation Rates and Compliance for Newly Prescribed Oral Contraceptives (Yasmin® or Any Other Oral Contraceptives (OC)

    Bayer 5446 participants Est. completion 2011-12 13 sites
    Other conditions: Contraception
    View official trial listing →
  • Status unknown NCT NCT00905723

    The Effects of Isoflavone and Estrogen in Sex Response in Climacteric Women

    Not yet reported Federal University of São Paulo 60 participants 1 site Stand-alone
    Other conditions: Postmenopausal Symptoms
    View official trial listing →
  • Completed NCT NCT00908570

    Topical Estriol for Vaginal Health

    Not yet reported Gynuity Health Projects 104 participants Est. completion 2011-03 2 sites
    Other conditions: Vaginal Health
    View official trial listing →
  • Completed NCT NCT00911716

    TC Avastin. ICORG 08-10, V6

    Not yet reported Cancer Trials Ireland 106 participants Est. completion 2015-09 8 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00913926

    Effects of Wellnara on Climacteric Symptoms

    Bayer 749 participants Est. completion 2009-05 1 site
    Other conditions: Postmenopause
    View official trial listing →
  • Completed NCT NCT00914693

    EU/LA Pearl Index Study - Transdermal Contraceptive Patch

    Not yet reported Bayer 1694 participants Est. completion 2011-09 66 sites
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT00915174

    Study to Evaluate the Effects of Neramexane on the Pharmacokinetics of a Combined Drospirenone/Ethinyl Estradiol Oral Contraceptive in Healthy Female Subjects

    Not yet reported Merz Pharmaceuticals GmbH 36 participants Est. completion 2009-11 1 site
    Other conditions: Healthy
    View official trial listing →
  • Withdrawn NCT NCT00915668

    A Study to Evaluate the Pharmacokinetic Drug Interaction Between Multiple Doses of JNJ-31001074 and a Single Dose of an Oral Contraceptive Containing Ethinyl Estradiol and Levonorgestrel in Women

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Est. completion 2011-03
    Other conditions: Pharmacokinetics, Drug Interactions, Healthy
    View official trial listing →
  • Completed NCT NCT00915915

    Inhibition of Ovulation and Pharmacokinetics of Transdermal Ethinylestradiol (EE) and Gestodene (GSD)

    Not yet reported Bayer 108 participants Est. completion 2010-04 2 sites
    Other conditions: Contraception, Ovulation Inhibition
    View official trial listing →
  • Completed NCT NCT00918476

    Investigation Of The Effect Of Steady State Filibuvir On The Pharmacokinetics Of Oral Contraceptives (Levonorgestrel And Ethinyl Estradiol)

    Not yet reported Pfizer 14 participants Est. completion 2011-02 1 site
    Other conditions: Hepatitis C
    View official trial listing →
  • Completed NCT NCT00918892

    Assessment of Candidate Protein Expression in Breast Cancer Specimens

    Case Comprehensive Cancer Center 460 participants Est. completion 2021-09-23 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT00919919

    Efficacy and Tolerability Study of Progesterone Vaginal Tablets (Endometrin®) in Menopausal Women Treated by Estrogen

    Not yet reported Rabin Medical Center 60 participants Est. completion 2010-11 1 site
    Other conditions: Endometrial Hyperplasia, Endometrial Cancer
    View official trial listing →
  • Completed NCT NCT00921115

    Anti-Hormone Therapy (With Anastrazole and Fulvestrant) Before Surgery to Treat Postmenopausal Women With Breast Cancer.

    Not yet reported University of Kansas Medical Center 42 participants Est. completion 2023-03-20 1 site
    Other conditions: Invasive Breast Cancer
    View official trial listing →
  • Completed NCT NCT00923572

    Yasmin Post Marketing Surveillance

    Bayer 777 participants Est. completion 2013-08 1 site
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT00924560

    A Multicenter Study to Evaluate the Effects of a 91-day Oral Contraceptive on Bone Mineral Density in Adolescent Females

    Not yet reported Duramed Research 1361 participants Est. completion 2012-08 46 sites
    Other conditions: Bone Mineral Density
    View official trial listing →
  • Terminated NCT NCT00925548

    STRIDE - STimulating Immune Response In aDvanced brEast Cancer

    Not yet reported EMD Serono 16 participants Est. completion 2010-08 29 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00927095

    Continuous Oral Contraceptive Treatment in Premenstrual Dysphoric Disorder (PMDD)

    Not yet reported University of North Carolina, Chapel Hill 67 participants Est. completion 2014-07 1 site
    Other conditions: Premenstrual Dysphoric Disorder
    View official trial listing →
  • Status unknown NCT NCT00927511

    A Study, Comparing a Dose-Titration Regimen of Fulvestrant With the Approved Dosing Regimen in Postmenopausal Patients With Hormone-Responsive Advanced Breast Cancer (ABC)

    Not yet reported Regina Elena Cancer Institute 104 participants Est. completion 2012-04 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT00932152

    Fulvestrant and Anastrozole as Consolidation Therapy in Postmenopausal Women With Advanced Non-small Cell Lung Cancer

    Not yet reported University of Pittsburgh 3 participants Est. completion 2013-01 1 site
    Other conditions: Non-small Cell Lung Cancer, Postmenopausal Women
    View official trial listing →
  • Completed NCT NCT00932321

    Study of Safety and Efficacy of an Oral Contraceptive

    Not yet reported Warner Chilcott 938 participants Est. completion 2004-11 34 sites
    Other conditions: Prevention of Pregnancy
    View official trial listing →
  • Completed NCT NCT00933179

    FC Patch Low: Metabolism Study

    Not yet reported Bayer 30 participants Est. completion 2010-09 1 site
    Other conditions: Contraception
    View official trial listing →
  • Withdrawn NCT NCT00935558

    Dendritic Cell Based Therapy for Breast Cancer Patients

    Not yet reported Inge Marie Svane 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00941057

    Bioequivalence Study: 2 mg Estradiol Valerate (EV) and 3 mg Dienogest (DNG) Without and With Levomefolate Calcium

    Not yet reported Bayer 43 participants Est. completion 2010-01 1 site
    Other conditions: Pharmacology, Clinical
    View official trial listing →
  • Completed NCT NCT00944918

    Study of Faslodex With or Without Concomitant Arimidex Versus Exemestane Following Progression on Non-steroidal Aromatase Inhibitors (NSAI)

    Not yet reported AstraZeneca 25 participants Est. completion 2011-06 2 sites
    Other conditions: Progression-free Survival
    View official trial listing →
  • Withdrawn NCT NCT00945360

    Aromatase Inhibitors for Treatment of Uterine Leiomyomas

    Not yet reported American University of Beirut Medical Center Est. completion 2011-05 1 site
    Other conditions: Symptomatic or Large Uterine Fibroids
    View official trial listing →
  • Completed NCT NCT00946192

    Fat Mediated Modulation of Reproductive and Endocrine Function in Young Athletes

    Not yet reported Massachusetts General Hospital 121 participants Est. completion 2021-04 1 site Stand-alone
    Other conditions: Exercise-related Amenorrhea
    View official trial listing →
  • Completed NCT NCT00949598

    Letrozole or Tamoxifen Citrate in Treating Older Postmenopausal Women Undergoing Surgery for Breast Cancer

    Not yet reported Institut du Cancer de Montpellier - Val d'Aurelle 177 participants Est. completion 2010-10 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT00954135

    Letrozole Plus Oral Cyclophosphamide Plus/Minus Sorafenib as Primary Systemic Treatment in Breast Cancer Patients

    Not yet reported University of Turin, Italy 190 participants Est. completion 2010-12 2 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00956813

    Flaxseed in Treating Postmenopausal Women With Hot Flashes Who Have a History of Breast Cancer or Other Cancer or Who Do Not Wish to Take Estrogen Therapy

    Not yet reported Alliance for Clinical Trials in Oncology 210 participants Est. completion 2013-05 107 sites
    Other conditions: Breast Cancer, Hot Flashes, Menopausal Symptoms, Unspecified Adult Solid Tumor, Protocol Specific
    View official trial listing →
  • Completed NCT NCT00959244

    Study of Urine Samples From Women With Newly Diagnosed Breast Cancer Enrolled on Clinical Trial UNMC-08105

    University of Nebraska 100 participants Est. completion 2009-09-25 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00963417

    Study of Bone Mineral Density in Women With Breast Cancer Treated With Triptorelin and Tamoxifen or Exemestane on Protocol IBCSG 25-02

    Not yet reported ETOP IBCSG Partners Foundation 119 participants Est. completion 2024-10-23 13 sites
    Other conditions: Breast Cancer, Osteoporosis
    View official trial listing →
  • Completed NCT NCT00963729

    Chemotherapy or Letrozole Before Surgery in Treating Postmenopausal Women With Breast Cancer That Can Be Removed By Surgery

    Not yet reported Imperial College London 756 participants Est. completion 2011-03 5 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT00967239

    Study of Blood Samples From High-Risk Postmenopausal Women Who Received Treatment on Breast Cancer Prevention Clinical Trials NSABP-P-1 or NSABP-P-2

    NSABP Foundation Inc 1881 participants
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00968214

    Study of Tumor and Blood Samples From Postmenopausal Women With Primary Breast Cancer Enrolled on Clinical Trial CAN-NCIC-MA27

    Alliance for Clinical Trials in Oncology 364 participants Est. completion 2018-09
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT00968968

    Continued HER2 Suppression With Lapatinib Plus Trastuzumab Versus Trastuzumab Alone

    Not yet reported Novartis Pharmaceuticals 37 participants Est. completion 2018-03-30 116 sites
    Other conditions: Cancer
    View official trial listing →
  • Completed NCT NCT00973102

    Resuscitative Endocrinology: Single-dose Clinical Uses for Estrogen-Traumatic Hemorrhagic Shock (RESCUE - Shock)

    Not yet reported University of Texas Southwestern Medical Center 50 participants Est. completion 2012-05 2 sites
    Other conditions: Hemorrhagic Shock
    View official trial listing →
  • Completed NCT NCT00975676

    Study of Estrogen Levels in Premenopausal Women Who Have Undergone Surgery for Breast Cancer and Are Receiving Triptorelin and Tamoxifen Citrate or Exemestane on Clinical Trial IBCSG 24-02

    Not yet reported ETOP IBCSG Partners Foundation 123 participants Est. completion 2016-12 24 sites Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00976651

    Low Dose Human Chorionic Gonadotropin: Influence on the Endometrium

    Not yet reported Universitair Ziekenhuis Brussel 30 participants Est. completion 2009-12 1 site
    Other conditions: Infertility
    View official trial listing →
  • Completed NCT NCT00983957

    Study to Assess the Effect of BMS-790052 on the Pharmacokinetics of Ortho Tri-Cyclen® in Healthy Female Subjects

    Not yet reported Bristol-Myers Squibb 47 participants Est. completion 2010-02 3 sites
    Other conditions: Chronic Hepatitis C
    View official trial listing →
  • Completed NCT NCT00984386

    Investigation of the Efficacy of Zesteem in Accelerating Early Wound Healing

    Not yet reported Renovo 44 participants Est. completion 2005-04 1 site
    Other conditions: Cicatrix, Wound-healing
    View official trial listing →
  • Completed NCT NCT00984399

    Serum Estradiol Levels In Postmenopausal Women With Breast Cancer Receiving Adjuvant Aromatase Inhibitors and Vaginal Estrogen

    Not yet reported Memorial Sloan Kettering Cancer Center 31 participants Est. completion 2024-05-13 5 sites Stand-alone
    Other conditions: Atrophic Vaginitis, Breast Cancer
    View official trial listing →
  • Completed NCT NCT00984789

    Birth Control Patch Study

    Not yet reported Bayer 393 participants Est. completion 2010-09 23 sites
    Other conditions: Contraception
    View official trial listing →
  • Terminated NCT NCT00988845

    Indole-3-Carbinol Effects on Estrogen Metabolism

    Not yet reported University of Wisconsin, Madison 38 participants Est. completion 2014-01 1 site
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT00988910

    Effects of Drospirenone-containing or -Not Containing Combined Oral Contraceptives on General and Sexual Well-being

    Bayer 632 participants Est. completion 2010-12 1 site
    Other conditions: Contraception
    View official trial listing →
  • Withdrawn NCT NCT00993642

    ERB-B4 After Treatment With HDAC Inhibitor in ER+ Tamoxifen Refractory Breast Cancer

    Not yet reported Tulane University Health Sciences Center Est. completion 2010-12 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00996580

    A Study to Evaluate the Efficacy and Safety of DR-103 for the Prevention of Pregnancy

    Not yet reported Teva Women's Health 3597 participants Est. completion 2011-09 94 sites
    Other conditions: Pregnancy Prevention
    View official trial listing →
  • Completed NCT NCT00997893

    Research Investigation of Soy and Estrogen

    Not yet reported University of Illinois at Chicago 96 participants Est. completion 2015-05 1 site
    Other conditions: Menopause, Hot Flashes
    View official trial listing →
  • Completed NCT NCT00998257

    Regulatory Post Marketing Surveillance Study on YAZ

    Bayer 770 participants Est. completion 2011-11 1 site
    Other conditions: Contraception, Premenstrual Syndrome, Acne
    View official trial listing →
  • Withdrawn NCT NCT00999479

    Post Operative Continuous Active Combination Sex Steroids for the Prevention of Recurrent Endometrioma Formation

    Not yet reported University of Oklahoma Est. completion 2011-10 1 site Stand-alone
    Other conditions: Endometrioma
    View official trial listing →
  • Active, not recruiting NCT NCT00999804

    Extension Study of Lapatinib Plus Herceptin With or Without Endocrine Therapy

    Not yet reported Baylor Breast Care Center 128 participants Est. completion 2026-01 8 sites Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00999921

    Effects of Tamoxifen in Premenopausal Women With Benign Breast Disease Not at High-Risk of Developing Breast Cancer

    Not yet reported Medical College and Hospital Kolkata 256 participants Est. completion 2015-01 1 site
    Other conditions: Benign Breast Disease, Fibrocystic Disease of Breast, Fibroadenoma, Mastalgia
    View official trial listing →
  • Withdrawn NCT NCT01004419

    Trial of ZD6474 and Faslodex in Non-Small Cell Lung Cancer

    Not yet reported University of Wisconsin, Madison Est. completion 2011-05
    Other conditions: Carcinoma, Non Small Cell Lung
    View official trial listing →
  • Completed NCT NCT01004744

    Pre-Surgical Intervention for Targeted Therapies for Breast Cancer

    Not yet reported Columbia University 10 participants Est. completion 2009-08 1 site
    Other conditions: Invasive Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT01004796

    Study of Biomarkers in Tissue Samples From Patients With Breast Cancer

    University of Wisconsin, Madison
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01005056

    Post-marketing, Observational Study to Confirm the Safety and Efficacy of MARVELON (Study P06083)

    Organon and Co 3838 participants Est. completion 2009-03
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT01007071

    Effects of Growth Hormone on Cognition and Cerebral Metabolism in Adults With Growth Hormone Deficiency

    Not yet reported Stanford University 11 participants Est. completion 2012-12-12 1 site Stand-alone
    Other conditions: Hypopituitarism
    View official trial listing →
  • Completed NCT NCT01009437

    Ritonavir and Its Effects on Biomarkers in Women Undergoing Surgery for Newly Diagnosed Breast Cancer

    Not yet reported Masonic Cancer Center, University of Minnesota 28 participants Est. completion 2014-07 2 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Withdrawn NCT NCT01013506

    Phase 2, Endocrine Therapy + OSI-906 With or Without Erlotinib for Hormone-sensitive Metastatic Breast Cancer

    Not yet reported Vanderbilt-Ingram Cancer Center Est. completion 2009-12
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT01015677

    A Study of MK-6913 for the Treatment of Hot Flashes in Postmenopausal Women (6913-004)

    Not yet reported Merck Sharp & Dohme LLC 99 participants Est. completion 2010-07-30
    Other conditions: Moderate to Severe Vasomotor Symptoms in Postmenopausal, Women
    View official trial listing →
  • Status unknown NCT NCT01022333

    The Potential for Oral Diindolylmethane (DIM) Supplementation to Increase the Production of the BRCA1 Protein in BRCA1 Mutation Carriers

    Not yet reported Women's College Hospital 300 participants Est. completion 2010-12 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01023178

    Comparison of Transdermal and Oral Estrogens in Adolescent Girls With Ovarian Failure

    Not yet reported Stanford University 20 participants Est. completion 2013-06 1 site
    Other conditions: Ovarian Failure, Premature
    View official trial listing →
  • Completed NCT NCT01031355

    Bioequivalence Study: 3 mg Estradiol Valerate (EV) With and Without Levomefolate Calcium

    Not yet reported Bayer 42 participants Est. completion 2010-03 1 site Stand-alone
    Other conditions: Contraception, Ovulation Inhibition
    View official trial listing →
  • Status unknown NCT NCT01040182

    Polymorphism of Estrogen Genes in Stroke

    Taipei Medical University WanFang Hospital 300 participants Est. completion 2010-11 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT01040845

    A Pharmacokinetic Study of Colchicine With an Oral Contraceptive

    Not yet reported Mutual Pharmaceutical Company, Inc. 30 participants Est. completion 2008-02 1 site
    Other conditions: Pharmacokinetics
    View official trial listing →
  • Completed NCT NCT01044056

    A Trial in Healthy Female Subjects to Compare the Pharmacokinetics of Ethinyl Estradiol of NuvaRing®, a Contraceptive Patch (EVRA(TM)) and an Oral Contraceptive (Microgynon® 30) (Study 34237 (P06650)) (COMPLETED)

    Not yet reported Organon and Co 24 participants Est. completion 2004-06
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT01044498

    A Study of Tocilizumab in Combination With an Oral Contraceptive in Patients With Rheumatoid Arthritis

    Not yet reported Hoffmann-La Roche 46 participants Est. completion 2012-02 6 sites
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT01044862

    Assessment of Multiple Intrauterine Gestations From Ovarian Stimulation

    Not yet reported Yale University 900 participants Est. completion 2014-03 14 sites
    Other conditions: Pregnancy, Unexplained Infertility
    View official trial listing →
  • Completed NCT NCT01046578

    Aromatase Inhibitor Effects on Ovarian Function During the Follicular and Early Luteal Phase in Women

    Not yet reported University of Saskatchewan 41 participants Est. completion 2012-02 1 site
    Other conditions: Fertility
    View official trial listing →
  • Completed NCT NCT01046643

    Early Menopause Hormone Treatment and Cognition

    Not yet reported University of Michigan 30 participants Est. completion 2012-03 1 site
    Other conditions: Menopausal Syndrome
    View official trial listing →
  • Completed NCT NCT01047358

    Post Marketing Surveillance Study To Observe Safety And Efficacy Of Aromasin In The Patients With Early Or Advanced Breast Cancer

    Pfizer 206 participants Est. completion 2014-06 22 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01048606

    Exercise and Phytoestrogens: Effect on Factors Predisposing to Cardiovascular Disease(CVD) in Postmenopausal Women

    Not yet reported Université de Sherbrooke 45 participants Est. completion 2012-11 1 site
    Other conditions: Overweight
    View official trial listing →
  • Status unknown NCT NCT01052623

    Status of Growth Hormone/ Insulin-like Growth Factor-1 (GH/IGF-1) Axis and Growth Failure in Ataxia Telangiectasia (AT)

    Not yet reported Johann Wolfgang Goethe University Hospital 24 participants Est. completion 2012-09 1 site Stand-alone
    Other conditions: Ataxia Telangiectasia, Growth Failure
    View official trial listing →
  • Completed NCT NCT01056042

    Efficacy of Injectable Contraceptive and Oral Contraceptive Administered After Surgical Treatment of Endometriosis With Pain

    Not yet reported Prince of Songkla University 112 participants Est. completion 2011-10 1 site
    Other conditions: Endometriosis
    View official trial listing →
  • Status unknown NCT NCT01058252

    Minimal Stimulation Protocol Using Aromek(Letrozole) and Follitrope(recFSH) Combined With INVOCell-Low Cost IVF

    Galaxy Pharma (Pvt) Limited 30 participants Est. completion 2022-03 2 sites
    Other conditions: Primary Infertility, Secondary Infertility, Low Responders, Mild to Moderate Male Factor Infertility
    View official trial listing →
  • Completed NCT NCT01063023

    Drug Interaction Oral Contraceptive Pill (OCP)

    Not yet reported Bristol-Myers Squibb 20 participants Est. completion 2010-06 1 site
    Other conditions: Hepatitis C Virus
    View official trial listing →
  • Completed NCT NCT01064453

    Angeliq Regulatory Post Marketing Surveillance

    Bayer 4078 participants Est. completion 2012-12 1 site
    Other conditions: Postmenopausal Period, Osteoporosis, Postmenopausal
    View official trial listing →
  • Completed NCT NCT01065220

    Sex Steroids and the Serotonin Transporter

    Not yet reported Medical University of Vienna 32 participants Est. completion 2014-01 1 site
    Other conditions: Transsexualism
    View official trial listing →
  • Status unknown NCT NCT01069211

    Clinical Outcomes After Letrozole Treatment According to the Estrogen Receptor Expression in Postmenopausal Women

    Korean Breast Cancer Study Group 876 participants Est. completion 2017-01 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01070979

    Hormone Replacement Therapy for Use in Postmenopausal Women for Relief of Hot Flushes and Urogenital Symptoms.

    Not yet reported Warner Chilcott 249 participants Est. completion 2003-09 32 sites
    Other conditions: Hormone Replacement Therapy
    View official trial listing →
  • Completed NCT NCT01073865

    Study to Compare Zoladex™ 10.8 mg With Zoladex 3.6 mg in Pre-menopausal Women With Breast Cancer

    Not yet reported AstraZeneca 222 participants Est. completion 2017-11-20 55 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01076582

    Comparative Trial in Hormone Withdrawal Associated Symptoms

    Not yet reported Bayer 592 participants Est. completion 2011-10 44 sites
    Other conditions: Oral Contraceptive
    View official trial listing →
  • Terminated NCT NCT01079949

    A Phase II Study to Assess the Efficacy and Safety of Luveris® (Lutropin Alfa) in Mid Follicular Phase for Controlled Ovarian Stimulation (COS) in Advanced Reproductive Age

    Not yet reported Merck KGaA, Darmstadt, Germany 93 participants Est. completion 2010-10 1 site
    Other conditions: Infertility, Ovulation Induction
    View official trial listing →
  • Completed NCT NCT01081613

    Imaging HSP90 Inhibitor AUY922 on VEGF-89ZR-bevacizumab Positron Emission Tomography (PET)

    University Medical Center Groningen 7 participants Est. completion 2012-02 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT01083641

    Estrogen for Triple Negative Breast Cancer

    Not yet reported University of Wisconsin, Madison 17 participants Est. completion 2015-03 1 site Stand-alone
    Other conditions: Female Breast Cancer
    View official trial listing →
  • Completed NCT NCT01085877

    Comparison of Two Vaginal Tablets, Produced at Different Sites, in Postmenopausal Women With Atrophic Vaginitis

    Not yet reported Novo Nordisk A/S 70 participants Est. completion 2010-05 1 site
    Other conditions: Menopause, Postmenopausal Vaginal Atrophy
    View official trial listing →
  • Terminated NCT NCT01087593

    Estrogens Effect on Pain in Postmenopausal Women Suffering of Fibromyalgia

    Not yet reported Ostergotland County Council, Sweden 29 participants Est. completion 2007-10 1 site
    Other conditions: Fibromyalgia
    View official trial listing →
  • Completed NCT NCT01087879

    The Effect of Hormonal Contraceptives on Androgens and Glucose Metabolism

    Not yet reported University of Oulu 45 participants Est. completion 2011-01 1 site
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT01088477

    Imaging of ER Density to Guide and Improve Tailored Therapy for Acquired Anti-hormonal Resistant Breast Cancer

    University Medical Center Groningen 21 participants Est. completion 2014-02 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01089049

    Effect of a Natural Health Product on Urinary Estrogen Metabolites

    Not yet reported, Not yet reported Nutrasource Pharmaceutical and Nutraceutical Services, Inc. 98 participants Est. completion 2010-05 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT01093235

    Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Nonmetastatic Breast Cancer

    Not yet reported Cambridge University Hospitals NHS Foundation Trust 800 participants 1 site
    Other conditions: Breast Cancer, Cardiac Toxicity, Perioperative/Postoperative Complications
    View official trial listing →
  • Terminated NCT NCT01096329

    A Pharmacokinetic (PK) Study to Compare the Absorption of Two Formulations of Transdermal Testosterone Spray and Intrinsa®

    Not yet reported VIVUS LLC 16 participants 1 site
    Other conditions: Hypoactive Sexual Desire Disorder
    View official trial listing →
  • Completed NCT NCT01101438

    A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer

    Not yet reported Canadian Cancer Trials Group 3649 participants Est. completion 2023-08-18 344 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT01103518

    Ethinyl Estradiol and Cyproterone Acetate in Irregular Menstruation

    Not yet reported Fundação Educacional Serra dos Órgãos 100 participants Est. completion 2011-01 1 site
    Other conditions: Amenorrhea, Dysmenorrhea, Menstruation Disturbances, Hyperandrogenism
    View official trial listing →
  • Status unknown NCT NCT01104571

    Trastuzumab or Lapatinib Ditosylate in Treating Women With Early Breast Cancer

    Not yet reported Institute of Cancer Research, United Kingdom 257 participants Est. completion 2025-09 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01109979

    Effect of Estradiol+Drospirenone Versus Estradiol+MPA on Endothelial Function

    Not yet reported Brigham and Women's Hospital 24 participants Est. completion 2016-06 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT01112358

    Lutropin Alfa in Women at Risk of Poor Response

    Not yet reported Merck KGaA, Darmstadt, Germany 58 participants Est. completion 2007-01-30 1 site
    Other conditions: Ovarian Stimulation
    View official trial listing →
  • Completed NCT NCT01120665

    Isolated and Associated Effects of Physical Exercise and Estrogen Therapy on Climactercs Women

    Not yet reported University of Sao Paulo General Hospital 62 participants Est. completion 2009-02 Stand-alone
    Other conditions: Women's Health
    View official trial listing →
  • Withdrawn NCT NCT01123135

    The Effect of Vaginal Estrogen Cream on Subjective and Objective Symptoms of Urodynamic Stress Incontinence

    Not yet reported University of California, Irvine Est. completion 2010-05 1 site
    Other conditions: Stress Urinary Incontinence
    View official trial listing →
  • Status unknown NCT NCT01123538

    Progestagen Type in Postmenopausal Hormone Therapy and Blood Gene Expression Profile

    Not yet reported University Hospital of North Norway 40 participants Est. completion 2012-10 1 site
    Other conditions: Pharmacogenomics, Systems Biology
    View official trial listing →
  • Completed NCT NCT01124695

    Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer

    Not yet reported ECOG-ACRIN Cancer Research Group 124 participants Est. completion 2022-12 294 sites
    Other conditions: Breast Cancer, Stage IV Breast Cancer
    View official trial listing →
  • Terminated NCT NCT01126801

    Effects of Estrogen and Hot Flashes on Mood in Postmenopausal Women

    Not yet reported Massachusetts General Hospital 2 participants Est. completion 2011-02 1 site
    Other conditions: Menopausal Depression
    View official trial listing →
  • Completed NCT NCT01129102

    Efficacy and Safety Study of NPC-01 to Treat Dysmenorrhea

    Not yet reported Nobelpharma 215 participants Est. completion 2011-04
    Other conditions: Dysmenorrhea
    View official trial listing →
  • Terminated NCT NCT01129830

    The Effect of DHEA on Markers of Ovarian Reserve in Women With Diminished Ovarian Reserve

    Not yet reported Virginia Center for Reproductive Medicine 200 participants Est. completion 2014-09 1 site
    Other conditions: Infertility
    View official trial listing →
  • Completed NCT NCT01142401

    Fulvestrant With or Without Bortezomib in Patients With Inoperable Locally Advanced or Metastatic Estrogen Receptor Positive Breast Cancer

    Not yet reported National Cancer Institute (NCI) 118 participants Est. completion 2021-01-08 21 sites
    Other conditions: Metastatic Breast Carcinoma, Stage IIIB Breast Cancer AJCC v7, Stage IIIC Breast Cancer AJCC v7, Stage IV Breast Cancer AJCC v6 and v7
    View official trial listing →
  • Terminated NCT NCT01147016

    Targeted T Cells After Neoadjuvant Chemotherapy in Treating Women With Stage II or III Breast Cancer Undergoing Surgery

    Not yet reported Barbara Ann Karmanos Cancer Institute 8 participants Est. completion 2017-07-26 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01147484

    A Study of Foretinib in Patients With Recurrent/Metastatic Breast Cancer

    Not yet reported NCIC Clinical Trials Group 47 participants Est. completion 2015-02-13 9 sites
    Other conditions: Recurrent Breast Cancer
    View official trial listing →
  • Completed NCT NCT01153581

    Sex Hormones and Orthostatic Tolerance

    Not yet reported Yale University 109 participants Est. completion 2013-05 1 site
    Other conditions: Orthostatic Intolerance
    View official trial listing →
  • Terminated NCT NCT01155063

    Evaluating The Safety Of Exemestane Following 2-3 Years Of Adjuvant Tamoxifen Therapy In Postmenopausal Early Breast Cancer Patients

    Pfizer 89 participants Est. completion 2011-09
    Other conditions: Early Breast Cancer
    View official trial listing →
  • Completed NCT NCT01157182

    Estradiol/Norethindrone Acetate Tablets, 1/0.5 mg Under Fasting Conditions

    Not yet reported Teva Pharmaceuticals USA 36 participants Est. completion 2007-04 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01160211

    A Study to Compare the Safety and Efficacy of an Aromatase Inhibitor in Combination With Lapatinib, Trastuzumab or Both for the Treatment of Hormone Receptor Positive, HER2+ Metastatic Breast Cancer

    Not yet reported Novartis Pharmaceuticals 369 participants Est. completion 2022-06-06 110 sites
    Other conditions: Neoplasms, Breast
    View official trial listing →
  • Completed NCT NCT01160718

    Fulvestrant With or Without AZD6244 in Treating Patients With Advanced Breast Cancer That Progressed After Aromatase Inhibitor Therapy

    Not yet reported Swiss Cancer Institute 46 participants Est. completion 2016-09 17 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01165307

    Medical Therapy Versus Radiofrequency Endometrial Ablation in the Initial Treatment of Menorrhagia

    Not yet reported Abimbola Famuyide 77 participants Est. completion 2015-10 1 site
    Other conditions: Menorrhagia
    View official trial listing →
  • Completed NCT NCT01170390

    Oral Contraceptives and Body Mass Index

    Not yet reported Oregon Health and Science University 32 participants Est. completion 2011-12 1 site
    Other conditions: Body Weight, Contraceptive Usage
    View official trial listing →
  • Status unknown NCT NCT01174225

    IUD Insertion Post First Trimester Abortion

    Not yet reported University of British Columbia 534 participants Est. completion 2023-06-30 1 site
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT01174524

    Improvement of Quality of Life in Patients Using Low-dose Pills in the Different Phases of Menacme

    Not yet reported Hospital Geral de Fortaleza 100 participants Est. completion 2008-11 1 site Stand-alone
    Other conditions: Quality of Life, Menopause, Contraception
    View official trial listing →
  • Status unknown NCT NCT01175759

    Role of Hypersensitivity to Female Sex Hormones in Women With Unexplained Recurrent Pregnancy Loss

    Not yet reported EVE Medical Systems Ltd. 40 participants Est. completion 2011-12 1 site Stand-alone
    Other conditions: Abortion, Recurrent
    View official trial listing →
  • Completed NCT NCT01178125

    A Study to Evaluate the Efficacy and Safety of DR-102 for the Prevention of Pregnancy

    Not yet reported Teva Branded Pharmaceutical Products R&D, Inc. 2858 participants Est. completion 2013-01 62 sites
    Other conditions: Contraception, Female Contraception
    View official trial listing →
  • Completed NCT NCT01181479

    Study to Evaluate the Contraceptive Efficacy/Safety of a Low Dose EE/LNG Transdermal Contraceptive Delivery System

    Not yet reported Agile Therapeutics 1504 participants Est. completion 2012-03 80 sites
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT01181726

    Estradiol/Norethindrone Acetate Tablets, 1/0.5 mg Under Fed Conditions

    Not yet reported Teva Pharmaceuticals USA 40 participants Est. completion 2007-02 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01182194

    Drospirenone/Ethinyl Estradiol (3 mg/0.02 mg) Tablets Under Fasting Conditions.

    Not yet reported Teva Pharmaceuticals USA 32 participants Est. completion 2006-08 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01182207

    Drospirenone/Ethinyl Estradiol (3 mg/0.02 mg) Tablets Under Non-Fasting Conditions

    Not yet reported Teva Pharmaceuticals USA 33 participants Est. completion 2006-08 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01185678

    Data on Oral Contraceptives Compliance in Non Stop Regimen

    Bayer 8416 participants Est. completion 2010-11 1 site
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT01185704

    Analysis of Two Therapeutic With Cetrotide® in Polycystic Ovarian (PCO) Women in Assisted Reproductive Technology (ART)

    Not yet reported Merck KGaA, Darmstadt, Germany 136 participants Est. completion 2012-02 1 site
    Other conditions: Polycystic Ovarian Syndrome
    View official trial listing →
  • Completed NCT NCT01186796

    Role of Endogenous Estrogen in Growth-Hormone Regulation in Postmenopausal Women

    Not yet reported Mayo Clinic 30 participants Est. completion 2013-06 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01194687

    Reproducibility of a Fecal Occult Blood Test Device for Gut Microbiota Analyses

    National Cancer Institute (NCI) 98 participants Est. completion 2018-09-14 1 site
    Other conditions: Normal Physiology
    View official trial listing →
  • Terminated NCT NCT01194908

    Re-expression of ER in Triple Negative Breast Cancers

    Not yet reported, Not yet reported Emory University 5 participants Est. completion 2014-01 1 site
    Other conditions: Breast Cancer, Breast Tumors, Breast Neoplasms
    View official trial listing →
  • Terminated NCT NCT01195974

    A Study to Evaluate the Pharmacokinetics of an Oral Contraceptive When Co-administered With GSK2248761 in Healthy Adult Female Subjects.

    Not yet reported ViiV Healthcare 13 participants Est. completion 2011-02-09 1 site
    Other conditions: Infection, Human Immunodeficiency Virus, HIV Infections
    View official trial listing →
  • Completed NCT NCT01197170

    Hormone Receptor Positive Disease Across Solid Tumor Types: A Phase I Study of Single-Agent Hormone Blockade and Combination Approaches With Targeted Agents to Provide Synergy and Overcome Resistance

    Not yet reported M.D. Anderson Cancer Center 277 participants Est. completion 2021-01-13 1 site
    Other conditions: Solid Tumors, Advanced Cancer
    View official trial listing →
  • Withdrawn NCT NCT01200537

    Optimizing Ovulation Induction in the Poor Responder

    Not yet reported Duke University Est. completion 2012-10 1 site
    Other conditions: IVF Poor Responders
    View official trial listing →
  • Completed NCT NCT01202591

    Safety and Efficacy of AZD4547 in Combination With Fulvestrant vs. Fulvestrant Alone in ER+ Breast Cancer Patients

    Not yet reported, Not yet reported AstraZeneca 127 participants Est. completion 2014-10 21 sites
    Other conditions: FGFR Inhibition, Pharmacokinetics, Biomarkers, ER+ Breast Cancer
    View official trial listing →
  • Completed NCT NCT01204190

    Investigation of Three Contraceptive Hormone Patches in Regard to Inhibition of Ovulation Following Application Over 3 Treatment Cycles in Healthy, Young Women.

    Not yet reported Bayer 173 participants Est. completion 2011-08 2 sites
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT01204840

    Growth Hormone for Poor Responders in in Vitro Fertilization (IVF)

    Not yet reported Ottawa Fertility Centre 38 participants Est. completion 2015-05 1 site
    Other conditions: Infertility, Poor Ovarian Reserve
    View official trial listing →
  • Completed NCT NCT01204957

    Brown Seaweed as a Breast Cancer Preventive

    Not yet reported, Not yet reported University of South Carolina 33 participants Est. completion 1999-03 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT01207102

    Study Of Abraxane® And Carboplatin As First-Line Treatment For Triple Negative Metastatic Breast Cancer

    Not yet reported Duke University 10 participants Est. completion 2014-06 2 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT01208324

    Estrogen and Serotonin on Changing Brain Chemistry

    Not yet reported University of Colorado, Denver 47 participants Est. completion 2018-11 1 site
    Other conditions: Menopause
    View official trial listing →
  • Completed NCT NCT01208779

    Epidemiology Study in Postmenopausal Women With Estrogen Receptor Positive Breast Cancer

    AstraZeneca 90 participants Est. completion 2012-11 2 sites
    Other conditions: Hormon Receptor Positive Breast Cancer
    View official trial listing →
  • Completed NCT NCT01209143

    A Study of Pharmacokinetic Drug Interaction Study of the Hedgehog Pathway Inhibitor GDC-0449 in Combination With Rosiglitazone or Combined Oral Contraceptive in Patients With Locally Advanced or Metastatic Solid Tumors That Are Refractory to Standard Therapy or for Whom No Standard Therapy Exists

    Not yet reported Genentech, Inc. 52 participants Est. completion 2012-03 3 sites
    Other conditions: Solid Cancers
    View official trial listing →
  • Terminated NCT NCT01210144

    EXpression PRofile Endometrium Samples Study

    Not yet reported Merck KGaA, Darmstadt, Germany 27 participants Est. completion 2010-08 1 site
    Other conditions: In Vitro Fertilization
    View official trial listing →
  • Completed NCT NCT01216176

    A Pharmacokinetic and Randomized Trial of Neoadjuvant Treatment With Anastrozole Plus AZD0530 in Postmenopausal Patients With Hormone Receptor Positive Breast Cancer

    Not yet reported, Not yet reported Joyce Marie Slingerland, MD 71 participants Est. completion 2018-02-07 2 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01216358

    Boston Migraine and Contraception Study

    Planned Parenthood League of Massachusetts 171 participants Est. completion 2011-12 1 site
    Other conditions: Headache
    View official trial listing →
  • Terminated NCT NCT01217411

    RO4929097 and Whole-Brain Radiation Therapy or Stereotactic Radiosurgery in Treating Patients With Brain Metastases From Breast Cancer

    Not yet reported, Not yet reported National Cancer Institute (NCI) 5 participants Est. completion 2011-11-30 2 sites
    Other conditions: Adult Solid Neoplasm, Extensive Stage Lung Small Cell Carcinoma, HER2/Neu Negative, HER2/Neu Positive, Male Breast Carcinoma, Metastatic Malignant Neoplasm in the Brain, Recurrent Breast Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Recurrent Lung Small Cell Carcinoma, Recurrent Melanoma, Stage IV Breast Cancer AJCC v6 and v7, Stage IV Cutaneous Melanoma AJCC v6 and v7, Stage IV Lung Non-Small Cell Cancer AJCC v7
    View official trial listing →
  • Completed NCT NCT01218386

    Pretreatment With Estradiol Valerate

    Not yet reported Universitair Ziekenhuis Brussel 80 participants Est. completion 2012-01 1 site Stand-alone
    Other conditions: Infertility
    View official trial listing →
  • Completed NCT NCT01219101

    The Effect of Ethinyl Estradiol on Polycystic Ovary Syndrome Women Undergoing Intrauterine Insemination

    Not yet reported Royan Institute 95 participants Est. completion 2013-02 1 site
    Other conditions: Infertility
    View official trial listing →
  • Completed NCT NCT01219153

    Extended High Dose Letrozole Regimen Versus Short Low Dose Letrozole Regimen as an Adjuvant to GnRH Antagonist Protocol in the Management of Poor Responders Undergoing IVF-ET

    Not yet reported Cairo University 136 participants Est. completion 2010-12 1 site
    Other conditions: Infertility
    View official trial listing →
  • Completed NCT NCT01219699

    A Study of BYL719 in Adult Patients With Advanced Solid Malignancies, Whose Tumors Have an Alteration of the PIK3CA Gene

    Not yet reported Novartis Pharmaceuticals 221 participants Est. completion 2020-04-16 11 sites Stand-alone
    Other conditions: Advanced Solid Tumors With an Alteration of the PIK3CA Gene, Estrogen Receptor Positive Breast Cancer
    View official trial listing →
  • Terminated NCT NCT01220128

    Evaluation of an Anti-cancer Immunotherapy Combined With Standard Neoadjuvant Treatment in Patients With WT1-positive Primary Invasive Breast Cancer

    Not yet reported GlaxoSmithKline 66 participants Est. completion 2014-11-14 36 sites
    Other conditions: Neoplasms, Breast
    View official trial listing →
  • Completed NCT NCT01221831

    Cycle Control Assessment of a Combined Oral Contraceptive Containing Estetrol and a Progestin P1 or P2

    Not yet reported Estetra 396 participants Est. completion 2011-09 10 sites
    Other conditions: Contraception
    View official trial listing →
  • Terminated NCT NCT01230970

    Exploratory Study to Assess the Short Term Intratumoural and Peripheral Effects of BN83495 in Postmenopausal Women With Newly Diagnosed Breast Cancer

    Not yet reported Ipsen 2 participants Est. completion 2011-05 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01231659

    Safety and Efficacy of RAD001 (Everolimus) in Combination With Letrozole in the Treatment of Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer

    Not yet reported Novartis Pharmaceuticals 72 participants Est. completion 2017-04-30 7 sites
    Other conditions: Postmenopausal Women, Locally Advanced Metastatic Breast Cancer, Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT01232075

    Extended Letrozole Regimen Versus Clomiphene Citrate for Superovulation in Patients With Unexplained Infertility Undergoing Intrauterine Insemination

    Not yet reported Cairo University 214 participants Est. completion 2010-12 2 sites
    Other conditions: Infertility
    View official trial listing →
  • Terminated NCT NCT01233947

    Study of AFP464 +/- Faslodex in ER + Breast Cancer

    Not yet reported Tigris Pharmaceuticals 7 participants Est. completion 2012-08 1 site
    Other conditions: Breast Neoplasm
    View official trial listing →
  • Completed NCT NCT01234857

    A Study of Ridaforolimus (MK-8669) in Combination With Dalotuzumab (MK-0646) Compared to Standard of Care Treatment in Estrogen Receptor Positive Breast Cancer Patients (MK-8669-041 AM3)

    Not yet reported Merck Sharp & Dohme LLC 115 participants Est. completion 2013-10-15
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01236768

    Transdermal Contraceptive Delivery System (TCDS), Also Known as AG200-15 Patch Arm

    Not yet reported Agile Therapeutics 407 participants Est. completion 2011-06 21 sites
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT01237327

    Multicenter Follow Up Study Of Subjects Who Participated In An Original Protocol Of Exemestane Vs. Megestrol Acetate In Postmenopausal Women With Metastatic Breast Cancer

    Not yet reported Pfizer 84 participants Est. completion 2009-12 7 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT01237535

    Luteal Phase Support With Progesterone Versus Estrogen and Progesterone on Pregnancy Rates

    Not yet reported Rabin Medical Center 400 participants Est. completion 2013-11 1 site Stand-alone
    Other conditions: Unexplained Infertility, Mild Male Factor
    View official trial listing →
  • Terminated NCT NCT01239745

    Aromasin® As Adjuvant Treatment In Postmenopausal Women With Invasive, Estrogen Receptor Positive Early Breast Cancer

    Pfizer 46 participants Est. completion 2011-10 11 sites
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Status unknown NCT NCT01239888

    Oxytocin and Tibolone Adjuncts in Treatment Resistant Depression - A Pilot Study

    Not yet reported The Alfred 15 participants 1 site
    Other conditions: Depression, Major Depressive Disorder
    View official trial listing →
  • Completed NCT NCT01243580

    AG200-15 Transdermal Contraceptive Delivery System (TCDS) of Levonorgestrel and Ethinyl Estradiol

    Not yet reported Agile Therapeutics 36 participants Est. completion 2009-12 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01246791

    Pharmacokinetics of NPC-01 After Single Oral Administration in Healthy Female Volunteers

    Not yet reported Nobelpharma 12 participants Est. completion 2011-05
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01248416

    Aromatase Inhibitors, Alone And In Combination With Growth Hormone In Adolescent Boys With Idiopathic Short Stature

    Not yet reported Nemours Children's Clinic 76 participants Est. completion 2016-09 4 sites
    Other conditions: Idiopathic Short Stature
    View official trial listing →
  • Completed NCT NCT01250314

    Radiological Biological Genetic and Micro-architectural Bone Determinants of Fractures in Men With Low Bone Mineral Density

    Not yet reported Assistance Publique - Hôpitaux de Paris 79 participants Est. completion 2010-12 1 site
    Other conditions: Osteoporosis
    View official trial listing →
  • Completed NCT NCT01250717

    Docetaxel Followed by Radical Prostatectomy in Patients With High Risk Localized Prostate Cancer

    Not yet reported Beth Israel Deaconess Medical Center 28 participants Est. completion 2011-05 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Status unknown NCT NCT01251263

    Prevention of Menstrual Migraines: Effects of Estrogen Add-back During the HFI in Patients Using Continuous Oral Contraceptives.

    Not yet reported Scott and White Hospital & Clinic 40 participants Est. completion 2012-10 1 site
    Other conditions: Menstrual Migraines, Menstrual Bleeding, Menstrual Spotting
    View official trial listing →
  • Terminated NCT NCT01251354

    Study of BN83495 in Post-menopausal Women With Endometrial Cancer Post-chemotherapy

    Not yet reported Ipsen 6 participants Est. completion 2011-07 9 sites
    Other conditions: Endometrial Cancer
    View official trial listing →
  • Completed NCT NCT01252186

    A Multicenter Study to Evaluate the Effects of a 91-Day Extended Cycle Oral Contraceptive on Hemostatic Parameters in Healthy Women

    Not yet reported Teva Women's Health 265 participants Est. completion 2011-12 24 sites
    Other conditions: Hemostasis, Oral Contraceptive
    View official trial listing →
  • Completed NCT NCT01253174

    Investigation of Bioequivalence of Ethinylestradiol (EE) and Drospirenone (DRSP) in Two Different Tablet Formulations: Yasmin and Yasmin + Levomefolate Calcium (Metafolin) & L-5-MTHF in Two Different Tablet Formulations: Levomefolate Calcium (Metafolin) and Yasmin + Levomefolate Calcium (Metafolin)

    Not yet reported Bayer 48 participants Est. completion 2007-07 1 site
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT01253187

    Investigation of Bioequivalence of Ethinylestradiol (EE) and Drospirenone (DRSP) in Two Different Tablet Formulations: YAZ and YAZ + Levomefolate Calcium (Metafolin) & L-5-MTHF in Two Different Tablet Formulations: Levomefolate Calcium (Metafolin) and YAZ + Levomefolate Calcium (Metafolin)

    Not yet reported Bayer 44 participants Est. completion 2007-09 1 site
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT01253824

    Pharmacodynamics of NPC-01/IKH-01; Effect of NPC-01/IKH-01 on Sexual Hormone Concentrations in Healthy Female Volunteers

    Not yet reported Nobelpharma 14 participants Est. completion 2011-07
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01254292

    LCS12 vs Combined Oral Contraceptive (COC) User Satisfaction Study

    Not yet reported Bayer 567 participants Est. completion 2014-05-28 94 sites
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT01257984

    Study to Investigate Compliance With the Oral Contraceptive SH T00186D in a Flexible Extended Regimen Supported by a Dispenser With a Reminder Function

    Not yet reported Bayer 508 participants Est. completion 2012-09 43 sites
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT01258660

    Assessment of the Pharmacodynamic Effect on Plasma Folate and Red Blood Cell Folate and Comparison of the Folate Metabolites During the 24 Weeks of Treatment (Yasmin + Metafolin Versus Yasmin + Folic Acid) Followed by a 20 Week Elimination Phase of Folate

    Not yet reported Bayer 172 participants Est. completion 2008-01 1 site
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT01260805

    A Bioequivalence Study Of Ethinylestradiol + Gestodene In Female And Healthy Volunteers.

    Not yet reported Pfizer 32 participants Est. completion 2010-10 1 site
    Other conditions: Bioequivalence, Ethinylestradiol, Gestodene, Harmonet
    View official trial listing →
  • Withdrawn NCT NCT01265017

    Role of Pregnancy Related Hormones in Lowering the Insulin Requirement in Pregnant Women With Type 1 Diabetes

    Not yet reported Sansum Diabetes Research Institute Est. completion 2020-06 1 site
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Status unknown NCT NCT01266213

    Fulvestrant (F)/Goserelin (G) vs Anastrozole (A)/G vs G for Premenopausal Women

    Not yet reported Samsung Medical Center 147 participants Est. completion 2019-12 1 site
    Other conditions: Metastatic Breast Cancer, Estrogen Receptor Positive Tumor, Breast Cancer Nos Premenopausal
    View official trial listing →
  • Completed NCT NCT01266408

    INAS-FOCUS (International Active Surveillance Study - Folate in Oral Contraceptives Utilization Study)

    Center for Epidemiology and Health Research, Germany 82921 participants Est. completion 2019-10-02 1 site
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT01268046

    Aging and Estrogen on Cortical Function

    Not yet reported, Not yet reported Massachusetts General Hospital 38 participants Est. completion 2013-12-02 1 site Stand-alone
    Other conditions: Memory Loss, Cognitive Changes, Postmenopausal Symptoms
    View official trial listing →
  • Terminated NCT NCT01272141

    A Study of Lapatinib in Combination With Everolimus in Patients With Advanced, Triple Negative Breast Cancer

    Not yet reported Emory University 5 participants Est. completion 2014-01 3 sites
    Other conditions: Breast Neoplasms, Breast Cancer, Cancer of the Breast
    View official trial listing →
  • Completed NCT NCT01273168

    Endoxifen in Adults With Hormone Receptor Positive Solid Tumors

    Not yet reported National Cancer Institute (NCI) 40 participants Est. completion 2025-12-19 1 site
    Other conditions: Hormone Receptor-Positive Breast, Gynecologic, Desmoid, Hormone Receptor-Positive Neoplasms
    View official trial listing →
  • Status unknown NCT NCT01278810

    Phase I Study of Novel Estrogen Receptor(ER) a36 Modifier Icaritin in Advanced Breast Cancer Patients

    Not yet reported Chinese Academy of Medical Sciences 30 participants Est. completion 2011-12 1 site
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT01281137

    Study of Changes in Estrogen Levels and Grip Strength in Postmenopausal Women Who Have Received 4 to 6 Years of Hormone Therapy for Breast Cancer and Are Currently Receiving Letrozole on Clinical Trial IBCSG-35-07

    ETOP IBCSG Partners Foundation 104 participants Est. completion 2019-05-15 2 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01282164

    The Glucagon Stimulation Test for Evaluation of Adult Growth Hormone Deficiency and Adrenocorticotropic Axis

    Not yet reported The Cleveland Clinic 43 participants Est. completion 2014-07 4 sites
    Other conditions: Adult Growth Hormone Deficiency, Hypothalamic-pituitary Disorders
    View official trial listing →
  • Completed NCT NCT01284244

    A Randomized Controlled Trial of the Uresta Continence Pessary

    Not yet reported Mount Sinai Hospital, Canada 36 participants Est. completion 2014-05 1 site
    Other conditions: Stress Urinary Incontinence
    View official trial listing →
  • Completed NCT NCT01286948

    Prevention of Ovulation Achieved by Single Intra-vaginal Administration of Levogel as Compared to Oral LNG

    Not yet reported Population Council 20 participants Est. completion 2014-11 2 sites
    Other conditions: Female Contraception
    View official trial listing →
  • Completed NCT NCT01291004

    A Study to Evaluate Ovarian Follicular Activity and Hormone Levels for DR-102 Compared to Two 28-Day Oral Contraceptives

    Not yet reported Teva Branded Pharmaceutical Products R&D, Inc. 206 participants Est. completion 2012-03-31 2 sites
    Other conditions: Follicle Development, Ovarian Follicle, Follicle Count, Follicle Size, Oral Contraceptive
    View official trial listing →
  • Completed NCT NCT01292785

    Effects of Sex Steroid Hormones on Human Brain Function, Structure and Connectivity

    Medical University of Vienna 80 participants Est. completion 2015-04 1 site
    Other conditions: Gender Identity Disorder
    View official trial listing →
  • Completed NCT NCT01293032

    Hormone Therapy Or Chemotherapy Before Surgery Based on Gene Expression Analysis in Treating Patients With Breast Cancer

    Not yet reported Virginia Commonwealth University 59 participants Est. completion 2016-03 8 sites
    Other conditions: Ductal Breast Carcinoma in Situ, Lobular Breast Carcinoma in Situ, Stage II Breast Cancer, Stage IIA Breast Cancer, Stage IIB Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer
    View official trial listing →
  • Completed NCT NCT01293747

    Pharmacokinetics of Injectable Estradiol and Progesterone Microspheres Suspension

    Not yet reported Productos Científicos S. A. de C. V. 30 participants Est. completion 2011-10 1 site
    Other conditions: Menopause
    View official trial listing →
  • Completed NCT NCT01295892

    Chronic Effects of Estrogen in Microcirculation

    Not yet reported Rio de Janeiro State University 44 participants Est. completion 2013-04 1 site Stand-alone
    Other conditions: Postmenopausal Symptoms
    View official trial listing →
  • Terminated NCT NCT01296555

    A Dose Escalation Study Evaluating the Safety and Tolerability of GDC-0032 in Participants With Locally Advanced or Metastatic Solid Tumors or Non-Hodgkin's Lymphoma (NHL) and in Combination With Endocrine Therapy in Locally Advanced or Metastatic Hormone Receptor-Positive Breast Cancer

    Not yet reported Genentech, Inc. 674 participants Est. completion 2021-06-25 31 sites
    Other conditions: Solid Cancers, Non-Hodgkin's Lymphoma
    View official trial listing →
  • Completed NCT NCT01297179

    A Study to Evaluate the Possible Effects of Taking Mirabegron While Taking a Contraceptive Pill

    Not yet reported Astellas Pharma Inc 30 participants Est. completion 2009-03 1 site
    Other conditions: Healthy Volunteers, Pharmacokinetics of Mirabegron
    View official trial listing →
  • Completed NCT NCT01297348

    Study Of Lybrel In Relation To Venous Thromboembolism

    Pfizer 598682 participants Est. completion 2012-04
    Other conditions: Venous Thrombosis, Pulmonary Embolism, Sinus Thrombosis, Intracranial
    View official trial listing →
  • Completed NCT NCT01300351

    Comparing the Efficacy and Tolerability of Fulvestrant 500 mg Versus 250 mg in Advanced Breast Cancer Women

    Not yet reported AstraZeneca 249 participants Est. completion 2014-03 15 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01300676

    The Effects of Tualang Honey on Postmenopausal Women

    Not yet reported, Not yet reported Universiti Sains Malaysia 79 participants Est. completion 2010-06 1 site
    Other conditions: Postmenopausal Syndrome
    View official trial listing →
  • Completed NCT NCT01301183

    Effects of Anorexia Nervosa on Peak Bone Mass

    Not yet reported Massachusetts General Hospital 75 participants Est. completion 2020-03 1 site
    Obstructive sleep apnea
    View official trial listing →
  • Terminated NCT NCT01303679

    1st Line Treatment of Bevacizumab-Taxane vs Bevacizumab-Exemestane in Metastatic Breast Cancer

    Not yet reported ARCAGY/ GINECO GROUP 117 participants Est. completion 2018-05 1 site
    Other conditions: First Line Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT01308814

    Perimenopausal Estrogen Replacement Therapy Study

    Not yet reported, Not yet reported University of North Carolina, Chapel Hill 172 participants Est. completion 2016-03 1 site
    Other conditions: Perimenopause, Menopause, Depression
    View official trial listing →
  • Completed NCT NCT01310647

    Antral Follicle Priming Prior to ICSI (Intracytoplasmic Sperm Injection) in Previously Diagnosed Low Responders

    Not yet reported Instituto de Investigacion Sanitaria La Fe 66 participants Est. completion 2014-02 1 site Stand-alone
    Other conditions: Ovarian Diseases
    View official trial listing →
  • Status unknown NCT NCT01311037

    The Combination of GnRh Analogue and Aromatase Inhibitor in Receptor Positive Premenopausal Women With Advanced Breast Cancer

    King Faisal Specialist Hospital & Research Center 2 participants 1 site
    Other conditions: Advanced Breast Cancer
    View official trial listing →
  • Completed NCT NCT01313039

    Evaluation of the Use of AZD6244 to Induce Increased ER Expression and Anti-Estrogen Response in ER-Negative/Low Breast Cancer

    Not yet reported University of Miami 4 participants Est. completion 2014-04 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01318005

    Oral Contraceptive (OC) Estrogen Dose and Breast Proliferation

    Not yet reported University of Southern California 82 participants Est. completion 2015-06-30 1 site
    Other conditions: Oral Contraceptive
    View official trial listing →
  • Completed NCT NCT01319968

    Postpartum Dyspareunia Resulting From Vaginal Atrophy

    Meir Medical Center 117 participants Est. completion 2013-09 2 sites
    Other conditions: Vulvovaginal Atrophy, Dyspareunia Among Puerperal Women
    View official trial listing →
  • Withdrawn NCT NCT01320046

    Vulvar Contact Dermatitis Resulting From Urine Incontinence

    Meir Medical Center Est. completion 2012-03 1 site
    Other conditions: Urinary Incontinence, Vulvar Pruritus, Vulvar Contact Dermatitis
    View official trial listing →
  • Withdrawn NCT NCT01320787

    18-F-Fluoroacetate as PET Imaging Agent

    Not yet reported M.D. Anderson Cancer Center
    Other conditions: Brain Cancer, Breast Cancer, Prostate Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT01327781

    Z-Endoxifen Hydrochloride in Treating Patients With Metastatic or Locally Recurrent Estrogen Receptor-Positive Breast Cancer

    Not yet reported National Cancer Institute (NCI) 62 participants Est. completion 2026-10-30 3 sites
    Other conditions: HER2/Neu Positive, Recurrent Breast Carcinoma, Stage IIIC Breast Cancer AJCC v7, Stage IV Breast Cancer AJCC v6 and v7
    View official trial listing →
  • Completed NCT NCT01328184

    Drug-drug Interaction of Empagliflozin (BI 10773) and Microgynon

    Not yet reported Boehringer Ingelheim 18 participants 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01329562

    CGRP, Estrogen, Cortisol, VIP, α-Amylase, PGE2, PGI2 and ß-Endorphin Levels in Menstrual Migraine Before and After Treximet

    Not yet reported Cady, Roger, M.D. 41 participants Est. completion 2012-06 2 sites
    Other conditions: Menstrual Migraine
    View official trial listing →
  • Completed NCT NCT01339442

    BKM120 and Fulvestrant for Treating Postmenopausal Patients With Estrogen Receptor-Positive Stage IV Breast Cancer

    Not yet reported Washington University School of Medicine 31 participants Est. completion 2016-12-28 1 site
    Other conditions: Estrogen Receptor-positive Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer
    View official trial listing →
  • Completed NCT NCT01340625

    Norethindrone/Ethinyl Estradiol 0.4 mg/35 Mcg Chewable Tablets Under Fasting Conditions

    Not yet reported Teva Pharmaceuticals USA 36 participants Est. completion 2007-01 1 site
    Other conditions: Bioequivalence
    View official trial listing →
  • Completed NCT NCT01344031

    MK2206 in Combination With Anastrozole, Fulvestrant, or Anastrozole and Fulvestrant in Treating Postmenopausal Women With Metastatic Breast Cancer

    Not yet reported National Cancer Institute (NCI) 31 participants 1 site
    Other conditions: Estrogen Receptor Positive, Invasive Breast Carcinoma, Recurrent Breast Carcinoma, Stage IV Breast Cancer AJCC v6 and v7
    View official trial listing →
  • Completed NCT NCT01344369

    Norethindrone/Ethinyl Estradiol 0.4 mg/35 Mcg Chewable Tablets Under Non-Fasted Conditions

    Not yet reported Teva Pharmaceuticals USA 36 participants Est. completion 2008-09 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01345786

    Bioequivalence of Nomegestrol Acetate (NOMAC) and Estradiol (E2) in Commercial Versus Phase 3 Pivotal Clinical Batches of NOMAC-E2 Tablets (P06328)

    Not yet reported Organon and Co 158 participants Est. completion 2010-06
    Other conditions: Healthy Postmenopausal Females
    View official trial listing →
  • Terminated NCT NCT01346579

    Biomarkers in Tissue Samples From Older Women With Breast Cancer

    Alliance for Clinical Trials in Oncology 505 participants Est. completion 2014-01
    Other conditions: Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT01349322

    Higher Per Daily Treatment-Dose Radiation Therapy or Standard Per Daily Treatment Radiation Therapy in Treating Patients With Early-Stage Breast Cancer That Was Removed by Surgery

    Not yet reported Radiation Therapy Oncology Group 2354 participants 415 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT01352091

    Adjuvant AI Combined With Zoladex

    Not yet reported Fudan University 670 participants Est. completion 2018-04 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT01353846

    Comparison Between Natural and Artificial Cycle in Recipient Oocyte Patients

    Not yet reported Instituto Valenciano de Infertilidad, IVI VALENCIA 70 participants Est. completion 2012-11 1 site
    Other conditions: Infertility
    View official trial listing →
  • Completed NCT NCT01360996

    Low Dose OC Therapy in Women With Polycystic Ovary Syndrome (PCOS): Impact of BMI on Hyperandrogenism

    Not yet reported Woman's 64 participants Est. completion 2015-02 1 site
    Other conditions: Polycystic Ovary Syndrome
    View official trial listing →
  • Completed NCT NCT01361958

    Minimal Effective Dose of Nomegestrol Acetate Inhibiting the Ovulation in Women Receiving Estradiol

    Not yet reported Theramex 38 participants Est. completion 1998-09
    Other conditions: Suppression of Ovulation
    View official trial listing →
  • Completed NCT NCT01367912

    Timing of Estrogen Support During the Luteal Phase of in Vitro Fertilization (IVF)/Intracytoplasmic Sperm Injection (ICSI) Cycle

    Not yet reported Zekai Tahir Burak Women's Health Research and Education Hospital 301 participants Est. completion 2008-11 1 site
    Other conditions: Infertility
    View official trial listing →
  • Terminated NCT NCT01368263

    Goserelin and Letrozole or Anastrozole in Premenopausal Patients With Stage II-III Estrogen Receptor-Positive Breast Cancer

    Not yet reported Washington University School of Medicine 8 participants Est. completion 2013-05 1 site
    Other conditions: Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer
    View official trial listing →
  • Completed NCT NCT01370551

    Clinical Study of Vaginal Lactobacilli and Estriol (Gynoflor®) for Atrophic Vaginitis in Breast Cancer Patients

    Not yet reported Medinova AG 16 participants Est. completion 2012-07 2 sites
    Other conditions: Atrophic Vaginitis
    View official trial listing →
  • Completed NCT NCT01370798

    Local Oestrogen Versus Placebo as Preoperative Treatment in Patients With Severe Hypospadias: Effects on Post-operative Complications

    Not yet reported Hospices Civils de Lyon 244 participants Est. completion 2017-09-18 4 sites
    Other conditions: Hypospadias
    View official trial listing →
  • Completed NCT NCT01372293

    71A/G HSD17B5 SNP and Effects of Oral Contraceptive Pill in PCOS Women

    Not yet reported Federal University of Rio Grande do Sul 49 participants Est. completion 2010-12
    Other conditions: Polycystic Ovary Syndrome
    View official trial listing →
  • Completed NCT NCT01373931

    A Study of LY2216684 in Healthy Females

    Not yet reported Eli Lilly and Company 20 participants Est. completion 2011-12 1 site
    Other conditions: Depressive Disorder, Major
    View official trial listing →
  • Completed NCT NCT01377324

    Molecular Imaging of Fulvestrant Effects on Availability of ER Binding Sites

    Not yet reported University Medical Center Groningen 16 participants Est. completion 2013-08 1 site
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT01381016

    Estrogen Sensitivity and Ovulatory Dysfunction in Obesity

    Not yet reported University of Colorado, Denver 30 participants Est. completion 2013-01 1 site Stand-alone
    Other conditions: Obesity, Infertility
    View official trial listing →
  • Completed NCT NCT01381874

    A Study of Abiraterone Acetate Plus Prednisone With or Without Exemestane in Postmenopausal Women With Estrogen Receptor-Positive (ER+) Metastatic Breast Cancer Progressing After Letrozole or Anastrozole Therapy

    Not yet reported Janssen Research & Development, LLC 297 participants Est. completion 2018-08-08 81 sites
    Other conditions: Metastatic ER+ Her2- Breast Cancer, Postmenopausal
    View official trial listing →
  • Status unknown NCT NCT01384331

    New Treatments for Troublesome Bleeding in Implanon Users

    Not yet reported Family Planning Association New South Wales 200 participants Est. completion 2013-04 1 site
    Other conditions: Menstrual Problem
    View official trial listing →
  • Completed NCT NCT01385137

    S0927:Omega3-Fatty Acid Supp in Treating Muscle&Bone Pain&Stiffness in Pts W/Stg I,II,III Brst Canc Rec'v Hormone Thpy

    Not yet reported SWOG Cancer Research Network 262 participants Est. completion 2014-03 292 sites
    Other conditions: Arthralgia, Breast Cancer, Pain
    View official trial listing →
  • Completed NCT NCT01385280

    Pilot Study Estradiol Followed by Exemestane Hormone Receptor + Metastatic Breast Cancer

    Not yet reported University of Arizona 13 participants Est. completion 2013-10 1 site
    Other conditions: Estrogen Receptor-positive Breast Cancer, Progesterone Receptor Positive Tumor, Recurrent Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    View official trial listing →
  • Completed NCT NCT01385332

    A Comparative Study of Two Patterns of Controlled Ovarian Hyperstimulation in Mid Follicular Phase or Early Luteal Phase for Egg Donors

    Not yet reported Parc de Salut Mar 10 participants Est. completion 2012-09 1 site
    Other conditions: Stimulation in the Ovary
    View official trial listing →
  • Completed NCT NCT01385618

    Gene-polymorphisms Relating to Human Subfertility

    Infertility Treatment Center Dortmund 150 participants Est. completion 2015-03 1 site
    Other conditions: Estradiol Receptor Polymorphism, Progesterone Receptor Polymorphism, IVF, Subfertility
    View official trial listing →
  • Completed NCT NCT01388491

    A Multinational Study to Evaluate the Effects of a 28-Day Oral Contraceptive on Hemostatic Parameters in Healthy Women

    Not yet reported Teva Branded Pharmaceutical Products R&D, Inc. 293 participants Est. completion 2012-09-30 27 sites
    Other conditions: Hemostasis, Oral Contraceptive
    View official trial listing →
  • Completed NCT NCT01389102

    Estradiol Transdermal Spray in the Treatment of Vasomotor Symptoms

    Not yet reported Lumara Health, Inc. 454 participants Est. completion 2006-11 43 sites
    Other conditions: Hot Flashes
    View official trial listing →
  • Terminated NCT NCT01393119

    Phase II, Dose Finding Study of GTx-758

    Not yet reported GTx 77 participants Est. completion 2012-12 21 sites Stand-alone
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT01394016

    A Phase 1 Study of LY2835219 In Participants With Advanced Cancer

    Not yet reported Eli Lilly and Company 225 participants Est. completion 2022-04-12 3 sites
    Other conditions: Advanced Cancer
    View official trial listing →
  • Completed NCT NCT01399086

    Fulvestrant in Postmenopausal Patients With Metastatic Breast Cancer

    Hellenic Oncology Research Group 140 participants Est. completion 2011-09 9 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01400776

    Safety & Efficacy WC3011 (Estradiol Vaginal Cream) in the Treatment of Vulvovaginal Atrophy in Postmenopausal Women

    Not yet reported Warner Chilcott 722 participants Est. completion 2012-02-27 70 sites
    Other conditions: Postmenopausal Vulvovaginal Atrophy
    View official trial listing →
  • Completed NCT NCT01402648

    Estrogen Receptor Beta Agonists (Eviendep) and Polyp Recurrence

    Not yet reported, Not yet reported CM&D Pharma Limited 60 participants Est. completion 2011-04 1 site
    Other conditions: Adenocarcinoma of Colon Recurrent
    View official trial listing →
  • Completed NCT NCT01407692

    Menstrual Cycle Hormones and Eating Behavior

    USDA, Western Human Nutrition Research Center 24 participants Est. completion 2012-12 1 site
    Other conditions: Dietary Habits, Food Preference
    View official trial listing →
  • Completed NCT NCT01408030

    North American Study of Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT)

    Not yet reported James Gossage 123 participants Est. completion 2014-09 6 sites
    Other conditions: Telangiectasia, Hereditary Hemorrhagic, Epistaxis
    View official trial listing →
  • Status unknown NCT NCT01414530

    Oral Contraceptive During Menopausal Transition

    Not yet reported Samsung Medical Center 52 participants 1 site
    Other conditions: Perimenopause
    View official trial listing →
  • Completed NCT NCT01418209

    MsFLASH-03: Comparative Efficacy of Low-Dose Estradiol and Venlafaxine XR for Treatment of Menopausal Symptoms

    Not yet reported Fred Hutchinson Cancer Center 339 participants Est. completion 2013-01 4 sites
    Other conditions: Hot Flashes, Menopause, Vasomotor Disturbance
    View official trial listing →
  • Completed NCT NCT01419353

    Programming by Estrogen Treatment in Gonadotropin Releasing Hormone Antagonist Protocol

    Not yet reported Meir Medical Center 63 participants Est. completion 2013-06 1 site Stand-alone
    Other conditions: Infertility
    View official trial listing →
  • Status unknown NCT NCT01420185

    Identification of Genes That Predict Local Recurrence in Samples From Patients With Breast Cancer Treated on NSABP-B-28

    NSABP Foundation Inc 1300 participants
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01421472

    A Trial of Preoperative MM-121 With Paclitaxel in HER2-negative Breast Cancer

    Not yet reported Merrimack Pharmaceuticals 196 participants Est. completion 2014-06 38 sites
    Other conditions: ER Positive, Her2 Negative Breast Cancer Patients, Triple Negative Breast Cancer Patients
    View official trial listing →
  • Status unknown NCT NCT01424618

    A Novel Approach to Endometrial Preparation in Recipients of Donor Eggs

    Not yet reported Kelly, Maureen, M.D. 20 participants 1 site
    Other conditions: Implantation, Embryo
    View official trial listing →
  • Terminated NCT NCT01425294

    Collection of Efficacy and Safety Data of Chinese Patients Who Have Received Faslodex 250mg Treatment

    AstraZeneca 231 participants Est. completion 2016-01-30 23 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT01425541

    Assessment of the Sensitivity of the Hypothalamic GnRH Pulse Generator to Estradiol and Progesterone Inhibition

    Not yet reported University of Virginia 60 participants Est. completion 2025-08 1 site Stand-alone
    Other conditions: Hyperandrogenemia, Polycystic Ovary Syndrome (PCOS)
    View official trial listing →
  • Completed NCT NCT01427595

    Effect of Metformin on Sensitivity of the GnRH Pulse Generator to Suppression by Estradiol and Progesterone

    Not yet reported University of Virginia 25 participants Est. completion 2015-01-17 1 site Stand-alone
    Other conditions: Polycystic Ovary Syndrome, Hyperandrogenism
    View official trial listing →
  • Terminated NCT NCT01428193

    Effects of Androgen Blockade on Sensitivity of the GnRH Pulse Generator to Suppression by Estradiol and Progesterone

    Not yet reported University of Virginia 4 participants Est. completion 2017-08 1 site
    Other conditions: Polycystic Ovary Syndrome, Hyperandrogenism
    View official trial listing →
  • Terminated NCT NCT01428245

    Assessment of Sensitivity of the Hypothalamic GnRH Pulse Generator to Estradiol and Progesterone Inhibition

    Not yet reported University of Virginia 3 participants Est. completion 2013-05-14 1 site Stand-alone
    Other conditions: Hyperandrogenemia, Polycystic Ovary Syndrome
    View official trial listing →
  • Terminated NCT NCT01430585

    Pre-Operative Study of PF-4691502 With Letrozole Compared To Letrozole Alone In Patients With Early Breast Cancer

    Not yet reported Pfizer 14 participants Est. completion 2012-12 5 sites
    Other conditions: Early Breast Cancer (Phase 2), Advanced Breast Cancer (Phase 1b)
    View official trial listing →
  • Completed NCT NCT01430650

    Endometrial Priming for Embryo Transfer

    Not yet reported Parc de Salut Mar 140 participants Est. completion 2015-07 1 site
    Other conditions: Sterility
    View official trial listing →
  • Completed NCT NCT01431872

    Systemic Dickkopf-related Protein 1 (DKK1)During Estrogen Level Changes in Post-menopausal Breast Cancer Patients Treated With Aromatase Inhibitors

    University of Arkansas 17 participants Est. completion 2015-08 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01432028

    Pharmacogenetic Study of Different Hormone Therapies in Recent Menopause Women

    Not yet reported Denusa Wiltgen 90 participants Est. completion 2011-04 1 site
    Other conditions: Postmenopause
    View official trial listing →
  • Completed NCT NCT01436513

    A Study To Compare The Amount Of Premarin Components That Is Absorbed Into The Blood Of Japanese Healthy Postmenopausal Women Following Oral Administration Of Two Different Tablets Of Premarin Under Fast and Fed Conditions.

    Not yet reported Pfizer 72 participants Est. completion 2012-03 1 site
    Other conditions: Primary Ovarian Insufficiency, Vaginitis, Metrorrhagia, Menopause
    View official trial listing →
  • Completed NCT NCT01437566

    Study of GDC-0941 or GDC-0980 With Fulvestrant Versus Fulvestrant in Advanced or Metastatic Breast Cancer in Participants Resistant to Aromatase Inhibitor Therapy

    Not yet reported Genentech, Inc. 318 participants Est. completion 2016-04 130 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01439282

    Eribulin in Combination With Capecitabine for Adjuvant Treatment in Estrogen Receptor-Positive Early Stage Breast Cancer

    Not yet reported Eisai Inc. 77 participants Est. completion 2014-05 23 sites
    Other conditions: Estrogen Receptor Positive Tumor, Breast Cancer
    View official trial listing →
  • Completed NCT NCT01439711

    Letrozole in Treating Postmenopausal Women With Ductal Carcinoma in Situ

    Not yet reported Alliance for Clinical Trials in Oncology 108 participants Est. completion 2018-01 32 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01441635

    Safety and Efficacy of Elagolix in Pre-Menopausal Women With Heavy Uterine Bleeding and Uterine Fibroids

    Not yet reported AbbVie (prior sponsor, Abbott) 271 participants Est. completion 2014-05-17 Stand-alone
    Other conditions: Heavy Uterine Bleeding, Uterine Fibroids
    View official trial listing →
  • Completed NCT NCT01441947

    Cabozantinib in Women With Metastatic Hormone-Receptor-Positive Breast Cancer

    Not yet reported Massachusetts General Hospital 68 participants Est. completion 2019-08-09 4 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01446159

    Study of MEDI-573 Plus Standard Endocrine Therapy for Women With Hormone-sensitive Metastatic Breast Cancer

    Not yet reported MedImmune LLC 188 participants Est. completion 2019-06-28 71 sites
    Other conditions: Hormone-sensitive, HER-2 Negative Metastatic Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT01448291

    Effect of the Etonogestrel 0.12mg/Ethinyl Estradiol 0.015mg Vaginal Ring on Vaginal Innate and Inflammatory Biomarkers

    Not yet reported Eastern Virginia Medical School 30 participants Est. completion 2013-03 1 site
    Other conditions: Vaginosis, Bacterial
    View official trial listing →
  • Completed NCT NCT01452373

    Dehydroepiandrosterone (DHEA) + Acolbifene Against Vasomotor Symptoms (Hot Flushes) in Postmenopausal Women

    Not yet reported EndoCeutics Inc. 238 participants Est. completion 2013-05 15 sites
    Other conditions: Vasomotor Symptoms, Hot Flushes
    View official trial listing →
  • Completed NCT NCT01455597

    Evaluate Long-Term Safety and Efficacy WC3011 (Estradiol Vaginal Cream)

    Not yet reported Warner Chilcott 309 participants Est. completion 2012-12-03 64 sites
    Other conditions: Vulvovaginal Atrophy
    View official trial listing →
  • Completed NCT NCT01458210

    A Study of the Effect of Dulaglutide on How the Body Handles Oral Contraceptive in Healthy Female Participants

    Not yet reported Eli Lilly and Company 22 participants Est. completion 2012-02 1 site
    Type 2 diabetes
    View official trial listing →
  • Status unknown NCT NCT01459445

    Metformin+ Drospirenone/ethinylestradiol30µg and Flow-mediated Dilation in Polycystic Ovary Syndrome

    Not yet reported Iuliu Hatieganu University of Medicine and Pharmacy 26 participants Est. completion 2012-01 1 site
    Other conditions: Polycystic Ovary Syndrome, Endothelial Dysfunction
    View official trial listing →
  • Completed NCT NCT01461070

    Intestine Bacteria and Breast Cancer Risk

    National Cancer Institute (NCI) 175 participants Est. completion 2020-05-22 1 site
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Completed NCT NCT01465022

    Breastfeeding and Oral Contraceptives: a Randomized, Controlled Trial

    Not yet reported University of New Mexico 197 participants Est. completion 2008-06
    Other conditions: Breast Feeding, Contraception
    View official trial listing →
  • Status unknown NCT NCT01466114

    Estriol Treatment in Multiple Sclerosis (MS): Effect on Cognition

    Not yet reported University of California, Los Angeles 64 participants Est. completion 2022-04 4 sites
    Other conditions: Relapsing-remitting Multiple Sclerosis, Secondary-progressive Multiple Sclerosis, Primary-progressive Multiple Sclerosis
    View official trial listing →
  • Completed NCT NCT01471106

    Phase II Short-term Adjuvant Therapy and Biomarker Studies With Targeted Agents in Women With Estrogen Receptor Negative Breast Cancer

    Not yet reported M.D. Anderson Cancer Center 26 participants Est. completion 2024-05-30 2 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01471457

    Trial of Trimosan Gel Effect on Pessary-associated Bacterial Vaginosis

    Not yet reported, Not yet reported University of New Mexico 184 participants Est. completion 2014-09 2 sites
    Other conditions: Bacterial Vaginosis
    View official trial listing →
  • Completed NCT NCT01475513

    Oral Contraceptives, Insulin Resistance and Cardiovascular Risk Profile in Pre-Menopausal Women

    Not yet reported Virginia Commonwealth University 47 participants Est. completion 2014-05-28 1 site
    Other conditions: Insulin Sensitivity, Cardiovascular Risk, Perimenopausal Disorder
    View official trial listing →
  • Terminated NCT NCT01475565

    Insulin Resistance Before and During Pregnancy in Women With Polycystic Ovary Syndrome

    Virginia Commonwealth University 2 participants Est. completion 2014-08 1 site
    Other conditions: Polycystic Ovary Syndrome, Insulin Resistance, Insulin Sensitivity, Obesity, Pregnancy
    View official trial listing →
  • Completed NCT NCT01477632

    Bioavailability of Three Oral Formulations for Hormone Replacement Therapy in Postmenopausal Women

    Not yet reported Novo Nordisk A/S 24 participants Est. completion 2005-06 1 site
    Other conditions: Menopause, Healthy
    View official trial listing →
  • Completed NCT NCT01480778

    Evaluation of Ciclo 21® Effect (Levonorgestrel + Ethinyl Estradiol) Compared to Nordette®.

    Not yet reported Azidus Brasil 62 participants Est. completion 2015-06 1 site
    Other conditions: Irregular Periods
    View official trial listing →
  • Completed NCT NCT01481883

    Selective Estrogen Receptor Modulators (SERMs) - A Potential Treatment for Psychotic Symptoms of Schizophrenia in Men?

    Not yet reported The Alfred 13 participants Est. completion 2019-02 1 site
    Other conditions: Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder
    View official trial listing →
  • Completed NCT NCT01482416

    Vascular Effect of Estrogens Versus Placebo Evaluated by Flow-mediated Dilatation of Brachial Artery

    Not yet reported Federal University of Minas Gerais 60 participants Est. completion 2014-08 1 site Stand-alone
    Other conditions: Unspecified Injury of Brachial Artery, Left Side, Initial Encounter
    View official trial listing →
  • Terminated NCT NCT01484041

    Dovitinib Plus an Aromatase Inhibitor for Metastatic Breast Cancer

    Not yet reported, Not yet reported Georgetown University 12 participants Est. completion 2017-12 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01489852

    Estrogen Pretreatment Prior to GnRH Antagonist Protocol

    Not yet reported Gemer 472 participants Est. completion 2011-05 1 site
    Other conditions: Infertility
    View official trial listing →
  • Completed NCT NCT01490190

    Study of the Use of a Contraceptive Vaginal Ring (NuvaRing) in Normal Daily Practice in Indian Women (P07733)

    Not yet reported Organon and Co 252 participants Est. completion 2012-12-05
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT01491737

    A Study of Pertuzumab in Combination With Trastuzumab Plus an Aromatase Inhibitor in Participants With Metastatic Human Epidermal Growth Factor Receptor 2 (HER2)-Positive and Hormone Receptor-Positive Advanced Breast Cancer

    Not yet reported Hoffmann-La Roche 258 participants Est. completion 2019-11-14 82 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01497977

    Phytoestrogen Supplementation in Postmenopausal Women

    Not yet reported American Medical Academy, Serbia 74 participants Est. completion 2010-06 1 site
    Other conditions: Low Serum Lipid Levels
    View official trial listing →
  • Completed NCT NCT01498861

    Drug Interaction Study Between Dolutegravir and an Oral Contraceptive Containing Norgestimate and Ethinylestradiol

    Not yet reported ViiV Healthcare 16 participants Est. completion 2012-03 1 site
    Other conditions: Infection, Human Immunodeficiency Virus
    View official trial listing →
  • Terminated NCT NCT01500473

    Therapeutic Effect of Desogestrel on Ventilatory Control in Patients With Congenital Central Hypoventilation Syndrome

    Not yet reported Children's Hospital Los Angeles 1 participants Est. completion 2016-05-11 1 site
    Other conditions: Congenital Central Hypoventilation Syndrome
    View official trial listing →
  • Completed NCT NCT01500863

    Endometrial Receptivity After GnRH Agonist Triggering

    Not yet reported IVI Madrid 35 participants 1 site Stand-alone
    Other conditions: Ovarian Hyperstimulation Syndrome
    View official trial listing →
  • Completed NCT NCT01501422

    Effect of Estrogen Therapy on Objective Sleep Quality in Postmenopausal Women

    Not yet reported Chulalongkorn University 40 participants Est. completion 2012-01 1 site Stand-alone
    Other conditions: Insomniac Postmenopausal Women
    View official trial listing →
  • Completed NCT NCT01504139

    The Luteal Phase After GnRHa Trigger - a Proof of Concept Study

    Not yet reported Regionshospitalet Viborg, Skive 93 participants Est. completion 2014-08 1 site
    Other conditions: Progesterone Levels, Infertility
    View official trial listing →
  • Completed NCT NCT01507454

    Vagifem® Used for the Treatment of Atrophic Vaginitis Due to Oestrogen Deficiency

    Novo Nordisk A/S 1613 participants Est. completion 2006-11 1 site
    Other conditions: Menopause, Postmenopausal Vaginal Atrophy
    View official trial listing →
  • Completed NCT NCT01508858

    Influence on the Effect of an Oral Contraceptive Drug After Administration of Liraglutide in Postmenopausal Women

    Not yet reported Novo Nordisk A/S 21 participants Est. completion 2007-04 1 site
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01509625

    Retrospective Study Assessment Treatment Response Faslodex®( 500 mg)

    Isabel Blancas 272 participants Est. completion 2014-03 7 sites
    Other conditions: Malignant Neoplasm of Breast Stage IV
    View official trial listing →
  • Completed NCT NCT01511822

    Clinical, Metabolic and Endocrine Effects of the Treatment With Drospirenone and Ethinyl Estradiol Alone or in Combination With Myo-inositol in Young Women With Polycystic Ovary Syndrome (PCOS) and Insulin Resistance

    Not yet reported AGUNCO Obstetrics and Gynecology Centre 1 site
    Other conditions: PCOS, Polycystic Ovary Syndrome
    View official trial listing →
  • Completed NCT NCT01515800

    S1105: Text-Messaging Intervention to Reduce Early Discontinuation of AI Therapy in Women With Early-Stage Breast Cancer

    Not yet reported SWOG Cancer Research Network 724 participants Est. completion 2018-02 204 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01518062

    Safety of Somatropin and Induction of Puberty With 17-beta-oestradiol in Girls With Turner Syndrome

    Not yet reported Novo Nordisk A/S 65 participants Est. completion 2003-09 1 site
    Other conditions: Genetic Disorder, Turner Syndrome
    View official trial listing →
  • Completed NCT NCT01519401

    Effect of Two Different Dosages of Ethinyl-estradiol in Association With Drospirenone in Women With Polycystic Ovary Syndrome.

    Not yet reported Catholic University of the Sacred Heart 50 participants Est. completion 2011-07 1 site
    Other conditions: Polycystic Ovary Syndrome, Estro-progestin Drugs
    View official trial listing →
  • Terminated NCT NCT01528345

    Trial Evaluating Dovitinib Combined With Fulvestrant, in Postmenopausal Patients With HER2- and HR+ Breast Cancer

    Not yet reported Novartis Pharmaceuticals 97 participants Est. completion 2015-04 67 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT01535066

    S1200: Acupuncture, Sham Acupuncture, or Wait List for Joint Symptoms Related to Aromatase Inhibitors in Pts W/Early-Stage Breast Cancer

    Not yet reported SWOG Cancer Research Network 226 participants Est. completion 2018-07-01 47 sites
    Other conditions: Breast Cancer, Pain
    View official trial listing →
  • Completed NCT NCT01535820

    The Effect of an Adhesive Overlay on the Delivery of Contraceptive Hormones From ORTHO EVRA® in Healthy Women

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 54 participants Est. completion 2011-07 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT01546454

    Relationship Between the Menstrual Cycle and Heart Disease in Women

    Not yet reported Oregon Health and Science University 5 participants Est. completion 2013-01 1 site Stand-alone
    Other conditions: Coronary Heart Disease
    View official trial listing →
  • Completed NCT NCT01547741

    Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer

    Not yet reported NSABP Foundation Inc 4242 participants Est. completion 2025-10-17 915 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01553773

    Postmenopausal Facial Skin After Estradiol and Genistein Topical Treatment

    Not yet reported Federal University of São Paulo 30 participants Est. completion 2005-03 1 site
    Other conditions: Atrophy
    View official trial listing →
  • Completed NCT NCT01556191

    Lung Cancer in Women Treated With Anti-oestrogens anD Inhibitors of EGFR

    Not yet reported Intergroupe Francophone de Cancerologie Thoracique 379 participants Est. completion 2020-06-17 61 sites
    Other conditions: Stage IV Lung Cancer
    View official trial listing →
  • Completed NCT NCT01560416

    Fulvestrant With or Without Ganetespib in HR+ Breast Cancer

    Not yet reported Dana-Farber Cancer Institute 50 participants Est. completion 2016-06-26 5 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01564056

    Adjuvant Systemic Treatment for (ER)-Positive HER2-negative Breast Carcinoma in Women Over 70 According to Genomic Grade (GG): Chemotherapy + Endocrine Treatment Versus Endocrine Treatment

    Not yet reported UNICANCER 1989 participants Est. completion 2026-04 84 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01569113

    Assessment of Effects on Ovarian Activity of a Combined Oral Contraceptive Pill When Preceded by the Intake of ellaOne® or Placebo.

    Not yet reported HRA Pharma 76 participants Est. completion 2012-08 3 sites
    Other conditions: Emergency Contraception
    View official trial listing →
  • Completed NCT NCT01569945

    Hormonal Stimulation in IUI Treatment: Is Clomifen Combined With Ethinyl Estradiol Better, Worse or Equal to Menopur

    Not yet reported University Hospital, Gasthuisberg 371 participants Est. completion 2011-12 1 site
    Other conditions: Subfertility
    View official trial listing →
  • Completed NCT NCT01570244

    Drug-drug Interaction of BI 201335 and Microgynon

    Not yet reported Boehringer Ingelheim 16 participants Est. completion 2012-08 1 site
    Other conditions: Hepatitis C, Chronic
    View official trial listing →
  • Completed NCT NCT01573377

    Efficacy of Metformin and Diane-35 on PCOS Patients,a Randomized, Controlled, Prospective Clinical Trial

    Not yet reported Chongqing Medical University 40 participants Est. completion 2013-02 1 site
    Other conditions: Polycystic Ovary Syndrome, Insulin Resistance
    View official trial listing →
  • Completed NCT NCT01573442

    Testosterone in Treating Postmenopausal Patients With Arthralgia Caused by Adjuvant Aromatase Inhibitor Treatment

    Not yet reported Alliance for Clinical Trials in Oncology 227 participants Est. completion 2019-09-01 529 sites
    Other conditions: Arthralgia, Breast Cancer, Hot Flashes, Musculoskeletal Complications, Sexual Dysfunction
    View official trial listing →
  • Completed NCT NCT01577017

    The Effects of Letrozole And Clomiphene Citrate For Induction of Ovulation In Polycystic Ovarian Syndrome(PCOS)

    Not yet reported Nik Hazlina 150 participants Est. completion 2012-03
    Other conditions: Polycystic Ovarian Syndrome
    View official trial listing →
  • Withdrawn NCT NCT01577199

    RCT of Low-dose Clomiphene vs. High Dose Gonadotropin Protocol for IVF Poor Responders

    Not yet reported Weill Medical College of Cornell University Est. completion 2012-12
    Other conditions: Infertility
    View official trial listing →
  • Completed NCT NCT01581814

    Effects of Drospirenone-ethinylestradiol and/or Metformin on Cardiovascular Risk in Hyperinsulinemic Women With Polycystic Ovary Syndrome

    Not yet reported Catholic University of the Sacred Heart 99 participants Est. completion 2012-03 1 site
    Other conditions: Polycystic Ovary Syndrome
    View official trial listing →
  • Completed NCT NCT01582074

    The Ultrasound Study of Tamoxifen

    National Cancer Institute (NCI) 247 participants Est. completion 2016-01-01 1 site
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Completed NCT NCT01586000

    A Dose-finding Study to Evaluate the Effect of a Contraceptive Vaginal Ring, Releasing Nestorone® and Estradiol, on Cycle Control, Ovulation Inhibition, and Pharmacokinetics in Normal Cycling Women

    Not yet reported Kimberly Myer 197 participants Est. completion 2015-05 8 sites
    Other conditions: Suppression of Ovulation
    View official trial listing →
  • Status unknown NCT NCT01588873

    Contraceptive Pill and Hormonal Vaginal Ring in Women With Polycystic Ovary Syndrome

    Not yet reported University of Oulu 42 participants Est. completion 2019-12 1 site
    Other conditions: Adverse Effect of Oral Contraceptives, Sequela
    View official trial listing →
  • Status unknown NCT NCT01590849

    Assessment of Autonomic Tone in Normotensive Women Using Combined Hormonal Oral Contraceptive Containing Drospirenone

    Not yet reported Instituto do Coracao 69 participants 1 site
    Other conditions: Contraceptive Affecting the Autonomic Nervous System, Contraceptive Affecting Blood Pressure
    View official trial listing →
  • Completed NCT NCT01594216

    Ruxolitinib in Estrogen Receptor Positive Breast Cancer

    Not yet reported Abramson Cancer Center at Penn Medicine 25 participants Est. completion 2016-04-09 1 site
    Other conditions: Estrogen-receptor Positive Invasive Metastatic Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT01595334

    Study on Influence of Leutinizing Hormone (LH) on Oocyte Maturity

    Not yet reported Southern Cross Fertility Centre 300 participants Est. completion 2012-11 3 sites
    Other conditions: Infertility
    View official trial listing →
  • Completed NCT NCT01596010

    Investigation of 2 Different Oral Formulations of Estradiol and Norethisterone in Healthy Women

    Not yet reported Novo Nordisk A/S 44 participants Est. completion 2007-11 1 site
    Other conditions: Menopause, Healthy
    View official trial listing →
  • Completed NCT NCT01597193

    Safety Study of Enzalutamide (MDV3100) in Patients With Incurable Breast Cancer

    Not yet reported Pfizer 101 participants Est. completion 2018-01-22 17 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01597388

    AZD2014 and Fulvestrant in Patients With ER+ Advanced Metastatic Breast Cancer

    Not yet reported AstraZeneca 99 participants Est. completion 2026-01-13 5 sites
    Other conditions: Advanced Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT01597986

    Drug Interaction Study of Isavuconazole and Oral Contraceptive Containing Ethinyl Estradiol and Norethindrone

    Not yet reported Astellas Pharma Global Development, Inc. 24 participants Est. completion 2012-06 1 site
    Other conditions: Pharmacokinetics of Isavuconazole, Pharmacokinetics of Ethinyl Estradiol and Norethindrone, Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT01598298

    S1202: Duloxetine Hydrochloride for Muscle/Joint Pain in Early-Stage Breast Cancer Receiving Hormone Therapy

    Not yet reported SWOG Cancer Research Network 299 participants Est. completion 2018-12-20 714 sites
    Other conditions: Breast Cancer, Musculoskeletal Complications, Pain
    View official trial listing →
  • Completed NCT NCT01600274

    Bioavailability Study With Oral Single Dose Administration of Ethinylestradiol and Dienogest

    Not yet reported Pharbil Waltrop GmbH 20 participants Est. completion 2010-02 1 site
    Other conditions: Focus: Bioequivalence
    View official trial listing →
  • Completed NCT NCT01602380

    A Global Study to Compare the Effects of Fulvestrant and Arimidex in a Subset of Patients With Breast Cancer.

    Not yet reported AstraZeneca 462 participants Est. completion 2026-01-16 118 sites
    Other conditions: Hormone Receptor Positive Breast Cancer
    View official trial listing →
  • Completed NCT NCT01602770

    Qlaira Post-authorization Safety Study Related to Most Common Adverse Events in Mexican Women Who Wish to Avoid Pregnancy

    Bayer 1 participants Est. completion 2017-10-31 1 site
    Other conditions: Contraception
    View official trial listing →
  • Status unknown NCT NCT01603745

    Effects of Drospirenone-ethinylestradiol and/or NOMAC-valerate Estradiol on Cardiovascular Risk in Women With Polycystic Ovary Syndrome

    Not yet reported Catholic University of the Sacred Heart 10 participants Est. completion 2012-10 1 site
    Other conditions: Polycystic Ovary Syndrome
    View official trial listing →
  • Completed NCT NCT01605071

    Timing Estrogen After MenoPaUSe

    Not yet reported University of Colorado, Denver 53 participants Est. completion 2017-01 1 site
    Other conditions: Insulin Resistance
    View official trial listing →
  • Completed NCT NCT01605396

    A Phase II Trial of Ridaforolimus and Exemestane, Compared to Ridaforolimus, Dalotuzumab and Exemestane in Participants With Breast Cancer (MK-8669-064)

    Not yet reported Merck Sharp & Dohme LLC 80 participants Est. completion 2018-03-15
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Status unknown NCT NCT01608698

    Comparison of Body Weight Change During Contraception With Belara and Yasmin

    Not yet reported Mahidol University 100 participants Est. completion 2016-02 1 site
    Other conditions: Body Weight Changes
    View official trial listing →
  • Completed NCT NCT01610284

    Phase III Study of BKM120/Placebo With Fulvestrant in Postmenopausal Patients With Hormone Receptor Positive HER2-negative Locally Advanced or Metastatic Breast Cancer Refractory to Aromatase Inhibitor

    Not yet reported Novartis Pharmaceuticals 1147 participants Est. completion 2019-04-19 268 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01611038

    Methylselenocysteine Effects on Circadian Rhythm

    Not yet reported Rutgers, The State University of New Jersey 100 participants Est. completion 2015-06 1 site
    Other conditions: Breast Cancer, Prostate Cancer
    View official trial listing →
  • Withdrawn NCT NCT01612728

    Treatment for Joint Pains Due to Aromatase Inhibitor Therapy in Breast Cancer

    Not yet reported Baylor Breast Care Center Est. completion 2014-10
    Other conditions: Breast Cancer, Arthralgia, Joint Pain
    View official trial listing →
  • Withdrawn NCT NCT01612910

    Oral Microencapsulated Diindolylmethane in Treating Patients With Stage II-III Triple Negative, Androgen Receptor Positive Breast Cancer Who Have Undergone Chemotherapy and Surgery

    Not yet reported Barbara Ann Karmanos Cancer Institute Est. completion 2014-02
    Other conditions: Breast Cancer Female
    View official trial listing →
  • Completed NCT NCT01613131

    Mirena and Estrogen for Control of Perimenopause Symptoms and Ovulation Suppression

    Not yet reported University of Colorado, Denver 39 participants Est. completion 2014-06 1 site
    Other conditions: Menopausal and Other Perimenopausal Disorders
    View official trial listing →
  • Status unknown NCT NCT01613170

    Premarin Versus Toviaz for Treatment of Overactive Bladder

    Not yet reported The Cleveland Clinic 90 participants Est. completion 2018-12 1 site
    Other conditions: Overactive Bladder
    View official trial listing →
  • Completed NCT NCT01615354

    A Study of Aleglitazar in Combination With Oral Contraceptive Healthy Volunteers

    Not yet reported Hoffmann-La Roche 18 participants Est. completion 2013-01 1 site
    Other conditions: Healthy Volunteer
    View official trial listing →
  • Terminated NCT NCT01616758

    Phase II Study of GTx024 in Women With Metastatic Breast Cancer

    Not yet reported GTx 22 participants Est. completion 2016-03 4 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT01625286

    Investigating Safety, Tolerability and Efficacy of AZD5363 When Combined With Paclitaxel in Breast Cancer Patients

    Not yet reported, Not yet reported AstraZeneca 148 participants Est. completion 2022-10-03 41 sites
    Other conditions: Advanced or Metastatic Breast Cancer, ER+ve Advanced or Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT01626222

    4EVER - Efficacy, Safety, Health Economics, Translational Research of Postmenopausal Women With Estrogen Receptor Positive Locally Advanced or Metastatic Breast Cancer

    Not yet reported Novartis Pharmaceuticals 301 participants Est. completion 2013-11 84 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT01631981

    PGL2001 Proof of Concept Study in Symptomatic Endometriosis

    Not yet reported PregLem SA 162 participants Est. completion 2014-05 20 sites
    Other conditions: Endometriosis
    View official trial listing →
  • Terminated NCT NCT01633060

    A Phase III Study of BKM120 With Fulvestrant in Patients With HR+,HER2-, AI Treated, Locally Advanced or Metastatic Breast Cancer Who Progressed on or After mTORi

    Not yet reported Novartis Pharmaceuticals 432 participants Est. completion 2017-09-21 197 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT01633528

    The Effect of Low Dose Aspirin in Increasing the Chance of Pregnancy

    Not yet reported Royan Institute 60 participants Est. completion 2015-02 1 site Stand-alone
    Other conditions: Infertility
    View official trial listing →
  • Terminated NCT NCT01633814

    Hormone Replacement and Neural Cardiovascular Control in Postmenopausal Women

    Not yet reported University of Missouri-Columbia 4 participants Est. completion 2015-08 1 site
    Other conditions: Menopause, Aging, Blood Pressure
    View official trial listing →
  • Terminated NCT NCT01634789

    A Pilot Bioavailability Study of 3 Test Tablet Formulations of Bazedoxifene Compared With A Reference Tablet Formulation of Bazedoxifene/Conjugated Estrogens in Healthy Postmenopausal Women

    Not yet reported Pfizer 2 participants Est. completion 2012-11 1 site
    Other conditions: Healthy
    View official trial listing →
  • Terminated NCT NCT01638767

    NuvaRing Versus Marvelon in the Coordination of In Vitro Fertilization Cycles

    Not yet reported Clinique Ovo 7 participants Est. completion 2014-07 1 site
    Other conditions: Infertility
    View official trial listing →
  • Completed NCT NCT01638910

    Efficacy and Safety of a Combined Oral Contraceptive of Estradiol Valerate and Dienogest in Healthy Female Subjects

    Not yet reported Bayer 955 participants Est. completion 2014-11 39 sites Stand-alone
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT01638923

    Study of a 4-phasic Oral Contraceptive for the Treatment of Heavy Menstrual Bleeding

    Not yet reported Bayer 339 participants Est. completion 2015-06 41 sites Stand-alone
    Other conditions: Metrorrhagia
    View official trial listing →
  • Completed NCT NCT01642186

    Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) With Leuprolide + Letrozole and (3) Everolimus + EDT in Patients With Unresectable Fibrolamellar Hepatocellular Carcinoma (FLL-HCC)

    Not yet reported Memorial Sloan Kettering Cancer Center 28 participants Est. completion 2021-07-16 6 sites
    Other conditions: Fibrolamellar Carcinoma, Fibrolamellar Liver Cancer
    View official trial listing →
  • Completed NCT NCT01645241

    Evolutive Potential of Embryos Obtained From Oocytes After Luteal Phase Ovarian Stimulation

    Not yet reported Fundacion Dexeus 15 participants Est. completion 2013-12 1 site Stand-alone
    Other conditions: INFERTILITY, Fertility Preservation, Ovulation Induction, Vitrification, Oocyte Donation
    View official trial listing →
  • Terminated NCT NCT01648751

    Vaginal Estrogen and Pelvic Floor Physical Therapy in Women With Symptomatic Mild Prolapse

    Not yet reported Pamela Moalli 21 participants Est. completion 2023-03-02 1 site Stand-alone
    Other conditions: Pelvic Organ Prolapse
    View official trial listing →
  • Completed NCT NCT01650168

    Prospective Controlled Cohort Study on the Safety of a Monophasic Oral Contraceptive Containing Nomegestrol Acetate (2.5mg) and 17ß-estradiol (1.5mg)

    Center for Epidemiology and Health Research, Germany 101498 participants Est. completion 2020-12 1 site
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT01653743

    Trial to Assess the Clinical Efficacy and Safety of MSJ-0011 in Inducing Ovulation in Anovulatory or Oligo-ovulatory Japanese Women

    Not yet reported Merck KGaA, Darmstadt, Germany 81 participants Est. completion 2014-12 6 sites
    Other conditions: Anovulation, Oligo-ovulation, Hypothalamic-pituitary Dysfunction, Polycystic Ovarian Syndrome
    View official trial listing →
  • Completed NCT NCT01654185

    Dimethyldiguanide Combined With Aromatase Inhibitor (AI) in Metastatic Breast Cancer

    Not yet reported Xichun Hu 60 participants Est. completion 2016-07 1 site
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT01654367

    Research of Zoledronic Acid and Aromatase Inhibitors as Adjuvant Therapy to Breast Cancer

    Not yet reported, Not yet reported Tianjin Medical University 300 participants Est. completion 2013-12 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01655225

    A Study of LY3023414 in Participants With Advanced Cancer

    Not yet reported Eli Lilly and Company 156 participants Est. completion 2022-02-02 8 sites
    Other conditions: Advanced Cancer, Metastatic Cancer, Non-Hodgkin's Lymphoma, Metastatic Breast Cancer, Malignant Mesothelioma, Non-small Cell Lung Cancer
    View official trial listing →
  • Terminated NCT NCT01656434

    Study of the Contraceptive Efficacy and Safety of a NOMAC-E2 Combined Oral Contraceptive (COC)(P06448)

    Not yet reported Organon and Co 3173 participants Est. completion 2014-02-12
    Other conditions: Contraception
    View official trial listing →
  • Withdrawn NCT NCT01658176

    Study Of PF-04691502 (PI3K/mTOR Inhibitor) In Combination With Exemestane Compared With Exemestane Alone In Patients With Advanced Breast Cancer

    Not yet reported Pfizer Est. completion 2015-04
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Status unknown NCT NCT01659008

    Estradiol vs Lysteda in Treatment of Heavy Menstrual Bleeding

    Not yet reported Kay I Waud MD PhD 100 participants Est. completion 2016-03 2 sites
    Other conditions: Menstrual Cycle and Uterine Bleeding Disorders
    View official trial listing →
  • Status unknown NCT NCT01666171

    Studying Changes in Breast Density in Patients With Early-Stage Breast Cancer Treated With Metformin Hydrochloride or Placebo on CAN-NCIC-MA.32

    Cancer and Leukemia Group B 458 participants
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT01668056

    Synchronization of Ovarian Stimulation for in Vitro Fertilization With Follicular Wave Emergence

    Not yet reported University of Sao Paulo General Hospital 30 participants Est. completion 2014-12 1 site
    Other conditions: Infertility
    View official trial listing →
  • Completed NCT NCT01668446

    Effect of Adding Sildenafil to Protocol of Endometrial Preparation in Outcome of Frozen-thawed Embryo Transfer Cycles

    Not yet reported farzaneh hojjat 2 participants Est. completion 2011-02 1 site
    Other conditions: Endometrial Preparation, Frozen Embryo Transfer
    View official trial listing →
  • Completed NCT NCT01669291

    Effect of GnRH Antagonist vs Agonist Long on IVF Outcome, Peak Estradiol Level,and Duration of Stimulation

    Not yet reported Main Line Fertility Center 43 participants Est. completion 2014-05 1 site
    Other conditions: Fertility
    View official trial listing →
  • Completed NCT NCT01669343

    Aromatase Inhibitor Host Factors Study

    Not yet reported Samuel Lunenfeld Research Institute, Mount Sinai Hospital 121 participants Est. completion 2016-12 3 sites
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Completed NCT NCT01670656

    A Study to Evaluate the Effect of Contraceptive Vaginal Rings on Primary Dysmenorrhea (P08257/MK-8175A/MK-8342B-057)

    Not yet reported Organon and Co 439 participants Est. completion 2013-09-12
    Other conditions: Dysmenorrhea
    View official trial listing →
  • Completed NCT NCT01670877

    Neratinib +/- Fulvestrant in Metastatic HER2 Non-amplified But HER2 Mutant Breast Cancer

    Not yet reported Washington University School of Medicine 56 participants Est. completion 2021-03-11 17 sites
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Active, not recruiting NCT NCT01674140

    S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer

    Not yet reported SWOG Cancer Research Network 1939 participants Est. completion 2030-01 1459 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01686828

    T-IR- Study to Understand the Effects of Testosterone and Estrogen on the Body's Response to the Hormone Insulin

    Not yet reported, Not yet reported University of Washington 53 participants Est. completion 2017-12 1 site
    Type 2 diabetes Other conditions: Insulin Resistance, Obesity, Androgen Deficiency, Metabolic Disease
    View official trial listing →
  • Withdrawn NCT NCT01691976

    Mild Cognitive Impairment in Men Following Androgen Deprivation

    Not yet reported Imperial College London Est. completion 2013-12 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT01694225

    Adherence Rate of Monthly Bubble Package Among Patients Prescribed Adjuvant Endocrine Therapy in Breast Cancer Survivors

    Not yet reported University of Louisville 87 participants Est. completion 2018-01-28 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT01698164

    Multi-centre Clinical Trial on Hormone Replacement Treatment in China

    Not yet reported Peking Union Medical College Hospital 1200 participants 1 site Stand-alone
    Cardiovascular disease Other conditions: Menopausal Syndrome, Osteoporosis, Breast Cancer
    View official trial listing →
  • Completed NCT NCT01698918

    Open-label, Phase II, Study of Everolimus Plus Letrozole in Postmenopausal Women With ER+, HER2- Metastatic or Locally Advanced Breast Cancer

    Not yet reported Novartis Pharmaceuticals 202 participants Est. completion 2021-01-13 52 sites
    Other conditions: Hormone Receptor Positive Breast Cancer
    View official trial listing →
  • Completed NCT NCT01701050

    Characterization of Circulating Tumor Cells (CTC) From Patients With Metastatic Breast Cancer Using the CTC-Endocrine Therapy Index

    Janssen Diagnostics, LLC 121 participants Est. completion 2016-11-10 20 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT01705249

    Bleeding Profile With Continuous Hormone Replacement Therapy of Activelle® in Postmenopausal Women

    Not yet reported Novo Nordisk A/S 191 participants Est. completion 2003-06-06 19 sites
    Other conditions: Menopause, Healthy
    View official trial listing →
  • Completed NCT NCT01709318

    A Dose-Finding Study to Evaluate Ovarian Function and Vaginal Bleeding in Next Generation Rings (P06109/MK-8175A/MK-8342B-012)

    Not yet reported Organon and Co 666 participants Est. completion 2013-10-22
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT01709942

    Use of Degarelix in Controlled Ovarian Hyperstimulation (COH) Protocol for Women With PoliCystic Ovarian Syndrome (PCOS)

    Not yet reported Centre for Endocrinology and Reproductive Medicine, Italy 80 participants Est. completion 2015-12 1 site
    Other conditions: PCOS, OHSS, INFERTILITY
    View official trial listing →
  • Withdrawn NCT NCT01714128

    FES-PET for Patients Treated on NCI Protocol 8762

    Not yet reported Washington University School of Medicine Est. completion 2015-12 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01714193

    A Study to Assess the Effects of Canagliflozin (JNJ-28431754) on the Pharmacokinetics and Safety of an Oral Contraceptive in Healthy Volunteers

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 30 participants Est. completion 2008-03
    Other conditions: Healthy
    View official trial listing →
  • Withdrawn NCT NCT01723579

    Efficacy and Safety of Oral NOMAC-E2 in Indian Women (P07057/MK-8175A-017)

    Not yet reported Organon and Co Est. completion 2015-05
    Other conditions: Contraception
    View official trial listing →
  • Active, not recruiting NCT NCT01723774

    PD 0332991 and Anastrozole for Stage 2 or 3 Estrogen Receptor Positive and HER2 Negative Breast Cancer

    Not yet reported Washington University School of Medicine 84 participants Est. completion 2027-11-07 4 sites
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Completed NCT NCT01723917

    Phytoserms for Menopause Symptoms and Age-Associated Memory Decline

    Not yet reported University of Southern California 71 participants Est. completion 2015-01 1 site
    Other conditions: Hot Flashes, Memory Loss
    View official trial listing →
  • Withdrawn NCT NCT01724242

    Vaginal DHEA for Women After Breast Cancer

    Not yet reported, Not yet reported Hadassah Medical Organization Est. completion 2014-12 1 site
    Other conditions: Vaginal Dryness, Breast Cancer, Urinary Incontinence, Quality of Life, Sexual Satisfaction
    View official trial listing →
  • Completed NCT NCT01724658

    Effectiveness of Testosterone Undecanoate to Improve Sexual Function in Postmenopausal Women

    Not yet reported Chulalongkorn University 70 participants Est. completion 2013-05 1 site
    Other conditions: Female Sexual Dysfunction
    View official trial listing →
  • Completed NCT NCT01726127

    Green Vegetables and Women's Health

    Not yet reported University of Wisconsin, Madison 66 participants Est. completion 2015-09 1 site
    Other conditions: Dietary Modification
    View official trial listing →
  • Completed NCT NCT01738152

    Non-Hormonal Vaginal Moisturizer in Hormone-Receptor Positive Postmenopausal Cancer Survivors Experiencing Estrogen Deprivation Symptoms on Vulvovaginal Health

    Not yet reported Memorial Sloan Kettering Cancer Center 106 participants Est. completion 2021-07-21 1 site Stand-alone
    Other conditions: Breast Cancer, Endometrial Cancer
    View official trial listing →
  • Completed NCT NCT01740427

    A Study of Palbociclib (PD-0332991) + Letrozole vs. Letrozole For 1st Line Treatment Of Postmenopausal Women With ER+/HER2- Advanced Breast Cancer (PALOMA-2)

    Not yet reported Pfizer 666 participants Est. completion 2023-11-09 305 sites
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Completed NCT NCT01741974

    Study of Anti-atherosclerotic and Estrogen-like Activity of Karinat in Perimenopausal Women

    Not yet reported Institute for Atherosclerosis Research, Russia 340 participants Est. completion 2012-10
    Other conditions: Menopausal Syndrome, Atherosclerosis
    View official trial listing →
  • Completed NCT NCT01743560

    An Open Label Study of Postmenopausal Women With Oestrogen Receptor Positive Locally Advanced or Metastatic Breast Cancer Treated With Everolimus (RAD001) With Exemestane, With Exploratory Epigenetic Marker Analysis

    Not yet reported Novartis Pharmaceuticals 52 participants Est. completion 2016-08-15 11 sites
    Other conditions: Oestrogen Receptor Positive Advanced Breast Cancer
    View official trial listing →
  • Completed NCT NCT01746732

    A Study of Evacetrapib in Healthy Female Participants

    Not yet reported Eli Lilly and Company 23 participants Est. completion 2013-05 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Terminated NCT NCT01753102

    Efficacy and Safety Of Spil's Estradiol Vaginal Tablet

    Not yet reported Sun Pharmaceutical Industries Limited 49 participants Est. completion 2013-04-30 1 site
    Other conditions: Vulvar Atrophy, Vaginal Atrophy
    View official trial listing →
  • Withdrawn NCT NCT01757327

    LDE225 in Treating Patients With Stage II-III Estrogen Receptor- and HER2-Negative Breast Cancer

    Not yet reported Washington University School of Medicine Est. completion 2019-12
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Withdrawn NCT NCT01763541

    Study of the Effect of Testosterone and Estradiol on NP Responses to Acute and Chronic Salt Loading

    Not yet reported Massachusetts General Hospital Est. completion 2016-02 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Status unknown NCT NCT01768247

    HCG (Human Chorionic Gonadotropin) Priming for Thin Endometrium in IVF (in Vitro Fertilization)

    Not yet reported Universitair Ziekenhuis Brussel 15 participants Est. completion 2014-01 1 site Stand-alone
    Other conditions: Endometrial Thickness, Pregnancy Outcome
    View official trial listing →
  • Terminated NCT NCT01776008

    Akt Inhibitor MK-2206 and Anastrozole With or Without Goserelin Acetate in Treating Patients With Stage II-III Breast Cancer

    Not yet reported National Cancer Institute (NCI) 16 participants Est. completion 2015-05-05 8 sites
    Other conditions: Estrogen Receptor Positive, HER2/Neu Negative, Recurrent Breast Carcinoma, Stage IIA Breast Cancer, Stage IIB Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer
    View official trial listing →
  • Completed NCT NCT01778985

    Effect of Preoperative Estrogen Treatment on Connective Tissues of the Pelvic Floor

    Not yet reported University of Texas Southwestern Medical Center 30 participants Est. completion 2013-04 1 site
    Other conditions: Pelvic Organ Prolapse, Menopause
    View official trial listing →
  • Completed NCT NCT01779947

    Study to Evaluate the Safety and Bioequivalence of Estradiol Vaginal Inserts, 10 mcg and Vagifem® 10 mcg and Compare to Placebo

    Not yet reported Amneal Pharmaceuticals, LLC 519 participants Est. completion 2012-12 25 sites
    Other conditions: Atrophic Vaginitis Due to Menopause
    View official trial listing →
  • Status unknown NCT NCT01780558

    A Study:the Different Outcomes Between Natural Cycle and Hormone Replacement Cycle in FET

    Not yet reported Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 600 participants Est. completion 2015-01 1 site
    Other conditions: Infertility
    View official trial listing →
  • Status unknown NCT NCT01780610

    The Effects of Two Endometrium Preparation Protocols in Frozen-thawed Embryo Transfer in Women With Irregular Cycles

    Not yet reported Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 670 participants Est. completion 2015-01 1 site
    Other conditions: Infertility
    View official trial listing →
  • Completed NCT NCT01783444

    A Phase II Study of Everolimus in Combination With Exemestane Versus Everolimus Alone Versus Capecitabine in Advance Breast Cancer.

    Not yet reported Novartis Pharmaceuticals 309 participants Est. completion 2018-07-30 83 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01785992

    A Study of the Safety and Effectiveness of Irosustat When Added to an AI in ER+ve Locally Advanced or Metastatic Breast Cancer.

    Not yet reported Imperial College London 27 participants Est. completion 2014-12 9 sites
    Other conditions: Locally Advanced Breast Cancer, Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT01790282

    Is Adding E2 to P4 Luteal Support In High Responder Long Gn-RH Agonist ICSI Cycles Detrimental to Outcome? RCT

    Not yet reported Mansoura Integrated Fertility Center 220 participants Est. completion 2015-03 1 site
    Other conditions: IVF, Infertility
    View official trial listing →
  • Status unknown NCT NCT01793038

    Clomiphene Citrate Plus uFSH Versus Aromatase Inhibitor Plus uFSH in Clomiphene Resistant Infertile PCOS Women

    Not yet reported Mansoura Integrated Fertility Center 160 participants Est. completion 2014-09 1 site
    Other conditions: Polycystic Ovary Syndrome, Infertility
    View official trial listing →
  • Completed NCT NCT01797120

    Study of Fulvestrant +/- Everolimus in Post-Menopausal, Hormone-Receptor + Metastatic Breast Ca Resistant to AI

    Not yet reported PrECOG, LLC. 131 participants Est. completion 2017-09-12 25 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Terminated NCT NCT01798836

    Oestradiol Pre-treatment in an Ultrashort Flare GnRH Agonist/GnRH Antagonist Protocol in Poor Responders Undergoing IVF

    Not yet reported, Not yet reported National and Kapodistrian University of Athens 17 participants Est. completion 2015-02 1 site
    Other conditions: Infertility
    View official trial listing →
  • Withdrawn NCT NCT01805817

    Comparison of Levonorgestrel Intrauterine System, Copper T Intrauterine Device and Oral Contraceptives on Life Quality

    Not yet reported Istanbul Training and Research Hospital 1 site
    Other conditions: Contraceptive Methods Comparison
    View official trial listing →
  • Completed NCT NCT01810315

    Influence of Reproductive Cycle and Menopause on HIV-1 Infection and TFV Gel Activity

    Not yet reported CONRAD 40 participants Est. completion 2014-10 1 site
    Other conditions: HIV Prevention
    View official trial listing →
  • Completed NCT NCT01813162

    In Vivo Drug Interaction Pharmacokinetic Study of Tenofovir 1% Gel and Three Commonly Used Vaginal Products

    Not yet reported CONRAD 101 participants Est. completion 2014-12 2 sites Stand-alone
    Other conditions: HIV Prevention
    View official trial listing →
  • Completed NCT NCT01814397

    Pilot Study to Evaluate the Effect of Aromatase Inhibitor Therapy on Pain Threshold in Breast Cancer Patients

    University of Michigan Rogel Cancer Center 50 participants Est. completion 2013-02 1 site
    Other conditions: Breast Cancer, Pain, Arthralgia
    View official trial listing →
  • Withdrawn NCT NCT01814865

    Anti-Proliferative Effects and Genomic Alterations of Abiraterone Acetate Compared to an Aromatase Inhibitor in Post-menopausal HR+ Operable Breast Cancer

    Not yet reported British Columbia Cancer Agency Est. completion 2013-12 4 sites
    Other conditions: Post-menopausal ER+ Stage I-IIIA Primary Operable Breast Cancer
    View official trial listing →
  • Completed NCT NCT01816139

    Multicenter Study to Evaluate Safety and Efficacy of WC3011 (Estradiol Vaginal Cream) in Postmenopausal Women

    Not yet reported Warner Chilcott 576 participants Est. completion 2013-11-19 48 sites
    Other conditions: Vulvovaginal Atrophy
    View official trial listing →
  • Completed NCT NCT01817400

    Mediators of Abnormal Reproductive Function in Obesity (MARO)

    Not yet reported University of Colorado, Denver 10 participants Est. completion 2014-12 1 site Stand-alone
    Other conditions: Infertility, Female, Obesity
    View official trial listing →
  • Completed NCT NCT01817530

    Safety and Efficacy in Premenopausal Women With Heavy Menstrual Bleeding (HMB) Associated With Uterine Fibroids (UF)

    Not yet reported AbbVie 571 participants Est. completion 2015-12
    Other conditions: Heavy Uterine Bleeding, Uterine Fibroids
    View official trial listing →
  • Completed NCT NCT01822288

    The Impact of Hormone Therapy on Lower Urinary Tract Symptoms, Sexual Function and Psychosomatic Disorder

    Not yet reported Far Eastern Memorial Hospital 125 participants Est. completion 2021-08-26 1 site
    Other conditions: Menopausal Syndromes
    View official trial listing →
  • Terminated NCT NCT01823835

    A Study of GDC-0810 Single Agent or in Combination With Palbociclib and/or a Luteinizing Hormone-Releasing Hormone (LHRH) Agonist in Women With Locally Advanced or Metastatic Estrogen Receptor Positive Breast Cancer

    Not yet reported, Not yet reported Genentech, Inc. 152 participants Est. completion 2020-03-13 14 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01831076

    Preoperative Hormone Therapy for Postmenopausal Women With ER+ Clinical Stage T2-4 Tumors

    Not yet reported University of Colorado, Denver 36 participants Est. completion 2022-01-06 1 site
    Other conditions: Breast Cancer, Stage II Breast Cancer, Stage III Breast Cancer
    View official trial listing →
  • Completed NCT NCT01833663

    Effectiveness and Safety Study of Solifenacin Succinate and Solifenacin Succinate + Estrogen to Treat OAB in Postmenopausal Women

    Not yet reported Peking Union Medical College Hospital 200 participants Est. completion 2013-10 1 site Stand-alone
    Other conditions: Overactive Bladder, Postmenopausal Disorder, Urination Disorders
    View official trial listing →
  • Completed NCT NCT01833858

    Human Chorionic Gonadotrophin in an Antagonist Protocol

    Not yet reported, Not yet reported Cairo University 60 participants Est. completion 2015-01 1 site
    Other conditions: Infertility
    View official trial listing →
  • Terminated NCT NCT01842217

    Validation of [18F]FES for Imaging of Brain Estrogen Receptors

    Not yet reported University Medical Center Groningen 3 participants Est. completion 2016-01 1 site
    Other conditions: Psychiatric/Mood Disorder | Patient, Estrogen Receptor Levels, Premenopausal, Postmenopausal
    View official trial listing →
  • Completed NCT NCT01843166

    Vaginal Estrogen With Pessary Treatment

    Not yet reported London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 150 participants Est. completion 2016-12 1 site
    Other conditions: Vaginal Infection, Urinary Tract Infection, Quality of Life
    View official trial listing →
  • Completed NCT NCT01845649

    Study to Evaluate Safety and Efficacy of WC3011 (Estradiol Vaginal Cream) in Postmenopausal Women With Dyspareunia

    Not yet reported Warner Chilcott 550 participants Est. completion 2013-11-20 57 sites
    Other conditions: Vulvovaginal Atrophy
    View official trial listing →
  • Completed NCT NCT01846728

    Effects of Estrogen Deficiency on Energy Expenditure

    Not yet reported University of Colorado, Denver 6 participants Est. completion 2016-10 1 site Stand-alone
    Other conditions: Obesity
    View official trial listing →
  • Status unknown NCT NCT01850095

    The Influence of Peripheral Androgen Conversion at Women Adult Acne

    Not yet reported Marco Alexandre Dias da Rocha 60 participants Est. completion 2015-01 1 site
    Other conditions: Acne, Quality of Life
    View official trial listing →
  • Completed NCT NCT01855971

    "Using Epigallocatechin Gallate (EGCG) and Cognitive Training to Modulate Cognitive Performance in Patients With Fragile X Syndrome" (TESFX)

    Not yet reported Parc de Salut Mar 44 participants Est. completion 2015-10-31 1 site
    Other conditions: Fragile X Syndrome
    View official trial listing →
  • Terminated NCT NCT01856036

    Anti-Tumor Immunity Induced by Cryoablation of Invasive Breast Cancers

    Not yet reported Saint John's Cancer Institute 2 participants Est. completion 2014-10 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01862835

    Impact of Estradiol Addback

    Not yet reported Mayo Clinic 43 participants Est. completion 2018-12-30 1 site Stand-alone
    Other conditions: Normal Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT01873170

    Quantification of Immune Cells in Women Using Contraception (CHIC II)

    University of Pittsburgh 326 participants Est. completion 2020-10 1 site
    Obstructive sleep apnea Other conditions: HIV, Contraception
    View official trial listing →
  • Completed NCT NCT01874184

    Group-Based Lifestyle Intervention in Measuring Biomarker Levels in Participants at High Risk for Breast Cancer

    Not yet reported University of Washington 17 participants 1 site
    Other conditions: Atypical Ductal Breast Hyperplasia, Atypical Lobular Breast Hyperplasia, BRCA1 Mutation Carrier, BRCA2 Mutation Carrier, Ductal Breast Carcinoma in Situ, Lobular Breast Carcinoma in Situ
    View official trial listing →
  • Terminated NCT NCT01874756

    The Efficacy and Safety of a Selective Estrogen Receptor Beta Agonist (LY500307) for Negative Symptoms and Cognitive Impairment Associated With Schizophrenia

    Not yet reported Indiana University 95 participants Est. completion 2017-12 4 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT01880086

    Clomiphene Citrate for the Treatment of Low Testosterone Associated With Chronic Opioid Pain Medication Administration

    Not yet reported Weill Medical College of Cornell University 13 participants Est. completion 2017-11 1 site
    Other conditions: Hypogonadism, Opioid-Related Disorders, Male Infertility
    View official trial listing →
  • Completed NCT NCT01881230

    Evaluate Risk/Benefit of Nab Paclitaxel in Combination With Gemcitabine and Carboplatin Compared to Gemcitabine and Carboplatin in Triple Negative Metastatic Breast Cancer (or Metastatic Triple Negative Breast Cancer)

    Not yet reported, Not yet reported Celgene 191 participants Est. completion 2016-10-28 140 sites
    Other conditions: Breast Tumor, Breast Cancer, Cancer of the Breast, Estrogen Receptor- Negative Breast Cancer, HER2- Negative Breast Cancer, Progesterone Receptor- Negative Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer, Triple-negative Breast Cancer, Triple-negative Metastatic Breast Cancer, Metastatic Breast Cancer
    View official trial listing →
  • Terminated NCT NCT01886794

    Hormonal Status on Blood Flow and Tissue in Pelvic Organ Prolapse

    Not yet reported The University of Texas Medical Branch, Galveston 7 participants Est. completion 2023-12-11 1 site Stand-alone
    Other conditions: Pelvic Floor Disorders
    View official trial listing →
  • Completed NCT NCT01896726

    A Study of Baricitinib and Birth Control Pills in Healthy Females

    Not yet reported Eli Lilly and Company 20 participants Est. completion 2013-10 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT01899079

    A Prospective Observational Study of Clinical Outcomes for the NanoString® Technologies Prosigna Gene Signature Assay

    NanoString Technologies, Inc. 217 participants Est. completion 2014-07 7 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01902264

    Study of Treatment With the Combination of Drospirenone Plus Ethinyl Estradiol Plus Levomefolate Calcium in Mexican Women Seeking Contraception

    Not yet reported Bayer 34 participants Est. completion 2015-02 1 site
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT01903031

    Evaluating Pharmacokinetic Interactions With Vaginal Ring Contraceptives and ART

    Not yet reported Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 84 participants Est. completion 2016-10-10 21 sites
    Other conditions: HIV-1 Infection
    View official trial listing →
  • Status unknown NCT NCT01907438

    Transformation Potential of E2 Exposed Breast Cancer Susceptibility Gene Mutation Heterozygous Epithelial Breast Cells

    Hadassah Medical Organization 30 participants Est. completion 2015-09 1 site
    Other conditions: BRCA1 Gene Mutation, BRCA2 Gene Mutation
    View official trial listing →
  • Completed NCT NCT01909141

    Ovulation Induction in Women With Clomiphene Citrate Resistant PCOS

    Not yet reported Cairo University 100 participants Est. completion 2014-04 1 site
    Other conditions: Polycystic Ovary Syndrome, Infertility
    View official trial listing →
  • Completed NCT NCT01916122

    Fluorestradiol (FES) PET/CT for Imaging Estrogen Receptor Status

    Not yet reported Memorial Sloan Kettering Cancer Center 54 participants Est. completion 2024-04-03 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT01918306

    GDC-0941 and Cisplatin in Treating Patients With Androgen Receptor-Negative Triple Negative Metastatic Breast Cancer

    Not yet reported, Not yet reported Vanderbilt-Ingram Cancer Center 11 participants Est. completion 2015-04 16 sites
    Other conditions: Estrogen Receptor Negative Breast Cancer, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast, Triple Negative Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer, Triple-negative Breast Cancer
    View official trial listing →
  • Completed NCT NCT01921374

    Mother-caregivers of Children With Duchenne Muscular Dystrophy

    Not yet reported Monica Levy Andersen 60 participants Est. completion 2014-07 1 site
    Other conditions: Other Diseases or Conditions
    View official trial listing →
  • Completed NCT NCT01923298

    Estradiol Levels in Patients Treated With Estring

    Not yet reported University of Arizona 14 participants Est. completion 2019-04-24 1 site
    Other conditions: Estrogen Levels Among Breast Cancer Patients
    View official trial listing →
  • Status unknown NCT NCT01924078

    Capecitabine Metronomic Chemotherapy Plus Aromatase Inhibitor for Postmenopausal Hormone Receptor Positive Breast Cancer

    Not yet reported Fudan University 100 participants Est. completion 2015-06 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT01926210

    Comparison of Ovarian Mild Stimulation and Controlled Ovarian Stimulation in Poor Ovarian Responders

    Not yet reported Huang Rui 500 participants Est. completion 2016-09 1 site
    Other conditions: Infertility
    View official trial listing →
  • Completed NCT NCT01928186

    FLT PET in Measuring Treatment Response in Patients With Newly Diagnosed Estrogen Receptor-Positive, HER2-Negative Stage I-III Breast Cancer

    Not yet reported University of Washington 28 participants Est. completion 2015-07-20 1 site
    Other conditions: Estrogen Receptor Positive, HER2/Neu Negative, Male Breast Carcinoma, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage IIA Breast Cancer, Stage IIB Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer
    View official trial listing →
  • Completed NCT NCT01933204

    Acupuncture for Relieving Perimenopausal Symptoms

    Not yet reported, Not yet reported Chengdu University of Traditional Chinese Medicine 220 participants Est. completion 2015-08 2 sites
    Other conditions: Perimenopause
    View official trial listing →
  • Completed NCT NCT01940653

    Optimal Length of Progesterone Supplementation Before the Transfer of Cryopreserved (Frozen)-Thawed Day 3 Embryos in an Artificial Cycle With Exogenous Estrogen and Progesterone

    Not yet reported Universitair Ziekenhuis Brussel 300 participants Est. completion 2017-12 1 site
    Other conditions: Progesterone Supplementation
    View official trial listing →
  • Withdrawn NCT NCT01941134

    Changes in Oral Contraceptive Hormones After Gastric Bypass Surgery

    Not yet reported Johns Hopkins University Est. completion 2017-12-06 1 site
    Other conditions: Bariatric Surgery Candidate, Contraception
    View official trial listing →
  • Terminated NCT NCT01941615

    Effect of BI 207127 + Faldaprevir on Blood Levels of Oral Contraceptives Containing Ethinylestradiol and Levonorgestrel

    Not yet reported Boehringer Ingelheim 18 participants Est. completion 2014-01 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01942135

    Palbociclib (PD-0332991) Combined With Fulvestrant In Hormone Receptor+ HER2-Negative Metastatic Breast Cancer After Endocrine Failure (PALOMA-3)

    Not yet reported Pfizer 521 participants Est. completion 2022-09-28 247 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT01942668

    A Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms

    Not yet reported TherapeuticsMD 1845 participants Est. completion 2016-10-28 119 sites
    Other conditions: Menopause
    View official trial listing →
  • Completed NCT NCT01942759

    The Prognostic Value of FDG PET/CT and Diffusion-weighed Imaging on Breast Cancer

    Bagcilar Training and Research Hospital 43 participants Est. completion 2014-06 1 site
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Completed NCT NCT01943812

    Substituted Frozen Embryo Transfer Cycles With GnRH-agonist Supplementation

    Not yet reported Peter Humaidan 287 participants Est. completion 2020-04 2 sites
    Other conditions: Pregnancy Loss, Frozen Embryo Transfer
    View official trial listing →
  • Completed NCT NCT01950182

    Trastuzumab Combined With Chemotherapy or Endocrine Therapy to Treat Metastatic Luminal B2 Breast Cancer

    Not yet reported Sun Yat-sen University 392 participants Est. completion 2020-05-31 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01953211

    Oral Contraceptive Hormone-free Interval Pituitary/ Ovarian Activity

    University of Southern California 64 participants 1 site
    Other conditions: Hypothalamic-pituitary-ovarian Axis, Gonadotropins, Ethinyl Estradiol, Contraceptive Efficacy
    View official trial listing →
  • Withdrawn NCT NCT01953445

    Paclitaxel and BKM120 Before Surgery in Treating Patients With Stage II or III Estrogen Receptor-Positive and HER2-Negative Breast Cancer

    Not yet reported Washington University School of Medicine Est. completion 2015-07
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Active, not recruiting NCT NCT01953588

    Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing Surgery

    Not yet reported Alliance for Clinical Trials in Oncology 1473 participants Est. completion 2027-04-01 860 sites
    Other conditions: Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Invasive Ductal Breast Carcinoma, Invasive Lobular Breast Carcinoma, Recurrent Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer
    View official trial listing →
  • Withdrawn NCT NCT01953809

    A Pharmacokinetics, Pharmacodynamics, and Safety Study of an Oral Contraceptive Containing Norethindrone and Ethinyl Estradiol When Co-administered With GSK1322322 in Healthy Adult Women

    Not yet reported GlaxoSmithKline Est. completion 2015-03
    Other conditions: Infections, Bacterial
    View official trial listing →
  • Terminated NCT NCT01953926

    Basket Study of Neratinib in Participants With Solid Tumors Harboring Somatic HER2 or EGFR Exon 18 Mutations

    Not yet reported Puma Biotechnology, Inc. 582 participants Est. completion 2023-01-02 60 sites
    Other conditions: Solid Tumors Harboring Somatic HER2 or EGFR Exon 18 Mutations
    View official trial listing →
  • Completed NCT NCT01958073

    Vaginal Estrogen for the Prevention of Recurrent Urinary Tract Infection in Postmenopausal Women

    Not yet reported University of California, San Diego 35 participants Est. completion 2017-12 2 sites Stand-alone
    Other conditions: Recurrent Urinary Tract Infection
    View official trial listing →
  • Terminated NCT NCT01963403

    Treatment of Unacceptable Bleeding Patterns in ETG Implant Users With an Oral Contraceptive

    Not yet reported University of California, Davis 26 participants Est. completion 2015-09 2 sites
    Other conditions: Abnormal Uterine Bleeding, Unspecified, Uterine Bleeding Heavy
    View official trial listing →
  • Completed NCT NCT01968135

    Does Concomitant Use of Combined Oral Hormonal Steroids Stop Bleeding in Women Using Etonogestrel Implants (Implanon/Nexplanon®)?: A Randomized Controlled Study

    Not yet reported University of Colorado, Denver 32 participants Est. completion 2014-11 1 site
    Other conditions: Uterine Hemorrhage, Contraception
    View official trial listing →
  • Completed NCT NCT01971723

    Multi-ingredient Supplement for Strength and Power

    Not yet reported Florida State University 32 participants Est. completion 2015-12 1 site
    Other conditions: Supplement
    View official trial listing →
  • Completed NCT NCT01972984

    Feasibility Study of Presurgical Hormone Therapy (Anastrozole) in Breast Cancer Patients

    Not yet reported Ottawa Hospital Research Institute 20 participants Est. completion 2014-08 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01973816

    MEdical Versus SUrgical Treatments of Rectal Endometriosis

    Not yet reported University Hospital, Rouen 78 participants Est. completion 2022-10-11 11 sites
    Other conditions: Endometriosis
    View official trial listing →
  • Completed NCT NCT01980680

    The Exogenous Progesterone Free Luteal Phase After GnRHa Trigger - a Pilot Study in Normo-responder IVF Patients

    Not yet reported Peter Humaidan 50 participants Est. completion 2020-05 1 site
    Other conditions: Infertility
    View official trial listing →
  • Active, not recruiting NCT NCT01984138

    REVIVE: Replens Versus Intra-Vaginal Estrogen for the Treatment of Vaginal Dryness on Aromatase Inhibitor Therapy

    Not yet reported Polly A. Niravath, MD 33 participants Est. completion 2026-06 1 site Stand-alone
    Other conditions: Estrogen Receptor Positive Breast Cancer, Breast Cancer
    View official trial listing →
  • Completed NCT NCT01984320

    Cabergoline and Coasting to Prevent OHSS

    Not yet reported Cairo University 300 participants Est. completion 2015-07 1 site
    Other conditions: OHSS
    View official trial listing →
  • Completed NCT NCT01986569

    Diagnostic Accuracy and Safety Study of FES PET/CT in Assessment of ER Status of Recurrent or Metastatic Breast Cancer

    Not yet reported Asan Medical Center 93 participants Est. completion 2016-11 1 site
    Other conditions: Recurrent Breast Cancer, Stage IV Breast Cancer
    View official trial listing →
  • Withdrawn NCT NCT01986764

    E2 and LDX for the Treatment of Cognitive Complaints After Oophorectomy

    Not yet reported University of Pennsylvania Est. completion 2013-07-01 1 site
    Other conditions: Planned RRSO
    View official trial listing →
  • Completed NCT NCT01988324

    AR and ER Imaging in Metastatic Breast Cancer

    Not yet reported University Medical Center Groningen 24 participants Est. completion 2015-09 2 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT01989780

    Bevacizumab Plus Paclitaxel Optimization Study With Interventional Aintenance Endocrine Therapy in Breast Cancer

    Not yet reported Japan Breast Cancer Research Group 160 participants Est. completion 2019-06 1 site
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT01992952

    Fulvestrant +/- Akt Inhibition in Advanced Aromatase Inhibitor Resistant Breast Cancer

    Not yet reported, Not yet reported Velindre NHS Trust 149 participants Est. completion 2025-12-31 21 sites
    Other conditions: Estrogen Receptor Positive Breast Cancer
    View official trial listing →
  • Completed NCT NCT01997333

    Study of Glembatumumab Vedotin (CDX-011) in Patients With Metastatic, gpNMB Over-Expressing, Triple Negative Breast Cancer

    Not yet reported Celldex Therapeutics 327 participants Est. completion 2018-08-07 140 sites
    Other conditions: Metastatic gpNMB Over-expressing Triple Negative Breast Cancer
    View official trial listing →
  • Completed NCT NCT01999569

    The Role of Estrogen in Luteinizing Hormone Surge and Ovulation

    Not yet reported Wake Forest University Health Sciences 10 participants Est. completion 2008-05 1 site
    Other conditions: Ovulation Disorder, Ovarian Cysts
    View official trial listing →
  • Status unknown NCT NCT02000193

    Maintenance Hormone Therapy for Postmenopausal HR Positive Advanced Breast Cancer

    Not yet reported Sun Yat-sen University 58 participants Est. completion 2018-12 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT02000596

    1303GCC: Trastuzmab & Pertuzumab With Hormonal Therapy or Chemotherapy in Women Aged 60 and Over.

    Not yet reported University of Maryland, Baltimore 2 participants Est. completion 2016-01 1 site
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT02002403

    Efficacy and Safety Study to Evaluate Two Doses of Oral DMI-5207 in Adult Subjects With Diabetic Macular Edema

    Not yet reported Unity Health Toronto 34 participants Est. completion 2012-04
    Other conditions: Diabetic Macular Edema
    View official trial listing →
  • Completed NCT NCT02007512

    Efficacy and Safety Study of Enzalutamide in Combination With Exemestane in Patients With Advanced Breast Cancer

    Not yet reported Pfizer 247 participants Est. completion 2024-08-23 135 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT02019589

    A Phase 3, Randomized, Three-Cycle, Double-Blind, Placebo-Controlled Study to Evaluate Induction of Secretory Conversion of Endometrium and Withdrawal Bleeding for Secondary Amenorrhea

    Not yet reported TherapeuticsMD 6 participants Est. completion 2014-10-31 22 sites
    Other conditions: Secondary Amenorrhea
    View official trial listing →
  • Status unknown NCT NCT02021097

    Study Evaluating Levonorgestrel and Ethinyl Estradiol for Oral Contraception

    Not yet reported Regenex Pharmaceutical, China 1008 participants Est. completion 2016-02 21 sites
    Other conditions: Oral Contraceptive
    View official trial listing →
  • Completed NCT NCT02026973

    Impact of Endogenous E2 on SSI and GH Rebound

    Not yet reported Mayo Clinic 62 participants Est. completion 2015-11 1 site
    Other conditions: Normal Healthy Volunteers
    View official trial listing →
  • Status unknown NCT NCT02027337

    Hemocoagulation and Lipoperoxidation in Women Using Combined Oral Contraceptives, Correction by Antioxidants

    Not yet reported Tyumen State Medical Academy 200 participants Est. completion 2015-10 1 site
    Other conditions: Polycystic Ovarian Syndrome, Hyperandrogenism, Menstrual Irregularities
    View official trial listing →
  • Completed NCT NCT02028364

    Pet Imaging as a Biomarker in Hormone Refractory postmenopausaL Women

    Not yet reported Jules Bordet Institute 55 participants Est. completion 2021-08-09 5 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT02028507

    Phase III Palbociclib With Endocrine Therapy vs. Capecitabine in HR+/HER2- MBC With Resistance to Aromatase Inhibitors

    Not yet reported Spanish Breast Cancer Research Group 693 participants Est. completion 2021-01-11 37 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT02032797

    Optimal Length of Progesterone Supplementation Before the Transfer of Cryopreserved(Frozen)-Thawed Embryos in an Artificial Cycle With Exogenous Estrogen and Progesterone.

    Not yet reported Universitair Ziekenhuis Brussel 300 participants Est. completion 2019-09 1 site
    Other conditions: Cryopreservation, Embryo Implantation, Progesteron
    View official trial listing →
  • Completed NCT NCT02033512

    TRANSDERMAL HRT RELIEVING POSTMENOPAUSAL SYMPTOMS

    Not yet reported University Potiguar 66 participants Est. completion 2008-04 1 site
    Other conditions: Menopause
    View official trial listing →
  • Completed NCT NCT02036879

    Gender Disparity and Hormones in Cystic Fibrosis

    Not yet reported University of Texas Southwestern Medical Center 55 participants Est. completion 2018-08 2 sites
    Other conditions: Cystic Fibrosis (CF)
    View official trial listing →
  • Completed NCT NCT02038335

    HIV-Target Cell Response in Women Initiating Various Contraceptive Methods in High HIV-Incidence Areas: Zim CHIC

    University of Pittsburgh 451 participants Est. completion 2020-12 1 site
    Obstructive sleep apnea Other conditions: Contraception, HIV, Microbiota
    View official trial listing →
  • Completed NCT NCT02040857

    Palbociclib in Combination With Adjuvant Endocrine Therapy for Hormone Receptor Positive, HER2 Negative Invasive Breast Cancer

    Not yet reported Dana-Farber Cancer Institute 162 participants Est. completion 2024-12-27 10 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT02042196

    Sex Hormones and Atherosclerosis Prevention in Perimenopausal Women

    Not yet reported University of Colorado, Denver 100 participants Est. completion 2016-05-02 1 site Stand-alone
    Other conditions: Menopause, Aging
    View official trial listing →
  • Completed NCT NCT02049957

    Safety and Efficacy Study of Sapanisertib in Combination With Exemestane or Fulvestrant in Postmenopausal Women With Estrogen Receptor Positive/Human Epidermal Growth Factor Receptor 2 Negative (ER+/HER2-) Metastatic Breast Cancer

    Not yet reported Calithera Biosciences, Inc 118 participants Est. completion 2018-06-29 40 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT02057029

    Assessment of the Decision-making Impact of the Breast Cancer Index in Recommending Extended Adjuvant Endocrine Therapy for Patients With Early Stage ER-positive Breast Cancer

    Not yet reported Yale University 96 participants Est. completion 2015-06 1 site
    Other conditions: Breast Cancer, Early Stage Estrogen Receptor (ER) Positive Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT02057133

    A Study of LY2835219 (Abemaciclib) in Combination With Therapies for Breast Cancer That Has Spread

    Not yet reported Eli Lilly and Company 198 participants Est. completion 2026-12 13 sites
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Completed NCT NCT02057536

    The Effect of an Exercise Program in Breast Cancer Patients With Joint Pain While Taking Aromatase Inhibitors.

    Not yet reported Christiana Care Health Services 30 participants Est. completion 2015-03 1 site
    Other conditions: Women With ER Positive Breast Cancer Taking (AI) w Joint Discomfort and Stiffness
    View official trial listing →
  • Completed NCT NCT02069093

    Open-label, Phase II Study of Stomatitis Prevention With a Steroid-based Mouthwash in Post-menopausal Women With Estrogen-receptor-positive (ER+), Human Epidermal Growth Factor Receptor 2 (HER2)- Metastatic or Locally Advanced Breast Cancer

    Not yet reported Novartis Pharmaceuticals 92 participants Est. completion 2016-03 23 sites
    Other conditions: Advanced Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT02072122

    Estrogen and the Outer Eye in Women During Fertility Treatment

    Meir Medical Center 30 participants Est. completion 2014-07
    Other conditions: Dry Eye Syndromes
    View official trial listing →
  • Status unknown NCT NCT02072512

    The Study of Goserelin Plus Fulvestrant Comparing With Goserelin Plus Anastrozole for Advanced Breast Cancer

    Not yet reported Hospital Affiliated to Military Medical Science, Beijing 180 participants Est. completion 2016-12 1 site
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT02077569

    AKT Inhibitor in Oestrogen Positive Breast Cancer

    Not yet reported University of Nottingham 48 participants Est. completion 2017-02-21 11 sites
    Other conditions: Invasive Breast Cancer
    View official trial listing →
  • Completed NCT NCT02080468

    Evaluate the Effect of Ethinyl Estradiol/Norgestimate on the Pharmacokinetics of Lomitapide in Healthy Female Subjects

    Not yet reported Aegerion Pharmaceuticals, Inc. 32 participants Est. completion 2014-04-24 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02086032

    The Effect of Different Types of Progestin on Sleeping of Menopausal Women

    Not yet reported Chiang Mai University 100 participants Est. completion 2015-07 1 site
    Other conditions: Menopausal and Postmenopausal Disorders
    View official trial listing →
  • Status unknown NCT NCT02086318

    A New Algorithm to Predict Ovarian Age

    University Magna Graecia 720 participants Est. completion 2018-06 1 site
    Other conditions: Infertility, Polycystic Ovary Syndrome, Premature Ovarian Failure (POF), Ovarian Cysts, Endometriosis
    View official trial listing →
  • Completed NCT NCT02088684

    Study of LEE011 With Fulvestrant and BYL719 or BKM120 in Advanced Breast Cancer

    Not yet reported Novartis Pharmaceuticals 70 participants Est. completion 2018-04-17 11 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT02088710

    Expectations and Side Effects of Endocrine Therapy in Women With Breast Cancer

    Philipps University Marburg 138 participants Est. completion 2020-02 1 site
    Other conditions: Female Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT02089854

    Adjuvant Endocrine Therapy for Estrogen Receptor-beta Positive Triple Negative Breast Cancer

    Not yet reported Peking Union Medical College Hospital 800 participants 1 site
    Other conditions: Female Breast Cancer
    View official trial listing →
  • Completed NCT NCT02100553

    Study Evaluating Effects of Multiple-Dose Administration of Itraconazole on the Single Dose Pharmacokinetics of Conjugated Estrogens/Bazedoxifene in Non-Obese and Obese Postmenopausal Women

    Not yet reported Pfizer 24 participants Est. completion 2014-06 2 sites
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02103569

    Drug Interaction Study of an OCP (Norethindrone (ND) Acetate and Ethinyl Estradiol (EE))With a Combination of Daclatasvir (DCV) Asunaprevir (ASV) and BMS-791325

    Not yet reported Bristol-Myers Squibb 20 participants Est. completion 2014-07
    Other conditions: Hepatitis C
    View official trial listing →
  • Active, not recruiting NCT NCT02107703

    A Study of Abemaciclib (LY2835219) Combined With Fulvestrant in Women With Hormone Receptor Positive HER2 Negative Breast Cancer

    Not yet reported Eli Lilly and Company 669 participants Est. completion 2027-12 146 sites
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Status unknown NCT NCT02114645

    The Effect of GnRH Agonist Administered in the Luteal Phase on ART Cycle Outcomes

    Not yet reported Zekai Tahir Burak Women's Health Research and Education Hospital 100 participants Est. completion 2015-04 1 site Stand-alone
    Other conditions: Infertility
    View official trial listing →
  • Withdrawn NCT NCT02115594

    Phase 2 Study of Fulvestrant With and Without Entinostat in Postmenopausal Women With ER+ Advanced Breast Cancer

    Not yet reported Syndax Pharmaceuticals Est. completion 2016-06 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT02116803

    An Open Label Multi-center Extension Study to Evaluate Long-term Safety/ Tolerability of Dovitinib in Patients With Solid Tumors Who Continue to Receive Treatment With Dovitinib (TKI258) in Novartis-sponsored Single Agent Dovitinib Studies Which Fulfilled the Requirements for the Primary Objective

    Not yet reported, Not yet reported Novartis Pharmaceuticals 12 participants Est. completion 2016-11-28 9 sites
    Other conditions: Solid Tumors
    View official trial listing →
  • Completed NCT NCT02118636

    Observational Study to Evaluate Mechanisms of Aromatase Inhibitor Associated Musculoskeletal Symptoms

    Lynn Henry 75 participants Est. completion 2015-09 1 site
    Other conditions: Breast Cancer, Arthralgia
    View official trial listing →
  • Completed NCT NCT02122198

    Vascular Mechanisms for the Effects of Loss of Ovarian Hormone Function on Cognition in Women

    Not yet reported University of Colorado, Denver 17 participants Est. completion 2017-09-15 2 sites
    Cardiovascular disease Other conditions: Cognitive Impairment, Executive Dysfunction, Endothelial Dysfunction
    View official trial listing →
  • Completed NCT NCT02123823

    BI 836845 in Estrogen Receptor Positive Metastatic Breast Cancer

    Not yet reported Boehringer Ingelheim 164 participants Est. completion 2021-12-14 38 sites
    Other conditions: Neoplasms
    View official trial listing →
  • Completed NCT NCT02127593

    A Bioequivalence Study of Norgestimate /Ethinyl Estradiol (NGM/EE) Tablets Manufactured at 2 Different Facilities

    Not yet reported Janssen Research & Development, LLC 101 participants Est. completion 2014-09 1 site
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT02129114

    Study to Evaluate the Safety and Efficacy of Dural Repair Patch in Neurosurgical Repairs

    Not yet reported Medprin Regenerative Medical Technologies Co., Ltd. 132 participants Est. completion 2015-05 1 site
    Other conditions: Neurosurgical Repairs
    View official trial listing →
  • Status unknown NCT NCT02132000

    Efficacy and Tolerability of Toremifene or Tamoxifen Therapy in Premenopausal Estrogen and Progesterone Receptor Positive Breast Cancer Patients

    Not yet reported, Not yet reported Fengxi Su 3036 participants Est. completion 2020-05 1 site
    Other conditions: Breast Cancer Patients in Premenopausal, Estrogen and/or Progesterone Receptor Positive
    View official trial listing →
  • Completed NCT NCT02137083

    A Trial Comparing Docetaxel Plus Fulvestrant With Docetaxel in Metastatic Breast Cancer

    Not yet reported Fudan University 22 participants Est. completion 2017-07 1 site
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Terminated NCT NCT02137837

    S1222 Trial (Everolimus, Anastrozole and Fulvestrant) in Post-Menopausal Stage IV Breast Cancer

    Not yet reported SWOG Cancer Research Network 37 participants Est. completion 2019-12-31 223 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Withdrawn NCT NCT02140437

    Fulvestrant Combined Anastrozole Versus Anastrozole in Luminal A-like Postmenopausal ABC

    Not yet reported Fudan University Est. completion 2016-06
    Other conditions: Carcinoma Breast Stage IV
    View official trial listing →
  • Completed NCT NCT02148393

    Implantation Enhancement by Elective Cryopreservation of All Viable Embryos

    Not yet reported Universitair Ziekenhuis Brussel 212 participants Est. completion 2017-02-28 1 site
    Other conditions: Infertility, OHSS
    View official trial listing →
  • Terminated NCT NCT02149173

    F-18 FES PET/CT in Measuring Hormone Expression in Patients With Primary, Recurrent, or Metastatic Breast Cancer Undergoing Endocrine-Targeted Therapy

    Not yet reported University of Washington 29 participants Est. completion 2021-01-13 1 site Stand-alone
    Other conditions: Estrogen Receptor Positive, Recurrent Breast Carcinoma, Stage IV Breast Cancer AJCC v6 and v7
    View official trial listing →
  • Completed NCT NCT02157467

    Study of Combined Oral Contraceptive Effects in Female Subjects

    Not yet reported ViiV Healthcare 46 participants Est. completion 2014-08-25
    Other conditions: Infection, Human Immunodeficiency Virus
    View official trial listing →
  • Completed NCT NCT02158507

    Pilot Study of Veliparib (ABT-888) and Lapatinib (Tykerb) in Patients With Metastatic, Triple Negative Breast Cancer

    Not yet reported University of Alabama at Birmingham 20 participants Est. completion 2021-07-22 1 site
    Other conditions: Metastatic Triple Negative Breast Cancer
    View official trial listing →
  • Completed NCT NCT02158572

    Efficacy, Safety and Tolerability Study of Agile AG200-15 Transdermal Contraceptive Delivery System

    Not yet reported Agile Therapeutics 2032 participants Est. completion 2016-11
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02159131

    Study to Evaluate the Pharmacokinetics of an Oral Contraceptive Containing Levonorgestrel and Ethinyl Estradiol When Co-administered With GSK1265744 in Healthy Adult Female Subjects

    Not yet reported ViiV Healthcare 20 participants Est. completion 2014-12 1 site
    Other conditions: Infections, Human Immunodeficiency Virus and Hepatitis
    View official trial listing →
  • Completed NCT NCT02159326

    Microgynon Riociguat Drug Interaction Study in Healthy Postmenopausal Women

    Not yet reported Bayer 31 participants Est. completion 2015-07 1 site
    Other conditions: Drug Interactions
    View official trial listing →
  • Completed NCT NCT02161614

    Vascular Effect of Estradiol Valerate Versus Placebo Evaluated by Flow-mediated Dilatation of Brachial Artery

    Not yet reported Federal University of Minas Gerais 60 participants Est. completion 2015-12 1 site Stand-alone
    Other conditions: Flow-mediated Dilation Evaluation of the Brachial Artery
    View official trial listing →
  • Completed NCT NCT02170038

    Clinical Study Investigating the Conversion of the Contraceptive Compound Norethisterone Within the Body Towards the Contraceptive Compound Ethinylestradiol

    Not yet reported Bayer 16 participants Est. completion 2015-03 1 site
    Other conditions: Pharmacokinetics
    View official trial listing →
  • Completed NCT NCT02175394

    Effect of Multiple BI 1356 Doses of on the Multiple-dose Pharmacokinetics of a Combination of Ethinylestradiol and Levonorgestrel in Healthy Female Premenopausal Subjects

    Not yet reported Boehringer Ingelheim 18 participants
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02182791

    Investigation of the Potential Pharmacokinetic Interaction Between Nevirapine (VIRAMUNE) and Ethinyl Estradiol/Norethindrone in HIV-1 Infected Women

    Not yet reported Boehringer Ingelheim 14 participants
    Other conditions: HIV Infections
    View official trial listing →
  • Completed NCT NCT02184364

    Klimadynon® in Comparison to Conjugated Oestrogens in Women Suffering From Menopausal Complaints

    Not yet reported Boehringer Ingelheim 161 participants
    Other conditions: Menopause
    View official trial listing →
  • Status unknown NCT NCT02186782

    Concomitant CC and E2 Versus CC Alone in Ovulation Induction

    Not yet reported Maher elesawi kamel elesawi 600 participants Est. completion 2018-08 3 sites
    Other conditions: Infertility, Anovulation
    View official trial listing →
  • Completed NCT NCT02187991

    Study to Compare Alisertib With Paclitaxel vs. Paclitaxel Alone in Metastatic or Locally Recurrent Breast Cancer

    Not yet reported US Oncology Research 169 participants Est. completion 2024-08-01 1 site
    Other conditions: Breast Cancer, Breast Carcinoma, Breast Tumors, Malignant Neoplasm of Breast
    View official trial listing →
  • Completed NCT NCT02188745

    ER Reactivation Therapy for Breast Cancer

    Not yet reported Dartmouth-Hitchcock Medical Center 20 participants Est. completion 2024-07-05 3 sites Stand-alone
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT02195986

    A Comparison of Estradiol Vaginal Cream to Estrace® Cream in 350 Postmenopausal Females With Atrophic Vaginitis

    Not yet reported Mylan Pharmaceuticals Inc 366 participants Est. completion 2014-12 21 sites
    Other conditions: Atrophic Vaginitis
    View official trial listing →
  • Completed NCT NCT02197000

    A Nutritional Intervention to Decrease Breast Density Among Female BRCA (BReast CAncer Susceptibility Gene) Carriers

    Not yet reported Rabin Medical Center 23 participants Est. completion 2018-10-10 1 site
    Other conditions: BRCA1 Gene Mutation, BRCA2 Gene Mutation
    View official trial listing →
  • Completed NCT NCT02197208

    A RCT Comparing Spontaneous Natural Cycles and Human Chorionic Gonadotrophin-induced Natural Cycles in FET

    Not yet reported The University of Hong Kong 300 participants Est. completion 2015-12 2 sites
    Other conditions: Subfertility, Pregnancy
    View official trial listing →
  • Completed NCT NCT02197897

    Evaluation the Treatment of Tamoxifen of Low/Intermediate Risk Bladder Tumors

    Not yet reported Baylor College of Medicine 15 participants Est. completion 2019-06-28 2 sites
    Other conditions: Bladder Cancer
    View official trial listing →
  • Completed NCT NCT02200952

    Luteal Phase Supplementation With Recombinant LH After GnRh Agonist Oocytes Triggering in Women at Risk of OHSS

    San Carlo Public Hospital, Potenza, Italy 16 participants Est. completion 2014-06-30 1 site
    Other conditions: Ovarian Hyperstimulation Syndrome
    View official trial listing →
  • Terminated NCT NCT02202746

    A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer

    Not yet reported Clovis Oncology, Inc. 178 participants Est. completion 2017-01-18 33 sites
    Other conditions: Breast Cancer, Metastatic Breast Cancer, MBC, HER2 Positive, HER2, Estrogen Receptor Positive, ER, Triple Negative
    View official trial listing →
  • Completed NCT NCT02206984

    Endocrine Response in Women With Invasive Lobular Breast Cancer

    Not yet reported Priscilla McAuliffe 201 participants Est. completion 2024-07-19 12 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT02210702

    Oral Contraceptive Ethinyl Estradiol Dose Effect on Postpartum Depression and Sexual Functioning Scales

    Not yet reported The Jones Institute 33 participants 1 site
    Other conditions: Postpartum Depressive Mood, Postpartum Sexual Function
    View official trial listing →
  • Terminated NCT NCT02213042

    Evaluation of Biomarkers Associated With Response to Subsequent Therapies in Subjects With HER2-Positive Metastatic Breast Cancer

    Not yet reported Novartis Pharmaceuticals 42 participants Est. completion 2020-06-04 51 sites
    Other conditions: Neoplasms, Breast
    View official trial listing →
  • Terminated NCT NCT02213757

    Effect of Vaginal Estrogen on Asymptomatic Microhematuria (AMH)

    Not yet reported Medstar Health Research Institute 29 participants Est. completion 2015-12 1 site Stand-alone
    Other conditions: Microscopic Hematuria
    View official trial listing →
  • Completed NCT NCT02215395

    An Open-label Study to Evaluate the Effects of Concurrent Administration of Vaginal Antimycotic Medication Miconazole Nitrate on the Pharmacokinetics of Nestorone and Ethinyl Estradiol Delivered by a Contraceptive Vaginal Ring in Normal Ovulating Women

    Not yet reported Population Council 45 participants Est. completion 2015-04 1 site
    Other conditions: Antifungal Drug Adverse Reaction
    View official trial listing →
  • Completed NCT NCT02216786

    A Randomized Study of AZD2014 in Combination With Fulvestrant in Metastatic or Advanced Breast Cancer

    Not yet reported Queen Mary University of London 333 participants Est. completion 2021-12-31 79 sites
    Other conditions: Estrogen Receptor Positive Breast Cancer
    View official trial listing →
  • Completed NCT NCT02218463

    Treatment of Prepubertal Labial Adhesions

    Not yet reported Children's Mercy Hospital Kansas City 43 participants Est. completion 2016-06 1 site
    Other conditions: Prepubertal Labial Adhesions
    View official trial listing →
  • Completed NCT NCT02219789

    Alisertib and Fulvestrant in Treating Patients With Hormone Receptor Positive Breast Cancer That is Metastatic or Locally Advanced and Cannot Be Removed by Surgery

    Not yet reported Mayo Clinic 10 participants Est. completion 2018-10-01 1 site
    Other conditions: Estrogen Receptor Positive, Progesterone Receptor Positive, Recurrent Breast Carcinoma, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    View official trial listing →
  • Completed NCT NCT02224313

    Effect of Oral Estradiol and Progesterone Therapy on Vaginal Cytokines in Postmenopausal Women

    Not yet reported Intira Sriprasert 20 participants Est. completion 2018-08 1 site
    Other conditions: Menopause
    View official trial listing →
  • Completed NCT NCT02225080

    Duragen® Secure Post Marketing Clinical Follow-up (PMCF)

    Integra LifeSciences Corporation 100 participants Est. completion 2016-06 5 sites
    Other conditions: Dura Mater Nick Cut or Tear, Surgery
    View official trial listing →
  • Completed NCT NCT02226302

    Linking Obesity and Estrogen-responsive Genes in Endometrial Cancer

    Queensland Centre for Gynaecological Cancer 16 participants Est. completion 2021-08 2 sites
    Other conditions: Endometrial Cancer
    View official trial listing →
  • Terminated NCT NCT02233621

    Assessment of Performance of [18F]-FES for Endometriosis Diagnosis

    Not yet reported University Hospital, Angers 31 participants Est. completion 2016-04-06 1 site
    Other conditions: Endometriosis
    View official trial listing →
  • Completed NCT NCT02237079

    Bazedoxifene/Conjugated Estrogens (BZA/CE) Improvement of Metabolism (BIM)

    Not yet reported Tulane University Health Sciences Center 17 participants Est. completion 2018-04 1 site
    Other conditions: Obesity, Glucose Homeostasis, Postmenopausal Symptoms
    View official trial listing →
  • Status unknown NCT NCT02237131

    Continuous Versus Cyclic Oral Contraceptives for Endometriosis

    Not yet reported University of Athens 50 participants Est. completion 2015-12 1 site
    Other conditions: Dysmenorrhea, Pelvic Pain, Dyspareunia, Endometrioma
    View official trial listing →
  • Active, not recruiting NCT NCT02238808

    A Study to See Whether Estrogen Can Slow the Growth of Some ER Positive Breast Cancers

    Not yet reported AHS Cancer Control Alberta 19 participants Est. completion 2028-06 1 site
    Other conditions: Estrogen Receptor Positive Breast Cancer
    View official trial listing →
  • Completed NCT NCT02244580

    Re-Evaluation of Tumor Samples From Women With Breast Cancer With the in Vitro Diagnostic Kit "MammaTyperTM"

    Not yet reported BioNTech Diagnostics GmbH 1010 participants Est. completion 2014-08 Stand-alone
    Other conditions: Invasive Breast Cancer
    View official trial listing →
  • Terminated NCT NCT02245438

    Effect of Tipranavir and Ritonavir on the Pharmacokinetic Characteristics of Norethindrone-Ethinyl Estradiol in Healthy Female Adult Volunteers

    Not yet reported Boehringer Ingelheim 52 participants
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02248090

    AZD9496 First Time in Patients Ascending Dose Study

    Not yet reported AstraZeneca 45 participants Est. completion 2019-04-03 6 sites
    Other conditions: ER+ HER2- Advanced Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT02251925

    Frozen Embryo Transfer in Natural and Hormonal Replacement Cycles

    Not yet reported Royan Institute 460 participants Est. completion 2015-11 1 site Stand-alone
    Other conditions: Infertility
    View official trial listing →
  • Completed NCT NCT02255175

    Perimenopausal Effects of Estradiol on Reward Responsiveness

    Not yet reported University of North Carolina, Chapel Hill 64 participants Est. completion 2018-10-17 1 site
    Other conditions: Perimenopausal Depression
    View official trial listing →
  • Completed NCT NCT02255396

    Estradiol and Testosterone Levels in Seminal Plasma of Men With Non-obstructive Azoospermia

    University Hospital, Clermont-Ferrand 50 participants Est. completion 2014-06 1 site
    Other conditions: Non-obstructive Azoospermia With Testicular Biopsy for Spermatozoa Extraction
    View official trial listing →
  • Completed NCT NCT02256540

    The Effects of Resveratrol and Acute Exercise on Endothelial Function in Postmenopausal Women

    Not yet reported University of Colorado, Denver 25 participants Est. completion 2016-03-25 1 site
    Other conditions: Endothelial Dysfunction
    View official trial listing →
  • Status unknown NCT NCT02257671

    Oral Contraceptives and Economic Behaviour

    Not yet reported Karolinska University Hospital 400 participants Est. completion 2015-12 1 site
    Other conditions: Female Contraception
    View official trial listing →
  • Completed NCT NCT02260661

    Phase I, Dose Study to Look at the Safety and Pharmacokinetics of AZD8835 in Patients With Advanced Solid Tumours

    Not yet reported AstraZeneca 20 participants Est. completion 2016-07 9 sites Stand-alone
    Other conditions: Advanced Solid Malignancies, Breast Cancer - ER+, HER2 -, Breast Cancer - ER+, HER2-, PIK3CA Gene Mutation
    View official trial listing →
  • Completed NCT NCT02263846

    Investigation of Sex Hormone Levels in Chinese Women With Invasive Breast Cancer

    Affiliated Hospital to Academy of Military Medical Sciences 1183 participants Est. completion 2013-07
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT02264743

    Oral Verses Patch Trial In Menopausal Women - Individualisation of Oestrogen Therapy

    Not yet reported Royal Brompton & Harefield NHS Foundation Trust 60 participants Est. completion 2015-11 3 sites
    Other conditions: Venous Thrombosis, Insulin Resistance
    View official trial listing →
  • Terminated NCT NCT02269670

    Phase II Study of Everolimus Beyond Progression

    Not yet reported Emory University 3 participants Est. completion 2021-01-25 3 sites
    Other conditions: Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Recurrent Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    View official trial listing →
  • Completed NCT NCT02269826

    Efficacy and Safety of Non-hormonal Vaginal Preparations in Treating Vaginal Dryness

    Not yet reported Dr. August Wolff GmbH & Co. KG Arzneimittel 117 participants Est. completion 2008-12 6 sites
    Other conditions: Vaginal Dryness
    View official trial listing →
  • Completed NCT NCT02271282

    Estradiol-Receptor Blockade in Older Men and Women

    Not yet reported Mayo Clinic 40 participants Est. completion 2016-05 1 site
    Other conditions: Normal Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT02273791

    HRT Versus MOS for Endometrial Preparation Prior to FET in PCOS Patients

    Mansoura University 126 participants Est. completion 2016-04 2 sites
    Other conditions: Infertility, Polycystic Ovarian Syndrome
    View official trial listing →
  • Completed NCT NCT02274571

    Raising Insulin Sensitivity in Post Menopause

    Not yet reported Pennington Biomedical Research Center 8 participants Est. completion 2017-04-11 1 site Stand-alone
    Other conditions: Menopause
    View official trial listing →
  • Withdrawn NCT NCT02292732

    A Pharmacokinetics (PK) and Safety Study to Determine the Effect of Repeat Dosing of Trametinib on Combined Oral Contraceptive (Norethindrone Plus Ethinyl Estradiol) in Female Subjects With Solid Tumors

    Not yet reported GlaxoSmithKline Est. completion 2017-05
    Other conditions: Cancer
    View official trial listing →
  • Completed NCT NCT02296801

    A Phase II Randomized Study Evaluating the Biological and Clinical Effects of the Combination of Palbociclib With Letrozole as Neoadjuvant Therapy in Post-Menopausal Women With Estrogen-Receptor Positive Primary Breast Cancer

    Not yet reported NSABP Foundation Inc 307 participants Est. completion 2019-03 52 sites
    Other conditions: Breast Cancer, Breast Carcinoma, Breast Tumors
    View official trial listing →
  • Completed NCT NCT02297438

    A Study Of Palbociclib (PD-0332991) + Letrozole VS. Placebo+ Letrozole For 1st Line Treatment Of Asian Postmenopausal Women With ER+/HER2- Advanced Breast Cancer [PALOMA-4]

    Not yet reported Pfizer 340 participants Est. completion 2025-02-24 54 sites
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Status unknown NCT NCT02304887

    The Relationship Between the Residual Renal Function and Osteoporosis Treatment

    Toshihiko Kono 1000 participants Est. completion 2019-01 1 site
    Other conditions: Osteoporosis
    View official trial listing →
  • Completed NCT NCT02308904

    Reproductive Capacity and Iron Burden in Thalassemia

    Not yet reported UCSF Benioff Children's Hospital Oakland 59 participants Est. completion 2020-09-01 1 site
    Other conditions: THALASSEMIA MAJOR
    View official trial listing →
  • Active, not recruiting NCT NCT02311933

    Tamoxifen Citrate or Z-Endoxifen Hydrochloride in Treating Patients With Locally Advanced or Metastatic, Estrogen Receptor-Positive, HER2-Negative Breast Cancer

    Not yet reported National Cancer Institute (NCI) 81 participants Est. completion 2027-02-02 559 sites
    Other conditions: Recurrent Breast Carcinoma, Stage III Breast Cancer AJCC v7, Stage IIIA Breast Cancer AJCC v7, Stage IIIB Breast Cancer AJCC v7, Stage IIIC Breast Cancer AJCC v7, Stage IV Breast Cancer AJCC v6 and v7
    View official trial listing →
  • Completed NCT NCT02313415

    Treatment of Infertility by Collagen Scaffold Loaded With Umbilical Cord Derived Mesenchyma Stem Cells

    Not yet reported The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 26 participants Est. completion 2017-08-31 1 site
    Other conditions: Infertility, Intrauterine Adhesions
    View official trial listing →
  • Withdrawn NCT NCT02316249

    Vaginal Creams to Reduce Vaginal Erosion in Pessary Users

    Not yet reported Northwell Health Est. completion 2015-08 1 site
    Other conditions: Atrophy of Vagina, Vaginal Ulceration, Vaginitis
    View official trial listing →
  • Completed NCT NCT02316509

    A Study of GDC-0927 in Postmenopausal Women With Locally Advanced or Metastatic Estrogen Receptor Positive Breast Cancer

    Not yet reported Genentech, Inc. 43 participants Est. completion 2020-01-10 13 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT02322060

    In Vitro Activation of Dormant Follicles for Patients With Primary Ovarian Insufficiency

    The First Affiliated Hospital of Zhengzhou University 35 participants Est. completion 2021-10 1 site
    Other conditions: in Vitro Activation, Dormant Follicle, Primary Ovarian Insufficiency, Ovarian Resistance Syndrome
    View official trial listing →
  • Completed NCT NCT02330250

    Effectiveness of Pharmaceutical Care in the Adherence of Systemic Lupus Erythematosus Treatment

    Not yet reported Oswaldo Cruz Foundation 131 participants Est. completion 2016-06 1 site
    Other conditions: Systemic Lupus Erythematosus, Medication Adherence
    View official trial listing →
  • Status unknown NCT NCT02330757

    HRT Versus MOS for Endometrial Preparation Prior to FET in Non PCOS Patients

    Not yet reported Mansoura University 150 participants Est. completion 2024-12-31 2 sites
    Other conditions: Infertility
    View official trial listing →
  • Completed NCT NCT02333253

    Delayed Start Versus Conventional Antagonist Protocol in Poor Responders Pretreated by Estradiol in Luteal Phase

    Not yet reported Cairo University 60 participants Est. completion 2016-01 1 site
    Other conditions: Other Complications Associated With Artificial Fertilization
    View official trial listing →
  • Completed NCT NCT02333370

    A Phase Ib Dose Escalation Study of the Combination of LEE011 With Letrozole and Dose Expansion of LEE011 With Hormonal Therapy for the Treatment of Pre-(With Goserelin) and Postmenopausal Women With Hormone Receptor Positive, HER2-negative, Advanced Breast Cancer

    Not yet reported Novartis Pharmaceuticals 88 participants Est. completion 2022-09-29 15 sites
    Other conditions: Hormone Receptor Positive, HER2-negative, Advanced Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT02338310

    Trial of Perioperative Endocrine Therapy - Individualising Care

    Not yet reported Institute of Cancer Research, United Kingdom 4486 participants Est. completion 2034-04 128 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT02338349

    A Phase I, Multicenter, Open-Label, Multi-Part, Dose-escalation Study of RAD1901 in Postmenopausal Women With Advanced Estrogen Receptor Positive and HER2-Negative Breast Cancer

    Not yet reported Stemline Therapeutics, Inc. 57 participants Est. completion 2020-04 1 site
    Other conditions: Advanced ER+, HER2-Negative Breast Cancer
    View official trial listing →
  • Terminated NCT NCT02340221

    A Study of Taselisib + Fulvestrant Versus Placebo + Fulvestrant in Participants With Advanced or Metastatic Breast Cancer Who Have Disease Recurrence or Progression During or After Aromatase Inhibitor Therapy

    Not yet reported Hoffmann-La Roche 631 participants Est. completion 2021-06-29 157 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT02344472

    Detect V / CHEVENDO (Chemo vs. Endo)

    Not yet reported Prof. Wolfgang Janni 271 participants Est. completion 2025-01-31 1 site
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Terminated NCT NCT02345772

    Neoadjuvant Hormonal Therapy Combined With Chemoimmunotherapy

    Not yet reported, Not yet reported Western Regional Medical Center 4 participants Est. completion 2015-11 1 site
    Other conditions: HER2-positive Breast Cancer, ER-positive Breast Cancer
    View official trial listing →
  • Completed NCT NCT02349113

    Effects of Acute Estrogen Therapy on Bone Formation

    Not yet reported Mayo Clinic 20 participants Est. completion 2012-09 Stand-alone
    Other conditions: Bone Loss, Age-related
    View official trial listing →
  • Terminated NCT NCT02349386

    Maintaining Suppression of Testosterone With Transdermal Estradiol Gel

    Not yet reported BHR Pharma, LLC 34 participants Est. completion 2018-01-10 12 sites
    Other conditions: Cancer of the Prostate
    View official trial listing →
  • Completed NCT NCT02349399

    Drug Utilization Study on Diane-35 (and Generics) in Three European Healthcare Databases

    Bayer 26065 participants Est. completion 2016-03-01 3 sites
    Other conditions: Acne Vulgaris
    View official trial listing →
  • Completed NCT NCT02352090

    Synthetic vs Natural Estrogen in Combined Oral Contraception

    Not yet reported Helsinki University Central Hospital 59 participants Est. completion 2018-12-30 2 sites Stand-alone
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT02352597

    Phytoestrogens as an Alternative to Estradiol in Ovulation Induction in PCOS

    Not yet reported Cairo University 150 participants Est. completion 2015-01
    Other conditions: Polycystic Ovaries
    View official trial listing →
  • Status unknown NCT NCT02353988

    AR-inhibitor Bicalutamide in Treating Patients With TNBC

    Not yet reported Jinling Hospital, China 60 participants Est. completion 2017-05 Stand-alone
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Completed NCT NCT02354001

    Selective Estrogen Receptor Modulators for Women of Child-bearing Age With Schizophrenia

    Not yet reported The Alfred 80 participants Est. completion 2019-01 1 site
    Other conditions: Schizophrenia, Schizoaffective Disorder
    View official trial listing →
  • Completed NCT NCT02362711

    Efficacy and Safety, Long-Term Study of NPC-16 to Treat Dysmenorrhea

    Not yet reported Nobelpharma 248 participants Est. completion 2017-01-28
    Other conditions: Dysmenorrhea
    View official trial listing →
  • Completed NCT NCT02367833

    Effects of Oral vs. Non-oral Contraceptives on the GH/IGF-1 Axis

    Not yet reported Penn State University 60 participants Est. completion 2018-12 1 site
    Other conditions: Bone; Disorder, Development and Growth
    View official trial listing →
  • Active, not recruiting NCT NCT02367846

    Assessing the Impact of Contraceptives on Bone Health Using 41Ca

    Not yet reported Penn State University 6 participants Est. completion 2028-12 1 site
    Other conditions: Other Disorders of Bone Development and Growth
    View official trial listing →
  • Active, not recruiting NCT NCT02373709

    Sequence Variations of Genes in the Estrogen Pathway and Perinatal Depression

    KK Women's and Children's Hospital 750 participants Est. completion 2028-12 1 site
    Other conditions: Postnatal Depression, Genetic Predisposition
    View official trial listing →
  • Terminated NCT NCT02374099

    Study to Assess the Efficacy and Safety of the Epigenetic Modifying Effects of CC-486 (Oral Azacitidine) in Combination With Fulvestrant

    Not yet reported Celgene 97 participants Est. completion 2017-11-21 35 sites
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Completed NCT NCT02376985

    Evaluation of Oral Care to Prevent Oral Mucositis in ER Positive MBC Patients Treated With Everolimus: Phase 3 RCT

    Not yet reported Comprehensive Support Project for Oncology Research 174 participants Est. completion 2018-10-16 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT02380755

    Clomiphene Citrate for the Treatment of Obesity Related Male Hypogonadism

    Not yet reported University of Sao Paulo 78 participants Est. completion 2017-01 1 site
    Other conditions: Obesity, Hypoandrogenism
    View official trial listing →
  • Status unknown NCT NCT02383030

    Fulvestrant as Maintenance Therapy After First-line Chemotherapy in HER2 - Postmenopausal MBC Patients

    Not yet reported Consorzio Oncotech 156 participants Est. completion 2017-12 20 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Withdrawn NCT NCT02383823

    Postprandial Lipidemia After a Meal With Different Types of Fat, Estrogen Treatment, Age and Gender in Healthy Subjects

    Not yet reported Herning Hospital Est. completion 2020-12-10 1 site
    Other conditions: Menopause
    View official trial listing →
  • Completed NCT NCT02384239

    A Study of Palbociclib in Combination With Fulvestrant or Tamoxifen as Treatment for Metastatic Breast Cancer

    Not yet reported University of California, San Francisco 70 participants Est. completion 2021-01-31 9 sites
    Other conditions: Metastatic Breast Cancer, Hormone Receptor Positive
    View official trial listing →
  • Completed NCT NCT02384408

    Hormone Replacement Therapy on the Postmenopausal Endometrium

    Not yet reported Universidade do Vale do Sapucai 100 participants Est. completion 2015-07 1 site Stand-alone
    Other conditions: Menopause
    View official trial listing →
  • Terminated NCT NCT02384746

    Phase I Study of the Combination of MLN9708 and Fulvestrant

    Not yet reported Dartmouth-Hitchcock Medical Center 9 participants Est. completion 2018-06-10 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT02385448

    Comparing the Use of Dienogest and Combined Oral Contraceptive Pills (Microgynon) to Reduce the Risk of Recurrence of Endometriotic Cyst After Conservative Surgery

    Not yet reported The University of Hong Kong 144 participants Est. completion 2019-02 1 site
    Other conditions: Endometriosis
    View official trial listing →
  • Completed NCT NCT02385916

    The Effects of EstroSense®/MD vs Placebo in Improving the Estrogen Profile in Females

    Not yet reported University of British Columbia 120 participants Est. completion 2020-04 1 site
    Other conditions: Estrogen Profile
    View official trial listing →
  • Completed NCT NCT02392611

    Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Alobresib (Formerly GS-5829) in Adults With Advanced Solid Tumors and Lymphomas and in Combination With Exemestane or Fulvestrant in Adults With Estrogen Receptor Positive Breast Cancer

    Not yet reported Gilead Sciences 33 participants Est. completion 2017-10-11 4 sites Stand-alone
    Other conditions: Solid Tumors and Lymphomas
    View official trial listing →
  • Status unknown NCT NCT02393482

    Psychological Impact of Amenorrhea in Women With Endometriosis

    Not yet reported University of Cagliari 50 participants Est. completion 2022-06 1 site
    Other conditions: Amenorrhea, Endometriosis, Quality of Life
    View official trial listing →
  • Status unknown NCT NCT02394496

    Overcoming Endocrine Resistance in Metastatic Breast Cancer

    Not yet reported Consorzio Oncotech 396 participants Est. completion 2017-01 69 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Terminated NCT NCT02395627

    Reversing Therapy Resistance With Epigenetic-Immune Modification

    Not yet reported University of California, San Francisco 38 participants Est. completion 2019-06-08 1 site
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Completed NCT NCT02400801

    Gonadotropin-releasing Hormone (GnRH) Downregulation Versus Oral Anticonception Prior to ART in Postoperative Endometriosis Patients

    Not yet reported Universitaire Ziekenhuizen KU Leuven 166 participants Est. completion 2018-01-26 1 site
    Other conditions: Endometriosis, Infertility
    View official trial listing →
  • Status unknown NCT NCT02404038

    A Study to Evaluate the Acceptability and Preference for Contraceptive Options as Proxy for HIV Prevention Methods

    Not yet reported Desmond Tutu HIV Centre 131 participants Est. completion 2020-02-28 1 site
    Other conditions: HIV
    View official trial listing →
  • Status unknown NCT NCT02404051

    Fulvestrant and EVerolimus Plus EXemestane in Metastatic Breast Cancer

    Not yet reported Consorzio Oncotech 745 participants Est. completion 2019-01 41 sites
    Other conditions: Metastatic Breast Cancer, Breast Cancer, Hormone Receptor Positive Tumor, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast, Locally Advanced Malignant Neoplasm
    View official trial listing →
  • Completed NCT NCT02406690

    Endometrial Receptivity Profile in Patients With Endometrial Proliferation Defects

    Reproductive Medicine Associates of New Jersey 1 participants Est. completion 2015-09-17 1 site
    Other conditions: Endometrial Dysfunction
    View official trial listing →
  • Completed NCT NCT02406794

    Effect of Kinesiotaping for the Treatment of Hormone-induced Myalgia in Women Given Breast Cancer Survivors

    Not yet reported, Not yet reported University of Malaga 156 participants Est. completion 2017-03 1 site
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Terminated NCT NCT02414776

    Hydroxychloroquine in Metastatic Estrogen Receptor-Positive Breast Cancer Progressing on Hormonal Therapy

    Not yet reported Western Regional Medical Center 3 participants Est. completion 2015-11 1 site
    Other conditions: Estrogen Receptor Positive Breast Cancer
    View official trial listing →
  • Completed NCT NCT02419729

    Evaluation of Fractional CO2 Laser Treatment Efficacy and Comparison to Vaginal Estrogen Therapy in Postmenopausal Women With Vulvovaginal Atrophy

    Not yet reported Faculdade de Medicina do ABC 45 participants Est. completion 2015-11 1 site Stand-alone
    Other conditions: Vulvovaginal Atrophy
    View official trial listing →
  • Completed NCT NCT02422615

    Study of Efficacy and Safety of LEE011 in Men and Postmenopausal Women With Advanced Breast Cancer.

    Not yet reported Novartis Pharmaceuticals 726 participants Est. completion 2023-01-11 174 sites
    Other conditions: Advanced Breast Cancer
    View official trial listing →
  • Completed NCT NCT02427386

    Homeopathic Treatment of Chronic Pelvic Pain in Women With Endometriosis

    Not yet reported University of Sao Paulo General Hospital 50 participants Est. completion 2016-12
    Other conditions: Endometriosis, Pelvic Pain
    View official trial listing →
  • Completed NCT NCT02431689

    Delayed Embryo Transfer in Poor Responders

    Not yet reported Cairo University 400 participants Est. completion 2018-05 3 sites
    Other conditions: Infertility
    View official trial listing →
  • Completed NCT NCT02434562

    Development and Validation of in Vitro Cell-based Bioassays for Nuclear Receptor Activation

    Universitaire Ziekenhuizen KU Leuven 73 participants Est. completion 2016-09-30
    Other conditions: Hypogonadism, Estrogens, Testosterone, Androgens
    View official trial listing →
  • Completed NCT NCT02437318

    Study Assessing the Efficacy and Safety of Alpelisib Plus Fulvestrant in Men and Postmenopausal Women With Advanced Breast Cancer Which Progressed on or After Aromatase Inhibitor Treatment.

    Not yet reported Novartis Pharmaceuticals 572 participants Est. completion 2023-06-09 197 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT02442895

    Biomarkers of Ovarian Reserve and Correlation With IVF Treatments

    U.O.S. Procreazione Medicalmente Assistita e Congelamento Gameti 236 participants Est. completion 2015-02 1 site
    Other conditions: Pregnancy, Ovarian
    View official trial listing →
  • Completed NCT NCT02447328

    A Single Arm, Tolerability and Safety Phase IV Study of Fulvestrant(Faslodex® ) as 2nd Line and Later Therapy in Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer

    Not yet reported AstraZeneca 83 participants Est. completion 2020-09-16 9 sites
    Other conditions: Locally Advanced or, Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT02449642

    LH Hormone Pulsation in the Luteal Phase in GnRH Antagonist IVF Cycles Triggered by GnRH Agonist for Final Oocyte Maturation

    Rambam Health Care Campus 10 participants Est. completion 2015-08 1 site
    Other conditions: Infertility
    View official trial listing →
  • Completed NCT NCT02449902

    TXV13-01 Estradiol Vaginal Softgel Capsules in Treating Postmenopausal Women With Symptoms of Vulvar and Vaginal Atrophy

    Not yet reported TherapeuticsMD 50 participants Est. completion 2013-09 1 site
    Other conditions: Menopause, Vulvovaginal Atrophy, Painful Intercourse, Dyspareunia
    View official trial listing →
  • Completed NCT NCT02449993

    Re-Examination of Tumor Material and Re-Evaluation of Patient Data From Patients Treated With Neo-adjuvant Therapy

    BioNTech Diagnostics GmbH 101 participants Est. completion 2014-10
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT02451228

    Indomethacin PK and PD Therapy in Pregnancy

    The University of Texas Medical Branch, Galveston 62 participants Est. completion 2018-12-31 6 sites
    Other conditions: Premature Labor, Pregnancy, Premature Birth
    View official trial listing →
  • Completed NCT NCT02455453

    Assessment of Functional Status of Estrogen Receptors in Breast Cancer by Positron Emission Tomography

    Not yet reported Washington University School of Medicine 47 participants Est. completion 2019-01-03 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT02458001

    Developing a Stepped Approach to Improving Sexual Function aFteR Treatment fOr gyNaecological Cancer

    Not yet reported University College, London 100 participants Est. completion 2017-03
    Other conditions: Cervical Cancer, Ovarian Cancer, Uterine Cancer, Vaginal Cancer, Vulval Cancer, Psychosexual Dysfunctions
    View official trial listing →
  • Completed NCT NCT02458404

    Effects of Varied Estrogen Doses on Endometrial Receptivity

    Reproductive Medicine Associates of New Jersey 19 participants Est. completion 2019-06 1 site
    Other conditions: Luteal Phase Defect
    View official trial listing →
  • Completed NCT NCT02458768

    Multicenter, Randomized, Open Label, Parallel Study to Evaluate the Efficacy & Safety of IVF-M HP Inj. vs. Menopur® Inj.

    Not yet reported LG Life Sciences 112 participants
    Other conditions: Infertility, Female
    View official trial listing →
  • Completed NCT NCT02460445

    Phlebotomy and Polycystic Ovary Syndrome

    Not yet reported Manuel Luque Ramírez 37 participants Est. completion 2020-06 1 site
    Other conditions: Hyperandrogenism, Metabolic Cardiovascular Syndrome
    View official trial listing →
  • Completed NCT NCT02463032

    Efficacy and Safety of GTx-024 in Patients With Estrogen Receptor (ER)+/Androgen Receptor (AR)+ Breast Cancer

    Not yet reported GTx 136 participants Est. completion 2019-03 4 sites
    Other conditions: ER+ and AR+ Breast Cancer
    View official trial listing →
  • Completed NCT NCT02463383

    Effect of PPARγ2 Polymorphism and NSAIDs on Acute Alcohol-induced Changes in Serum Estrogens Among Post-menopausal Women

    Not yet reported Professor Lars Ove Dragsted 25 participants Est. completion 2015-12 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT02467673

    Nanoparticulate Versus Micronized Steroids Delivery for Transdermal Hormone Replacement Therapy

    Not yet reported University Potiguar 185 participants Est. completion 2012-07 3 sites
    Other conditions: Menopausal Syndrome
    View official trial listing →
  • Status unknown NCT NCT02467686

    Breast Cancer, Sexuality and Black Cohosh

    Not yet reported Irmandade da Santa Casa de Misericordia de Sao Paulo 60 participants Est. completion 2017-12 1 site
    Other conditions: Sexuality
    View official trial listing →
  • Completed NCT NCT02475265

    Transdermal Estrogen in Older Premenopausal Women With Anorexia Nervosa

    Not yet reported Massachusetts General Hospital 11 participants Est. completion 2018-07-30 1 site
    Obstructive sleep apnea Other conditions: Osteoporosis
    View official trial listing →
  • Terminated NCT NCT02476955

    Open-label Phase 1b Study of ARQ 092 in Combination With Anastrozole

    Not yet reported ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) 41 participants Est. completion 2019-05-07 5 sites
    Other conditions: Solid Tumors, Ovarian Cancer, Endometrial Cancer
    View official trial listing →
  • No Longer Available NCT NCT02480777

    Expanded Access for Single Patient Treatment of Autologous Human Schwann Cells (ahSC) for Peripheral Nerve Repair

    W. Dalton Dietrich 1 site
    Other conditions: Sciatic Nerve Injury
    View official trial listing →
  • Completed NCT NCT02480881

    A Drug-drug Interaction Study Between BMS-663068 and Oral Contraceptives in Healthy Female Volunteers (DDI)

    Not yet reported ViiV Healthcare 26 participants Est. completion 2016-01-11 2 sites
    Other conditions: Infection, Human Immunodeficiency Virus
    View official trial listing →
  • Status unknown NCT NCT02480985

    The PIT-TBI Pilot Study

    Not yet reported CHU de Quebec-Universite Laval 70 participants Est. completion 2018-03 5 sites
    Other conditions: Pituitary Disorders, Traumatic Brain Injury
    View official trial listing →
  • Completed NCT NCT02482753

    Trial of Chidamide in Combination With Exemestane in Patients With Advanced Breast Cancer

    Not yet reported Chipscreen Biosciences, Ltd. 365 participants Est. completion 2021-02 22 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Withdrawn NCT NCT02483871

    Dose Optimization of Rosuvastatin in Early Stage and Metastatic Estrogen Receptor Positive Breast Cancer Patients on Endocrine Therapy

    Not yet reported Duke University Est. completion 2017-05-10 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT02485821

    Vaginal Estradiol Pretreatment in Labour Induction With Misoprostol

    Not yet reported, Not yet reported Ain Shams University 200 participants Est. completion 2016-02 1 site
    Other conditions: Failed Induction of Labor
    View official trial listing →
  • Completed NCT NCT02486757

    Investigation of Female Reproductive Hormone Dynamics During Adolescence

    Not yet reported Massachusetts General Hospital 9 participants Est. completion 2016-03-01 1 site
    Other conditions: Menstruation Disturbances
    View official trial listing →
  • Completed NCT NCT02491983

    Palbociclib in Combination With Fulvestrant or Letrozole in Patients With ER+, HER2- Advanced Breast Cancer

    Not yet reported MedSIR 486 participants Est. completion 2020-01 48 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT02494297

    DUS on the Prescribing Indications for CPA/EE in 5 European Countries

    Center for Epidemiology and Health Research, Germany 1597 participants Est. completion 2016-10-31 1 site
    Other conditions: Hirsutism, Androgenetic Alopecia, Severe Anemia, Seborrhea, PCOS
    View official trial listing →
  • Terminated NCT NCT02494713

    Hormonal Therapy and Chemotherapy Followed by Prostatectomy in Patients With Prostate Cancer

    Not yet reported The University of Texas Health Science Center, Houston 4 participants Est. completion 2017-09-14 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Status unknown NCT NCT02496052

    The Efficacy and Safety of the Dried Biological Amnion Graft in Patients With Intrauterine Adhesions

    Not yet reported Beijing Obstetrics and Gynecology Hospital 300 participants Est. completion 2017-06 1 site Stand-alone
    Other conditions: Intrauterine Adhesions
    View official trial listing →
  • No Longer Available NCT NCT02510079

    Emergent Expanded Access for ahSC Augmentation of Nerve Autografts After Severe Peripheral Nerve Injury.

    W. Dalton Dietrich 1 site
    Other conditions: Sciatic Nerve Injury
    View official trial listing →
  • Completed NCT NCT02511639

    Maintenance Aromatase Inhibitors (AIs)+ Everolimus vs AIs in Hormone Receptor Positive Metastatic Breast Cancer Patients

    Not yet reported Istituto Oncologico Veneto IRCCS 110 participants Est. completion 2020-07-31 16 sites
    Other conditions: Breast Cancer Metastatic
    View official trial listing →
  • Active, not recruiting NCT NCT02515110

    Hypofractionated Regional Nodal Irradiation Clinical Trial for Women With Breast Cancer

    Not yet reported Virginia Commonwealth University 137 participants Est. completion 2028-04-30 2 sites
    Other conditions: Breast Cancer, Node-positive Breast Cancer, Breast Adenocarcinoma, Invasive Breast Carcinoma, Lobular Breast Carcinoma In Situ
    View official trial listing →
  • Completed NCT NCT02516202

    The Vaginal Health Trial

    Not yet reported Fred Hutchinson Cancer Center 302 participants Est. completion 2017-07 2 sites
    Other conditions: Atrophy of Vagina, Menopause, Dyspareunia (Female)
    View official trial listing →
  • Completed NCT NCT02518009

    GEnder Dysphoria Treatment in Sweden

    Karolinska Institutet 40 participants Est. completion 2022-05 1 site
    Other conditions: Transsexualism
    View official trial listing →
  • Terminated NCT NCT02524288

    Efficacy and Safety of Etonogestrel + 17β-Estradiol Vaginal Ring in Women at Risk for Pregnancy (MK-8342B-061)

    Not yet reported Organon and Co 1941 participants Est. completion 2016-09-16
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT02524561

    KEEPS Mammographic Density And Breast Health Ancillary Study

    Not yet reported Brigham and Women's Hospital 517 participants Est. completion 2013-12 1 site
    Other conditions: Mammographic Density, Abnormal Mammogram
    View official trial listing →
  • Completed NCT NCT02524769

    The Estrogen Impact on Overactive Bladder Syndrome: Female Pelvic Floor Microbiomes and Antimicrobial Peptides

    Not yet reported Loyola University 27 participants Est. completion 2017-06 1 site
    Other conditions: Overactive Bladder
    View official trial listing →
  • Status unknown NCT NCT02525276

    Female Sex Hormones, Insulin Resistance and Effects of Exercise in a Human Experimental Model of Menopause

    Not yet reported Copenhagen University Hospital, Rigshospitalet 48 participants Est. completion 2018-08
    Metabolic syndrome
    View official trial listing →
  • Completed NCT NCT02528383

    Trial of Vaginal Estrogen for Urogenital Symptom Relief in Women on Aromatase Inhibitors

    Not yet reported Susan Tannenbaum 3 participants Est. completion 2017-05 1 site Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT02529683

    Study of Nuvaring Acceptability, Adherence and Biological Effects Among HIV-negative Women in Kenya

    Not yet reported Centers for Disease Control and Prevention 200 participants Est. completion 2015-08
    Other conditions: Hormonal Contraception
    View official trial listing →
  • Status unknown NCT NCT02530411

    Fulvestrant +/- Vandetanib in Advanced Aromatase Inhibitor Resistant Breast Cancer

    Not yet reported Velindre NHS Trust 160 participants Est. completion 2020-12 5 sites Stand-alone
    Other conditions: Neoplasms
    View official trial listing →
  • Completed NCT NCT02530424

    "Neo-Adjuvant Treatment With Palbociclib: Effect on Ki67 and Apoptosis Before, During and After Treatment "

    Not yet reported Fondazione Michelangelo 102 participants Est. completion 2019-11 7 sites
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Terminated NCT NCT02531321

    Protease Inhibitors and Combined Oral Contraceptive Pharmacokinetics and Pharmacodynamics

    Not yet reported University of Southern California 17 participants Est. completion 2016-11-01 1 site
    Other conditions: Contraception, HIV
    View official trial listing →
  • Completed NCT NCT02533427

    Study to Evaluate Effect of Sofosbuvir/Velpatasvir/GS-9857 Fixed-Dose Combination on the Pharmacokinetics of a Representative Hormonal Contraceptive Medication, Norgestimate/Ethinyl Estradiol

    Not yet reported Gilead Sciences 15 participants Est. completion 2016-03-18 1 site
    Other conditions: HCV Infection
    View official trial listing →
  • Completed NCT NCT02536742

    Palbociclib in Molecularly Characterized ER-positive/HER2-negative Metastatic Breast Cancer

    Not yet reported ETOP IBCSG Partners Foundation 124 participants Est. completion 2022-12-22 19 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT02538484

    Impact of Omega 3 Fatty Acid Supplementation on Aromatase in Obese Subjects

    Not yet reported The University of Texas Health Science Center at San Antonio 24 participants Est. completion 2020-03-26 2 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT02540330

    A Pre-Surgical PK Study of IM and Intraductally Delivered Fulvestrant

    Not yet reported Atossa Therapeutics, Inc. 3 participants Est. completion 2020-08-13 3 sites
    Other conditions: Female Breast Carcinoma, Female Ductal Carcinoma In Situ
    View official trial listing →
  • Completed NCT NCT02549430

    To Reverse ENDocrine Resistance Trial - PD 0332991 Monotherapy vs PD 0332991 in Combination With the Endocrine Therapy

    Not yet reported Fondazione Sandro Pitigliani 115 participants Est. completion 2017-02-09 6 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT02550977

    Russia/Ukraine Suppression of Ovarian Activity Study

    Not yet reported Bayer 91 participants Est. completion 2016-08-15 8 sites
    Other conditions: Contraception
    View official trial listing →
  • Status unknown NCT NCT02556411

    Comparison of Estrogen-progestin Therapy in Continuous Regimen Versus Combination Estrogen-progestin Therapy in Continuous Regimen Plus Levonorgestrel-releasing Intrauterine System (LNG-IUS)

    Not yet reported University of Cagliari 50 participants Est. completion 2022-06-01
    Other conditions: Adenomyosis, Chronic Pelvic Pain
    View official trial listing →
  • Completed NCT NCT02558426

    Estrogen Receptors and Chronic Venous Disease

    University of Catanzaro 40 participants Est. completion 2015-09
    Other conditions: Estrogen Excess, Varicose Veins
    View official trial listing →
  • Terminated NCT NCT02560051

    Hormone Therapy Plus Chemotherapy as Initial Treatment for Local Failures or Advanced Prostate Cancer

    Not yet reported The University of Texas Health Science Center, Houston 19 participants Est. completion 2017-09-14 1 site
    Other conditions: Prostatic Neoplasms
    View official trial listing →
  • Active, not recruiting NCT NCT02564848

    Safety and Efficacy of Omission of Sentinel Node Biopsy in Patients With Estrogen-Positive Breast Cancer Over Age 65

    Not yet reported Cedars-Sinai Medical Center 200 participants Est. completion 2029-03 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT02569801

    A Study of GDC-0810 Versus Fulvestrant in Postmenopausal Women With Advanced or Metastatic Breast Cancer Resistant to Aromatase Inhibitor (AI) Therapy

    Not yet reported Genentech, Inc. 71 participants Est. completion 2020-02-28 44 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT02577601

    Impact of Combined Hormonal Contraceptives on UPA

    Not yet reported Oregon Health and Science University 36 participants Est. completion 2017-06-17 1 site
    Other conditions: Contraception
    View official trial listing →
  • Terminated NCT NCT02577913

    European Active Surveillance Study Comparing Regimens of Administration in Combined Hormonal Contraception

    Center for Epidemiology and Health Research, Germany 2281 participants Est. completion 2019-05-22 1 site
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT02580448

    CYP17 Lyase and Androgen Receptor Inhibitor Treatment With Seviteronel Trial (INO-VT-464-006; NCT02580448)

    Not yet reported, Not yet reported Innocrin Pharmaceutical 175 participants Est. completion 2019-01 36 sites Stand-alone
    Other conditions: Cancer of the Breast, Breast Cancer, Advanced Breast Cancer, Metastatic Breast Cancer, Male Breast Cancer, Triple Negative Breast Cancer, ER+ Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT02592083

    Neoadjuvant Response-guided Treatment of Slowly Proliferating Hormone Receptor Positive Tumors

    Not yet reported Thomas Hatschek 10 participants Est. completion 2029-02 1 site
    Other conditions: Early-Stage Breast Carcinoma, Hormone Receptor Positive Tumor
    View official trial listing →
  • Completed NCT NCT02598557

    Alternative Dosing of Exemestane Before Surgery in Treating Postmenopausal Patients With Stage 0-II Estrogen Positive Breast Cancer

    Not yet reported National Cancer Institute (NCI) 180 participants Est. completion 2023-02-02 5 sites
    Other conditions: Stage 0 Breast Cancer AJCC v6 and v7, Stage I Breast Cancer AJCC v7, Stage IA Breast Cancer AJCC v7, Stage IB Breast Cancer AJCC v7, Stage II Breast Cancer AJCC v6 and v7, Stage IIA Breast Cancer AJCC v6 and v7, Stage IIB Breast Cancer AJCC v6 and v7
    View official trial listing →
  • Suspended NCT NCT02599077

    Impact vs. Dienogest: A Combined Oral Contraceptive in the Size of Endometriomas

    Not yet reported, Not yet reported Fundación Santa Fe de Bogota 50 participants Est. completion 2018-11 1 site
    Other conditions: Endometriosis
    View official trial listing →
  • Completed NCT NCT02599714

    Study of AZD2014 and Palbociclib in Patients With Estrogen Receptor Positive (ER+) Metastatic Breast Cancer

    Not yet reported AstraZeneca 54 participants Est. completion 2023-11-23 7 sites
    Other conditions: Advanced and Metastatic Breast Cancer
    View official trial listing →
  • Terminated NCT NCT02605070

    Pilot Study on the Effects of FSH Treatment on the Epigenetic Characteristics of Spermatozoa in Infertile Patients With Severe Oligozoospermia

    Not yet reported Instituto de Investigacion Sanitaria La Fe 30 participants Est. completion 2017-06-13 1 site
    Other conditions: Male Infertility
    View official trial listing →
  • Completed NCT NCT02613039

    Oral Contraceptive Therapy and Sexuality

    Not yet reported University of Florence 10 participants Est. completion 2019-02 1 site
    Other conditions: Contraceptive Usage, Sexual Behavior, Mental Health Wellness 1
    View official trial listing →
  • Terminated NCT NCT02616146

    Efficacy and Safety of Etonogestrel + 17β-Estradiol Vaginal Ring and Levonorgestrel-Ethinyl Estradiol Combined Oral Contraceptive in Adult Women at Risk for Pregnancy (MK-8342B-062)

    Not yet reported Organon and Co 2016 participants Est. completion 2016-10-06 14 sites
    Other conditions: Contraception
    View official trial listing →
  • Status unknown NCT NCT02617108

    Intrauterine Balloon and Postoperative Estrogen Therapy in the Prevention of Adhesion Reformation After Hysteroscopic Adhesiolysis

    Not yet reported Fu Xing Hospital, Capital Medical University 310 participants Est. completion 2021-11 Stand-alone
    Other conditions: Uterine Septum
    View official trial listing →
  • Withdrawn NCT NCT02617537

    To Investigate Efficacy of YAZ in the Treatment of Dysmenorrhea

    Not yet reported Bayer Est. completion 2017-10
    Other conditions: Dysmenorrhea
    View official trial listing →
  • Completed NCT NCT02618148

    Hormone Estradiol Replacement Therapy Additional Herbals

    Not yet reported Trieu, Nguyen Thi, M.D. 60 participants Est. completion 2015-06 1 site Stand-alone
    Other conditions: Menopause
    View official trial listing →
  • Completed NCT NCT02620124

    GnRH Agonist as Luteal Support in FET Cycles

    Not yet reported Turku University Hospital 100 participants Est. completion 2015-10 Stand-alone
    Other conditions: Infertility
    View official trial listing →
  • Completed NCT NCT02622087

    The Impact of Sex Hormones on One-session Treatment for Spider Phobia in Women

    Not yet reported The University of New South Wales 90 participants Est. completion 2017-06-15 1 site
    Other conditions: Phobia, Specific
    View official trial listing →
  • Terminated NCT NCT02624388

    Study of Genistein in Pediatric Oncology Patients (UVA-Gen001)

    Not yet reported University of Virginia 4 participants Est. completion 2021-09 1 site Stand-alone
    Obstructive sleep apnea Other conditions: Lymphoma, Childhood Lymphoma, Solid Tumor, Childhood Solid Tumor, Neuroblastoma, Ewing Sarcoma, Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Soft Tissue Sarcoma, Medulloblastoma, Germ Cell Tumor, Wilms Tumor, Brain Neoplasms, Medulloblastoma, Childhood, Neuroectodermal Tumors, Primitive
    View official trial listing →
  • Completed NCT NCT02625935

    Prospective Observational Study Evaluating Treatment Decision Impact of Prosigna® in Early Stage Breast Cancer Patients

    NanoString Technologies, Inc. 206 participants Est. completion 2017-10-10 4 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT02626208

    Dose Finding Study of Contraceptive Vaginal Ring With Different Estradiol Levels in Combination With Nestorone

    Not yet reported Premier Research 65 participants Est. completion 2017-03 7 sites
    Other conditions: Suppression of Ovulation
    View official trial listing →
  • Status unknown NCT NCT02626507

    Phase I Study of Combination of Gedatolisib With Palbociclib and Faslodex in Patients With ER+/HER2- Breast Cancer

    Not yet reported Hoffman Oncology 18 participants Est. completion 2022-03-15 2 sites Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT02627703

    (Oncotype DX®) in Estrogen Receptor Positive (ER+) HER-2 Negative (HER 2-) 1-3 Node Positive (pN1) Breast Cancer

    British Columbia Cancer Agency 80 participants 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT02630693

    Two Different Schedules of Palbociclib + Second Line Endocrine Therapy in Estrogen Receptor Positive, HER2 Neg Advanced/Metastatic Breast Cancer

    Not yet reported Canadian Cancer Trials Group 180 participants Est. completion 2023-11-29 22 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT02632045

    Study of Efficacy of Ribociclib After Progression on CDK4/6 Inhibition in Patients With HR+ HER2- Advanced Breast Cancer

    Not yet reported Melissa K Accordino 169 participants Est. completion 2022-01-04 13 sites
    Other conditions: Metastatic Breast Cancer, Breast Carcinoma
    View official trial listing →
  • Completed NCT NCT02636972

    The Progression From Dysmenorrhoea to Chronic Pelvic Pain

    University of Adelaide 56 participants Est. completion 2016-01 1 site
    Other conditions: Dysmenorrhoea, Pelvic Pain, Chronic Pain
    View official trial listing →
  • Status unknown NCT NCT02638922

    Evaluation and Treatment of Tall Statured Girls

    Copenhagen University Hospital, Rigshospitalet 304 participants Est. completion 2017-12
    Other conditions: Constitutional Tall Stature
    View official trial listing →
  • Completed NCT NCT02640755

    Absorption, Metabolism, Excretion and Pharmacokinetics of a Single Dose [14C]AZD2014 Followed by a Multiple Dose Phase

    Not yet reported AstraZeneca 4 participants Est. completion 2017-07-06 1 site
    Other conditions: Solid Malignancies
    View official trial listing →
  • Completed NCT NCT02640976

    Poor Ovarian Stimulation Response in In Vitro Fertilization (IVF) Program

    Not yet reported Cairo University 216 participants Est. completion 2015-08
    Other conditions: Infertility
    View official trial listing →
  • Status unknown NCT NCT02646735

    Fulvestrant 500mg With Exemestane Endocrine Therapy for Postmenopausal Advanced Breast Cancer Patients

    Not yet reported Chinese Academy of Medical Sciences 148 participants Est. completion 2020-12 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT02648477

    Pembrolizumab and Doxorubicin Hydrochloride or Anti-Estrogen Therapy in Treating Patients With Triple-Negative or Hormone Receptor-Positive Metastatic Breast Cancer

    Not yet reported City of Hope Medical Center 30 participants Est. completion 2023-12-30 6 sites Stand-alone
    Other conditions: Estrogen Receptor Negative, Estrogen Receptor Positive, HER2/Neu Negative, Progesterone Receptor Negative, Progesterone Receptor Positive, Stage IV Breast Cancer, Triple-Negative Breast Carcinoma
    View official trial listing →
  • Completed NCT NCT02650817

    Phase IB Study to Evaluate RAD1901 on the Availability of Estrogen Receptor Binding Sites in Metastatic Breast Cancer

    Not yet reported Stemline Therapeutics, Inc. 16 participants Est. completion 2019-10-18 5 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT02652650

    A Study to Investigate the Effect of JNJ-63623872 at Steady-state on the Steady-state Pharmacokinetics of Ethinylestradiol and Norethindrone

    Not yet reported Janssen Research & Development, LLC 18 participants Est. completion 2016-06 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02654054

    Efficacy and Safety of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women

    Not yet reported AbbVie 413 participants Est. completion 2018-12-12 96 sites
    Other conditions: Uterine Fibroids, Heavy Menstrual Bleeding
    View official trial listing →
  • Completed NCT NCT02654119

    Cyclophosphamide, Paclitaxel, and Trastuzumab in Treating Stage I-II HER2/Neu Positive Breast Cancer After Surgery

    Not yet reported University of Nebraska 20 participants Est. completion 2025-12-08 3 sites Stand-alone
    Other conditions: HER2 Positive Breast Carcinoma, Stage I Breast Cancer AJCC v7, Stage IA Breast Cancer AJCC v7, Stage IB Breast Cancer AJCC v7, Stage II Breast Cancer AJCC v6 and v7, Stage IIA Breast Cancer AJCC v6 and v7, Stage IIB Breast Cancer AJCC v6 and v7
    View official trial listing →
  • Status unknown NCT NCT02655146

    the Effects of GnRHa Add up to Routine Luteal Phase Support on Frozen Embryo Implantation in Frozen Embryo Transfer .

    Not yet reported Chong Qing Reproducive and Genetic Institute 700 participants Est. completion 2017-03 1 site
    Other conditions: Infertility
    View official trial listing →
  • Completed NCT NCT02657343

    An Open-Label, Phase Ib/II Clinical Trial Of Cdk 4/6 Inhibitor, Ribociclib (Lee011), In Combination With Trastuzumab Or T-Dm1 For Advanced/Metastatic Her2-Positive Breast Cancer.

    Not yet reported, Not yet reported Dana-Farber Cancer Institute 25 participants Est. completion 2022-06-30 2 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT02660294

    Intrauterine Autologous PRP Infusion Compared to HRT for Enhancing Endometrial Thickness in Patients Undergoing ICSI

    Not yet reported, Not yet reported Ain Shams University 30 participants Est. completion 2017-04 1 site
    Other conditions: Infertility
    View official trial listing →
  • Terminated NCT NCT02668783

    Efficacy and Safety of Etonogestrel + 17β-Estradiol Vaginal Ring (MK-8342B) in Women With Primary Dysmenorrhea (With Optional Extension) (MK-8342B-059)

    Not yet reported Organon and Co 25 participants Est. completion 2016-09-07
    Other conditions: Moderate to Severe Primary Dysmenorrhea
    View official trial listing →
  • Completed NCT NCT02668796

    To Study Generic Estradiol 10 mcg Vaginal Tablets in the Treatment of Vulvar and Vaginal Atrophy in Post Menopausal Women.

    Not yet reported Glenmark Pharmaceuticals Ltd. India 522 participants Est. completion 2016-09-21 1 site
    Other conditions: Vulvar and Vaginal Atrophy
    View official trial listing →
  • Terminated NCT NCT02668822

    Efficacy and Safety of Etonogestrel + 17β-Estradiol Vaginal Ring (MK-8342B) in the Treatment of Women With Primary Dysmenorrhea (MK-8342B-060)

    Not yet reported Organon and Co 18 participants Est. completion 2016-09-12
    Other conditions: Dysmenorrhea
    View official trial listing →
  • Terminated NCT NCT02669238

    Evaluation of a Subcutaneous Progestogen Implants in the Medical Management of Painful Endometriosis

    Not yet reported, Not yet reported Centre Hospitalier Universitaire de la Réunion 2 participants Est. completion 2019-10-10 1 site
    Other conditions: Endometriosis
    View official trial listing →
  • Completed NCT NCT02670785

    A Safety and Efficacy Study of Estradiol Vaginal Capsule in Postmenopausal Women With Vulvovaginal Atrophy

    Not yet reported Warner Chilcott 203 participants Est. completion 2016-11-14 20 sites
    Other conditions: Vulvovaginal Atrophy, Menopause, Dyspareunia
    View official trial listing →
  • Completed NCT NCT02672826

    Description of the Endothelial Phenotypes From the Subcutaneous Abdominal and Gluteo-femoral Adipose Tissues in Women

    Not yet reported University Hospital, Toulouse 50 participants Est. completion 2016-12 1 site
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT02673606

    Impact of Estrogen on Fear Extinction R61

    Not yet reported NYU Langone Health 136 participants Est. completion 2019-04-15 1 site
    Other conditions: Fear, Fear; Examination, Phobic
    View official trial listing →
  • Completed NCT NCT02675231

    A Study of Abemaciclib (LY2835219) in Women With HR+, HER2+ Locally Advanced or Metastatic Breast Cancer

    Not yet reported Eli Lilly and Company 237 participants Est. completion 2023-11-09 93 sites
    Other conditions: Hormone Receptor Positive Breast Cancer, HER-2 Positive Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT02677259

    Luteal Phase Estradiol Support for In Vitro Fertilization/Intracytoplasmic Sperm Injection Cycles

    Not yet reported One Fertility 506 participants Est. completion 2018-06
    Other conditions: IVF
    View official trial listing →
  • Completed NCT NCT02680366

    Treatment of Severe Asherman Syndrome by Collagen Scaffold Loaded With Autologous Bone Marrow Mononuclear Cells

    Not yet reported The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 152 participants Est. completion 2022-07-22 1 site Stand-alone
    Other conditions: Infertility, Asherman Syndrome
    View official trial listing →
  • Status unknown NCT NCT02681536

    Miniflare Versus Long Protocol in Poor Responders

    Not yet reported Woman's Health University Hospital, Egypt 200 participants Est. completion 2016-09 1 site
    Other conditions: Infertility
    View official trial listing →
  • Completed NCT NCT02684032

    A Study To Assess The Tolerability And Clinical Activity Of Gedatolisib In Combination With Palbociclib/Letrozole Or Palbociclib/Fulvestrant In Women With Metastatic Breast Cancer

    Not yet reported Celcuity Inc 141 participants Est. completion 2022-01-19 41 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT02689843

    Effects of Cyproterone Compound-spironolactone, Metformin and Pioglitazone on Inflammatory Markers in PCOS

    Not yet reported Shiraz University of Medical Sciences 90 participants Est. completion 2018-12-30 1 site
    Other conditions: Polycystic Ovary Syndrome
    View official trial listing →
  • Status unknown NCT NCT02690480

    Fulvestrant (F)+Placebo vs F+Palbociclib First Line for Postmenopausal Hormone Receptor+ Advanced Breast Cancer

    Not yet reported Spanish Breast Cancer Research Group 189 participants Est. completion 2023-12 32 sites
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Completed NCT NCT02691494

    Efficacy and Safety of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women (Replicate Study)

    Not yet reported AbbVie 378 participants Est. completion 2019-01-23 105 sites
    Other conditions: Uterine Fibroids, Heavy Menstrual Bleeding
    View official trial listing →
  • Completed NCT NCT02691936

    Comparison of Vaginal Laser Therapy to Vaginal Estrogen Therapy

    Not yet reported The Cleveland Clinic 69 participants Est. completion 2018-12 6 sites
    Other conditions: Atrophic Vaginitis, Menopause
    View official trial listing →
  • Completed NCT NCT02692755

    Palbociclib / Letrozole or Fulvestrant in African American Women With HR+ HER2- Breast Cancer

    Not yet reported, Not yet reported Georgetown University 35 participants Est. completion 2021-03-23 6 sites
    Other conditions: Hormone Receptor Positive HER-2 Negative Breast Cancer
    View official trial listing →
  • Terminated NCT NCT02693002

    Estrogen Diastolic Heart Failure

    Not yet reported Gretchen Wells 4 participants Est. completion 2016-11 1 site
    Other conditions: Menopause
    View official trial listing →
  • Terminated NCT NCT02697851

    Pharmacokinetic Effect of Evotaz/Microgynon Co-administration

    Not yet reported St Stephens Aids Trust 13 participants Est. completion 2017-10-31 1 site
    Other conditions: HIV
    View official trial listing →
  • Completed NCT NCT02701348

    Radiological and Biological Tumoural and Peri-tumoural Factors in Neoadjuvant Endocrine-treated Breast Cancers

    Not yet reported NHS Tayside 31 participants Est. completion 2020-12-24 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT02701452

    Ovarian Hyperstimulation Syndrome in Patients Triggered by GnRH Agonist for Excessive Follicular Response

    Not yet reported University Hospital, Lille 1 participants Est. completion 2019-01-01
    Other conditions: Ovarian Hyperstimulation Syndrome, Hypercoagulability
    View official trial listing →
  • Completed NCT NCT02710214

    A TSEC for Symptom Management in Menopausal Women With Multiple Sclerosis

    Not yet reported University of California, San Francisco 24 participants Est. completion 2019-04-24 1 site Stand-alone
    Other conditions: Menopause, Multiple Sclerosis
    View official trial listing →
  • Completed NCT NCT02710708

    YAZ Post Authorization Safety Study (PASS)/Post Authorization Efficacy Study (PAES) in China

    Not yet reported Bayer 1921 participants Est. completion 2018-07-03 38 sites
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT02712814

    Subtypes of Provoked Vestibulodynia

    Meir Medical Center 113 participants Est. completion 2021-08 1 site
    Other conditions: Provoked Localized Vulvodynia
    View official trial listing →
  • Status unknown NCT NCT02715232

    Effects of Sex Steroids on the Serotonin System

    Not yet reported Medical University of Vienna 92 participants Est. completion 2020-12 1 site
    Other conditions: Gender Dysphoria
    View official trial listing →
  • Completed NCT NCT02718144

    Assessment of Safety and Efficacy of Estetrol in Postmenopausal Women With Advanced Estrogen Receptor Positive (ER+) Breast Cancer

    Not yet reported, Not yet reported Pantarhei Oncology B.V. 12 participants Est. completion 2019-12-31 2 sites Stand-alone
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Completed NCT NCT02720224

    Study Conducted to Further Understand the Elimination Pathways, Metabolite Profile and PK Profile of 14C-estetrol

    Not yet reported Estetra 6 participants Est. completion 2016-04 1 site
    Other conditions: Contraception, Menopause
    View official trial listing →
  • Completed NCT NCT02726971

    Comparison of Different Doses of Oestrogen Therapy for Preventing Intrauterine Adhesion

    Not yet reported, Not yet reported Fu Xing Hospital, Capital Medical University 141 participants Est. completion 2016-08 1 site
    Other conditions: Asherman Syndrome
    View official trial listing →
  • Completed NCT NCT02729545

    The Efficacy and Safety Study of Tung's Acupuncture for Polycystic Ovarian Syndrome

    Not yet reported Beijing Hospital of Integrated Traditional Chinese and Western Medicine 60 participants Est. completion 2018-05 1 site
    Other conditions: Polycystic Ovarian Syndrome
    View official trial listing →
  • Completed NCT NCT02729701

    Pilot Study of the Effect of Duavee® on Benign Breast Tissue Proliferation

    Not yet reported University of Kansas Medical Center 28 participants Est. completion 2019-06 2 sites Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT02730429

    Trial of Letrozole + Palbociclib/Placebo in Metastatic Endometrial Cancer

    Not yet reported Nordic Society of Gynaecological Oncology - Clinical Trials Unit 78 participants Est. completion 2021-12-15 1 site
    Other conditions: Endometrial Cancer
    View official trial listing →
  • Status unknown NCT NCT02733731

    The Treatment Effect of Chinese Herbal Compound Ointment on Atrophic Vaginitis

    Not yet reported First Affiliated Hospital, Sun Yat-Sen University 80 participants Est. completion 2016-06 1 site
    Other conditions: Atrophic Vaginitis
    View official trial listing →
  • Active, not recruiting NCT NCT02734290

    Standard of Care Chemotherapy Plus Pembrolizumab for Breast Cancer

    Not yet reported, Not yet reported Providence Health & Services 29 participants Est. completion 2026-12 2 sites
    Other conditions: Triple Negative Breast Cancer
    View official trial listing →
  • Terminated NCT NCT02734615

    Phase I/Ib Trial of LSZ102 Single Agent or LSZ102 + LEE011 or LSZ102 + BYL719 in ER+ Breast Cancers

    Not yet reported Novartis Pharmaceuticals 199 participants Est. completion 2021-09-13 10 sites
    Other conditions: Advanced or Metastatic ER+ Breast Cancer
    View official trial listing →
  • Completed NCT NCT02736032

    Cryopreserved-thawed Embryo Transfer With or Without Gonadotropin Releasing Hormone Agonist

    Not yet reported Cairo University 310 participants Est. completion 2018-05 3 sites
    Other conditions: Infertility
    View official trial listing →
  • Completed NCT NCT02737800

    Effect of Prolonged GnRh Agonists on Results of Intracytoplasmic Sperm Injection (ICSI ) in Endometrioma Patients

    Not yet reported Kasr El Aini Hospital 88 participants Est. completion 2017-08 1 site
    Other conditions: Endometrioma
    View official trial listing →
  • Active, not recruiting NCT NCT02738866

    Palbociclib With Fulvestrant for Metastatic Breast Cancer After Treatment With Palbociclib and an Aromatase Inhibitor

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 60 participants Est. completion 2026-12 5 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT02744131

    OCP vs Metformin for Improvement in Clinical Symptoms and Metabolic Markers in Indian PCOS Women

    Not yet reported Kar Clinic & Hospital Pvt. Ltd. 100 participants Est. completion 2019-12 1 site
    Other conditions: Polycystic Ovary Syndrome
    View official trial listing →
  • Terminated NCT NCT02751385

    Investigation of the Effect of Nintedanib on the Pharmacokinetics of a Combination of Ethinylestradiol and Levonorgestrel in Patients With Non-small Cell Lung Cancer

    Not yet reported Boehringer Ingelheim 2 participants Est. completion 2017-11-28 1 site
    Other conditions: Carcinoma, Non-Small-Cell Lung
    View official trial listing →
  • Status unknown NCT NCT02752568

    Assisted Hatching Versus Endometrial Scratch in Recurrent Implantation Failure

    Not yet reported Kasr El Aini Hospital 300 participants Est. completion 2016-12
    Other conditions: Recurrent Implantation Failure
    View official trial listing →
  • Completed NCT NCT02752893

    Estrogen Receptor-Positive Breast Cancer Patient-Derived Xenografts

    Dartmouth-Hitchcock Medical Center 10 participants Est. completion 2019-04-03 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT02753686

    Treatment of Canadian Men and Pre/Peri/Post-menopausal Women With ER+ Advanced Breast Cancer in the Real-World Setting With Hormone Therapy ± Targeted Therapy

    Novartis Pharmaceuticals 440 participants Est. completion 2022-12-01 25 sites
    Other conditions: HR+ HER2- Men, Pre/Postmenopausal Advanced Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT02755038

    Scalp Hair Estradiol and Progesterone Level Determination in Women (Proof of Concept Study)

    Bnai Zion Medical Center 40 participants Est. completion 2017-03 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02756364

    Sapanisertib in Combination With Fulvestrant in Women With Advanced or Metastatic Breast Cancer After Aromatase Inhibitor Therapy

    Not yet reported Calithera Biosciences, Inc 141 participants Est. completion 2019-11-25 53 sites
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Withdrawn NCT NCT02757287

    Desogestrel (DSG) and Corifollitropin(FSH-CTP) Alfa for Ovarian Stimulation in Donors

    Not yet reported Fundacion Dexeus Est. completion 2018-12-01 1 site
    Other conditions: Infertility
    View official trial listing →
  • Status unknown NCT NCT02757469

    Oral Contraceptives as Infertility Treatments for Premature Ovarian Failure

    Not yet reported Navy General Hospital, Beijing 20 participants Est. completion 2021-05 1 site
    Other conditions: Primary Ovarian Insufficiency, Menopause, Premature
    View official trial listing →
  • Completed NCT NCT02758431

    Cardiovascular Outcomes of Low Testosterone

    Not yet reported University of Colorado, Denver 232 participants Est. completion 2023-01-04 1 site
    Other conditions: Hypogonadism
    View official trial listing →
  • Completed NCT NCT02760030

    Endocrine Therapy Fulvestrant & Palbociclib or Aromatase Inhibitor Therapy in Treating Older Patients With Hormone Responsive Breast Cancer That Cannot Be Removed by Surgery

    Not yet reported Ohio State University Comprehensive Cancer Center 14 participants Est. completion 2025-08-31 3 sites
    Other conditions: Estrogen Receptor and/or Progesterone Receptor Positive, HER2/Neu Negative, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage IIA Breast Cancer, Stage IIB Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer
    View official trial listing →
  • Terminated NCT NCT02761694

    Vevorisertib (ARQ 751) as a Single Agent or in Combination With Other Anti-Cancer Agents, in Solid Tumors With PIK3CA / AKT / PTEN Mutations (MK-4440-001)

    Not yet reported ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) 78 participants Est. completion 2021-03-10 6 sites
    Other conditions: Cancer, Solid Tumors
    View official trial listing →
  • Active, not recruiting NCT NCT02763566

    A Study of Abemaciclib (LY2835219) in Participants With Breast Cancer

    Not yet reported Eli Lilly and Company 463 participants Est. completion 2028-03 45 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT02767661

    Metronomic Capecitabine Plus Aromatase Inhibitor for First Line Treatment in HR(+), Her2(-) Metastatic Breast Cancer

    Not yet reported Sun Yat-sen University 263 participants Est. completion 2023-08-25 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT02769104

    Aromatase Inhibitors Plus Chemotherapy vs Chemotherapy as Neoadjuvant Treatment in Postmenopausal HR(+) Breast Cancer

    Not yet reported Zhejiang Cancer Hospital 120 participants Est. completion 2019-12 1 site
    Other conditions: Neoadjuvant Therapy
    View official trial listing →
  • Completed NCT NCT02770365

    Comparative Safety and Efficacy of Two Treatments in the Treatment of Vulvar and Vaginal Atrophy

    Not yet reported Padagis LLC 695 participants Est. completion 2016-11 1 site
    Other conditions: Atrophy
    View official trial listing →
  • Completed NCT NCT02770469

    Culturally Tailored Educational and Support Program to Increase Quality of Life Among Korean Breast Cancer Survivors

    Not yet reported University of Maryland, College Park 86 participants Est. completion 2016-06 Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT02773784

    Comparison of CNB and Surgical Specimens for ER, PgR, HER2 Status and Ki67 Index in Invasive Breast Cancer.

    Peking University 314 participants Est. completion 2016-09 1 site
    Other conditions: Invasive Breast Cancer
    View official trial listing →
  • Completed NCT NCT02779855

    Talimogene Laherparepvec in Combination With Neoadjuvant Chemotherapy in Triple Negative Breast Cancer

    Not yet reported, Not yet reported H. Lee Moffitt Cancer Center and Research Institute 50 participants Est. completion 2025-08-26 1 site
    Other conditions: Breast Cancer, Ductal Carcinoma, Invasive Breast Carcinoma, Invasive Ductal Breast Carcinoma
    View official trial listing →
  • Terminated NCT NCT02780791

    Maturation of Follicles After Transplantation of Ovarian Tissue Into the Pelvic Wall and the Ovary

    Not yet reported Insel Gruppe AG, University Hospital Bern 1 participants Est. completion 2020-07-31 1 site
    Other conditions: Infertility, Ovarian Failure, Premature
    View official trial listing →
  • Withdrawn NCT NCT02792153

    Estradiol and Fear Extinction in Anorexia Nervosa (AN)

    Not yet reported Johns Hopkins University Est. completion 2018-08-22 1 site Stand-alone
    Obstructive sleep apnea
    View official trial listing →
  • Completed NCT NCT02792465

    A Study of Investigational Drug CFI-402257 in Patients With Advanced Solid Tumors

    Not yet reported University Health Network, Toronto 52 participants Est. completion 2025-06-12 3 sites
    Other conditions: Advanced Solid Cancers, Breast Cancer
    View official trial listing →
  • Completed NCT NCT02792517

    Erenumab (AMG 334) Plus Combined Oral Contraceptive Drug Interaction Study in Healthy Females

    Not yet reported Amgen 41 participants Est. completion 2016-09-09 4 sites Stand-alone
    Other conditions: Headache, Migraine
    View official trial listing →
  • Completed NCT NCT02793089

    Risk of Ectopic Pregnancy and Variation of Luteal Estradiol and Progesterone Levels in IVF

    IVI Vigo 578 participants Est. completion 2016-05
    Other conditions: Ectopic Pregnancy
    View official trial listing →
  • Completed NCT NCT02795039

    Bioequivalence Study of Fulvestrant Injection 50 mg/mL in Healthy Post-menopausal Female Subjects

    Not yet reported Fresenius Kabi 266 participants Est. completion 2017-03-03 3 sites
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02817841

    E4 FREEDOM (Female Response Concerning Efficacy and Safety of Estetrol/Drospirenone as Oral Contraceptive in a Multicentric Study) - United States/Canada Study

    Not yet reported Estetra 2148 participants Est. completion 2018-11-16 2 sites
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT02820961

    Drug-Drug Interaction Study of Entinostat and Exemestane in Postmenopausal Women With ER+ Breast Cancer

    Not yet reported Syndax Pharmaceuticals 61 participants Est. completion 2021-07-12 3 sites
    Other conditions: Breast Cancer, Estrogen Receptor Positive Breast Cancer
    View official trial listing →
  • Completed NCT NCT02821702

    Fertility Post Placenta Accrete

    Not yet reported Sheba Medical Center 135 participants Est. completion 2019-12 1 site Stand-alone
    Other conditions: Fertility
    View official trial listing →
  • Terminated NCT NCT02823262

    A Breast Cancer Treatment Decision Aid for Women Aged 70 and Older

    Not yet reported Beth Israel Deaconess Medical Center 65 participants Est. completion 2022-03 2 sites Stand-alone
    Other conditions: Breast Cancer, Estrogen Receptor Positive Breast Cancer, Node-negative Breast Cancer, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast
    View official trial listing →
  • Completed NCT NCT02832180

    The Effect of BMS-986142 on the Pharmacokinetics of a Combined Oral Contraceptive (OC) Containing Ethinyl Estradiol (EE) and Norethindrone Acetate (NET) in Healthy Female Subjects

    Not yet reported Bristol-Myers Squibb 25 participants Est. completion 2016-10 2 sites
    Other conditions: Arthritis
    View official trial listing →
  • Completed NCT NCT02834312

    E4Relief (Response to Estetrol in Life Improvement for MEnopausal-associated Hot Flushes)

    Not yet reported Donesta Bioscience 260 participants Est. completion 2018-01-22 1 site
    Other conditions: Hot Flushes
    View official trial listing →
  • Completed NCT NCT02835846

    Investigation of the Effect of the Female Urinary Microbiome on Incontinence

    Not yet reported Loyola University 35 participants Est. completion 2018-05 1 site Stand-alone
    Other conditions: Overactive Bladder, Incontinence, Nocturia
    View official trial listing →
  • Status unknown NCT NCT02838576

    Effects of Hormone Replacement Therapy on Arthralgia in Postmenopausal Women

    Not yet reported Hospital de Clinicas de Porto Alegre 72 participants Est. completion 2020-12-31 1 site Stand-alone
    Other conditions: Arthralgia
    View official trial listing →
  • Completed NCT NCT02841202

    The Effect of Oral Contraceptive Pills On Eyes

    Not yet reported Kayseri Education and Research Hospital 40 participants Est. completion 2016-07
    Other conditions: Adverse Effect of Oral Contraceptives, Subsequent Encounter
    View official trial listing →
  • Completed NCT NCT02845219

    A Trial Investigating the Influence of Oral Semaglutide on Pharmacokinetics of Ethinylestradiol and Levonorgestrel in an Oral Contraceptive Combination Drug in Healthy Postmenopausal Females

    Not yet reported Novo Nordisk A/S 25 participants Est. completion 2016-12 1 site
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT02845388

    Sildenafil Citrate in Frozen Embryo Transfer

    Not yet reported Omar Ahmed El Sayed Saad 90 participants Est. completion 2016-06
    Other conditions: Infertility
    View official trial listing →
  • Completed NCT NCT02846142

    Study to Assess the Safety, Tolerability, PK, ECG Effects, Food Effect, and Drug-drug Interaction (DDI) of Hormonal Contraceptives of PTI-428 in Healthy Female Volunteers

    Not yet reported Proteostasis Therapeutics, Inc. 94 participants Est. completion 2017-03 1 site
    Other conditions: Healthy Volunteer
    View official trial listing →
  • Completed NCT NCT02847806

    Effects of Replacement Therapy With Sexual Steroid Hormones on the Insulin Sensitivity of Hypogonadal Man

    Not yet reported University Hospital, Caen 6 participants Est. completion 2016-08 1 site
    Other conditions: Hypogonadism
    View official trial listing →
  • Withdrawn NCT NCT02853071

    Efficacy and Safety of Estracyt® in Metastatic Breast Cancer

    Not yet reported Centre Hospitalier Universitaire de Besancon Est. completion 2020-01 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT02855294

    The Effect of Oral Contraceptives on Women Balance

    Not yet reported Cairo University 100 participants Est. completion 2016-07 1 site
    Other conditions: Joint Stabilioty
    View official trial listing →
  • Status unknown NCT NCT02855632

    The Efficacy of G-CSF Against Adhesion Reformation After Hysteroscopic Adhesiolysis

    Not yet reported Sir Run Run Shaw Hospital 240 participants Est. completion 2019-12 1 site
    Other conditions: Intrauterine Adhesion
    View official trial listing →
  • Completed NCT NCT02859285

    A Study Evaluating the Effects of Topical Clitoral Estradiol Cream in Post Menopausal Women

    Not yet reported ProHealth Care, Inc 30 participants Est. completion 2020-03-10 1 site
    Other conditions: Hypoactive Sexual Desire Disorder
    View official trial listing →
  • Completed NCT NCT02860000

    Alisertib With or Without Fulvestrant in Treating Patients With Locally Advanced or Metastatic, Endocrine-Resistant Breast Cancer

    Not yet reported Mayo Clinic 96 participants Est. completion 2025-02-14 8 sites
    Other conditions: Estrogen Receptor Status, HER2/Neu Negative, Invasive Breast Carcinoma, Postmenopausal, Stage III Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    View official trial listing →
  • Withdrawn NCT NCT02860897

    Patient Adherence to Premarin Versus Vagifem Therapy After Female Pelvic Reconstructive Surgery

    Not yet reported University Hospitals Cleveland Medical Center Est. completion 2017-07 1 site Stand-alone
    Other conditions: Estrogen, Menopause, Pelvic Floor Disorders, Surgery
    View official trial listing →
  • Completed NCT NCT02866786

    The Effects of OCP and Metformin on Clinical, Hormonal, Metabolic and Ultrasonographic Characteristics in PCOS

    Not yet reported S.C.B. Medical College and Hospital 101 participants Est. completion 2017-08-01 1 site
    Other conditions: Polycystic Ovary Syndrome
    View official trial listing →
  • Completed NCT NCT02866955

    Evaluation of the Efficacy of Estramustine in Patient With Breast Cancer Progression After Treatment With Aromatase Inhibitor.

    Not yet reported Institut de Cancérologie de Lorraine 100 participants Est. completion 2015-08-28 21 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT02871791

    Palbociclib With Everolimus + Exemestane In BC

    Not yet reported, Not yet reported Dana-Farber Cancer Institute 41 participants Est. completion 2021-09 1 site
    Other conditions: Human Epidermal Growth Factor 2 Negative Carcinoma of Breast, Hormone Receptor (HR)-Positive Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT02871986

    Pubertal Induction in Individuals With Hypogonadism

    University College, London 24 participants Est. completion 2020-03 1 site
    Other conditions: Primary Amenorrhoea, Hypothalamic Amenorrhoea, Hypogonadotrophic Hypogonadism, Hypopituitarism, Turner's Syndrome, Primary Ovarian Insufficiency
    View official trial listing →
  • Completed NCT NCT02872818

    Apoptotic Signaling Pathways in Rats With Endometrial Hyperplasia

    Not yet reported Kayseri Education and Research Hospital 40 participants Est. completion 2015-03 1 site
    Other conditions: Apoptotic Signal Pathways in Endometrial Hyperplasia
    View official trial listing →
  • Completed NCT NCT02874248

    E4/DRSP Single and Multiple Dose PK and Early QT Study

    Not yet reported Estetra 55 participants Est. completion 2016-11-21
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT02885454

    To Evaluate the Effects of Odalasvir and AL-335 With Simeprevir on the Single-Dose Pharmacokinetics of Ethinylestradiol and Drospirenone in Healthy Female Participants

    Not yet reported Janssen Research & Development, LLC 24 participants Est. completion 2016-12 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02887885

    Sustainability of Vaginal Estrogen Therapy in Postmenopausal Women

    Insel Gruppe AG, University Hospital Bern 32 participants Est. completion 2020-04-10 1 site
    Other conditions: Atrophy of Vagina, Postmenopause
    View official trial listing →
  • Completed NCT NCT02892214

    The Reciprocal Relations Between Psychosocial Characteristics and the Progression of Vestibulodynia

    Meir Medical Center 113 participants Est. completion 2021-12 1 site
    Other conditions: Localized Provoked Vulvodynia
    View official trial listing →
  • Completed NCT NCT02892942

    NATural Ovarian Stimulation

    Not yet reported Assistance Publique - Hôpitaux de Paris 129 participants Est. completion 2019-02-08 1 site
    Other conditions: Infertility
    View official trial listing →
  • Completed NCT NCT02894398

    Study in Women With Advanced Breast Cancer Receiving Palbociclib With AI or Fulvestrant

    Not yet reported iOMEDICO AG 388 participants Est. completion 2023-02-15 70 sites
    Other conditions: Breast Cancer, Hormone Receptor Positive Tumor, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast
    View official trial listing →
  • Completed NCT NCT02900664

    A Study of PDR001 in Combination With CJM112, EGF816, Ilaris® (Canakinumab) or Mekinist® (Trametinib)

    Not yet reported Novartis Pharmaceuticals 283 participants Est. completion 2021-03-17 23 sites
    Other conditions: Colorectal Cancer, Triple Negative Breast Cancer, NSCLC - Adenocarcinoma
    View official trial listing →
  • Status unknown NCT NCT02909361

    Fulvestrant 500mg in Patients With Advanced Breast Cancer

    Fudan University 500 participants Est. completion 2022-10 1 site
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT02910050

    Bicalutamide Plus Aromatase Inhibitors in ER(+)/AR(+)/HER2(-) Metastatic Breast Cancer

    Not yet reported Xu fei 58 participants Est. completion 2018-12 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT02911844

    Estrogen Receptor Antagonist in Patients With Pulmonary Arterial Hypertension

    Not yet reported University of Pennsylvania 5 participants Est. completion 2018-12-05 1 site
    Other conditions: Pulmonary Arterial Hypertension
    View official trial listing →
  • Status unknown NCT NCT02915380

    Pituitary Dysfunction After Aneurysmal Subarachnoid Hemorrhage

    Dr. Rita Bertuetti 50 participants Est. completion 2018-01
    Other conditions: Thyroid Disfunction, Subarachnoid Haemorrhage From Cerebral Aneurism Rupture, Pituitary Disfunction
    View official trial listing →
  • Completed NCT NCT02920671

    Muscle OXPHOS and Nutrient Homeostasis

    University of Pennsylvania 45 participants Est. completion 2024-08-28 2 sites
    Other conditions: Mitochondrial Diseases, Obesity
    View official trial listing →
  • Completed NCT NCT02922127

    Compare Daily Ulipristal Acetate and Combined Oral Contraceptive Effects on Breast Epithelial Cell Proliferation

    Not yet reported Columbia University 29 participants Est. completion 2019-10-21 2 sites
    Other conditions: Contraception
    View official trial listing →
  • Withdrawn NCT NCT02922348

    Hormone Replacement for Premature Ovarian Insufficiency

    Not yet reported University of Pennsylvania Est. completion 2018-12-01 1 site
    Other conditions: Primary Ovarian Insufficiency
    View official trial listing →
  • Completed NCT NCT02925494

    An Extension Study to Evaluate the Efficacy and Safety of Elagolix in Premenopausal Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids

    Not yet reported AbbVie 433 participants Est. completion 2019-03-22 124 sites
    Other conditions: Uterine Fibroids, Heavy Menstrual Bleeding
    View official trial listing →
  • Completed NCT NCT02927392

    Brown Adipose Tissue Activity in Pre- and Postmenopausal Women

    Not yet reported University of Colorado, Denver 69 participants Est. completion 2023-05-02 1 site
    Other conditions: Menopause, Obesity
    View official trial listing →
  • Completed NCT NCT02931695

    Ventricular Repolarization During the Pregnancy-to-Postpartum Transition (QuTe)

    French Cardiology Society 90 participants Est. completion 2026-02-03 1 site
    Other conditions: Pregnancy, Long QT Syndrome
    View official trial listing →
  • Terminated NCT NCT02936206

    Examination of Breast Cancer Cells of Pre-menopausal and Post-menopausal Women Before and After Exposure to Tamoxifen or Fulvestrant.

    Not yet reported Icahn School of Medicine at Mount Sinai 2 participants Est. completion 2020-05-01 3 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT02939898

    Mapping the Endocrine Determinants of Ovarian Stimulation to Optimize Outcomes in Fresh Embryo Transfer Cycles

    Not yet reported, Not yet reported Sven O. Skouby 33 participants Est. completion 2018-01 1 site
    Other conditions: Infertility
    View official trial listing →
  • Completed NCT NCT02946684

    Effect of Addition of Aromatase Inhibitor to Ovarian Stimulation Therapy in IVF Treatment

    Not yet reported, Not yet reported Sven O. Skouby 129 participants Est. completion 2018-10-30 4 sites
    Other conditions: Infertility
    View official trial listing →
  • Active, not recruiting NCT NCT02947685

    Randomized, Open Label, Clinical Study of the Targeted Therapy, Palbociclib, to Treat Metastatic Breast Cancer

    Not yet reported Alliance Foundation Trials, LLC. 518 participants Est. completion 2026-07-31 106 sites
    Other conditions: HER-2 Positive Breast Cancer, Estrogen Receptor Positive Breast Cancer
    View official trial listing →
  • Completed NCT NCT02951949

    Estrogen Exposure and Atherosclerosis in Postmenopausal Women

    University of Valencia 92 participants Est. completion 2015-12 1 site
    Other conditions: Atherosclerosis, Menopause, Estrogens, Carotid Intima-media Thickness, Coronary Stenoses, Women
    View official trial listing →
  • Completed NCT NCT02953860

    Fulvestrant Plus Enzalutamide in ER+/Her2- Advanced Breast Cancer

    Not yet reported University of Colorado, Denver 32 participants Est. completion 2020-04-10 3 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT02955394

    Preoperative Fulvestrant With or Without Enzalutamide in ER+/Her2- Breast Cancer

    Not yet reported University of Colorado, Denver 61 participants Est. completion 2027-02 3 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT02957630

    "E4/DRSP Endocrine Function, Metabolic Control and Hemostasis Study"

    Not yet reported, Not yet reported Estetra 101 participants Est. completion 2017-10-09 1 site
    Other conditions: Contraception, Liver Metabolism, Hemostasis Parameter
    View official trial listing →
  • Completed NCT NCT02958852

    A Clinical Trial to Compare Efficacy and Tolerability of Atorvastatin in Addition to Endocrine Treatment With Focus on Mechanisms of Resistance to Endocrine Treatment (Fulvestrant/Aromatase Inhibitors) in Patients With Advanced Breast Cancer

    Not yet reported Lund University Hospital 126 participants Est. completion 2025-01-15 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT02964507

    Dose Escalation and Expansion Study of GSK525762 in Combination With Fulvestrant in Participants With Hormone Receptor-positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Advanced or Metastatic Breast Cancer

    Not yet reported GlaxoSmithKline 124 participants Est. completion 2021-07-19 38 sites
    Other conditions: Neoplasms
    View official trial listing →
  • Completed NCT NCT02967510

    Study Evaluating the Efficacy and Safety of Three Formulations of Ultra-low Dose Estriol Vaginal Gel (0.005%, 0.002%, 0.0008% Estriol Vaginal Gel) for the Treatment of Vaginal Dryness in Postmenopausal Women With Vulvovaginal Atrophy

    Not yet reported ITF Research Pharma, S.L.U. 283 participants Est. completion 2018-05 23 sites
    Other conditions: Vaginal Atrophy
    View official trial listing →
  • Completed NCT NCT02969590

    Regulation of Cervical Mucus Secretion

    Not yet reported Oregon Health and Science University 5 participants Est. completion 2017-08-23 1 site
    Other conditions: Fertility, Contraception
    View official trial listing →
  • Completed NCT NCT02970682

    SFX-01 in the Treatment and Evaluation of Metastatic Breast Cancer

    Not yet reported Evgen Pharma 60 participants Est. completion 2019-03 10 sites
    Other conditions: Breast Neoplasm
    View official trial listing →
  • Status unknown NCT NCT02983071

    G1T38, a CDK 4/6 Inhibitor, in Combination With Fulvestrant in Hormone Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer

    Not yet reported, Not yet reported G1 Therapeutics, Inc. 102 participants Est. completion 2023-10 8 sites
    Other conditions: Carcinoma, Ductal, Breast, Breast Cancer, Breast Neoplasm
    View official trial listing →
  • Terminated NCT NCT02983604

    GS-5829 in Combination With Fulvestrant or Exemestane in Women With Advanced Estrogen Receptor Positive, HER2 Negative-Breast Cancer

    Not yet reported, Not yet reported Gilead Sciences 14 participants Est. completion 2018-07-19 6 sites
    Other conditions: Advanced Estrogen Receptor Positive HER2- Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT02984696

    Total Antioxidant Capacity Before and After HRT in Hypotalamic Amenorrhea

    Not yet reported Catholic University of the Sacred Heart 20 participants Est. completion 2017-12 1 site
    Other conditions: Hypothalamic Amenorrhea
    View official trial listing →
  • Completed NCT NCT02988986

    TAK-228 Plus Tamoxifen in Patients With ER-Positive, HER2-negative Breast Cancer

    Not yet reported The Methodist Hospital Research Institute 28 participants Est. completion 2019-03-30 3 sites Stand-alone
    Other conditions: Estrogen Receptor Positive Breast Cancer
    View official trial listing →
  • Completed NCT NCT02995694

    A Study Comparing Estradiol Vaginal Cream to Estrace® Cream in Females With Atrophic Vaginitis

    Not yet reported Alvogen Pine Brook LLC 535 participants Est. completion 2016-12
    Other conditions: Atrophic Vaginitis
    View official trial listing →
  • Completed NCT NCT02995772

    Neoadjuvant Hormonal Therapy Compared to Neoadjuvant Chemotherapy in Stage IIIB/C and IV Breast Cancer Patients

    Not yet reported Dharmais National Cancer Center Hospital 122 participants Est. completion 2018-11 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT02996760

    Influence Instillation Plasma Rich in Growth Factors in Endometrial Cavity Endometrial Development in Assisted Reproduction.

    Not yet reported IVI Bilbao 22 participants Est. completion 2021-12-31 1 site Stand-alone
    Other conditions: Endometrial Development
    View official trial listing →
  • Completed NCT NCT02997995

    Durvalumab and Endocrine Therapy in ER+/Her2- Breast Cancer After CD8+ Infiltration Effective Immune-Attractant Exposure

    Not yet reported UNICANCER 61 participants Est. completion 2020-08-28 29 sites
    Other conditions: Breast Cancer, Estrogen Receptor Positive Tumor, Menopause, Hormone Antagonist
    View official trial listing →
  • Terminated NCT NCT03003949

    The Menopause Transition: Estrogen Variability, Stress Reactivity and Mood

    Not yet reported University of North Carolina, Chapel Hill 82 participants Est. completion 2020-05-10 2 sites
    Other conditions: Perimenopausal Disorder, Stress, Emotional
    View official trial listing →
  • Withdrawn NCT NCT03005275

    A Comparison of Cost - Effectiveness of Stimulated ICSI and IVM Strategy in PCOS Women

    Not yet reported Vietnam National University Est. completion 2017-04
    Other conditions: Infertility
    View official trial listing →
  • Active, not recruiting NCT NCT03006172

    To Evaluate the Safety, Tolerability, and Pharmacokinetics of Inavolisib Single Agent in Participants With Solid Tumors and in Combination With Endocrine and Targeted Therapies in Participants With Breast Cancer

    Not yet reported Genentech, Inc. 200 participants Est. completion 2026-12-31 12 sites
    Other conditions: Breast Cancer, Solid Tumor
    View official trial listing →
  • Completed NCT NCT03007979

    Alternative Dosing Schedule of Palbociclib in Metastatic Hormone Receptor Positive Breast Cancer

    Not yet reported Washington University School of Medicine 55 participants Est. completion 2023-03-31 2 sites
    Other conditions: Breast Cancer, Breast Carcinoma, Cancer of Breast, Malignant Tumor of Breast
    View official trial listing →
  • Terminated NCT NCT03018106

    Ospemifene vs. Conjugated Estrogens in the Treatment of Postmenopausal Sexual Dysfunction

    Not yet reported Emory University 1 participants Est. completion 2017-09-29 4 sites Stand-alone
    Other conditions: Sexual Dysfunction, Physiological
    View official trial listing →
  • Completed NCT NCT03018366

    Atherosclerosis, Immune Mediated Inflammation and Hypoestrogenemia in Young Women

    Not yet reported Cedars-Sinai Medical Center 29 participants Est. completion 2023-02-01 1 site
    Cardiovascular disease Other conditions: Estrogen Deficiency, Functional Hypothalamic Amenorrhea, Endothelial Dysfunction
    View official trial listing →
  • Completed NCT NCT03020953

    The Anabolic Effects of Estrogen on Skeletal Muscles

    Not yet reported University of Aarhus 31 participants Est. completion 2018-02-15 1 site Stand-alone
    Other conditions: Estrogen Supplementation
    View official trial listing →
  • Status unknown NCT NCT03024580

    A Study Evaluating Megestrol Acetate Modulation in Hormone Receptor Positive Advanced Breast Cancer

    Not yet reported Instituto Nacional de Cancer, Brazil 20 participants Est. completion 2020-09 1 site
    Other conditions: Breast Neoplasm
    View official trial listing →
  • Status unknown NCT NCT03033160

    Vaginal Estrogen for Asymptomatic Microscopic Hematuria

    Not yet reported Boston Urogynecology Associates 68 participants Est. completion 2020-12-30 1 site
    Other conditions: Asymptomatic Microscopic Hematuria
    View official trial listing →
  • Status unknown NCT NCT03037944

    Levonorgestrel-releasing Intrauterine System Versus a Low-dose Combined Oral Contraceptive for Management of Adenomyosis Uteri

    Not yet reported Ain Shams Maternity Hospital 32 participants Est. completion 2018-12-01 1 site Stand-alone
    Other conditions: Adenomyosis
    View official trial listing →
  • Completed NCT NCT03041129

    Post-Prandial Liver Glucose Metabolism in PCOS

    University of Colorado, Denver 19 participants Est. completion 2018-09-29 1 site
    Other conditions: Polycystic Ovarian Syndrome, Obesity, Hepatic Steatosis
    View official trial listing →
  • Completed NCT NCT03043820

    Raloxifene Augmentation in Patients With a Schizophrenia Spectrum Disorder

    Not yet reported Iris Sommer 110 participants Est. completion 2021-07-01 1 site
    Other conditions: Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder, Psychosis NOS
    View official trial listing →
  • Completed NCT NCT03043924

    Functional Study of the Hypothalamus in Magnetic Resonance Imaging (MRI) in Polycystic Ovary Syndrome (PCOS)

    Not yet reported University Hospital, Lille 52 participants Est. completion 2022-04-15 1 site
    Other conditions: Polycystic Ovary Syndrome
    View official trial listing →
  • Completed NCT NCT03047330

    Menopausal Sleep Fragmentation and Body Fat Gain

    Not yet reported Brigham and Women's Hospital 41 participants Est. completion 2022-08-01 1 site
    Other conditions: Menopause
    View official trial listing →
  • Completed NCT NCT03049735

    LIBERTY 1: Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids

    Not yet reported Myovant Sciences GmbH 388 participants Est. completion 2020-08-24 110 sites
    Other conditions: Heavy Menstrual Bleeding, Uterine Fibroid
    View official trial listing →
  • Completed NCT NCT03056755

    Study Assessing the Efficacy and Safety of Alpelisib Plus Fulvestrant or Letrozole, Based on Prior Endocrine Therapy, in Patients With PIK3CA Mutant, HR+, HER2- Advanced Breast Cancer Who Have Progressed on or After Prior Treatments

    Not yet reported Novartis Pharmaceuticals 383 participants Est. completion 2024-11-12 94 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT03060304

    The Effect of Tamoxifen on Clinical Outcome in Women With Thin Endometrium Undergoing Frozen Thawed Cycle.

    Not yet reported Sun Yat-sen University 100 participants Est. completion 2020-06
    Other conditions: Endometrium
    View official trial listing →
  • Completed NCT NCT03063684

    Fractional / Pixel CO2 Laser Treatment of Vulvar Atrophy and Lichen Sclerosus

    Not yet reported Hadassah Medical Organization 16 participants Est. completion 2019-04-28 1 site Stand-alone
    Other conditions: Vaginal Atrophy, Lichen Sclerosus
    View official trial listing →
  • Withdrawn NCT NCT03069781

    The Effects of 17β-estradiol on Skeletal Muscle

    Not yet reported McMaster University Est. completion 2018-08-14 1 site
    Other conditions: Muscle Atrophy
    View official trial listing →
  • Completed NCT NCT03074045

    LCS16 vs. COC User Satisfaction and Tolerability Study

    Not yet reported Bayer 145 participants Est. completion 2022-08-05 9 sites
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT03075956

    Safety, Tolerability and Pharmacokinetics of Estetrol (E4) After Single and Multiple Oral Doses in Healthy Female Volunteers

    Not yet reported Estetra 31 participants Est. completion 2017-08-02 1 site
    Other conditions: Contraception, Menopause
    View official trial listing →
  • Completed NCT NCT03077555

    Ovulation and Follicular Development Associated With Mid Follicular Phase Initiation of Combined Hormonal Contraception

    Not yet reported Mahidol University 69 participants Est. completion 2018-02-28 1 site
    Other conditions: Ovulation Inhibition
    View official trial listing →
  • Terminated NCT NCT03077698

    An Endometrial Cancer Study for Women With Recurrent or Persistent Endometrial Cancer

    Not yet reported Xenetic Biosciences, Inc. 25 participants Est. completion 2020-07-17 25 sites
    Other conditions: Endometrial Cancer
    View official trial listing →
  • Completed NCT NCT03077711

    Methenamine Hippurate Versus Trimethoprim in the Prevention of Recurrent UTIs

    Not yet reported Endeavor Health 92 participants Est. completion 2019-06-21 1 site
    Other conditions: Urinary Tract Infections, Recurrent
    View official trial listing →
  • Completed NCT NCT03078751

    Adjuvant Ribociclib With Endocrine Therapy in Hormone Receptor+/HER2- High Risk Early Breast Cancer

    Not yet reported Novartis Pharmaceuticals 54 participants Est. completion 2020-03-09 33 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT03079011

    PAlbociclib and Circulating Tumor DNA for ESR1 Mutation Detection

    Not yet reported UNICANCER 1017 participants Est. completion 2025-09-22 82 sites Stand-alone
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT03081130

    Intravenous Laser Irradiation Effect on Treatment Resistant Thin Endometrium

    Kaohsiung Veterans General Hospital. 60 participants Est. completion 2018-03-31 1 site
    Other conditions: Endometrium, Laser
    View official trial listing →
  • Withdrawn NCT NCT03081234

    Adjuvant Ribociclib With Endocrine Therapy in Hormone Receptor+/HER2- Intermediate Risk Early Breast Cancer

    Not yet reported Novartis Pharmaceuticals Est. completion 2025-11-17
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT03091595

    E4/DRSP Ovarian Function Inhibition Study

    Not yet reported Estetra 82 participants Est. completion 2018-06-08 1 site
    Other conditions: Prevention of Pregnancy
    View official trial listing →
  • Completed NCT NCT03096847

    Study for Women and Men With Hormone-receptor Positive Locally Advanced or Metastatic Breast Cancer

    Not yet reported Novartis Pharmaceuticals 502 participants Est. completion 2020-02-06 84 sites
    Other conditions: Advanced Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT03097120

    The Estrogen Replacement and Atherosclerosis Trial ; Primary Outcome Measure is Mean Minimal Coronary Artery Diameter After Avg of 3.2 Yrs.

    Not yet reported Wake Forest University Health Sciences 309 participants Est. completion 2001-01 1 site
    Other conditions: Heart Disease
    View official trial listing →
  • Completed NCT NCT03099174

    This Study in Patients With Different Types of Cancer (Solid Tumours) Aims to Find a Safe Dose of Xentuzumab in Combination With Abemaciclib With or Without Hormonal Therapies. The Study Also Tests How Effective These Medicines Are in Patients With Lung and Breast Cancer

    Not yet reported Boehringer Ingelheim 133 participants Est. completion 2024-05-16 30 sites
    Other conditions: Neoplasms, Breast Neoplasms
    View official trial listing →
  • Completed NCT NCT03101085

    S-Equol in Alzheimer's Disease 2 Trial

    Not yet reported, Not yet reported Russell Swerdlow 40 participants Est. completion 2021-03-01 2 sites
    Other conditions: Alzheimer Disease
    View official trial listing →
  • Completed NCT NCT03111511

    A Study in Healthy Female Participants to Investigate the Effect of JNJ-56136379 at Steady-state on the Single-dose Pharmacokinetics of Ethinylestradiol and Drospirenone (Oral Contraceptive) and on the Single-dose Pharmacokinetics of Midazolam (Probe Substrate for Cytochrome P450 3A4)

    Not yet reported Janssen Sciences Ireland UC 18 participants Est. completion 2017-08-23 1 site
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT03111615

    HOrmone Therapy Immediately After Histological Diagnosis of Breast Cancer

    Not yet reported Centro Hospitalar Lisboa Ocidental 90 participants Est. completion 2020-05-01 1 site
    Other conditions: Hormone Dependent Neoplasms, Breast Cancer Female
    View official trial listing →
  • Completed NCT NCT03116022

    Use of Estriol at Distal Third of Vagina Improving Coital Pain in Post-menopause Women

    Not yet reported University of Sao Paulo 125 participants Est. completion 2024-01-31 1 site
    Other conditions: Dyspareunia, Menopause, Sexual Dysfunction
    View official trial listing →
  • Status unknown NCT NCT03120715

    Pregnancy Outcome of Women Using Low Molecular Weight Heparin Before Frozen-thawed Embryo Transfer

    Not yet reported Nanfang Hospital, Southern Medical University 342 participants Est. completion 2017-09-05 1 site Stand-alone
    Other conditions: Infertility
    View official trial listing →
  • Status unknown NCT NCT03120728

    Application for the Etonogestrel/Ethinyl Estradiol Ring

    Not yet reported University of Southern California 36 participants Est. completion 2018-07-01 2 sites
    Other conditions: Emergency Contraception, Healthy, Reproductive Age Women
    View official trial listing →
  • Completed NCT NCT03124524

    Treatment Choice in Primary Dysmenorrhea

    Not yet reported Adana Numune Training and Research Hospital 99 participants Est. completion 2016-10-10
    Other conditions: Primary Dysmenorrhea
    View official trial listing →
  • Terminated NCT NCT03126097

    A Study to Investigate the Interaction Between JNJ-64155806 and Ethinylestradiol/Drospirenone in Healthy Females

    Not yet reported Janssen Research & Development, LLC 18 participants Est. completion 2017-05-26 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT03126773

    A Prospective Multicenter Study on Patients'Satisfaction With Angeliq® Micro in Real Clinical Practice Conducted in Russia

    Bayer 1570 participants Est. completion 2020-06-18 1 site
    Other conditions: Menopause
    View official trial listing →
  • Terminated NCT NCT03137693

    Preoperative Stereotactic Ablative Body Radiotherapy (SABR) for Early-Stage Breast Cancer

    Not yet reported H. Lee Moffitt Cancer Center and Research Institute 20 participants Est. completion 2020-01-27 1 site
    Other conditions: Breast Cancer, Breast Cancer Female, Breast Adenocarcinoma
    View official trial listing →
  • Completed NCT NCT03155048

    The Effects of Estrogen on Artificial Endometrium

    Not yet reported Memorial Sisli Hospital, Istanbul 317 participants Est. completion 2018-09-01 1 site
    Other conditions: Infertility
    View official trial listing →
  • Completed NCT NCT03161873

    Cycle and Pregnancy Monitoring With Wearable Sensor Technology (AVA)

    University of Zurich 194 participants Est. completion 2020-11 1 site
    Other conditions: Fertility Disorders, Early Pregnancy
    View official trial listing →
  • Status unknown NCT NCT03162809

    Needle-Free Monitoring for IVF Patient Cycles

    Boston IVF 300 participants Est. completion 2021-06 1 site
    Other conditions: Infertility
    View official trial listing →
  • Status unknown NCT NCT03167749

    Effect of Liver Cirrhosis on Semen Parameters and Reproductive Hormones

    Assiut University 90 participants Est. completion 2019-03
    Other conditions: Male Infertility
    View official trial listing →
  • Status unknown NCT NCT03168074

    Phase II Study of Single Agent Lenvatinib

    Not yet reported National University Hospital, Singapore 30 participants Est. completion 2021-03-28 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Withdrawn NCT NCT03169738

    QUILT-3.044: NANT Non-small Cell Lung Cancer (NSCLC) Vaccine: Combination Immunotherapy in Subjects With NSCLC Who Have Progressed After Treatment With PD-1/PD-L1 Inhibitors

    Not yet reported, Not yet reported ImmunityBio, Inc. Est. completion 2021-12-28
    Other conditions: Non-small Cell Lung Cancer
    View official trial listing →
  • Withdrawn NCT NCT03169764

    QUILT-3.047: NANT Head and Neck Squamous Cell Carcinoma (HNSCC) Vaccine: Combination Immunotherapy in Subjects With HNSCC Who Have Progressed on or After Chemotherapy and PD-1/PD-L1 Therapy

    Not yet reported, Not yet reported ImmunityBio, Inc. Est. completion 2021-12-28
    Other conditions: Head and Neck Squamous Cell Carcinoma
    View official trial listing →
  • Withdrawn NCT NCT03169777

    QUILT-3.050: NANT Colorectal Cancer (CRC) Vaccine: Combination Immunotherapy in Subjects With Recurrent or Metastatic CRC

    Not yet reported, Not yet reported ImmunityBio, Inc. Est. completion 2021-12-28
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Terminated NCT NCT03172533

    Estrogen Replacement in Anorexia Nervosa

    Not yet reported University of Erlangen-Nürnberg Medical School 11 participants Est. completion 2019-01-15 1 site
    Obstructive sleep apnea
    View official trial listing →
  • Completed NCT NCT03174691

    Early Luteal Progesterone Profile in IVF Patients Triggered With hCG

    Not yet reported Vietnam National University 161 participants Est. completion 2017-08-08 1 site
    Other conditions: Infertility
    View official trial listing →
  • Completed NCT NCT03176238

    Study in Post-menopausal Women With Hormone Receptor Positive, HER2-negative Advanced Breast Cancer

    Not yet reported Novartis Pharmaceuticals 235 participants Est. completion 2019-01-29 55 sites
    Other conditions: Post Menopausal Breast Cancer
    View official trial listing →
  • Completed NCT NCT03178695

    Inovium Ovarian Rejuvenation Trials

    Not yet reported Ascendance Biomedical 200 participants Est. completion 2018-05-01 1 site
    Other conditions: Perimenopausal Disorder, Menopause, Menopause, Premature, Menopause Related Conditions, Menopause Premature Symptomatic, Menopause Premature Asymptomatic, Premature Ovarian Failure, Premature Ovarian Failure, Familial, Premature Ovarian Failure 2A, Premature Ovarian Failure 3, Premature Ovarian Failure 4, Premature Ovarian Failure 1, Premature Ovarian Failure 5, Premature Ovarian Failure 6, Premature Ovarian Failure 7, Premature Ovarian Failure 9, Premature Ovarian Failure 8, Infertility, Infertility, Female, Infertility Unexplained
    View official trial listing →
  • Completed NCT NCT03179904

    TVB-2640 and Trastuzumab With Paclitaxel or Endocrine Therapy for Treatment of HER2 Positive Metastatic Breast Cancer

    Not yet reported Mayo Clinic 17 participants Est. completion 2026-03-13 3 sites
    Other conditions: Advanced Breast Carcinoma, HER2-Positive Breast Carcinoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, HER2-positive Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT03182634

    The UK Plasma Based Molecular Profiling of Advanced Breast Cancer to Inform Therapeutic CHoices (plasmaMATCH) Trial

    Not yet reported Institute of Cancer Research, United Kingdom 1150 participants Est. completion 2023-11 19 sites
    Other conditions: Advanced Breast Cancer
    View official trial listing →
  • Completed NCT NCT03183102

    The Role of the Gut Microbiota in Estrogen Metabolism and Dietary Flax as a Potential Modulator.

    Not yet reported Colorado State University 30 participants Est. completion 2022-12-30 1 site Stand-alone
    Other conditions: Menopause
    View official trial listing →
  • Status unknown NCT NCT03192293

    Metformin and Simvastatin in Addition to Fulvestrant

    Not yet reported National University Hospital, Singapore 28 participants Est. completion 2019-01-20 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Withdrawn NCT NCT03197584

    QUILT-3.051: NANT Ovarian Cancer Vaccine: Combination Immunotherapy in Subjects With Epithelial Ovarian Cancer Who Have Progressed on or After Standard-of-care (SoC) Therapy

    Not yet reported, Not yet reported ImmunityBio, Inc. Est. completion 2021-12-28
    Other conditions: Ovarian Cancer
    View official trial listing →
  • Completed NCT NCT03201913

    Study of TTC-352 in Patients With Metastatic Breast Cancer Progressing on Endocrine Therapy

    Not yet reported TTC Oncology, LLC 15 participants Est. completion 2020-04-30 4 sites
    Other conditions: Metastatic ER+ Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT03202862

    The Efficacy of Fulvestrant in ESR1(Estrogen Receptor 1) Mutated Metastatic Breast Cancer

    Not yet reported Fudan University 50 participants Est. completion 2019-08-01
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Completed NCT NCT03204318

    SPIRIT 1: Efficacy and Safety Study of Relugolix in Women With Endometriosis-Associated Pain

    Not yet reported Myovant Sciences GmbH 638 participants Est. completion 2021-04-08 123 sites
    Other conditions: Endometriosis Related Pain
    View official trial listing →
  • Completed NCT NCT03204331

    SPIRIT 2: Efficacy and Safety Study of Relugolix in Women With Endometriosis-Associated Pain

    Not yet reported Myovant Sciences GmbH 623 participants Est. completion 2021-05-31 91 sites
    Other conditions: Endometriosis Related Pain
    View official trial listing →
  • Completed NCT NCT03210246

    Drug-drug Interaction Study: Influence of Vilaprisan on Pharmacodynamics (PD) and Pharmacokinetics (PK) of a Combined Oral Contraceptive (COC)

    Not yet reported Bayer 71 participants Est. completion 2019-01-23 2 sites
    Other conditions: Clinical Trial ,Phase I
    View official trial listing →
  • Completed NCT NCT03213457

    A Clinical Study to Evaluate the Safety and Efficacy of Elagolix in Participants With Moderate to Severe Endometriosis-Associated Pain

    Not yet reported AbbVie 681 participants Est. completion 2023-12-06 197 sites
    Other conditions: Endometriosis
    View official trial listing →
  • Completed NCT NCT03219476

    Neoadjuvant Endocrine Therapy in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Node-Negative Breast Cancer

    Not yet reported Medical College of Wisconsin 37 participants Est. completion 2025-03-20 1 site
    Other conditions: Breast Cancer, Invasive Breast Cancer
    View official trial listing →
  • Terminated NCT NCT03220178

    Impact of eHealth-support on Quality of Life in Metastatic Breast Cancer Patients Treated With Palbociclib and Endocrine Therapy

    Not yet reported Palleos Healthcare GmbH 532 participants Est. completion 2021-12-07 1 site
    Other conditions: Breast Neoplasm
    View official trial listing →
  • Completed NCT NCT03232281

    Study to Compare the Oestradiol Suppression, Clinical Efficacy and Safety of Two Formulations of Triptorelin (Triptorelin Pamoate PR 3-month and Triptorelin Acetate PR 1-month) in Chinese Subjects With Endometriosis

    Not yet reported Ipsen 300 participants Est. completion 2019-11-16 24 sites
    Other conditions: Endometriosis
    View official trial listing →
  • Completed NCT NCT03236545

    Menopause Effects on Vascular Function

    Not yet reported University of Delaware 48 participants Est. completion 2022-11-01 1 site Stand-alone
    Other conditions: Cardiovascular Risk Factor
    View official trial listing →
  • Completed NCT NCT03236740

    OCP vs Metformin on Ovarian Stromal Blood Flow in PCOS

    Not yet reported S.C.B. Medical College and Hospital 101 participants Est. completion 2018-03-15 1 site
    Other conditions: PCOS
    View official trial listing →
  • Completed NCT NCT03236974

    Study to Compare the Effects of AZD9496 vs Fulvestrant in Breast Cancer.

    Not yet reported AstraZeneca 49 participants Est. completion 2019-02-12 12 sites
    Other conditions: Postmenopausal Women With ER+ HER2- Primary Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT03237117

    Effect of Growth Hormone on Uterine Receptivity in Women With RIF in an Oocyte Donation Program

    Not yet reported Competence Centre on Health Technologies 105 participants Est. completion 2017-12-31 1 site
    Other conditions: Female Infertility
    View official trial listing →
  • Status unknown NCT NCT03238092

    Comparison Between Testosterone and Estradiol Over the Homogenization of Follicular Cohort

    Not yet reported Hospital de Clinicas de Porto Alegre 26 participants Est. completion 2018-03
    Other conditions: Fertility Disorders
    View official trial listing →
  • Completed NCT NCT03240081

    Treating Postmenopausal Dyspareunia Where it Hurts

    Not yet reported Oregon Health and Science University 50 participants Est. completion 2019-11-21 1 site
    Other conditions: Dyspareunia
    View official trial listing →
  • Status unknown NCT NCT03240159

    Long Antagonist Protocol for IVF With Single Luteal Dose of Degarelix

    Not yet reported Assisting Nature 120 participants Est. completion 2021-06-30 1 site
    Other conditions: Pregnancy, Ovarian
    View official trial listing →
  • Terminated NCT NCT03241810

    Phase 2 Trial of Seribantumab Plus Fulvestrant in Postmenopausal Women With Metastatic Breast Cancer

    Not yet reported Elevation Oncology 22 participants Est. completion 2018-11-30 59 sites Stand-alone
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT03249402

    A Study to Evaluate the Effect of Multiple Oral Doses of JNJ-42847922 on the Steady-state Pharmacokinetics of an Oral Contraceptive Containing Ethinyl Estradiol and Levonorgestrel in Healthy Female Adult Participants

    Not yet reported Janssen-Cilag International NV 24 participants Est. completion 2017-11-24 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT03250676

    Trial of H3B-6545, in Women With Locally Advanced or Metastatic Estrogen Receptor-positive, HER2 Negative Breast Cancer

    Not yet reported, Not yet reported Eisai Inc. 151 participants Est. completion 2023-10-26 39 sites
    Other conditions: Breast Neoplasms, Breast Cancer, Estrogen-receptor Positive Breast Cancer, Cancer, Breast, Breast Cancer Female, Breast Adenocarcinoma, Estrogen Receptor Positive Tumor, ER Positive
    View official trial listing →
  • Completed NCT NCT03258307

    Comparison of Perilipin, Leptin, Adipolipin, Adiponectin, Resistin, Visfatin, Estrone Levels Pre-post Omentectomy

    Not yet reported Istanbul Training and Research Hospital 25 participants Est. completion 2018-12-31 1 site
    Other conditions: Gynecologic Cancer
    View official trial listing →
  • Completed NCT NCT03259711

    Comparison of Cardiotoxicity Induced by Selective Estrogen REceptor Modulators and aNti-Aromatase

    Groupe Hospitalier Pitie-Salpetriere 20000 participants Est. completion 2017-08-14 1 site
    Other conditions: Cardiac Affections
    View official trial listing →
  • Completed NCT NCT03262727

    The Effect of BMS-986165 Combined With an Oral Contraceptive (Ethinyl Estradiol/Norethindrone) in Healthy Female Patients

    Not yet reported Bristol-Myers Squibb 49 participants Est. completion 2017-12-19 1 site
    Other conditions: Systemic Lupus Erythematosus, Arthritic Psoriasis, Psoriasis, Inflammatory Bowel Diseases
    View official trial listing →
  • Completed NCT NCT03262740

    The Effect of BMS-986195 Combined With an Oral Contraceptive (Ethinyl Estradiol/Norethindrone) in Healthy Female Patients

    Not yet reported Bristol-Myers Squibb 58 participants Est. completion 2018-01-30 2 sites
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Status unknown NCT NCT03264781

    The Effect of Cyclofem® for the Treatment of Irregular Uterine Bleeding in Implant Contraceptive Users

    Not yet reported, Not yet reported Chulalongkorn University 44 participants Est. completion 2017-12 1 site
    Other conditions: Uterine Bleeding
    View official trial listing →
  • Withdrawn NCT NCT03266562

    Estrogen Receptor Expression in Breast Cancer - Assessed With Positron Emission Mammography

    Not yet reported Mayo Clinic Est. completion 2019-04-30 1 site
    Other conditions: Breast Neoplasm
    View official trial listing →
  • Completed NCT NCT03266926

    Does the Use of Bupivacaine Soaked Vaginal Packing Following Vaginal Surgery Decrease Postoperative Pain?

    Sunnybrook Health Sciences Centre 140 participants Est. completion 2018-03-01 1 site
    Other conditions: Pelvic Organ Prolapse, Postoperative Pain
    View official trial listing →
  • Status unknown NCT NCT03269916

    Fertility and Ovarian Reserve Function in the Patient With Inflammatory Bowel Disease

    Not yet reported Sixth Affiliated Hospital, Sun Yat-sen University 80 participants Est. completion 2018-08-01 1 site Stand-alone
    Other conditions: Fertility Disorders, Ovarian Reserve Function, Pregnancy Outcomes
    View official trial listing →
  • Completed NCT NCT03271489

    Long-Term Safety Study of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women

    Not yet reported AbbVie 478 participants Est. completion 2024-06-28 157 sites
    Other conditions: Heavy Menstrual Bleeding, Uterine Fibroids
    View official trial listing →
  • Completed NCT NCT03280563

    A Study of Multiple Immunotherapy-Based Treatment Combinations in Hormone Receptor (HR)-Positive Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Breast Cancer

    Not yet reported, Not yet reported Hoffmann-La Roche 144 participants Est. completion 2024-09-26 22 sites
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Active, not recruiting NCT NCT03281902

    Genetic Analysis in Blood and Tumor Samples From Patients With Advanced or Metastatic Estrogen Receptor Positive and HER2 Negative Breast Cancer Receiving Palbociclib and Endocrine Therapy

    Mayo Clinic 68 participants Est. completion 2028-03-04 3 sites
    Other conditions: Advanced Breast Carcinoma, Locally Advanced Breast Carcinoma, Metastatic Breast Carcinoma, Recurrent Breast Carcinoma, Stage III Breast Cancer AJCC v7, Stage IIIA Breast Cancer AJCC v7, Stage IIIB Breast Cancer AJCC v7, Stage IIIC Breast Cancer AJCC v7, Stage IV Breast Cancer AJCC v6 and v7
    View official trial listing →
  • Status unknown NCT NCT03283345

    Effect of Menstrual Cycle on Traumatic Systemic Response

    Not yet reported Kocaeli University 89 participants Est. completion 2018-11
    Other conditions: Systemic Inflammatory Response Syndrome
    View official trial listing →
  • Terminated NCT NCT03284957

    Phase 1/2 Study of Amcenestrant (SAR439859) Single Agent and in Combination With Other Anti-cancer Therapies in Postmenopausal Women With Estrogen Receptor Positive Advanced Breast Cancer

    Not yet reported, Not yet reported Sanofi 136 participants Est. completion 2024-11-08 25 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT03289559

    Effects of Testosterone and Fat Utilization

    Not yet reported University of Colorado, Denver 13 participants Est. completion 2014-01-01
    Other conditions: Healthy, Volunteers
    View official trial listing →
  • Terminated NCT NCT03294694

    Ribociclib + PDR001 in Breast Cancer and Ovarian Cancer

    Not yet reported Dana-Farber Cancer Institute 33 participants Est. completion 2020-10-14 3 sites
    Other conditions: Metastatic Hormone-Receptor-Positive (HR+) Breast Cancer, HER2-Negative Breast Cancer, Metastatic Epithelial Ovarian Cancer
    View official trial listing →
  • Completed NCT NCT03295487

    ToT and Estrogen in Postmenopausal Females

    Not yet reported, Not yet reported Kasr El Aini Hospital 210 participants Est. completion 2020-11-30 1 site
    Other conditions: Stress Urinary Incontinence, Postmenopausal Disorder
    View official trial listing →
  • Completed NCT NCT03300518

    Effectiveness of Estradiol Valerate Pretreatment in Antagonist Protocol for Poor Ovarian Response Patient

    Not yet reported Reproductive & Genetic Hospital of CITIC-Xiangya 552 participants Est. completion 2021-08-18 1 site
    Other conditions: Infertility
    View official trial listing →
  • Completed NCT NCT03301233

    Effect Sildenafil and Estradiiol Valerate on Endometrial Thickness in Infertile Women

    Not yet reported Ain Shams University 90 participants Est. completion 2018-07-30 1 site Stand-alone
    Other conditions: Endometrial Thickness
    View official trial listing →
  • Completed NCT NCT03310541

    AZD5363 in Patients With Advanced Solid Tumors Harboring AKT Mutations

    Not yet reported Memorial Sloan Kettering Cancer Center 12 participants Est. completion 2023-05-03 3 sites
    Other conditions: Breast Cancer, Prostate Cancer, Advanced Solid Tumors
    View official trial listing →
  • Completed NCT NCT03312738

    A Study of Everolimus Plus Exemestane in Chinese Postmenopausal Women With Estrogen Receptor Positive, Locally Advanced, Recurrent, or Metastatic Breast Cancer After Recurrence or Progression on Non-steroidal Aromatase Inhibitor

    Not yet reported Novartis Pharmaceuticals 159 participants Est. completion 2022-04-25 15 sites
    Other conditions: Advanced Breast Cancer
    View official trial listing →
  • Completed NCT NCT03318263

    CIrCuLAting Dna ESr1 Gene Mutations Analysis

    Not yet reported Institut de Cancérologie de Lorraine 146 participants Est. completion 2022-12-22 10 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT03321981

    MCLA-128 With Trastuzumab/Chemotherapy in HER2+ and With Endocrine Therapy in ER+ and Low HER2 Breast Cancer.

    Not yet reported Merus B.V. 105 participants Est. completion 2023-07-26 25 sites
    Other conditions: Breast Cancer Metastatic
    View official trial listing →
  • Terminated NCT NCT03322215

    HR+/HER2- Advanced Breast Cancer and Endocrine Resistance

    Not yet reported Theodoros Foukakis 42 participants Est. completion 2023-10-31 9 sites
    Other conditions: Breast Cancer Metastatic
    View official trial listing →
  • Completed NCT NCT03324061

    Study to Evaluate the Safety, Tolerability, and PK of Fulvestrant After IM Administration

    Not yet reported Eagle Pharmaceuticals, Inc. 600 participants Est. completion 2018-07-12 12 sites
    Other conditions: Pharmacokinetics
    View official trial listing →
  • Status unknown NCT NCT03329898

    Comparing the Efficacy of Two Methods for the Therapy of Uterine Adhesion

    Not yet reported Beijing Obstetrics and Gynecology Hospital 200 participants Est. completion 2018-11-25 1 site Stand-alone
    Other conditions: Intrauterine Adhesion
    View official trial listing →
  • Completed NCT NCT03332303

    Study to Evaluate the Equivalence of Estradiol Vaginal Cream to Reference Standard in the Treatment of Vaginal Atrophy

    Not yet reported Prasco LLC 540 participants Est. completion 2018-03-15 27 sites
    Other conditions: Vulvar and Vaginal Atrophy
    View official trial listing →
  • Active, not recruiting NCT NCT03332797

    A Study of GDC-9545 Alone or in Combination With Palbociclib and/or Luteinizing Hormone-Releasing Hormone (LHRH) Agonist in Locally Advanced or Metastatic Estrogen Receptor-Positive Breast Cancer

    Not yet reported Genentech, Inc. 181 participants Est. completion 2027-07-31 23 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT03333564

    Effect of Vitamin D3 and Omega-3FA on Estradiol

    Not yet reported Applied Science Private University 116 participants Est. completion 2017-02
    Other conditions: Vitamin D Deficiency
    View official trial listing →
  • Completed NCT NCT03336437

    Estrogen and the Urogenital Microbiome in GSM

    Not yet reported Oregon Health and Science University 40 participants Est. completion 2019-08-23 1 site
    Other conditions: Menopause
    View official trial listing →
  • Terminated NCT NCT03343067

    A Study to Evaluate Safety and Efficacy of Elagolix in Participants With Endometriosis With Associated Moderate to Severe Pain

    Not yet reported AbbVie 11 participants Est. completion 2018-10-23 37 sites
    Other conditions: Endometriosis
    View official trial listing →
  • Completed NCT NCT03343912

    Estriol and Trimegestone Dose-response Trial With Single Dose Application of Vaginal Rings

    Not yet reported Galeno Desenvolvimento de Pesquisas Clínicas 36 participants Est. completion 2018-02-15 1 site
    Other conditions: Pregnancy
    View official trial listing →
  • Completed NCT NCT03344536

    A Study of Debio 1347 Plus Fulvestrant in Patients With Metastatic Breast Cancer

    Not yet reported, Not yet reported Memorial Sloan Kettering Cancer Center 10 participants Est. completion 2021-08-12 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT03346317

    Comparing the Efficacy of Two Methods in the Prevention of Adhesion Reformation After Hysteroscopic Adhesiolysis

    Not yet reported Beijing Obstetrics and Gynecology Hospital 100 participants Est. completion 2018-05-20 1 site Stand-alone
    Other conditions: Intrauterine Adhesion
    View official trial listing →
  • Status unknown NCT NCT03351062

    Efficacy of Tamoxifen Versus Toremifene in CYP2D6 IM/PM of Premenopausal Patients With ER-positive Early Breast Cancer

    Not yet reported Chinese Anti-Cancer Association 844 participants Est. completion 2025-12 21 sites
    Other conditions: Breast Cancer Female
    View official trial listing →
  • Status unknown NCT NCT03351205

    The Efficacy of Estrogen Therapy Against Adhesion Reformation After Hysteroscopic Adhesiolysis

    Not yet reported Beijing Obstetrics and Gynecology Hospital 100 participants Est. completion 2018-11-22 1 site Stand-alone
    Other conditions: Intrauterine Adhesion
    View official trial listing →
  • Completed NCT NCT03353857

    Drug-drug Interaction Between Rifampicin and Progestins/Ethinylestradiol and Midazolam

    Not yet reported Bayer 68 participants Est. completion 2019-02-19 2 sites
    Other conditions: Biological Availability
    View official trial listing →
  • Status unknown NCT NCT03353883

    Early Preparation With Gonadotropin- Releasing Hormon (GnRh) Agonists Injection With Frozen-Thawed Embryo Transfer?

    Not yet reported, Not yet reported Benha University 200 participants Est. completion 2018-08 1 site
    Other conditions: Infertility, Female
    View official trial listing →
  • Completed NCT NCT03355157

    A Randomized, Open-label, Multi-center Phase IV Study Evaluating Palbociclib Plus Endocrine Treatment Versus a Chemotherapy-based Treatment Strategy in Patients With Hormone Receptor Positive / HER2 Negative Breast Cancer in a Real World Setting (GBG 93 - PADMA Study).

    Not yet reported GBG Forschungs GmbH 130 participants Est. completion 2024-08-30 1 site
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT03355651

    Efficacy and Tolerability of a Nutritional Supplement, Plactive Progen, in ACL Reconstruction

    Not yet reported OPKO Health, Inc. 80 participants Est. completion 2017-03-03
    Other conditions: ACL Reconstruction
    View official trial listing →
  • Status unknown NCT NCT03357640

    Are the Combined Oral Contraceptive Pills Needed for Management of the Simple Ovarian Cysts in Reproductive Women?

    Not yet reported, Not yet reported Benha University 118 participants Est. completion 2018-06 1 site
    Other conditions: Ovary Cyst
    View official trial listing →
  • Completed NCT NCT03358823

    Study on the Brain Network of Angelman Syndrome

    Fudan University 150 participants Est. completion 2019-05-20 1 site
    Other conditions: Angelman Syndrome
    View official trial listing →
  • Completed NCT NCT03361969

    Evaluation of Effects of Estetrol on Testosterone Suppression and Quality of Life in Prostate Cancer Patients Treated With an LHRH Agonist.

    Not yet reported Pantarhei Oncology B.V. 63 participants Est. completion 2020-05-15 6 sites
    Other conditions: Prostatic Neoplasm
    View official trial listing →
  • Completed NCT NCT03363828

    The Temporo-spatial Dynamics of Genital Tract Microbiota

    Peter Humaidan 27 participants Est. completion 2021-01-08 2 sites
    Other conditions: Infertility, Female
    View official trial listing →
  • Completed NCT NCT03363997

    Pharmacokinetics and Pharmacodynamics of 3 Dosages of Estriol After Continuous Vaginal Administration for 21 Days

    Not yet reported Galeno Desenvolvimento de Pesquisas Clínicas 31 participants Est. completion 2017-06-06 1 site
    Other conditions: Menopause
    View official trial listing →
  • Completed NCT NCT03368898

    Quality of Life in Premenopausal Women With Heavy Menstrual Bleeding

    Bakirkoy Dr. Sadi Konuk Research and Training Hospital 104 participants Est. completion 2019-12-30 1 site
    Other conditions: Heavy Menstrual Bleeding
    View official trial listing →
  • Status unknown NCT NCT03373149

    Growth Hormone Co-treatment Within a GnRH Antagonist Protocol in Patients With Poor Ovarian Response

    Not yet reported Riyadh Fertility and Reproductive Health center 228 participants Est. completion 2020-11 1 site
    Other conditions: Infertility, Female
    View official trial listing →
  • Withdrawn NCT NCT03377101

    Fulvestrant and Palbociclib With or Without Copanlisib in Treating Patients With Hormone Receptor Positive, HER2 Negative, Stage IV Breast Cancer

    Not yet reported National Cancer Institute (NCI) Est. completion 2018-08-07
    Other conditions: Estrogen Receptor Positive, HER2/Neu Negative, Progesterone Receptor Positive, Stage IV Breast Cancer AJCC v6 and v7
    View official trial listing →
  • Completed NCT NCT03382834

    Selective Estrogen Receptor Modulators to Enhance the Efficacy of Viral Reactivation With Histone Deacetylase Inhibitors

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 31 participants Est. completion 2023-07-27 15 sites
    Other conditions: HIV Infections
    View official trial listing →
  • Completed NCT NCT03385551

    Study to Evaluate Estradiol Vaginal Tablets vs Promestriene Vaginal Cream

    Instituto Palacios 120 participants Est. completion 2020-09-30 2 sites
    Other conditions: Vulvovaginal Atrophy
    View official trial listing →
  • Terminated NCT NCT03386162

    SAFIR-PI3K A Phase II Randomized Maintenance Trial Comparing Alpelisib and Fulvestrant Versus Chemotherapy in PIK3CA Mutated Advanced Breast Cancer

    Not yet reported UNICANCER 31 participants Est. completion 2022-11-18 14 sites
    Other conditions: Breast Cancer, PI3K, Alpelisib
    View official trial listing →
  • Completed NCT NCT03390608

    Prognostic and Predictive Factors for Small Breast Tumors

    Karolinska Institutet 35002 participants Est. completion 2016-07-30 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT03393845

    Study of Pembrolizumab Plus Fulvestrant in Hormone Receptor Positive, HER-2 Negative Advanced/Metastatic Breast Cancer Patients

    Not yet reported Nancy Chan, MD 47 participants Est. completion 2027-09-01 5 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT03394027

    ONC201 in Recurrent/Refractory Metastatic Breast Cancer and Advanced Endometrial Carcinoma

    Not yet reported National Cancer Institute (NCI) 30 participants Est. completion 2021-10-07 1 site Stand-alone
    Other conditions: Triple Negative Breast Cancer, Endometrial Cancer, Hormone Receptor Positive, HER2 Negative Breast Cancer
    View official trial listing →
  • Terminated NCT NCT03395288

    Nutraceutical Efficacy for rUTI

    Not yet reported, Not yet reported Washington University School of Medicine 61 participants Est. completion 2020-04-25 1 site
    Other conditions: Urinary Tract Infections
    View official trial listing →
  • Completed NCT NCT03395665

    Estradiol, Progesterone and Endometrial Thickness in Frozen Euploid Embryo Transfer

    Fundacion Dexeus 299 participants Est. completion 2018-01 1 site
    Other conditions: Infertility, Preimplantation Genetic Diagnosis/Screening, Miscarriage
    View official trial listing →
  • Completed NCT NCT03395756

    Depot Medroxyprogesterone Acetate as Emergency Contraception

    Not yet reported University of Southern California 30 participants Est. completion 2020-10-30 1 site
    Other conditions: Emergency Contraception, Contraception
    View official trial listing →
  • Completed NCT NCT03412890

    LIBERTY EXTENSION: Efficacy and Safety Extension Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids

    Not yet reported Myovant Sciences GmbH 477 participants Est. completion 2021-01-13 150 sites
    Other conditions: Heavy Menstrual Bleeding, Uterine Fibroid
    View official trial listing →
  • Status unknown NCT NCT03416764

    Estradiol-mediated Neural Plasticity as Potential Mediator of Neurofeedback Treatment Change for Traumatized Women

    Not yet reported Tel-Aviv Sourasky Medical Center 100 participants Est. completion 2022-02-20 1 site Stand-alone
    Other conditions: Posttraumatic Stress Disorder (PTSD)
    View official trial listing →
  • Completed NCT NCT03418363

    How DHEA Supplements Affect Coagulation in Women Using Birth Control Pills

    Not yet reported Oregon Health and Science University 15 participants Est. completion 2019-12-11 1 site
    Other conditions: Contraceptive Usage, Coagulation
    View official trial listing →
  • Completed NCT NCT03418831

    Adjunctive Selective Estrogen Receptor Modulators on Negative and Cognitive Symptoms of Schizophrenia in Women

    Not yet reported Shanghai Mental Health Center 45 participants Est. completion 2019-07-30 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Status unknown NCT NCT03421639

    Aromatase Plus GnRH Analogue Versus GnRH Analog Alone in Adenomyosis

    Not yet reported Centre for Endocrinology and Reproductive Medicine, Italy 300 participants Est. completion 2024-09-30 3 sites
    Other conditions: Uterine Adenomyosis, Recurrent Implantation Failure, Menstrual Pain
    View official trial listing →
  • Completed NCT NCT03422809

    Cyclic Variation in Micronutrient Concentrations and Plasma Volume

    Alison Gernand 47 participants Est. completion 2018-11-20 1 site
    Other conditions: Plasma Volume, Micronutrients, Menstrual Cycle
    View official trial listing →
  • Active, not recruiting NCT NCT03425838

    Endocrine Therapy Plus CDK4/6 in First or Second Line for Hormone (SONIA) Receptor Positive Advanced Breast Cancer

    Not yet reported Borstkanker Onderzoek Groep 1050 participants Est. completion 2028-12 72 sites
    Other conditions: Breast Neoplasm Female
    View official trial listing →
  • Completed NCT NCT03426228

    In Vitro Fertilization Impact on Metabolic Parameters

    University of Warwick 344 participants Est. completion 2020-01-05 1 site
    Other conditions: GDM, Insulin Resistance, Glucose Intolerance, PCOS, Obesity
    View official trial listing →
  • Status unknown NCT NCT03430024

    Nuclear Myosin VI - a Therapeutic Target in Breast Cancer

    Maidstone & Tunbridge Wells NHS Trust 120 participants Est. completion 2020-12 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT03432416

    Study of Efficacy, Cycle Control, and Safety of a NES-E2 Contraceptive Vaginal Ring

    Not yet reported Premier Research 385 participants Est. completion 2021-12-14 11 sites
    Other conditions: Healthy Women, Female Contraception
    View official trial listing →
  • Status unknown NCT NCT03436303

    The Benefits and Risks of Different Menopausal Hormone Replacement Therapy Regimes in the Treatment of Menopause Syndrome

    Not yet reported Peking Union Medical College Hospital 120 participants Est. completion 2018-12-01 1 site
    Other conditions: Menopause Syndrome
    View official trial listing →
  • Completed NCT NCT03436992

    Estrogen and Diabetes

    Not yet reported Augusta University 143 participants Est. completion 2023-12-31 2 sites
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Terminated NCT NCT03439046

    Study of the Molecular Features of Postmenopausal Women With HR+ HER2-negative aBC on First-line Treatment With Ribociclib and Letrozole and, in Patients With a PIK3CA Mutation, on Second-line Treatment With Alpelisib Plus Fulvestrant

    Not yet reported Novartis Pharmaceuticals 287 participants Est. completion 2023-12-11 41 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT03442504

    Prediction of Response to 2nd-line Hormone Therapy by FES CT/PET in Patients With Metastatic Breast Cancer

    Not yet reported Institut Cancerologie de l'Ouest 57 participants Est. completion 2024-06 4 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT03443089

    Comparative Bioavailability of Two Injectable Suspension Formulations of Medroxyprogesterone Acetate+Estradiol Cypionate

    Not yet reported Galeno Desenvolvimento de Pesquisas Clínicas 24 participants Est. completion 2017-08-01 1 site
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT03447132

    Fulvestrant Versus Fulvestrant Plus Palbociclib in Operable Breast Cancer Responding to Fulvestrant

    Not yet reported International Cancer Research Group, United Arab Emirates 354 participants Est. completion 2021-07-20 14 sites
    Other conditions: Breast Neoplasm Female
    View official trial listing →
  • Completed NCT NCT03450135

    Neurophysiology, Estrogen, and Stress Exposure in the Emergence of Depression in Adolescent Girls

    University of North Carolina, Chapel Hill 53 participants Est. completion 2020-06-30 1 site
    Other conditions: Adolescent Development, Stress, Emotional Disturbances
    View official trial listing →
  • Completed NCT NCT03451110

    Study to Assess the Pharmacokinetic Drug-Drug Interactions of Lemborexant When Coadministered With an Oral Contraceptive, Famotidine, or Fluconazole in Healthy Subjects

    Not yet reported Eisai Inc. 50 participants Est. completion 2018-03-23 1 site
    Other conditions: Healthy Subjects
    View official trial listing →
  • Active, not recruiting NCT NCT03452878

    Evaluation of the Functional Results of Bilateral Amygdalotomy for Refractory Aggressive Patients

    Hospital Sirio-Libanes 4 participants Est. completion 2026-12-31
    Other conditions: Aggression
    View official trial listing →
  • Completed NCT NCT03455270

    G1T48, an Oral SERD, Alone and in Combination With Palbociclib in ER-Positive, HER2-Negative Advanced Breast Cancer

    Not yet reported G1 Therapeutics, Inc. 107 participants Est. completion 2022-09-29 15 sites
    Other conditions: Carcinoma, Ductal, Breast, Breast Cancer Female, Breast Neoplasm, Breast Cancer, Metastatic Breast Cancer, Advanced Breast Cancer, Stage IV Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT03458221

    Signal TrAnsduction Pathway Activity Analysis in OVarian cancER

    Not yet reported, Not yet reported Gynaecologisch Oncologisch Centrum Zuid 148 participants Est. completion 2026-10-01 6 sites Stand-alone
    Other conditions: Recurrent Ovarian Cancer, Signal Transduction Pathway Deregulation, Therapy-Associated Cancer
    View official trial listing →
  • Completed NCT NCT03462251

    Ribociclib and Endocrine Therapy or Chemotherapy With or Without Bevacizumab for Metastatic Breast Cancer in First Line

    Not yet reported iOMEDICO AG 41 participants Est. completion 2022-11-30 27 sites
    Other conditions: Breast Cancer, Hormone Receptor Positive Tumor, HER 2 Negative Breast Cancer
    View official trial listing →
  • Completed NCT NCT03470610

    Administration of Vaginal and Rectal Progesterone During FET Cycles

    Thor Haahr 277 participants Est. completion 2019-09-01 1 site
    Other conditions: Infertility
    View official trial listing →
  • Completed NCT NCT03477396

    Ribociclib and Aromatase Inhibitor in Treating Older Participants With Hormone Receptor Positive Metastatic Breast Cancer

    Not yet reported City of Hope Medical Center 2 participants Est. completion 2023-06-05 9 sites
    Other conditions: Estrogen Receptor and/or Progesterone Receptor Positive, HER2/Neu Negative, Stage IV Breast Cancer AJCC v6 and v7
    View official trial listing →
  • Completed NCT NCT03478020

    Oral AQX-1125 and Combination Oral Contraceptive Drug-Drug Interaction Study

    Not yet reported Aquinox Pharmaceuticals (Canada) Inc. 32 participants Est. completion 2018-04-05 1 site
    Other conditions: Healthy Volunteer
    View official trial listing →
  • Completed NCT NCT03479879

    Estradiol Pretreatment With Misoprostol in Second Trimester Miscarriage

    Not yet reported, Not yet reported Ain Shams University 200 participants Est. completion 2018-12-20 1 site
    Other conditions: Miscarriage
    View official trial listing →
  • Terminated NCT NCT03480659

    Detection of Breast Cancer With Non-invasive Method Based on DNA Methylation of Circulated Tumor DNA, PBMC

    HKGepitherapeutics 165 participants Est. completion 2021-09-01 1 site
    Other conditions: Breast Cancer, Breast Cancer Female
    View official trial listing →
  • Completed NCT NCT03481998

    A Study of SHR6390 in Combination With Letrozole or Anastrozole or Fulvestrant in Patients With HR Positive and HER2 Negative Advanced Breast Cancer

    Not yet reported, Not yet reported Jiangsu HengRui Medicine Co., Ltd. 104 participants Est. completion 2022-07-30 4 sites
    Other conditions: Advanced Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT03489473

    FESPET Study: Female EStrogen recePtor in Endometrial Cancer Treatment

    Radboud University Medical Center 40 participants Est. completion 2021-12-01
    Other conditions: Endometrial Cancer
    View official trial listing →
  • Completed NCT NCT03493126

    Vaginal Estrogen on Postpartum Atrophy, Perineal Pain, and Sexual Function

    Not yet reported Ohio State University 59 participants Est. completion 2020-09-01 1 site
    Other conditions: Vaginal Atrophy
    View official trial listing →
  • Status unknown NCT NCT03497702

    Neo-adjuvant Chemotherapy With Letrozole in Patients With Estrogen Receptor Positive/HER-2 Negative Breast Cancer

    Not yet reported National Cancer Center, Korea 114 participants Est. completion 2024-01 1 site
    Other conditions: Breast Cancer, Invasive Breast Cancer
    View official trial listing →
  • Completed NCT NCT03498313

    Unique Effects of Perimenstrual Estradiol or Progesterone Supplementation on Perimenstrual Suicidality

    Not yet reported University of Illinois at Chicago 60 participants Est. completion 2021-05-09 1 site
    Other conditions: Suicidal Ideation
    View official trial listing →
  • Completed NCT NCT03505736

    Stress Test in Detecting Heart Damage in Premenopausal Women With Stage I-III Breast Cancer

    Wake Forest University Health Sciences 25 participants Est. completion 2020-03-05 1 site
    Other conditions: Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIA Breast Cancer AJCC v8, Anatomic Stage IIB Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8, Anatomic Stage IIIC Breast Cancer AJCC v8, Premenopausal, Prognostic Stage I Breast Cancer AJCC v8, Prognostic Stage IA Breast Cancer AJCC v8, Prognostic Stage IB Breast Cancer AJCC v8, Prognostic Stage II Breast Cancer AJCC v8, Prognostic Stage IIA Breast Cancer AJCC v8, Prognostic Stage IIB Breast Cancer AJCC v8, Prognostic Stage III Breast Cancer AJCC v8, Prognostic Stage IIIA Breast Cancer AJCC v8, Prognostic Stage IIIB Breast Cancer AJCC v8, Prognostic Stage IIIC Breast Cancer AJCC v8
    View official trial listing →
  • Withdrawn NCT NCT03506399

    A Study of Lanabecestat in Healthy Female Participants Taking Oral Contraceptive

    Not yet reported Eli Lilly and Company Est. completion 2018-10 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT03507088

    Study to Determine the Utility of FES-PET in the Prediction of Response to Fulvestrant in Women With Estrogen Positive Metastatic Breast Cancer

    Not yet reported Zhimin Shao 36 participants Est. completion 2018-07-01 2 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT03518528

    Comparison of Vaginal and Transdermal Oestrogen Before Frozen Thawed Embryo Transfer

    University Hospital, Angers 100 participants Est. completion 2018-12 1 site
    Other conditions: Embryo Transfer, Infertility
    View official trial listing →
  • Terminated NCT NCT03519178

    A Study of PF-06873600 in People With Cancer

    Not yet reported, Not yet reported Pfizer 155 participants Est. completion 2024-10-30 54 sites
    Other conditions: HR+ HER2- Metastatic Breast Cancer, Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer, Triple Negative Breast Cancer, Male Breast Cancer
    View official trial listing →
  • Terminated NCT NCT03531437

    Comparison of Coagulation Profiles Between Zoely and Minidoz: RCT

    Not yet reported Mahidol University 112 participants Est. completion 2018-04-18
    Other conditions: Contraception, Hypercoagulability
    View official trial listing →
  • Active, not recruiting NCT NCT03531645

    Fulvestrant Plus Abemaciclib in Women With Advanced Low Grade Serous Carcinoma

    Not yet reported M.D. Anderson Cancer Center 18 participants Est. completion 2027-09-30 1 site
    Other conditions: Malignant Neoplasms of Female Genital Organs
    View official trial listing →
  • Status unknown NCT NCT03540979

    Endometrial Preparation in Frozen Embryo Transfer Cycles

    Not yet reported Meir Medical Center 100 participants Est. completion 2019-12
    Other conditions: Reproductive Behavior
    View official trial listing →
  • Withdrawn NCT NCT03544073

    GnRH Agonist at Embryo Transfer: IVF Outcomes

    Not yet reported Maimonides Medical Center Est. completion 2021-06-30 1 site Stand-alone
    Other conditions: Infertility, Infertility, Female, Infertility, Male
    View official trial listing →
  • Status unknown NCT NCT03544762

    Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation

    Not yet reported National Taiwan University Hospital 60 participants Est. completion 2020-12-31 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT03547024

    A Study in Healthy Participants to Evaluate the Effects of Multiple Doses of JNJ-55308942 on Cytochrome P450 Substrate Activity and on the Pharmacokinetics of Levonorgestrel/Ethinyl Estradiol

    Not yet reported Janssen-Cilag International NV 14 participants Est. completion 2018-08-30 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT03554044

    T-VEC With Chemotherapy or Endocrine Therapy in Treating Participants With HER2- Negative Breast Cancer

    Not yet reported University of California, San Francisco 20 participants Est. completion 2023-12-31 1 site
    Other conditions: Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8, Anatomic Stage IIIC Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Estrogen Receptor Positive, HER2/Neu Negative, Invasive Breast Carcinoma, Prognostic Stage III Breast Cancer AJCC v8, Prognostic Stage IIIA Breast Cancer AJCC v8, Prognostic Stage IIIB Breast Cancer AJCC v8, Prognostic Stage IIIC Breast Cancer AJCC v8, Prognostic Stage IV Breast Cancer AJCC v8, Recurrent Breast Carcinoma
    View official trial listing →
  • Completed NCT NCT03555877

    Anti-hormonal Therapie With Ribociclib in HR-positive / HER2- Negative Metastatic Breast Cancer

    Not yet reported GBG Forschungs GmbH 56 participants Est. completion 2022-07-21 1 site
    Other conditions: Breast Cancer Metastatic
    View official trial listing →
  • Status unknown NCT NCT03556800

    Study to Investigate the Pharmacokinetics & Safety Following One Application of 3 Different Doses 0.5,0.75,& 1.25 gm,a Transdermal Estradiol Cream (VML-0203), in Comparison to a Single Dose of EstroGel 1.25 gm to Healthy Post-menopausal Women.

    Not yet reported Viramal Limited 20 participants Est. completion 2022-06-30 1 site
    Other conditions: Menopause
    View official trial listing →
  • Status unknown NCT NCT03557619

    A Study to Assess the Effect of Venetoclax on Ethinyl Estradiol and Levonorgestrel in Female Participants With Different Hematological Malignancies

    Not yet reported AbbVie 12 participants Est. completion 2026-03-21 4 sites
    Other conditions: Hematologic Malignancies
    View official trial listing →
  • Status unknown NCT NCT03558399

    Frozen Blastocyst Transfer Using Conventional Timing Versus Timing by Endometrial Receptivity Analysis

    Not yet reported Shady Grove Fertility Reproductive Science Center 800 participants Est. completion 2021-09-23 1 site
    Other conditions: Implantation Failure, Infertility, Female
    View official trial listing →
  • Completed NCT NCT03560531

    A Study of ZN-c5 in Subjects With Breast Cancer

    Not yet reported, Not yet reported Zeno Alpha Inc. 181 participants Est. completion 2022-12-22 38 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT03560856

    A Biomarker Study of Palbociclib + Fulvestrant for Second, and Third Line of Postmenopausal Women With hr+/her2- Advanced Breast Cancer

    Not yet reported Assistance Publique - Hôpitaux de Paris 54 participants Est. completion 2022-06-01
    Other conditions: Breast Cancer, HR+/HER2-negative Breast Cancer, Metastasis
    View official trial listing →
  • Terminated NCT NCT03566485

    Atezolizumab and Cobimetinib or Idasanutlin in Participants With Stage IV or Unresectable Recurrent Estrogen Receptor Positive Breast Cancer

    Not yet reported, Not yet reported Vanderbilt-Ingram Cancer Center 12 participants Est. completion 2020-12-10 1 site
    Other conditions: Stage III Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer, Estrogen Receptor-positive, HER2/Neu Negative
    View official trial listing →
  • Completed NCT NCT03568708

    Primary Ovarian Insufficiency: Phenotype and Optimal Treatment

    Not yet reported Children's Hospital Medical Center, Cincinnati 19 participants Est. completion 2023-01-05 1 site Stand-alone
    Other conditions: Primary Ovarian Insufficiency
    View official trial listing →
  • Active, not recruiting NCT NCT03573648

    Neoadjuvant Endocrine Therapy, Palbociclib, Avelumab in Estrogen Receptor Positive Breast Cancer

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 33 participants Est. completion 2027-03-30 4 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT03578172

    HMG Stimulation Versus HRT for Endometrial Preparation Prior to Blastocyst Transfer in Moderate to Severe IUA Patients

    Not yet reported Reproductive & Genetic Hospital of CITIC-Xiangya 186 participants Est. completion 2019-11-20 1 site
    Other conditions: Infertility, Female, Intrauterine Adhesion
    View official trial listing →
  • Status unknown NCT NCT03581201

    The Relationship of the Intestinal Microbiome and the Menstrual Cycle

    Medical University of Vienna 20 participants Est. completion 2020-07-01 1 site
    Other conditions: Sex Hormones, Microbial Colonization
    View official trial listing →
  • Status unknown NCT NCT03582865

    Genetic Study of CYP2D6 Enzyme and Therapeutic Drug Monitoring of Tamoxifen

    Assiut University 100 participants Est. completion 2020-12
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT03584009

    A Phase II Study Comparing The Efficacy Of Venetoclax + Fulvestrant Vs. Fulvestrant In Women With Estrogen Receptor-Positive, Her2-Negative Locally Advanced Or Metastatic Breast Cancer Who Experienced Disease Recurrence Or Progression During Or After CDK4/6 Inhibitor Therapy

    Not yet reported Hoffmann-La Roche 103 participants Est. completion 2021-05-06 40 sites
    Other conditions: Estrogen Receptor-positive (ER+)/Human Epidermal Growth Factor Receptor (HER2)-Negative Locally Advanced or Metastatic Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT03584971

    Estrogen and Cooperation, Competitiveness, and Risk Preferences

    RWTH Aachen University 80 participants Est. completion 2021-12-30 1 site
    Other conditions: Behavioral Correlates of Estradiol
    View official trial listing →
  • Completed NCT NCT03585712

    Effect of Norgestrel 75 mcg on Cervical Mucus and Ovarian Activity During Perfect Use, After One Delayed Intake and After a Missed Pill

    Not yet reported HRA Pharma 52 participants Est. completion 2020-04-07 2 sites
    Other conditions: Contraception
    View official trial listing →
  • Status unknown NCT NCT03591549

    Fulvestrant in Metastatic Breast Cancer

    Not yet reported Assiut University 30 participants Est. completion 2021-10-01
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT03608241

    A STUDY TO ESTIMATE THE EFFECT OF PF-06651600 ON THE PHARMACOKINETICS (PK) OF ORAL CONTRACEPTIVE (OC)

    Not yet reported Pfizer 12 participants Est. completion 2018-11-23 2 sites
    Other conditions: Healthy Females
    View official trial listing →
  • Terminated NCT NCT03619044

    The Use of FES-PET Imaging as a Tool to Detect a Possible Reversion of Estrogen Receptor (ER)-α Status in Patients With Metastatic Breast Cancer HER2 + and ERα Neg Treated With Trastuzumab + Pertuzumab + Taxane.

    Not yet reported Institut Claudius Regaud 4 participants Est. completion 2021-07-09 6 sites
    Other conditions: HER2-positive Breast Cancer
    View official trial listing →
  • Completed NCT NCT03620643

    Crizotinib in Lobular Breast, Diffuse Gastric and Triple Negative Lobular Breast Cancer or CDH1-mutated Solid Tumours

    Not yet reported Royal Marsden NHS Foundation Trust 33 participants Est. completion 2024-08-30 5 sites
    Other conditions: Lobular Breast Carcinoma, Gastric Cancer, Triple Negative Breast Cancer, CDH1 Gene Mutation
    View official trial listing →
  • Status unknown NCT NCT03620929

    Estrogen in the Prevention of Adhesion Reformation

    Not yet reported Fu Xing Hospital, Capital Medical University 186 participants Est. completion 2022-12-01 1 site Stand-alone
    Other conditions: Asherman Syndrome
    View official trial listing →
  • Completed NCT NCT03628066

    Biological and Clinical Effects of Palbociclib With Ovarian Suppression and Letrozole in the Neoadjuvant Treatment of Breast Cancer

    Not yet reported NSABP Foundation Inc 24 participants Est. completion 2021-01-30 15 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT03631680

    The Role of Estrogen in Adipocyte Remodeling Following Surgical Menopause

    Pennington Biomedical Research Center 2 participants Est. completion 2022-11-11 1 site
    Other conditions: Menopause Surgical, Estrogen Deficiency, Adiposity
    View official trial listing →
  • Completed NCT NCT03633331

    Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer

    Not yet reported Alliance for Clinical Trials in Oncology 93 participants Est. completion 2026-02-27 447 sites
    Other conditions: Estrogen Receptor-positive Breast Cancer, HER2/Neu Negative, Stage IV Breast Cancer AJCC v6 and v7
    View official trial listing →
  • Active, not recruiting NCT NCT03640624

    Multidisciplinary Treatment of Chronic Vulvar Pain

    Not yet reported Norwegian University of Science and Technology 106 participants Est. completion 2027-06 1 site
    Other conditions: Vulvodynia, Chronic Pain
    View official trial listing →
  • Completed NCT NCT03642665

    Natural Versus Artificial Cycle for Frozen-Thawed Embryo Transfer

    Not yet reported Universitaire Ziekenhuizen KU Leuven 554 participants Est. completion 2024-11-01 1 site
    Other conditions: Embryo Transfer
    View official trial listing →
  • Completed NCT NCT03643510

    Evaluating Cancer Response to Treatment With Abemaciclib and Fulvestrant in Women With Recurrent Endometrial Cancer

    Not yet reported Memorial Sloan Kettering Cancer Center 27 participants Est. completion 2026-03-12 7 sites
    Other conditions: Adenocarcinoma of Endometrium
    View official trial listing →
  • Status unknown NCT NCT03651427

    Cross-sex Hormone Therapy and Neuronal Plasticity

    Not yet reported Hospital de Clinicas de Porto Alegre 30 participants Est. completion 2019-03-30 1 site Stand-alone
    Other conditions: Gender Dysphoria
    View official trial listing →
  • Completed NCT NCT03652623

    Transgender Youth and PrEP: PK, Safety, Uptake & Adherence - PK Study

    Not yet reported, Not yet reported Hektoen Institute for Medical Research 49 participants Est. completion 2023-11-30 1 site
    Other conditions: HIV/AIDS, Gender, Behavior and Behavior Mechanisms
    View official trial listing →
  • Completed NCT NCT03654274

    SPIRIT EXTENSION: Efficacy and Safety Extension Study of Relugolix in Women With Endometriosis-Associated Pain

    Not yet reported Myovant Sciences GmbH 802 participants Est. completion 2023-01-31 169 sites
    Other conditions: Endometriosis
    View official trial listing →
  • Withdrawn NCT NCT03658213

    To Compare ZOLADEX 10.8 mg With ZOLADEX 3.6mg in Chinese Pre-menopausal ER+ HER2- Early Breast Cancer.

    Not yet reported AstraZeneca Est. completion 2021-11-04 11 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT03662516

    A Study to Determine the Effects of PF-04965842 on the Pharmacokinetics of Oral Contraceptive Steroids in Healthy Female Subjects

    Not yet reported Pfizer 17 participants Est. completion 2019-01-19 1 site
    Other conditions: Healthy Females
    View official trial listing →
  • Completed NCT NCT03663075

    Effect of Group Education and Individual Counselling on Mental Health and Quality of Life in 45-60 Year Old Women

    Not yet reported Vastra Gotaland Region 370 participants Est. completion 2020-11-06 1 site Stand-alone
    Other conditions: Women's Health, Quality of Life, Mental Health, Menopause, Primary Health Care, Sick Leave
    View official trial listing →
  • Active, not recruiting NCT NCT03663543

    Intravenous Estrogen in Kidney Transplant Study

    Not yet reported, Not yet reported University of Pennsylvania 30 participants Est. completion 2027-05-01 1 site
    Other conditions: Ischemia Reperfusion Injury
    View official trial listing →
  • Completed NCT NCT03675581

    A Study to Test Whether Nintedanib Influences the Components of Birth-control Pills in Women With Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD)

    Not yet reported Boehringer Ingelheim 17 participants Est. completion 2019-10-10 10 sites
    Other conditions: Scleroderma, Systemic
    View official trial listing →
  • Completed NCT NCT03681691

    The Interaction Between Diabetes and Estradiol on Human Brain Metabolism in Postmenopausal Women

    Not yet reported Wake Forest University Health Sciences 12 participants Est. completion 2021-07-19 1 site
    Other conditions: Diabetes Type 2, Dementia
    View official trial listing →
  • Completed NCT NCT03684096

    Effect of Non-estrogenic Pollen Extract PCC-100 on Hot Flushes

    Not yet reported University Hospital, Ghent 69 participants Est. completion 2023-01-31 1 site
    Other conditions: Breast Cancer, Hot Flashes, Postmenopausal Symptoms
    View official trial listing →
  • Completed NCT NCT03685331

    HOPE: Olaparib, Palbociclib and Fulvestrant in Patients With BRCA Mutation-associated, HR+, HER2-metastatic Breast Cancer

    Not yet reported Abramson Cancer Center at Penn Medicine 9 participants Est. completion 2025-12-01 1 site
    Other conditions: Metastatic Breast Cancer, Locally Advanced Breast Cancer, Advanced Breast Cancer, BRCA2 Mutation, BRCA1 Mutation
    View official trial listing →
  • Completed NCT NCT03689543

    Estrogen Receptor Beta and Mood

    Not yet reported National Institute of Mental Health (NIMH) 74 participants Est. completion 2024-09-09 1 site Stand-alone
    Other conditions: Perimenopause-Related Depression
    View official trial listing →
  • Completed NCT NCT03691493

    Radiation Therapy, Palbociclib, and Hormone Therapy in Treating Breast Cancer Patients With Bone Metastasis

    Not yet reported Emory University 36 participants Est. completion 2022-10-13 10 sites
    Other conditions: Anatomic Stage IV Breast Cancer AJCC v8, Estrogen Receptor Positive, HER2/Neu Negative, Metastatic Breast Carcinoma, Metastatic Malignant Neoplasm in the Bone, Progesterone Receptor Positive, Prognostic Stage IV Breast Cancer AJCC v8
    View official trial listing →
  • Completed NCT NCT03703492

    Hybrid Molecular Imaging of ER in Breast Cancer Patients With DCIS

    Not yet reported University of Wisconsin, Madison 12 participants Est. completion 2024-01-02 1 site Stand-alone
    Other conditions: Breast Cancer, Ductal Carcinoma in Situ - Category
    View official trial listing →
  • Terminated NCT NCT03709082

    Palbociclib in Estrogen Receptor Positive (ER+) Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Metastatic Breast Cancer

    Not yet reported, Not yet reported University of Kansas Medical Center 3 participants Est. completion 2021-02-03 5 sites
    Other conditions: HER2-positive Breast Cancer, Breast Cancer Metastatic
    View official trial listing →
  • Completed NCT NCT03718494

    Continuation of The Kronos Early Estrogen Prevention Study (KEEPS)

    Mayo Clinic 299 participants Est. completion 2022-09-01 6 sites
    Other conditions: Alzheimer Dementia
    View official trial listing →
  • Completed NCT NCT03719495

    Evaluation of Endocrine Therapy Effects of Host Immunity in Early Stage Breast Cancer

    Duke University 68 participants Est. completion 2023-07-31 1 site
    Other conditions: Breast Cancer, Estrogen Receptor-positive Breast Cancer, Healthy
    View official trial listing →
  • Completed NCT NCT03720847

    Effect of Perimenstrual Ovarian Steroid Supplementation on Perimenstrual Suicidality

    Not yet reported University of North Carolina, Chapel Hill 30 participants Est. completion 2017-11 1 site
    Other conditions: Suicidal Ideation
    View official trial listing →
  • Withdrawn NCT NCT03724955

    Pilot E2 for Hypogonadal Women With CFBD

    Not yet reported Emory University Est. completion 2021-06 1 site
    Other conditions: Cystic Fibrosis Related Bone Disease
    View official trial listing →
  • Active, not recruiting NCT NCT03725059

    Study of Pembrolizumab (MK-3475) Versus Placebo in Combination With Neoadjuvant Chemotherapy & Adjuvant Endocrine Therapy in the Treatment of Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer (MK-3475-756/KEYNOTE-756)

    Not yet reported Merck Sharp & Dohme LLC 1240 participants Est. completion 2031-01-24 244 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT03725436

    ALRN-6924 and Paclitaxel in Treating Patients With Advanced, Metastatic, or Unresectable Solid Tumors

    Not yet reported M.D. Anderson Cancer Center 28 participants Est. completion 2026-03-11 1 site
    Other conditions: Advanced Malignant Solid Neoplasm, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8, Anatomic Stage IIIC Breast Cancer AJCC v8, Estrogen Receptor Positive, HER2/Neu Negative, Metastatic Malignant Solid Neoplasm, Prognostic Stage III Breast Cancer AJCC v8, Prognostic Stage IIIA Breast Cancer AJCC v8, Prognostic Stage IIIB Breast Cancer AJCC v8, Prognostic Stage IIIC Breast Cancer AJCC v8, Recurrent Breast Carcinoma, TP53 wt Allele, Unresectable Malignant Solid Neoplasm
    View official trial listing →
  • Terminated NCT NCT03725696

    The Effect of Bariatric Surgery on Spermatogenesis

    The Cleveland Clinic 25 participants Est. completion 2020-12-31 1 site
    Other conditions: Bariatric Surgery Candidate, Sexual Function and Fertility Disorders
    View official trial listing →
  • Completed NCT NCT03726931

    FES (16α-[18F]-Fluoro-17β-estradiol)-PET: Towards a New Standard to Stage Locally Advanced and Recurrent, Estrogen Receptor Positive (ER+) Breast Cancer? Pilot Study to Compare [18F]FES-PET and [18F]FDG-PET

    Not yet reported Amsterdam UMC, location VUmc 40 participants Est. completion 2023-01-29 1 site Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT03740009

    Effects of a Tissue Selective Estrogen Complex (TSEC) on Depression and the Neural Reward System in the Perimenopause"

    Not yet reported University of North Carolina, Chapel Hill 20 participants Est. completion 2021-05-17 1 site Stand-alone
    Other conditions: Perimenopausal Disorder, Depression
    View official trial listing →
  • Active, not recruiting NCT NCT03740204

    The Role of Estrogen in the Neurobiology of Eating Disorders

    Not yet reported Massachusetts General Hospital 120 participants Est. completion 2026-12-31 1 site
    Other conditions: Eating Disorders, Hypoestrogenemia
    View official trial listing →
  • Completed NCT NCT03747198

    Methylsulfonylmethane on Knee Laxity

    Not yet reported University of California, Davis 32 participants Est. completion 2019-10-01 1 site Stand-alone
    Other conditions: Ligament Injury, Ligament; Laxity, Tendon Rupture, Tendon Injuries
    View official trial listing →
  • Withdrawn NCT NCT03749733

    Bioequivalence of Two Fixed-dose Combination Tablets Containing Estradiol and Nomegestrol Acetate

    Not yet reported Grünenthal GmbH Est. completion 2019-12 1 site
    Other conditions: Bioequivalence
    View official trial listing →
  • Completed NCT NCT03751800

    A Study Run at Multiple Study Sites to Test Whether the SAMANTA Questionnaire That is Used to Diagnose Heavy Menstrual Bleeding (HMB), Can Also be Used to Assess Changes of Severity of HMB in Women With HMB Who Are Treated During 12 Months With a Chronic Hormonal Treatment

    Bayer 422 participants Est. completion 2021-05-18 1 site
    Other conditions: Menorrhagia
    View official trial listing →
  • Completed NCT NCT03755037

    Clomiphene Citrate, Estradiol and Sildenafil for Induction of Ovulation in Unexplained Infertility

    Not yet reported Nesreen Abdel Fattah Abdullah Shehata 150 participants Est. completion 2018-04-30 1 site
    Other conditions: Female Infertility
    View official trial listing →
  • Completed NCT NCT03757117

    Gender-Affirmative Transgender Care to Improve the HIV Treatment Cascade

    Not yet reported Asociación Civil Impacta Salud y Educación, Peru 220 participants Est. completion 2018-03-31 1 site Stand-alone
    Other conditions: HIV-1-infection
    View official trial listing →
  • Completed NCT NCT03767335

    MEN1611 With Trastuzumab (+/- Fulvestrant) in Metastatic Breast Cancer

    Not yet reported Menarini Group 62 participants Est. completion 2024-02-23 27 sites
    Other conditions: Advanced or Metastatic Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT03772353

    Pyrotinib, Dalpiciclib(SHR6390) and Endocrine Therapy in Subjects With Dual-receptor Positive(ER+/HER2+) Advanced Breast Cancer

    Not yet reported, Not yet reported Fudan University 59 participants Est. completion 2025-12-10 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT03773263

    New Application of Sequential in Vitro Muturation System for Infertility Patients With Polycystic Ovary Syndrome

    Not yet reported Sun Yat-sen University 300 participants Est. completion 2020-03 5 sites
    Other conditions: Polycystic Ovary Syndrome, Infertility
    View official trial listing →
  • Completed NCT NCT03774472

    Hydroxychloroquine, Palbociclib, and Letrozole Before Surgery in Treating Patients With Estrogen Receptor Positive, HER2 Negative Breast Cancer

    Not yet reported, Not yet reported M.D. Anderson Cancer Center 15 participants Est. completion 2024-04-17 1 site
    Other conditions: Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIA Breast Cancer AJCC v8, Anatomic Stage IIB Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8, Anatomic Stage IIIC Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Prognostic Stage I Breast Cancer AJCC v8, Prognostic Stage IA Breast Cancer AJCC v8, Prognostic Stage IB Breast Cancer AJCC v8, Prognostic Stage IIA Breast Cancer AJCC v8, Prognostic Stage IIB Breast Cancer AJCC v8, Prognostic Stage III Breast Cancer AJCC v8, Prognostic Stage IIIA Breast Cancer AJCC v8, Prognostic Stage IIIB Breast Cancer AJCC v8, Prognostic Stage IIIC Breast Cancer AJCC v8, Prognostic Stage IV Breast Cancer AJCC v8
    View official trial listing →
  • Completed NCT NCT03778931

    Phase 3 Trial of Elacestrant Versus Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer

    Not yet reported Stemline Therapeutics, Inc. 478 participants Est. completion 2024-08-22 244 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT03779633

    Preoperative Oestrogen in Postmenopausal Women With Pelvic Organ Prolapse

    Not yet reported Medical University of Vienna 120 participants Est. completion 2020-08-27 2 sites
    Other conditions: Pelvic Organ Prolapse
    View official trial listing →
  • Completed NCT NCT03781063

    Evaluation of Lasofoxifene Versus Fulvestrant in Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation

    Not yet reported Sermonix Pharmaceuticals Inc. 100 participants Est. completion 2025-05-08 51 sites Stand-alone
    Other conditions: Locally Advanced or Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT03783897

    A Drug-drug Interaction Study to Investigate the Effect of Coadministration of EDP-305 on the PK of a Combined Oral Contraceptive in Healthy Female Subjects

    Not yet reported Enanta Pharmaceuticals, Inc 43 participants Est. completion 2019-06-18 1 site
    MASH
    View official trial listing →
  • Completed NCT NCT03786393

    Estrogen Receptor 1 Gene Polymorphism Frequency in Fibromyalgia Syndrome

    Nigde Omer Halisdemir University 200 participants Est. completion 2021-05-15 1 site
    Other conditions: Fibromyalgia
    View official trial listing →
  • Completed NCT NCT03786952

    Stress, Sex, and the Generalization of Fear

    Not yet reported Ohio Northern University 606 participants Est. completion 2022-06-30 1 site
    Other conditions: Psychological Stress
    View official trial listing →
  • Status unknown NCT NCT03788681

    Luteal Phase Support With Estradiol In Poor Responders Undergoing In Vitro Fertilization

    Not yet reported Ain Shams University 170 participants Est. completion 2019-09-01 1 site
    Other conditions: ICSI
    View official trial listing →
  • Status unknown NCT NCT03789123

    Effects of Dienogest and Dienogest Plus Estradiol Valerate in Ovarian Endometrioma

    Not yet reported Bagcilar Training and Research Hospital 710 participants Est. completion 2019-12-01 1 site Stand-alone
    Other conditions: Ovarian Reserve
    View official trial listing →
  • Completed NCT NCT03798197

    Effect of Food on the Bioavailability of 30 mg Estetrol (E4) Tablet in Healthy Postmenopausal Female Volunteers

    Not yet reported Donesta Bioscience 28 participants Est. completion 2019-04-06 1 site
    Other conditions: Food-effect
    View official trial listing →
  • Completed NCT NCT03803228

    Dual Ovarian Stimulation (DUOSTIM) for Poor Ovarian Responders

    Not yet reported Centre Hospitalier Intercommunal Creteil 88 participants Est. completion 2021-11-24 4 sites Stand-alone
    Other conditions: Fertility Disorders
    View official trial listing →
  • Withdrawn NCT NCT03803761

    A Study of a New Drug Combination, Copanlisib and Fulvestrant, in Advanced Breast Cancer

    Not yet reported, Not yet reported National Cancer Institute (NCI) Est. completion 2022-02-19 7 sites
    Other conditions: Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Metastatic Malignant Neoplasm in the Brain, Prognostic Stage IV Breast Cancer AJCC v8
    View official trial listing →
  • Completed NCT NCT03809546

    Individual Differences in Drug Response

    Not yet reported University of Chicago 60 participants Est. completion 2021-06-01 1 site
    Other conditions: Differential Female Response to Δ9-tetrahydrocannabinol (THC)
    View official trial listing →
  • Completed NCT NCT03809988

    PALbociclib Rechallenge in horMone Receptor-posItive/HER2- Negative Advanced Breast Cancer (PALMIRA)

    Not yet reported MedSIR 198 participants Est. completion 2022-11-30 53 sites
    Other conditions: Breast Cancer, Advanced Breast Cancer, Hormone Receptor Positive Tumor, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast
    View official trial listing →
  • Completed NCT NCT03815929

    Oophorectomy, Estrogen Therapy and Cardiovascular Disease Risk in Young Women

    Not yet reported Mayo Clinic 35 participants Est. completion 2023-08-28 1 site
    Other conditions: Cardiovascular Risk Reduction
    View official trial listing →
  • Terminated NCT NCT03816839

    Evaluation of Orally Administered Amcenestrant (SAR439859) in Japanese Postmenopausal Patients With Advanced Breast Cancer (AMEERA-2)

    Not yet reported Sanofi 10 participants Est. completion 2024-12-26 3 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT03819140

    Continuous Versus Cyclical OCP Use in PCOS

    Not yet reported University of California, San Francisco 51 participants Est. completion 2022-10-16 1 site
    Other conditions: Polycystic Ovary Syndrome
    View official trial listing →
  • Active, not recruiting NCT NCT03820830

    Palbociclib for HR Positive / HER2-negative Isolated Locoregional Recurrence of Breast Cancer

    Not yet reported ETOP IBCSG Partners Foundation 405 participants Est. completion 2029-01-01 53 sites Stand-alone
    Other conditions: Breast Cancer Recurrent
    View official trial listing →
  • Completed NCT NCT03831711

    68-Ga-RM2 PET/MRI in Imaging Patients With Estrogen Receptor-Positive Breast Cancer

    Not yet reported, Not yet reported Andrei Iagaru 5 participants Est. completion 2021-11-15 1 site
    Other conditions: Breast Carcinoma, Estrogen Receptor Positive
    View official trial listing →
  • Status unknown NCT NCT03832894

    Oestradiol Supplementation in Luteal Long Agonist Fresh In Vitro Fertilization/Intra Cytoplasmic Sperm Injection ( IVF/ICSI) Cycle .

    Not yet reported Cairo University 2 participants Est. completion 2020-01-01 1 site
    Other conditions: Infertility
    View official trial listing →
  • Completed NCT NCT03832972

    Performance During Menstrual Cycle

    University of Aarhus 40 participants Est. completion 2022-04-01 1 site
    Other conditions: Performance
    View official trial listing →
  • Completed NCT NCT03837015

    Estrogen, Probiotics and Vaginal Health to Prevent HIV Infection in ACB Women

    Not yet reported McMaster University 50 participants Est. completion 2021-12-14 1 site
    Other conditions: HIV-1-infection, Bacterial Vaginoses
    View official trial listing →
  • Completed NCT NCT03837626

    ENAC Blockade and Arterial Stiffness

    Not yet reported, Not yet reported University of Missouri-Columbia 137 participants Est. completion 2025-04-30 1 site
    Other conditions: Overweight and Obesity, Insulin Resistance
    View official trial listing →
  • Completed NCT NCT03843346

    The Impact of the Gene Recurrence Score on Chemotherapy Prescribing in ER Positive, Lymph Node Positive Early Stage Breast Cancer

    Cancer Trials Ireland 87 participants Est. completion 2021-02-02 10 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT03843736

    The Role of Dysbiosis of Gut Microbiota in the Pathogenesis of PCOS.

    Not yet reported Peking Union Medical College Hospital 200 participants Est. completion 2020-12-31 1 site
    Other conditions: Polycystic Ovary Syndrome
    View official trial listing →
  • Completed NCT NCT03844412

    Vestibulodynia: Understanding Pathophysiology and Determining Appropriate Treatments

    Not yet reported Duke University 209 participants Est. completion 2024-05-30 2 sites
    Other conditions: Vestibulodynia, Temporomandibular Disorder, Fibromyalgia Syndrome, Irritable Bowel Syndrome, Migraines, Tension Headache, Endometriosis, Interstitial Cystitis, Back Pain, Chronic Fatigue Syndrome
    View official trial listing →
  • Completed NCT NCT03844685

    Red Clover and Lifestyle Changes to Contrast Menopausal Symptoms in Premenopausal Breast Cancer Patients Given Tamoxifen

    Not yet reported Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 88 participants Est. completion 2016-02-23 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Withdrawn NCT NCT03846583

    Tucatinib + Abemaciclib + Herceptin for HER2+ MBC

    Not yet reported Dana-Farber Cancer Institute Est. completion 2020-09-22 Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT03854175

    Effect of Vaginal Sildenafil Citrate on Endometrial Preparation and Outcome in Frozen Thawed Embryo Transfer Cycles

    Not yet reported Cairo University 80 participants Est. completion 2020-01 1 site
    Other conditions: Infertility
    View official trial listing →
  • Completed NCT NCT03854903

    WI231696: Bosutinib, Palbocicilib and Fulvestrant for HR+HER2- Advanced Breast Cancer Refractory to a CDK4/6 Inhibitor

    Not yet reported Georgetown University 19 participants Est. completion 2025-01-09 1 site
    Other conditions: Metastatic Breast Cancer, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast, Hormone Receptor Positive Breast Cancer
    View official trial listing →
  • Withdrawn NCT NCT03856268

    Understanding the Roles of Hormones in Adipocyte Remodeling Following Menopause

    Pennington Biomedical Research Center Est. completion 2022-11-11 1 site
    Other conditions: Menopause Surgical, Estrogen Deficiency, Adiposity, Follicle-Stimulating Hormone Deficiency, Hormone Deficiency
    View official trial listing →
  • Completed NCT NCT03856970

    Study to Evaluate the Effect of IW-3718 on the Pharmacokinetics of Oral Contraceptive, Levothyroxine, Glyburide, and Digoxin in Healthy Adult Volunteers

    Not yet reported Ironwood Pharmaceuticals, Inc. 87 participants Est. completion 2019-07-03 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT03860636

    The Accuracy of Endometrial Ultrasound to Predict Implantation

    University of Nottingham 155 participants Est. completion 2022-04-13 1 site
    Other conditions: Infertility, Subfertility
    View official trial listing →
  • Status unknown NCT NCT03868202

    Follicle Stimulating Hormone (FSH) Glycosylation in Women: Effect of Estradiol

    Not yet reported Eastern Virginia Medical School 10 participants Est. completion 2020-01 1 site
    Other conditions: Follicle Stimulating Hormone Glycosylation, Urinary FSH21/FSH24 Ratio, Estradiol Effect
    View official trial listing →
  • Completed NCT NCT03870399

    Study of Tamoxifen in Well Differentiated Neuroendocrine Tumors and Hormone Receptor Positive Expression

    Not yet reported AC Camargo Cancer Center 23 participants Est. completion 2023-05-13 2 sites
    Other conditions: Neuroendocrine Tumors, Progesterone Receptor Positive Tumor, Estrogen Receptor Positive Tumor
    View official trial listing →
  • Status unknown NCT NCT03873428

    Evaluation of the Unconformity of the Hormonal Status of Metastatic Lesions During a First Relapse of Breast Cancer Initially Expressing Estrogen Receptors: a Pilot Study on the Interest of PET With FES

    Not yet reported Centre Georges Francois Leclerc 25 participants Est. completion 2025-10-18 2 sites
    Other conditions: FES TEP in Detection of Estrogen Receptors
    View official trial listing →
  • Terminated NCT NCT03875313

    Study of CB-839 (Telaglenastat) in Combination With Talazoparib in Patients With Solid Tumors

    Not yet reported, Not yet reported Calithera Biosciences, Inc 33 participants Est. completion 2020-07-29 9 sites Stand-alone
    Other conditions: Solid Tumor, Clear Cell Renal Cell Carcinoma, TNBC - Triple-Negative Breast Cancer, Colorectal Cancer, CRC, RCC, ccRCC
    View official trial listing →
  • Completed NCT NCT03876145

    The Four Methods of Ovarian Stimulation in Patients With Polycystic Ovarian Syndrome

    Not yet reported Royan Institute 120 participants Est. completion 2020-11-20 1 site
    Other conditions: Polycystic Ovary Syndrome, Ovarian Hyperstimulation Syndrome
    View official trial listing →
  • Completed NCT NCT03878823

    Safety and Pharmacokinetics of ODM-209

    Not yet reported, Not yet reported Orion Corporation, Orion Pharma 38 participants Est. completion 2024-01-09 4 sites
    Other conditions: Prostate Cancer Metastatic, Advanced Breast Cancer, Castration-resistant Prostate Cancer, Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT03886389

    Breast Cancer Diet Intervention Study

    Not yet reported Helse Stavanger HF 80 participants Est. completion 2017-07-07
    Other conditions: Early-stage Breast Cancer, Carbohydrate Engorgement, Proliferation, Insulin Resistance, Estrogen Receptor-positive Breast Cancer
    View official trial listing →
  • Completed NCT NCT03887728

    Comparison of Blood Flow in the Arteriae Uterinae in Ovarian Stimulation Cycles

    ART Fertility Clinics LLC 124 participants Est. completion 2020-12-14 1 site
    Other conditions: Endometrial Receptivity
    View official trial listing →
  • Completed NCT NCT03890042

    Dienogest for Treatment of Adenomyotic Uteri

    Not yet reported Assiut University 100 participants Est. completion 2020-08-01 1 site
    Other conditions: Adenomyosis
    View official trial listing →
  • Status unknown NCT NCT03898401

    Effect of PRP Injection in Releiving of Symptoms of Senile Vaginitis

    Not yet reported Ain Shams University 30 participants Est. completion 2019-10-30 2 sites Stand-alone
    Other conditions: Senile Vaginitis
    View official trial listing →
  • Completed NCT NCT03901131

    PROMES: A Clinical Study in Which Researchers Want to Learn More About the Safety Profile of MESIGYNA (Norethisterone Enantate 50 mg and Estradiol Valerate 5 mg) Used as a Medication to Prevent Pregnancy for Adult Women in Reproductive Age in the Peruvian Population at the Outpatient Clinic.

    Bayer 296 participants Est. completion 2022-02-17 1 site
    Other conditions: Contraceptive
    View official trial listing →
  • Withdrawn NCT NCT03905941

    Relative Desirability of Metformin vs. Birth Control Pill in Treating PCOS in Women of Later Reproductive Age

    Not yet reported University of Virginia Est. completion 2024-11-25 1 site
    Other conditions: Polycystic Ovary Syndrome
    View official trial listing →
  • Status unknown NCT NCT03910712

    Pyrotinib Combined With Trastuzumab and AI in the First-line Treatment of HER2 Positive/ HR Positive MBC

    Not yet reported Peking Union Medical College Hospital 250 participants Est. completion 2023-12-01
    Other conditions: Breast Cancer Female, HER2-positive Breast Cancer, Hormone Receptor Positive Malignant Neoplasm of Breast, Metastatic Breast Cancer, Breast Diseases, Hormone Receptor Positive Tumor
    View official trial listing →
  • Status unknown NCT NCT03913208

    Priority to Cryopreservation Strategy (PCS) in IVF-ICSI Cycles

    Not yet reported Tanta University 1000 participants Est. completion 2024-12-31 1 site Stand-alone
    Other conditions: Infertility, IVF, ICSI, Cryopreservation
    View official trial listing →
  • Completed NCT NCT03915054

    Amphiregulin Versus Non-Amphiregulin Supplementation to Maturation Culturing Medium in IVM.

    Not yet reported Mỹ Đức Hospital 30 participants Est. completion 2020-01-31 1 site
    Other conditions: PCOS, IVM
    View official trial listing →
  • Completed NCT NCT03916744

    A Study of Giredestrant (GDC-9545) in Postmenopausal Women With Stage I-III Operable, Estrogen Receptor-Positive Breast Cancer

    Not yet reported Genentech, Inc. 75 participants Est. completion 2021-05-25 15 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT03917082

    Limited Adjuvant Endocrine Therapy for Low Risk Breast Cancer

    Not yet reported British Columbia Cancer Agency 290 participants Est. completion 2029-05-01 1 site
    Other conditions: Breast Cancer Female, Hormone Receptor Positive Tumor
    View official trial listing →
  • Completed NCT NCT03921710

    CAPA-IVM Versus STANDARD IVM

    Not yet reported Mỹ Đức Hospital 80 participants Est. completion 2018-10-10 1 site
    Other conditions: Infertility, Female
    View official trial listing →
  • Completed NCT NCT03921736

    Reversal of an Unfavorable Effect of Hydrochlorothiazide Compared to Angiotensin Converting Enzyme Inhibitor on Serum Uric Acid and Oxypurines Levels by Estrogen-progestin Therapy in Hypertensive Postmenopausal Women.

    Not yet reported Anna Posadzy-Małaczyńska 180 participants Est. completion 2005-11-17 Stand-alone
    Other conditions: Hypertension, Hyperuricemia, Menopause
    View official trial listing →
  • Status unknown NCT NCT03925233

    Breast Cancer Treatment Based on Organ-like Culture

    Xijing Hospital 300 participants Est. completion 2021-12-15 1 site
    Other conditions: Breast Cancer Organoids
    View official trial listing →
  • Completed NCT NCT03926936

    FUlvestrant in Gynecological Cancers That Are Potentially Hormone Sensitive: the FUCHSia Study

    Not yet reported Frederic Amant 17 participants Est. completion 2022-12-27 14 sites
    Obstructive sleep apnea Other conditions: Endometrial Stromal Sarcoma, Endometrial Cancer, Sex Cord Stromal Tumor, Serous Ovarian Tumor
    View official trial listing →
  • Status unknown NCT NCT03927456

    A Study of SHR6390 in Combination With Fulvestrant in Patients With HR Positive and HER2 Negative Advanced Breast Cancer

    Not yet reported Jiangsu HengRui Medicine Co., Ltd. 357 participants Est. completion 2022-12-30 1 site
    Other conditions: Advanced Breast Cancer
    View official trial listing →
  • Completed NCT NCT03930706

    SHorter Treatment of Replacement Therapy for Frozen Embryo Transfer (FET)

    Not yet reported Universitair Ziekenhuis Brussel 150 participants Est. completion 2021-03-31 1 site Stand-alone
    Other conditions: Infertility
    View official trial listing →
  • Active, not recruiting NCT NCT03939897

    Testing the Addition of Copanlisib to Usual Treatment (Fulvestrant and Abemaciclib) in Metastatic Breast Cancer

    Not yet reported National Cancer Institute (NCI) 24 participants Est. completion 2027-07-31 14 sites
    Other conditions: Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Metastatic HER2-Negative Breast Carcinoma, Metastatic Hormone Receptor-Positive Breast Carcinoma, Recurrent Breast Carcinoma
    View official trial listing →
  • Active, not recruiting NCT NCT03941730

    Estradiol in Treating Patients With ER Beta Positive, Triple Negative Locally Advanced or Metastatic Breast Cancer

    Not yet reported Mayo Clinic 8 participants Est. completion 2026-12-31 9 sites
    Other conditions: Advanced Triple-Negative Breast Carcinoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Triple-Negative Breast Carcinoma, Recurrent Breast Carcinoma
    View official trial listing →
  • Terminated NCT NCT03943823

    Postmenopausal Pessary Users: Estrogen Versus Trimosan

    Not yet reported The University of Texas Health Science Center, Houston 4 participants Est. completion 2021-04-08 1 site
    Other conditions: Vaginosis, Vaginosis, Bacterial, Vaginal Discharge
    View official trial listing →
  • Active, not recruiting NCT NCT03944434

    FACILE: FeAsibility of First-line RiboCIclib in OLdEr Patients with Advanced Breast Cancer

    Not yet reported Fondazione Sandro Pitigliani 116 participants Est. completion 2025-11-27 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT03945513

    A Multicenter, Non-Comparative Trial on the Contraceptive Efficacy, Safety, and Tolerability of LPRI-424, 13 Cycles

    Not yet reported Insud Pharma 1034 participants Est. completion 2023-09-08 1 site
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT03945812

    Platelet-Rich Plasma vs. Granulocyte Colony-Stimulating Factor vs. Placebo and Outcomes in Frozen Embryo Transfer

    Not yet reported Wael Elbanna Clinic 665 participants Est. completion 2023-03-08 1 site
    Other conditions: Infertility, Frozen Embryo Transfer (FET)
    View official trial listing →
  • Status unknown NCT NCT03946722

    Modified Downregulation for Women With Adenomyosis of the Uterus Prior to Frozen-thawed Embryo Transfer.

    Not yet reported University College, London 162 participants Est. completion 2024-05-17 1 site
    Other conditions: Adenomyosis
    View official trial listing →
  • Completed NCT NCT03949985

    Longitudinal Hemostatic Profile After Stopping Estroprogestative Contraceptives

    University Hospital, Geneva 103 participants Est. completion 2020-09-14 1 site
    Other conditions: Venous Thromboembolism, Contraception
    View official trial listing →
  • Terminated NCT NCT03954587

    What is the Optimal Cycle Regimen for Frozen- Thawed Embryo Transfer Cycles

    ART Fertility Clinics LLC 4 participants Est. completion 2020-07-30 1 site
    Other conditions: Infertility, Female Infertility, Pregnancy Early
    View official trial listing →
  • Active, not recruiting NCT NCT03959891

    AKT Inhibitor, Ipatasertib, With Endocrine and CDK 4/6 Inhibitor for Patients With Metastatic Breast Cancer (TAKTIC)

    Not yet reported Massachusetts General Hospital 77 participants Est. completion 2027-08 1 site Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT03961880

    Impact of Recurrence Score on Adjuvant Treatment Decisions in Breast Cancer Patients

    University Hospital Tuebingen 270 participants Est. completion 2025-06-30 1 site
    Other conditions: Breast Cancer Female
    View official trial listing →
  • Status unknown NCT NCT03967457

    Comprehensive Study on the Quality of Life in Cervical Cancer Patients

    Lei Li 10000 participants Est. completion 2023-06-01 1 site
    Other conditions: Quality of Life, Cervical Cancer, Urodynamics, Rectum Dynamics, Sex Dysfunction, Pelvic Floor Disorders, Ovarian Reserve Function, Survivorship, Disease-free Survival, Overall Survival
    View official trial listing →
  • Completed NCT NCT03973229

    Neuroendocrine Risk for PTSD in Women

    Not yet reported Emory University 127 participants Est. completion 2025-04-30 1 site
    Other conditions: PTSD, Trauma
    View official trial listing →
  • Status unknown NCT NCT03981341

    Impact of Estrogen + Estradiol Receptor Alpha Modulator Therapy on Oxidative Stress in Post-menopausal Women With and Without Sleep Apnea

    Not yet reported Laval University 36 participants Est. completion 2023-12-01 1 site
    Other conditions: Sleep Apnea, Post Menopausal, Oxidative Stress
    View official trial listing →
  • Completed NCT NCT03984825

    Effect of GSK3640254 on the Pharmacokinetics of a Combination Oral Contraceptive

    Not yet reported ViiV Healthcare 23 participants Est. completion 2019-08-16 1 site
    Other conditions: HIV Infections
    View official trial listing →
  • Completed NCT NCT03994432

    Effect of Mediterranean Diet and Physical Activity in Patients With Endometriosis

    Not yet reported Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico 140 participants Est. completion 2023-11-20 1 site
    Other conditions: Endometriosis
    View official trial listing →
  • Withdrawn NCT NCT03996057

    Methenamine in a Non-antibiotic, Multimodal Approach to UTI Prevention

    Not yet reported Washington University School of Medicine Est. completion 2022-02-11 Stand-alone
    Other conditions: UTI, Female Urogenital Diseases, UTI - Lower Urinary Tract Infection
    View official trial listing →
  • Completed NCT NCT03996603

    Investigation of Microbiomes of Postmenopausal Women Looking for Outcomes and Response to Estrogen Therapy

    Not yet reported University of Alabama at Birmingham 25 participants Est. completion 2021-01-14 1 site
    Other conditions: Female Urogenital Diseases, Vaginal Atrophy, Postmenopausal Atrophic Vaginitis, Genitourinary Disease, Postmenopausal Symptoms
    View official trial listing →
  • Completed NCT NCT03998761

    Progesterone Versus Progesterone Plus Dydrogesterone in FET

    Not yet reported Mỹ Đức Hospital 1364 participants Est. completion 2021-01-31 1 site
    Other conditions: Infertility
    View official trial listing →
  • Withdrawn NCT NCT04002635

    Letrozole for Frozen Embryo Transfer (FET) in Patients With Polycystic Ovary Syndrome (PCOS)

    Not yet reported CRG UZ Brussel Est. completion 2022-04-01
    Other conditions: Infertility, Female, Polycystic Ovary Syndrome, IVF, Ovulation Disorder
    View official trial listing →
  • Completed NCT NCT04002934

    Bazedoxifene Acetate as a Remyelinating Agent in Multiple Sclerosis

    Not yet reported Riley Bove, MD 63 participants Est. completion 2025-05-20 1 site
    Other conditions: Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting
    View official trial listing →
  • Completed NCT NCT04006626

    18F-FES PET/CT's Additional Clinical Value in ER+ BC

    Fudan University 19 participants Est. completion 2019-06-20 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT04007874

    Oral Contraceptive Pill Compared With Vitamin E in Women With Migraine

    Not yet reported Leiden University Medical Center 360 participants Est. completion 2024-12 1 site
    Other conditions: Migraine, Migraine;Menstrual
    View official trial listing →
  • Status unknown NCT NCT04009473

    Stem Cell Therapy and Growth Factor Ovarian in Vitro Activation

    Not yet reported, Not yet reported Forever Young d.o.o. 100 participants Est. completion 2021-12 3 sites
    Other conditions: Menopause, Menopause Ovarian Failure, Ovarian Failure, Premature Ovarian Failure, Premature Ovarian Failure 1, Premature Ovarian Failure 2A, Premature Ovarian Failure 2B, Premature Ovarian Failure 3, Premature Ovarian Failure 4, Premature Ovarian Failure 5, Premature Ovarian Failure 6, Premature Ovarian Failure 7, Premature Ovarian Failure 8, Premature Ovarian Failure 9, Premature Ovarian Failure 10, Premature Ovarian Failure 11, Premature Ovarian Failure 12, Premature Ovarian Failure 13, Premature Ovarian Failure 14, Ovarian Insufficiency, Ovarian Failure Secondary, Ovarian Failure, Premature, Ovarian Insufficiency, Primary, Menopause, Premature
    View official trial listing →
  • Status unknown NCT NCT04012918

    Capecitabine in Combination With Aromatase Inhibitor Versus Aromatase Inhibitors, in Hormonal Receptor Positive Recurrent or Metastatic Breast Cancer Patients, Randomized Controlled Study

    Not yet reported Ain Shams University 124 participants Est. completion 2021-02 1 site
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT04013438

    Luteal Phase Support During Frozen Embryo Transfer Cycle

    Not yet reported Royan Institute 60 participants Est. completion 2019-04-30 1 site Stand-alone
    Other conditions: Infertility, Female, Frozen Embryo Transfer
    View official trial listing →
  • Completed NCT NCT04016753

    A Study Measuring the Effectiveness of BMS-986256 Combined With Oral Contraceptive in Healthy Female Participants

    Not yet reported Bristol-Myers Squibb 32 participants Est. completion 2020-02-21 1 site
    Other conditions: Healthy Participants
    View official trial listing →
  • Completed NCT NCT04018274

    Effect of PF-06651600 on the Pharmacokinetics of Oral Contraceptive Steroids

    Not yet reported Pfizer 29 participants Est. completion 2019-10-16 2 sites
    Other conditions: Healthy
    View official trial listing →
  • Withdrawn NCT NCT04021017

    PRE-GAiN Bone Health Pilot Study

    Not yet reported University of Saskatchewan Est. completion 2022-12-13 1 site Stand-alone
    Obstructive sleep apnea
    View official trial listing →
  • Terminated NCT NCT04024436

    A Study of TAS-120 in Patients With Metastatic Breast Cancer

    Not yet reported Taiho Oncology, Inc. 64 participants Est. completion 2023-09-06 37 sites
    Other conditions: Metastatic Breast Cancer, FGFR 1 High Amplification, FGFR2 Amplification
    View official trial listing →
  • Terminated NCT NCT04031885

    A Study of Abemaciclib (LY2835219) in Combination With Fulvestrant Compared to Chemotherapy in Women With HR Positive, HER2 Negative Metastatic Breast Cancer

    Not yet reported Eli Lilly and Company 4 participants Est. completion 2020-08-11 61 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT04033172

    Pyrotinib Plus Fulvestrant in Patients With HR+/HER2+ Metastatic Breast Cancer (Pyrotinib+Fulvestrant )

    Not yet reported Chinese Academy of Medical Sciences 40 participants Est. completion 2021-09-01 1 site
    Other conditions: Breast Cancer, HER2-positive Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT04034589

    Pyrotinib in Combination With Fulvestrant in Patients With HER2 Positive,HR-Positive Metastatic Breast Cancer

    Not yet reported Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 46 participants Est. completion 2022-07-06 2 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT04036500

    Transgender Estradiol

    Not yet reported Medical College of Wisconsin 11 participants Est. completion 2020-07-13 1 site
    Other conditions: Transgender Persons
    View official trial listing →
  • Withdrawn NCT NCT04038489

    COX Inhibition and Biomarkers During Neoadjuvant Chemoendocrine Therapy for ER+, HER2- Stage I-III Breast Cancer

    Not yet reported University of Virginia Est. completion 2023-04-30 1 site
    Other conditions: Breast Cancer, Estrogen Receptor-positive Breast Cancer
    View official trial listing →
  • Completed NCT NCT04039204

    Elagolix for Fertility Enhancement Clinical Trial

    Not yet reported Wake Forest University Health Sciences 10 participants Est. completion 2023-08-09 1 site Stand-alone
    Other conditions: Endometriosis, Unexplained Infertility
    View official trial listing →
  • Active, not recruiting NCT NCT04045379

    LASER and Radiofrequency and Genitourinary Syndrome of Menopause

    Not yet reported Federal University of São Paulo 195 participants Est. completion 2025-08 1 site
    Other conditions: Postmenopausal Atrophic Vaginitis, Postmenopausal Symptoms, Genitourinary Symptoms
    View official trial listing →
  • Status unknown NCT NCT04046159

    Radiotherapy Versus Low-Dose Tamoxifen Following Breast Conserving Surgery for Low-Risk Breast Ductal Carcinoma in Situ

    Not yet reported National Taiwan University Hospital 810 participants Est. completion 2025-12-31 1 site
    Other conditions: Breast Ductal Carcinoma in Situ
    View official trial listing →
  • Status unknown NCT NCT04050592

    Discontinuation of Postmenopausal Hormone Therapy: Impact on the Cardiovascular System and Quality of Life

    Not yet reported Hanna Savolainen-Peltonen 150 participants Est. completion 2022-12 1 site
    Cardiovascular disease Other conditions: Menopause, Atherosclerosis, Estrogen Replacement Therapy
    View official trial listing →
  • Completed NCT NCT04051320

    Characterizing the Neural Substrates of Irritability in Women: an Experimental Neuroendocrine Model

    Not yet reported University of North Carolina, Chapel Hill 23 participants Est. completion 2022-07-19 1 site
    Other conditions: Perinatal Depression, Post Partum Depression, Depression, Postpartum, Depression
    View official trial listing →
  • Active, not recruiting NCT NCT04052555

    Testing the Addition of an Anti-cancer Drug, Berzosertib, to the Usual Treatment (Radiation Therapy) for Chemotherapy-Resistant Triple-Negative and Estrogen and/or Progesterone Receptor Positive, HER2 Negative Breast Cancer

    Not yet reported National Cancer Institute (NCI) 42 participants Est. completion 2027-02-24 14 sites
    Other conditions: Bilateral Breast Carcinoma, HER2-Negative Breast Carcinoma, Localized Breast Carcinoma, Recurrent Breast Carcinoma, Triple-Negative Breast Carcinoma
    View official trial listing →
  • Active, not recruiting NCT NCT04053322

    Durvalumab, With Olaparib and Fulvestrant in Advanced ER+, HER2- Breast Cancer Patients.

    Not yet reported UNICANCER 172 participants Est. completion 2027-08 2 sites
    Other conditions: ER-positive and HER2-negative Metastatic or Locally Advanced Breast Cancer, a Germline or Somatic BRCA Mutation, or a Deleterious Alteration of Other Genes Involved in Homologous Recombination Repair (HRR) or in MSI Status
    View official trial listing →
  • Completed NCT NCT04055129

    Hormone Induced Effects on Ligament Laxity and Lower Extremity Motor Control

    University of St. Augustine for Health Sciences 52 participants Est. completion 2023-08-01 1 site
    Other conditions: Hormone Influence on Ligament Laxity and Motor Control
    View official trial listing →
  • Terminated NCT NCT04059484

    Phase 2 Study of Amcenestrant (SAR439859) Versus Physician's Choice in Locally Advanced or Metastatic ER-positive Breast Cancer

    Not yet reported Sanofi 367 participants Est. completion 2025-01-02 109 sites
    Other conditions: Breast Cancer Metastatic
    View official trial listing →
  • Terminated NCT NCT04060862

    A Study of Ipatasertib Plus Palbociclib and Fulvestrant Versus Placebo Plus Palbociclib and Fulvestrant in Hormone Receptor Positive and HER2 Negative Locally Advanced Unresectable or Metastatic Breast Cancer

    Not yet reported Hoffmann-La Roche 20 participants Est. completion 2023-08-29 20 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT04066283

    Effects of Aging and Gender-Affirming Hormone Therapy on Vascular Endothelial Function and Metabolic Profiles in Transgender Women

    University of Colorado, Denver 29 participants Est. completion 2023-12-31 1 site
    Other conditions: Transgender, Gender Identity, Vascular Stiffness, Vascular Inflammation, Insulin Sensitivity, Blood Pressure, Lipid Disorder, Appetitive Behavior
    View official trial listing →
  • Completed NCT NCT04072952

    A Phase 1/2 Trial of ARV-471 Alone and in Combination With Palbociclib (IBRANCE®) in Participants With ER+/HER2- Locally Advanced or Metastatic Breast Cancer

    Not yet reported, Not yet reported Arvinas Estrogen Receptor, Inc. 219 participants Est. completion 2026-03-05 16 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT04079218

    Accelerated Genital Tract Aging in HIV: Estradiol Clinical Trial

    Not yet reported Kerry Murphy 60 participants Est. completion 2023-08-09 1 site
    Other conditions: HIV Infection, Vaginal Atrophy, Menopause, Menopause Related Conditions, Aging, Premature Aging, Atrophic Vaginitis, Dysbiosis, Vaginitis
    View official trial listing →
  • Completed NCT NCT04080297

    Dose Escalation Study in Female Subjects With Breast Cancer Receiving Aromatase Inhibitor or Tamoxifen

    Not yet reported Que Oncology 21 participants Est. completion 2014-07-28
    Other conditions: Vasomotor Symptoms (VMS)
    View official trial listing →
  • Withdrawn NCT NCT04088032

    Neoadjuvant Study of Abemaciclib, Durvalumab, and an Aromatase Inhibitor Early Stage Breast Cancer

    Not yet reported Alison Stopeck Est. completion 2020-12-31 1 site
    Other conditions: Breast Cancer Female, Locally Advanced Breast Cancer, Hormone Receptor Positive Malignant Neoplasm of Breast
    View official trial listing →
  • Status unknown NCT NCT04088110

    Pyrotinib Combined With Trastuzumab Plus Aromatase Inhibitor in Treatment of Breast Cancer

    Not yet reported Fuzhou General Hospital 77 participants Est. completion 2023-11 1 site
    Other conditions: Breast Cancer Female, HER2-positive Breast Cancer, Hormone Receptor Positive Malignant Neoplasm of Breast, Metastatic Breast Cancer, Breast Diseases, Hormone Receptor Positive Tumor
    View official trial listing →
  • Completed NCT NCT04090957

    Estetrol for the Treatment of Moderate to Severe Vasomotor Symptoms in Postmenopausal Women (E4Comfort II)

    Not yet reported Estetra 1015 participants Est. completion 2022-08-18 117 sites
    Other conditions: Vasomotor Symptoms, Menopausal Symptoms
    View official trial listing →
  • Status unknown NCT NCT04092673

    Study of eFT226 in Subjects With Selected Advanced Solid Tumor Malignancies

    Not yet reported, Not yet reported Effector Therapeutics 30 participants Est. completion 2025-03-31 14 sites
    Other conditions: Solid Tumor, Adult
    View official trial listing →
  • Status unknown NCT NCT04093518

    Estradiol as add-on to Antipsychotics

    Not yet reported Tangent Data 100 participants Est. completion 2020-11-01 1 site
    Other conditions: Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorders
    View official trial listing →
  • Status unknown NCT NCT04100655

    The Effect of the GM-CSF Gel on the Endometrial Thickness in Infertile Women With Thin Endometrium

    Not yet reported Sir Run Run Shaw Hospital 96 participants Est. completion 2020-12 1 site
    Other conditions: Thin Endometrium
    View official trial listing →
  • Status unknown NCT NCT04101656

    Accelerated Partial Irradiation of the Breast: New Altered Fractionation

    Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 174 participants Est. completion 2026-06-15 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT04103476

    Advancing Postmenopausal Preventive Therapy

    Not yet reported University of Southern California 385 participants Est. completion 2026-12-31 1 site
    Other conditions: Atherosclerosis, Cognitive Decline
    View official trial listing →
  • Completed NCT NCT04109066

    Study of Nivolumab Versus Placebo in Combination With Neoadjuvant Chemotherapy and Adjuvant Endocrine Therapy in Participants With High-risk, Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor 2-Negative (HER2-) Primary Breast Cancer

    Not yet reported Bristol-Myers Squibb 521 participants Est. completion 2023-12-27 240 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT04112368

    Cyclical Neuroactive Steroid Changes, Arousal, and Proximal Suicide Risk: An Experimental Approach

    Not yet reported University of Illinois at Chicago 124 participants Est. completion 2024-08-01 1 site
    Other conditions: Suicidal Ideation
    View official trial listing →
  • Completed NCT NCT04114500

    The Association Between Serum E2 and P on the Day of FET and the Pregnancy Outcome

    Al Baraka Fertility Hospital 402 participants Est. completion 2019-05-05 1 site
    Other conditions: Frozen Embryo Transfer
    View official trial listing →
  • Terminated NCT NCT04131517

    A Study to Test the Interaction of Padsevonil With Oral Contraceptives in Healthy Female Participants

    Not yet reported UCB Biopharma SRL 14 participants Est. completion 2020-05-22 1 site
    Other conditions: Healthy Female Participants
    View official trial listing →
  • Status unknown NCT NCT04137640

    Palbociclib + Letrozole Versus Epirubicin + Cyclophosphamide and Sequential Docetaxel as Neoadjuvant Chemotherapy

    Not yet reported Shengjing Hospital 152 participants Est. completion 2026-05-31 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT04142762

    A Study to Assess CYP3A4 Modulator, Oral Contraceptive, and pH Modifier Drug Interactions for ABI-H2158 in Healthy Adults

    Not yet reported Assembly Biosciences 80 participants Est. completion 2020-01-29 1 site
    Other conditions: Chronic Hepatitis B
    View official trial listing →
  • Completed NCT NCT04150731

    16α-18F-fluor-17β-estradiol PET/CT for Visualisation of Estrogen Receptor Positive Liver Metastases From Breast Cancer

    Not yet reported, Not yet reported University of Aarhus 8 participants Est. completion 2023-06-28 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT04152057

    Pyrotinib Maleate Tablets Combined With Albumin Paclitaxel and Trastuzumab for Her2-positive Breast Cancer

    Not yet reported, Not yet reported West China Hospital 20 participants Est. completion 2021-04 1 site Stand-alone
    Other conditions: Breast Cancer, HER2 Positive, Combination Chemotherapy
    View official trial listing →
  • Withdrawn NCT NCT04159493

    A Randomized Controlled Phase 2 Study to Determine Lowest Efficacious Dose of Ovestin in Vulvar and Vaginal Atrophy

    Not yet reported Aspen USA Inc Est. completion 2023-05-15
    Other conditions: Vaginal Atrophy
    View official trial listing →
  • Status unknown NCT NCT04163380

    Resistance Training and Sex Hormone Concentrations During the Menstrual Cycle

    Not yet reported Southern Illinois University Edwardsville 25 participants Est. completion 2021-12 1 site
    Other conditions: Women's Health
    View official trial listing →
  • Completed NCT NCT04172987

    A Study of the Effect of Tirzepatide on How the Body Handles Birth Control Pills in Healthy Female Participants

    Not yet reported Eli Lilly and Company 40 participants Est. completion 2021-02-09 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT04176757

    A Study of ZN-c5 in Participants With Breast Cancer

    Not yet reported Zeno Alpha Inc. 35 participants Est. completion 2021-05-25 10 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT04185311

    Ipilimumab, Nivolumab, and Talimogene Laherparepvec Before Surgery in Treating Participants With Localized, Triple-Negative or Estrogen Receptor Positive, HER2 Negative Breast Cancer-deleted

    Not yet reported Jonsson Comprehensive Cancer Center 6 participants Est. completion 2023-05-17 1 site
    Other conditions: Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIA Breast Cancer AJCC v8, Anatomic Stage IIB Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8, HER2/Neu Negative, Invasive Ductal Carcinoma, Not Otherwise Specified, Progesterone Receptor Negative, Prognostic Stage 0 Breast Cancer AJCC v8, Prognostic Stage I Breast Cancer AJCC v8, Prognostic Stage IA Breast Cancer AJCC v8, Prognostic Stage IB Breast Cancer AJCC v8, Prognostic Stage II Breast Cancer AJCC v8, Prognostic Stage IIA Breast Cancer AJCC v8, Prognostic Stage IIB Breast Cancer AJCC v8, Prognostic Stage IIIA Breast Cancer AJCC v8, Prognostic Stage IIIB Breast Cancer AJCC v8, Triple-Negative Breast Carcinoma
    View official trial listing →
  • Active, not recruiting NCT NCT04188548

    A Study of LY3484356 in Participants With Advanced or Metastatic Breast Cancer or Endometrial Cancer

    Not yet reported Eli Lilly and Company 379 participants Est. completion 2027-12 74 sites
    Other conditions: Breast Cancer, Advanced Breast Cancer, Metastatic Breast Cancer, Endometrial Cancer
    View official trial listing →
  • Terminated NCT NCT04190056

    Pembrolizumab and Tamoxifen With or Without Vorinostat for the Treatment of Estrogen Receptor Positive Breast Cancer

    Not yet reported University of California, San Francisco 1 participants Est. completion 2023-06-15 1 site
    Other conditions: Anatomic Stage IV Breast Cancer AJCC v8, Prognostic Stage IV Breast Cancer AJCC v8
    View official trial listing →
  • Status unknown NCT NCT04190927

    A New Hormone Replacement Paradigm: Physiologic Restoration Study

    Not yet reported Women's Hormone Network 100 participants Est. completion 2023-08-01
    Other conditions: Menopause, Perimenopausal Disorder, Menopause Related Conditions
    View official trial listing →
  • Active, not recruiting NCT NCT04191499

    A Study Evaluating the Efficacy and Safety of Inavolisib + Palbociclib + Fulvestrant vs Placebo + Palbociclib + Fulvestrant in Participants With PIK3CA-Mutant, Hormone Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer

    Not yet reported, Not yet reported Hoffmann-La Roche 325 participants Est. completion 2027-11-15 135 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT04192266

    Estrogen and Fear in PTSD

    Not yet reported The University of Texas Health Science Center, Houston 83 participants Est. completion 2024-12-02 2 sites Stand-alone
    Other conditions: PTSD
    View official trial listing →
  • Completed NCT NCT04193852

    Bioavailability of Dienogest and Ethinyl Estradiol Tablets 2.0 mg/0.03 mg With Regards to Reference Product

    Not yet reported Laboratorios Andromaco S.A. 10 participants Est. completion 2019-11-25 1 site
    Other conditions: Bioequivalence
    View official trial listing →
  • Completed NCT NCT04194905

    Bioavailability of Levonorgestrel/Ethinyl Estradiol Tablets 0.1 mg/0.02 mg With Regards to Reference Product

    Not yet reported Laboratorios Andromaco S.A. 10 participants Est. completion 2020-12-15 1 site
    Other conditions: Bioequivalence
    View official trial listing →
  • Enrolling by invitation NCT NCT04202094

    Fertility in Young Adults Who Did (Not) Store Testicular Tissue Before a Treatment Leading to Fertility Problems

    Not yet reported Universitair Ziekenhuis Brussel 50 participants Est. completion 2030-12 1 site
    Other conditions: Childhood Cancer, Hematological Disorders
    View official trial listing →
  • Completed NCT NCT04209881

    Ovarian Reserve and Ankylosing Spondylitis

    Kanuni Sultan Suleyman Training and Research Hospital 50 participants Est. completion 2020-05-19 1 site
    Other conditions: Ovarian Diseases, Ankylosing Spondylitis, Anti-Mullerian Hormone Deficiency
    View official trial listing →
  • Status unknown NCT NCT04212702

    ESR1 Mutations in Asian ER+ Metastatic Breast Cancer on Hormonal Therapy-based Treatments

    National Taiwan University Hospital 123 participants Est. completion 2021-12-31 2 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT04214288

    A Study to Investigate Efficacy and Safety With Oral AZD9833 Compared With Intramuscular Fulvestrant in Post-menopausal Women at Least 18 Years of Age With Advanced ER-positive HER2 Negative Breast Cancer

    Not yet reported AstraZeneca 240 participants Est. completion 2027-06-16 85 sites
    Other conditions: Advanced ER-Positive HER2-Negative Breast Cancer
    View official trial listing →
  • Completed NCT NCT04224272

    Phase 2a Study of ZW25 in Combination With Palbociclib Plus Fulvestrant

    Not yet reported Jazz Pharmaceuticals 51 participants Est. completion 2025-06-30 13 sites
    Other conditions: HER2+/HR+ Breast Cancer
    View official trial listing →
  • Completed NCT NCT04225221

    Neurobiology of Bulimia Nervosa

    Not yet reported University of North Carolina, Chapel Hill 10 participants Est. completion 2022-04-04 1 site
    Obstructive sleep apnea
    View official trial listing →
  • Terminated NCT NCT04227327

    Study Evaluating Abemaciclib + Aromatase Inhibitors in HR+, HER2- Advanced Breast Cancer Patients (HERMIONE-7)

    Not yet reported University of Milano Bicocca 31 participants Est. completion 2024-07-25 39 sites
    Other conditions: Advanced Breast Cancer
    View official trial listing →
  • Completed NCT NCT04230070

    Bioavailability of Levonorgestrel and Ethinyl Estradiol Tablets 15.0 mg/0.03 mg With Regards to Reference Product

    Not yet reported Laboratorios Andromaco S.A. 30 participants Est. completion 2020-11-17 1 site
    Other conditions: Bioequivalence
    View official trial listing →
  • Completed NCT NCT04232813

    Evaluation of the Acceptability and Efficacy of 10 Micrograms of Estradiol Vaginal Tablets vs Promestriene Vaginal Cream

    Not yet reported Instituto Palacios 120 participants Est. completion 2020-11-30 1 site
    Other conditions: Vulvovaginal Atrophy
    View official trial listing →
  • Completed NCT NCT04240106

    Niraparib Plus Aromatase Inhibitors for Luminal-like(HER2-,ER+) and gBRCA or HDR+ Metastatic Breast Cancer (LUZERN)

    Not yet reported MedSIR 14 participants Est. completion 2023-11-17 10 sites
    Other conditions: Breast Cancer, Breast Cancer Metastatic
    View official trial listing →
  • Completed NCT NCT04247126

    A Study of SY 5609, a Selective CDK7 Inhibitor, in Advanced Solid Tumors

    Not yet reported Syros Pharmaceuticals 105 participants Est. completion 2023-03-30 16 sites Stand-alone
    Other conditions: Advanced Solid Tumor, Breast Cancer, Small-cell Lung Cancer, Pancreatic Cancer
    View official trial listing →
  • Status unknown NCT NCT04247204

    Assessment of Endometrial and Sub-endometrial Vascularity Before and After PRP Infusion in Frozen Embryo Transfer Cycles

    Not yet reported Hatem AbuHashim 30 participants Est. completion 2020-10-05 Stand-alone
    Other conditions: Frozen Embryo Transfer
    View official trial listing →
  • Terminated NCT NCT04252859

    [18F]Fluoroestradiol-PET/CT Imaging of Invasive Lobular Carcinoma

    Not yet reported University of Utah 44 participants Est. completion 2024-12-07 1 site Stand-alone
    Other conditions: Invasive Lobular Breast Carcinoma
    View official trial listing →
  • Active, not recruiting NCT NCT04255160

    Impact of Estradiol on Endothelial Function in Peri-Menopausal Women

    Not yet reported University of Delaware 80 participants Est. completion 2026-10-31 1 site
    Other conditions: Perimenopause, Vasodilation, Estrogen
    View official trial listing →
  • Completed NCT NCT04255277

    To Study the Effect of Cenerimod on the Electrical Activity of the Heart, in Men and Women. To Study the Effect of Cenerimod on the Use of Oral Contraceptives in Women. To Study the Effect That Charcoal Has on the Elimination of Cenerimod From the Body, in Women and Men.

    Not yet reported Viatris Innovation GmbH 97 participants Est. completion 2021-10-18 1 site
    Other conditions: Healthy Subjects
    View official trial listing →
  • Status unknown NCT NCT04256200

    Efficacy of Dienogest Versus Oral Contraceptive Pills on Pain Associated With Endometriosis

    Not yet reported, Not yet reported American University of Beirut Medical Center 100 participants Est. completion 2021-12 1 site
    Other conditions: Endometriosis
    View official trial listing →
  • Terminated NCT NCT04256941

    Aromatase Inhibitor Therapy With or Without Fulvestrant for the Treatment of HR Positive Metastatic Breast Cancer With an ERS1 Activating Mutation, the INTERACT Study

    Not yet reported M.D. Anderson Cancer Center 4 participants Est. completion 2023-09-22 1 site
    Other conditions: Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Prognostic Stage IV Breast Cancer AJCC v8
    View official trial listing →
  • Completed NCT NCT04257500

    Does Vaginal Delivery of Combined Hormonal Contraception Affect the Risk of Metabolic Syndrome in Overweight/Obese Women With PCOS

    Not yet reported Andrea Roe, MD, MPH 22 participants Est. completion 2025-08-22 1 site
    Other conditions: Polycystic Ovary Syndrome
    View official trial listing →
  • Completed NCT NCT04258163

    Association of Survival With Maintenance Therapy in Patients With Metastatic Breast Cancer After First-line Chemotherapy

    Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 760 participants Est. completion 2019-07-01 3 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Withdrawn NCT NCT04258410

    Quercetin for Cardio-Skeletal Muscle Health and Estrogen Deficiency

    Not yet reported Wake Forest University Health Sciences Est. completion 2024-01
    Other conditions: Menopause Related Conditions
    View official trial listing →
  • Completed NCT NCT04259996

    Impact of Serum Progesterone in Modified Natural Cycles and Stimulated Cycles on Ongoing Pregnancy Rate

    Instituto Valenciano de Infertilidad, IVI VALENCIA 488 participants Est. completion 2023-07-01 1 site
    Other conditions: Infertility, Female
    View official trial listing →
  • Completed NCT NCT04267250

    Effect Of Multiple Dose PF-06700841 On The Pharmacokinetics Of Single Dose Oral Contraceptive Steroids

    Not yet reported Pfizer 18 participants Est. completion 2020-11-06 2 sites
    Other conditions: Healthy Female Volunteers
    View official trial listing →
  • Status unknown NCT NCT04268927

    Extended Letrozole Regimen Co-treatment With Gonadotropin Releasing Hormone Antagonist Protocol Versus Gonadotropin Releasing Hormone Antagonist Protocol in Poor Responders Undergoing IVF-ET

    Not yet reported Cairo University 106 participants Est. completion 2020-04-20 2 sites
    Other conditions: Infertility
    View official trial listing →
  • Active, not recruiting NCT NCT04270149

    Cancer Peptides Plus GM-CSF and Adjuvant in Breast Cancer

    Not yet reported Herbert Lyerly 8 participants Est. completion 2027-08-01 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT04272008

    The Effects of Annovera™ and Tampon Co-Usage on the Pharmacokinetics of Segesterone Acetate and Ethinyl Estradiol

    Not yet reported TherapeuticsMD 21 participants Est. completion 2021-06-08 2 sites
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT04276272

    D4 Choline Breast PET/CT

    Imperial College London 6 participants Est. completion 2023-11-03 1 site
    Other conditions: HER2-negative Breast Cancer, ER Positive Breast Cancer, Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT04278053

    Evaluation of Sports Supplements on Blood Flow

    Not yet reported University of Arkansas, Fayetteville 24 participants Est. completion 2019-05-08 1 site
    Other conditions: Determine the Effects of Nitrosigine and Citrulline-malate on Flow-mediated Dilation Among Young Adults
    View official trial listing →
  • Terminated NCT NCT04278755

    Binge Eating & Birth Control

    Not yet reported University of North Carolina, Chapel Hill 8 participants Est. completion 2022-05-17 1 site
    Obstructive sleep apnea Other conditions: Binge Eating, Eating Disorders, Binge-Eating Disorder
    View official trial listing →
  • Withdrawn NCT NCT04280523

    TranspulmonarY Estrogen Gradient and Estrogen Receptors (TYEGER) in PAH

    Vanderbilt University Medical Center Est. completion 2023-12-31 1 site
    Other conditions: Pulmonary Arterial Hypertension
    View official trial listing →
  • Status unknown NCT NCT04282031

    A Study of BPI-1178 in Patients With Advanced Solid Tumor and HR+/HER2- Breast Cancer

    Not yet reported, Not yet reported Beta Pharma (Suzhou) Co., Ltd. 224 participants Est. completion 2025-06-30 1 site
    Other conditions: Advanced Solid Tumor, HR+/HER2- Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT04283435

    Endometrial Effects of Sildenafil in Frozen-Thawed Cycles in Women With Thin Endometrium

    Not yet reported Cairo University 100 participants Est. completion 2022-03-01 1 site Stand-alone
    Other conditions: IVF, Endometrial Receptivity
    View official trial listing →
  • Completed NCT NCT04283656

    Evaluating Drug Interactions Between Doravirine With Estradiol and Spironolactone in Healthy Transgender Women

    Not yet reported Thomas Jefferson University 8 participants Est. completion 2022-12-30 1 site
    Other conditions: Transgender Health, Gender Dysphoria, Transgender Women, Human Immunodeficiency Virus
    View official trial listing →
  • Completed NCT NCT04285892

    Embryo Developmental Potential in a Novel 2-step IVM System

    Not yet reported Universitair Ziekenhuis Brussel 23 participants Est. completion 2023-12-31 1 site Stand-alone
    Other conditions: In Vitro Maturation of Oocytes
    View official trial listing →
  • Active, not recruiting NCT NCT04288089

    A Study of H3B-6545 in Combination With Palbociclib in Women With Advanced or Metastatic Estrogen Receptor-Positive Human Epidermal Growth Factor Receptor-2 (HER2)-Negative Breast Cancer

    Not yet reported Eisai Inc. 31 participants Est. completion 2027-03-31 8 sites
    Other conditions: Receptors, Estrogen, Genes, Erbb-2, Breast Neoplasms
    View official trial listing →
  • Status unknown NCT NCT04289974

    Predicted Biomarkers of CDK4/6 Inhibitors (Palbociclib) in ER-positive Metastasis Breast Cancer

    Chinese Academy of Medical Sciences 100 participants Est. completion 2022-04 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT04290390

    Annovera™ Drug-Drug Interaction Study

    Not yet reported TherapeuticsMD 67 participants Est. completion 2021-01-06 1 site
    Other conditions: Women, Contraception
    View official trial listing →
  • Completed NCT NCT04294225

    Anastrozole and Letrozole After Surgery for the Treatment of Stage I-III Breast Cancer

    Not yet reported Mayo Clinic 161 participants Est. completion 2022-12-12 3 sites
    Other conditions: Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIA Breast Cancer AJCC v8, Anatomic Stage IIB Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8, Anatomic Stage IIIC Breast Cancer AJCC v8, Early-Stage Breast Carcinoma, Invasive Breast Carcinoma, Prognostic Stage I Breast Cancer AJCC v8, Prognostic Stage IA Breast Cancer AJCC v8, Prognostic Stage IB Breast Cancer AJCC v8, Prognostic Stage II Breast Cancer AJCC v8, Prognostic Stage IIA Breast Cancer AJCC v8, Prognostic Stage IIB Breast Cancer AJCC v8, Prognostic Stage III Breast Cancer AJCC v8, Prognostic Stage IIIA Breast Cancer AJCC v8, Prognostic Stage IIIB Breast Cancer AJCC v8, Prognostic Stage IIIC Breast Cancer AJCC v8
    View official trial listing →
  • Terminated NCT NCT04296942

    BN-Brachyury, Entinostat, Adotrastuzumab Emtansine and M7824 in Advanced Stage Breast Cancer (BrEAsT)

    Not yet reported National Cancer Institute (NCI) 1 participants Est. completion 2021-10-22 1 site Stand-alone
    Other conditions: Breast Cancer, Triple Negative Breast Cancer, HER2+ Breast Cancer, Hormone Receptor Negative Breast Cancer, Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT04300790

    Study to Evaluate the Effect of Metformin in the Prevention of HG in HR[+]/HER2[-] PIK3CA-mut Advanced BC Patients

    Not yet reported MedSIR 69 participants Est. completion 2025-03-16 19 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT04301934

    Fractional CO2 Vaginal LASER Therapy for Recurrent Urinary Tract Infection

    Not yet reported Mayo Clinic 12 participants Est. completion 2023-04-30 1 site
    Other conditions: Urinary Tract Infections
    View official trial listing →
  • Completed NCT NCT04305093

    Data Mining: Precision Analytical Retrospective Data Correlation

    Precision Analytical, Inc. 144561 participants Est. completion 2023-03-28 1 site
    Other conditions: Obesity; Endocrine, Hormone Disturbance
    View official trial listing →
  • Terminated NCT NCT04305236

    Neo-Adjuvant Abemaciclib With Fulvestrant in Patients With ER/PR +HER Negative Breast Cancer

    Not yet reported University of California, Irvine 1 participants Est. completion 2022-02-16 1 site
    Other conditions: Breast Neoplasm, Hormone Receptor Positive Breast Carcinoma
    View official trial listing →
  • Active, not recruiting NCT NCT04305496

    Capivasertib+Fulvestrant vs Placebo+Fulvestrant as Treatment for Locally Advanced (Inoperable) or Metastatic HR+/HER2- Breast Cancer

    Not yet reported AstraZeneca 818 participants Est. completion 2026-06-22 215 sites
    Other conditions: Locally Advanced (Inoperable) or Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT04309643

    Drug-drug Interaction Study of CTP-543 and Oral Contraceptives in Healthy Female Subjects

    Not yet reported Concert Pharmaceuticals 21 participants Est. completion 2020-07-08 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Withdrawn NCT NCT04316169

    Hydroxychloroquine, Abemaciclib and Endocrine Therapy in Hormone Receptor Positive (HR+)/Her 2 Negative Breast Cancer

    Not yet reported Medical College of Wisconsin Est. completion 2028-01 1 site
    Other conditions: Solid Tumor, Advanced Breast Cancer
    View official trial listing →
  • Completed NCT NCT04330677

    Dissecting the Role of Estradiol in Mediating Gender-specific Anxiolytic and Prosocial Effects of Oxytocin

    Not yet reported University Hospital, Bonn 487 participants Est. completion 2020-01-25 1 site Stand-alone
    Other conditions: Oxytocin, Estrogen, Fear Extinction, Emotion Processing, Memory
    View official trial listing →
  • Status unknown NCT NCT04334330

    Palbociclib, Trastuzumab,Pyrotinib and Fulvestrant Treatment in Patients With Brain Metastasis From ER/PR Positive, HER-2 Positive Breast Cancer: A Multi-center, Prospective Study in China

    Not yet reported Sun Yat-sen University 34 participants Est. completion 2024-12-31 2 sites
    Other conditions: Breast Cancer, Brain Metastases
    View official trial listing →
  • Completed NCT NCT04336891

    Effect of Testosterone Treatment on Clitoral Arteries' Hemodynamic Parameters.

    University of Florence 81 participants Est. completion 2020-03-31 1 site
    Other conditions: Hypoactive Sexual Desire Disorder, Vulvovaginal Disease, Menopause Related Conditions, Dyspareunia (Female Excluding Psychogenic), Hypoestrogenism, Arousal Disorders, Sexual
    View official trial listing →
  • Status unknown NCT NCT04337658

    Anti-HER2 Therapy + Fulvestrant/Capecitabine in Women With HR+, HER2+, Non-visceral Metastases Stage IV Breast Cancer

    Not yet reported Second Affiliated Hospital, Zhejiang University, School of Medicine 493 participants Est. completion 2026-04-30 2 sites
    Other conditions: HER2-positive Breast Cancer
    View official trial listing →
  • Withdrawn NCT NCT04347135

    Evaluating Endometriosis With 16α-(18)F-fluoro-17β-estradiol ([F-18] FES) PET/MRI

    Not yet reported, Not yet reported Annie (Annie) T. Packard Est. completion 2024-04-30 1 site
    Other conditions: Endometriosis
    View official trial listing →
  • Completed NCT NCT04352777

    Impact of Endocrine Therapy and Abemaciclib on Host and Tumor Immune Cell Repertoire/Function in Advanced ER+/HER2- Breast Cancer

    Not yet reported Duke University 18 participants Est. completion 2025-06-25 1 site
    Other conditions: Metastatic Breast Cancer, Locally Advanced Breast Cancer, Hormone Receptor Positive Tumor
    View official trial listing →
  • Status unknown NCT NCT04355520

    A Study of TQ-B3525 Tablets Combined With Fulvestrant Injection in Subjects With HR-positive, HER2-negative and PIK3CA Mutation Advanced Breast Cancer

    Not yet reported, Not yet reported Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 42 participants Est. completion 2021-09 4 sites
    Other conditions: HR-positive, HER2-negative and PIK3CA Mutation Advanced Breast Cancer
    View official trial listing →
  • Terminated NCT NCT04359329

    Estrogen Patch for COVID-19 Symptoms

    Not yet reported Sharon Nachman 2 participants Est. completion 2020-07-30 1 site
    Other conditions: COVID
    View official trial listing →
  • Status unknown NCT NCT04359576

    Frozen-thawed Embryo Transfers and Hormone Substitution on Thrombotic Risk Markers

    Horsens Hospital 50 participants Est. completion 2024-12 1 site
    Other conditions: Frozen Embryo Transfer
    View official trial listing →
  • Completed NCT NCT04374773

    Effects of Pregnancy-associated Hormones on THC Metabolism in Women

    Not yet reported University of Washington 14 participants Est. completion 2026-02-28 1 site
    Other conditions: Pregnancy Related, Cannabis Use
    View official trial listing →
  • Terminated NCT NCT04379024

    Pilot Study of Effects of Duavee® on Imaging and Blood Biomarkers In Women With Menopausal Symptoms

    Not yet reported Carol Fabian, MD 11 participants Est. completion 2021-07-31 1 site
    Other conditions: Focus of Study is Healthy Women at Risk for Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT04393194

    The Effect of Intra-vaginal Conjugated Estrogen Cream on Ring Pessary Use for Pelvic Organ Prolapse

    Not yet reported Peking Union Medical College Hospital 420 participants Est. completion 2022-09-01 Stand-alone
    Other conditions: Pelvic Floor Prolapse
    View official trial listing →
  • Completed NCT NCT04417569

    A Proof of Concept Study of Serum Progesterone Levels for IVF/ICSI Following HCG Trigger for Oocyte Maturation

    ART Fertility Clinics LLC 10 participants Est. completion 2021-06-30 1 site
    Other conditions: Infertility, Infertility, Female, IVF, hCG
    View official trial listing →
  • Completed NCT NCT04418908

    Estrogen, Diabetes, and Endothelial Function

    Not yet reported University of Colorado, Denver 40 participants Est. completion 2018-10-22
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Status unknown NCT NCT04419727

    Estrogen Receptors and Peripheral Artery Disease

    University of Catanzaro 40 participants Est. completion 2020-11-02 1 site
    Other conditions: Estrogen Deficiency, Peripheral Artery Disease
    View official trial listing →
  • Completed NCT NCT04420598

    DS-8201a for trEatment of aBc, BRain Mets, And Her2[+] Disease

    Not yet reported MedSIR 41 participants Est. completion 2023-04-04 16 sites Stand-alone
    Other conditions: Advanced Breast Cancer, HER2-positive Breast Cancer, Brain Metastases, Leptomeningeal Metastasis
    View official trial listing →
  • Completed NCT NCT04423068

    Inpatient Adolescent Contraception

    Not yet reported Children's Mercy Hospital Kansas City 25 participants Est. completion 2023-04-04 1 site
    Other conditions: Pregnancy Related, Contraception, Contraceptive Usage, Contraception Behavior, Pregnancy
    View official trial listing →
  • Completed NCT NCT04424173

    Combined Hormone Therapy, C-reactive Protein(CRP) Levels and Life Quality in Natural Menopause Women

    Karadeniz Technical University 45 participants Est. completion 2008-08-30
    Other conditions: CRP, Menopause
    View official trial listing →
  • Status unknown NCT NCT04433897

    Effect of Hormonal Replacement Therapy on Nocturia in Postmenopausal Women

    University Hospital, Ghent 300 participants Est. completion 2025-12-31 1 site
    Other conditions: Nocturia
    View official trial listing →
  • Completed NCT NCT04436744

    A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Giredestrant Plus Palbociclib Compared With Anastrozole Plus Palbociclib for Postmenopausal Women With Estrogen Receptor-Positive and HER2-Negative Untreated Early Breast Cancer (coopERA Breast Cancer)

    Not yet reported Hoffmann-La Roche 221 participants Est. completion 2021-11-24 65 sites
    Other conditions: Early Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT04443348

    Pre-op Pembro + Radiation Therapy in Breast Cancer (P-RAD)

    Not yet reported Laura M. Spring, MD 120 participants Est. completion 2026-12-31 10 sites
    Other conditions: Triple Negative Breast Cancer, Hormone Receptor Positive (HR+), HER2-negative Breast Cancer, Biopsy-proven, Positive Lymph Node(s)
    View official trial listing →
  • Completed NCT NCT04445025

    Comparison Elagolix vs Depot Leuprolide Prior to Frozen Embryo Transfers in Patients With Endometriosis

    Not yet reported Colorado Center for Reproductive Medicine 30 participants Est. completion 2024-12-30 1 site
    Other conditions: Infertility, Endometriosis
    View official trial listing →
  • Status unknown NCT NCT04447872

    The LUTEAL Trial: Luteal Stimulation vs. Estrogen Priming Protocol

    Not yet reported Northwell Health 142 participants Est. completion 2025-06 1 site
    Other conditions: Infertility, Diminished Ovarian Reserve, IVF
    View official trial listing →
  • Status unknown NCT NCT04453332

    Effects of Hormone Replacement Therapy on Cardiovascular Risk and Body Composition Parameters

    Not yet reported Hospital de Clinicas de Porto Alegre 60 participants Est. completion 2021-12 1 site
    Other conditions: Menopause, Hormone Replacement Therapy
    View official trial listing →
  • Terminated NCT NCT04454749

    Endometrial Compaction and Its Influence on Pregnancy Rate in Frozen Embryo Cycle Regimes

    ART Fertility Clinics LLC 3 participants Est. completion 2021-03-04 1 site
    Other conditions: Endometrial Disorder, Infertility, Female, IVF, Pregnancy Early
    View official trial listing →
  • Completed NCT NCT04458662

    Iron and Muscular Damage: FEmale Metabolism and Menstrual Cycle During Exercise

    Universidad Politecnica de Madrid 103 participants Est. completion 2020-06-01 1 site
    Other conditions: Iron-deficiency, Inflammation, Exercise Induced Iron-deficiency, Exercise Induced Muscle Damage, Regulation of Sex Hormones on Hepcidin, Regulation of Sex Hormones on Muscle Damage, Iron Metabolism Disorders
    View official trial listing →
  • Terminated NCT NCT04460807

    Exemestane in Hormone Receptor Positive High Grade Ovarian Cancer

    Not yet reported Ente Ospedaliero Ospedali Galliera 23 participants Est. completion 2023-04-27 47 sites
    Other conditions: Ovarian Cancer
    View official trial listing →
  • Status unknown NCT NCT04468438

    Role of Estrogen in the Flarring up of Lupus Nepheritis

    Assiut University 100 participants Est. completion 2021-03-01
    Other conditions: Activity of Lupus Nepheritis
    View official trial listing →
  • Completed NCT NCT04471805

    4 mA tDCS, Estrogen, and Leg Muscle Fatigability

    Not yet reported University of Iowa 10 participants Est. completion 2021-11-01 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT04478760

    Trans & Non-binary Reference Intervals While on Hormone Therapy Study

    King's College Hospital NHS Trust 250 participants Est. completion 2024-05-14 1 site
    Other conditions: Transgender Persons, Hormone Replacement Therapy, Reference Values
    View official trial listing →
  • Completed NCT NCT04482920

    Effect of Hormone Therapy on Renal Function

    University of Colorado, Denver 22 participants Est. completion 2023-08-31 1 site
    Other conditions: Transgenderism, Kidney Diseases, Kidney Injury
    View official trial listing →
  • Completed NCT NCT04483505

    Rogaratinib, Palbociclib y Fulvestrant in Patients With Breast Cancer.

    Not yet reported Fundacion CRIS de Investigación para Vencer el Cáncer 9 participants Est. completion 2023-04-04 8 sites
    Other conditions: Breast Cancer Metastatic, Hormone Receptor Positive Malignant Neoplasm of Breast
    View official trial listing →
  • Active, not recruiting NCT NCT04485013

    TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers

    Not yet reported Tizona Therapeutics, Inc 240 participants Est. completion 2027-06-01 41 sites Stand-alone
    Other conditions: Cancer
    View official trial listing →
  • Withdrawn NCT NCT04487392

    Photobiomodulation Effect on Vulvovaginal Atrophy in Postmenopausal Women.

    Not yet reported University of Nove de Julho Est. completion 2021-12-30
    Other conditions: Vulvovaginal Atrophy
    View official trial listing →
  • Status unknown NCT NCT04488107

    Safety, Tolerability, Pharmacokinetics and Antitumor Activity of FCN-437c

    Not yet reported, Not yet reported Ahon Pharmaceutical Co., Ltd. 78 participants Est. completion 2022-06-30 1 site Stand-alone
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Enrolling by invitation NCT NCT04488614

    Prospective Breast Cancer Biobanking

    Helse Stavanger HF 1200 participants Est. completion 2030-07-15 2 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Withdrawn NCT NCT04498520

    Abexinostat, Palbociclib, and Fulvestrant for the Treatment of Breast or Gynecologic Cancer

    Not yet reported Pamela Munster Est. completion 2025-06-30
    Other conditions: Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8, Anatomic Stage IIIC Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Hormone Receptor Positive Breast Carcinoma, Locally Advanced Breast Carcinoma, Metastatic Breast Carcinoma, Metastatic Endometrioid Adenocarcinoma, Metastatic Fallopian Tube Carcinoma, Metastatic HER2 Negative Breast Carcinoma, Metastatic Malignant Solid Neoplasm, Metastatic Ovarian Carcinoma, Metastatic Primary Peritoneal Carcinoma, Prognostic Stage III Breast Cancer AJCC v8, Prognostic Stage IIIA Breast Cancer AJCC v8, Prognostic Stage IIIB Breast Cancer AJCC v8, Prognostic Stage IIIC Breast Cancer AJCC v8, Prognostic Stage IV Breast Cancer AJCC v8, Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma, Recurrent Primary Peritoneal Carcinoma, Refractory Breast Carcinoma, Stage IV Fallopian Tube Cancer AJCC v8, Stage IV Ovarian Cancer AJCC v8, Stage IV Primary Peritoneal Cancer AJCC v8, Stage IV Uterine Corpus Cancer AJCC v8, Stage IVA Fallopian Tube Cancer AJCC v8, Stage IVA Ovarian Cancer AJCC v8, Stage IVA Primary Peritoneal Cancer AJCC v8, Stage IVA Uterine Corpus Cancer AJCC v8, Stage IVB Fallopian Tube Cancer AJCC v8, Stage IVB Ovarian Cancer AJCC v8, Stage IVB Primary Peritoneal Cancer AJCC v8, Stage IVB Uterine Corpus Cancer AJCC v8
    View official trial listing →
  • Completed NCT NCT04499131

    Impact of Different Doses and Routes of Exogenous Progesterone Administration on Endometrial Receptivity Parameters

    Not yet reported Instituto Valenciano de Infertilidad, IVI VALENCIA 109 participants Est. completion 2025-12-31 1 site
    Other conditions: Infertility, Female, ENDOMETRIAL RECEPTIVITY
    View official trial listing →
  • Withdrawn NCT NCT04503161

    The Effect of an ASC-seeded Collagen Hydrogel on Cerebrospinal Fluid Leak Rates Following Skull Base Surgery

    Not yet reported Stanford University Est. completion 2022-09
    Other conditions: CSF Leak
    View official trial listing →
  • Status unknown NCT NCT04503915

    Estrogen Supplementation Mode in HRT-FET Cycle: a RCT

    Not yet reported Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 784 participants Est. completion 2023-12-01 Stand-alone
    Other conditions: Hormone Replacement Therapy, Estrogen, Live Birth Rate
    View official trial listing →
  • Completed NCT NCT04505826

    A Dose Escalation/Expansion Study of Oral OP-1250 in Subjects With Advanced and/or Metastatic HR+, HER2- Breast Cancer

    Not yet reported, Not yet reported Olema Pharmaceuticals, Inc. 153 participants Est. completion 2024-07-30 19 sites Stand-alone
    Other conditions: Hormone Receptor Positive Breast Carcinoma, HER2-negative Breast Cancer
    View official trial listing →
  • Completed NCT NCT04507022

    The Outcome of Two Protocols Used to Prepare Endometrium for Frozen Embryo Transfer

    Not yet reported Rahem Fertility Center 112 participants Est. completion 2021-02-05 1 site Stand-alone
    Other conditions: Infertility, Infertility, Female, Infertility, Male
    View official trial listing →
  • Completed NCT NCT04508582

    Cardiac and Immune Cell Function in Preeclampsia

    Queen Mary University of London 86 participants Est. completion 2024-03-06 1 site
    Cardiovascular disease Other conditions: Preeclampsia, Hypertension, Pregnancy Induced Hypertension, Pregnancy Related, Cardiovascular Risk Factor, Heart Diseases
    View official trial listing →
  • Status unknown NCT NCT04513405

    Estrogens Levels and Receptors Status and Skin Tears

    Not yet reported University of Catanzaro 1200 participants Est. completion 2022-09-01 1 site
    Other conditions: Skin Tear, Estrogen Deficiency
    View official trial listing →
  • Completed NCT NCT04514159

    A Study of ZN-c5 and Abemaciclib in Participants With Breast Cancer

    Not yet reported Zeno Alpha Inc. 14 participants Est. completion 2022-10-24 5 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT04515472

    Effect of Gender Affirming Hormone Therapy on Glucose Metabolism

    Not yet reported The University of Texas Health Science Center at San Antonio 24 participants Est. completion 2025-03-17 1 site
    Other conditions: Transgender Persons
    View official trial listing →
  • Active, not recruiting NCT NCT04524000

    Study Assessing the Efficacy and Safety of Treatment With Alpelisib Plus Fulvestrant in Japanese Men and Postmenopausal Women With Advanced Breast Cancer

    Not yet reported Novartis Pharmaceuticals 24 participants Est. completion 2027-02-27 15 sites
    Other conditions: Advanced Breast Cancer
    View official trial listing →
  • Completed NCT NCT04524026

    RIOTC: Reducing the Impact of Ovarian Stimulation. Novel Approaches to Luteal Support in IVF-Study 2

    Not yet reported Nicholas Macklon 25 participants Est. completion 2020-11-30 2 sites
    Other conditions: IVF
    View official trial listing →
  • Completed NCT NCT04524728

    Patterns of Treatment and Outcome of Palbociclib Plus Endocrine Therapy

    Istituti Clinici Scientifici Maugeri SpA 191 participants Est. completion 2020-06 1 site
    Other conditions: Breast, Neoplasm Malignant, Female
    View official trial listing →
  • Withdrawn NCT NCT04531748

    Selective Estrogen Modulation and Melatonin in Early COVID-19

    Not yet reported Reena Mehra, MD Est. completion 2022-09
    Other conditions: Covid19
    View official trial listing →
  • Completed NCT NCT04531943

    Feminizing Hormone Therapy and the Rectal Mucosa Immune Environment in Transgender Women

    Emory University 285 participants Est. completion 2024-04-04 1 site
    Other conditions: HIV Prevention
    View official trial listing →
  • Completed NCT NCT04537078

    Progestin Primed Double Stimulation Protocol Versus Flexible GnRH Antagonist Protocol in Poor Responders

    Not yet reported El Shatby University Hospital for Obstetrics and Gynecology 90 participants Est. completion 2021-09-01 1 site
    Other conditions: Infertility, Female
    View official trial listing →
  • Status unknown NCT NCT04539626

    Estrogen Therapy in Non-severe COVID-19 Patients

    Not yet reported CMN "20 de Noviembre" 44 participants Est. completion 2023-12-31 1 site Stand-alone
    Other conditions: Covid-19
    View official trial listing →
  • Active, not recruiting NCT NCT04544189

    Study Assessing the Efficacy and Safety of Treatment With Alpelisib Plus Fulvestrant Versus Placebo Plus Fulvestrant in Chinese Men and Postmenopausal Women With Advanced Breast Cancer

    Not yet reported Novartis Pharmaceuticals 69 participants Est. completion 2027-01-29 24 sites
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Completed NCT NCT04544475

    A Randomized, Single Center Pilot Study Comparing Hyaluronic Acid to Vaginal Estrogen for Treatment of Genitourinary Syndrome of Menopause

    Not yet reported NYU Langone Health 49 participants Est. completion 2022-10-03 1 site
    Other conditions: Genitourinary Syndrome of Menopause (GSM)
    View official trial listing →
  • Active, not recruiting NCT NCT04546009

    A Study Evaluating the Efficacy and Safety of Giredestrant Combined With Palbociclib Compared With Letrozole Combined With Palbociclib in Participants With Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer (persevERA Breast Cancer)

    Not yet reported Hoffmann-La Roche 992 participants Est. completion 2027-07-31 255 sites
    Other conditions: Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT04546347

    A Study to Assess the Rel Bioavailability, Food Effect and Absolute Bioavailability on the Pharmacokinetics of AZD9833

    Not yet reported AstraZeneca 32 participants Est. completion 2021-01-07 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Terminated NCT NCT04551144

    Effect of Transgender Therapy on Muscle, Fat and Tissue Receptors

    St. Louis University 4 participants Est. completion 2023-01-18 1 site
    Other conditions: Gender Incongruence, Transgenderism
    View official trial listing →
  • Active, not recruiting NCT NCT04551807

    Natural Versus Programmed Frozen Embryo Transfer (NatPro)

    Not yet reported JHSPH Center for Clinical Trials 788 participants Est. completion 2026-04-01 15 sites
    Other conditions: Pregnancy Related, Pre-Eclampsia
    View official trial listing →
  • Active, not recruiting NCT NCT04553133

    PF-07104091 as a Single Agent and in Combination Therapy

    Not yet reported Pfizer 157 participants Est. completion 2026-12-31 22 sites
    Other conditions: Small Cell Lung Cancer, Ovarian Cancer, Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT04556773

    A Phase 1b Study of T-DXd Combinations in HER2-low Advanced or Metastatic Breast Cancer

    Not yet reported AstraZeneca 138 participants Est. completion 2027-06-01 37 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT04557449

    Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors

    Not yet reported Pfizer 362 participants Est. completion 2027-11-23 39 sites
    Obstructive sleep apnea Other conditions: Prostate Cancer, Breast Neoplasms, Adenocarcinoma of Lung
    View official trial listing →
  • Status unknown NCT NCT04558268

    Low Dose Prednisone Therapy in Women With Recurrent Pregnancy Loss

    Not yet reported, Not yet reported Soroka University Medical Center 242 participants Est. completion 2021-10 1 site Stand-alone
    Other conditions: Recurrent Pregnancy Loss(RPL), Recurrent Miscarriage
    View official trial listing →
  • Completed NCT NCT04564378

    Association Between Fuchs' Endothelial Corneal Dystrophy Severity and Estrogen Exposure

    State University of New York at Buffalo 43 participants Est. completion 2023-09-01 1 site
    Other conditions: Fuchs Dystrophy
    View official trial listing →
  • Active, not recruiting NCT NCT04567420

    DNA-guided Second Line Adjuvant Therapy for High Residual Risk, Estrogen Receptor Positive, HER-2 Negative Breast Cancer (DARE)

    Not yet reported Criterium, Inc. 70 participants Est. completion 2028-12-31 19 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT04568902

    Study of H3B-6545 in Japanese Women With Estrogen Receptor (ER)-Positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Breast Cancer

    Not yet reported Eisai Co., Ltd. 33 participants Est. completion 2025-10-01 2 sites
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Completed NCT NCT04572295

    A Study of E7090 as Monotherapy and in Combination With Other Anticancer Agents in Participants With Estrogen Receptor Positive (ER+) and Human Epidermal Growth Receptor 2 Negative (HER2-) Recurrent/Metastatic Breast Cancer

    Not yet reported Eisai Co., Ltd. 51 participants Est. completion 2026-06-18 11 sites
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Completed NCT NCT04574999

    Study to Determine Efficacy & Safety of a Low Concentration Estriol (0.005%) in Postmenopausal Vaginal Atrophy.

    Not yet reported Italfarmaco S.A 167 participants Est. completion 2009-02-23 12 sites
    Other conditions: Vaginal Atrophy
    View official trial listing →
  • Active, not recruiting NCT NCT04576455

    A Study Evaluating the Efficacy and Safety of Giredestrant Compared With Physician's Choice of Endocrine Monotherapy in Participants With Previously Treated Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer (acelERA Breast Cancer)

    Not yet reported Hoffmann-La Roche 303 participants Est. completion 2027-08-25 81 sites
    Other conditions: Estrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT04579380

    Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 Alterations

    Not yet reported Seagen, a wholly owned subsidiary of Pfizer 217 participants Est. completion 2026-12-31 108 sites
    Other conditions: Uterine Neoplasms, Uterine Cervical Neoplasms, Biliary Tract Neoplasms, Urologic Neoplasms, Carcinoma, Non-Small-Cell Lung, HER2 Mutations Breast Neoplasms
    View official trial listing →
  • Active, not recruiting NCT NCT04584255

    Niraparib + Dostarlimab In BRCA Mutated Breast Cancer

    Not yet reported Dana-Farber Cancer Institute 66 participants Est. completion 2029-07-17 8 sites Stand-alone
    Other conditions: Stage I Breast Cancer, Stage II Breast Cancer, Stage III Breast Cancer, Breast Cancer, HER2-negative Breast Cancer, Germline BRCA1 Gene Mutation, Germline BRCA2 Gene Mutation, Deleterious PALB2 Gene Mutation
    View official trial listing →
  • Completed NCT NCT04588298

    A Study to Investigate the Biological Effects of AZD9833 in Women With ER-positive, HER2 Negative Primary Breast Cancer

    Not yet reported AstraZeneca 135 participants Est. completion 2023-06-19 12 sites
    Other conditions: HER2-negative Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT04590417

    Assessment of Drug-drug Interactions Between Feminizing Hormone Therapy and Emtricitabine/Tenofovir Alafenamide Concomitantly for Pre-exposure Prophylaxis Among Transgender Women

    Not yet reported Thai Red Cross AIDS Research Centre 20 participants Est. completion 2025-10-01 1 site
    Other conditions: Drug Interaction
    View official trial listing →
  • Completed NCT NCT04595682

    Estradiol Effects on Alcohol Across the Menstrual Cycle

    Not yet reported Mark Fillmore 100 participants Est. completion 2024-11-06 1 site
    Other conditions: Alcohol Use, Unspecified
    View official trial listing →
  • Status unknown NCT NCT04597099

    Androgen Blockade and Progesterone Augmentation of Gonadotropin Secretion

    Not yet reported University of Virginia 10 participants Est. completion 2025-10-01 1 site
    Other conditions: PCOS, Polycystic Ovary Syndrome
    View official trial listing →
  • Completed NCT NCT04603183

    ABemaciclib, ET ± paclItaxel in aGgressive HR+/HER2- MBC trIaL

    Not yet reported MedSIR 162 participants Est. completion 2025-06-30 31 sites
    Other conditions: Breast Cancer Metastatic
    View official trial listing →
  • Withdrawn NCT NCT04606550

    MonaLisa Laser Intervention for Post-Menopausal Breast Cancer Patients: A SHE CAN Study

    Not yet reported Mount Sinai Hospital, Canada Est. completion 2022-07-01
    Other conditions: Breast Cancer Female, Genitourinary Syndrome of Menopause
    View official trial listing →
  • Completed NCT NCT04607382

    Survey on Menstrual Symptoms, Health Related Quality of Life and Work Productivity in Patients Suffering From Pain During Menstruation (Dysmenorrhea) in Japan

    Bayer 397 participants Est. completion 2021-06-30 1 site
    Other conditions: Dysmenorrhea
    View official trial listing →
  • Completed NCT NCT04615767

    D-chiro-inositol Increases Androgens and Reduces Estrogens in Human Serum

    Not yet reported AGUNCO Obstetrics and Gynecology Centre 10 participants Est. completion 2020-12-16 1 site
    Other conditions: Low Serum Testosterone Levels in Man
    View official trial listing →
  • Completed NCT NCT04616417

    Investigational Oocyte Cryopreservation for Medical and Non Medical Indications

    Not yet reported University of Illinois at Chicago 29 participants Est. completion 2023-03-20 1 site
    Other conditions: Infertility, Female, Deferred Childbearing
    View official trial listing →
  • Status unknown NCT NCT04616729

    DEPO-Trigger Trial: GnRH Agonist DEPOt TRIGGER for Final Oocyte Maturation

    Not yet reported, Not yet reported Universitair Ziekenhuis Brussel 30 participants Est. completion 2025-12-31 2 sites
    Other conditions: Breast Cancer Female
    View official trial listing →
  • Completed NCT NCT04619914

    the Effect of Clomiphene Citrate Plus Estradiol Valerate Versus Letrozole on Endometrial Thickness and Pregnancy Rate in Infertile Women

    Not yet reported Laylay Mohammed Khalleefah Alhibshi 160 participants Est. completion 2019-08-10 1 site Stand-alone
    Other conditions: Endometrial Thickness, Pregnancy Rate
    View official trial listing →
  • Completed NCT NCT04629846

    Study in Participants With Early-Stage or Locally Advanced Human Epidermal Growth Factor Receptor (HER) 2-Positive and Estrogen Receptor/Progesterone Receptor Negative Breast Cancer to Evaluate the Efficiency and Safety of Treatment With Trastuzumab Plus (+) QL1209/Pertuzumab + Docetaxel.

    Not yet reported Qilu Pharmaceutical Co., Ltd. 517 participants Est. completion 2023-10-24 2 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT04631835

    Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer

    Not yet reported Jiangsu Hansoh Pharmaceutical Co., Ltd. 54 participants Est. completion 2023-08-31 3 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT04639661

    Predictors of Periodontal Outcomes Post-sanative Therapy

    Brock University 12 participants Est. completion 2021-10-20 2 sites
    Other conditions: Periodontal Diseases, Periodontal Pocket
    View official trial listing →
  • Completed NCT NCT04641624

    sFlt- 1, PIGF, and Niacin Levels in Women With Premature Ovarian Insufficiency

    Cengiz Gokcek Women's and Children's Hospital 90 participants Est. completion 2021-08-30 1 site
    Other conditions: Premature Ovarian Insufficiency
    View official trial listing →
  • Completed NCT NCT04647487

    A Study of LY3484356 in Women With Breast Cancer Before Having Surgery

    Not yet reported Eli Lilly and Company 87 participants Est. completion 2022-11-11 19 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT04650581

    Fulvestrant and Ipatasertib for Advanced HER-2 Negative and Estrogen Receptor Positive (ER+) Breast Cancer Following Progression on First Line CDK 4/6 Inhibitor and Aromatase Inhibitor

    Not yet reported Canadian Cancer Trials Group 250 participants Est. completion 2026-12-31 39 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT04657536

    Evaluating the Efficacy of Temperature-controlled Radiofrequency (TRF) in the Treatment of Vulvovaginal Atrophy.

    Not yet reported Peking University People's Hospital 200 participants Est. completion 2021-12 1 site
    Other conditions: Postmenopausal Vulvovaginal Atrophy
    View official trial listing →
  • Status unknown NCT NCT04666805

    Effect of Endocrine Therapy Duration on Clinical Outcome of Patients With HR+ Intraductal Carcinoma of the Breast

    First Hospital of China Medical University 1354 participants Est. completion 2021-01-15 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT04669587

    ER+/HER2- Locally Advanced or Metastatic Breast Cancer (ENZENO Study)

    Not yet reported, Not yet reported EnhancedBio USA Inc. 106 participants Est. completion 2024-01-31 8 sites
    Other conditions: Estrogen Receptor-Positive, HER2-Negative, Locally Advanced Breast Cancer, Metastatic Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT04671966

    Sex Differences in Myocardial Steatosis Induced Left Ventricular Dysfunction

    Not yet reported The University of Texas at Arlington 100 participants Est. completion 2024-12 1 site Stand-alone
    Other conditions: Heart Diseases, Left Ventricular Dysfunction
    View official trial listing →
  • Terminated NCT NCT04675827

    De-escalation Adjuvant Chemo in HER2+/ER-/node-neg Early BC Patients Who Achieved PCR After Neoadjuvant Chemo & Dual HER2 Blockade

    Not yet reported Jules Bordet Institute 139 participants Est. completion 2024-11-26 85 sites
    Other conditions: HER2-positive Breast Cancer, ER-Negative Breast Cancer, PR-Negative Breast Cancer, Node-negative Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT04692103

    Serial FES PET/CT to Measure Hormone Expression in Patients Undergoing Endocrine Targeted Therapy

    Not yet reported University of Washington 2 participants Est. completion 2041-04-30 1 site Stand-alone
    Other conditions: Estrogen Receptor Positive, Primary or Recurrent Breast Carcinoma, Stage IV Breast Cancer AJCC v6 and v7
    View official trial listing →
  • Completed NCT NCT04707196

    A Study of Abemaciclib in Indian Women With Advanced Breast Cancer

    Not yet reported Eli Lilly and Company 200 participants Est. completion 2023-01-09 15 sites
    Other conditions: Breast Neoplasms, Neoplasm Metastasis
    View official trial listing →
  • Completed NCT NCT04709094

    A Drug Interaction Study of Danicopan

    Not yet reported Alexion Pharmaceuticals, Inc. 52 participants Est. completion 2020-04-17 1 site
    Other conditions: Healthy
    View official trial listing →
  • Active, not recruiting NCT NCT04711252

    A Comparative Study of AZD9833 Plus Palbociclib Versus Anastrozole Plus Palbociclib in Patients With ER-Positive HER2 Negative Breast Cancer Who Have Not Received Any Systemic Treatment for Advanced Disease

    Not yet reported AstraZeneca 1371 participants Est. completion 2029-02-01 263 sites
    Other conditions: ER-Positive HER2-Negative Breast Cancer
    View official trial listing →
  • Completed NCT NCT04713904

    Bioavailability of Clormadinone/Ethinyl Estradiol Tablets 2 mg/0.02 mg With Regards to Reference Product

    Not yet reported Laboratorios Andromaco S.A. 38 participants Est. completion 2021-02-02 1 site
    Other conditions: Bioequivalence
    View official trial listing →
  • Completed NCT NCT04714554

    A Study of the Effects of Erythromycin on the Pharmacokinetics of Relugolix, Estradiol, and Norethindrone in Healthy Postmenopausal Women and on the Pharmacokinetics of Relugolix in Healthy Adult Men

    Not yet reported Myovant Sciences GmbH 43 participants Est. completion 2021-03-29 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT04718636

    A Study to Evaluate Effects of CC-99677 on the Pharmacokinetics of an Oral Contraceptive in Healthy Female Participants

    Not yet reported Celgene 28 participants Est. completion 2021-08-03 3 sites
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT04719273

    Onapristone and Anastrozole for the Treatment of Refractory Hormone Receptor Positive Endometrial Cancer

    Not yet reported Thomas Jefferson University 14 participants Est. completion 2025-12-17 2 sites Stand-alone
    Other conditions: Refractory Endometrial Adenocarcinoma, Refractory Endometrial Carcinoma, Refractory Endometrial Clear Cell Adenocarcinoma, Refractory Endometrial Endometrioid Adenocarcinoma, Refractory Endometrial Mixed Cell Adenocarcinoma, Refractory Endometrial Serous Adenocarcinoma, Refractory Endometrial Undifferentiated Carcinoma
    View official trial listing →
  • Status unknown NCT NCT04721522

    The Impact of Endometrial Compaction on Assisted Reproductive Technology Outcome

    Zagazig University 356 participants Est. completion 2024-06-01 1 site
    Other conditions: Embryo Implantation, ART
    View official trial listing →
  • Terminated NCT NCT04726332

    Study of XL102 as Single-Agent and Combination Therapy in Subjects With Solid Tumors (QUARTZ-101)

    Not yet reported Exelixis 52 participants Est. completion 2024-05-02 5 sites
    Other conditions: Neoplasm Malignant, Epithelial Ovarian Cancer, Triple Negative Breast Cancer, Hormone Receptor Positive Breast Carcinoma, Metastatic Castration-resistant Prostate Cancer
    View official trial listing →
  • Completed NCT NCT04733235

    the Effect of Endometrial Compaction Caused by Progesterone Effect on Pregnancy Outcomes

    Akdeniz University 205 participants Est. completion 2021-07-15 1 site
    Other conditions: Infertility, Female Infertility, Frozen-thawed Embryo Transfer
    View official trial listing →
  • Terminated NCT NCT04738292

    Onapristone and Fulvestrant for ER+ HER2- Metastatic Breast Cancer After Endocrine Therapy and CDK4/6 Inhibitors (The SMILE Study)

    Not yet reported University of Wisconsin, Madison 11 participants Est. completion 2023-05-15 2 sites
    Other conditions: ER-positive Breast Cancer, HER2-negative Breast Cancer, Metastatic Cancer
    View official trial listing →
  • Completed NCT NCT04746313

    Prevalence of Hyperprolactinemia in Systemic Scleroderma

    University Hospital, Lille 71 participants Est. completion 2021-05-12 1 site
    Other conditions: Sclerosis, Systemic, Scleroderma, Hyperprolactinemia
    View official trial listing →
  • Status unknown NCT NCT04753177

    The Neoadjuvant Combined Hormone Therapy in Premenopausal Women With Locally Advanced ER+/HER2- Breast Cancer

    Not yet reported, Not yet reported Saint Petersburg State Budgetary Healthcare Institution, City Clinical Oncology Dispensary 120 participants Est. completion 2024-01-28 1 site
    Other conditions: The Neoadjuvant Therapy
    View official trial listing →
  • Completed NCT NCT04756037

    Study of the Safety and Contraceptive Efficacy of Relugolix Combination Therapy in Women With Uterine Fibroids or Endometriosis Who Are at Risk for Pregnancy

    Not yet reported Sumitomo Pharma Switzerland GmbH 1164 participants Est. completion 2026-03-31 112 sites
    Other conditions: Contraception
    View official trial listing →
  • Active, not recruiting NCT NCT04759248

    Study With Atezolizumab in Combination With Trastuzumab and Vinorelbine in HER2-positive Advanced/Metastatic Breast Cancer

    Not yet reported SOLTI Breast Cancer Research Group 55 participants Est. completion 2027-07-01 15 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT04760691

    Pre-Exposure Prophylaxis (PrEP)- Gender Affirming Hormone Therapy (GAHT) Interactions in TGW

    Not yet reported Johns Hopkins University 13 participants Est. completion 2025-03-24 1 site Stand-alone
    Other conditions: HIV, Prophylaxis, Transgender
    View official trial listing →
  • Active, not recruiting NCT NCT04762979

    Alpelisib (BYL719) in Combination With Continued Endocrine Therapy Following Progression on Endocrine Therapy in Hormone Receptor Positive, HER2 Negative, PIK3CA Mutant Metastatic Breast Cancer

    Not yet reported Marina N Sharifi 44 participants Est. completion 2026-05 4 sites
    Other conditions: Hormone Receptor Positive Breast Carcinoma, HER2-negative Breast Cancer, PIK3CA Mutant Metastatic Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT04767451

    Levels of Selected Microelements in Premature Ovarian Insufficiency

    Cengiz Gokcek Women's and Children's Hospital 100 participants Est. completion 2021-10-30 1 site
    Other conditions: Premature Ovarian Failure
    View official trial listing →
  • Completed NCT NCT04769401

    Effects of E2, P4 and LH Levels on the Day of Transfer and Endometrial Cavity Thickness on Implantation Success in Patients With Frozen-thawed Embryo Transfer Cycle

    Not yet reported Bezmialem Vakif University 238 participants Est. completion 2021-11-21 2 sites
    Other conditions: Infertility, IVF, Progesterone
    View official trial listing →
  • Completed NCT NCT04777929

    The Relationship of Phthalate Exposure During Pregnancy and Preeclampsia

    Second Affiliated Hospital of Wenzhou Medical University 60 participants Est. completion 2022-10-31 1 site
    Other conditions: Phthalate Exposure, Preeclampsia, Estrogen, Progestin
    View official trial listing →
  • Completed NCT NCT04778514

    A Crossover Acceptability Study Assessing a DPP Capsule for HIV and Pregnancy Prevention

    Not yet reported Population Council 30 participants Est. completion 2023-09-11 1 site
    Other conditions: HIV Infections, Contraception
    View official trial listing →
  • Terminated NCT NCT04778982

    Study of KN026 in Combination With Palbociclib and Fulvestrant in Patients With Advanced Breast Cancer

    Jiangsu Alphamab Biopharmaceuticals Co., Ltd 4 participants Est. completion 2023-03-15 1 site
    Other conditions: HER2-positive Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT04796623

    A Study of TQB3616 Capsules Combined With Fulvestrant Injection in Subjects With Advanced Breast Cancer

    Not yet reported Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 122 participants Est. completion 2024-05-24 17 sites
    Other conditions: HR-positive, HER2-negative Advanced Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT04797338

    Gonadotropin Releasing Hormone Agonist (GnRHa) Versus Estrogen and Progesterone for Luteal Support in High Responders

    Not yet reported Assaf-Harofeh Medical Center 100 participants Est. completion 2021-09-30 1 site
    Other conditions: Pregnancy Early, Miscarriage, Ovarian Hyperstimulation Syndrome
    View official trial listing →
  • Completed NCT NCT04800146

    A Study on the Immune-response to COVID-19 Vaccination in Cancer Patients - the IOSI-COVID-19-001 Study

    Ilaria Colombo 177 participants Est. completion 2023-03-21 1 site
    Other conditions: Covid19, Cancer
    View official trial listing →
  • Status unknown NCT NCT04800705

    Levels of Selected Macroelements in Premature Ovarian Insufficiency

    Cengiz Gokcek Women's and Children's Hospital 140 participants Est. completion 2021-12-30 1 site
    Other conditions: Premature Ovarian Failure
    View official trial listing →
  • Completed NCT NCT04804020

    Natural Cycle vs. Modified Natural Cycle vs. Artificial Cycle Protocol for Endometrial Preparation.

    Not yet reported Mỹ Đức Hospital 1428 participants Est. completion 2023-12-31 1 site
    Other conditions: IVF, Frozen Embryo Transfer
    View official trial listing →
  • Completed NCT NCT04818632

    AZD9833 China PK Study

    Not yet reported AstraZeneca 28 participants Est. completion 2023-09-07 4 sites
    Other conditions: ER+, HER2-, Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT04819906

    Effect of Estetrol Monohydrate (E4) on QTc Interval

    Not yet reported Estetra 32 participants Est. completion 2021-07-14 1 site
    Other conditions: Prolonged QTc Interval
    View official trial listing →
  • Active, not recruiting NCT NCT04821141

    Phase IIB Trial of Bazedoxifene Plus Conjugated Estrogens

    Not yet reported University of Kansas Medical Center 120 participants Est. completion 2027-07-31 6 sites
    Other conditions: Risk Reduction, Breast Cancer
    View official trial listing →
  • Completed NCT NCT04821375

    Pilot Study of Bazedoxifene Plus Conjugated Estrogen on Imaging and Blood Biomarkers

    Not yet reported Carol Fabian, MD 16 participants Est. completion 2024-12-31 1 site
    Other conditions: Increased Risk for Development of Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT04822012

    Anti COVID-19 Antibodies in Follicular Fluid and Spermatic Fluid

    Meir Medical Center 50 participants Est. completion 2021-06-01 1 site
    Other conditions: SARS-CoV-2
    View official trial listing →
  • Completed NCT NCT04822857

    The Impact of Menopause on the Development of Heart Failure and Organ Damage of Hypertension

    Polish Mother Memorial Hospital Research Institute 86 participants Est. completion 2020-12-30 1 site
    Other conditions: Hypertension, Menopause
    View official trial listing →
  • Completed NCT NCT04828824

    Premature Discontinuation of Contraceptive Implants

    Not yet reported University of Colorado, Denver 600 participants Est. completion 2025-11-12 1 site
    Other conditions: Contraception Behavior
    View official trial listing →
  • Status unknown NCT NCT04831151

    The Effect of Polycystic Ovary Syndrome Treatment on Metabolomics

    Not yet reported Inonu University 42 participants Est. completion 2023-06 1 site
    Other conditions: Polycystic Ovary Syndrome
    View official trial listing →
  • Active, not recruiting NCT NCT04833140

    Estrogen Administration for the Treatment of NASH in Postmenopausal Women

    Not yet reported Massachusetts General Hospital 50 participants Est. completion 2027-07-09 1 site
    MASH
    View official trial listing →
  • Completed NCT NCT04841499

    Effects of a Seven-day BASIS™ Supplementation on Menopausal Syndromes and Measurements of the Urinary Vitamin B3 and Estradiol Levels in Pre-, Peri- and Post-menopause

    Not yet reported University of South Alabama 40 participants Est. completion 2021-07-15 1 site
    Other conditions: Menopause
    View official trial listing →
  • Active, not recruiting NCT NCT04851613

    Study to Evaluate Efficacy & Safety of Afuresertib Plus Fulvestrant in Patients With Locally Advanced or Metastatic HR+/HER2- Breast Cancer

    Not yet reported Laekna Limited 256 participants Est. completion 2026-12-30 55 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT04852081

    Analysis of Therapy Sequence in Women With HR+, HER2 - mBC in Moscow: A Multicenter Retrospective Observational Study.

    Blokhin's Russian Cancer Research Center 1000 participants Est. completion 2021-12-01 1 site
    Other conditions: Breast Cancer Stage IV
    View official trial listing →
  • Status unknown NCT NCT04853069

    Oestrogen Treatment for COVID-19 Symptoms

    Not yet reported Hamad Medical Corporation 2000 participants Est. completion 2022-03-31 1 site
    Other conditions: COVID-19
    View official trial listing →
  • Completed NCT NCT04855383

    Intramuscular Injection of Human Chorionic Gonadotropin in Frozen Embryo Transfer Cycles

    Not yet reported Royan Institute 200 participants Est. completion 2023-06-20 1 site
    Other conditions: Embryo Implantation
    View official trial listing →
  • Status unknown NCT NCT04856306

    Myomectomy vs Uterine Artery Embolization vs GnRh Antagonist for AUB-L

    Medstar Health Research Institute 300 participants Est. completion 2025-08-30 1 site
    Other conditions: Heavy Menstrual Bleeding, Fibroid Uterus
    View official trial listing →
  • Status unknown NCT NCT04856371

    Study of CYH33 in Combination With Endocrine Therapy With or Without Palbociclib in Patients With HR+, HER2- Advanced Breast Cancer

    Not yet reported Haihe Biopharma Co., Ltd. 228 participants Est. completion 2022-12
    Other conditions: Advanced Breast Cancer
    View official trial listing →
  • Terminated NCT NCT04862143

    Pilot Decentralized Clinical Trial in Men and Pre and Post-menopausal Women With Breast Cancer and a Specific Mutation (PIK3CA) Treated With Alpelisib in Combination With Fulvestrant

    Not yet reported Novartis Pharmaceuticals 2 participants Est. completion 2022-09-19 1 site
    Other conditions: Advanced Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT04862663

    Capivasertib + CDK4/6i + Fulvestrant for Advanced/Metastatic HR+/HER2- Breast Cancer (CAPItello-292)

    Not yet reported AstraZeneca 893 participants Est. completion 2029-08-14 225 sites
    Other conditions: Locally Advanced (Inoperable) or Metastatic Breast Cancer
    View official trial listing →
  • Terminated NCT NCT04865029

    Estradiol and Progesterone in Hospitalized COVID-19 Patients

    Not yet reported Tulane University 10 participants Est. completion 2022-01-25 1 site
    Other conditions: Covid19
    View official trial listing →
  • Terminated NCT NCT04869943

    Efficacy Evaluation of Enobosarm Monotherapy in Treatment of AR+/ER+/HER2- Metastatic Breast Cancer

    Not yet reported Veru Inc. 52 participants Est. completion 2024-01-09 54 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT04883814

    18F-fluoroestradiol (FES) PET/CT for Breast Cancer

    Not yet reported Hoag Memorial Hospital Presbyterian 124 participants Est. completion 2023-12-15 1 site Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT04891926

    Hormonal Influences on Diuresis

    Not yet reported University Hospital, Ghent 70 participants Est. completion 2018-09-30 Stand-alone
    Other conditions: Nocturia, Menopause, LUTS, Diuresis
    View official trial listing →
  • Active, not recruiting NCT NCT04895358

    Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy for HR+/HER2- Locally Recurrent Inoperable or Metastatic Breast Cancer (MK-3475-B49/KEYNOTE-B49)

    Not yet reported Merck Sharp & Dohme LLC 342 participants Est. completion 2027-12-18 256 sites
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Terminated NCT NCT04899349

    Study of Safety and Efficacy of Dapagliflozin + Metformin XR Versus Metformin XR in Participants With HR+, HER2-, Advanced Breast Cancer While on Treatment With Alpelisib and Fulvestrant

    Not yet reported Novartis Pharmaceuticals 2 participants Est. completion 2023-05-10 2 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT04899778

    Do Oral Contraceptives Protect Against ACL Injuries in Female Athletes

    Not yet reported Cedars-Sinai Medical Center 73 participants Est. completion 2024-06-30 1 site
    Other conditions: Ligament Injury
    View official trial listing →
  • Withdrawn NCT NCT04901299

    Fulvestrant + Neratinib In Breast Cancer

    Not yet reported Massachusetts General Hospital Est. completion 2025-07-01 2 sites
    Other conditions: Stage IV (Metastatic) Breast Cancer, Metastatic Breast Cancer, ER Positive Breast Cancer, PR-Positive Breast Cancer, HER2-negative Breast Cancer, Invasive Breast Cancer
    View official trial listing →
  • Completed NCT NCT04901377

    A Study to Gather Information About User Satisfaction in Women in Russia Who Take Estradiol Valerate/Dienogest

    Bayer 255 participants Est. completion 2023-04-20 1 site
    Other conditions: Oral Contraception
    View official trial listing →
  • Completed NCT NCT04916509

    Treatment Patterns and Clinical Outcomes Among Patients Receiving Palbociclib Combinations for Hormone Receptor Positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2 ) Advanced/Metastatic Breast Cancer in the Arabian Gulf Region

    Pfizer 258 participants Est. completion 2022-12-27 7 sites
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Active, not recruiting NCT NCT04920708

    Fulvestrant, Ipatasertib and CDK4/6 Inhibition in Metastatic ER+/HER2- Breast Cancer Patients Without ctDNA Suppression

    Not yet reported Royal Marsden NHS Foundation Trust 57 participants Est. completion 2027-06 13 sites
    Other conditions: Metastatic Breast Cancer, ER+ Breast Cancer, Advanced Breast Cancer
    View official trial listing →
  • Completed NCT NCT04923867

    Suturable DuraGen™ PMCF Study

    Integra LifeSciences Corporation 106 participants Est. completion 2024-07-31 3 sites
    Other conditions: Cerebrospinal Fluid Leak
    View official trial listing →
  • Completed NCT NCT04930224

    Serum GPER-1 and Oxidant/Antioxidant Levels on Retinopathy in Diabetic Patients

    Kahramanmaras Sutcu Imam University 120 participants Est. completion 2020-04-25 1 site
    Other conditions: Diabetes Mellitus, Diabetic Retinopathy, Hormones
    View official trial listing →
  • Withdrawn NCT NCT04933240

    Tamoxifen Versus Estradiol for Unscheduled Bleeding in Etonogestrel Implant Users, a Randomized Pilot Trial

    Not yet reported Virginia Commonwealth University Est. completion 2024-12 2 sites
    Other conditions: Vaginal Bleeding
    View official trial listing →
  • Completed NCT NCT04934696

    A Study to Characterize the Drug Levels of an Oral Contraceptive With and Without BMS-986166 in Healthy Female Participants of Childbearing Potential

    Not yet reported Bristol-Myers Squibb 25 participants Est. completion 2022-01-25 1 site
    Other conditions: Healthy Participants
    View official trial listing →
  • Status unknown NCT NCT04942015

    Honghuaruyi Wan for Endometriosis Dysmenorrhea

    Not yet reported Beijing University of Chinese Medicine 164 participants Est. completion 2023-12-31 Stand-alone
    Other conditions: Endometriosis, Dysmenorrhea
    View official trial listing →
  • Active, not recruiting NCT NCT04961996

    A Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuvant Endocrine Monotherapy in Participants With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer (lidERA Breast Cancer)

    Not yet reported Hoffmann-La Roche 4170 participants Est. completion 2033-09-30 622 sites
    Other conditions: Early Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT04962386

    Clinical Efficacy of Hormone Replacement Therapy in Treating Perimenopausal Women With MGD

    Second Affiliated Hospital, Zhejiang University, School of Medicine 30 participants Est. completion 2022-03-06 2 sites
    Other conditions: Meibomian Gland Dysfunction
    View official trial listing →
  • Status unknown NCT NCT04962789

    Endometrial Compaction in Assissted Reproduction

    Assiut University 145 participants Est. completion 2023-10-01 1 site
    Other conditions: Infertility, Female
    View official trial listing →
  • Completed NCT NCT04964193

    Bioequivalence Study of Cyproterone Acetate and Ethinyl Estradiol in Healthy Female Volunteers

    Not yet reported PT Sydna Farma 24 participants Est. completion 2019-09-26 1 site
    Other conditions: Drug Use
    View official trial listing →
  • Active, not recruiting NCT NCT04964934

    Phase III Study to Assess AZD9833+ CDK4/6 Inhibitor in HR+/HER2-MBC With Detectable ESR1m Before Progression (SERENA-6)

    Not yet reported AstraZeneca 315 participants Est. completion 2028-09-01 264 sites
    Other conditions: ER-Positive HER2-Negative Breast Cancer
    View official trial listing →
  • Terminated NCT NCT04965688

    Biology Guided Therapy for Breast Cancer for ER Positive

    Not yet reported Inova Health Care Services 2 participants Est. completion 2024-03-13 1 site
    Other conditions: Breast Cancer, Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer
    View official trial listing →
  • Terminated NCT NCT04967248

    A NIS of Alpelisib in Combination With Fulvestrant in Postmenopausal Women, and Men, With HR+,HER2- , Locally Advanced or Metastatic Breast Cancer With a PIK3CA Mutation, After Disease Progression Following Endocrine Therapy as Monotherapy, in the Real-world Setting

    Novartis Pharmaceuticals 4 participants Est. completion 2024-10-18
    Other conditions: Hormone Receptor Positive HER2 Negative Breast Cancer With a PIK3CA Mutation
    View official trial listing →
  • Status unknown NCT NCT04972032

    Efficacy of Estrogen-intrauterine Stent System After Intrauterine Adhesiolysis

    Not yet reported Limin Feng 246 participants Est. completion 2025-03 1 site Stand-alone
    Other conditions: Intrauterine Adhesion
    View official trial listing →
  • Completed NCT NCT04972396

    Pemvidutide (ALT-801) DDI Study in Healthy Volunteers

    Not yet reported Altimmune, Inc. 40 participants Est. completion 2022-05-15 2 sites
    MASH
    View official trial listing →
  • Active, not recruiting NCT NCT04975308

    A Study of Imlunestrant, Investigator's Choice of Endocrine Therapy, and Imlunestrant Plus Abemaciclib in Participants With ER+, HER2- Advanced Breast Cancer

    Not yet reported Eli Lilly and Company 874 participants Est. completion 2027-08 243 sites
    Other conditions: Breast Neoplasms, Neoplasm Metastasis
    View official trial listing →
  • Completed NCT NCT04979091

    Sex Hormone Dysregulations Are Associated With Critical Illness in COVID-19 Patients

    Universitätsklinikum Hamburg-Eppendorf 100 participants Est. completion 2021-05-31 1 site
    Other conditions: Covid19, Critical Illness
    View official trial listing →
  • Status unknown NCT NCT04984070

    Research on Risk Factors and Interventions of Polycystic Ovary Syndrome Complicated With Depression and Anxiety

    Not yet reported Fudan University 100 participants Est. completion 2024-12-31 1 site
    Other conditions: PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries, Depression, Anxiety
    View official trial listing →
  • Completed NCT NCT04989348

    Euploid Rate of Blastocyst Derived From PPOS VS Antagonist Protocol

    Not yet reported Shanghai First Maternity and Infant Hospital 240 participants Est. completion 2024-02-20 1 site
    Other conditions: IVF
    View official trial listing →
  • Completed NCT NCT04997525

    Estradiol and Progesterone Levels Following Frozen Embryo Transfer

    Not yet reported Copenhagen University Hospital at Herlev 305 participants Est. completion 2024-12-06 1 site
    Other conditions: Infertility
    View official trial listing →
  • Status unknown NCT NCT04999540

    Tucidinostat and Fulvestrant in Hormone-receptor Positive Advanced Breast Cancer

    Not yet reported Guangdong Women and Children Hospital 73 participants Est. completion 2024-12-30
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT05000736

    Comparative Effectiveness of Palbociclib Plus AI Versus Fulvestrant for HR+/HER2- ABC

    Chinese Academy of Medical Sciences 600 participants Est. completion 2022-09-01 1 site
    Other conditions: Hormone Receptor Positive Advanced Breast Cancer
    View official trial listing →
  • Completed NCT NCT05002738

    Desogestrel-containing COCP Pharmacokinetic Validation Study

    Not yet reported University of Colorado, Denver 22 participants Est. completion 2022-11-28 1 site
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT05010707

    Transgender Estradiol Affirming Therapy

    Not yet reported Washington University School of Medicine 39 participants Est. completion 2024-01-01 1 site
    Other conditions: Transgenderism
    View official trial listing →
  • Completed NCT NCT05012644

    Comparative Real World Tumor Response in Pre-menopausal Metastatic Breast Cancer Patients Treated With Palbociclib + Aromatase Inhibitor or Aromatase Inhibitor Alone

    Pfizer 197 participants Est. completion 2021-12-09 1 site
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT05021094

    Clinical Observation on Kuntai Capsule in Treating Early-onset Ovarian Hypofunction

    Not yet reported Affiliated Hospital of Nantong University 120 participants Est. completion 2023-12-31 6 sites Stand-alone
    Other conditions: Primary Ovarian Insufficiency
    View official trial listing →
  • Status unknown NCT NCT05021861

    Evaluation of Periodontal Status and hsCRP Levels in Females With PCOS on CPA/EE Combination Drug Regimen

    Postgraduate Institute of Dental Sciences Rohtak 150 participants Est. completion 2022-09-30 1 site
    Other conditions: Periodontitis, Polycystic Ovary Syndrome, Gingivitis
    View official trial listing →
  • Completed NCT NCT05022342

    Study of PIK3CA Mutations and Effectiveness and Tolerability Outcomes of Alpelisib in Real-world

    Novartis Pharmaceuticals 595 participants Est. completion 2025-02-11 28 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT05026502

    A Study to Assess Patient-Reported Quality of Life and Effectiveness on Control of Bleeding in Adult Participants With Heavy Menstrual Bleeding Due to Uterine Fibroids Taking Oral Oriahnn Capsules

    AbbVie 23 participants Est. completion 2022-08-30 1 site
    Other conditions: Heavy Menstrual Bleeding, Uterine Fibroids
    View official trial listing →
  • Completed NCT NCT05030038

    Oral Aromatase Inhibitors Modify the Gut Microbiome

    Wake Forest University Health Sciences 24 participants Est. completion 2025-07-28 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT05033574

    The State of Sexual Development in Children With Inherited Epidermolysis Bullosa

    National Medical Research Center for Children's Health, Russian Federation 50 participants Est. completion 2023-06-01 1 site
    Obstructive sleep apnea Other conditions: Dermatologic Disease, Kindler Syndrome, Puberty Disorders, Hormone Disturbance
    View official trial listing →
  • Active, not recruiting NCT NCT05038735

    Study to Assess the Efficacy and Safety of Alpelisib Plus Fulvestrant in Participants With HR-positive (HR+), HER2-negative, Advanced Breast Cancer After Treatment With a CDK4/6 Inhibitor and an Aromatase Inhibitor.

    Not yet reported Novartis Pharmaceuticals 210 participants Est. completion 2027-02-26 68 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT05043506

    European Treatment Patterns and Outcomes Associated With First-Line CDK4/6 Inhibition and Hormonal Therapies

    Pfizer 1939 participants Est. completion 2023-11-02 64 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT05047848

    Clinical Study of Chidamide Combined With Fulvestrant in the Treatment of Hormone Receptor-positive Advanced Breast Cancer

    Not yet reported Liaoning Cancer Hospital & Institute 82 participants Est. completion 2023-09-18 1 site
    Other conditions: Advanced Breast Cancer
    View official trial listing →
  • Completed NCT NCT05050981

    Effects of Menopause Hormonal Therapy and Selective Serotonin Reuptake Inhibitor on Cognition, Sexual Function and Quality of Life

    Faculdade de Medicina do ABC 74 participants Est. completion 2022-02-28 1 site
    Other conditions: Menopause
    View official trial listing →
  • Withdrawn NCT NCT05051293

    Comparison of the Concentration of Estrogen and Testosterone Ratio in Male Patients With Cirrhosis and Hypotension

    Methodist Health System Est. completion 2024-08-17
    Other conditions: Hypotension, Cirrhosis
    View official trial listing →
  • Completed NCT NCT05054374

    A Study of Mirdametinib on Its Own or in Combination With Fulvestrant in People With Solid Tumor Cancer

    Not yet reported, Not yet reported Memorial Sloan Kettering Cancer Center 6 participants Est. completion 2023-10-26 4 sites Stand-alone
    Other conditions: Breast Cancer, Breast Cancer Stage IV, HER2-negative Breast Cancer, Solid Carcinoma, MEK1 Gene Mutation, MEK2 Gene Mutation, Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT05054751

    GB491 Combined With Fulvestrant for HR+ HER2- Locally Advanced or Metastatic Breast Cancer

    Not yet reported Genor Biopharma Co., Ltd. 275 participants Est. completion 2024-03-30 54 sites
    Other conditions: Locally Advanced or Metastatic Breast Cancer
    View official trial listing →
  • Enrolling by invitation NCT NCT05059626

    Endometriosis and Microvascular Dysfunction; Simvastatin and Duavee

    Not yet reported Penn State University 28 participants Est. completion 2026-12-31 1 site
    Other conditions: Endometriosis
    View official trial listing →
  • Completed NCT NCT05061472

    A 6-month Observational Study on Combined Oral Contraceptives and Body Weight in Pre-Menopausal Women With Overweight or Obesity

    University of Colorado, Denver 20 participants Est. completion 2023-08-23 2 sites
    Other conditions: Contraceptive Usage, Overweight or Obesity, Body Weight Changes, Appetitive Behavior, Eating Behavior
    View official trial listing →
  • Active, not recruiting NCT NCT05063786

    Trastuzumab + Alpelisib +/- Fulvestrant vs Trastuzumab + CT in Patients With PIK3CA Mutated Previously Treated HER2+ Advanced BrEasT Cancer (ALPHABET)

    Not yet reported Spanish Breast Cancer Research Group 27 participants Est. completion 2026-06 106 sites
    Other conditions: Advanced Breast Cancer
    View official trial listing →
  • Completed NCT NCT05064332

    A Study To Estimate The Effect of PF-06650833 On The Pharmacokinetics (PK) of Oral Contraceptive (OC)

    Not yet reported Pfizer 10 participants Est. completion 2021-12-16 1 site
    Other conditions: Healthy
    View official trial listing →
  • Terminated NCT NCT05065411

    Efficacy & Safety Evaluation of Enobosarm in Combo With Abemaciclib in Treatment of ER+HER2- Metastatic Breast Cancer

    Not yet reported Veru Inc. 5 participants Est. completion 2024-01-09 30 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT05069038

    Clinical Trial Assessing the Safety of Neoadjuvant Palbociclib in Combination With Endocrine Therapy

    Not yet reported University of Nebraska 51 participants Est. completion 2032-09 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Withdrawn NCT NCT05073237

    Effects of Novel Estrogens on Glucose and Lipids in Postmenopausal Prediabetic Women Veterans

    Not yet reported VA Office of Research and Development Est. completion 2024-04-08 1 site
    Prediabetes Other conditions: Menopause, Obesity
    View official trial listing →
  • Status unknown NCT NCT05075512

    The Efficacy and Safety of Anlotinib Combined With Fulvestrant in Patients With Advanced Breast Cancer

    Not yet reported Zhejiang Cancer Hospital 40 participants Est. completion 2026-08-31 1 site
    Other conditions: Breast Neoplasm Female
    View official trial listing →
  • Status unknown NCT NCT05076695

    Neoadjuvant With Trastuzumab, Pyrotinib Plus Palbociclib and Fulvestrant in HER2-positive, ER-positive Breast Cancer

    Not yet reported Fudan University 37 participants Est. completion 2024-10-15 1 site
    Other conditions: Estrogen Receptor-positive Breast Cancer, HER2-positive Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT05077449

    A Study of XZP-3287 in Combination With Fulvestrant in Patients With Advanced Breast Cancer

    Not yet reported Xuanzhu Biopharmaceutical Co., Ltd. 300 participants Est. completion 2029-11 1 site
    Other conditions: Advanced Breast Cancer
    View official trial listing →
  • Withdrawn NCT NCT05079360

    Efficacy Evaluation of Sabizabulin Monotherapy Versus Active Control for Treatment of ER+HER2- Metastatic Breast Cancer

    Not yet reported Veru Inc. Est. completion 2024-05-26 26 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Terminated NCT NCT05080842

    A Study of AC682 for the Treatment of Locally Advanced or Metastatic ER+ Breast Cancer

    Not yet reported Accutar Biotechnology Inc 21 participants Est. completion 2024-04-04 5 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT05082025

    Phase 2 Study of PI3K Inhibitor Copanlisib in Combination With Fulvestrant in Selected ER+ and/or PR+ Cancers With PI3K (PIK3CA, PIK3R1) and/or PTEN Alterations

    Not yet reported M.D. Anderson Cancer Center 7 participants Est. completion 2025-12-12 1 site
    Other conditions: Endometrial Cancer, Ovarian Cancer
    View official trial listing →
  • Terminated NCT NCT05085002

    A Study of Lerociclib in Participants With Advanced Breast Cancer

    Not yet reported EQRx, Inc. 100 participants Est. completion 2023-11-29 21 sites
    Other conditions: Advanced Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT05090358

    Preventing High Blood Sugar in People Being Treated for Metastatic Breast Cancer

    Not yet reported Memorial Sloan Kettering Cancer Center 15 participants Est. completion 2027-10-08 9 sites
    Other conditions: Breast Cancer, Breast Cancer Stage IV, Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT05093205

    STUDY TO EVALUATE THE EFFECT OF PF-06882961 ON SINGLE DOSE ATORVASTATIN, MEDAZOLAM AND ORALCONTRACEPTIVE PHARMACOKINETICS IN HEALTHY ADULT PARTICIPANTS

    Not yet reported Pfizer 35 participants Est. completion 2022-07-06 1 site
    Other conditions: Healthy Adults
    View official trial listing →
  • Completed NCT NCT05095597

    Umbilical Cord Plasma for Treating Endometrial Pathologies (Thin Endometrium / Asherman's Syndrome/ Endometria Atrophy)

    Not yet reported Fundación IVI 15 participants Est. completion 2025-01-27 1 site Stand-alone
    Other conditions: Asherman Syndrome, Endometrial Atrophy
    View official trial listing →
  • Status unknown NCT NCT05096065

    Study to Evaluate the Pharmacodynamics and Efficacy of Leuprolide Tablets (Ovarest®) in Women With Endometriosis

    Not yet reported Enteris BioPharma Inc. 16 participants Est. completion 2022-05 4 sites
    Other conditions: Endometriosis
    View official trial listing →
  • Completed NCT NCT05098574

    Oral Contraceptives for Treating Premenstrual Dysphoric Disorder in Bipolar Disorder

    Not yet reported St. Joseph's Healthcare Hamilton 17 participants Est. completion 2024-04-11 1 site
    Other conditions: Premenstrual Dysphoric Disorder, Bipolar Disorder
    View official trial listing →
  • Active, not recruiting NCT NCT05105854

    Hand Osteoarthritis: Investigating Pain Trajectories and Association With Biomarkers Including Estrogen Cohort

    University of Oxford 120 participants Est. completion 2029-02-07 2 sites
    Osteoarthritis
    View official trial listing →
  • Completed NCT NCT05107804

    Energy Restriction and Hormones in Premenopausal Women

    Not yet reported Penn State University 47 participants Est. completion 2006-11
    Other conditions: Menstruation Disturbances, Luteal Phase Defect
    View official trial listing →
  • Completed NCT NCT05109676

    Monitoring of Progesterone Administered in Infertile Patients During a Cycle of Frozen Embryo Transfer.

    Not yet reported University Hospital, Toulouse 300 participants Est. completion 2022-06-03 1 site
    Other conditions: IVF
    View official trial listing →
  • Status unknown NCT NCT05112692

    Progestin-primed Ovarian Stimulation Protocol Versus GnRH Antagonist Protocol in Polycystic Ovary Syndrome Patients Undergoing IVF/ICSI Cycles

    Not yet reported Mansoura University 200 participants Est. completion 2023-12
    Other conditions: PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries
    View official trial listing →
  • Status unknown NCT NCT05118685

    Estrogen and Platelet Rich Plasma in Treatment of Atrophic Vaginitis

    Not yet reported Fayoum University 100 participants Est. completion 2023-09 2 sites
    Other conditions: Atrophic Vaginitis, Postmenopausal Atrophic Vaginitis
    View official trial listing →
  • Status unknown NCT NCT05133674

    Therapeutic Dose Monitoring (TDM) of Tamoxifen

    Not yet reported Karolinska University Hospital 40 participants Est. completion 2023-03-01 1 site
    Other conditions: Breast Cancer, Breast Carcinoma, Breast Tumors, Cancer of Breast, Malignant Neoplasm of Breast
    View official trial listing →
  • Status unknown NCT NCT05135013

    The Association of Hormonal Intake and Demographic Factors With Breast Cancer Risk. An Egyptian Case-controlled Study

    NewGiza University 200 participants Est. completion 2022-03-31
    Other conditions: Observational Study
    View official trial listing →
  • Status unknown NCT NCT05135104

    Study Of Real-World Evidence In Patients Treated With Palbociclib During a 2.5 Years Follow-Up Period

    Asociatia Oncohelp - Centrul de Oncologie Oncohelp 650 participants Est. completion 2024-05-25 7 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT05139121

    Study of the Safety and Efficacy of MR-100A-01 in Approximately 1200 Healthy Women for up to 13 Cycles

    Not yet reported Mylan Technologies Inc. 1320 participants Est. completion 2025-01-15 100 sites
    Other conditions: Contraception
    View official trial listing →
  • Status unknown NCT NCT05140655

    Effectiveness and Safety of Fulvestrant in Postmenopausal Women With Advanced Breast Cancer HR+, HER2-

    Dr. Reddy's Laboratories SAS 40 participants Est. completion 2022-08-19 1 site
    Other conditions: Breast Neoplasm Female
    View official trial listing →
  • Status unknown NCT NCT05143723

    Luteal Phase Support With Daily Administration of Gonadotropin-releasing Hormone Agonist Compared to Progesterone/Estradiol in IVF/ICSI Cycles With Ovulation Triggering With GnRH-a

    Not yet reported Kuban State Medical University 102 participants Est. completion 2022-06-10 1 site
    Other conditions: Infertility
    View official trial listing →
  • Completed NCT NCT05153564

    A Research Study Looking Into the Effect of Semaglutide and NNC0480 0389 on Blood Levels of a Birth Control Pill in Woman After Menopause

    Not yet reported Novo Nordisk A/S 27 participants Est. completion 2022-09-01 1 site
    Type 2 diabetes
    View official trial listing →
  • Active, not recruiting NCT NCT05154487

    A Study of Alpelisib and Fulvestrant to Treat Endometrial Cancer

    Not yet reported GOG Foundation 51 participants Est. completion 2028-11-01 21 sites Stand-alone
    Other conditions: Endometroid Endometrial Cancer
    View official trial listing →
  • Status unknown NCT NCT05156814

    Comparative Study to Evaluate the Efficacy and Safety of the Fixed-dose Combination of Estradiol / Dydrogesterone in Perimenopausal Women

    Not yet reported Scientific Research Institute of Public Health, Russian Federation 150 participants Est. completion 2023-05 1 site
    Other conditions: Perimenopausal Disorder, Hot Flashes
    View official trial listing →
  • Status unknown NCT NCT05156879

    Aspirin for the Management of Endometriosis-associated Pelvic Pain

    Not yet reported Women's Hospital School Of Medicine Zhejiang University 220 participants Est. completion 2025-06 1 site
    Other conditions: Pelvic Pain
    View official trial listing →
  • Active, not recruiting NCT NCT05161195

    Roll-over Study to Allow Continued Access to Ribociclib

    Not yet reported Novartis Pharmaceuticals 134 participants Est. completion 2030-08-14 73 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT05161338

    Impact of Vaginal Microbiome on Vaginal Absorption of Exogenous Progesterone: a Pilot Study.

    Not yet reported Instituto Valenciano de Infertilidad, IVI VALENCIA 100 participants Est. completion 2023-04-30 1 site
    Other conditions: Infertility, Female
    View official trial listing →
  • Withdrawn NCT NCT05168865

    Letrozole Versus Hormonal Preparation in Frozen Cycles of PCOS Patients.

    Not yet reported Dubai Fertility Center Est. completion 2024-04-01
    Other conditions: Frozen Embryo Transfer, Polycystic Ovarian Disease, Letrozole, Hormone Replacement Therapy, Live Birth, Miscarriage
    View official trial listing →
  • Active, not recruiting NCT NCT05169567

    Abemaciclib (LY2835219) Plus Fulvestrant Compared to Placebo Plus Fulvestrant in Previously Treated Breast Cancer

    Not yet reported Eli Lilly and Company 368 participants Est. completion 2027-12 138 sites
    Other conditions: Breast Neoplasm, Neoplasm Metastasis
    View official trial listing →
  • Terminated NCT NCT05176080

    Famitinib Plus SHR6390 and Endocrine Therapy in the Treatment of HR-positive, HER2-negative Advanced Breast Cancer

    Not yet reported, Not yet reported Henan Cancer Hospital 46 participants Est. completion 2024-07-03 1 site
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT05177432

    Quadratic Phenotypic Optimisation Platform (QPOP) Utilisation to Enhance Selection of Patient Therapy Through Patient Derived Organoids in Breast Cancer

    Not yet reported National University Hospital, Singapore 26 participants Est. completion 2025-12-31 1 site Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT05183828

    Effect of HSD3B1 (1245C) Gene Mutation on Treatment of Stage I-III Breast Cancer

    Not yet reported University of Washington 62 participants Est. completion 2026-05-13 1 site
    Other conditions: Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, Breast Adenocarcinoma, Invasive Breast Carcinoma of No Special Type
    View official trial listing →
  • Completed NCT NCT05184777

    Evaluation of Salivary ELISA for Hormone Monitoring in IVF Patients

    Not yet reported Instituto Valenciano de Infertilidad, IVI VALENCIA 120 participants Est. completion 2023-02-20 1 site
    Other conditions: Infertility, Female, Reproductive Sterility
    View official trial listing →
  • Status unknown NCT NCT05186545

    An Exploratory Study of Surufatinib Combined With Chidamide and Fulvestrant in HR Positive Unresectable Metastatic Breast Cancer

    Not yet reported The First Affiliated Hospital of Zhengzhou University 63 participants Est. completion 2025-07 5 sites
    Other conditions: Breast Cancer, Breast Cancer Female
    View official trial listing →
  • Completed NCT NCT05189145

    Hormonal Monitoring and Progesterone Adjustment in Frozen Embryo Transfer Cycles

    Not yet reported Alexandria University 600 participants Est. completion 2021-10-01 1 site Stand-alone
    Other conditions: Female Infertility
    View official trial listing →
  • Completed NCT NCT05189873

    GnRH Agonist Plus Hormone Replacement Therapy vs Hormone Replacement Therapy on IVF Outcomes

    Not yet reported Tehran University of Medical Sciences 128 participants Est. completion 2022-01-03 1 site
    Other conditions: Polycystic Ovary Syndrome, Infertility, Female
    View official trial listing →
  • Withdrawn NCT NCT05191004

    Study of NUV-422 in Combination With Fulvestrant in Patients With HR+HER2- aBC

    Not yet reported, Not yet reported Nuvation Bio Inc. Est. completion 2026-09 5 sites
    Other conditions: Advanced Breast Cancer, Metastatic Breast Cancer, Breast Cancer, Breast Carcinoma, Cancer of the Breast, Cancer of Breast, Malignant Tumor of Breast, Breast Tumor
    View official trial listing →
  • Completed NCT NCT05195164

    The Effects of Orchiectomy and Age on Vascular and Metabolic Health in Older Versus Younger Transgender Women

    University of Colorado, Denver 17 participants Est. completion 2023-12-31 1 site
    Other conditions: Transgender, Gender Identity, Vascular Stiffness, Vascular Inflammation, Insulin Sensitivity, Blood Pressure, Lipid Disorder, Appetitive Behavior
    View official trial listing →
  • Completed NCT NCT05197374

    Effect of Estradiol Pretreatment on Antagonist ICSI Cycles

    Not yet reported Alexandria University 114 participants Est. completion 2021-11-15 1 site Stand-alone
    Other conditions: Female Infertility
    View official trial listing →
  • Terminated NCT NCT05207709

    Ribociclib vs. Palbociclib in Patients With Advanced Breast Cancer Within the HER2-Enriched Intrinsic Subtype

    Not yet reported SOLTI Breast Cancer Research Group 61 participants Est. completion 2026-03-26 71 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT05226871

    Study for Participants Continuing From Pfizer-sponsored Palbociclib (a Study Medicine) Studies

    Not yet reported Pfizer 35 participants Est. completion 2029-12-31 23 sites
    Other conditions: Breast Cancer, Head and Neck Cancer
    View official trial listing →
  • Status unknown NCT NCT05227391

    Live Birth After Letrozole-stimulated Cycles Versus Hormone Replacement Treatment Cycles for the First Frozen Embryo Transfer in Women With PCOS

    Not yet reported Reproductive & Genetic Hospital of CITIC-Xiangya 1078 participants Est. completion 2024-12-31 1 site
    Other conditions: PCOS
    View official trial listing →
  • Active, not recruiting NCT NCT05230810

    Clinical Trial of Alpelisb and Tucatinib in Patients With PIK3CA-Mutant HER2+ Metastatic Breast Cancer.

    Not yet reported, Not yet reported Criterium, Inc. 40 participants Est. completion 2026-06-30 4 sites
    Other conditions: HER2-positive Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT05232344

    Sexual Intercourse and Vaginal Absorption of Progesterone

    Not yet reported University Hospital, Montpellier 40 participants Est. completion 2024-02-29 1 site
    Other conditions: Infertility
    View official trial listing →
  • Withdrawn NCT NCT05238831

    SMMART Adaptive Clinical Treatment (ACT) Trial

    Not yet reported OHSU Knight Cancer Institute Est. completion 2026-05-31
    Other conditions: Advanced Breast Carcinoma, Advanced Malignant Solid Neoplasm, Advanced Ovarian Carcinoma, Advanced Pancreatic Carcinoma, Advanced Prostate Carcinoma, Advanced Sarcoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Recurrent Adult Soft Tissue Sarcoma, Recurrent Breast Carcinoma, Recurrent Ovarian Carcinoma, Recurrent Prostate Carcinoma, Stage II Pancreatic Cancer AJCC v8, Stage III Ovarian Cancer AJCC v8, Stage III Pancreatic Cancer AJCC v8, Stage IV Ovarian Cancer AJCC v8, Stage IV Pancreatic Cancer AJCC v8
    View official trial listing →
  • Active, not recruiting NCT NCT05238922

    Study of INCB123667 in Subjects With Advanced Solid Tumors

    Not yet reported Incyte Corporation 291 participants Est. completion 2027-08-31 41 sites
    Other conditions: Solid Tumors
    View official trial listing →
  • Completed NCT NCT05243823

    Vaginal Estradiol Tablets (Vagifem®) and Endometrial Cancer Risk in the Treatment of Postmenopausal Vaginal Atrophy

    Novo Nordisk A/S 500000 participants Est. completion 2022-07-31 1 site
    Other conditions: Postmenopausal Vaginal Atrophy
    View official trial listing →
  • Status unknown NCT NCT05244811

    Treat of Functional Ovarian Cysts by Compare Between Cocs and Progesterone Only Pills

    Not yet reported Sohag University 60 participants Est. completion 2023-01
    Other conditions: Ovarian Neoplasms
    View official trial listing →
  • Active, not recruiting NCT NCT05251714

    CFI-402257, a Potent and Selective TTK Inhibitor, in Solid Tumors and With Fulvestrant in Breast Cancer

    Not yet reported, Not yet reported Treadwell Therapeutics, Inc 44 participants Est. completion 2026-08 4 sites
    Other conditions: Advanced Solid Tumor, Breast Cancer
    View official trial listing →
  • Terminated NCT NCT05252416

    (VELA) Study of BLU-222 in Advanced Solid Tumors

    Not yet reported Blueprint Medicines Corporation 50 participants Est. completion 2025-07-04 23 sites
    Obstructive sleep apnea Other conditions: Advanced Solid Tumors, HR+ Breast Cancer, CCNE1 Amplification, HER2-negative Breast Cancer, Ovarian Cancer, Endometrial Cancer, Gastric Cancer, Esophageal Adenocarcinoma
    View official trial listing →
  • Active, not recruiting NCT NCT05262400

    A Study to Learn About the Study Medicine (Called PF-07220060 in Combination With PF-07104091) In Participants With Breast Cancer and Solid Tumors

    Not yet reported, Not yet reported Pfizer 235 participants Est. completion 2027-02-26 44 sites
    Other conditions: Breast Cancer, Solid Tumors
    View official trial listing →
  • Terminated NCT NCT05264506

    Contraceptive Efficacy and Safety of NOMAC-E2 Combined Oral Contraceptive

    Not yet reported Organon and Co 3055 participants Est. completion 2024-01-26 103 sites
    Other conditions: Contraception
    View official trial listing →
  • Status unknown NCT NCT05264649

    Effect of Acupuncture vs Chinese Medicine vs Combined Therapy on Aromatase Inhibitor-related Arthralgia Among Women With Early-Stage Breast Cancer

    Not yet reported Show Chwan Memorial Hospital 72 participants Est. completion 2023-03-03 1 site
    Other conditions: Arthralgia
    View official trial listing →
  • Active, not recruiting NCT NCT05266105

    A Phase 1 Study of Oral OP-1250 in Combination With Palbociclib in HR+/HER2- Breast Cancer Patients

    Not yet reported Olema Pharmaceuticals, Inc. 60 participants Est. completion 2026-03 8 sites Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT05282940

    Bioavailability of Levonorgestrel and Ethinyl Estradiol Tablets 15.0 mg/0.03 mg With Regards to Reference Product

    Not yet reported Laboratorios Andromaco S.A. 36 participants Est. completion 2022-04-08 1 site
    Other conditions: Therapeutic Equivalency
    View official trial listing →
  • Active, not recruiting NCT NCT05293964

    Phase I Study to Evaluate SIM0270 Alone or in Combination in ER+, HER2- Locally Advanced or Metastatic Breast Cancer

    Not yet reported Jiangsu Simcere Pharmaceutical Co., Ltd. 214 participants Est. completion 2025-09-08 1 site Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT05296746

    Neoadjuvant and Adjuvant Ribociclib and ET for Clinically High-risk ER+ and HER2- Breast Cancer

    Not yet reported SOLTI Breast Cancer Research Group 1100 participants Est. completion 2031-12-01 51 sites
    Other conditions: Breast Cancer Stage II
    View official trial listing →
  • Active, not recruiting NCT NCT05296798

    A Study to Evaluate the Efficacy and Safety of Giredestrant in Combination With Phesgo (Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf) Versus Phesgo in Participants With Locally Advanced or Metastatic Breast Cancer (heredERA Breast Cancer)

    Not yet reported Hoffmann-La Roche 922 participants Est. completion 2030-12-31 202 sites
    Other conditions: Locally Advanced or Metastatic Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT05300841

    The Effect of Pretreatment With Dydrogesterone Vs Combined Estradiol Valerate and Dydrogestrone on Clinical Pregnancy Outcome of ICSI in PCOS Patients"

    Not yet reported Sohag University 500 participants Est. completion 2023-05-01
    Other conditions: PCOS, ICSI
    View official trial listing →
  • Status unknown NCT NCT05302726

    Impact of Exogenous Estrogens on Cotisol Levels During Synacthen Stimulation

    Not yet reported Copenhagen University Hospital, Rigshospitalet 20 participants Est. completion 2023-06-01 1 site
    Other conditions: Adrenal Insufficiency, Hypogonadism Female
    View official trial listing →
  • Active, not recruiting NCT NCT05306340

    A Study Evaluating the Efficacy and Safety of Giredestrant Plus Everolimus Compared With the Physician's Choice of Endocrine Therapy Plus Everolimus in Participants With Estrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer (evERA Breast Cancer)

    Not yet reported Genentech, Inc. 373 participants Est. completion 2026-10-15 136 sites
    Other conditions: Estrogen Receptor (ER)-Positive, HER2-negative, Locally Advanced or Metastatic Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT05306405

    Comparative Study Between Only Vaginal Misoprostol and Vaginal Misoprostol and Estradiol Cream

    Not yet reported, Not yet reported Ain Shams University 120 participants Est. completion 2022-08-30 1 site
    Other conditions: Cervix; Pregnancy
    View official trial listing →
  • Status unknown NCT NCT05308342

    Clinical Study of Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Premature Ovarian Insufficiency

    Not yet reported Li-jun Ding 66 participants Est. completion 2023-12-01 1 site Stand-alone
    Other conditions: Premature Ovarian Insufficiency
    View official trial listing →
  • Active, not recruiting NCT NCT05309655

    Cardiac Outcomes With Near-Complete Estrogen Deprivation

    Not yet reported Duke University 90 participants Est. completion 2028-12-01 3 sites Stand-alone
    Other conditions: Breast Cancer, Triple Negative Breast Cancer, Cardiovascular Complications
    View official trial listing →
  • Terminated NCT NCT05317364

    Topical Vaginal Estrogen for Postpartum Obstetric Anal Sphincter Injury Recovery

    Not yet reported University of Alabama at Birmingham 38 participants Est. completion 2026-02-13 1 site
    Other conditions: Obstetric; Injury Pelvic Floor, Sexual Dysfunction, Anal Incontinence, Urinary Incontinence
    View official trial listing →
  • Completed NCT NCT05318989

    Genetic Aspects of Vaginal Aging

    Żelazna Medical Centre, LLC 120 participants Est. completion 2023-07-10 1 site
    Other conditions: Genitourinary Agents
    View official trial listing →
  • Active, not recruiting NCT NCT05319873

    Ribociclib, Tucatinib, and Trastuzumab for the Treatment of HER2 Positive Breast Cancer

    Not yet reported, Not yet reported Jonsson Comprehensive Cancer Center 18 participants Est. completion 2028-04-01 1 site
    Other conditions: Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIA Breast Cancer AJCC v8, Anatomic Stage IIB Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8, Anatomic Stage IIIC Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Invasive Breast Carcinoma, Locally Advanced HER2-Positive Breast Carcinoma, Metastatic HER2-Positive Breast Carcinoma, Prognostic Stage IB Breast Cancer AJCC v8, Prognostic Stage II Breast Cancer AJCC v8, Prognostic Stage IIA Breast Cancer AJCC v8, Prognostic Stage IIB Breast Cancer AJCC v8, Prognostic Stage III Breast Cancer AJCC v8, Prognostic Stage IIIA Breast Cancer AJCC v8, Prognostic Stage IIIB Breast Cancer AJCC v8, Prognostic Stage IIIC Breast Cancer AJCC v8, Prognostic Stage IV Breast Cancer AJCC v8
    View official trial listing →
  • Status unknown NCT NCT05328440

    Treatment of Dalpiciclib Combined With Pyrotinib for Trastuzumab-sensitive HER2+ Advanced Breast Cancer(DAP-Her-02)

    Not yet reported Henan Cancer Hospital 120 participants Est. completion 2026-01-01 1 site
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Completed NCT NCT05332106

    Bioavailability of Estradiol Valerate and Dienogest 2 mg/2 mg With Regards to Reference Product

    Not yet reported Laboratorios Andromaco S.A. 10 participants Est. completion 2022-03-22 1 site Stand-alone
    Other conditions: Bioequivalence
    View official trial listing →
  • Completed NCT NCT05340010

    Administration of Human Chorionic Gonadotrophin Before Secretory Transformation of Frozen-thawed Embryo Transfer Cycles

    Not yet reported Alexandria University 180 participants Est. completion 2022-07-30 1 site Stand-alone
    Other conditions: hCG, FET, Frozen-thawed Embryo Transfe, Human Chorionic Gonadotrophin
    View official trial listing →
  • Completed NCT NCT05346159

    Effects of Adrenal Androgens on Gender-typed Behavior in Girls With Turner Syndrome

    Sohag University 78 participants Est. completion 2023-05-31 1 site
    Other conditions: Turner Syndrome
    View official trial listing →
  • Status unknown NCT NCT05358678

    Cesarean Section Scar Niche: The Impact on ART Outcome

    Rahem Fertility Center 266 participants Est. completion 2023-05 1 site
    Other conditions: Cesarean Section, ART
    View official trial listing →
  • Completed NCT NCT05360550

    A Study to Evaluate the Effect of a Contraceptive Vaginal Ring LSP- 5415 on Ovarian Function in Healthy Adult Females

    Not yet reported Lupin Research Inc 26 participants Est. completion 2023-01-12 1 site
    Other conditions: Pregnancy Prevention
    View official trial listing →
  • Completed NCT NCT05360576

    An Open-label, Randomized, 2-Period, Crossover, Pharmacokinetics Study

    Not yet reported Lupin Research Inc 40 participants Est. completion 2022-07-04 1 site
    Other conditions: Pregnancy Prevention
    View official trial listing →
  • Completed NCT NCT05361655

    Real-World Effectiveness of Palbociclib in Combination With an Aromatase Inhibitor

    Pfizer 2888 participants Est. completion 2021-09-01 1 site
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT05367973

    Study of DARE-HRT1 Over 12 Weeks in Healthy PostMenopausal Women

    Not yet reported, Not yet reported Daré Bioscience, Inc. 21 participants Est. completion 2023-03-23 2 sites
    Other conditions: Vulvovaginal Atrophy, Vasomotor Symptoms
    View official trial listing →
  • Completed NCT NCT05377879

    An Advanced Decision Support Tool for Personalized Medicine for IVF Using Modeling and Optimization

    Not yet reported Stochastic Research Technologies LLC 44 participants Est. completion 2022-07-01 1 site Stand-alone
    Other conditions: IVF
    View official trial listing →
  • Terminated NCT NCT05384119

    Phase 1b/2 Study of TTI-101 in Combination for Patients With Metastatic Hormone Receptor-Positive and HER2-Negative Breast Cancer

    Not yet reported Tvardi Therapeutics, Incorporated 6 participants Est. completion 2024-05-06 6 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT05387577

    Coagulation and Fibrinolysis of Estradiol in Transwomen

    Not yet reported Medical College of Wisconsin 6 participants Est. completion 2022-11-23 1 site
    Other conditions: Transgenderism, Clotting Disorder
    View official trial listing →
  • Completed NCT NCT05388656

    Estrogen Variability and Irritability During the Menopause Transition

    Not yet reported University of North Carolina, Chapel Hill 40 participants Est. completion 2025-01-17 1 site
    Other conditions: Menopause, Irritable Mood
    View official trial listing →
  • Active, not recruiting NCT NCT05392608

    SEQUence of Endocrine Therapy in Advanced Luminal Breast Cancer (SEQUEL-Breast)

    Not yet reported Borstkanker Onderzoek Groep 130 participants Est. completion 2028-03 25 sites
    Other conditions: Neoplasm, Breast, Congenital, Familial and Genetic Disorders
    View official trial listing →
  • Completed NCT NCT05392985

    Detection and Analysis of MBC With Heterogeneous ER Expression

    Fudan University 51 participants Est. completion 2022-12-15 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT05411380

    Tucidinostat Combined With Metronomic Capecitabine and Endocrine Therapy for Advanced HR-positive, HER2-negative Breast Cancer After CDK4/6 Inhibitor.

    Not yet reported wang shusen 73 participants Est. completion 2025-04-01 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT05418426

    A Phase 1, Open-Label, Parallel Group Study to Evaluate the Pharmacokinetics and Safety of DARE-HRT1 in Healthy PostMenopausal Women

    Not yet reported Daré Bioscience, Inc. 34 participants Est. completion 2022-01-27 2 sites
    Other conditions: Vulvovaginal Atrophy, Vasomotor Symptoms
    View official trial listing →
  • Completed NCT NCT05427617

    Circulating Tumor DNA (ctDNA)-Guided Late-Line Treatment in Patients With Late-Stage Breast Cancer

    Hunan Cancer Hospital 223 participants Est. completion 2021-06-30
    Other conditions: Metastatic Breast Cancer, Circulating Tumor DNA, Gene Abnormality
    View official trial listing →
  • Terminated NCT NCT05428215

    Comparison of PKs of 17-Beta-Estradiol Via Sublingual Placement Versus Swallowing in Male-to-Female Transgender Patients

    Not yet reported MaineHealth 2 participants Est. completion 2023-07-20 1 site
    Other conditions: Gender Dysphoria
    View official trial listing →
  • Status unknown NCT NCT05433480

    A Study of BPI-16350 in Combination With Fulvestrant in Patients With HR+ and HER2- Locally Advanced, Recurrent or Metastatic Breast Cancer

    Not yet reported Betta Pharmaceuticals Co., Ltd. 274 participants Est. completion 2025-07-31 64 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT05443282

    Ovarian Reserve and Matrix Metalloproteinases

    Ankara City Hospital Bilkent 133 participants Est. completion 2022-03-07 1 site
    Other conditions: Oxidative Stress, Ovarian Insufficiency, Primary, Ovarian Failure, Premature
    View official trial listing →
  • Completed NCT NCT05448924

    Isolated Growth Hormone Deficiency and Amennorrhea

    Universitas Padjadjaran 1 participants Est. completion 2022-01-31 1 site
    Other conditions: Growth Hormone Deficiency
    View official trial listing →
  • Terminated NCT NCT05458375

    Vaginal Estradiol Use in Pessary Care

    Not yet reported University of South Florida 11 participants Est. completion 2023-04-26 1 site Stand-alone
    Other conditions: Pelvic Organ Prolapse, Urinary Incontinence, Pessary Ulcer of Vagina, Vaginal Atrophy
    View official trial listing →
  • Active, not recruiting NCT NCT05463601

    Mecapegfilgrastim for the Prevention of Dalpiciclib -Induced Neutropenia in Advanced Breast Cancer

    Not yet reported Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 132 participants Est. completion 2026-12-31 1 site
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT05464654

    Vaginal Biorevitalization With Polydeoxyribonucleotides for the Improvement of the Genitourinary Syndrome of Menopause

    Not yet reported Hospital Regional 1o de Octubre 136 participants Est. completion 2022-12-31 1 site
    Other conditions: Genitourinary Syndrome of Menopause, Postmenopausal Disorder, Menopause, Vagina Atrophy
    View official trial listing →
  • Completed NCT NCT05469204

    Effect of Estrogen Treatment on Drug Metabolism and Transport

    Not yet reported University of Washington 22 participants Est. completion 2025-07-30 1 site
    Other conditions: Transgender Persons
    View official trial listing →
  • Completed NCT NCT05472779

    Periurethral vs Intravaginal Estrogen for Prevention of Recurrent Urinary Tract Infections

    Not yet reported Stephanie Wang Zuo 114 participants Est. completion 2025-06-25 4 sites Stand-alone
    Other conditions: Recurrent Urinary Tract Infection
    View official trial listing →
  • Completed NCT NCT05478746

    Effects of Flourish HEC on Localized Provoked Vulvodynia

    Not yet reported Vaginal Biome Science 7 participants Est. completion 2024-01-15 1 site
    Other conditions: Vulvodynia, Vestibulodynia, Vulvar Diseases, Vulvar Vestibulitis, Vulvar Pain
    View official trial listing →
  • Not yet recruiting NCT NCT05483634

    Compare Vaginal Estrogen and Platelet-rich Plasma Over Women With Genitourinary Syndrome of Menopause

    Mackay Memorial Hospital 40 participants Est. completion 2027-06-30 1 site
    Other conditions: Menopause, Platelet-rich Plasma, Estrogen Replacement Therapy, Vaginal Atrophy
    View official trial listing →
  • Terminated NCT NCT05489679

    A Study of AC682 In Chinese Patients With ER+/HER2- Locally Advanced or Metastatic Breast Cancer

    Not yet reported Accutar Biotechnology Inc 6 participants Est. completion 2023-09-28 3 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT05492487

    A Pilot Study on Fertility Conservative Treatment of Atypical Endometrial Hyperplasia in Singapore

    Not yet reported KK Women's and Children's Hospital 60 participants Est. completion 2023-03-31 3 sites Stand-alone
    Other conditions: Endometrial Hyperplasia, Fertility Issues, Disease Regression, Treatment Side Effects
    View official trial listing →
  • Completed NCT NCT05493202

    Superovulation And Urinary Concentration of Estrone

    Olive Fertility Centre 30 participants Est. completion 2022-07-30 1 site
    Other conditions: in Vitro Fertilization, Hormone Testing
    View official trial listing →
  • Completed NCT NCT05501769

    ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer

    Not yet reported Arvinas Estrogen Receptor, Inc. 32 participants Est. completion 2025-08-25 9 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT05501886

    Gedatolisib Plus Fulvestrant With or Without Palbociclib vs Standard-of-Care for the Treatment of Patients With Advanced or Metastatic HR+/HER2- Breast Cancer (VIKTORIA-1)

    Not yet reported Celcuity Inc 701 participants Est. completion 2026-12-31 235 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT05504213

    A Phase Ib Study of HS-10352 Plus Fulvestrant in Patients With Advanced Breast Cancer

    Not yet reported Jiangsu Hansoh Pharmaceutical Co., Ltd. 224 participants Est. completion 2025-12-31 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT05505162

    Assessing the Effect of Multiple Doses of Zibotentan on the Pharmacokinetics of Single Doses of Combined Oral Contraceptives in Healthy Female Participants of Non-childbearing Potential.

    Not yet reported AstraZeneca 24 participants Est. completion 2023-01-10 1 site
    Other conditions: Healthy Female Participants
    View official trial listing →
  • Active, not recruiting NCT NCT05508906

    Phase 1b Study of OP-1250 (Palazestrant) in Combination With Ribociclib, Alpelisib, Everolimus, or Atirmociclib in ER+, HER2- Breast Cancer

    Not yet reported Olema Pharmaceuticals, Inc. 190 participants Est. completion 2028-01-31 16 sites Stand-alone
    Other conditions: Metastatic Breast Cancer, ER-positive Breast Cancer, HER2-negative Breast Cancer, Breast Cancer, Locally Advanced Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT05509790

    A Study of LY3484356 in Chinese Participants With Advanced Breast Cancer

    Not yet reported Eli Lilly and Company 17 participants Est. completion 2026-12 4 sites
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Completed NCT NCT05531357

    Physiologic Mechanisms Underlying Ovarian Follicular Waves During the Menstrual Cycle

    University of Saskatchewan 50 participants Est. completion 2024-03-26 1 site
    Other conditions: Reproductive Issues
    View official trial listing →
  • Withdrawn NCT NCT05538689

    Surgical Myomectomy Followed by Oral Myfembree Versus Standard of Care Trial (SOUL)

    Not yet reported University of Chicago Est. completion 2024-10-24 6 sites
    Other conditions: Metrorrhagia, Pelvic Pain, Menorrhagia, Leiomyoma
    View official trial listing →
  • Completed NCT NCT05549505

    A Trial Using ARV-471 or Anastrozole in Post-Menopausal Women With Breast Cancer Prior to Surgery

    Not yet reported Arvinas Inc. 152 participants Est. completion 2024-07-25 49 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT05551897

    A Study to Assess the Pharmacokinetics of Camizestrant (AZD9833) When Administered Alone and in Combination With Itraconazole

    Not yet reported AstraZeneca 14 participants Est. completion 2022-12-28 1 site
    Other conditions: Healthy Subjects
    View official trial listing →
  • Terminated NCT NCT05554354

    Testing the Use of Fulvestrant and Binimetinib Targeted Treatment for NF1 Mutation in Hormone Receptor-Positive Metastatic Breast Cancer (A ComboMATCH Treatment Trial)

    Not yet reported National Cancer Institute (NCI) 1 participants Est. completion 2025-04-04 196 sites
    Other conditions: Anatomic Stage IV Breast Cancer AJCC v8, Metastatic HER2-Negative Breast Carcinoma, Metastatic Hormone Receptor-Positive Breast Carcinoma
    View official trial listing →
  • Status unknown NCT NCT05556317

    Effect of Resistive Exercise on Insomnia in Post Menopausal Women

    Not yet reported Cairo University 56 participants Est. completion 2022-11-15 1 site
    Other conditions: Sleep Disturbances and Insomnia
    View official trial listing →
  • Terminated NCT NCT05560685

    SMART-ER: Symptom Monitoring With Patient-reported Outcomes

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 10 participants Est. completion 2025-05-06 2 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT05562518

    GRACE-trial: a Randomized Active-controlled Trial for vulvovaGinal atRophy in breAst Cancer Patients on Endocrine Therapy.

    Not yet reported University Hospital, Ghent 31 participants Est. completion 2026-03-02 1 site
    Other conditions: Vulvovaginal Atrophy, Breast Cancer
    View official trial listing →
  • Completed NCT NCT05564702

    An Advanced Decision Support Tool, Opt-IVF for Clinical Ivf Practice

    Not yet reported Stochastic Research Technologies LLC 93 participants Est. completion 2023-03-15 1 site Stand-alone
    Other conditions: Infertility
    View official trial listing →
  • Status unknown NCT NCT05569577

    An Open Labeled RCT on the Effect of Additional hCG Injection for LPS on Pregnancy Outcomes in IHH Patients

    Not yet reported Fudan University 46 participants Est. completion 2025-12-31 2 sites Stand-alone
    Other conditions: Luteal Phase Deficiency, Luteal Phase Support, Idiopathic Hypogonadotropic Hypogonadism
    View official trial listing →
  • Status unknown NCT NCT05574881

    Dalpiciclib, Fulvestrant, Trastuzumab and Pertuzumab in HR Positive, HER2 Positive Metastatic Breast Cancer

    Not yet reported, Not yet reported Fudan University 72 participants Est. completion 2025-01-01 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT05576740

    Influence of Menstrual Cycle Stages on Female Athletes

    Universitat Jaume I 41 participants Est. completion 2022-07-15 1 site
    Other conditions: Menstrual Cycle, Sports
    View official trial listing →
  • Completed NCT NCT05579574

    A Study to Investigate the Interaction of BMS-986322 and a Combined Oral Hormonal Contraceptive (Ethinyl Estradiol [EE]/Norethindrone [NET]) in Healthy Female Participants

    Not yet reported Bristol-Myers Squibb 42 participants Est. completion 2023-06-01 2 sites
    Other conditions: Healthy Participants
    View official trial listing →
  • Completed NCT NCT05586711

    Local DHEA and Estradiol on Dyspareunia in Postmenopausal Women

    Not yet reported Angelica Lindén Hirschberg 170 participants Est. completion 2024-12-15 1 site
    Other conditions: Vulvovaginal Atrophy, Genitourinary Syndrome of Menopause
    View official trial listing →
  • Status unknown NCT NCT05587920

    Effect of Oestrogen on Musculoskeletal Outcomes

    Army Health Branch, British Army 100 participants Est. completion 2024-06-01 1 site
    Other conditions: Contraception, Estrogen Deficiency, Estrogen Excess
    View official trial listing →
  • Active, not recruiting NCT NCT05596409

    ELACESTRANT in Women and Men With CDK4/6 Inhibitor-Naive Estrogen Receptor Positive, HER-2 Negative Metastatic Breast Cancer Study

    Not yet reported Stemline Therapeutics, Inc. 61 participants Est. completion 2027-11 22 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT05607004

    (Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer

    Not yet reported Atossa Therapeutics, Inc. 87 participants Est. completion 2027-04 14 sites
    Other conditions: Breast Neoplasms, Invasive Breast Cancer, Estrogen-receptor-positive Breast Cancer, HER2-negative Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT05607303

    Effect of Hormones on Frequency of Headache and Brain Structure and Function in Puberty

    University of Colorado, Denver 138 participants Est. completion 2027-06-30 1 site
    Other conditions: Headache, Gender Identity
    View official trial listing →
  • Completed NCT NCT05613777

    A Study in Healthy Women to Test Whether BI 425809 Influences the Amount of a Contraceptive in the Blood

    Not yet reported Boehringer Ingelheim 19 participants Est. completion 2023-10-04 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT05617820

    Study Comparing Estradiol Vaginal Inserts 4mcg To IMVEXXY ® (Estradiol Vaginal Inerts 4 mcg) In The Treatment Of Dyspareunia in Women With Vulvur and Vaginal Atrophy

    Not yet reported Teva Pharmaceuticals USA 1050 participants Est. completion 2024-03-15 48 sites
    Other conditions: Dyspareunia
    View official trial listing →
  • Terminated NCT NCT05618613

    Study of Elacestrant in Combination With Onapristone in Patients With Advanced or Metastatic Breast Cancer

    Not yet reported, Not yet reported Context Therapeutics Inc. 4 participants Est. completion 2023-06-23 3 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT05620355

    Efficacy and Safety of BG2109 in Subjects With Heavy Menstrual Bleeding Associated With Uterine Fibroids.

    Not yet reported Bio Genuine (Shanghai) Biotech Co., Ltd. 312 participants Est. completion 2025-03 29 sites
    Other conditions: Uterine Fibroids, Heavy Menstrual Bleeding
    View official trial listing →
  • Completed NCT NCT05623397

    A Deep Learning Method to Evaluate QT on Ribociclib

    CMC Ambroise Paré 70 participants Est. completion 2025-10-08 4 sites
    Other conditions: Breast Cancer, Ribociclib
    View official trial listing →
  • Active, not recruiting NCT NCT05625087

    Detection of Tumor DNA in the Blood of Patients Receiving Standard Therapy for Hormone Receptor-positive (HR+) Non-HER2 Expressing (HER2-) Metastatic Breast Cancer as a Tool to Select Those Who May Benefit From the Next Course of Fulvestrant in Combination With Alpelisib or Ribociclib

    Not yet reported UNICANCER 162 participants Est. completion 2030-06 44 sites
    Other conditions: Breast Cancer Stage IV
    View official trial listing →
  • Completed NCT NCT05631795

    Study to Assess the Safety of Alpelisib Plus Fulvestrant, in Men and Post-menopausal Women With HR-positive, HER2-negative, Advanced Breast Cancer (aBC) With PIK3CA Mutation, Whose Disease Progressed on or After Endocrine Treatment

    Not yet reported Novartis Pharmaceuticals 40 participants Est. completion 2025-06-12 12 sites
    Other conditions: Advanced Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT05640778

    Neoadjuvant Dalpiciclib Plus Aromatase Inhibitors in Luminal B/HER2-negative Breast Cancer (DANCER)

    Not yet reported Second Affiliated Hospital, Zhejiang University, School of Medicine 30 participants Est. completion 2025-10-31 1 site
    Other conditions: Luminal B/HER2-negative Breast Cancer
    View official trial listing →
  • Completed NCT NCT05645393

    Effect of Estradiol Topical Products

    Not yet reported University of Maryland, Baltimore 4 participants Est. completion 2025-03-30 1 site
    Other conditions: Menopause
    View official trial listing →
  • Completed NCT NCT05645406

    Estrogen Hormone Products

    Not yet reported University of Maryland, Baltimore 8 participants Est. completion 2025-06-15 1 site
    Other conditions: Menopause
    View official trial listing →
  • Status unknown NCT NCT05651087

    Evaluate Efficacy and Safety of LACUDY for Improving Vaginal Environment in Breast Cancer Patient

    Not yet reported Gun Oh Chong 60 participants Est. completion 2023-02-28
    Other conditions: Hormone Receptor-positive Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT05654532

    Study of AC699 in Patients With Estrogen Receptor Positive/Human Epidermal Growth Factor Receptor 2 Negative (ER+/HER2-) Locally Advanced or Metastatic Breast Cancer

    Not yet reported Accutar Biotechnology Inc 100 participants Est. completion 2026-05-31 9 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT05654623

    A Study to Learn About a New Medicine Called Vepdegestrant (ARV-471, PF-07850327) in People Who Have Advanced Metastatic Breast Cancer

    Not yet reported Pfizer 624 participants Est. completion 2028-05-15 312 sites
    Other conditions: Advanced Breast Cancer
    View official trial listing →
  • Completed NCT NCT05657171

    "Effect of CPA/EE Drug on Periodontal Tissue and hsCRP Levels in PCOS Patients With Gingivitis

    Postgraduate Institute of Dental Sciences Rohtak 47 participants Est. completion 2023-12-30 1 site
    Other conditions: Periodontal Diseases
    View official trial listing →
  • Terminated NCT NCT05658874

    A Multidisciplinary, Multimodal Bundled Care Approach to Chronic Pelvic Pain

    Not yet reported Jocelyn Fitzgerald 26 participants Est. completion 2025-12-30 1 site Stand-alone
    Other conditions: Interstitial Cystitis, Levator Spasm, Bladder Pain Syndrome
    View official trial listing →
  • Completed NCT NCT05659563

    Preoperative Window Opportunity Study With Giredestrant or Tamoxifen in Premenopausal Women With ER+/HER2[-] & Ki67≥10%

    Not yet reported MedSIR 92 participants Est. completion 2025-01-30 18 sites
    Other conditions: Breast Cancer, Breast Cancer, Early-Onset
    View official trial listing →
  • Status unknown NCT NCT05660356

    Growth Hormone Deficiency in Mild Traumatic Brain Injury

    Not yet reported University of Calgary 20 participants Est. completion 2025-02 Stand-alone
    Other conditions: Growth Hormone Treatment, Growth Hormone Deficiency, Concussion, Mild, Concussion Post Syndrome
    View official trial listing →
  • Status unknown NCT NCT05663892

    Drug-Drug Interaction Study in Trans Women Living With HIV

    Not yet reported Maple Leaf Research 45 participants Est. completion 2025-01 1 site Stand-alone
    Other conditions: Hiv, Transgenderism
    View official trial listing →
  • Status unknown NCT NCT05673694

    To Evaluate a Phase Ia/Ib Clinical Study of EG017 in Patients With Advanced Breast Cancer.

    Not yet reported Changchun GeneScience Pharmaceutical Co., Ltd. 70 participants Est. completion 2026-01-02 5 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT05678192

    Effect of Menopausal Hormone Therapy on Immune System Parameters

    Not yet reported Federal State Budget Institution Research Center for Obstetrics, Gynecology and Perinatology Ministry of Healthcare 40 participants Est. completion 2023-03-01 1 site
    Other conditions: Last Period Not Earlier Than 6 Months Ago
    View official trial listing →
  • Status unknown NCT NCT05683119

    The Effect of Menstrual Cycle and Oral Contraceptive Pill Phase on Aspects of Exercise Physiology

    Not yet reported Western University, Canada 20 participants Est. completion 2024-12 1 site
    Other conditions: Menstrual Cycle, Oral Contraceptives
    View official trial listing →
  • Status unknown NCT NCT05692297

    Denosumab Treatment in CKD Patients at High Risk of Fracture

    Not yet reported Capital Medical University 102 participants Est. completion 2025-12-31 1 site
    Chronic kidney disease Other conditions: Fracture, Bone Density, Low, End Stage Renal Disease
    View official trial listing →
  • Status unknown NCT NCT05699356

    Surgical and Non Surgical Treatment Option in Poly Cystic Ovary Cases

    Sohag University 150 participants Est. completion 2023-03-28 1 site
    Other conditions: Poly Cystic Ovary Treatment for Infertility
    View official trial listing →
  • Completed NCT NCT05700006

    Pilot Observational Study Examining the Effect of Endocrine Therapy on Aging

    University of Michigan 94 participants Est. completion 2026-02-26 1 site
    Other conditions: Breast Neoplasm Female, Arthralgia, Aging
    View official trial listing →
  • Completed NCT NCT05706753

    A Study of Milvexian in Healthy Adult Females

    Not yet reported Janssen Pharmaceutica N.V., Belgium 20 participants Est. completion 2023-07-20 1 site
    Other conditions: Healthy Female
    View official trial listing →
  • Terminated NCT NCT05716139

    Natural Cycle vs Programmed Cycle Frozen Embryo Transfer

    Not yet reported Indira IVF Hospital Pvt Ltd 172 participants Est. completion 2024-03-26 1 site
    Other conditions: Infertility, Frozen Embryo Transfer, Preeclampsia and Eclampsia
    View official trial listing →
  • Status unknown NCT NCT05716152

    Hormonal Associations in Male Patients With Psoriasis Vulgaris

    Sohag University 102 participants Est. completion 2024-08-01
    Other conditions: Psoriasis Vulgaris
    View official trial listing →
  • Active, not recruiting NCT NCT05723601

    Preference of Women With Recurrent Urinary Tract Infection for Vaginal Estradiol Tablet vs Cream

    Not yet reported Wake Forest University Health Sciences 21 participants Est. completion 2027-01 1 site
    Other conditions: Recurrent Urinary Tract Infection
    View official trial listing →
  • Status unknown NCT NCT05724407

    Molecular Signature for Breast Cancer

    Assistance Publique - Hôpitaux de Paris 220 participants Est. completion 2023-12
    Other conditions: Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT05730647

    Prospective Observational Study of Adjuvant Hormone Treatment in Estrogen-receptor Positive Premenopausal Early Breast Cancer Patients

    Consorzio Oncotech 600 participants Est. completion 2032-07-31 40 sites
    Other conditions: Early Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT05734950

    Biological Characteristics of Older Women (> 70 Years) With ER Positive, HER2 Negative Early Breast Cancer

    Royal Marsden NHS Foundation Trust 100 participants Est. completion 2023-08-31 1 site
    Other conditions: Breast Cancer Female
    View official trial listing →
  • Status unknown NCT NCT05737329

    Efficacy, Safety, and Tolerability of Higher Doses Estrogen Therapy in Women With Premature Ovarian Insufficiency

    Not yet reported, Not yet reported Federal State Budget Institution Research Center for Obstetrics, Gynecology and Perinatology Ministry of Healthcare 80 participants Est. completion 2023-04 1 site
    Other conditions: Primary Ovarian Insufficiency
    View official trial listing →
  • Active, not recruiting NCT NCT05739136

    MYFEMBREE®: A Retrospective Cohort Study Using an Administrative Healthcare Database to Assess Pregnancy Outcomes in Women Treated With Relugolix Combination Therapy

    Sumitomo Pharma Switzerland GmbH 530 participants Est. completion 2027-05 1 site
    Other conditions: Pregnancy Related, Pregnancy Complications, Pregnancy, High Risk
    View official trial listing →
  • Active, not recruiting NCT NCT05741060

    Effect of Equol Supplementation on Arterial Stiffness and Cognition in Healthy Volunteers

    Not yet reported Akira Sekikawa 369 participants Est. completion 2027-01-30 3 sites
    Other conditions: Arterial Stiffness, White Matter Lesions, Cognitive Decline
    View official trial listing →
  • Completed NCT NCT05753098

    Effect of Sildenafil Citrate Compared to Estrogen as Adjuvant Therapy for Unexplained Infertility

    Not yet reported Beni-Suef University 148 participants Est. completion 2023-01-31 1 site Stand-alone
    Other conditions: Subfertility, Female
    View official trial listing →
  • Completed NCT NCT05759949

    First-in-Human Study of RLY-5836 in Advanced Breast Cancer and Other Solid Tumors

    Not yet reported Relay Therapeutics, Inc. 41 participants Est. completion 2025-04-11 7 sites
    Other conditions: PIK3CA Mutation, Solid Tumor, Adult, HER2-negative Breast Cancer, Breast Cancer, Metastatic Breast Cancer, Advanced Breast Cancer, Unresectable Solid Tumor, Hormone Receptor Positive Tumor
    View official trial listing →
  • Completed NCT NCT05762042

    Comparison of the Efficacy and Tolerability of Femal Versus Placebo

    Not yet reported Azienda Ospedaliera Ordine Mauriziano di Torino 34 participants Est. completion 2022-04-01 2 sites
    Other conditions: Breast Cancer, Menopause
    View official trial listing →
  • Status unknown NCT NCT05769712

    A Multicenter Cross-sectional Study of Shear Wave Ultrasound Imaging in Evaluating Supraspinatus Tendon Elasticity

    Guangdong Second Provincial General Hospital 361 participants Est. completion 2023-11-05 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT05774405

    Short-term Effects of Transdermal Estradiol on Female COVID-19 Patients

    Not yet reported Istanbul University - Cerrahpasa 9169 participants Est. completion 2021-07-31 1 site
    Other conditions: COVID-19, Hormone Replacement Therapy
    View official trial listing →
  • Status unknown NCT NCT05780489

    Evaluation of Salivary ELISA for Hormone Monitoring in Donors

    Not yet reported Instituto Valenciano de Infertilidad, IVI VALENCIA 200 participants Est. completion 2024-12 2 sites
    Other conditions: Infertility, Female, Reproductive Sterility
    View official trial listing →
  • Completed NCT NCT05781685

    The Influence of Testosterone on Experimental Pain Perception

    Not yet reported University of New Mexico 20 participants Est. completion 2018-07-17 1 site
    Other conditions: Acute Pain
    View official trial listing →
  • Completed NCT NCT05782725

    Subclinical Hypothyroidism and Normogonadotropic Anovulation

    Jagiellonian University 300 participants Est. completion 2024-01-10 1 site
    Other conditions: Polycystic Ovary Syndrome, Hypothalamic-Pituitary-Ovarian Axis Dysfunction (Disorder)
    View official trial listing →
  • Completed NCT NCT05783479

    Pharmacological Preparation of the Cervix for Hysteroscopy

    Not yet reported Jagiellonian University 96 participants Est. completion 2023-01-31 1 site
    Other conditions: Uterine Polyp, Uterine Bleeding, Endometrium; Senility
    View official trial listing →
  • Status unknown NCT NCT05788952

    The Role of Intestinal and Vaginal Microbiota, Estrogenic Activity, Metabolic Profile & Nutritional Status in Endometriosis

    Universidade Nova de Lisboa 60 participants Est. completion 2024-12-01 1 site
    Other conditions: Endometriosis
    View official trial listing →
  • Status unknown NCT NCT05792410

    A Phase Ⅰb/Ⅱ Clinical Study of SHR-A1811 Combined With Other Therapies in Patients With HER2 Low Advanced or Metastatic Breast Cancer.

    Not yet reported, Not yet reported Jiangsu HengRui Medicine Co., Ltd. 300 participants Est. completion 2025-02-27
    Other conditions: HER2 Low Advanced or Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT05797987

    Negative ER Expression Assessed by 18F-FES PET/CT in the MBC With ER-positive Primary Tumor

    Fudan University 52 participants Est. completion 2023-08-01 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT05800197

    Neoadjuvant Endocrine Therapy in Breast Cancer. Real Clinical Practice in Russia

    Blokhin's Russian Cancer Research Center 300 participants Est. completion 2025-01-15 1 site
    Other conditions: Breast Cancer, Neoadjuvant Endocrine Therapy
    View official trial listing →
  • Status unknown NCT NCT05801705

    Comparative Evaluation of Efficacy and Safety of Toremifene, Tamoxifen, and Aromatase Inhibitor Plus Ovarian Function Suppression in Hormone Receptor-Positive Early Breast Cancer Among Non-Low-Risk Premenopausal Women: A Real-World Study

    Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 700 participants Est. completion 2023-12-30 1 site
    Other conditions: Hormone-receptor-positive Breast Cancer, Premenopausal Breast Cancer, Breast Cancer Patients at Intermediate to High Risk, Ovarian Function Suppression Combined With Aromatase Inhibitor or Tamoxifen or Torimefen
    View official trial listing →
  • Status unknown NCT NCT05802277

    Characterization of the Mechanical Properties of the Hamstring Muscle Group in Female.

    Not yet reported EZUS-LYON 1 130 participants Est. completion 2024-04-01 1 site
    Other conditions: Menstrual Cycle, Oral Contraceptive Use
    View official trial listing →
  • Terminated NCT NCT05802303

    Estrogen (Gel)Transdermal vs Oral Estrogen for Endometrial Preparation

    Not yet reported Indira IVF Hospital Pvt Ltd 172 participants Est. completion 2024-03-26 1 site
    Other conditions: Frozen Embryo Transfer, Infertility, Female
    View official trial listing →
  • Status unknown NCT NCT05806671

    Dalpiciclib Plus Fulvestrant With Pyrotinib in Hormone Receptor-positive, HER2-low Advanced Breast Cancer That Progressed on Previous CDK4/6i Plus AI Therapy

    Not yet reported Tianjin Medical University Cancer Institute and Hospital 30 participants Est. completion 2025-12 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT05826964

    Levels of Circulating Tumor DNA as a Predictive Marker for Early Switch in Treatment for Patients With Metastatic (Stage IV) Breast Cancer

    Not yet reported University of Miami 24 participants Est. completion 2029-07-31 1 site Stand-alone
    Other conditions: Breast Cancer, ER-positive Breast Cancer, HER2-negative Breast Cancer, Metastatic Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT05835089

    Evaluation of Some Puberty-related Hormones Among Children and Adolescents With Chronic Kidney Diseases

    Sohag University 50 participants Est. completion 2024-05 1 site
    Chronic kidney disease
    View official trial listing →
  • Status unknown NCT NCT05863975

    Treatment of HPV Infection in Perimenopausal and Postmenopausal Women

    Not yet reported Qianfoshan Hospital 150 participants Est. completion 2025-12-31
    Other conditions: HPV Infection
    View official trial listing →
  • Completed NCT NCT05865262

    Protocol TRANS and QT Repolarization

    University Hospital, Bordeaux 120 participants Est. completion 2023-01-01 1 site
    Other conditions: Transgender Individuals, QTc Interval
    View official trial listing →
  • Active, not recruiting NCT NCT05870579

    [177Lu]Lu-NeoB in Combination With Ribociclib and Fulvestrant in Participants With ER+, HER2- and GRPR+ Advanced Breast Cancer

    Not yet reported Novartis Pharmaceuticals 28 participants Est. completion 2032-05-27 13 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT05872425

    Efficacy and Safety of Dingkundan Combined With Combination Oral Contraceptives in the Treatment of PCOS

    Not yet reported Guangdong Women and Children Hospital 120 participants Est. completion 2024-04-01 1 site
    Other conditions: PCOS
    View official trial listing →
  • Completed NCT NCT05877235

    Serum Concentration of Endogenous Estrogens and Sirtuin-1 After Administration of Atorvastatin and Quercetin:

    Not yet reported InCor Heart Institute 60 participants Est. completion 2024-06-23 1 site
    Cardiovascular disease Other conditions: Menopause
    View official trial listing →
  • Status unknown NCT NCT05880394

    Study of Dotatate Imaging in Breast Cancer

    Not yet reported Hoag Memorial Hospital Presbyterian 30 participants Est. completion 2024-07-31 1 site
    Other conditions: Breast Cancer Stage IV
    View official trial listing →
  • Status unknown NCT NCT05890287

    A Study of Chidamide Plus Endocrine in Maintenance Treatment of HR+/HER2- Breast Cancer After First-line Chemotherapy

    Not yet reported Tianjin Medical University Cancer Institute and Hospital 60 participants Est. completion 2026-10-01 1 site
    Other conditions: HR Positive HER2 Negative Advanced Breast Cancer
    View official trial listing →
  • Completed NCT NCT05891262

    A Study to Evaluate the Drug-drug Interaction of BMS-986196 With Oral Contraceptives in Healthy Female Participants

    Not yet reported Bristol-Myers Squibb 15 participants Est. completion 2023-08-25 1 site
    Other conditions: Healthy Female Volunteers
    View official trial listing →
  • Completed NCT NCT05894954

    Precision Medicine Approach for Early Dementia & Mild Cognitive Impairment

    Not yet reported Alzheimer's Prevention and Reversal Project, Inc. 73 participants Est. completion 2026-02-09 6 sites
    Other conditions: Mild Cognitive Impairment, Dementia, Mild
    View official trial listing →
  • Completed NCT NCT05896384

    A Study in Women With Overweight or Obesity to Test Whether Different Doses of BI 456906 Influence the Amount of a Contraceptive in the Blood

    Not yet reported Boehringer Ingelheim 32 participants Est. completion 2025-03-26 1 site
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT05903716

    The Effects of Systemic Isotretinoin Treatment on Adrenal Steroid and Sex Hormones Level in Severe Acne Vulgaris

    Marmara University 40 participants Est. completion 2023-06-30 1 site
    Other conditions: Acne Vulgaris
    View official trial listing →
  • Completed NCT NCT05903820

    Rhythmic Estradiol and Bone Health

    Not yet reported Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 48 participants Est. completion 2024-10-28 1 site
    Other conditions: Osteoporosis Risk, Menopause
    View official trial listing →
  • Withdrawn NCT NCT05905341

    Study of PF-07224826, as a Single Agent or in Combination With Endocrine Therapy in Participants With Breast Cancer and Other Advanced Solid Tumors.

    Not yet reported Pfizer Est. completion 2028-04-13
    Obstructive sleep apnea Other conditions: Breast Cancer, Ovarian Cancer, Non-small Cell Lung Cancer (NSCLC), Endometrial, Solid Tumors
    View official trial listing →
  • Active, not recruiting NCT NCT05909397

    Vepdegestrant (ARV-471/PF-07850327) + Palbociclib vs Letrozole + Palbociclib in ER(+)/HER2(-) Advanced Breast Cancer

    Not yet reported Pfizer 59 participants Est. completion 2026-12-30 29 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT05914792

    Longitudinal ctDNA Surveillance for Older Women With ER+ Breast Cancer Who Omit Surgery

    University of Pittsburgh 49 participants Est. completion 2026-07-01 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT05928650

    Comparison of Menstrual Function Among Sprinters, Long Marathon Runners, and Non-Athletic Females

    Cairo University 42 participants Est. completion 2023-07-31 1 site
    Other conditions: Menstruation Disturbances
    View official trial listing →
  • Terminated NCT NCT05932667

    Milademetan and Fulvestrant in GATA3-mutant, ER+HER- Advanced or Metastatic Breast Cancer

    Not yet reported Institut Curie 1 participants Est. completion 2023-11-30 6 sites
    Other conditions: Advanced or Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT05932771

    Resistance Exercise and Hydrolyzed Collagen Supplementation

    Not yet reported Rob Erskine 21 participants Est. completion 2023-04-30 1 site Stand-alone
    Other conditions: Diet, Food, and Nutrition
    View official trial listing →
  • Terminated NCT NCT05934942

    A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood

    Not yet reported Boehringer Ingelheim 29 participants Est. completion 2024-02-08 1 site
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT05951413

    The Effect of Sildenafil Citrate on Frozen Embryo Transfer Cycles

    Not yet reported, Not yet reported Beni-Suef University 110 participants Est. completion 2023-09-30 1 site
    Other conditions: IVF
    View official trial listing →
  • Active, not recruiting NCT NCT05952557

    An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)

    Not yet reported AstraZeneca 5511 participants Est. completion 2037-05-06 661 sites
    Other conditions: Breast Cancer, Early Breast Cancer
    View official trial listing →
  • Completed NCT NCT05963984

    A Study of Samuraciclib in Combination With Fulvestrant in Metastatic or Locally Advanced Breast Cancer in Adult Participants

    Not yet reported Carrick Therapeutics Limited 60 participants Est. completion 2025-08-28 32 sites
    Other conditions: Metastatic Breast Cancer, Locally Advanced Breast Cancer, Breast Cancer
    View official trial listing →
  • Suspended NCT NCT05980091

    Optimal Timing of Euploid Day 6 Blastocyst Transfer in Frozen HRT Cycles, Day 6 or Day 7 of Progesterone Administration.

    Not yet reported ART Fertility Clinics LLC 316 participants Est. completion 2026-12-30 2 sites
    Other conditions: Infertility, Fertility Issues, Infertility, Female
    View official trial listing →
  • Status unknown NCT NCT05982470

    Effect of Menopause Hormone Therapy In Postmenopausal Women With CSVD And MCI

    Not yet reported Beijing Tiantan Hospital 328 participants Est. completion 2025-10-01 1 site
    Other conditions: Cerebral Small Vessel Diseases, Postmenopausal Symptoms, Mild Cognitive Impairment, White Matter Hyperintensity
    View official trial listing →
  • Completed NCT NCT05985590

    A Study to Investigate the Effects of BMS-986278 on Drospirenone and Ethinyl Estradiol Drug Levels in Healthy Female Participants

    Not yet reported Bristol-Myers Squibb 37 participants Est. completion 2023-12-11 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Not yet recruiting NCT NCT05986071

    I/II Phase Study Evaluating M1774 in Combination With Fulvestrant in HR+ and HER2- Advanced Breast Cancers

    Not yet reported, Not yet reported Institut Paoli-Calmettes 57 participants Est. completion 2027-10-15 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT05994599

    Comparative Bioavailability Study of Ethinyl Estradiol/Etonogestrel Vaginal Ring

    Not yet reported Evestra Inc. 36 participants Est. completion 2023-12-11 1 site
    Other conditions: Healthy Women, Female, Contraception
    View official trial listing →
  • Active, not recruiting NCT NCT06001762

    TRADE: Dose Escalation Tolerability of Abemaciclib in HR+ HER2- Early Stage Breast Cancer

    Not yet reported Dana-Farber Cancer Institute 90 participants Est. completion 2027-01-01 12 sites Stand-alone
    Other conditions: Breast Cancer, Early-stage Breast Cancer, High Risk Breast Carcinoma
    View official trial listing →
  • Terminated NCT NCT06005610

    Estradiol Therapy In Transgender Women to Research Interactions With HIV Therapy

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 93 participants Est. completion 2025-08-21 18 sites
    Other conditions: HIV I Infection
    View official trial listing →
  • Status unknown NCT NCT06014398

    Improving Survivorship and Health-related Quality of Life in Patients With Primary Brain Tumours

    Not yet reported Royal College of Surgeons, Ireland 50 participants Est. completion 2025-09-01 2 sites
    Other conditions: Hypopituitarism, Radiotherapy-Induced Hypopituitarism, Brain Tumor
    View official trial listing →
  • Active, not recruiting NCT NCT06016738

    OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer

    Not yet reported Olema Pharmaceuticals, Inc. 510 participants Est. completion 2028-02-29 233 sites
    Other conditions: Breast Cancer, Advanced Breast Cancer, Metastatic Breast Cancer, ER Positive Breast Cancer, HER2 Negative Breast Carcinoma
    View official trial listing →
  • Status unknown NCT NCT06026553

    Assessing Ketorolac (Toradol) at Oocyte Retrieval

    Not yet reported Shady Grove Fertility Reproductive Science Center 400 participants Est. completion 2025-01 2 sites
    Other conditions: Infertility, Infertility, Female, Oocyte Retrieval, Postoperative Pain, Embryo Transfer
    View official trial listing →
  • Status unknown NCT NCT06031493

    A Multimodal Intervention Program to Improve Sexual Health and Self-perceived Quality of Life in Patients Treated for Cervical Cancer (PROVIDENCE)

    Not yet reported Hospital Clinic of Barcelona 122 participants Est. completion 2025-04 2 sites
    Other conditions: Cervical Cancer, Sexual Dysfunction, Quality of Life
    View official trial listing →
  • Completed NCT NCT06039826

    A Study of LY3437943 in Postmenopausal Female Participants Who Are Overweight or Obese

    Not yet reported Eli Lilly and Company 46 participants Est. completion 2024-07-11 2 sites
    Other conditions: Overweight
    View official trial listing →
  • Active, not recruiting NCT NCT06043310

    Estrogen and Microvascular Function

    Medical College of Wisconsin 45 participants Est. completion 2031-12 1 site
    Cardiovascular disease Other conditions: Estrogen, Microvasculature, Oral Contraceptive Use
    View official trial listing →
  • Completed NCT NCT06047184

    Phase I Study of BEBT-209 in Women With Advanced Breast Cancer

    Not yet reported BeBetter Med Inc 100 participants Est. completion 2024-01-30 2 sites
    Other conditions: Advanced Breast Cancer
    View official trial listing →
  • Completed NCT NCT06053827

    Natural Frozen Embryo Transfer (FET) vs Substituted Frozen Embryo Transfer (FET)

    Clinique Ovo 1207 participants Est. completion 2024-07-18 1 site
    Other conditions: Fertility Disorders
    View official trial listing →
  • Completed NCT NCT06057896

    Effects of Combined Natural Molecules on Metabolic Syndrome in Menopausal Women

    Lo.Li.Pharma s.r.l 200 participants Est. completion 2023-08-15 1 site
    Metabolic syndrome Other conditions: Menopause, Climacteric Syndrome
    View official trial listing →
  • Withdrawn NCT NCT06058728

    A Study to Evaluate Changes in Hair in Adult Participants Taking Oral Oriahnn Capsules With Heavy Menstrual Bleeding (HMB) Associated With Uterine Fibroids (UF)

    AbbVie Est. completion 2026-08 1 site
    Other conditions: Uterine Fibroids (UF)
    View official trial listing →
  • Active, not recruiting NCT NCT06065748

    A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer)

    Not yet reported Hoffmann-La Roche 1050 participants Est. completion 2029-02-12 311 sites
    Other conditions: Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT06067217

    Comparative Study of Tranexamic Acid, Estrogen for Treatment AUB in DMPA Users

    Not yet reported Department of Medical Services Ministry of Public Health of Thailand 52 participants Est. completion 2024-08-30 2 sites
    Other conditions: Abnormal Uterine Bleeding, Tranexamic Acid, Estrogen, Depot Medroxyprogesterone Acetate
    View official trial listing →
  • Status unknown NCT NCT06067256

    A Multicentre, Prospective, Open-label, Non-comparative Study

    Not yet reported Italfarmaco 228 participants Est. completion 2024-06 1 site
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT06071442

    Potential Drug Interaction Study Between Vemircopan and Rosuvastatin, Metformin, Levonorgestrel/Ethinyl Estradiol-containing Oral Contraceptives, and Carbamazepine

    Not yet reported Alexion Pharmaceuticals, Inc. 60 participants Est. completion 2024-04-12 1 site
    Other conditions: Healthy Participants
    View official trial listing →
  • Terminated NCT NCT06074055

    PRogrammed Versus Modified Natural Cycle After Euploid Failed Embryo Transfer

    Not yet reported Reproductive Medicine Associates of New Jersey 9 participants Est. completion 2024-10-21 2 sites
    Other conditions: Infertility, Female
    View official trial listing →
  • Completed NCT NCT06074757

    Open Label, Sequential Dosing , Single Ascending Dose and Multiple Dose Safety Tolerability and Pharmacokinetic Study

    Not yet reported Kashiv BioSciences, LLC 48 participants Est. completion 2023-10-01 1 site
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT06083935

    Evaluation of the Effects of Diosmin/Hespiridin Combination on the Clinical Outcomes in Patients With Polycystic Ovary Syndrome

    Not yet reported Ain Shams University 120 participants Est. completion 2024-12-01
    Other conditions: Poly Cystic Ovary Syndrome
    View official trial listing →
  • Completed NCT NCT06086340

    Study to Compare Overall Survival in Medicare Patients With Metastatic Breast Cancer Treated With a Medicine Called Palbociclib in Combination With Aromatase Inhibitor and Aromatase Inhibitor by Itself.

    Pfizer 779 participants Est. completion 2024-01-24 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT06105632

    A Study to Learn About the Study Medicine Called PF-07220060 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment

    Not yet reported Pfizer 333 participants Est. completion 2028-01-21 48 sites
    Other conditions: Advanced or Metastatic Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT06109623

    Correlation Between Changes in Sex Hormone Levels and Stress Urinary Incontinence in Women

    RenJi Hospital 1226 participants Est. completion 2023-12-01
    Other conditions: Urinary Incontinence,Stress
    View official trial listing →
  • Active, not recruiting NCT NCT06110793

    A Study of Lenvatinib, Pembrolizumab, and Fulvestrant in People With Breast Cancer

    Not yet reported, Not yet reported Memorial Sloan Kettering Cancer Center 56 participants Est. completion 2027-11 7 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT06115577

    Endometrial Tissues and Mononuclear Cells Receptivity in Pathogenesis of Endometrial Proliferative Processes

    Pirogov Russian National Research Medical University 92 participants Est. completion 2022-08-01
    Other conditions: Endometrial Hyperplasia Without Atypia, Endometrial Hyperplasia With Atypia, Endometrial Cancer, Peripheral Blood Mononuclear Cells, Postmenopause, Estrogen Receptor, Progesterone Receptor
    View official trial listing →
  • Completed NCT NCT06116201

    Influences of Long Term Hormone Therapy on Physical Fitness and Vascular Function in Transgender Women

    Not yet reported Chulalongkorn University 60 participants Est. completion 2021-07-31 1 site
    Other conditions: Transgender Women
    View official trial listing →
  • Completed NCT NCT06132620

    Clinical Efficacy of Qingxin Zishen Decoction in Treating Menopausal Syndrome and Neuroendocrine Mechanism of Regulating KNDy Neurons

    Not yet reported Yun Chen 60 participants Est. completion 2018-06-30 1 site
    Other conditions: Menopause
    View official trial listing →
  • Completed NCT NCT06136208

    Pharmacokinetic Aspects of 25-mg Estradiol Pellet in Climacteric Women

    Not yet reported Science Valley Research Institute 20 participants Est. completion 2025-07-30 1 site
    Other conditions: Climacteric Syndrome, Menopause, Hypoestrogenism
    View official trial listing →
  • Completed NCT NCT06148129

    Immunohistochemistry Role in Better Prognosis of Endometrial Carcinoma Patients

    Not yet reported Zagazig University 96 participants Est. completion 2022-03-01 1 site
    Other conditions: Endometrial Cancer
    View official trial listing →
  • Status unknown NCT NCT06172322

    A Phase Ib/Ⅱ Study of NTQ1062 in Combination With Fulvestrant in Patients With Advanced HR Positive /HER-2 Negative Breast Cancer

    Not yet reported Nanjing Chia-tai Tianqing Pharmaceutical 42 participants Est. completion 2025-07 1 site
    Other conditions: HR Positive/HER-2 Negative Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT06181305

    Endometrial Preparation in Frozen Embryo Transfer Cycles

    Not yet reported Rahem Fertility Center 210 participants Est. completion 2024-12-25 1 site Stand-alone
    Other conditions: IVF
    View official trial listing →
  • Completed NCT NCT06188026

    A Research Study Looking at How the Compound NNC0194-0499 Works With Birth Control Pills in Women Not Able to Bear Children.

    Not yet reported Novo Nordisk A/S 34 participants Est. completion 2024-12-30 1 site
    Other conditions: Healthy Volunteers (Non-alcoholic Steatohepatitis)
    View official trial listing →
  • Terminated NCT NCT06191289

    Neurocognitive Mechanisms of Perimenstrual Estrogen Effects on Suicidality

    Not yet reported University of Illinois at Chicago 11 participants Est. completion 2024-12-01 1 site
    Other conditions: Suicide
    View official trial listing →
  • Status unknown NCT NCT06195202

    Serum Estradiol (E2) Levels in Breast Cancer Patients During Endocrine Therapy by High Performance Liquid Chromatography-tandem Mass Spectrometry (LC-MS /MS)

    Sun Yat-sen University 2000 participants Est. completion 2026-08-31 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Withdrawn NCT NCT06195280

    SUPerficial ENDometriosis In Magnetic Resonance Imaging

    Not yet reported GCS Ramsay Santé pour l'Enseignement et la Recherche Est. completion 2026-03 1 site Stand-alone
    Other conditions: Endometriosis
    View official trial listing →
  • Status unknown NCT NCT06204016

    Estradiol and Stress Reactivity in Women

    International Research Training Group 2804 74 participants Est. completion 2025-12 1 site
    Other conditions: Stress vs. Control, Estradiol vs. Placebo
    View official trial listing →
  • Status unknown NCT NCT06214442

    Effects of the Menstrual Cycle on Triceps Surae Properties in Women

    Marco Aurélio Vaz, PhD 40 participants Est. completion 2024-12-31 1 site
    Other conditions: Menstrual Cycle, Achilles Tendon
    View official trial listing →
  • Status unknown NCT NCT06220266

    Effects of Phytoestrogen From Pueraria Mirifica in Improvement of Serum Lipid Parameters in Postmenopausal Women

    Not yet reported, Not yet reported Dhurakij Pundit University 10 participants Est. completion 2024-11 1 site
    Other conditions: Dyslipidemias, Hypertriglyceridemia, Hypercholesterolemia, Hyper-LDL-cholesterolemia, Hypo HDL Cholesterolaemia, Postmenopausal Symptoms
    View official trial listing →
  • Status unknown NCT NCT06233058

    Drospirenone (3 mg) + Ethinyl Estradiol (0.03 mg) Tablets Relative to Yasmin®

    Not yet reported Bio-innova Co., Ltd 32 participants Est. completion 2024-05-27
    Other conditions: Healthy Subjects
    View official trial listing →
  • Status unknown NCT NCT06233071

    Drospirenone (3 mg) + Ethinyl Estradiol (0.02 mg) Tablets Relative to Yaz®

    Not yet reported Bio-innova Co., Ltd 32 participants Est. completion 2024-05-02 1 site
    Other conditions: Healthy Subjects
    View official trial listing →
  • Completed NCT NCT06236659

    Acute Resistance Exercise and Hydrolyzed Collagen Supplementation

    Not yet reported Rob Erskine 10 participants Est. completion 2023-09-30 1 site
    Other conditions: Diet, Food, Nutrition
    View official trial listing →
  • Active, not recruiting NCT NCT06239467

    First-in-Human Study of OKI-219 in Advanced Solid Tumors and Advanced Breast Cancer

    Not yet reported OnKure, Inc. 200 participants Est. completion 2027-08-01 33 sites
    Other conditions: Advanced Cancer, Breast Cancer, Advanced Solid Tumors, PI3K Gene Mutation
    View official trial listing →
  • Status unknown NCT NCT06243432

    Estrogen Receptors and HER2 Levels' Expression in Luminal Metastatic Breast Cancer

    Fondazione Policlinico Universitario Agostino Gemelli IRCCS 600 participants Est. completion 2025-03-01 1 site
    Other conditions: Advanced Breast Carcinoma
    View official trial listing →
  • Active, not recruiting NCT NCT06247995

    A Phase I/II, Dose Finding and Optimization Study of [177Lu]Lu-NeoB in Combination With Capecitabine in Patients With GRPR+, ER+, HER2- Metastatic Breast Cancer After Progression on Previous Endocrine Therapy in Combination With a CDK4/6 Inhibitor.

    Not yet reported, Not yet reported Novartis Pharmaceuticals 20 participants Est. completion 2027-04-14 23 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT06250205

    Evaluate the Pharmacokinetics of a Combined Oral Contraceptive (COC) With and Without Obicetrapib

    Not yet reported NewAmsterdam Pharma 30 participants Est. completion 2024-04-26 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT06253195

    BGB-43395 Alone or as Part of Combination Therapies in Chinese Participants With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors

    Not yet reported BeOne Medicines 33 participants Est. completion 2026-04-23 7 sites
    Other conditions: Advanced Solid Tumor, Metastatic Solid Tumor, Hormone-receptor-positive Breast Cancer, Breast Cancer, Metastatic Breast Cancer, Hormone Receptor Positive Malignant Neoplasm of Breast, HER2-negative Breast Cancer
    View official trial listing →
  • Completed NCT NCT06253702

    Brain Blood Flow Responses to Stress: Sex Differences

    Not yet reported University of Wisconsin, Madison 22 participants Est. completion 2025-05-31 1 site
    Other conditions: Cerebrovascular Disorders
    View official trial listing →
  • Active, not recruiting NCT NCT06257264

    A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors

    Not yet reported BeiGene 103 participants Est. completion 2026-08-31 24 sites
    Other conditions: Breast Cancer, Small Cell Lung Cancer, Ovarian Cancer, Gastric Cancer, Hormone-receptor-positive Breast Cancer, Hormone Receptor Positive HER-2 Negative Breast Cancer, Advanced Solid Tumor, Endometrial Cancer, Prostate Cancer, TNBC - Triple-Negative Breast Cancer, GastroEsophageal Cancer, Bladder Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT06271551

    Transdermal Estradiol and Exercise in Mitigating Adverse Effects of Androgen Deprivation Therapy for Prostate Cancer Radiation Therapy

    Not yet reported Central Finland Hospital District 310 participants Est. completion 2029-12 Stand-alone
    Other conditions: Prostate Cancer
    View official trial listing →
  • Withdrawn NCT NCT06279195

    Phenotyping of Idiopathic Pelvic Pain With Real-time Uterine Imaging and Relugolix-Combination Therapy Treatment

    Not yet reported Endeavor Health Est. completion 2025-11-02 1 site
    Other conditions: Pelvic Pain
    View official trial listing →
  • Not yet recruiting NCT NCT06306404

    Sleeping Through Menopause

    Not yet reported VU University of Amsterdam 222 participants Est. completion 2030-01-01 Stand-alone
    Other conditions: Menopause, Insomnia
    View official trial listing →
  • Completed NCT NCT06308614

    Estetrol for the Treatment of Female Sexual Arousal Disorder in Postmenopausal Women

    Not yet reported Estetra 82 participants Est. completion 2025-04-21 24 sites
    Other conditions: Sexual Dysfunction, Physiological
    View official trial listing →
  • Completed NCT NCT06310616

    A Study to Investigate the Potential Drug-Drug Interaction Between VH4524184 and Oral Contraceptive (Loestrin) in Healthy Adult Female Participants

    Not yet reported ViiV Healthcare 26 participants Est. completion 2024-08-15 1 site
    Other conditions: HIV Infections
    View official trial listing →
  • Completed NCT NCT06312033

    Estradiol's Effect on Brain Volume and Connectivity

    Not yet reported International Research Training Group 2804 32 participants Est. completion 2021-12-31 1 site Stand-alone
    Other conditions: Emotion Regulation, Estradiol
    View official trial listing →
  • Completed NCT NCT06316180

    The Use of Drospirenone/Estetrol in Random Start Rapid Endometrial Preparation

    Not yet reported University of Palermo 80 participants Est. completion 2024-03-01 2 sites
    Other conditions: Endometrial Polyp, Endometrial Diseases
    View official trial listing →
  • Completed NCT NCT06316206

    The Use of Ethinylestradiol/Dienogest in Random Start Rapid Endometrial Preparation

    Not yet reported University of Palermo 80 participants Est. completion 2024-03-01 2 sites
    Other conditions: Endometrial Polyp, Endometrial Diseases
    View official trial listing →
  • Completed NCT NCT06316219

    The Use of Nomegestrol Acetate/Estradiol in Random Start Rapid Endometrial Preparation

    Not yet reported University of Palermo 80 participants Est. completion 2024-03-01 2 sites
    Other conditions: Endometrial Polyp, Endometrial Diseases
    View official trial listing →
  • Not yet recruiting NCT NCT06318403

    Estradiol Supplementation and Rotator Cuff Repair

    Not yet reported University of Utah 58 participants Est. completion 2030-12 Stand-alone
    Other conditions: Rotator Cuff Tears, Rotator Cuff Injuries, Rotator Cuff Syndrome, Menopause Related Conditions, Menopause
    View official trial listing →
  • Completed NCT NCT06324851

    The Use of Drospirenone/Estetrol, Nomegestrol Acetate/Estradiol and Ethinylestradiol/Dienogest in Random Start Rapid Endometrial Preparation

    Not yet reported University of Palermo 150 participants Est. completion 2024-03-01 2 sites
    Other conditions: Endometrial Polyp, Endometrial Diseases
    View official trial listing →
  • Status unknown NCT NCT06341283

    A Retrospective Real-world Study of Abemaciclib in HR+ Breast Cancer

    The Affiliated Hospital of Qingdao University 200 participants Est. completion 2025-07-01 1 site
    Other conditions: Breast Cancer, Neoplasms, Breast Diseases
    View official trial listing →
  • Completed NCT NCT06344767

    Positive ER Expression Assessed by 18F-FES PET/CT in the MBC with ER-negative Primary Tumor

    Fudan University 19 participants Est. completion 2024-05-05 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT06346457

    Breast Cancer & Antiestrogenic Therapy & Brain

    International Research Training Group 2804 180 participants Est. completion 2026-04-01 1 site
    Other conditions: Breast Cancer Female, Healthy Female, Menopause, Anti-estrogenic Therapy
    View official trial listing →
  • Active, not recruiting NCT NCT06353269

    Adherence to Vaginal Estrogen Therapy in Hypoestrogenic Women With Recurrent Urinary Tract Infections

    Not yet reported University of California, Irvine 111 participants Est. completion 2027-09 1 site Stand-alone
    Other conditions: Recurrent Urinary Tract Infection, Hypoestrogenism
    View official trial listing →
  • Completed NCT NCT06354257

    A Study to Investigate the Pharmacokinetics of a Combined Oral Contraceptive When Given Alone and in Combination With GSK3036656 in Female Participants of Non-childbearing Potential Aged 18 to 65 Years of Age

    Not yet reported GlaxoSmithKline 20 participants Est. completion 2024-07-01 1 site
    Other conditions: Tuberculosis
    View official trial listing →
  • Status unknown NCT NCT06358014

    Assessment of the Improvement in Cognitive Levels of Postmenopausal Depression Patients by Estrogen

    Not yet reported Xiao Wang 40 participants Est. completion 2024-12-30 1 site Stand-alone
    Other conditions: Postmenopausal Depression, Estrogen
    View official trial listing →
  • Completed NCT NCT06363812

    Probability of OncotypeDx to Reallocate As Low or High Risk of Recurrence Breast Cancer Patients with Uncertain Biology

    Fondazione Sandro Pitigliani 258 participants Est. completion 2024-12-31 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT06369363

    Estrogen Deficiency on Cardiovascular Risk

    Not yet reported Milton S. Hershey Medical Center 20 participants Est. completion 2028-11
    Cardiovascular disease Other conditions: Postmenopausal Symptoms
    View official trial listing →
  • Status unknown NCT NCT06370221

    The Effect of Psoriatic Arthritis on Female Sexual Dysfunction

    Egymedicalpedia 180 participants Est. completion 2024-12-30 1 site
    Other conditions: Psoriatic Arthritis
    View official trial listing →
  • Completed NCT NCT06375707

    First-Line Ribociclib Plus Endocrine Therapy Versus Chemotherapy With or Without Subsequent Endocrine Therapy in Patients With Rapidly Progressive HR-Positive/HER2-Negative Advanced Breast Cancer

    Not yet reported The First Affiliated Hospital with Nanjing Medical University 74 participants Est. completion 2026-05-30 1 site
    Other conditions: Advanced Breast Cancer
    View official trial listing →
  • Completed NCT NCT06380205

    A Study to Evaluate the Drug Interaction Between Povorcitinib and the Oral Contraceptive Levonorgestrel/Ethinyl Estradiol in Healthy Adult Females

    Not yet reported Incyte Corporation 24 participants Est. completion 2024-06-07 1 site
    Other conditions: Healthy Participants
    View official trial listing →
  • Completed NCT NCT06396208

    "Quick-starting" of a Quadriphasic Contraceptive Pills, 1 - 3 mg Estradiol Valerate/ 2 - 3 mg Dienogest VS 20 mcg Ethinylestradiol/75 mcg Gestodene Focusing on Ovulation Inhibition

    Not yet reported Chulalongkorn University 40 participants Est. completion 2024-10-20 1 site Stand-alone
    Other conditions: Ultrasound Finding: Ovulation Inhibition, Ovarian Activities, Cervical Mucus, Serum Hormonal Profile
    View official trial listing →
  • Completed NCT NCT06396221

    "Quick-starting" of a New Combined Hormonal Contraceptive Pills, 15 mg Estetrol/3 mg Drospirenone VS 20 mcg Ethinylestradiol/75 mcg Gestodene Focusing on Ovulation Inhibition

    Not yet reported Chulalongkorn University 36 participants Est. completion 2024-09-30 1 site
    Other conditions: Ultrasound Finding: Ovulation Inhibition, Ovarian Activities, Cervical Mucus, Serum Hormonal Profile
    View official trial listing →
  • Status unknown NCT NCT06405243

    Myoinositol, L-arginine and Chromium With Letrozole for Ovulation Induction in Polycystic Ovarian Syndrome Patients

    Not yet reported Beni-Suef University 100 participants Est. completion 2024-12-31 2 sites Stand-alone
    Other conditions: Polycystic Ovary Syndrome
    View official trial listing →
  • Terminated NCT NCT06408168

    Phase II Study of REPotrectinib With or Without Fulvestrant in Patients With Hormone Receptor-positive Human Epidermal Growth Factor 2-negative Metastatic Invasive LObular Carcinoma Who Received a Prior Endocrine Therapy in Combination With Cyclin-dependent Kinase 4 and 6 Inhibitor (REPLOT Trial)

    Not yet reported M.D. Anderson Cancer Center 6 participants Est. completion 2025-12-08 1 site
    Other conditions: Hormone Receptor-positive Human Epidermal Growth Factor 2-negative, Metastatic Invasive LObular Carcinoma
    View official trial listing →
  • Terminated NCT NCT06419855

    Study to Evaluate the Effectivity and Safety of BIOSCAFF®H Compared to DuraGen®, in Patients Undergoing Dural Repair

    Top Health S.A.P.I DE C.V. 2 participants Est. completion 2025-02-18 4 sites
    Other conditions: Cerebrospinal Fluid Leakage
    View official trial listing →
  • Completed NCT NCT06425978

    Efficacy of the Use of Cellular Matrix/ A-CP-HA Kit

    Not yet reported Fundación Santiago Dexeus Font 192 participants Est. completion 2026-03-23 1 site
    Other conditions: Genitourinary Syndrome of Menopause
    View official trial listing →
  • Completed NCT NCT06426771

    Effect of Antimullerian Hormone Levels on the Inflammatory Index, Phytochemical Index and NRF Nutrient Density

    Etlik Zubeyde Hanım Women's Health Care, Training and Research Hospital 90 participants Est. completion 2024-11-10 1 site
    Other conditions: AMH, Diet Habit, Ovarian Failure, Polycystic Ovary Syndrome
    View official trial listing →
  • Active, not recruiting NCT NCT06428396

    Study of Belzutifan (MK-6482) Plus Fulvestrant for ER+/HER2- Metastatic Breast Cancer (MK-6482-029/LITESPARK-029)

    Not yet reported Merck Sharp & Dohme LLC 120 participants Est. completion 2028-12-25 41 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT06440967

    A Study to Confirm if Fezolinetant Helps Reduce Hot Flashes in Women With Breast Cancer Who Are Having Hormone Therapy

    Not yet reported Astellas Pharma Global Development, Inc. 982 participants Est. completion 2028-04-30 110 sites
    Other conditions: Hot Flashes
    View official trial listing →
  • Active, not recruiting NCT NCT06447623

    Apatinib Combined With cdk4/6i in First-line Treatment for HR+/HER2- SNF4 Subtype Breast Cancer

    Not yet reported Fudan University 184 participants Est. completion 2029-02-01 1 site
    Other conditions: Advanced Breast Cancer, HR+/HER2- Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT06454084

    Investigation of Endothelium-dependent Vasodilation in Human Gingiva

    Not yet reported Semmelweis University 80 participants Est. completion 2025-12-31 1 site
    Other conditions: Vasodilation, Oral Soft Tissue Conditions
    View official trial listing →
  • Completed NCT NCT06461039

    A Research Study Looking at How the Compound NNC0487-0111 Works With Birth Control Pills and Affects Emptying of the Stomach in Women Not Able to Become Pregnant

    Not yet reported Novo Nordisk A/S 43 participants Est. completion 2025-04-04 1 site
    Other conditions: Obesity
    View official trial listing →
  • Status unknown NCT NCT06467942

    Effects of Chinese Medicine and Lactobacillus in Persistent HPV Infection

    Not yet reported Peking University People's Hospital 240 participants Est. completion 2024-12-31 1 site
    Other conditions: Human Papilloma Virus Infection
    View official trial listing →
  • Status unknown NCT NCT06474988

    Characterization of Biophysical and Mechanical Parameters on Skin of Breast Cancer Patients

    European Institute of Oncology 150 participants Est. completion 2025-05-31 1 site
    Other conditions: Breast Cancer, Estrogen Receptor Positive Tumor
    View official trial listing →
  • Not yet recruiting NCT NCT06480682

    Relative Energy Deficiency in Sport and Dance

    University of Wolverhampton 200 participants Est. completion 2029-07-30 1 site
    Other conditions: Relative Energy Deficiency in Sport, Bone Stress Reaction
    View official trial listing →
  • Active, not recruiting NCT NCT06494150

    Nab-Sirolimus and Endocrine Therapy in Recurrent Low Grade Serous Ovarian Cancer (NARETO)

    Not yet reported University of Oklahoma 37 participants Est. completion 2029-09 1 site
    Other conditions: Low Grade Ovarian Serous Adenocarcinoma
    View official trial listing →
  • Active, not recruiting NCT NCT06495164

    A Real-life Study to Understand the Use and Effects of Palbociclib in US Patients With Breast Cancer

    Pfizer 1 participants Est. completion 2026-12-30 1 site
    Other conditions: Breast Cancer, Malignant Neoplasm of Breast
    View official trial listing →
  • Active, not recruiting NCT NCT06497270

    A 3D Bioprinted Hormone-producing Model for BRCA Mutated Patients After Risk Reducing Surgery: the DISC-OVARY Trial

    Not yet reported Fondazione Policlinico Universitario Agostino Gemelli IRCCS 3 participants Est. completion 2027-06-01 1 site
    Other conditions: BRCA Mutation, Estrogen Deficiency, Surgical Menopause, Menopause Related Conditions, Menopause, Premature, Ovarian Cancer
    View official trial listing →
  • Completed NCT NCT06504953

    Evaluation of Anterior Tibial Knee Translation in Healthy Women With and Without Hormone Therapy

    Not yet reported Centre Hospitalier Universitaire de Nice 72 participants Est. completion 2026-06-17 1 site Stand-alone
    Other conditions: Women, Tibial Translation, Hormone
    View official trial listing →
  • Active, not recruiting NCT NCT06506955

    Futibatinib in Patients Previously Enrolled in an Antecedent Futibatinib as Monotherapy or Combination Therapy.

    Not yet reported, Not yet reported Taiho Oncology, Inc. 15 participants Est. completion 2027-04-30 9 sites
    Other conditions: Advanced/Metastatic Cancer
    View official trial listing →
  • Completed NCT NCT06508944

    Efficacy of Vaginal 17β-Estradiol on the Urinary Storage Symptoms in Postmenopausal Women

    Not yet reported Mahidol University 86 participants Est. completion 2024-10-31 1 site
    Other conditions: Lower Urinary Tract Symptoms, Female Genitourinary Disease, Urinary Stress Incontinence, Urinary Urge Incontinence, Nocturia, Quality of Life, Voiding Disorders, Vagina Atrophy, Urethral Atrophy, Overactive Bladder, Overactive Bladder Syndrome, Bladder, Overactive
    View official trial listing →
  • Completed NCT NCT06525675

    Study to Evaluate the Extended Overall Survival (OS) Data From PARSIFAL Study (The PARSIFAL-LONG Study)

    MedSIR 419 participants Est. completion 2024-09-02 36 sites
    Other conditions: Metastatic Breast Cancer, Advanced Breast Cancer, Luminal Breast Cancer, HER2-negative Breast Cancer, ER-positive Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT06531668

    A Clinical Trial to Examine the Efficacy of a Supplement to Support Hormone Regulation in Women

    Not yet reported Scale Media Inc 50 participants Est. completion 2024-09-07 1 site
    Other conditions: Hormone Regulation
    View official trial listing →
  • Status unknown NCT NCT06546397

    Study on the Effect of Combined Estrogen and Progestogen Therapy on Endometrial Repair After Induced Abortion

    Not yet reported Women's Hospital School Of Medicine Zhejiang University 200 participants Est. completion 2025-12-31 1 site
    Other conditions: Pregnancy Complications
    View official trial listing →
  • Completed NCT NCT06547164

    A Study to Investigate the Pharmacokinetics of Midazolam After Repeated Doses of Camizestrant (AZD9833) and to Investigate the Pharmacokinetics of Camizestrant When Administered Alone and in Combination With Carbamazepine in Healthy Post-Menopausal Female Participants

    Not yet reported AstraZeneca 40 participants Est. completion 2025-08-20 1 site
    Other conditions: Healthy Participants
    View official trial listing →
  • Status unknown NCT NCT06561022

    Precision Treatment of HR+ HER2- Advanced Breast Cancer Based on SNF Molecular Subtyping

    Not yet reported Fudan University 260 participants Est. completion 2026-06-30 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT06577181

    Effect of HCG on Endometrial Preparation in Frozen Embryo Transfer

    Assiut University 50 participants Est. completion 2026-05-10 1 site
    Other conditions: IVF
    View official trial listing →
  • Status unknown NCT NCT06577974

    Role of Medical Treatment in Endometriosis Patients Undergoing ICSI

    Not yet reported Cairo University 129 participants Est. completion 2025-03-01 2 sites
    Other conditions: Endometriosis
    View official trial listing →
  • Active, not recruiting NCT NCT06577987

    Safety/Efficacy Study of CID-078 in Patients With Advanced Solid Tumor Malignancies

    Not yet reported Circle Pharma 220 participants Est. completion 2027-03-14 10 sites
    Other conditions: Advanced Solid Tumor, Metastatic Solid Tumor, Refractory Solid Tumor, Cancer, Lung Cancer, Triple Negative Breast Cancer, Breast Neoplasms, Neuroendocrine Tumors, Neuroendocrine Carcinoma, RB1 Gene Mutation
    View official trial listing →
  • Status unknown NCT NCT06580535

    Effect of Esterogen Receptor Modulator on Gene in Bipolar Diseas

    Assiut University 100 participants Est. completion 2025-12
    Other conditions: Bipolar Disorder
    View official trial listing →
  • Active, not recruiting NCT NCT06590857

    Trial of 225Ac-DOTATATE (RYZ101) in Subjects With ER+, HER2-negative Unresectable or Metastatic Breast Cancer Expressing SSTRs.

    Not yet reported, Not yet reported RayzeBio, Inc. 16 participants Est. completion 2033-11 31 sites
    Other conditions: Metastatic Breast Cancer, HER2-negative Breast Cancer, ER+ Breast Cancer, Advanced Breast Cancer, Metastatic Breast Cancer With Bone Involvement, Bone Metastases in Subjects With Advanced Breast Cancer, ER-Positive HER2-Negative Breast Cancer, Estrogen Receptor-positive Breast Cancer, Hormone-sensitive Metastatic Breast Cancer, Hormone-Sensitive Breast Cancer
    View official trial listing →
  • Completed NCT NCT06608186

    Can Drospirenone be Used to Prevent LH Surge in Controlled Ovarian Stimulation in PCOS?!

    Not yet reported, Not yet reported Ahmed Saad 50 participants Est. completion 2025-01-19 1 site
    Other conditions: PCOS (Polycystic Ovary Syndrome)
    View official trial listing →
  • Withdrawn NCT NCT06613516

    Effect of Capivasertib on ctDNA in ER Positive Breast Cancer

    Not yet reported Imperial College London Est. completion 2025-09-16 1 site
    Other conditions: Breast Cancer, Oestrogen Receptor Positive Breast Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT06623903

    Early Changes in Metabolic Health in Breast Cancer Patients Initiating Endocrine Therapy

    Aarhus University Hospital 112 participants Est. completion 2025-07-31 1 site
    Other conditions: Early Breast Cancer, Metabolic Health, Estrogen Receptor Positive Breast Cancer
    View official trial listing →
  • Enrolling by invitation NCT NCT06629233

    Evaluation of a Novel Technique for the Discovery of New, Tumor-specific Targets for the Deployment of Innovative Immunotherapeutics Against Cancer.

    Not yet reported University Ghent 36 participants Est. completion 2025-12-31 2 sites
    Other conditions: Estrogen Receptor Positive Breast Cancer
    View official trial listing →
  • Completed NCT NCT06633705

    Changes in Neighbouring Microbiota in Genitourinary Syndrome

    Not yet reported Koc University Hospital 31 participants Est. completion 2024-07-10 1 site
    Other conditions: Genitourinary Syndrome of Menopause
    View official trial listing →
  • Active, not recruiting NCT NCT06635447

    Capivasertib+Fulvestrant asTreatment for Locally Advanced(Inoperable) or Metastatic HR+/HER2- Breast Cancer in Chinese Patients

    Not yet reported AstraZeneca 293 participants Est. completion 2027-01-10 76 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT06637189

    Protocol with Progestin-primed Ovarian Stimulation (PPOS) from the Beginning of Stimulation Versus Protocol with GnRH Antagonists for Ovarian Stimulation in Patients Undergoing DUOSTIM with Embryo Accumulation for PGT-A.

    Not yet reported Ginefiv 144 participants Est. completion 2025-12-31 Stand-alone
    Other conditions: Stimulation in the Ovary, Embryo, Oocyte, Oocyte Retrieval, Fertilization in Vitro, Blastocyst, PGT-A
    View official trial listing →
  • Completed NCT NCT06654570

    Effects of Vaginal Estrogen on Serum Estradiol During Aromatase Inhibitor Therapy in Breast Cancer Patients with Vulvovaginal Atrophy: a Prospective Trial

    Not yet reported Helsinki University Central Hospital 20 participants Est. completion 2024-10-10 1 site Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT06657105

    A Study to Investigate the Pharmacokinetics of Ethinyl Estradiol and Levonorgestrel When Given Alone and in Combination With Baxdrostat in Healthy Females of Non-childbearing Potential

    Not yet reported AstraZeneca 22 participants Est. completion 2025-02-03 1 site
    Other conditions: Healthy Participants
    View official trial listing →
  • Completed NCT NCT06671405

    An Open-label Study in Healthy Participants to Evaluate AZD0780 as an Object or Precipitant of CYP3A4-mediated Drug-drug Interactions

    Not yet reported AstraZeneca 59 participants Est. completion 2025-02-17 1 site
    Other conditions: Dyslipidaemia
    View official trial listing →
  • Active, not recruiting NCT NCT06680921

    A Study of SIM0270 Combined With Everolimus vs. Treatment of Physician's Choice in Patients With ER+/HER2- Advanced Breast Cancer (SIMRISE)

    Not yet reported Jiangsu Simcere Pharmaceutical Co., Ltd. 482 participants Est. completion 2028-08-31 57 sites
    Other conditions: Locally Advanced or Metastatic Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT06691035

    Immunologic Targeting of ESR1 Receptor for Hormone Receptor Expressing Metastatic Breast Cancer

    Not yet reported H. Lee Moffitt Cancer Center and Research Institute 18 participants Est. completion 2027-11 1 site Stand-alone
    Other conditions: Breast Cancer Metastatic Breast Cancer, HER2-negative Breast Cancer
    View official trial listing →
  • Enrolling by invitation NCT NCT06691815

    Triptorelin for Early Diagnosis of Hypogonadotrophic Hypogonadism

    Not yet reported Hospital de Niños R. Gutierrez de Buenos Aires 48 participants Est. completion 2026-09 1 site
    Other conditions: Pubertal Delay, Hypogonadism, Hypogonadotropic, Constitutional Delay in Growth and Puberty (CDGP)
    View official trial listing →
  • Completed NCT NCT06695039

    Diagnostic Performance of [18F]FES PET/CT for Axillary LN Metastasis in ER-positive Breast Cancer

    Not yet reported Asan Medical Center 71 participants Est. completion 2025-10-02 1 site
    Other conditions: Breast Cancer Invasive
    View official trial listing →
  • Active, not recruiting NCT NCT06702618

    Evaluation of TQB3616 Capsules in a Phase II Clinical Trial for Recurrent/Metastatic Breast Cancer

    Not yet reported Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 33 participants Est. completion 2026-12 13 sites Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT06706414

    NT-NOA - Novel Treatment of Some Men With Non-Obstructive Azoospermia

    Not yet reported, Not yet reported Martin Blomberg Jensen 16 participants Est. completion 2026-08 1 site
    Other conditions: Infertility, Male
    View official trial listing →
  • Active, not recruiting NCT NCT06715514

    Menopausal Hormone Therapy, GLP-1 Agonists, and Glucose and Energy Homeostasis in Postmenopausal Women With Diabetes

    Not yet reported Lia Bally 96 participants Est. completion 2026-12-31 1 site
    Type 2 diabetes Other conditions: Menopause
    View official trial listing →
  • Active, not recruiting NCT NCT06760637

    Study of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Breast Cancer Who Have Not Received Anticancer Treatment for Advanced/Metastatic Disease

    Not yet reported Pfizer 1035 participants Est. completion 2037-12-29 463 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT06764186

    A Phase IIIB Study to Evaluate the Use of Capivasertib in Combination With Fulvestrant in Patients With Advanced Breast Cancer Who Have Relapsed/Progressed on ET and CDK4/6 Inhibitor Reflecting Real World Clinical Practice in Spain

    Not yet reported AstraZeneca 101 participants Est. completion 2027-12-31 17 sites
    Other conditions: Locally Advanced or Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT06773429

    Estradiol and Brain Age

    International Research Training Group 2804 32 participants Est. completion 2019-07-31 1 site
    Other conditions: Estradiol (E2) Vs. Placebo (PLAC), Estradiol
    View official trial listing →
  • Completed NCT NCT06778733

    Effectiveness of Low Dose Gonadotropin Stimulation Protocol Vs High Dose Gonadotropin Protocol in Poor Responders

    Not yet reported University of Athens 22 participants Est. completion 2024-04-30 2 sites
    Other conditions: Female Infertility
    View official trial listing →
  • Completed NCT NCT06783192

    A Drug-Drug Interaction Study of MK 8527 With a Combined Oral Contraceptive (LNG/EE)

    Not yet reported Merck Sharp & Dohme LLC 14 participants Est. completion 2023-10-11 1 site
    Other conditions: Human Immunodeficiency Virus (HIV), HIV Pre-Exposure Prophylaxis
    View official trial listing →
  • Completed NCT NCT06799884

    A Drug-drug Interaction Trial in Healthy Female Participants to Investigate the Effect of Aprocitentan on Combined Hormonal Contraceptives

    Not yet reported Idorsia Pharmaceuticals Ltd. 19 participants Est. completion 2025-02-21 1 site
    Other conditions: Drug Drug Interaction
    View official trial listing →
  • Completed NCT NCT06800690

    Impact of Menstrual Phase on Oral Glucose Sensitivity

    Rutgers, The State University of New Jersey 22 participants Est. completion 2024-12-10 1 site
    Other conditions: Ovulation, Menstruation
    View official trial listing →
  • Completed NCT NCT06802211

    CBG Normalization After Discontinuation of COC's

    Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 24 participants Est. completion 2025-11-18 1 site
    Other conditions: Combined Oral Contraceptive Cessation
    View official trial listing →
  • Active, not recruiting NCT NCT06805084

    Transcripts with Retained H/ACA Box SnoRNA Sequences As Biomarkers for Estrogen Dependence in Lum-B Breast Carcinomas

    IRCCS Azienda Ospedaliero-Universitaria di Bologna 80 participants Est. completion 2031-12 1 site
    Other conditions: Breast Adenocarcinoma, Luminal B Breast Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT06806072

    BALNEOTHERAPY FOR BREAST CANCER PATIENTS UNDERGOING ENDOCRINE THERAPY

    Not yet reported Parc de Salut Mar 96 participants Est. completion 2027-05-31 1 site Stand-alone
    Other conditions: Breast Cancer Early Stage Breast Cancer (Stage 1-3)
    View official trial listing →
  • Not yet recruiting NCT NCT06808347

    Difference in Serum Estrogen Level Based on Methods of Vaginal Estrogen Application (fingertip Vs Applicator Use) in Post-menopausal Women

    Not yet reported Walter Reed National Military Medical Center 110 participants Est. completion 2025-09-30
    Other conditions: Postmenopausal Atrophic Vaginitis, Genitourinary Syndrome of Menopause
    View official trial listing →
  • Withdrawn NCT NCT06810765

    Trifecta Research Study

    Not yet reported Johns Hopkins University Est. completion 2027-12 1 site Stand-alone
    Other conditions: PTSD - Post Traumatic Stress Disorder, Cognitive Dysfunction, Brain Trauma, Brain Injuries
    View official trial listing →
  • Completed NCT NCT06816355

    Exogenous Sex Hormones and PONV

    Riverside University Health System Medical Center 7348 participants Est. completion 2025-02-04 1 site
    Other conditions: Postoperative Nausea and Vomiting, Sex Hormone, Transgender
    View official trial listing →
  • Completed NCT NCT06820307

    Evaluation of the Effect of Suzetrigine (SUZ) on the Pharmacokinetics of Oral Contraceptives in Healthy Female Participants

    Not yet reported Vertex Pharmaceuticals Incorporated 50 participants Est. completion 2025-04-29 1 site
    Other conditions: Pain
    View official trial listing →
  • Completed NCT NCT06830486

    Effects of Activity on Diabetes Risk Among Breast Cancer Survivors on Endocrine Therapy (ABIDE)

    University of Colorado, Denver 40 participants Est. completion 2023-10-31 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Enrolling by invitation NCT NCT06847386

    Effect of Hysteroscopic Metroplasty on Reproductive Outcome in Patients with RIF

    Not yet reported Shanghai First Maternity and Infant Hospital 200 participants Est. completion 2025-06-30 1 site Stand-alone
    Other conditions: Recurrent Implantation Failure, T-Shaped Uterus
    View official trial listing →
  • Terminated NCT NCT06851442

    Clinical Trial of Evaluating TQB3912 Tablets Combined With Fulvestrant Injection±TQB3616 Capsules for Locally Advanced or Metastatic Hormone Receptor(HR)-Positive and Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Breast Cancer

    Not yet reported, Not yet reported Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 8 participants Est. completion 2025-11-20 17 sites Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT06879002

    Comparing IVF/ICSI Cycle Outcomes of Post Ovulation Ovarian Stimulation Protocol With Elonva Without GnRH Antagonist to Follicular Phase Day 2 Stimulation Fixed Day 5 Antagonist Protocol

    ART Fertility Clinics LLC 252 participants Est. completion 2027-12-30 2 sites
    Other conditions: Stimulation in the Ovary, IVF Outcome
    View official trial listing →
  • Not yet recruiting NCT NCT06882499

    Stereotactic Ablative Body Radiotherapy (SABR) With Maintenance of Systemic Therapy Versus Physicians' Choice of Systemic Therapy for Oligoprogressive ER-positive, Her-2 Negative Breast Cancer II

    Not yet reported Peter MacCallum Cancer Centre, Australia 74 participants Est. completion 2032-11-01
    Other conditions: Breast Cancer, Metastatic, Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT06908941

    The Cardiovascular Benefits of Resistance Training and Dark Chocolate in Female Adults

    Not yet reported National Cheng Kung University 31 participants Est. completion 2024-07-31 1 site
    Other conditions: Vascular Function in Healthy Volunteers
    View official trial listing →
  • Not yet recruiting NCT NCT06913075

    FET in Adenomyosis

    Not yet reported Indira IVF Hospital Pvt Ltd 700 participants Est. completion 2026-12-23 1 site
    Other conditions: Adenomyosis
    View official trial listing →
  • Completed NCT NCT06924229

    Corneal Changes in Estrogen-Dependent Breast Cancer After Hormonal Treatment

    Not yet reported Sohag University 40 participants Est. completion 2025-01-01 1 site
    Other conditions: Braest Cancer, Dry Eye
    View official trial listing →
  • Not yet recruiting NCT NCT06929325

    Sirolimus for Injection (Albumin-bound) Combined With Fulvestrant for HR+/HER2- Advanced/Metastatic Breast Cancer Patients Previously Treated With CDK4/6 Inhibitors

    Not yet reported CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 312 participants Est. completion 2027-12 1 site
    Other conditions: HR+/HER2- Advanced/Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT06929416

    Estrogen and Propofol Injection Pain

    Konya City Hospital 90 participants Est. completion 2025-09-10 1 site
    Other conditions: Pain, Estradiol, Assisted Reproductive Techniques
    View official trial listing →
  • Withdrawn NCT NCT06938711

    A Rollover Protocol of Elacestrant, in Combination With Onapristone, for Patients With ER+, PR+, HER2- Advanced or Metastatic Breast Cancer

    Not yet reported, Not yet reported Context Therapeutics Inc. Est. completion 2023-12 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT06941142

    A Study of Sirolimus (Albumin-Bound) in Combination With Palbociclib and Fulvestrant for the Treatment of Advanced Breast Cancer

    Not yet reported CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 382 participants Est. completion 2028-06
    Other conditions: Advanced Breast Cancer
    View official trial listing →
  • Completed NCT NCT06942936

    A Study to Investigate the Impact of Multiple Doses of Itraconazole on AZD5004 in Healthy Participants and Multiple Doses of AZD5004 on Combined Oral Ethinyl Oestradiol and Levonorgestrel in Healthy Female Participants

    Not yet reported AstraZeneca 51 participants Est. completion 2026-01-28 2 sites
    Other conditions: Healthy Participants
    View official trial listing →
  • Active, not recruiting NCT NCT06957379

    Sirolimus for Injection (Albumin-bound) in Combination With Endocrine Therapy for HR+/HER2- Advanced/Metastatic Breast Cancer Patients Who Have Failed Standard Therapy

    Not yet reported CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 78 participants Est. completion 2025-12 1 site
    Other conditions: HR+/HER2- Advanced/Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT06958965

    Resistance Exercise Training on Vascular and Physical Function in Postmenopausal Women

    Not yet reported National Yang Ming Chiao Tung University 32 participants Est. completion 2025-11-03 1 site
    Other conditions: Postmenopausal Women
    View official trial listing →
  • Active, not recruiting NCT NCT06963840

    Effect of Theronomic Ova-All Care on Biomarkers of Ovarian Health in Adult Female With Polycystic Ovarian Syndrome

    Not yet reported Wellizen Australia 16 participants Est. completion 2025-08 1 site
    Other conditions: Polycystic Ovarian Syndrome (PCOS)
    View official trial listing →
  • Withdrawn NCT NCT06978478

    An Imaging Study in ER Negative Breast Cancer by Targeting αvβ6

    Not yet reported Queen Mary University of London Est. completion 2020-07-27 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT06996093

    Chemotherapy Omission in HR-positive/HER2-negative Breast Cancer With Lymph Node Negative Disease Receiving Adjuvant Endocrine Therapy and CDK4/6 Inhibitor

    Not yet reported Fudan University 2508 participants Est. completion 2034-06-01 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT07003373

    Comparison of Two Protocols in Frozen Embryo Transfer

    Not yet reported Malihe Mahmoudinia 112 participants Est. completion 2026-07-05 Stand-alone
    Other conditions: IVF Outcomes
    View official trial listing →
  • Completed NCT NCT07007416

    Impact of Supraphysiological Estradiol on ECG in IVF Patients

    Konya City Hospital 62 participants Est. completion 2025-01-31 1 site
    Other conditions: In Vitro Fertilization, Estradiol, Cardiac Electrophysiology, Electrocardiography (ECG), Reproductive Endocrinology
    View official trial listing →
  • Not yet recruiting NCT NCT07020429

    Efficacy and Safety of Huanjingjian Decoction in Women With Premature Ovarian Insufficiency

    Not yet reported Shanghai Pulmonary Hospital, Shanghai, China 276 participants Est. completion 2030-07-30 1 site Stand-alone
    Other conditions: Premature Ovarian Insufficiency
    View official trial listing →
  • Not yet recruiting NCT NCT07021664

    Health, Imaging, and Cognition Across the Menopausal Transition

    Université de Sherbrooke 45 participants Est. completion 2026-07-01 1 site
    Other conditions: Menopause
    View official trial listing →
  • Completed NCT NCT07027332

    Liver Stiffness And Steatosis Assessment In Women With Polycystic Ovary Syndrome Using Fibroscan

    Bezmialem Vakif University 36 participants Est. completion 2025-03-08 1 site
    Other conditions: Polycystic Ovary Syndrome, Non-Alcoholic Fatty Liver Disease
    View official trial listing →
  • Withdrawn NCT NCT07038070

    Via, a Hyaluronic Acid (HLA) Based Vaginal Moisturizer Study

    Not yet reported NYU Langone Health Est. completion 2026-05-01 1 site Stand-alone
    Other conditions: Genitourinary Syndrome of Menopause (GSM)
    View official trial listing →
  • Active, not recruiting NCT NCT07038369

    A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations

    Not yet reported Atavistik Bio, Inc 134 participants Est. completion 2029-01-31 8 sites
    Other conditions: Advanced Solid Tumors, Breast Cancer, Breast Carcinoma, Breast Neoplasms, ER Positive Breast Cancer, Cervical Cancers, Cervical Neoplasms, Cervical Carcinoma, Triple Negative Breast Cancer, Gynecologic Cancers, Gynecologic Neoplasm, Endometrial Cancer, Endometrial Neoplasm, Endometrial Carcinoma (EC), Fallopian Cancer, Ovarian Carcinoma, Ovarian Cancer, Ovarian Neoplasms, Prostate Cancers, Prostate Carcinoma, Solid Tumors, Neoplasms, Neoplasms by Site, Breast Diseases, Uterine Neoplasms, Genital Neoplasms, Female, Urogenital Neoplasms
    View official trial listing →
  • Not yet recruiting NCT NCT07041814

    A Study Comparing Different Treatment Approaches for the Initiation of Puberty in Girls With Turner Syndrome Using a TRIFECTA-DARED Approach for Rare Diseases

    Not yet reported Universiti Kebangsaan Malaysia Medical Centre 24 participants Est. completion 2029-10-31 1 site
    Other conditions: Turner Syndrome
    View official trial listing →
  • Not yet recruiting NCT NCT07060391

    A Prospective Multicenter RCT Study of Deep Jugular Lymphovenous Anastomosis in the Treatment of Alzheimer's Disease

    Not yet reported Shanghai Jiao Tong University School of Medicine 186 participants Est. completion 2027-01-31
    Other conditions: Alzheimer's Disease
    View official trial listing →
  • Completed NCT NCT07074327

    Effects of VX-407 on the Pharmacokinetics of Oral Contraceptives in Healthy Participants

    Not yet reported Vertex Pharmaceuticals Incorporated 74 participants Est. completion 2026-02-27 1 site
    Other conditions: Autosomal Dominant Polycystic Kidney Disease (ADPKD)
    View official trial listing →
  • Not yet recruiting NCT NCT07078435

    Innate Immunity, MIcrobiota and Inovative Treatments in Endometriosis

    Not yet reported University Hospital, Grenoble 40 participants Est. completion 2027-09-30 1 site
    Other conditions: Endometriosis, Immunity, Microbiota
    View official trial listing →
  • Completed NCT NCT07096024

    A Study to Understand About the Study Medicine Palbociclib in Breast Cancer Patients After it is Out in the Japanese Market

    Pfizer 95637 participants Est. completion 2025-02-07 1 site
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Completed NCT NCT07103603

    MHT and Liver Function in Postmenopausal Women

    Not yet reported Ipek B. Ozcivit Erkan, MD 44 participants Est. completion 2025-12-30 1 site
    Other conditions: Menopause, Non Alcholic Fatty Liver Disease, Hepatic Steatosis
    View official trial listing →
  • Completed NCT NCT07157930

    Prenatal Hormonal Markers and Sleep Characteristics in Young Adults With Joint Hypermobility

    Nigde Omer Halisdemir University 180 participants Est. completion 2025-12-17 1 site
    Other conditions: Joint Hypermobility, Healty Controls, Sleep, Androgen Effect, Hormonal
    View official trial listing →
  • Not yet recruiting NCT NCT07163481

    A Trial to Evaluate Sacituzumab Govitecan in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Metastatic Breast Cancer Progressed on CDK4/6 Inhibitors

    Not yet reported Hunan Cancer Hospital 12 participants Est. completion 2026-12 1 site Stand-alone
    Other conditions: Stage IV (Metastatic) Breast Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT07173556

    A Phase Ib/II Study of QLC1401 Combined With CDK4/6 or mTOR Inhibitors in ER+/HER2- Advanced Breast Cancer

    Not yet reported, Not yet reported Qilu Pharmaceutical Co., Ltd. 96 participants Est. completion 2028-10
    Other conditions: Advanced Breast Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT07176143

    hBMSC Uterine Artery Infusion for Severe IUA-Related Infertility

    Not yet reported Sixth Affiliated Hospital, Sun Yat-sen University 60 participants Est. completion 2028-12-30 Stand-alone
    Other conditions: Intrauterine Adhesions
    View official trial listing →
  • Not yet recruiting NCT NCT07179939

    Maintenance Therapy in HER2-Positive Unresectable Locally Recurrent or Metastatic Breast Cancer: A Phase II Study

    Not yet reported Fudan University 288 participants Est. completion 2031-12-30 1 site
    Other conditions: HER2-positive Breast Cancer
    View official trial listing →
  • Completed NCT NCT07181343

    A Drug-Drug Interaction Study Between HS-10374 Tablets and Drospirenone and Ethinyl Estradiol Tablets(Yasmin®)

    Not yet reported Hansoh BioMedical R&D Company 18 participants Est. completion 2025-08-19 1 site
    Other conditions: Psoriasis (PsO)
    View official trial listing →
  • Completed NCT NCT07190430

    A Study to Learn If the Study Medicine Called PF-08049820 Changes How the Body Processes the Other Study Medicines Called Oral Contraceptives, Midazolam, and Dabigatran in Healthy Adult Female Participants

    Not yet reported Pfizer 16 participants Est. completion 2025-12-15 1 site
    Other conditions: Atopic Dermatitis
    View official trial listing →
  • Not yet recruiting NCT NCT07201259

    Exploring Gut Microbiome Differences in Female Cancer Patients With Varied Ovarian Function and Fertility Outcomes Following Immune Checkpoint Inhibitor Therapy

    West China Second University Hospital 40 participants Est. completion 2026-10-10 1 site
    Other conditions: Malignant Tumors
    View official trial listing →
  • Active, not recruiting NCT NCT07204093

    Ultra-Safe Hormonal Strategy: Transdermal Estradiol Added to Progestins for Endometriosis

    Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico 138 participants Est. completion 2026-02 1 site
    Other conditions: Endometriosis
    View official trial listing →
  • Not yet recruiting NCT NCT07212712

    The Role of Estrogen and Testosterone in Determining Brain Blood Flow and Metabolic Regulation in Humans

    Not yet reported University of British Columbia 50 participants Est. completion 2027-12-31 1 site Stand-alone
    Other conditions: Cerebral Blood Flow, Cerebral Blood Flow Regulation, Sex Differences, Exercise, Vascular
    View official trial listing →
  • Terminated NCT NCT07214662

    A Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-0587 as a Monotherapy and in Combination With Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer

    Not yet reported Genentech, Inc. 3 participants Est. completion 2026-06-24 4 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT07215806

    Effect of Evobrutinib on Pharmacokinetics of a Combined Oral Contraceptive

    Not yet reported Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany 20 participants Est. completion 2022-11-25 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT07229209

    Oral Contraceptive Pills Versus Levonorgestrel-Releasing Intrauterine System for Niche-Related Abnormal Uterine Bleeding

    Not yet reported Benha University 166 participants Est. completion 2025-11-01 1 site
    Other conditions: Abnormal Uterine Bleeding, Cesarean Section Complications, Uterine Scar
    View official trial listing →
  • Not yet recruiting NCT NCT07235618

    A Study of Entinostat in Combination With Fulvestrant for the Treatment of Locally Advanced or Metastatic Breast Cancer

    Not yet reported Sun Yat-sen University 50 participants Est. completion 2028-12-30 1 site
    Other conditions: Locally Advanced or Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT07235774

    A Drug-drug Interaction Study of Vorasidenib and a Combined Oral Contraceptive in Healthy Female Participants

    Not yet reported Institut de Recherches Internationales Servier (I.R.I.S.) 28 participants Est. completion 2026-03-13 1 site
    Other conditions: Healthy Adult Female Participants
    View official trial listing →
  • Not yet recruiting NCT NCT07245316

    Avoiding Surgery in Estrogen Receptor Positive Atypical Ductal Hyperplasia and In-situ Carcinoma Treated With Endocrine Treatment Trial

    Not yet reported Jeong Eon Lee 340 participants Est. completion 2032-12-31 1 site
    Other conditions: Ductal Carcinoma in Situ of the Breast
    View official trial listing →
  • Not yet recruiting NCT NCT07260825

    Use of Topical Testosterone and Estrogen vs Estrogen Alone in Vulvodynia: a Randomized Controlled Trial

    Not yet reported, Not yet reported TriHealth Inc. 44 participants Est. completion 2026-08 2 sites
    Other conditions: Vulvodynia, Dyspareunia, Lichen Sclerosus of Vulva
    View official trial listing →
  • Completed NCT NCT07269327

    An Ethno-bridging Study of Pergoveris in Healthy Premenopausal Participants of Japanese or Caucasian Origin

    Not yet reported Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany 24 participants Est. completion 2026-03-09 1 site
    Other conditions: Fertility
    View official trial listing →
  • Completed NCT NCT07272889

    Drug-drug Interaction Study of Bemnifosbuvir/Ruzasvir (BEM/RZR) and Ethinyl Estradiol/Levonorgestrel (EE/LNG)

    Not yet reported Atea Pharmaceuticals, Inc. 24 participants Est. completion 2026-02-17 1 site
    Other conditions: Healthy Volunteer Study
    View official trial listing →
  • Enrolling by invitation NCT NCT07275463

    [99mTc]Tc-DB8 Accumulation in Primary Tumor in Breast Cancer With Positive and Negative Estrogen Receptor Expression

    Not yet reported Tomsk National Research Medical Center of the Russian Academy of Sciences 40 participants Est. completion 2026-12-31 1 site Stand-alone
    Other conditions: Primary Breast Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT07317895

    Sensitivity to Ovarian Hormones and Depression in Adolescents

    University of Calgary 94 participants Est. completion 2027-08-31 1 site
    Other conditions: Depressed
    View official trial listing →
  • Completed NCT NCT07318337

    Effect of Drospirenone-Ethinyl Estradiol (20microgram vs 30 Microgram) on Free Androgen Index in PCOS

    Not yet reported Mst.Sumyara Khatun 60 participants Est. completion 2025-06-30 1 site
    Other conditions: PCOS (Polycystic Ovary Syndrome)
    View official trial listing →
  • Not yet recruiting NCT NCT07328789

    Factors Influencing Cardiac Rehabilitation Success

    Pomeranian Medical University Szczecin 150 participants Est. completion 2029-07-01
    Other conditions: Rehabilitation
    View official trial listing →
  • Not yet recruiting NCT NCT07333937

    Neratinib Combined With Fulvestrant and Eribulin in the Treatment ofHR+/HER2+ Advanced Breast Cancer

    Not yet reported Xijing Hospital 35 participants Est. completion 2028-11-20
    Other conditions: Brest Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT07340619

    Clinical Trial Evaluating the Biological Activity of a New Drug Identified as Prifetrastat (PF-07248144), Combined With Fulvestrant for the Treatment of Patients With Hormone Receptor Positive (HR+) and HER2 Negative (HER2-) Breast Cancer Extended to Other Organs.

    Not yet reported UNICANCER 51 participants Est. completion 2029-11-18 8 sites
    Other conditions: Metastatic (Stage IV) Melanoma
    View official trial listing →
  • Completed NCT NCT07346287

    ASSIST-VLA: Assessment of Symptom-Specific Improvement in Diagnosed Vaginal Atrophy Following Laser Therapy

    Not yet reported Stratpharma AG 11 participants Est. completion 2026-02-19 1 site Stand-alone
    Other conditions: Vaginal Atrophy, Atrophic Vaginitis, Genitourinary Syndrome of Menopause (GSM)
    View official trial listing →
  • Not yet recruiting NCT NCT07366632

    A Study of Single Dose of BL0175 in Postmenopausal Women

    Not yet reported Shanghai Best-Link Bioscience, LLC 27 participants Est. completion 2026-12-21 Stand-alone
    Other conditions: Postmenopausal Women
    View official trial listing →
  • Not yet recruiting NCT NCT07378241

    Effects of Patients' Hormone Levels on Sedoanalgesia

    Izmir City Hospital 100 participants Est. completion 2026-04-30
    Other conditions: Consumption of Anaesthetic Agents, Sedoanalgesia
    View official trial listing →
  • Completed NCT NCT07379502

    Endometrial Response in Polyendocrine Metabolic Ovarian Syndrome (PMOS) Treated With Letrozole Alone or With Added Estradiol Valerate

    Not yet reported CMH Kharian Medical College 60 participants Est. completion 2026-08-31 1 site Stand-alone
    Other conditions: Polyendocrine Metabolic Ovarian Syndrome (PMOS)
    View official trial listing →
  • Not yet recruiting NCT NCT07381569

    To Study the Safety and Efficacy of A Novel Intrauterine Estrogen-Releasing System in Induced Abortion

    Not yet reported Peking Union Medical College Hospital 200 participants Est. completion 2026-08-31 1 site
    Other conditions: Abortion, Induced
    View official trial listing →
  • Completed NCT NCT07388511

    A Study of Elenestinib in Healthy Adult Female Participants

    Not yet reported Blueprint Medicines Corporation 20 participants Est. completion 2026-04-02 1 site
    Other conditions: Healthy Participants
    View official trial listing →
  • Not yet recruiting NCT NCT07393321

    A Phase III Clinical Trial of NTQ1062 in Combination With Fulvestrant for the Treatment of Advanced or Metastatic HR+/HER2- Breast Cancer

    Not yet reported Nanjing Chia-tai Tianqing Pharmaceutical 210 participants Est. completion 2031-08-31
    Other conditions: HR Positive/HER2 Negative Advanced or Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT07398924

    Vaginal Estradiol and Oral Guaifenesin in Clomiphene Ovulation Induction

    Not yet reported Yuzuncu Yil University 90 participants Est. completion 2023-06-23 1 site
    Other conditions: Female Infertility, Anovulatory Infertility, Unexplained Infertility
    View official trial listing →
  • Terminated NCT NCT07408089

    Study of the Kinesin Oral Molecular Degrader BBI-940 in Subjects With Advanced or Metastatic Breast Cancer

    Not yet reported Boundless Bio, Inc. 8 participants Est. completion 2026-07-28 8 sites Stand-alone
    Other conditions: Breast Cancer, Metastatic Breast Cancer, Advanced Breast Cancer
    View official trial listing →
  • Completed NCT NCT07414784

    A Study of ABBV-295 Subcutaneous Injections to Assess Pharmacokinetics and Adverse Events in Healthy Adult Women Participants With Overweight or Obesity Taking Oral Contraceptives

    Not yet reported AbbVie 20 participants Est. completion 2026-08-04 2 sites
    Other conditions: Healthy Volunteer
    View official trial listing →
  • Active, not recruiting NCT NCT07416578

    Clinical Study on the Effect of Umbilical Cord Mesenchymal Stem Cell Exosomes on Endometrial Repair of Intrauterine Adhesions

    Not yet reported Sixth Affiliated Hospital, Sun Yat-sen University 60 participants Est. completion 2026-12-31 1 site Stand-alone
    Other conditions: Intrauterine Adhesions, Exosomes
    View official trial listing →
  • Not yet recruiting NCT NCT07420218

    Menopausal Hormones and Sympathetic Activation

    Not yet reported University of Delaware 80 participants Est. completion 2030-12-31 Stand-alone
    Other conditions: Perimenopausal Women
    View official trial listing →
  • Not yet recruiting NCT NCT07423611

    ctDNA-Guided Chemotherapy Omission With Ribociclib Plus Endocrine Therapy in HR-Positive/HER2-Negative Breast Cancer

    Not yet reported Fudan University 388 participants Est. completion 2030-12-31 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT07450300

    Assessment of the Feasibility of Frozen Embryo Transfers in a Natural Cycle Among Obese Compared to Non-Obese Patients

    Clinique Mathilde 1831 participants Est. completion 2026-01-31 1 site
    Other conditions: Infertility, Female
    View official trial listing →
  • Not yet recruiting NCT NCT07455773

    Experimental Study on the Use of Intrauterine Infusion of Autologous Platelet-rich Plasma (PRGF-IUI) in Patients With Recurrent Implantation Failure and/or Refractory Thin Endometrium

    Not yet reported Azienda Sanitaria Locale di Asti 80 participants Est. completion 2027-12 Stand-alone
    Other conditions: Recurrent Implantation Failure, Endometrial Receptivity Disorders, Embryo Implantation, Platelet-Rich Plasma, Platelet-rich Plasma (PRP), Infertility, Female
    View official trial listing →
  • Not yet recruiting NCT NCT07462663

    SHAPE-ENDO: Pilot Randomized Trial of Multimodal Pre-Surgical Optimization Versus Standard Surgery in Patients With Obesity and Early-Stage Endometrial Cancer

    Not yet reported Hospital Universitari de Bellvitge 80 participants Est. completion 2035-01
    Other conditions: Endometrial Cancer, Endometrial Cancer Stage I, Atypical Endometrial Hyperplasia and Endometrial Carcinoma Stage I, Atypical Endometrial Hyperplasia, Endometrial Intraepithelial Neoplasia, Obesity & Overweight, BMI>40, Obesity, Obesity Grade III
    View official trial listing →
  • Not yet recruiting NCT NCT07466498

    Estrogen to Improve Quality of Life for Men With Newly Diagnosed or Recurrent Metastatic Hormone Sensitive Prostate Cancer, EQUIP Trial

    Not yet reported Fred Hutchinson Cancer Center 60 participants Est. completion 2029-06-01 1 site Stand-alone
    Other conditions: Castration-Sensitive Prostate Adenocarcinoma, Metastatic Castration-Sensitive Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8
    View official trial listing →
  • Not yet recruiting NCT NCT07480681

    Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of HLX97 (a KAT6A/B Inhibitor) in Patients With Advanced/Metastatic Solid Tumor

    Not yet reported Shanghai Henlius Biotech 138 participants Est. completion 2028-06
    Other conditions: Advanced/Metastatic Solid Tumors
    View official trial listing →
  • Not yet recruiting NCT NCT07496294

    Comparison of Oral Dydrogesterone and Vaginal Progesterone in Menopausal Hormone Therapy

    Not yet reported Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital 200 participants Est. completion 2027-10 1 site Stand-alone
    Other conditions: Menopausal Women, Menopausal Symptom Relief, Hormone Therapy, Menopausal Hormone Therapy
    View official trial listing →
  • Not yet recruiting NCT NCT07499999

    Randomized Double-Blind Phase II Trial of Baby Exemestane Versus Baby Tamoxifen in Post-Menopausal Women at High Risk for Breast Cancer

    Not yet reported Dana-Farber Cancer Institute 140 participants Est. completion 2028-08-31 2 sites Stand-alone
    Other conditions: Breast Cancer, Ductal Carcinoma, Estrogen-receptor-positive Breast Cancer, Atypical Lobular Hyperplasia, BRCA2 Mutation, CHEK2 Gene Mutation, Ataxia Telangiectasia Mutated Gene Mutation
    View official trial listing →
  • Completed NCT NCT07502417

    A Phase 1 Study to Assess the Effect of ABBV-722 on Ethinyl Estradiol and Levonorgestrel Drug Levels in Healthy Adult Female Participants

    Not yet reported AbbVie 15 participants Est. completion 2026-07-02 1 site
    Other conditions: Healthy Volunteer
    View official trial listing →
  • Completed NCT NCT07509411

    Anti-TNFα Therapy for Improving Pregnancy Rates in Endometriosis Patients With Failed ICSI

    Not yet reported Benha University 145 participants Est. completion 2026-08-07 1 site
    Other conditions: Endometriosis
    View official trial listing →
  • Completed NCT NCT07513480

    Pretreatment With CPA-EE, Metformin and Myoinositol in PCOS With High AMH

    Not yet reported Mst.Sumyara Khatun 68 participants Est. completion 2026-02-20 1 site
    Other conditions: PCOS
    View official trial listing →
  • Active, not recruiting NCT NCT07523711

    Effect of Maridebart Cafraglutide on How Oral Contraceptives Are Absorbed and Processed in the Body in Postmenopausal Female Participants Living With Overweight or Obesity

    Not yet reported Amgen 49 participants Est. completion 2026-11-18 2 sites
    Other conditions: Overweight, Obesity
    View official trial listing →
  • Active, not recruiting NCT NCT07525791

    A Research Study Looking Into How NNC0662-0419 Works With Birth Control Pills and Emptying of the Stomach in Women Not Able to Become Pregnant With Excess Body Weight

    Not yet reported Novo Nordisk A/S 41 participants Est. completion 2027-06-18 1 site
    Other conditions: Overweight, Obesity
    View official trial listing →
  • Completed NCT NCT07526207

    Estradiol 8 vs 12 mg for Endometrial Preparation in HRT-FET

    Not yet reported Cairo University 850 participants Est. completion 2026-02-26 2 sites
    Other conditions: Infertility (IVF Patients), Infertility Assisted Reproductive Technology, Frozen Embryo Transfer (FET), Endometrial Preparation, Clinical Pregnancy Rates
    View official trial listing →
  • Not yet recruiting NCT NCT07526948

    Vaginal Estradiol vs Moisturizer to Improve Postmenopausal Vaginal Aging Symptoms and the Microbiome in Women Living With HIV

    Not yet reported Albert Einstein College of Medicine 62 participants Est. completion 2029-10-14 1 site
    Other conditions: Menopausal Complaints, Vaginal Atrophy, Genitourinary Symptoms, HIV (Human Immunodeficiency Virus), Menopause Related Conditions, Vaginitis, Perimenopause
    View official trial listing →
  • Not yet recruiting NCT NCT07527806

    Optimization of Dynamic Neoadjuvant Therapy Strategies for HER2-Positive Breast Cancer Based on HER2-PET/CT Molecular Imaging

    Not yet reported Peking University Cancer Hospital & Institute 156 participants Est. completion 2029-12-31
    Other conditions: Breast Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT07535905

    Clinical Trial to Observe the Effects of Tamoxifen on Testosterone Recovery in Medically Castrated Prostate Cancer Patients

    Not yet reported University Health Network, Toronto 96 participants Est. completion 2030-10 1 site Stand-alone
    Other conditions: Hypogonadism, Prostate Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT07542964

    Transgender Analysis of Nephrological Studies Focused on Renal Metrics

    Amsterdam UMC, location VUmc 60 participants Est. completion 2028-09 1 site
    Other conditions: Kidney Disease, Kidney Injury, Transgender Individuals
    View official trial listing →
  • Not yet recruiting NCT NCT07544966

    Teen Vulnerability to Irritability: Brain and Estrogen Changes

    Not yet reported University of North Carolina, Chapel Hill 50 participants Est. completion 2029-04 2 sites
    Other conditions: Depression - Major Depressive Disorder, Irritability
    View official trial listing →
  • Enrolling by invitation NCT NCT07568574

    Impact of Medically Supervised Performance-Enhancing Substances (PES) on Elite Athletes

    Not yet reported Enhanced Emirates Limited 60 participants Est. completion 2033-03-01 1 site
    Other conditions: Safety and Impact of Medically Supervised Performance Enhancing Substance Usage in Healthy Elite Athletes
    View official trial listing →
  • Withdrawn NCT NCT07570966

    Study of ERW316 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors

    Not yet reported, Not yet reported Novartis Pharmaceuticals Est. completion 2031-08-01
    Other conditions: Advanced HR+/HER2- Breast Cancer, Advanced CCNE1-amplified Solid Tumors, Metastatic Castration-resistant Prostate Cancer (mCRPC)
    View official trial listing →
  • Completed NCT NCT07581054

    Super-Resolution Ultrasound Microvascular Mapping for Non-Invasive Breast Cancer Molecular Subtyping: A Validated Nomogram

    Anhui Provincial Cancer Hospital 94 participants Est. completion 2026-01-26 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT07581288

    Measurement of Urinary Hormones in Patients With Abnormal Uterine Bleeding to Study Uterine Cancer Progression

    University of British Columbia 50 participants Est. completion 2026-09 1 site
    Other conditions: Uterine Bleeding, Uterine Cancer, Uterine Neoplasms, Endometrial Cancer, Endometrial Hyperplasia, Endometrial Intraepithelial Neoplasia, Menstrual Cycle, Reproductive Endocrinology
    View official trial listing →
  • Not yet recruiting NCT NCT07596212

    BRE-06: Study to Increase Tolerance to Aromatase Inhibitors for Patients With Early-Stage Hormone Receptor Positive Breast Cancer Who Developed Hypoactive Sexual Desire Disorder

    Not yet reported, Not yet reported University of Illinois at Chicago 100 participants Est. completion 2031-09 1 site
    Other conditions: Early-stage Breast Cancer, Hypoactive Sexual Desire Disorder, Hormone Receptor Positive Breast Carcinoma, Breast Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT07618039

    MOving Forward With MENopause Treatment Through Pharmacists' Expanded Roles in Hormone Health

    Dalhousie University 200 participants Est. completion 2027-12-31
    Other conditions: Menopause, Pharmacists
    View official trial listing →
  • Not yet recruiting NCT NCT07618390

    A Phase ll, Interventional, Single-arm Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib and Fulvestrant in Chinese Patients With PIK3CA-mutant, HR-positive, HER2-negative Locally Advanced or Metastatic Breast Cancer.

    Not yet reported Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 160 participants Est. completion 2028-12
    Other conditions: Breast Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT07618923

    Neoadjuvant Dalpiciclib + AI → SHR-A1811 for HR+/HER2-Low Breast Cancer

    Not yet reported Tang-Du Hospital 20 participants Est. completion 2029-01
    Other conditions: Breast Cancer, HR Positive/HER2 Low Breast Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT07619066

    A Phase II Study of Zongertinib Plus Fulvestrant in Participants With HR-positive/HER2-negative Advanced Breast Cancer Harboring HER2 Mutations.

    Not yet reported MedSIR 25 participants Est. completion 2028-11-28
    Other conditions: Advanced Breast Cancer, Hormone Receptor Positive / HER2-negative Breast Cancer, HER2 Mutation
    View official trial listing →
  • Not yet recruiting NCT NCT07624903

    Letrozole Versus Methotrexate for Management of Undisturbed Ectopic Pregnancy

    Not yet reported Kafrelsheikh University 70 participants Est. completion 2027-07 1 site
    Other conditions: Ectopic Pregnancy
    View official trial listing →
  • Not yet recruiting NCT NCT07634601

    Elacestrant With Everolimus for the Treatment of Recurrent Advanced or Metastatic ER-Positive Endometrial Cancer

    Not yet reported Jonsson Comprehensive Cancer Center 50 participants Est. completion 2029-12-18 1 site
    Other conditions: Advanced Endometrial Carcinoma, Metastatic Endometrial Carcinoma, Recurrent Endometrial Carcinoma, Stage III Endometrial Cancer, Stage IV Endometrial Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT07635017

    Assessing the Effects of Hormones on Noninvasive Transcranial Stimulation

    Not yet reported Carnegie Mellon University 25 participants Est. completion 2028-07-01 1 site Stand-alone
    Other conditions: Cortical Excitability, Healthy, TMS, Menstrual Cycle, Menopause
    View official trial listing →
  • Not yet recruiting NCT NCT07642700

    GnRH Agonist Pretreatment in Persistent Chronic Endometritis Undergoing FET

    Guoxia Yang 150 participants Est. completion 2028-06-01
    Other conditions: Chronic Endometritis
    View official trial listing →
  • Suspended NCT NCT07656792

    A Study in Japanese Healthy Men to Test How Well Different Doses of BI 3031185 Are Tolerated and a Study in Japanese Healthy Women to Test Whether BI 3031185 Influences the Amount of a Contraceptive in the Blood

    Not yet reported Boehringer Ingelheim 36 participants Est. completion 2026-11-26 1 site
    Other conditions: Healthy
    View official trial listing →
  • Not yet recruiting NCT NCT07657442

    Risk-Stratified Hypofractionated Radiotherapy After Breast-Conserving Surgery for Early Breast Cancer

    Not yet reported Cancer Institute and Hospital, Chinese Academy of Medical Sciences 649 participants Est. completion 2032-12-31 1 site
    Other conditions: Early Stage Breast Carcinoma, Breast Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT07658183

    A Clinical Trial Comparing the Efficacy and Safety of Different Doses of BL0175 Injection in Treating Postmenopausal Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Locally Advanced or Metastatic Breast Cancer

    Not yet reported Shanghai Best-Link Bioscience, LLC 120 participants Est. completion 2028-05-31 Stand-alone
    Other conditions: Breast Cancer (Locally Advanced or Metastatic)
    View official trial listing →
  • Not yet recruiting NCT NCT07676331

    Clinical Study of Local and Systemic Biological Impact of GLP1/GIP-Receptor Agonists in Patients With Breast Cancer: The CLARA Trial

    Not yet reported Universitaire Ziekenhuizen KU Leuven 168 participants Est. completion 2028-05-01
    Other conditions: Hormone-receptor-positive Breast Cancer, Early Breast Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT07679269

    Roll-Over Study of Alpelisib (BYL719) for Continued Access and Long-Term Safety.

    Not yet reported Novartis Pharmaceuticals 51 participants Est. completion 2032-04-20
    Other conditions: PIK3CA-Related Overgrowth Spectrum (PROS), Breast Neoplasms (Including Advanced or Metastatic Breast Cancer With PIK3CA Mutation)
    View official trial listing →
  • Not yet recruiting NCT NCT07714616

    Evaluation of the Contraceptive Efficacy and Safety of a New Concentration of an Antiandrogenic Progestogen Combined With a Reduced-Dose Estrogen (LUNA)

    Not yet reported Eurofarma Laboratorios S.A. 1600 participants Est. completion 2030-05-31
    Other conditions: Contraception
    View official trial listing →
  • Not yet recruiting NCT NCT07716046

    Fulvestaciclib Combined With Anti-HER2 and Endocrine Therapy for HR+/HER2+ Advanced Breast Cancer

    Not yet reported Fudan University 240 participants Est. completion 2032-12-31
    Other conditions: Breast Cancer, HER2-positive Breast Cancer, Hormone Receptor-positive Breast Cancer, HR+/HER2+ Breast Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT07724145

    Association Between Female Hormonal Profile and Wound Healing

    University Hospital, Geneva 84 participants Est. completion 2028-12 1 site
    Other conditions: Wound Healing, Wound Healing Complication, Estradiol
    View official trial listing →
  • Completed NCT NCT07727863

    Effect of Estradiol Pretreatment on Follicular Synchronization and IVF Outcomes in Women With Polycystic Ovary Syndrome Undergoing ICSI Using GnRH Antagonist Protocol

    Not yet reported Cairo University 61 participants Est. completion 2026-06-21 1 site
    Other conditions: PCOS GnRH Antagonist and GnRH Agonist IVF/ICSI Cycles, IVF Outcomes
    View official trial listing →
  • Not yet recruiting NCT NCT07729046

    Neu Direction: Testing the Efficacy of Adding HER Inhibition to Standard of Care in Metastatic MLH1-low Endocrine-resistant ER+/HER2- Breast Cancer

    Not yet reported University of California, San Diego 150 participants Est. completion 2035-06 1 site
    Other conditions: Metastatic Invasive Breast Cancer, Resistant Breast Cancer, ER+, HER2-, Metastatic Breast Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT07732452

    Hormone thERapy Effects on BRAin-HEART Health During the Menopausal Transition

    Not yet reported McGill University Health Centre/Research Institute of the McGill University Health Centre 100 participants Est. completion 2029-01
    Cardiovascular disease Other conditions: Menopause, Perimenopause, Vasomotor Symptoms, Menopausal Hormone Therapy, Cardiac Remodeling, Myocardial Fibrosis, Microvascular Dysfunction, Cognitive Function Assessment
    View official trial listing →
  • Not yet recruiting NCT NCT07736261

    Drospirenone-Primed Ovarian Stimulation Versus GnRH Antagonist Protocol in Poor Ovarian Responders Undergoing Freeze-All IVF/ICSI

    Not yet reported, Not yet reported Ahmed Saad 100 participants Est. completion 2027-11 1 site
    Other conditions: Poor Ovarian Reserve, Infertility (IVF Patients)
    View official trial listing →
  • Completed NCT NCT07739589

    A Postmarketing Open-Label Study to Assess Residual Levonorgestrel (LNG) and Ethinyl Estradiol (EE) Content of TWIRLA® (Levonorgestrel and Ethinyl Estradiol) Transdermal System

    Not yet reported Insud Pharma 28 participants Est. completion 2021-11-16 1 site
    Other conditions: Residual Drug Amount of EE and LNG
    View official trial listing →
  • Not yet recruiting NCT NCT07748208

    A Study Evaluating the Safety of Inavolisib and Fulvestrant With or Without Palbociclib in Participants With Advanced Breast Cancer (ABC) and Type 2 Diabetes

    Not yet reported Hoffmann-La Roche 40 participants Est. completion 2029-09-30
    Other conditions: Breast Cancer, Diabetes Type II
    View official trial listing →
  • Not yet recruiting NCT NCT07753954

    Medical Imaging to Re-evaluate Elacestrant Clinical Usage

    Not yet reported Jules Bordet Institute 160 participants Est. completion 2031-08-19
    Other conditions: ER+ / HER2- Advanced Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT07754630

    Analysis of the Hormonal Implant and Transdermal Estradiol Gel in Climacteric Women

    Not yet reported Nutrindo Ideais Research Center 50 participants Est. completion 2027-10-01 1 site
    Other conditions: Menopause, Hypoestrogenism, Hormonal Therapy
    View official trial listing →
  • Completed NCT NCT07763847

    Effect of Elagolix in Symptomatic Endometrioma in Comparison to Combined Oral Contraceptive Pill.

    Not yet reported Mst.Sumyara Khatun 60 participants Est. completion 2026-04-16 1 site
    Other conditions: Endometrioma
    View official trial listing →
  • Not yet recruiting NCT NCT07766369

    A Study to Assess Potential Drug-Drug Interactions of E2086 in Healthy Participants

    Not yet reported Eisai Inc. 93 participants Est. completion 2026-11-12 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Not yet recruiting NCT NCT07767474

    A Study to Evaluate ATX-898 in Participants With Advanced Solid Tumors

    Not yet reported, Not yet reported Antares Therapeutics, Inc 343 participants Est. completion 2030-01-31
    Other conditions: Advanced Solid Tumors
    View official trial listing →
  • Completed NCT NCT07770594

    Effect of Dienogest in Symptomatic Endometrioma in Comparison to Combined Oral Contraceptive Pill.

    Not yet reported Mst.Sumyara Khatun 60 participants Est. completion 2026-04-16 1 site
    Other conditions: Endometrioma
    View official trial listing →
  • Not yet recruiting NCT NCT07782840

    QL1706 Plus Neoadjuvant Endocrine Therapy in HR-Positive/HER2-Negative Breast Cancer With a Poor Response to Neoadjuvant Chemotherapy

    Not yet reported Hebei Medical University Fourth Hospital 40 participants Est. completion 2028-12-01
    Other conditions: Breast Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT07784036

    JYP0035 Capsules Plus Fulvestrant in PIK3CA-Mutant HR+/HER2- Advanced Breast Cancer

    Not yet reported Chengdu JOYO pharma Co., Ltd. 171 participants Est. completion 2029-06-30
    Other conditions: Breast Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT07784582

    Pre-pubertal Low Dose Transdermal Estradiol in Turner Syndrome

    Not yet reported Children's National Research Institute 15 participants Est. completion 2027-06 1 site
    Other conditions: Turner Syndrome, Primary Ovarian Insufficiency
    View official trial listing →
  • Not yet recruiting NCT NCT07787520

    A Study of LAE118 as Monotherapy and in Combination With Antitumor Agents in Advanced Solid Tumors

    Not yet reported Laekna Limited 150 participants Est. completion 2029-12 6 sites Stand-alone
    Other conditions: Patients With Advanced Solid Tumors
    View official trial listing →
  • Not yet recruiting NCT NCT07791173

    Evaluation of Temporomandibular Disorders During Pregnancy

    Zeynep Serra Kalkan 60 participants Est. completion 2027-05 1 site
    Other conditions: Temporomandibular Disorders (TMD), Pregnancy
    View official trial listing →
  • Not yet recruiting NCT NCT07791394

    Does Estrogen Blunt the Effects of Exercise Training on Glycemic Control

    Not yet reported University of Waterloo 24 participants Est. completion 2027-04 1 site Stand-alone
    Other conditions: To Determine Whether Estrogen Influences the Effects of Training on Glycemic Control and Insulin Sensitivity
    View official trial listing →
  • Not yet recruiting NCT NCT07795606

    An Observational Study to Learn How Mirena and Other Progestogen Treatments Are Used for Endometrial Protection in Women 40+ With a Uterus in the United States Receiving Estrogen Therapy, and Their Respective Health Outcomes

    Bayer 456000 participants Est. completion 2026-12-31 2 sites
    Other conditions: Estrogen Therapy
    View official trial listing →
  • Not yet recruiting NCT NCT07799246

    Brain and Blood Vessel Health Following Endometriosis Treatment in People With Endometriosis

    Not yet reported Colorado State University 45 participants Est. completion 2029-06-30
    Other conditions: Endometriosis, Endometriosis and Dysmenorrhea, Endometriosis (Diagnosis)
    View official trial listing →
  • Not yet recruiting NCT NCT07802626

    Adding Capivasertib to Standard Treatment in HR Positive, HER2 Negative Metastatic Breast Cancer Based on ctDNA Testing

    Not yet reported SWOG Cancer Research Network 1084 participants Est. completion 2035-10-30
    Other conditions: HR Positive/HER-2 Negative Breast Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT07805382

    Dynamic Relationships Between Estrogen Fluctuations, Sleep, and Psychiatric Complexity Among Adolescent Females With ADHD

    Duke University 30 participants Est. completion 2027-08 1 site
    Other conditions: ADHD
    View official trial listing →
  • Not yet recruiting NCT NCT07806968

    Effect of Postural Correction Exercises on Pelvic Floor Dysfunction in Postmenopausal Osteoporotic Women

    Not yet reported Cairo University 60 participants Est. completion 2027-03-31 1 site Stand-alone
    Other conditions: Osteoporosis, Postmenopausal
    View official trial listing →
  • Not yet recruiting NCT NCT07808060

    A Study of Eloralintide (LY3841136) in Female Participants With Obesity or Overweight

    Not yet reported Eli Lilly and Company 34 participants Est. completion 2027-06 2 sites
    Other conditions: Obesity, Overweight
    View official trial listing →
  • Not yet recruiting NCT NCT07811232

    A Study of AL58805 in Advanced, Metastatic GYN, STS or Breast Cancers

    Not yet reported, Not yet reported Advenchen Pharmaceuticals, LLC. 138 participants Est. completion 2031-09-01 1 site Stand-alone
    Other conditions: Endometrial Neoplasms, Soft Tissue Sarcoma (STS), Breast Neoplasms
    View official trial listing →
  • Not yet recruiting NCT NCT07818278

    Cycle-to-cycle Variability of Progesterone in the Endometrium in Patients Undergoing an Euploid Blastocyst Transfer in a Hormone Replacement Therapy (HRT) Cycle (PROMICOFET)

    Not yet reported University Hospital, Ghent 70 participants Est. completion 2029-08-31 1 site Stand-alone
    Other conditions: Fertility, Implantation, Embryo
    View official trial listing →
  • Active, not recruiting NCT NCT07821086

    Effects of Estrogen Therapy on Lipid Metabolism and Insulin Sensitivity in Hypogonadal Women

    Not yet reported Khyber Medical University Peshawar 30 participants Est. completion 2026-09-20 1 site Stand-alone
    Other conditions: Female Hypogonadism
    View official trial listing →
  • Not yet recruiting NCT NCT07827573

    A Study to Learn How Well Participants With a Specific Type of Early Breast Cancer (ER-Positive, HER2-Negative) Tolerate and Stay on Treatment With Giredestrant and How They Feel During Treatment

    Not yet reported Hoffmann-La Roche 1500 participants Est. completion 2032-11-30
    Other conditions: Early Breast Cancer, Estrogen Receptor-Positive Breast Cancer, HER2-Negative Breast Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT07833501

    Estradiol Levels According to Body Mass Index in Premenopausal Patients With Breast Cancer

    D'Or Institute for Research and Education 172 participants Est. completion 2027-05-30
    Other conditions: Hormone Receptor-Positive Breast Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT07840443

    Phase II Study of CAmizestrant in Resectable Endometrial Adenocarcinoma

    Not yet reported University Health Network, Toronto 30 participants Est. completion 2028-10-26 6 sites
    Other conditions: Estrogen Receptor-positive, Early Stage Endometrial Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT07851649

    A Study to Assess the Bioavailability and Adhesion of Estradiol/Levonorgestrel TDS in Healthy Post-Menopausal Female Participants

    Not yet reported Corium Innovations, Inc. 68 participants Est. completion 2026-09-26 1 site
    Other conditions: Healthy Female Participants, Postmenopause
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources

Also known as: Estrone, Estrogen, Arthcal ESTROGEN, BiEST 5.0 Estrogen Cream - 3.6oz, 3.6oz BiEST 2.5 Estrogen Cream, Bealions Estrogen, Estradiol Valerate

Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.